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The publication of these European Resuscitation Council (ERC)
uidelines for cardiopulmonary resuscitation (CPR) updates those
hatwere published in 2005 andmaintains the established5-yearly
ycle of guideline changes.1 Like the previous guidelines, these
010guidelines are basedon themost recent International Consen-
us on CPR Science with Treatment Recommendations (CoSTR),2
hich incorporated the results of systematic reviews of a wide
ange of topics relating to CPR. Resuscitation science continues to
dvance, andclinical guidelinesmustbeupdated regularly to reﬂect
hese developments and advise healthcare providers on best prac-
ice. In between the 5-yearly guideline updates, interim scientiﬁc
tatements can informthehealthcareprovider aboutnewtherapies
hat might inﬂuence outcome signiﬁcantly.3
This executive summary provides the essential treatment algo-
ithms for the resuscitation of children and adults and highlights
he main guideline changes since 2005. Detailed guidance is pro-
ided in each of the remaining nine sections, which are published
s individual papers within this issue of Resuscitation. The sections
f the 2010 guidelines are:
1. Executive summary;
2. Adult basic life support and use of automated externaldeﬁbrillators;4
3. Electrical therapies: automated external deﬁbrillators, deﬁbril-
lation, cardioversion and pacing;5
4. Adult advanced life support;6
∗ Corresponding author.
E-mail address: jerry.nolan@btinternet.com (J.P. Nolan).
1 Appendix A (the list of the writing group members).
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.0215. Initial management of acute coronary syndromes;7
6. Paediatric life support;8
7. Resuscitation of babies at birth;9
8. Cardiac arrest in special circumstances: electrolyte abnormali-
ties, poisoning, drowning, accidental hypothermia, hyperther-
mia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy,
electrocution;10
9. Principles of education in resuscitation;11
10. The ethics of resuscitation and end-of-life decisions.12
The guidelines that followdonot deﬁne the onlyway that resus-
citation can be delivered; they merely represent a widely accepted
view of how resuscitation should be undertaken both safely and
effectively. The publication of new and revised treatment recom-
mendationsdoesnot imply that current clinical care is eitherunsafe
or ineffective.
Summary of main changes since 2005 Guidelines
Basic life support
Changes in basic life support (BLS) since the 2005 guidelines
include:4,13
• Dispatchers should be trained to interrogate callers with strict
protocols to elicit information. This information should focus on
the recognition of unresponsiveness and the quality of breathing.
In combination with unresponsiveness, absence of breathing or
any abnormality of breathing should start a dispatch protocol for
suspected cardiac arrest. The importance of gasping as sign of
cardiac arrest is emphasised.
• All rescuers, trained or not, should provide chest compressions
to victims of cardiac arrest. A strong emphasis on delivering
evier Ireland Ltd. All rights reserved.
1 itation
•
E
d
e
•
•
•
•
•
•
•
A
S
•
•220 J.P. Nolan et al. / Resusc
high quality chest compressions remains essential. The aim
should be to push to a depth of at least 5 cm at a rate of at
least 100 compressionsmin−1, to allow full chest recoil, and to
minimise interruptions in chest compressions. Trained rescuers
should also provide ventilations with a compression–ventilation
(CV) ratio of 30:2. Telephone-guided chest compression-only CPR
is encouraged for untrained rescuers.
The use of prompt/feedback devices during CPR will enable
immediate feedback to rescuers and is encouraged. The data
stored in rescue equipment can be used to monitor and improve
the quality of CPR performance and provide feedback to profes-
sional rescuers during debrieﬁng sessions.
lectrical therapies: automated external deﬁbrillators,
eﬁbrillation, cardioversion and pacing5,14
The most important changes in the 2010 ERC Guidelines for
lectrical therapies include:
The importance of early, uninterrupted chest compressions is
emphasised throughout these guidelines.
Much greater emphasis on minimising the duration of the pre-
shock and post-shock pauses; the continuation of compressions
during charging of the deﬁbrillator is recommended.
Emphasis on resumption of chest compressions following deﬁb-
rillation; in combination with continuation of compressions
during deﬁbrillator charging, the delivery of deﬁbrillation should
be achievable with an interruption in chest compressions of no
more than 5 s.
The safety of the rescuer remains paramount, but there is recog-
nition in these guidelines that the risk of harm to a rescuer from
a deﬁbrillator is very small, particularly if the rescuer is wearing
gloves. The focus is now on a rapid safety check to minimise the
pre-shock pause.
When treating out-of-hospital cardiac arrest, emergencymedical
services (EMS) personnel should provide good-quality CPR while
a deﬁbrillator is retrieved, applied and charged, but routine deliv-
ery of a speciﬁed period of CPR (e.g., 2 or 3min) before rhythm
analysis and a shock is delivered is no longer recommended.
For some emergency medical services that have already fully
implemented a speciﬁed period of chest compressions before
deﬁbrillation, given the lack of convincing data either support-
ing or refuting this strategy, it is reasonable for them to continue
this practice.
The use of up to three-stacked shocks may be considered if
VF/VT occurs during cardiac catheterisation or in the early post-
operative period following cardiac surgery. This three-shock
strategy may also be considered for an initial, witnessed VF/VT
cardiac arrest when the patient is already connected to a manual
deﬁbrillator.
Encouragement of the further development of AED programmes
– there is a need for further deployment of AEDs in both public
and residential areas.
dult advanced life support
The most important changes in the 2010 ERC Advanced Life
upport (ALS) Guidelines include6,15:
Increased emphasis on the importance of minimally interrupted
high-quality chest compressions throughout any ALS interven-
tion: chest compressionsarepausedbrieﬂyonly toenable speciﬁc
interventions.
Increased emphasis on the use of ‘track-and-trigger systems’ to
detect the deteriorating patient and enable treatment to prevent
in-hospital cardiac arrest.81 (2010) 1219–1276
• Increased awareness of the warning signs associated with the
potential risk of sudden cardiac death out of hospital.
• Removal of the recommendation for a speciﬁed period of
cardiopulmonary resuscitation (CPR) before out-of-hospital
deﬁbrillation following cardiac arrest unwitnessed by EMS per-
sonnel.
• Continuation of chest compressions while a deﬁbrillator is
charged – this will minimise the pre-shock pause.
• The role of the precordial thump is de-emphasised.
• The use of up to three quick successive (stacked) shocks
for ventricular ﬁbrillation/pulseless ventricular tachycardia
(VF/VT) occurring in the cardiac catheterisation laboratory
or in the immediate post-operative period following cardiac
surgery.
• Delivery of drugs via a tracheal tube is no longer recommended –
if intravenous access cannot be achieved, drugs should be given
by the intraosseous (IO) route.
• When treating VF/VT cardiac arrest, adrenaline 1mg is given
after the third shock once chest compressions have restarted and
then every 3–5min (during alternate cycles of CPR). Amiodarone
300mg is also given after the third shock.
• Atropine is no longer recommended for routine use in asystole or
pulseless electrical activity (PEA).
• Reduced emphasis on early tracheal intubation unless achieved
by highly skilled individuals with minimal interruption to chest
compressions.
• Increased emphasis on the use of capnography to conﬁrm and
continually monitor tracheal tube placement, quality of CPR and
toprovide anearly indicationof returnof spontaneous circulation
(ROSC).
• Thepotential role of ultrasound imagingduringALS is recognised.
• Recognition of the potential harm caused by hyperoxaemia after
ROSC is achieved: once ROSC has been established and the oxy-
gen saturation of arterial blood (SaO2) can be monitored reliably
(by pulse oximetry and/or arterial blood gas analysis), inspired
oxygen is titrated to achieve a SaO2 of 94–98%.
• Much greater detail and emphasis on the treatment of the post-
cardiac arrest syndrome.
• Recognition that implementation of a comprehensive, structured
post-resuscitation treatment protocol may improve survival in
cardiac arrest victims after ROSC.
• Increased emphasis on the use of primary percutaneous coronary
intervention in appropriate (including comatose) patients with
sustained ROSC after cardiac arrest.
• Revision of the recommendation for glucose control: in adults
with sustained ROSC after cardiac arrest, blood glucose values
>10mmol l−1 (>180mgdl−1) should be treated but hypogly-
caemia must be avoided.
• Use of therapeutic hypothermia to include comatose survivors of
cardiac arrest associated initially with non-shockable rhythms as
well shockable rhythms. The lower level of evidence for use after
cardiac arrest from non-shockable rhythms is acknowledged.
• Recognition that many of the accepted predictors of poor out-
come in comatose survivors of cardiac arrest are unreliable,
especially if the patient has been treated with therapeutic
hypothermia.
Initial management of acute coronary syndromes
Changes in the management of acute coronary syndrome since
the 2005 guidelines include7,16:• The term non-ST elevation myocardial infarction-acute coronary
syndrome (NSTEMI-ACS) has been introduced for both NSTEMI
and unstable angina pectoris because the differential diagnosis
is dependent on biomarkers that may be detectable only after
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several hours, whereas decisions on treatment are dependent on
the clinical signs at presentation.
History, clinical examinations, biomarkers, ECG criteria and risk
scores are unreliable for the identiﬁcation of patients who may
be safely discharged early.
The role of chest pain observation units (CPUs) is to identify, by
using repeated clinical examinations, ECG and biomarker testing,
those patients who require admission for invasive procedures.
This may include provocative testing and, in selected patients,
imaging procedures such as cardiac computed tomography,mag-
netic resonance imaging, etc.
Non-steroidal anti-inﬂammatory drugs (NSAIDs) should be
avoided.
Nitrates should not be used for diagnostic purposes.
Supplementary oxygen is to be given only to those patients with
hypoxaemia, breathlessness or pulmonary congestion. Hyperox-
aemia may be harmful in uncomplicated infarction.
Guidelines for treatment with acetyl salicylic acid (ASA) have
been made more liberal: ASA may now be given by bystanders
with or without EMS dispatcher assistance.
Revised guidance for new anti-platelet and anti-thrombin treat-
ment forpatientswithSTelevationmyocardial infarction (STEMI)
and non-STEMI-ACS based on therapeutic strategy.
Gp IIb/IIIa inhibitors before angiography/percutaneous coronary
intervention (PCI) are discouraged.
The reperfusion strategy in STEMI has been updated:
◦ Primary PCI (PPCI) is the preferred reperfusion strategy pro-
vided it is performed in a timely manner by an experienced
team.
◦ A nearby hospital may be bypassed by the EMS provided PPCI
can be achieved without too much delay.
◦ The acceptable delay between start of ﬁbrinolysis and ﬁrst bal-
loon inﬂation varies widely between about 45 and 180min
depending on infarct localisation, age of the patient, and dura-
tion of symptoms.
◦ ‘Rescue PCI’ should be undertaken if ﬁbrinolysis fails.
◦ The strategy of routine PCI immediately after ﬁbrinolysis (‘facil-
itated PCI’) is discouraged.
◦ Patients with successful ﬁbrinolysis but not in a PCI-capable
hospital should be transferred for angiography and even-
tual PCI, performed optimally 6–24h after ﬁbrinolysis (the
‘pharmaco-invasive’ approach).
◦ Angiography and, if necessary, PCI may be reasonable in
patients with ROSC after cardiac arrest and may be part of a
standardised post-cardiac arrest protocol.
◦ To achieve these goals, the creation of networks including EMS,
non PCI capable hospitals and PCI hospitals is useful.
Recommendations for the use of beta-blockers are more
restricted: there is no evidence for routine intravenous beta-
blockers except in speciﬁc circumstances such as for the
treatment of tachyarrhythmias. Otherwise, beta-blockers should
be started in low doses only after the patient is stabilised.
Guidelines on the use of prophylactic anti-arrhythmics
angiotensin, converting enzyme (ACE) inhibitors/angiotensin
receptor blockers (ARBs) and statins are unchanged.
aediatric life support
Major changes in thesenewguidelines forpaediatric life support
nclude8,17:Recognition of cardiac arrest – Healthcare providers cannot reli-
ably determine the presence or absence of a pulse in less than
10 s in infants or children. Healthcare providers should look
for signs of life and if they are conﬁdent in the technique,81 (2010) 1219–1276 1221
they may add pulse palpation for diagnosing cardiac arrest
and decide whether they should begin chest compressions or
not. The decision to begin CPR must be taken in less than
10 s. According to the child’s age, carotid (children), brachial
(infants) or femoral pulse (children and infants) checks may be
used.
• The CV ratio used for children should be based on whether
one, or more than one rescuer is present. Lay rescuers, who
usually learn only single-rescuer techniques, should be taught
to use a ratio of 30 compressions to 2 ventilations, which is
the same as the adult guidelines and enables anyone trained
in BLS to resuscitate children with minimal additional infor-
mation. Rescuers with a duty to respond should learn and use
a 15:2 CV ratio; however, they can use the 30:2 ratio if they
are alone, particularly if they are not achieving an adequate
number of compressions. Ventilation remains a very impor-
tant component of CPR in asphyxial arrests. Rescuers who are
unable or unwilling to provide mouth-to-mouth ventilation
should be encouraged to perform at least compression-only
CPR.
• The emphasis is on achieving quality compressions of an ade-
quate depth with minimal interruptions to minimise no-ﬂow
time. Compress the chest to at least one third of the anterior-
posterior chest diameter in all children (i.e., approximately 4 cm
in infants and approximately 5 cm in children). Subsequent
complete release is emphasised. For both infants and children,
the compression rate should be at least 100 but not greater
than 120min−1. The compression technique for infants includes
two-ﬁnger compression for single rescuers and the two-thumb
encircling technique for two or more rescuers. For older children,
a one- or two-hand technique can be used, according to rescuer
preference.
• Automated external deﬁbrillators (AEDs) are safe and successful
when used in children older than 1 year of age. Purpose-
made paediatric pads or software attenuate the output of the
machine to 50–75 J and these are recommended for children
aged 1–8 years. If an attenuated shock or a manually adjustable
machine is not available, an unmodiﬁed adult AED may be used
in children older than 1 year. There are case reports of suc-
cessful use of AEDs in children aged less than 1 year; in the
rare case of a shockable rhythm occurring in a child less than
1 year, it is reasonable to use an AED (preferably with dose
attenuator).
• To reduce the no ﬂow time, when using a manual deﬁbrillator,
chest compressions are continued while applying and charg-
ing the paddles or self-adhesive pads (if the size of the child’s
chest allows this). Chest compressions are paused brieﬂy once
the deﬁbrillator is charged to deliver the shock. For simplicity and
consistencywithadultBLSandALSguidance, a single-shockstrat-
egy using a non-escalating dose of 4 J kg−1 (preferably biphasic,
but monophasic is acceptable) is recommended for deﬁbrillation
in children.
• Cuffed tracheal tubes can be used safely in infants and young chil-
dren. The size should be selected by applying a validated formula.
• The safety and value of using cricoid pressure during tracheal
intubation is not clear. Therefore, the application of cricoid pres-
sure should be modiﬁed or discontinued if it impedes ventilation
or the speed or ease of intubation.
• Monitoring exhaled carbon dioxide (CO2), ideally by capnog-
raphy, is helpful to conﬁrm correct tracheal tube position and
recommended during CPR to help assess and optimize its quality.
• Once spontaneous circulation is restored, inspired oxygen should
be titrated to limit the risk of hyperoxaemia.
• Implementation of a rapid response system in a paediatric in-
patient setting may reduce rates of cardiac and respiratory arrest
and in-hospital mortality.
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New topics in the 2010 guidelines include channelopathies and
several new special circumstances: trauma, single ventricle pre-
andpost-1st stage repair, post-Fontancirculation, andpulmonary
hypertension.
esuscitation of babies at birth
The following are the main changes that have been made to the
uidelines for resuscitation at birth in 20109,18:
For uncompromised babies, a delay in cord clamping of at least
1min from the complete delivery of the infant, is now recom-
mended. As yet there is insufﬁcient evidence to recommend an
appropriate time for clamping the cord inbabieswhoare severely
compromised at birth.
For term infants, air should be used for resuscitation at birth.
If, despite effective ventilation, oxygenation (ideally guided by
oximetry) remains unacceptable, use of a higher concentration
of oxygen should be considered.
Preterm babies less than 32 weeks gestation may not reach the
same transcutaneous oxygen saturations in air as those achieved
by termbabies. Therefore blended oxygen and air should be given
judiciously and its use guided by pulse oximetry. If a blend of
oxygen and air is not available use what is available.
Preterm babies of less than 28 weeks gestation should be com-
pletely covered up to their necks in a food-grade plastic wrap or
bag,without drying, immediately after birth. They should then be
nursed under a radiant heater and stabilised. They should remain
wrapped until their temperature has been checked after admis-
sion. For these infants delivery room temperatures should be at
least 26 ◦C.
The recommended CV ratio for CPR remains at 3:1 for newborn
resuscitation.
Attempts to aspirate meconium from the nose and mouth of
the unborn baby, while the head is still on the perineum, are
not recommended. If presented with a ﬂoppy, apnoeic baby
born through meconium it is reasonable to rapidly inspect the
oropharynx to remove potential obstructions. If appropriate
expertise is available, tracheal intubation and suction may be
useful. However, if attempted intubation is prolonged or unsuc-
cessful, start mask ventilation, particularly if there is persistent
bradycardia.
If adrenaline is given then the intravenous route is recommended
using a dose of 10–30gkg−1. If the tracheal route is used, it is
likely that a dose of at least 50–100gkg−1 will be needed to
achieve a similar effect to 10gkg−1 intravenously.
Detection of exhaled carbon dioxide in addition to clinical assess-
ment is recommended as the most reliable method to conﬁrm
placement of a tracheal tube in neonates with spontaneous cir-
culation.
Newly born infants born at term or near-term with evolving
moderate to severe hypoxic–ischaemic encephalopathy should,
where possible, be treated with therapeutic hypothermia. This
does not affect immediate resuscitation but is important for post-
resuscitation care.
rinciples of education in resuscitation
The key issues identiﬁed by the Education, Implementation and
eams (EIT) task force of the International Liaison Committee on
esuscitation (ILCOR) during the Guidelines 2010 evidence evalu-
tion process are11,19:
Educational interventions shouldbeevaluated toensure that they
reliably achieve the learning objectives. The aim is to ensure that
learners acquire and retain the skills and knowledge that will81 (2010) 1219–1276
enable them to act correctly in actual cardiac arrests and improve
patient outcomes.
• Short video/computer self-instruction courses, with minimal or
no instructor coaching, combined with hands-on practice can be
considered as an effective alternative to instructor-led basic life
support (CPR and AED) courses.
• Ideally all citizens should be trained in standard CPR that includes
compressions and ventilations. There are circumstances how-
ever where training in compression-only CPR is appropriate (e.g.,
opportunistic training with very limited time). Those trained in
compression-only CPR should be encouraged to learn standard
CPR.
• Basic and advanced life support knowledge and skills deteriorate
in as little as 3–6 months. The use of frequent assessments will
identify those individuals who require refresher training to help
maintain their knowledge and skills.
• CPR prompt or feedback devices improve CPR skill acquisition
and retention and should be considered during CPR training for
laypeople and healthcare professionals.
• An increased emphasis on non-technical skills (NTS) such as
leadership, teamwork, taskmanagement and structured commu-
nication will help improve the performance of CPR and patient
care.
• Teambrieﬁngs to plan for resuscitation attempts, and debrieﬁngs
based on performance during simulated or actual resuscitation
attempts should be used to help improve resuscitation team and
individual performance.
• Research about the impact of resuscitation training on actual
patient outcomes is limited. Althoughmanikin studies are useful,
researchers should be encouraged to study and report the impact
of educational interventions on actual patient outcomes.
Epidemiology and outcome of cardiac arrest
Ischaemic heart disease is the leading cause of death in the
world.20 In Europe, cardiovascular disease accounts for around 40%
of all deaths under the age of 75 years.21 Sudden cardiac arrest
is responsible for more than 60% of adult deaths from coronary
heart disease.22 Summary data from 37 communities in Europe
indicate that the annual incidence of EMS-treated out-of-hospital
cardiopulmonary arrests (OHCAs) for all rhythms is 38 per 100,000
population.22a Based on these data, the annual incidence of EMS-
treated ventricular ﬁbrillation (VF) arrest is 17 per 100,000 and
survival to hospital discharge is 10.7% for all-rhythm and 21.2%
for VF cardiac arrest. Recent data from 10 North American sites
are remarkably consistent with these ﬁgures: median rate of sur-
vival tohospital dischargewas8.4%afterEMS-treatedcardiac arrest
from any rhythm and 22.0% after VF.23 There is some evidence
that long-termsurvival rates after cardiac arrest are increasing.24,25
On initial heart rhythm analysis, about 25–30% of OHCA victims
have VF, a percentage that has declined over the last 20 years.26–30
It is likely that many more victims have VF or rapid ventricular
tachycardia (VT) at the time of collapse but, by the time the ﬁrst
electrocardiogram (ECG) is recorded by EMS personnel, the rhythm
hasdeteriorated to asystole.31,32 When the rhythm is recorded soon
after collapse, in particular by an on-site AED, the proportion of
patients in VF can be as high as 59%33 to 65%.34
The reported incidence of in-hospital cardiac arrest ismore vari-
able, but is in the range of 1–5 per 1000 admissions.35 Recent data
from the American Heart Association’s National Registry of CPR
indicate that survival to hospital discharge after in-hospital cardiac
arrest is 17.6% (all rhythms).36 The initial rhythm is VF or pulseless
VT in 25% of cases and, of these, 37% survive to leave hospital; after
PEA or asystole, 11.5% survive to hospital discharge.
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he International Consensus on Cardiopulmonary
cience
The International Liaison Committee on Resuscitation (ILCOR)
ncludes representatives from the American Heart Association
AHA), the European Resuscitation Council (ERC), the Heart and
troke Foundation of Canada (HSFC), the Australian and New
ealand Committee on Resuscitation (ANZCOR), Resuscitation
ouncil of Southern Africa (RCSA), the Inter-American Heart Foun-
ation (IAHF), and the Resuscitation Council of Asia (RCA). Since
000, researchers from the ILCOR member councils have evalu-
ted resuscitation science in 5-yearly cycles. The conclusions and
ecommendations of the 2005 International Consensus Conference
n Cardiopulmonary Resuscitation and Emergency Cardiovascular
are With Treatment Recommendations were published at the end
f 2005.37,38 The most recent International Consensus Conference
as held in Dallas in February 2010 and the published conclusions
nd recommendations from this process form the basis of these
010 ERC Guidelines.2
Each of the six ILCOR task forces [basic life support (BLS);
dvanced life support (ALS); acute coronary syndromes (ACS);
aediatric life support (PLS); neonatal life support (NLS); and edu-
ation, implementation and teams (EIT)] identiﬁed topics requiring
vidence evaluation and invited international experts to review
hem. The literature reviews followed a standardised ‘worksheet’
emplate including a speciﬁcally designed grading system to deﬁne
he level of evidence of each study.39 When possible, two expert
eviewers were invited to undertake independent evaluations for
ach topic. The 2010 International Consensus Conference involved
13 experts from 30 countries. During the 3 years leading up
o this conference, 356 worksheet authors reviewed thousands
f relevant, peer-reviewed publications to address 277 speciﬁc
esuscitation questions, each in standard PICO (Population, Inter-
ention, Comparison Outcome) format.2 Each science statement
ummarised theexperts’ interpretationof all relevantdataona spe-
iﬁc topic and consensus draft treatment recommendations were
dded by the relevant ILCOR task force. Final wording of science
tatements and treatment recommendations was completed after
urther review by ILCOR member organisations and the editorial
oard.2
The comprehensive conﬂict of interest (COI) policy that was
reated for the 2005 International Consensus Conference40 was
evised for 2010.41 Representatives of manufacturers and industry
id not participate in either of the 2005 and the 2010 conferences.rom science to guidelines
As in 2005, the resuscitation organisations forming ILCOR will
ublish individual resuscitation guidelines that are consistent
Fig. 1.1. Chain o81 (2010) 1219–1276 1223
with the science in the consensus document, but will also con-
sider geographic, economic and system differences in practice,
and the availability of medical devices and drugs. These 2010
ERC Resuscitation Guidelines are derived from the 2010 CoSTR
document but represent consensus among members of the ERC
Executive Committee. The ERC Executive Committee considers
these new recommendations to be the most effective and easily
learned interventions that can be supported by current knowl-
edge, research and experience. Inevitably, even within Europe,
differences in the availability of drugs, equipment, and person-
nel will necessitate local, regional and national adaptation of these
guidelines. Many of the recommendations made in the ERC Guide-
lines 2005 remain unchanged in 2010, either because no new
studies have been published or because new evidence since 2005
has merely strengthened the evidence that was already avail-
able.
Conﬂict of interest policy for the 2010 ERC Guidelines
All authors of these 2010 ERC Resuscitation Guidelines have
signed COI declarations (Appendix B).
The Chain of Survival
The actions linking the victim of sudden cardiac arrest with sur-
vival are called the Chain of Survival (Fig. 1.1). The ﬁrst link of this
chain indicates the importance of recognising those at risk of car-
diac arrest and calling for help in the hope that early treatment
can prevent arrest. The central links depict the integration of CPR
and deﬁbrillation as the fundamental components of early resus-
citation in an attempt to restore life. Immediate CPR can double or
triple survival from VF OHCA.42–45 Performing chest-compression-
only CPR is better than giving no CPR at all.46,47 Following VFOHCA,
cardiopulmonary resuscitation plus deﬁbrillation within 3–5min
of collapse can produce survival rates as high as 49–75%.48–55 Each
minute of delay before deﬁbrillation reduces the probability of sur-
vival to discharge by 10–12%.42,56 The ﬁnal link in the Chain of
Survival, effective post-resuscitation care, is targeted at preserving
function, particularly of the brain and heart. In hospital, the impor-
tance of early recognition of the critically ill patient and activation
of a medical emergency or rapid response team, with treatment
aimed at preventing cardiac arrest, is now well accepted.6 Over the
last few years, the importance of the post-cardiac arrest phase of
treatment, depicted in the fourth ring of the Chain of Survival, has
been increasingly recognised.3 Differences in post-cardiac arrest
treatment may account for some of the inter-hospital variability in
outcome after cardiac arrest.57–63
f Survival.
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(Fig. 1.2. Basic life support algorithm.
dult basic life support
dult BLS sequence
Throughout this section, the male gender implies both males
nd females.
Basic life support comprises the following sequence of actions
Fig. 1.2).
1. Make sure you, the victim and any bystanders are safe.
2. Check the victim for a response:
• gently shake his shoulders and ask loudly: “Are you all right?“
3a. If he responds:
• leave him in the position in which you ﬁnd him, provided there
is no further danger;
• try to ﬁnd out what is wrong with him and get help if needed;
• reassess him regularly.
3b. If he does not respond:
• shout for help◦ turn the victim onto his back and then open the airway using
head; tilt and chin lift;
◦ place your hand on his forehead and gently tilt his head back;
◦ with your ﬁngertips under the point of the victim’s chin, lift
the chin to open the airway.81 (2010) 1219–1276
4. Keeping the airway open, look, listen and feel for breathing:
• look for chest movement;
• listen at the victim’s mouth for breath sounds;
• feel for air on your cheek;
• decide if breathing is normal, not normal or absent.
In the ﬁrst few minutes after cardiac arrest, a victim may be
barely breathing, or taking infrequent, slow and noisy gasps. Do
not confuse this with normal breathing. Look, listen and feel for
no more than 10 s to determine whether the victim is breathing
normally. If you have any doubt whether breathing is normal, act
as if it is not normal.
5a. If he is breathing normally:
• turn him into the recovery position (see below);
• send or go for help – call 112 or local emergency number for an
ambulance;
• continue to assess that breathing remains normal.
5b. If the breathing is not normal or absent:
• send someone for help and to ﬁnd and bring an AED if available;
or if you are on your own, use your mobile phone to alert the
ambulance service – leave the victimonlywhen there is no other
option;
• start chest compression as follows:
◦ kneel by the side of the victim;
◦ place the heel of one hand in the centre of the victim’s chest;
(which is the lower half of the victim’s breastbone (sternum));
◦ place the heel of your other hand on top of the ﬁrst hand;
◦ interlock the ﬁngers of your hands and ensure that pressure is
not applied over the victim’s ribs. Keep your arms straight. Do
not apply any pressure over the upper abdomen or the bottom
end of the sternum.
◦ position yourself vertically above the victim’s chest and press
down on the sternum at least 5 cm (but not exceeding 6 cm);
◦ after each compression, release all the pressure on the chest
without losing contact between your hands and the ster-
num; repeat at a rate of at least 100min−1 (but not exceeding
120min−1);
◦ compression and release should take equal amounts of time.
6a. Combine chest compression with rescue breaths.
• After 30 compressions open the airway again using head tilt and
chin lift.
• Pinch the soft part of the nose closed, using the index ﬁnger and
thumb of your hand on the forehead.
• Allow the mouth to open, but maintain chin lift.
• Take a normal breath and place your lips around his mouth,
making sure that you have a good seal.
• Blow steadily into the mouth while watching for the chest to
rise, taking about 1 s as in normal breathing; this is an effective
rescue breath.
• Maintaining head tilt and chin lift, take your mouth away from
the victim and watch for the chest to fall as air comes out.
• Take another normal breath and blow into the victim’s mouth
once more to achieve a total of two effective rescue breaths. The
two breaths should not take more than 5 s in all. Then return
your hands without delay to the correct position on the sternum
and give a further 30 chest compressions.
• Continue with chest compressions and rescue breaths in a ratio
of 30:2.
• Stop to recheck the victim only if he starts to wake up: to move,
opens eyes and to breathe normally. Otherwise, do not interrupt
resuscitation.
If your initial rescue breath does not make the chest rise as in
normal breathing, then before your next attempt:
• look into the victim’s mouth and remove any obstruction;
• recheck that there is adequate head tilt and chin lift;
• do not attempt more than two breaths each time before return-
ing to chest compressions.
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If there ismore than one rescuer present, another rescuer should
take over delivering CPR every 2min to prevent fatigue. Ensure
that interruption of chest compressions is minimal during the
changeover of rescuers.
6b. Chest-compression-only CPR may be used as follows:
• if you are not trained, or are unwilling to give rescue breaths,
give chest compressions only;
• if only chest compressions aregiven, these shouldbe continuous,
at a rate of at least 100min−1 (but not exceeding 120min−1).
7. Do not interrupt resuscitation until:
• professional help arrives and takes over; or
• the victim starts to wake up: to move, opens eyes and to breathe
normally; or
• you become exhausted.
ecognition of cardiorespiratory arrest
Checking the carotid pulse (or any other pulse) is an inaccu-
ate method of conﬁrming the presence or absence of circulation,
oth for lay rescuers and for professionals.64–66 Healthcare pro-
essionals, as well as lay rescuers, have difﬁculty determining the
resence or absence of adequate or normal breathing in unre-
ponsive victims.67,68 This may be because the victim is making
ccasional (agonal) gasps, which occur in the ﬁrst minutes after
nset in up to 40% of cardiac arrests.69 Laypeople should be taught
o begin CPR if the victim is unconscious (unresponsive) and not
reathing normally. It should be emphasised during training that
he presence of agonal gasps is an indication for starting CPR imme-
iately.
nitial rescue breaths
In adults needing CPR, the cardiac arrest is likely to have a pri-
ary cardiac cause – CPR should start with chest compression
ather than initial ventilations. Time should not be spent checking
he mouth for foreign bodies unless attempted rescue breathing
ails to make the chest rise.
entilation
During CPR, the optimal tidal volume, respiratory rate and
nspired oxygen concentration to achieve adequate oxygenation
ndCO2 removal is unknown. During CPR, bloodﬂow to the lungs is
ubstantially reduced, so an adequate ventilation–perfusion ratio
an be maintained with lower tidal volumes and respiratory rates
han normal.70 Hyperventilation is harmful because it increases
ntrathoracic pressure, which decreases venous return to the heart
nd reduces cardiac output. Interruptions in chest compression
educe survival.71
Rescuers should give each rescue breath over about 1 s, with
nough volume to make the victim’s chest rise, but to avoid rapid
r forceful breaths. The time taken to give two breaths should not
xceed5 s. These recommendations apply to all formsof ventilation
uring CPR, including mouth-to-mouth and bag-mask ventilation
ith and without supplementary oxygen.
hest compression
Chest compressions generate a small but critical amount of
loodﬂowto thebrain andmyocardiumand increase the likelihood
hat deﬁbrillation will be successful. Optimal chest compression
echnique comprises: compressing the chest at a rate of at least
00min−1 and to a depth of at least 5 cm (for an adult), but
ot exceeding 6 cm; allowing the chest to recoil completely after
ach compression72,73; taking approximately the same amount
f time for compression as relaxation. Rescuers can be assisted81 (2010) 1219–1276 1225
to achieve the recommended compression rate and depth by
prompt/feedback devices that are either built into the AED or man-
ual deﬁbrillator, or are stand-alone devices.
Compression-only CPR
Some healthcare professionals as well as lay rescuers indicate
that they would be reluctant to perform mouth-to-mouth ventila-
tion, especially in unknown victims of cardiac arrest.74,75 Animal
studies have shown that chest-compression-only CPR may be as
effective as combined ventilation and compression in the ﬁrst
few minutes after non-asphyxial arrest.76,77 If the airway is open,
occasional gasps and passive chest recoil may provide some air
exchange, but this may result in ventilation of the dead space
only.69,78–80 Animal and mathematical model studies of chest-
compression-only CPR have shown that arterial oxygen stores
deplete in 2–4min.81,82 In adults, the outcome of chest compres-
sion without ventilation is signiﬁcantly better than the outcome of
giving no CPR at all in non-asphyxial arrest.46,47 Several studies of
human cardiac arrest suggest equivalence of chest-compression-
only CPR and chest compressions combined with rescue breaths,
but none of these studies exclude the possibility that chest-
compression-only is inferior to chest compressions combined with
ventilations.47,83 Chest compression-only may be sufﬁcient only
in the ﬁrst few minutes after collapse. Chest-compression-only
CPR is not as effective as conventional CPR for cardiac arrests of
non-cardiac origin (e.g., drowning or suffocation) in adults and
children.84,85 Chest compression combined with rescue breaths is,
therefore, the method of choice for CPR delivered by both trained
lay rescuers and professionals. Laypeople should be encouraged to
perform compression-only CPR if they are unable or unwilling to
provide rescue breaths, or when instructed during an emergency
call to an ambulance dispatcher centre.
Risks to the rescuer
Physical effects
The incidence of adverse effects (muscle strain, back symp-
toms, shortness of breath, hyperventilation) on the rescuer from
CPR training and actual performance is very low.86 Severalmanikin
studies have found that, as a result of rescuer fatigue, chest com-
pression depth can decrease as little as 2min after starting chest
compressions.87 Rescuers should change about every 2min to pre-
vent a decrease in compression quality due to rescuer fatigue.
Changing rescuers should not interrupt chest compressions.
Risks during deﬁbrillation
A large randomised trial of public access deﬁbrillation showed
that AEDs can be used safely by laypeople and ﬁrst responders.88 A
systematic review identiﬁed only eight papers that reported a total
of 29 adverse events associated with deﬁbrillation.89 Only one of
these adverse events was published after 1997.90
Disease transmission
There are only very few cases reported where performing CPR
has been linked to disease transmission. Three studies showed that
barrier devices decreased transmission of bacteria in controlled
laboratory settings.91,92 Because the risk of disease transmission
is very low, initiating rescue breathing without a barrier device
is reasonable. If the victim is known to have a serious infection
appropriate precautions are recommended.Recovery position
There are several variations of the recovery position, each with
its own advantages. No single position is perfect for all victims.93,94
The position should be stable, near to a true lateral position with
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Fig. 1.3. Adult foreign-body airway obstruc
Table 1.1
Differentiation between mild and severe foreign body airway obstruction (FBAO)a
Sign Mild obstruction Severe obstruction
“Are you choking?” “Yes” Unable to speak,
may nod
Other signs Can speak, cough, breathe Cannot
breathe/wheezy
breathing/silent
t
b
F
b
a
a
b
E
d
p
A
w
o
d
Sattempts to
cough/unconsciousness
a General signs of FBAO: attack occurs while eating; victim may clutch his neck.
he head dependent, and with no pressure on the chest to impair
reathing.95
oreign-body airway obstruction (choking)
Foreign-body airway obstruction (FBAO) is an uncommon
ut potentially treatable cause of accidental death.96 The signs
nd symptoms enabling differentiation between mild and severe
irway obstruction are summarised in Table 1.1. The adult foreign-
ody airway obstruction (choking) sequence is shown in Fig. 1.3.
lectrical therapies: automated external
eﬁbrillators, deﬁbrillation, cardioversion and
acing
utomated external deﬁbrillators
Automated external deﬁbrillators (AEDs) are safe and effective
hen used by either laypeople or healthcare professionals (in- or
ut-of-hospital). Use of an AED by a layperson makes it possible to
eﬁbrillate many minutes before professional help arrives.
equence for use of an AEDThe ERC AED algorithm is shown in Fig. 1.4.
1. Make sure you, the victim, and any bystanders are safe.
2. Follow the Adult BLS sequence:tion (choking) sequence. © 2010 ERC.
• if the victim is unresponsive and not breathing normally, send
someone for help and to ﬁnd and bring an AED if available;
• if you are on your own, use yourmobile phone to alert the ambu-
lance service – leave the victim only when there is no other
option.
3. Start CPR according to the adult BLS sequence. If you are on your
own and the AED is in your immediate vicinity, startwith applying
the AED.
4. As soon as the AED arrives:
• switch on the AED and attach the electrode pads on the victim’s
bare chest;
• if more than one rescuer is present, CPR should be continued
while electrode pads are being attached to the chest;
• follow the spoken/visual directions immediately;
• ensure that nobody is touching the victim while the AED is
analysing the rhythm.
5a. If a shock is indicated:
• ensure that nobody is touching the victim;
• push shock button as directed;
• immediately restart CPR 30:2;
• continue as directed by the voice/visual prompts.
5b. If no shock is indicated:
• immediately resume CPR, using a ratio of 30 compressions to 2
rescue breaths;
• continue as directed by the voice/visual prompts.
6. Continue to follow the AED prompts until:
• professional help arrives and takes over;
• the victim starts to wake up: moves, opens eyes and breathes
normally;
• you become exhausted.
Public access deﬁbrillation programmes
Automated external deﬁbrillator programmes should be
actively considered for implementation in public places such as
airports,52 sport facilities, ofﬁces, in casinos55 and on aircraft,53where cardiac arrests are usually witnessed and trained rescuers
are quickly on scene. Lay rescuer AED programmes with very rapid
response times, and uncontrolled studies using police ofﬁcers as
ﬁrst responders,97,98 have achieved reported survival rates as high
as 49–74%.
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The full potential of AEDs has not yet been achieved, because
hey are used mostly in public settings, yet 60–80% of cardiac
rrests occur at home. Public access deﬁbrillation (PAD) and ﬁrst
esponder AED programmes may increase the number of victims
ho receive bystander CPR and early deﬁbrillation, thus improving
urvival from out-of-hospital SCA.99 Recent data from nationwide
tudies in Japan and the USA33,100 showed that when an AED was
vailable, victims were deﬁbrillated much sooner and with a better
hance of survival. Programmes that make AEDs publicly available
n residential areas have not yet been evaluated. The acquisition
f an AED for individual use at home, even for those considered at
igh risk of sudden cardiac arrest, has proved not to be effective.101
n-hospital use of AEDsAt the time of the 2010 Consensus on CPR Science Conference,
here were no published randomised trials comparing in-hospital
se of AEDs with manual deﬁbrillators. Two lower-level studies
f adults with in-hospital cardiac arrest from shockable rhythmsm. © 2010 ERC.
showed higher survival-to-hospital discharge rates when deﬁbril-
lation was provided through an AED programme than with manual
deﬁbrillation alone.102,103 Despite limited evidence, AEDs should
be considered for the hospital setting as a way to facilitate early
deﬁbrillation (a goal of <3min from collapse), especially in areas
where healthcare providers have no rhythm recognition skills or
where they use deﬁbrillators infrequently. An effective system for
training and retraining should be in place.104 Enough healthcare
providers should be trained to enable the ﬁrst shock to be given
within 3min of collapse anywhere in the hospital. Hospitals should
monitor collapse-to-ﬁrst shock intervals andmonitor resuscitation
outcomes.
Shock in manual versus semi-automatic modeManyAEDs can be operated in bothmanual and semi-automatic
mode but few studies have compared these two options. The semi-
automaticmode has been shown to reduce time to ﬁrst shockwhen
used both in-hospital105 and pre-hospital106 settings, and results
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n higher VF conversion rates,106 and delivery of fewer inappro-
riate shocks.107 Conversely, semi-automatic modes result in less
ime spent performing chest compressions,107,108 mainly because
f a longer pre-shock pause associated with automated rhythm
nalysis. Despite these differences, no overall difference in ROSC,
urvival, or discharge rate from hospital has been demonstrated in
ny study.105,106,109 The deﬁbrillation mode that affords the best
utcome will depend on the system, skills, training and ECG recog-
ition skills of rescuers. A shorter pre-shock pause and lower total
ands-off-ratio increases vital organ perfusion and the probabil-
ty of ROSC.71,110,111 With manual deﬁbrillators and some AEDs
t is possible to perform chest compressions during charging and
hereby reduce thepre-shockpause to less than5 s. Trained individ-
als may deliver deﬁbrillation in manual mode but frequent team
raining and ECG recognition skills are essential.
trategies before deﬁbrillation
inimising the pre-shock pause
The delay between stopping chest compressions and delivery of
he shock (the pre-shock pause) must be kept to an absolute mini-
um; even 5–10 s delay will reduce the chances of the shock being
uccessful.71,110,112 The pre-shock pause can easily be reduced to
ess than 5 s by continuing compressions during charging of the
eﬁbrillator andbyhaving anefﬁcient teamcoordinatedbya leader
ho communicates effectively. The safety check to ensure that
obody is in contact with the patient at the moment of deﬁbril-
ation should be undertaken rapidly but efﬁciently. The negligible
isk of a rescuer receiving an accidental shock is minimised even
urther if all rescuers wear gloves.113 The post-shock pause is min-
mised by resuming chest compressions immediately after shock
elivery (see below). The entire process of deﬁbrillation should be
chievable with no more than a 5 s interruption to chest compres-
ions.
ads versus paddles
Self-adhesive deﬁbrillation pads have practical beneﬁts over
addles for routine monitoring and deﬁbrillation.114–118 They are
afe and effective and are preferable to standard deﬁbrillation
addles.119
ibrillation waveform analysis
It is possible to predict, with varying reliability, the success
f deﬁbrillation from the ﬁbrillation waveform.120–139 If optimal
eﬁbrillation waveforms and the optimal timing of shock deliv-
ry can be determined in prospective studies, it should be possible
o prevent the delivery of unsuccessful high energy shocks and
inimise myocardial injury. This technology is under active devel-
pment and investigation but current sensitivity and speciﬁcity is
nsufﬁcient to enable introduction of VF waveform analysis into
linical practice.
PR before deﬁbrillation
Several studies have examined whether a period of CPR prior
o deﬁbrillation is beneﬁcial, particularly in patients with an
nwitnessed arrest or prolonged collapse without resuscitation.
review of evidence for the 2005 guidelines resulted in the rec-
mmendation that it was reasonable for EMS personnel to give
period of about 2min of CPR before deﬁbrillation in patients
ith prolonged collapse (>5min).140 This recommendation was
ased on clinical studies, which showed that when response times81 (2010) 1219–1276
exceeded 4–5min, a period of 1.5–3min of CPR before shock deliv-
ery improved ROSC, survival to hospital discharge141,142 and 1 year
survival142 for adults with out-of-hospital VF or VT compared with
immediate deﬁbrillation.
More recently, two randomised controlled trials documented
that a period of 1.5–3min of CPR by EMS personnel before deﬁb-
rillation did not improve ROSC or survival to hospital discharge
in patients with out-of-hospital VF or pulseless VT, regardless of
EMS response interval.143,144 Four other studies have also failed
to demonstrate signiﬁcant improvements in overall ROSC or sur-
vival tohospital dischargewith an initial periodofCPR,141,142,145,146
although one did showahigher rate of favourable neurological out-
come at 30 days and 1 year after cardiac arrest.145 Performing chest
compressionswhile retrieving and charging a deﬁbrillator has been
shown to improve the probability of survival.147
In any cardiac arrest they have not witnessed, EMS personnel
should provide good-quality CPR while a deﬁbrillator is retrieved,
applied and charged, but routine delivery of a speciﬁed period of
CPR (e.g., 2 or 3min) before rhythm analysis and a shock is deliv-
ered is not recommended. Some emergency medical services have
already fully implemented a speciﬁed period of chest compres-
sions before deﬁbrillation; given the lack of convincing data either
supporting or refuting this strategy, it is reasonable for them to
continue this practice.
Delivery of deﬁbrillation
One shock versus three-stacked shock sequence
Interruptions inexternal chest compression reduces thechances
of converting VF to another rhythm.71 Studies have shown a sig-
niﬁcantly lower hands-off-ratio with a one-shock instead of a
three-stacked shock protocol148 and some,149–151 but not all,148,152
have suggested a signiﬁcant survival beneﬁt from this single-shock
strategy.
Whendeﬁbrillation iswarranted, give a single shockand resume
chest compressions immediately following the shock. Do not delay
CPR for rhythm analysis or a pulse check immediately after a
shock. Continue CPR (30 compressions:2 ventilations) for 2min
until rhythm analysis is undertaken and another shock given (if
indicated) (see Advanced life support).6
If VF/VT occurs during cardiac catheterisation or in the early
post-operative period following cardiac surgery (when chest com-
pressions could disrupt vascular sutures), consider delivering up
to three-stacked shocks before starting chest compressions (see
Special circumstances).10 This three-shock strategymay also be con-
sidered for an initial, witnessed VF/VT cardiac arrest if the patient
is already connected to a manual deﬁbrillator. Although there are
no data supporting a three-shock strategy in any of these circum-
stances, it is unlikely that chest compressions will improve the
already very high chance of return of spontaneous circulationwhen
deﬁbrillation occurs early in the electrical phase, immediately after
onset of VF.
Waveforms
Monophasic deﬁbrillators are no longer manufactured, and
although many will remain in use for several years, biphasic deﬁb-
rillators have now superseded them.
Monophasic versus biphasic deﬁbrillation
Although biphasic waveforms are more effective at terminating
ventricular arrhythmias at lower energy levels, have demonstrated
greater ﬁrst shock efﬁcacy than monophasic waveforms, and have
greater ﬁrst shock efﬁcacy for long duration VF/VT.153–155 No
randomised studies have demonstrated superiority in terms of
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eurologically intact survival to hospital discharge. Biphasic wave-
orms have been shown to be superior to monophasic waveforms
or elective cardioversion of atrial ﬁbrillation, with greater overall
uccess rates, using less cumulative energy and reducing the sever-
ty of cutaneous burns,156–159 and are the waveform of choice for
his procedure.
nergy levels
Optimal energy levels for both monophasic and biphasic wave-
orms are unknown. The recommendations for energy levels are
ased on a consensus following careful review of the current liter-
ture.
irst shock
There are no new published studies looking at the optimal
nergy levels for monophasic waveforms since publication of the
005guidelines. Relatively fewstudiesonbiphasicwaveformshave
een published in the past 5 years on which to reﬁne the 2005
uidelines. There is no evidence that one biphasic waveform or
evice is more effective than another. First shock efﬁcacy of the
iphasic truncated exponential (BTE) waveform using 150–200 J
as been reported as 86–98%.153,154,160–162 First shock efﬁcacy
f the rectilinear biphasic (RLB) waveform using 120 J is up to
5% (data not published in the paper but supplied by person-
el communication).155 Two studies have suggested equivalence
ith lower andhigher starting energy biphasic deﬁbrillation.163,164
lthough human studies have not shown harm (raised biomarkers,
CG changes, ejection fraction) from any biphasic waveform up to
60 J,163,165 several animal studies have suggested the potential for
arm with higher energy levels.166–169
The initial biphasic shock should be no lower than 120 J for RLB
aveforms and150 J for BTEwaveforms. Ideally, the initial biphasic
hock energy should be at least 150 J for all waveforms.
econd and subsequent shocks
The 2005 guidelines recommended either a ﬁxed or escalating
nergy strategy for deﬁbrillation and there is no evidence to change
his recommendation.
ardioversion
If electrical cardioversion is used to convert atrial or ventric-
lar tachyarrhythmias, the shock must be synchronised to occur
ith the R wave of the electrocardiogram rather than with the T
ave: VF can be induced if a shock is delivered during the rela-
ive refractory portion of the cardiac cycle.170 Biphasic waveforms
re more effective than monophasic waveforms for cardioversion
f AF.156–159 Commencing at high energy levels does not improve
ardioversion rates compared with lower energy levels.156,171–176
n initial synchronised shock of 120–150 J, escalating if necessary
s a reasonable strategy based on current data. Atrial ﬂutter and
aroxysmal SVTgenerally require less energy than atrial ﬁbrillation
or cardioversion.175 Give an initial shock of 100 J monophasic or
0–120 Jbiphasic.Give subsequent shocksusing stepwise increases
n energy.177 The energy required for cardioversion of VT depends
n themorphological characteristics and rate of the arrhythmia.178
se biphasic energy levels of 120–150 J for the initial shock. Con-
ider stepwise increases if the ﬁrst shock fails to achieve sinus
hythm.178acing
Consider pacing in patients with symptomatic bradycardia
efractory to anti-cholinergic drugs or other second line therapy81 (2010) 1219–1276 1229
(see Advanced life support).6 Immediate pacing is indicated espe-
cially when the block is at or below the His-Purkinje level. If
transthoracic pacing is ineffective, consider transvenous pacing.
Implantable cardioverter deﬁbrillators
Implantable cardioverter deﬁbrillators (ICDs) are implanted
because a patient is considered to be at risk from, or has had, a life-
threatening shockable arrhythmia. On sensing a shockable rhythm,
an ICD will discharge approximately 40 J through an internal pac-
ing wire embedded in the right ventricle. On detecting VF/VT, ICD
devices will discharge no more than eight times, but may reset if
they detect a new period of VF/VT. Discharge of an ICD may cause
pectoral muscle contraction in the patient, and shocks to the res-
cuer have been documented.179 In view of the low energy levels
discharged by ICDs, it is unlikely that any harm will come to the
rescuer, but the wearing of gloves and minimising contact with the
patient while the device is discharging is prudent.
Adult advanced life support
Prevention of in-hospital cardiac arrest
Early recognition of the deteriorating patient and prevention
of cardiac arrest is the ﬁrst link in the Chain of Survival.180 Once
cardiac arrest occurs, fewer than 20% of patients having an in-
hospital cardiac arrest will survive to go home.36,181,182 Prevention
of in-hospital cardiac arrest requires staff education, monitoring of
patients, recognition of patient deterioration, a system to call for
help and an effective response.183
The problem
Cardiac arrest in patients in unmonitored ward areas is not
usually a sudden unpredictable event, nor is it usually caused
by primary cardiac disease.184 These patients often have slow
and progressive physiological deterioration, involving hypoxaemia
and hypotension that is unnoticed by staff, or is recognised but
treated poorly.185–187 Many of these patients have unmonitored
arrests, and the underlying cardiac arrest rhythm is usually non-
shockable182,188; survival to hospital discharge is poor.36,181,188
Education in acute care
Staff education is an essential part of implementing a system to
prevent cardiac arrest.189 In an Australian study, virtually all the
improvement in the hospital cardiac arrest rate occurred during
the educational phase of implementation of a medical emergency
team (MET) system.190,191
Monitoring and recognition of the critically ill patient
To assist in the early detection of critical illness, each patient
should have a documented plan for vital signs monitoring that
identiﬁes which variables need to be measured and the frequency
of measurement.192 Many hospitals now use early warning scores
(EWS) or calling criteria to identify the need to escalatemonitoring,
treatment, or to call for expert help (‘track and trigger’).193–197
The response to critical illnessThe response to patients who are critically ill or who are
at risk of becoming critically ill is usually provided by medical
emergency teams (MET), rapid response teams (RRT), or critical
care outreach teams (CCOT).198–200 These teams replace or coexist
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ith traditional cardiac arrest teams, which typically respond to
atients already in cardiac arrest. MET/RRT usually comprise med-
cal and nursing staff from intensive care and general medicine and
espond to speciﬁc calling criteria. CCOT are based predominantly
n individual or teams of nurses.201 A recentmeta-analysis showed
RT/MET systems were associated with a reduction in rates of car-
iopulmonary arrest outside the intensive care unit but are not
ssociated with lower hospital mortality rates.202 Medical emer-
ency teams have an important role in improving end-of-life and
o-not-attempt resuscitation (DNAR) decision-making, which at
east partly accounts for the reduction in cardiac arrest rates.203–206
uidelines for prevention of in-hospital cardiac arrest
Hospitals should provide a system of care that includes: (a) staff
ducation about the signs of patient deterioration, and the ratio-
ale for rapid response to illness, (b) appropriate and regular vital
igns monitoring of patients, (c) clear guidance (e.g., via calling cri-
eria or early warning scores) to assist staff in the early detection of
atient deterioration, (d) a clear, uniformsystemof calling for assis-
ance, and (e) an appropriate and timely clinical response to calls
or assistance.183 The following strategies may prevent avoidable
n-hospital cardiac arrests:
1. Provide care for patients who are critically ill or at risk of clin-
ical deterioration in appropriate areas, with the level of care
provided matched to the level of patient sickness.
2. Critically ill patients need regular observations: each patient
should have a documented plan for vital signs monitoring that
identiﬁes which variables need to be measured and the fre-
quency of measurement according to the severity of illness or
the likelihood of clinical deterioration and cardiopulmonary
arrest. Recent guidance suggests monitoring of simple physi-
ological variables including pulse, blood pressure, respiratory
rate, conscious level, temperature and SpO2.192,207
3. Use a track and trigger system (either ‘calling criteria’ or early
warning system) to identify patients who are critically ill and,
or at risk of clinical deterioration and cardiopulmonary arrest.
4. Use a patient charting system that enables the regular mea-
surement and recording of vital signs and, where used, early
warning scores.
5. Have a clear and speciﬁc policy that requires a clinical response
to abnormal physiology, based on the track and trigger system
used. This should include advice on the further clinicalmanage-
ment of the patient and the speciﬁc responsibilities of medical
and nursing staff.
6. The hospital should have a clearly identiﬁed response to crit-
ical illness. This may include a designated outreach service or
resuscitation team (e.g., MET, RRT system) capable of respond-
ing in a timely fashion to acute clinical crises identiﬁed by the
track and trigger system or other indicators. This service must
be available 24h per day. The team must include staff with the
appropriate acute or critical care skills.
7. Train all clinical staff in the recognition, monitoring and man-
agement of the critically ill patient. Include advice on clinical
management while awaiting the arrival of more experienced
staff. Ensure that staff know their role(s) in the rapid response
system.
8. Hospitals must empower staff of all disciplines to call for help
when they identify a patient at risk of deterioration or car-
diac arrest. Staff should be trained in the use of structured
communication tools (e.g., SBAR – Situation-Background-
Assessment-Recommendation)208 to ensure effective han-
dover of information between doctors, nurses and other
healthcare professions.81 (2010) 1219–1276
9. Identify patients for whom cardiopulmonary arrest is an antic-
ipated terminal event and in whom CPR is inappropriate, and
patients who do not wish to be treated with CPR. Hospitals
should have a DNAR policy, based on national guidance, which
is understood by all clinical staff.
10. Ensure accurate audit of cardiac arrest, ‘false arrest’, unex-
pected deaths and unanticipated ICU admissions using
common datasets. Audit also the antecedents and clinical
response to these events.
Prevention of sudden cardiac death (SCD) out-of-hospital
Coronary artery disease is the commonest cause of SCD. Non-
ischaemic cardiomyopathy and valvular disease account for most
other SCD events. A small percentage of SCDs are caused by
inherited abnormalities (e.g., Brugada syndrome, hypertrophic car-
diomyopathy) or congenital heart disease. Most SCD victims have
a history of cardiac disease and warning signs, most commonly
chest pain, in the hour before cardiac arrest.209 Apparently healthy
children and young adults who suffer SCD can also have signs and
symptoms (e.g., syncope/pre-syncope, chest pain and palpitations)
that should alert healthcare professionals to seek expert help to
prevent cardiac arrest.210–218
Prehospital resuscitation
EMS personnel
There is considerable variation across Europe in the structure
and process of EMS systems. Some countries have adopted almost
exclusivelyparamedic/emergencymedical technician (EMT)-based
systemswhile other incorporate prehospital physicians to a greater
or lesser extent. Studies indirectly comparing resuscitation out-
comes between physician-staffed and other systems are difﬁcult
to interpret because of the extremely high variability between sys-
tems, independent of physician-stafﬁng.23 Given the inconsistent
evidence, the inclusion or exclusion of physicians among prehospi-
tal personnel responding to cardiac arrests will depend largely on
existing local policy.
Termination of resuscitation rules
One high-quality, prospective study has demonstrated that
application of a ‘basic life support termination of resuscitation rule’
is predictive of death when applied by deﬁbrillation-only emer-
gency medical technicians.219 The rule recommends termination
when there is noROSC, no shocks are administered, and the arrest is
not witnessed by EMS personnel. Prospectively validated termina-
tion of resuscitation rules such as the ‘basic life support termination
of resuscitation rule’ can be used to guide termination of pre-
hospital CPR in adults; however, these must be validated in an
emergency medical services system similar to the one in which
implementation isproposed.Other rules for variousprovider levels,
including in-hospital providers,maybehelpful to reducevariability
in decision-making; however, rules should be prospectively vali-
dated before implementation.
In-hospital resuscitation
After in-hospital cardiac arrest, the division between basic life
support and advanced life support is arbitrary; in practice, the
resuscitationprocess is a continuumand isbasedoncommonsense.
The public expect that clinical staff can undertake CPR. For all in-
hospital cardiac arrests, ensure that:
• cardiorespiratory arrest is recognised immediately;
• help is summoned using a standard telephone number;
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CPR is started immediately using airway adjuncts if indicated,
deﬁbrillation attempted as rapidly as possible and certainly
within 3min.
All clinical areas should have immediate access to resus-
itation equipment and drugs to facilitate rapid resuscitation
f the patient in cardiopulmonary arrest. Ideally, the equip-
ent used for CPR (including deﬁbrillators) and the layout of
quipment and drugs should be standardised throughout the
ospital.220,221
The resuscitation teammay take the formof a traditional cardiac
rrest team, which is called only when cardiac arrest is recognised.
lternatively, hospitalsmayhave strategies to recognise patients at
isk of cardiac arrest and summon a team (e.g., MET or RRT) before
ardiac arrest occurs.
An algorithm for the initial management of in-hospital cardiac
rrest is shown in Fig. 1.5.
One person starts CPR as others call the resuscitation team and
collect the resuscitation equipment and a deﬁbrillator. If only one
member of staff is present, this will mean leaving the patient.
Give 30 chest compressions followed by 2 ventilations.
Minimise interruptions and ensure high-quality compressions.
Undertaking good-quality chest compressions for a prolonged
time is tiring;withminimal interruption, try to change theperson
doing chest compressions every 2min.
Maintain the airway and ventilate the lungswith themost appro-
priate equipment immediately to hand. A pocket mask, which
maybesupplementedwithanoral airway, isusually readily avail-
able. Alternatively, use a supraglottic airway device (SAD) and
self-inﬂating bag, or bag-mask, according to local policy. Tracheal
intubation should be attempted only by those who are trained,
competent and experienced in this skill. Waveform capnogra-
phy should be routinely available for conﬁrming tracheal tube
placement (in the presence of a cardiac output) and subsequent
monitoring of an intubated patient.
Use an inspiratory time of 1 s and give enough volume to produce
anormal chest rise. Add supplemental oxygen as soon as possible.of in-hospital cardiac arrest. © 2010 ERC.
• Once the patient’s trachea has been intubated or a SAD has been
inserted, continue chest compressions uninterrupted (except
for deﬁbrillation or pulse checks when indicated), at a rate of
at least 100min−1, and ventilate the lungs at approximately
10breathsmin−1. Avoid hyperventilation (both excessive rate
and tidal volume), which may worsen outcome.
• If there is no airway and ventilation equipment available, con-
sider giving mouth-to-mouth ventilation. If there are clinical
reasons to avoid mouth-to-mouth contact, or you are unwilling
or unable to do this, do chest compressions until help or airway
equipment arrives.
• When the deﬁbrillator arrives, apply the paddles to the patient
and analyse the rhythm. If self-adhesive deﬁbrillation pads are
available, apply these without interrupting chest compressions.
The use of adhesive electrode pads or a ‘quick-look’ paddles tech-
nique will enable rapid assessment of heart rhythm compared
with attaching ECG electrodes.222 Pause brieﬂy to assess the
heart rhythm. With a manual deﬁbrillator, if the rhythm is VF/VT
charge the deﬁbrillator while another rescuer continues chest
compressions. Once the deﬁbrillator is charged, pause the chest
compressions, ensure that all rescuers are clear of the patient and
then give one shock. If using anAED follow theAED’s audio-visual
prompts.
• Restart chest compressions immediately after the deﬁbrilla-
tion attempt. Minimise interruptions to chest compressions.
Using a manual deﬁbrillator it is possible to reduce the pause
between stopping and restarting of chest compressions to less
than 5 s.
• Continue resuscitation until the resuscitation team arrives or the
patient shows signs of life. Follow the voice prompts if using an
AED. If using a manual deﬁbrillator, follow the universal algo-
rithm for advanced life support.
• Once resuscitation is underway, and if there are sufﬁcient staff
present, prepare intravenous cannulae anddrugs likely to beused
by the resuscitation team (e.g., adrenaline).
• Identify one person to be responsible for handover to the resus-
citation team leader. Use a structured communication tool for
handover (e.g., SBAR, RSVP).208,223 Locate the patient’s records.
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The quality of chest compressions during in-hospital CPR is
frequently sub-optimal.224,225 The importance of uninterrupted
chest compressions cannot be over emphasised. Even short inter-
ruptions to chest compressions are disastrous for outcome and
every effort must be made to ensure that continuous, effective
chest compression is maintained throughout the resuscitation
attempt. The team leader should monitor the quality of CPR and
alternate CPR providers if the quality of CPR is poor. Continu-
ous ETCO2 monitoring can be used to indicate the quality of CPR:
although an optimal target for ETCO2 during CPR has not been
established, a value of less than 10mmHg (1.4 kPa) is associated
with failure to achieve ROSC and may indicate that the quality of
chest compressions should be improved. If possible, the person
providing chest compressions shouldbe changedevery2min, but
without causing long pauses in chest compressions.lgorithm. © 2010 ERC.
ALS treatment algorithm
Although the ALS cardiac arrest algorithm (Fig. 1.6) is applicable
to all cardiac arrests, additional interventions may be indicated for
cardiac arrest caused by special circumstances (see Section 8).10
The interventions that unquestionably contribute to improved
survival after cardiac arrest are prompt and effective bystander BLS,
uninterrupted, high-quality chest compressions and early deﬁbril-
lation for VF/VT. The use of adrenaline has been shown to increase
ROSC, but no resuscitation drugs or advanced airway interventions
have been shown to increase survival to hospital discharge after
cardiac arrest.226–229 Thus, although drugs and advanced airways
are still included among ALS interventions, they are of secondary
importance to early deﬁbrillation and high-quality, uninterrupted
chest compressions.
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As with previous guidelines, the ALS algorithm distinguishes
etween shockable and non-shockable rhythms. Each cycle is
roadly similar, with a total of 2min of CPR being given before
ssessing the rhythm and where indicated, feeling for a pulse.
drenaline 1mg is given every 3–5min until ROSC is achieved
the timing of the initial dose of adrenaline is described
elow.
hockable rhythms (ventricular ﬁbrillation/pulseless
entricular tachycardia)
The ﬁrst monitored rhythm is VF/VT in approximately 25% of
ardiac arrests, both in-36 or out-of-hospital.24,25,146 VF/VT will
lso occur at some stage during resuscitation in about 25% of
ardiac arrests with an initial documented rhythm of asystole or
EA.36 Having conﬁrmed cardiac arrest, summon help (includ-
ng the request for a deﬁbrillator) and start CPR, beginning with
hest compressions, with a CV ratio of 30:2. When the deﬁbrillator
rrives, continue chest compressionswhile applying the paddles or
elf-adhesive pads. Identify the rhythm and treat according to the
LS algorithm.
If VF/VT is conﬁrmed, charge the deﬁbrillator while another
rescuer continues chest compressions. Once the deﬁbrillator is
charged, pause the chest compressions, quickly ensure that all
rescuers are clear of the patient and then give one shock (360-J
monophasic or 150–200 J biphasic).
Minimise the delay between stopping chest compressions and
delivery of the shock (the preshock pause); even 5–10 s delay
will reduce the chances of the shock being successful.71,110
Without reassessing the rhythmor feeling for apulse, resumeCPR
(CV ratio 30:2) immediately after the shock, starting with chest
compressions. Even if the deﬁbrillation attempt is successful in
restoring a perfusing rhythm, it takes time until the post-shock
circulation is established230 and it is very rare for a pulse to
be palpable immediately after deﬁbrillation.231 Furthermore, the
delay in trying to palpate a pulse will further compromise the
myocardium if a perfusing rhythm has not been restored.232
Continue CPR for 2min, thenpause brieﬂy to assess the rhythm; if
still VF/VT, give a second shock (360-J monophasic or 150–360-J
biphasic). Without reassessing the rhythm or feeling for a pulse,
resume CPR (CV ratio 30:2) immediately after the shock, starting
with chest compressions.
Continue CPR for 2min, then pause brieﬂy to assess the rhythm;
if still VF/VT, give a third shock (360-J monophasic or 150–360-J
biphasic). Without reassessing the rhythm or feeling for a pulse,
resume CPR (CV ratio 30:2) immediately after the shock, starting
with chest compressions. If IV/IO access has been obtained, give
adrenaline1mgandamiodarone300mgoncecompressionshave
resumed. If ROSC has not been achieved with this 3rd shock the
adrenaline will improve myocardial blood ﬂow and may increase
the chance of successful deﬁbrillation with the next shock. In
animal studies, peak plasma concentrations of adrenaline occur
at about 90 s after a peripheral injection.233 If ROSC has been
achieved after the 3rd shock it is possible that the bolus dose of
adrenaline will cause tachycardia and hypertension and precip-
itate recurrence of VF. However, naturally occurring adrenaline
plasma concentrations are high immediately after ROSC,234 and
any additional harm caused by exogenous adrenaline has not
been studied. Interrupting chest compressions to check for a per-
fusing rhythm midway in the cycle of compressions is also likely
to be harmful. The use of waveform capnography may enable
ROSC to be detected without pausing chest compressions and
may be a way of avoiding a bolus injection of adrenaline after
ROSC has been achieved. Two prospective human studies have81 (2010) 1219–1276 1233
shown that a signiﬁcant increase in end-tidal CO2 occurs when
return of spontaneous circulation occurs.235,236
• After each 2-min cycle of CPR, if the rhythm changes to asystole
or PEA, see ‘non-shockable rhythms’ below. If a non-shockable
rhythmispresent and the rhythmisorganised (complexes appear
regular or narrow), try to palpate a pulse. Rhythm checks should
be brief, and pulse checks should be undertaken only if an organ-
ised rhythm is observed. If there is any doubt about the presence
of a pulse in the presence of an organised rhythm, resume CPR. If
ROSC has been achieved, begin post-resuscitation care.
Regardless of the arrest rhythm, give further doses of adrenaline
1mg every 3–5min until ROSC is achieved; in practice, this
will be once every two cycles of the algorithm. If signs of
life return during CPR (purposeful movement, normal breath-
ing, or coughing), check the monitor; if an organised rhythm
is present, check for a pulse. If a pulse is palpable, continue
post-resuscitation care and/or treatment of peri-arrest arrhyth-
mia. If no pulse is present, continue CPR. Providing CPR with
a CV ratio of 30:2 is tiring; change the individual undertaking
compressions every 2min, while minimising the interruption in
compressions.
Precordial thump
A single precordial thump has a very low success rate for car-
dioversion of a shockable rhythm237–239 and is likely to succeed
only if given within the ﬁrst few seconds of the onset of a shock-
able rhythm.240 There is more success with pulseless VT than
with VF. Delivery of a precordial thump must not delay calling for
help or accessing a deﬁbrillator. It is therefore appropriate therapy
only when several clinicians are present at a witnessed, monitored
arrest, and when a deﬁbrillator is not immediately to hand.241 In
practice, this is only likely to be in a critical care environment such
as the emergency department or ICU.239
Airway and ventilation
During the treatmentofpersistentVF, ensuregood-quality chest
compressions between deﬁbrillation attempts. Consider reversible
causes (4 Hs and 4 Ts) and, if identiﬁed, correct them. Check the
electrode/deﬁbrillating paddle positions and contacts, and the ade-
quacy of the coupling medium, e.g., gel pads. Tracheal intubation
provides the most reliable airway, but should be attempted only if
the healthcare provider is properly trained and has regular, ongo-
ing experience with the technique. Personnel skilled in advanced
airway management should attempt laryngoscopy and intubation
without stopping chest compressions; a brief pause in chest com-
pressions may be required as the tube is passed through the vocal
cords, but this pause should not exceed 10 s. Alternatively, to avoid
any interruptions in chest compressions, the intubation attempt
may be deferred until return of spontaneous circulation. No studies
have shown that tracheal intubation increases survival after cardiac
arrest. After intubation, conﬁrm correct tube position and secure it
adequately. Ventilate the lungs at 10breathsmin−1; do not hyper-
ventilate thepatient. Once thepatient’s tracheahas been intubated,
continue chest compressions, at a rate of 100min−1 without paus-
ing during ventilation.
In the absence of personnel skilled in tracheal intubation, a
supraglottic airway device (e.g., laryngeal mask airway) is an
acceptable alternative (Section 4e). Once a supraglottic airway
device has been inserted, attempt to deliver continuous chest
compressions, uninterrupted during ventilation. If excessive gas
leakage causes inadequate ventilation of the patient’s lungs, chest
compressions will have to be interrupted to enable ventilation
(using a CV ratio of 30:2).
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ntravascular access
Establish intravenous access if this has not already been
chieved. Peripheral venous cannulation is quicker, easier to per-
orm and safer than central venous cannulation. Drugs injected
eripherally must be followed by a ﬂush of at least 20ml of ﬂuid. If
ntravenous access is difﬁcult or impossible, consider the IO route.
ntraosseous injection of drugs achieves adequate plasma concen-
rations in a time comparable with injection through a central
enous catheter.242 The recent availability ofmechanical IOdevices
as increased the ease of performing this technique.243
Unpredictable plasma concentrations are achieved when drugs
re given via a tracheal tube, and the optimal tracheal dose of most
rugs is unknown, thus, the tracheal route for drug delivery is no
onger recommended.
rugs
Adrenaline. Despite the widespread use of adrenaline during
esuscitation, and several studies involving vasopressin, there is no
lacebo-controlled study that shows that the routine use of any
asopressor at any stage during human cardiac arrest increases
eurologically intact survival to hospital discharge. Despite the
ack of human data, the use of adrenaline is still recommended,
ased largely on animal data and increased short-term survival in
umans.227,228 The optimal dose of adrenaline is not known, and
here are no data supporting the use of repeated doses. There are
ew data on the pharmacokinetics of adrenaline during CPR. The
ptimal duration of CPR and number of shocks that should be given
efore giving drugs is unknown. There is currently insufﬁcient evi-
ence to support or refute the use of any other vasopressor as
n alternative to, or in combination with, adrenaline in any car-
iac arrest rhythm to improve survival or neurological outcome.
n the basis of expert consensus, for VF/VT give adrenaline after
he third shock once chest compressions have resumed, and then
epeat every 3–5min during cardiac arrest (alternate cycles). Do
ot interrupt CPR to give drugs.
Anti-arrhythmic drugs. There is no evidence that giving any
nti-arrhythmic drug routinely during human cardiac arrest
ncreases survival to hospital discharge. In comparison with
lacebo244 and lidocaine,245 the use of amiodarone in shock-
efractory VF improves the short-term outcome of survival to
ospital admission. On the basis of expert consensus, if VF/VT per-
ists after three shocks, give 300mg amiodarone by bolus injection.
further dose of 150mg may be given for recurrent or refrac-
ory VF/VT, followed by an infusion of 900mg over 24h. Lidocaine,
mgkg−1, may be used as an alternative if amiodarone is not avail-
ble, butdonot give lidocaine if amiodaronehasbeengivenalready.
Magnesium. The routine use of magnesium in cardiac arrest
oes not increase survival.246–250 and is not recommended in car-
iac arrest unless torsades de pointes is suspected (see peri-arrest
rrhythmias).
Bicarbonate. Routine administration of sodium bicarbonate
uring cardiac arrest and CPR or after ROSC is not recommended.
ive sodium bicarbonate (50mmol) if cardiac arrest is associated
ith hyperkalaemia or tricyclic antidepressant overdose; repeat
he dose according to the clinical condition and the result of serial
lood gas analysis.on-shockable rhythms (PEA and asystole)
Pulseless electrical activity (PEA) is deﬁned as cardiac arrest in
hepresenceof electrical activity thatwouldnormallybeassociated
ith a palpable pulse. PEA is often caused by reversible conditions,81 (2010) 1219–1276
and can be treated if those conditions are identiﬁed and corrected.
Survival following cardiac arrest with asystole or PEA is unlikely
unless a reversible cause can be found and treated effectively.
If the initial monitored rhythm is PEA or asystole, start CPR 30:2
and give adrenaline 1mg as soon as venous access is achieved. If
asystole is displayed, checkwithout stoppingCPR, that the leads are
attached correctly. Once an advanced airway has been sited, con-
tinue chest compressionswithout pausing during ventilation. After
2min of CPR, recheck the rhythm. If asystole is present, resumeCPR
immediately. If an organised rhythm is present, attempt to palpate
a pulse. If no pulse is present (or if there is anydoubt about the pres-
ence of a pulse), continue CPR. Give adrenaline 1mg (IV/IO) every
alternate CPR cycle (i.e., about every 3–5min) once vascular access
is obtained. If a pulse is present, begin post-resuscitation care. If
signs of life return during CPR, check the rhythm and attempt to
palpate a pulse.
During the treatment of asystole or PEA, following a 2-min cycle
of CPR, if the rhythm has changed to VF, follow the algorithm for
shockable rhythms. Otherwise, continue CPR and give adrenaline
every 3–5min following the failure to detect a palpable pulse with
the pulse check. If VF is identiﬁed on themonitormidway through a
2-min cycle of CPR, complete the cycle of CPR before formal rhythm
and shock delivery if appropriate – this strategy will minimise
interruptions in chest compressions.
Atropine
Asystole during cardiac arrest is usually caused by primary
myocardial pathology rather than excessive vagal tone and there
is no evidence that routine use of atropine is beneﬁcial in the
treatment of asystole or PEA. Several recent studies have failed
to demonstrate any beneﬁt from atropine in out-of-hospital or in-
hospital cardiac arrests226,251–256; and its routine use for asystole
or PEA is no longer recommended.
Potentially reversible causes
Potential causes or aggravating factors for which speciﬁc treat-
ment exists must be considered during any cardiac arrest. For ease
of memory, these are divided into two groups of four based upon
their initial letter: either H or T. More details on many of these
conditions are covered in Section 8.10
Fibrinolysis during CPR
Fibrinolytic therapy should not be used routinely in cardiac
arrest.257 Consider ﬁbrinolytic therapy when cardiac arrest is
caused by proven or suspected acute pulmonary embolus. Follow-
ing ﬁbrinolysis during CPR for acute pulmonary embolism, survival
and good neurological outcomehave been reported in cases requir-
ing in excess of 60min of CPR. If a ﬁbrinolytic drug is given in these
circumstances, consider performing CPR for at least 60–90min
before termination of resuscitation attempts.258,259 Ongoing CPR
is not a contraindication to ﬁbrinolysis.
Intravenous ﬂuids
Hypovolaemia is a potentially reversible cause of cardiac arrest.
Infuse ﬂuids rapidly if hypovolaemia is suspected. In the initial
stages of resuscitation there are no clear advantages to using col-
loid, so use 0.9% sodium chloride or Hartmann’s solution. Whether
ﬂuids should be infused routinely during primary cardiac arrest is
controversial. Ensure normovolaemia, but in the absence of hypo-
volaemia, infusion of an excessive volume of ﬂuid is likely to be
harmful.260
Use of ultrasound imaging during advanced life support
Several studies have examined the use of ultrasound during
cardiac arrest to detect potentially reversible causes. Although no
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tudieshave shown thatuseof this imagingmodality improvesout-
ome, there is no doubt that echocardiography has the potential
o detect reversible causes of cardiac arrest (e.g., cardiac tam-
onade, pulmonary embolism, aortic dissection, hypovolaemia,
neumothorax).261–268 When available for use by trained clini-
ians, ultrasound may be of use in assisting with diagnosis and
reatment of potentially reversible causes of cardiac arrest. The
ntegration of ultrasound into advanced life support requires
onsiderable training if interruptions to chest compressions
re to be minimised. A sub-xiphoid probe position has been
ecommended.261,267,269 Placement of the probe just before chest
ompressions are paused for a planned rhythmassessment enables
well-trained operator to obtain views within 10 s. Absence of
ardiac motion on sonography during resuscitation of patients in
ardiac arrest is highly predictive of death270–272 although sensi-
ivity and speciﬁcity has not been reported.
irway management and ventilation
Patients requiring resuscitation often have an obstructed air-
ay, usually secondary to loss of consciousness, but occasionally
t may be the primary cause of cardiorespiratory arrest. Prompt
ssessment, with control of the airway and ventilation of the lungs,
s essential. There are three manoeuvres that may improve the
atency of an airway obstructed by the tongue or other upper air-
ay structures: head tilt, chin lift, and jaw thrust.
Despite a total lack of published data on the use of nasopharyn-
eal and oropharyngeal airways during CPR, they are often helpful,
nd sometimes essential, to maintain an open airway, particularly
hen resuscitation is prolonged.
During CPR, give oxygen whenever it is available. There are no
ata to indicate the optimal arterial blood oxygen saturation (SaO2)
uring CPR. There are animal data273 and some observational clin-
cal data indicating an association between high SaO2 after ROSC
nd worse outcome.274 Initially, give the highest possible oxygen
oncentration. As soon as the arterial blood oxygen saturation can
e measured reliably, by pulse oximeter (SpO2) or arterial blood
as analysis, titrate the inspired oxygen concentration to achieve
n arterial blood oxygen saturation in the range of 94–98%.
lternative airway devices versus tracheal intubation
There is insufﬁcient evidence to support or refute the use of
ny speciﬁc technique to maintain an airway and provide ventila-
ion in adults with cardiopulmonary arrest. Despite this, tracheal
ntubation is perceived as the optimal method of providing and
aintaining a clear and secure airway. It should be used only
hen trained personnel are available to carry out the procedure
ith a high level of skill and conﬁdence. There is evidence that,
ithout adequate training and experience, the incidence of com-
lications, is unacceptably high.275 In patientswith out-of-hospital
ardiac arrest the reliably documented incidence of unrecognised
esophageal intubation ranges from0.5% to 17%: emergency physi-
ians – 0.5%276; paramedics – 2.4%,277 6%,278,279 9%,280 17%.281
rolonged attempts at tracheal intubation are harmful; stopping
hest compressions during this time will compromise coronary
nd cerebral perfusion. In a study of prehospital intubation by
aramedics during 100 cardiac arrests, the total duration of the
nterruptions in CPR associated with tracheal intubation attempts
as 110 s (IQR 54–198 s; range 13–446 s) and in 25% the inter-
uptions were more than 3min.282 Tracheal intubation attempts
ccounted for almost 25% of all CPR interruptions. Healthcare per-
onnel who undertake prehospital intubation should do so only
ithin a structured, monitored programme, which should include
omprehensive competency-based training and regular oppor-
unities to refresh skills. Personnel skilled in advanced airway81 (2010) 1219–1276 1235
management should be able to undertake laryngoscopy without
stopping chest compressions; a brief pause in chest compressions
will be required only as the tube is passed through the vocal cords.
No intubation attempt should interrupt chest compressions for
more than10 s.After intubation, tubeplacementmustbeconﬁrmed
and the tube secured adequately.
Several alternative airway devices have been considered for air-
way management during CPR. There are published studies on the
use during CPR of the Combitube, the classic laryngealmask airway
(cLMA), the Laryngeal Tube (LT) and the I-gel, but none of these
studies have been powered adequately to enable survival to be
studiedas aprimaryendpoint; instead,most researchershave stud-
ied insertion and ventilation success rates. The supraglottic airway
devices (SADs) are easier to insert than a tracheal tube and, unlike
tracheal intubation, can generally be inserted without interrupting
chest compressions.283
Conﬁrmation of correct placement of the tracheal tube
Unrecognised oesophageal intubation is the most serious com-
plication of attempted tracheal intubation. Routine use of primary
and secondary techniques to conﬁrm correct placement of the tra-
cheal tube should reduce this risk. Primary assessment includes
observation of chest expansion bilaterally, auscultation over the
lung ﬁelds bilaterally in the axillae (breath sounds should be equal
and adequate) and over the epigastrium (breath sounds should
not be heard). Clinical signs of correct tube placement are not
completely reliable. Secondary conﬁrmation of tracheal tube place-
mentby anexhaled carbondioxideor oesophageal detectiondevice
should reduce the risk of unrecognised oesophageal intubation but
the performance of the available devices varies considerably and
all of them should be considered as adjuncts to other conﬁrmatory
techniques.284 None of the secondary conﬁrmation techniques will
differentiate between a tube placed in a main bronchus and one
placed correctly in the trachea.
The accuracy of colorimetric CO2 detectors, oesophageal detec-
tor devices and non-waveform capnometers does not exceed the
accuracy of auscultation and direct visualization for conﬁrm-
ing the tracheal position of a tube in victims of cardiac arrest.
Waveform capnography is the most sensitive and speciﬁc way
to conﬁrm and continuously monitor the position of a tracheal
tube in victims of cardiac arrest and should supplement clinical
assessment (auscultation and visualization of tube through cords).
Existing portablemonitorsmake capnographic initial conﬁrmation
and continuous monitoring of tracheal tube position feasible in
almost all settings, including out-of-hospital, emergency depart-
ment, and in-hospital locations where intubation is performed. In
the absence of a waveform capnograph it may be preferable to use
a supraglottic airway device when advanced airway management
is indicated.
CPR techniques and devices
At best, standard manual CPR produces coronary and cerebral
perfusion that is just 30% of normal.285 Several CPR techniques
and devices may improve haemodynamics or short-term survival
when used by well-trained providers in selected cases. However,
the success of any technique or device depends on the education
and training of the rescuers and on resources (including personnel).
In the hands of some groups, novel techniques and adjuncts may
be better than standard CPR. However, a device or techniquewhich
provides good quality CPR when used by a highly trained team or
in a test setting may show poor quality and frequent interruptions
when used in an uncontrolled clinical setting.286 While no circula-
tory adjunct is currently recommended for routine use instead of
manual CPR, some circulatory adjuncts are being routinely used in
bothout-of-hospital and in-hospital resuscitation. It is prudent that
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escuers are well-trained and that if a circulatory adjunct is used, a
rogram of continuous surveillance be in place to ensure that use
f the adjunct does not adversely affect survival. Although man-
al chest compressions are often performed very poorly,287–289 no
djunct has consistently been shown to be superior to conventional
anual CPR.
mpedance threshold device (ITD)
The impedance threshold device (ITD) is a valve that limits air
ntry into the lungs during chest recoil between chest compres-
ions; this decreases intrathoracic pressure and increases venous
eturn to the heart. A recentmeta-analysis demonstrated improved
OSC and short-term survival but no signiﬁcant improvement in
ither survival to discharge or neurologically intact survival to dis-
harge associated with the use of an ITD in the management of
dult OHCApatients.290 In the absence of data showing that the ITD
ncreases survival to hospital discharge, its routine use in cardiac
rrest is not recommended.
und University cardiac arrest system (LUCAS) CPR
The Lund University cardiac arrest system (LUCAS) is a gas-
riven sternal compression device that incorporates a suction cup
or active decompression. Although animal studies showed that
UCAS-CPR improveshaemodynamicandshort-termsurvival com-
aredwith standard CPR.291,292 there are no published randomised
uman studies comparing LUCAS-CPR with standard CPR.
oad-distributing band CPR (AutoPulse)
The load-distributing band (LDB) is a circumferential chest com-
ression device comprising a pneumatically actuated constricting
and and backboard. Although the use of LDB-CPR improves
aemodynamics,293–295 results of clinical trials have been con-
icting. Evidence from one multicentre randomised control trial
n over 1000 adults documented no improvement in 4-h sur-
ival and worse neurological outcome when LDB-CPR was used
y EMS providers for patients with primary out-of-hospital car-
iac arrest.296 A non-randomised human study reported increased
urvival to discharge following OHCA.297
he current status of LUCAS and AutoPulse
Two large prospective randomised multicentre studies are cur-
ently underway to evaluate the LDB (AutoPulse) and the Lund
niversity Cardiac Arrest System (LUCAS). The results of these
tudies are awaited with interest. In hospital, mechanical devices
ave been used effectively to support patients undergoing pri-
ary coronary intervention (PCI)298,299 andCT scans300 andalso for
rolonged resuscitation attempts (e.g., hypothermia,301,302 poison-
ng, thrombolysis for pulmonary embolism, prolonged transport
tc) where rescuer fatigue may impair the effectiveness of manual
hest compression. In the prehospital environment where extrica-
ion of patients, resuscitation in conﬁned spaces and movement of
atients on a trolley often preclude effective manual chest com-
ressions, mechanical devices may also have an important role.
uring transport tohospital,manualCPR isoftenperformedpoorly;
echanical CPR can maintain good quality CPR during an ambu-
ance transfer.303,304 Mechanical devices also have the advantage of
llowing deﬁbrillation without interruption in external chest com-
ression. The role of mechanical devices in all situations requires
urther evaluation.81 (2010) 1219–1276
Peri-arrest arrhythmias
The correct identiﬁcation and treatment of arrhythmias in the
critically ill patient may prevent cardiac arrest from occurring or
from reoccurring after successful initial resuscitation. These treat-
ment algorithms should enable the non-specialist ALS provider to
treat the patient effectively and safely in an emergency. If patients
are not acutely ill there may be several other treatment options,
including the use of drugs (oral or parenteral) that will be less
familiar to the non-expert. In this situation there will be time to
seek advice from cardiologists or other senior doctors with the
appropriate expertise.
The initial assessment and treatment of a patient with an
arrhythmia should follow the ABCDE approach. Key elements in
this process include assessing for adverse signs; administration of
high ﬂow oxygen; obtaining intravenous access, and establishing
monitoring (ECG, bloodpressure, SpO2).Whenever possible, record
a 12-lead ECG; this will help determine the precise rhythm, either
before treatment or retrospectively. Correct any electrolyte abnor-
malities (e.g., K+, Mg2+, Ca2+). Consider the cause and context of
arrhythmias when planning treatment.
The assessment and treatment of all arrhythmias addresses two
factors: the condition of the patient (stable versus unstable), and
the nature of the arrhythmia. Anti-arrhythmic drugs are slower in
onset and less reliable than electrical cardioversion in converting a
tachycardia to sinus rhythm; thus, drugs tend tobe reserved for sta-
ble patients without adverse signs, and electrical cardioversion is
usually the preferred treatment for the unstable patient displaying
adverse signs.
Adverse signs
The presence or absence of adverse signs or symptoms will dic-
tate the appropriate treatment formost arrhythmias. The following
adverse factors indicate a patient who is unstable because of the
arrhythmia.
1. Shock – this is seen as pallor, sweating, cold and clammyextrem-
ities (increased sympathetic activity), impaired consciousness
(reduced cerebral blood ﬂow), and hypotension (e.g., systolic
blood pressure <90mmHg).
2. Syncope – loss of consciousness, which occurs as a consequence
of reduced cerebral blood ﬂow.
3. Heart failure – arrhythmias compromise myocardial perfor-
mance by reducing coronary artery blood ﬂow. In acute
situations this ismanifestedbypulmonaryoedema (failureof the
left ventricle) and/or raised jugular venous pressure, and hepatic
engorgement (failure of the right ventricle).
4. Myocardial ischaemia – this occurs when myocardial oxy-
gen consumption exceeds delivery. Myocardial ischaemia may
present with chest pain (angina) or may occur without pain as
an isolated ﬁnding on the 12 lead ECG (silent ischaemia). The
presence ofmyocardial ischaemia is especially important if there
is underlying coronary artery disease or structural heart dis-
ease because itmay cause further life-threatening complications
including cardiac arrest.
Treatment options
Having determined the rhythm and the presence or absence of
adverse signs, the options for immediate treatment are categorised
as:
1. Electrical (cardioversion, pacing).
2. Pharmacological (anti-arrhythmic (and other) drugs).
J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1237
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achycardias
f the patient is unstable
If the patient is unstable and deteriorating, with any of the
dverse signs and symptoms described above being caused by
he tachycardia, attempt synchronised cardioversion immedi-
tely (Fig. 1.7). In patients with otherwise normal hearts, serious
igns and symptoms are uncommon if the ventricular rate is
150beatsmin−1. Patients with impaired cardiac function or sig-
iﬁcant comorbidity may be symptomatic and unstable at lower
eart rates. If cardioversion fails to restore sinus rhythm and the
atient remains unstable, give amiodarone 300mg intravenously
ver 10–20min and re-attempt electrical cardioversion. The load-
ng dose of amiodarone can be followed by an infusion of 900mg
ver 24h.
Fig. 1.8. Bradycardia algo81 (2010) 1219–1276
If the patient is stable
If the patient with tachycardia is stable (no adverse signs or
symptoms) and is not deteriorating, drug treatment is likely to be
appropriate (Fig. 1.7). Vagalmanoeuvresmay be appropriate initial
treatment for a supraventricular tachycardia.
Bradycardia
A bradycardia is deﬁned as a heart rate of <60beatsmin−1.
Assess the patient with bradycardia using the ABCDE approach.
Consider the potential cause of the bradycardia and look for
the adverse signs. Treat any reversible causes of bradycardia
identiﬁed in the initial assessment. If adverse signs are present
start to treat the bradycardia. Initial treatments are pharma-
cological, with pacing being reserved for patients unresponsive
rithm. © 2010 ERC.
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o pharmacological treatments or with risks factors for asystole
Fig. 1.8).
ost-resuscitation care
Successful ROSC is the just the ﬁrst step toward the goal
f complete recovery from cardiac arrest. The post-cardiac
rrest syndrome, which comprises post-cardiac arrest brain
njury, post-cardiac arrest myocardial dysfunction, the systemic
schaemia/reperfusion response, and the persistent precipitat-
ng pathology, often complicates the post-resuscitation phase.3
he severity of this syndrome will vary with the duration and
ause of cardiac arrest. It may not occur at all if the car-
iac arrest is brief. Post-cardiac arrest brain injury manifests
s coma, seizures, myoclonus, varying degrees of neurocogni-
ive dysfunction and brain death. Among patients surviving to
CU admission but subsequently dying in-hospital, brain injury
s the cause of death in 68% after out-of-hospital cardiac arrest
nd in 23% after in-hospital cardiac arrest.227,305 Post-cardiac
rrest brain injury may be exacerbated by microcirculatory fail-
re, impaired autoregulation, hypercarbia, hyperoxia, pyrexia,
yperglycaemia and seizures. Signiﬁcant myocardial dysfunction
s common after cardiac arrest but typically recovers by 2–3
ays.306,307 Thewhole body ischaemia/reperfusionof cardiac arrest
ctivates immunological and coagulation pathways contributing to
ultiple organ failure and increasing the risk of infection.308,309
hus, the post-cardiac arrest syndrome has many features in com-
on with sepsis, including intravascular volume depletion and
asodilation.310,311
irway and breathing
Hypoxaemia and hypercarbia both increase the likelihood of a
urther cardiac arrest andmay contribute to secondary brain injury.
everal animal studies indicate that hyperoxaemia causes oxida-
ive stress and harms post-ischaemic neurones.273,312–315 A clinical
egistry study documented that post-resuscitation hyperoxaemia
as associated with worse outcome, compared with both normox-
emia and hypoxaemia.274 In clinical practice, as soon as arterial
lood oxygen saturation can be monitored reliably (by blood gas
nalysis and/or pulse oximetry), it may be more practicable to
itrate the inspired oxygen concentration to maintain the arterial
lood oxygen saturation in the range of 94–98%. Consider tracheal
ntubation, sedation and controlled ventilation in any patient with
btunded cerebral function. There arenodata to support the target-
ng of a speciﬁc arterial PCO2 after resuscitation fromcardiac arrest,
ut it is reasonable to adjust ventilation to achieve normocarbia
nd to monitor this using the end-tidal PCO2 and arterial blood gas
alues.
irculation
It is well recognised that post-cardiac arrest patients with
TEMI should undergo early coronary angiography and percuta-
eous coronary intervention (PCI) but, because chest pain and/or
T elevation are poor predictors of acute coronary occlusion in
hese patients,316 this intervention should be considered in all
ost-cardiac arrest patients who are suspected of having coronary
rtery disease.316–324 Several studies indicate that the combination
f therapeutic hypothermia andPCI is feasible and safe after cardiac
rrest caused by acute myocardial infarction.317,323–326Post-cardiac arrest myocardial dysfunction causes haemody-
amic instability, which manifests as hypotension, low cardiac
ndex and arrhythmias.306 If treatment with ﬂuid resuscitation and
asoactive drugs is insufﬁcient to support the circulation, consider
nsertion of an intra-aortic balloon pump.317,325 In the absence of81 (2010) 1219–1276 1239
deﬁnitive data, target the mean arterial blood pressure to achieve
an adequate urine output (1ml kg−1 h−1) and normal or decreasing
plasma lactate values, taking into consideration the patient’s nor-
mal blood pressure, the cause of the arrest and the severity of any
myocardial dysfunction.3
Disability (optimizing neurological recovery)
Control of seizures
Seizures or myoclonus or both occur in 5–15% of adult
patients who achieve ROSC and 10–40% of those who remain
comatose.58,327–330 Seizures increase cerebral metabolism by up
to 3-fold331 and may cause cerebral injury: treat promptly and
effectively with benzodiazepines, phenytoin, sodium valproate,
propofol, or a barbiturate. No studies directly address the use of
prophylactic anticonvulsant drugs after cardiac arrest in adults.
Glucose control
There is a strong association between high blood glucose
after resuscitation from cardiac arrest and poor neurological
outcome.58,332–338 A large randomised trial of intensive glucose
control (4.5–6.0mmol l−1) versus conventional glucose control
(10mmol l−1 or less) in general ICU patients reported increased 90-
day mortality in patients treated with intensive glucose control.339
Another recent study and two meta-analyses of studies of tight
glucose control versus conventional glucose control in critically ill
patients showed no signiﬁcant difference in mortality but found
tight glucose control was associated with a signiﬁcantly increased
risk of hypoglycaemia.340–342 Severe hypoglycaemia is associated
with increased mortality in critically ill patients,343 and comatose
patients are at particular risk from unrecognised hypoglycaemia.
There is some evidence that, irrespective of the target range, vari-
ability in glucose values is associated with mortality.344 Based on
the available data, following ROSC blood glucose should be main-
tained at ≤10mmol l−1 (180mgdl−1).345 Hypoglycaemia should be
avoided. Strict glucose control should not be implemented in adult
patientswithROSC after cardiac arrest because of the increased risk
of hypoglycaemia.
Temperature control
Treatment of hyperpyrexia. A period of hyperthermia (hyper-
pyrexia) is common in the ﬁrst 48h after cardiac arrest.346–348
Several studies document an association between post-cardiac
arrest pyrexia and poor outcomes.58,346,348–351 There are no ran-
domised controlled trials evaluating the effect of treatment of
pyrexia (deﬁned as ≥37.6 ◦C) compared to no temperature con-
trol in patients after cardiac arrest. Although the effect of elevated
temperature on outcome is not proved, it seems prudent to treat
any hyperthermia occurring after cardiac arrest with antipyretics
or active cooling.
Therapeutic hypothermia. Animal and human data indicate
that mild hypothermia is neuroprotective and improves outcome
after a period of global cerebral hypoxia-ischaemia.352,353 Cool-
ing suppresses many of the pathways leading to delayed cell
death, including apoptosis (programmed cell death). Hypother-
mia decreases the cerebral metabolic rate for oxygen (CMRO2) by
about 6% for each 1 ◦C reduction in temperature354 and this may
reduce the release of excitatory amino acids and free radicals.352
Hypothermia blocks the intracellular consequences of excitotoxin
exposure (high calciumandglutamate concentrations) and reduces
the inﬂammatory response associated with the post-cardiac arrest
syndrome.
All studies of post-cardiac arrest therapeutic hypothermia have
included only patients in coma. There is good evidence supporting
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he use of induced hypothermia in comatose survivors of out-of-
ospital cardiac arrest caused by VF. One randomised trial355 and a
seudo-randomised trial356 demonstrated improved neurological
utcome at hospital discharge or at 6 months in comatose patients
fter out-of-hospital VF cardiac arrest. Cooling was initiated within
inutes to hours after ROSC and a temperature range of 32–34 ◦C
as maintained for 12–24h. Extrapolation of these data to other
ardiac arrests (e.g., other initial rhythms, in-hospital arrests, pae-
iatric patients) seems reasonable but is supported by only lower
evel data.317,357–363
The practical application of therapeutic hypothermia is divided
nto three phases: induction,maintenance, and rewarming.364 Ani-
al data indicate that earlier cooling after ROSC produces better
utcomes.365 External and/or internal cooling techniques can be
sed to initiate cooling. An infusion of 30mlkg−1 of 4 ◦C saline or
artmann’s solution decreases core temperature by approximately
.5 ◦C. Othermethods of inducing and/ormaintaining hypothermia
nclude: simple ice packs and/or wet towels; cooling blankets or
ads;water or air circulating blankets;water circulating gel-coated
ads; intravascular heat exchanger; and cardiopulmonary bypass.
In the maintenance phase, a cooling method with effective
emperature monitoring that avoids temperature ﬂuctuations is
referred. This is best achieved with external or internal cooling
evices that include continuous temperature feedback to achieve a
et target temperature. Plasmaelectrolyte concentrations, effective
ntravascular volume and metabolic rate can change rapidly dur-
ng rewarming, as they do during cooling. Thus, rewarmingmust be
chieved slowly: the optimal rate is not known, but the consensus
s currently about 0.25–0.5 ◦C of warming per hour.362
The well-recognised physiological effects of hypothermia need
o be managed carefully.364
rognostication
Two-thirds of those dying after admission to ICU following out-
f-hospital cardiacarrestdie fromneurological injury; thishasbeen
hown both with227 and without305 therapeutic hypothermia. A
uarter of those dying after admission to ICU following in-hospital
ardiac arrest die from neurological injury. A means of predicting
eurological outcome that can be applied to individual patients
mmediately after ROSC is required. Many studies have focused on
rediction of poor long-term outcome (vegetative state or death),
ased on clinical or test ﬁndings that indicate irreversible brain
njury, to enable clinicians to limit care or withdraw organ sup-
ort. The implications of these prognostic tests are such that they
hould have 100% speciﬁcity or zero false positive rate (FPR), i.e.,
roportion of individuals who eventually have a ‘good’ long-term
utcome despite the prediction of a poor outcome.
linical examination
There are no clinical neurological signs that predict poor out-
ome (Cerebral Performance Category [CPC] 3 or 4, or death)
eliably less than 24h after cardiac arrest. In adult patients who
re comatose after cardiac arrest, and who have not been treated
ith hypothermia and who do not have confounding factors (such
s hypotension, sedatives or muscle relaxants), the absence of both
upillary light and corneal reﬂex at ≥72h reliably predicts poor
utcome (FPR 0%; 95% CI 0–9%).330 Absence of vestibulo-ocular
eﬂexes at ≥24h (FPR 0%; 95% CI 0–14%)366,367 and a GCS motor
core of 2 or less at ≥72h (FPR 5%; 95% CI 2–9%)330 are less reliable.
ther clinical signs, including myoclonus, are not recommended
or predicting poor outcome. The presence of myoclonus status in
dults is strongly associated with poor outcome,329,330,368–370 but
are cases of good neurological recovery have been described and
ccurate diagnosis is problematic.371–37581 (2010) 1219–1276
Biochemical markers
Evidence does not support the use of serum (e.g., neuronal spe-
ciﬁc enolase, S100 protein) or CSF biomarkers alone as predictors
of poor outcomes in comatose patients after cardiac arrest with or
without treatmentwith therapeutic hypothermia (TH). Limitations
included small numbers of patients studied and/or inconsistency in
cut-off values for predicting poor outcome.
Electrophysiological studies
No electrophysiological study reliably predicts outcome of a
comatose patient within the ﬁrst 24h after cardiac arrest. If
somatosensory evoked potentials (SSEP) are measured after 24h
in comatose cardiac arrest survivors not treated with therapeu-
tic hypothermia, bilateral absence of the N20 cortical response to
median nerve stimulation predicts poor outcome (death or CPC 3
or 4) with a FPR of 0.7% (95% CI: 0.1–3.7%).376
Imaging studies
Many imaging modalities (magnetic resonance imaging [MRI],
computed tomography [CT], single photon emission com-
puted tomography [SPECT], cerebral angiography, transcranial
Doppler, nuclear medicine, near infra-red spectroscopy [NIRS])
have been studied to determine their utility for prediction
of outcome in adult cardiac arrest survivors.15 There are
no high-level studies that support the use of any imaging
modality to predict outcome of comatose cardiac arrest sur-
vivors.
Impact of therapeutic hypothermia on prognostication
There is inadequate evidence to recommend a speciﬁc approach
to prognosticating poor outcome in post-cardiac arrest patients
treated with therapeutic hypothermia. There are no clinical neuro-
logical signs, electrophysiological studies, biomarkers, or imaging
modalities that can reliably predict neurological outcome in the
ﬁrst 24h after cardiac arrest. Based on limited available evidence,
potentially reliable prognosticators of poor outcome in patients
treated with therapeutic hypothermia after cardiac arrest include
bilateral absence of N20 peak on SSEP ≥24h after cardiac arrest
(FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil-
lary reﬂexes 3 or more days after cardiac arrest (FPR 0%, 95% CI
0–48%).368,377 Limited available evidence also suggests that a Glas-
gow Motor Score of 2 or less at 3 days post-ROSC (FPR 14% [95% CI
3–44%])368 and the presence of status epilepticus (FPR of 7% [95%
CI 1–25%] to 11.5% [95% CI 3–31%])378,379 are potentially unreliable
prognosticators of poor outcome in post-cardiac arrest patients
treated with therapeutic hypothermia. Given the limited available
evidence, decisions to limit care should not be made based on the
results of a single prognostication tool.
Organ donation
Solid organs have been successfully transplanted after cardiac
death.380 This group of patients offers an untapped opportunity
to increase the organ donor pool. Organ retrieval from non-heart
beating donors is classiﬁed as controlled or uncontrolled.381 Con-
trolled donation occurs after planned withdrawal of treatment
following non-survivable injuries/illnesses. Uncontrolled dona-
tion describes donation after a patient is brought in dead or
with on-going CPR that fails to restore a spontaneous circula-
tion.Cardiac arrest centres
There is wide variability in survival among hospitals caring
for patients after resuscitation from cardiac arrest.57–63 There
is some low-level evidence that ICUs admitting more than 50
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ost-cardiac arrest patients per year produce better survival
ates than those admitting less than 20 cases per year.61 There
s indirect evidence that regional cardiac resuscitation systems
f care improve outcome ST elevation myocardial infarction
STEMI).382–404
The implication from all these data is that specialist cardiac
rrest centres and systems of caremay be effective but, as yet, there
s no direct evidence to support this hypothesis.405–407
nitial management of acute coronary syndromes
ntroduction
The incidence of acute STEMI is decreasing in many Euro-
ean countries408; however, the incidence of non-STEMI acute
oronary syndrome (non-STEMI-ACS) is increasing.409,410 Although
n-hospital mortality from STEMI has been reduced signiﬁcantly by
odern reperfusion therapy and improved secondary prophylaxis,
he overall 28-day mortality is virtually unchanged because about
wo-thirds of those who die do so before hospital arrival, mostly
rom lethal arrhythmias triggered by ischaemia.411 Thus, the best
hance of improving survival from an ischaemic attack is reducing
he delay from symptomonset to ﬁrstmedical contact and targeted
reatment started in the early out-of-hospital phase.
The term acute coronary syndrome (ACS) encompasses three
ifferent entities of the acute manifestation of coronary heart dis-
ase: STEMI, NSTEMI and unstable angina pectoris (UAP). Non-ST
levation myocardial infarction and UAP are usually combined in
he termnon-STEMI-ACS. The common pathophysiology of ACS is a
uptured or eroded atherosclerotic plaque.412 Electrocardiographic
ECG) characteristics (absence or presence of ST elevation) differ-
ntiate STEMI from NSTEMI-ACS. The latter may present with ST
egment depression, nonspeciﬁc ST segment wave abnormalities,
r even a normal ECG. In the absence of ST elevation, an increase
n the plasma concentration of cardiac biomarkers, particularly tro-
onin T or I as themost speciﬁcmarkers ofmyocardial cell necrosis,
ndicates NSTEMI.
ig. 1.9. Deﬁnitions of acute coronary syndromes (ACS); STEMI, ST elevation myocardial
ectoris.81 (2010) 1219–1276 1241
Acute coronary syndromes are the commonest cause of malig-
nant arrhythmias leading to sudden cardiac death. The therapeutic
goals are to treat acute life-threatening conditions, such as VF or
extreme bradycardia, and to preserve left ventricular function and
prevent heart failure by minimising the extent of myocardial dam-
age. The current guidelines address the ﬁrst hours after onset of
symptoms. Out-of-hospital treatment and initial therapy in the
emergency department (ED) may vary according to local capabili-
ties, resources and regulations. The data supporting out-of-hospital
treatment are often extrapolated from studies of initial treatment
after hospital admission; there are fewhigh-quality out-of-hospital
studies. Comprehensive guidelines for the diagnosis and treatment
of ACS with and without ST elevation have been published by the
European Society of Cardiology and the American College of Cardi-
ology/American Heart Association. The current recommendations
are in line with these guidelines (Figs. 1.9 and 1.10).413,414
Diagnosis and risk stratiﬁcation in acute coronary
syndromes
Patients at risk, and their families, should be able to recognize
characteristic symptoms such as chest pain, which may radiate
into other areas of the upper body, often accompanied by other
symptoms including dyspnoea, sweating, nausea or vomiting and
syncope. They should understand the importance of early activa-
tion of the EMS system and, ideally, should be trained in basic life
support (BLS). Optimal strategies for increasing layperson aware-
ness of the various ACS presentations and improvement of ACS
recognition in vulnerable populations remain to be determined.
Moreover, EMSdispatchersmust be trained to recognizeACS symp-
toms and to ask targeted questions.
Signs and symptoms of ACSTypically ACS appears with symptoms such as radiating chest
pain, shortness of breath and sweating; however, atypical symp-
toms or unusual presentations may occur in the elderly, in females,
and in diabetics.415,416 None of these signs and symptoms of ACS
can be used alone for the diagnosis of ACS.
infarction; NSTEMI, non-ST elevation myocardial infarction; UAP, unstable angina
1242 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
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oading dose, may be chosen as an alternative to clopidogrel in patients with STEMI
he time of writing, ticagrelor has not yet been approved as an alternative to clopid
2-lead ECG
A 12-lead ECG is the key investigation for assessment of an ACS.
n case of STEMI, it indicates the need for immediate reperfusion
herapy (i.e., primary percutaneous coronary intervention (PCI) or
rehospital ﬁbrinolysis). When an ACS is suspected, a 12-lead ECG
hould be acquired and interpreted as soon as possible after ﬁrst
atient contact, to facilitate earlier diagnosis and triage. Prehospital
r EDECGyields useful diagnostic informationwhen interpretedby
rained health care providers.417
Recording of a 12-lead ECG out-of-hospital enables advanced
otiﬁcation to the receiving facility and expedites treatment deci-
ions after hospital arrival. Paramedics and nurses can be trained
o diagnose STEMI without direct medical consultation, as long as
here is strict concurrent provision of medically directed quality
ssurance. If interpretation of the prehospital ECG is not available
n-site, computer interpretation418,419 or ﬁeld transmission of the
CG is reasonable.
iomarkersIn the absence of ST elevation on the ECG, the presence of
suggestive history and elevated concentrations of biomarkers
troponin T and troponin I, CK, CK-MB, myoglobin) characterise
on-STEMI and distinguish it from STEMI and unstable anginarcutaneous coronary intervention; UFH, unfractionated heparin. *Prasugrel, 60mg
lanned PPCI provided there is no history of stroke or transient ischaemic attack. At
respectively. Measurement of a cardiac-speciﬁc troponin is prefer-
able. Elevated concentrations of troponin are particularly helpful in
identifying patients at increased risk of adverse outcome.420
Decision rules for early discharge
Attempts have been made to combine evidence from history,
physical examination serial ECGs and serial biomarker measure-
ment in order to form clinical decision rules that would help triage
of ED patients with suspected ACS.
None of these rules is adequate and appropriate to identify ED
chest pain patients with suspected ACS who can be safely dis-
charged from the ED.421
Chest pain observation protocols
In patients presenting to the ED with a history suggestive of
ACS, but normal initial workup, chest pain (observation) units
may represent a safe and effective strategy for evaluating patients.
They reduce length of stay, hospital admissions and health-
care costs, improve diagnostic accuracy and improve quality of
life.422 There is no direct evidence demonstrating that chest pain
units or observation protocols reduce adverse cardiovascular out-
comes, particularly mortality, for patients presenting with possible
ACS.
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reatment of acute coronary syndromes—symptoms
Glyceryl trinitrate is an effective treatment for ischaemic chest
ain and has beneﬁcial haemodynamic effects, such as dilation of
he venous capacitance vessels, dilation of the coronary arteries
nd, to a minor extent, the peripheral arteries. Glyceryl trinitrate
ay be considered if the systolic blood pressure is above 90mmHg
nd the patient has ongoing ischaemic chest pain. Glyceryl trini-
rate can also be useful in the treatment of acute pulmonary
ongestion. Nitrates should not be used in patients with hypoten-
ion (systolic blood pressure ≤90mmHg), particularly if combined
ith bradycardia, and in patients with inferior infarction and sus-
ected right ventricular involvement. Use of nitrates under these
ircumstances can decrease the blood pressure and cardiac output.
Morphine is the analgesic of choice for nitrate-refractory pain
nd also has calming effects on the patient making sedatives
nnecessary in most cases. Since morphine is a dilator of venous
apacitance vessels, it may have additional beneﬁt in patients with
ulmonary congestion. Give morphine in initial doses of 3–5mg
ntravenously and repeat every few minutes until the patient is
ain-free. Non-steroidal anti-inﬂammatory drugs (NSAIDs) should
e avoided for analgesia because of their pro-thrombotic effects.423
Monitoring of the arterial oxygen saturation (SaO2) with pulse
ximetry will help to determine the need for supplemental oxy-
en. These patients do not need supplemental oxygen unless
hey are hypoxaemic. Limited data suggest that high-ﬂow oxy-
en may be harmful in patients with uncomplicated myocardial
nfarction.424–426 Aimtoachieveanoxygen saturationof 94–98%, or
8–92% if the patient is at risk of hypercapnic respiratory failure.427
reatment of acute coronary syndromes—cause
nhibitors of platelet aggregation
Inhibition of platelet aggregation is of primary importance for
nitial treatment of coronary syndromes as well as for secondary
revention, since platelet activation and aggregation is the key
rocess initiating an ACS.
cetylsalicylic acid (ASA)
Large randomised controlled trials indicate decreased mortal-
ty when ASA (75–325mg) is given to hospitalised patients with
CS. A few studies have suggested reducedmortality if ASA is given
arlier.428,429 Therefore, give ASA as soon as possible to all patients
ith suspected ACS unless the patient has a known true allergy to
SA. ASA may be given by the ﬁrst healthcare provider, bystander
r by dispatcher assistance according to local protocols. The initial
ose of chewable ASA is 160–325mg. Other forms of ASA (soluble,
V) may be as effective as chewed tablets.
DP receptor inhibitors
Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl-
riazolo-pyrimidine, ticagrelor, inhibit the ADP receptor irre-
ersibly, which further reduces platelet aggregation in addition to
hat produced by ASA.
If given in addition to heparin and ASA in high-risk non-STEMI-
CS patients, clopidogrel improves outcome.430,431 Clopidogrel
hould be given as early as possible in addition to ASA and an
ntithrombin to all patients presenting with non-STEMI-ACS. If a
onservative approach is selected, give a loading dose of 300mg;
ith a planned PCI strategy, an initial dose of 600mg may be pre-erred. Prasugrel or ticagrelor can be given instead of clopidogrel.
Although there is no large study on the use of clopidogrel for
re-treatment of patients presenting with STEMI and planned PCI,
t is likely that this strategy is beneﬁcial. Since platelet inhibition
s more profound with a higher dose, a 600mg loading dose given81 (2010) 1219–1276 1243
as soon as possible is recommended for patients presenting with
STEMI and planned PCI. Prasugrel or ticagrelor can be used instead
of clopidogrel before planned PCI. Patientswith STEMI treatedwith
ﬁbrinolysis should be treated with clopidogrel (300mg loading
dose up to an age of 75 years and 75mg without loading dose if
>75 years of age) in addition to ASA and an antithrombin.
Glycoprotein (Gp) IIB/IIIA inhibitors
Gp IIB/IIIA receptor is the common ﬁnal link of platelet aggre-
gation. Eptiﬁbatide and tiroﬁban lead to reversible inhibition,
while abciximab leads to irreversible inhibition of the Gp IIB/IIIA
receptor. There are insufﬁcient data to support routine pre-
treatment with Gp IIB/IIIA inhibitors in patients with STEMI or
non-STEMI-ACS.
Antithrombins
Unfractionated heparin (UFH) is an indirect inhibitor of throm-
bin, which in combination with ASA is used as an adjunct with
ﬁbrinolytic therapy or primary PCI (PPCI) and is an important part
of treatment of unstable angina and STEMI. There are now several
alternative antithrombins for the treatment of patients with ACS.
In comparison with UFH, these alternatives have a more speciﬁc
factor Xa activity (low molecular weight heparins [LMWH], fonda-
parinux) or are direct thrombin inhibitors (bivalirudin). With these
newer antithrombins, in general, there is no need to monitor the
coagulation system and there is a reduced risk of thrombocytope-
nia.
In comparisonwithUFH, enoxaparin reduces the combinedend-
point of mortality, myocardial infarction and the need for urgent
revascularisation, if givenwithin the ﬁrst 24–36h of onset of symp-
toms of non-STEMI-ACS.432,433 For patients with a planned initial
conservative approach, fondaparinux and enoxaparin are reason-
able alternatives to UFH. For patients with an increased bleeding
risk consider giving fondaparinux or bivalirudin, which cause less
bleeding than UFH.434–436 For patients with a planned invasive
approach, enoxaparin or bivalirudin are reasonable alternatives to
UFH.
Several randomised studies of patients with STEMI under-
going ﬁbrinolysis have shown that additional treatment with
enoxaparin instead of UFH produced better clinical outcomes
(irrespective of the ﬁbrinolytic used) but a slightly increased
bleeding rate in elderly (≥75 years) and low weight patients
(BW<60kg).437–439
Enoxaparin is a safe and effective alternative to UFH for con-
temporary PPCI (i.e., broad use of thienopyridines and/orGp IIB/IIIA
receptor blockers).440,441 There are insufﬁcient data to recommend
any LMWH other than enoxaparin for PPCI in STEMI. Bivalirudin is
also a safe alternative to UFH for STEMI and planned PCI.
Strategies and systems of care
Several systematic strategies to improve quality of out-of-
hospital care for patients with ACS have been investigated. These
strategies are principally intended to promptly identify patients
with STEMI in order to shorten the delay to reperfusion treatment.
Also triage criteria have been developed to select high-risk patients
with non-STEMI-ACS for transport to tertiary care centres offering
24/7 PCI services. In this context, several speciﬁc decisions have to
be made during initial care beyond the basic diagnostic steps nec-
essary for clinical evaluation of the patient and interpretation of a
12-lead ECG. These decisions relate to:
(1) Reperfusion strategy in patients with STEMI i.e., PPCI vs. pre-
hospital ﬁbrinolysis.
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2) Bypassingacloserbutnon-PCI capablehospital and takingmea-
sures to shorten the delay to intervention if PPCI is the chosen
strategy.
3) Procedures in special situations e.g., for patients successfully
resuscitated from non-traumatic cardiac arrest, patients with
shock or patients with non-STEMI-ACS who are unstable or
have signs of very high risk.
eperfusion strategy in patients presenting with STEMI
For patients presenting with STEMI within 12h of symptom
nset, reperfusion should be initiated as soon as possible indepen-
ent of themethod chosen.414,442–444 Reperfusionmay be achieved
ith ﬁbrinolysis, with PPCI, or a combination of both. Efﬁcacy of
eperfusion therapy is profoundly dependent on the duration of
ymptoms. Fibrinolysis is effective speciﬁcally in the ﬁrst 2–3h
fter symptom onset; PPCI is less time sensitive.445 Giving ﬁb-
inolytics out-of-hospital to patients with STEMI or signs and
ymptoms of an ACS with presumed new LBBB is beneﬁcial. Fib-
inolytic therapy can be given safely by trained paramedics, nurses
r physicians using an established protocol.446–451 The efﬁcacy is
reatest within the ﬁrst 3h of the onset of symptoms.452 Patients
ith symptoms of ACS and ECG evidence of STEMI (or presum-
bly new LBBB or true posterior infarction) presenting directly to
he ED should be given ﬁbrinolytic therapy as soon as possible
nless there is timely access to PPCI. Healthcare professionals who
ive ﬁbrinolytic therapymust be aware of its contraindications and
isks.
rimary percutaneous intervention
Coronary angioplasty with or without stent placement has
ecome the ﬁrst-line treatment for patients with STEMI, because
t has been shown to be superior to ﬁbrinolysis in the combined
ndpoints of death, stroke and reinfarction in several studies and
eta-analyses.453,454
ibrinolysis versus primary PCI
Several reports and registries comparing ﬁbrinolytic (including
re-hospital administration) therapy with PPCI showed a trend of
mproved survival if ﬁbrinolytic therapy was initiated within 2h
f onset of symptoms and was combined with rescue or delayed
CI.455–457 If PPCI cannot be accomplished within an adequate
imeframe, independent of the need for emergent transfer, then
mmediate ﬁbrinolysis should be considered unless there is a
ontraindication. For those STEMI patients presenting in shock,
rimary PCI (or coronary artery bypass surgery) is the preferred
eperfusion treatment. Fibrinolysis should be considered only if
here is a substantial delay to PCI.
riage and inter-facility transfer for primary PCI
The risk of death, reinfarction or stroke is reduced if patients
ith STEMI are transferred promptly from community hospitals
o tertiary care facilities for PPCI.383,454,458 It is less clear whether
mmediate ﬁbrinolytic therapy (in- or out-of-hospital) or transfer
or PPCI is superior for younger patients presenting with anterior
nfarction and within a short duration of <2–3h.459 Transfer of
TEMI patients for PPCI is reasonable for those presenting more
han 3h but less than 12h after the onset of symptoms, provided
hat the transfer can be achieved rapidly.ombination of ﬁbrinolysis and percutaneous coronary
ntervention
Fibrinolysis and PCI may be used in a variety of combina-
ions to restore coronary blood ﬂow and myocardial perfusion.
here are several ways in which the two therapies can be81 (2010) 1219–1276
combined. Facilitated PCI is PCI performed immediately after ﬁb-
rinolysis, a pharmaco-invasive strategy refers to PCI performed
routinely 3–24h after ﬁbrinolysis, and rescue PCI is deﬁned as
PCI performed for a failed reperfusion (as evidenced by <50%
resolution of ST segment elevation at 60–90min after comple-
tion of ﬁbrinolytic treatment). These strategies are distinct from
a routine PCI approach where the angiography and intervention
is performed several days after successful ﬁbrinolysis. Several
studies and meta-analyses demonstrate worse outcome with rou-
tine PCI performed immediately or as early as possible after
ﬁbrinolysis.458,460 Therefore routine facilitated PCI is not recom-
mended even if there may be some speciﬁc subgroups of patients
thatmay beneﬁt from this procedure.461 It is reasonable to perform
angiography and PCI when necessary in patients with failed ﬁbri-
nolysis according to clinical signs and/or insufﬁcient ST-segment
resolution.462
In the case of clinically successful ﬁbrinolysis (evidenced
by clinical signs and ST-segment resolution >50%), angiography
delayed by several hours after ﬁbrinolysis (the ‘pharmaco-invasive’
approach) has been shown to improve outcome. This strategy
includes early transfer for angiography and PCI if necessary after
ﬁbrinolytic treatment.463,464
Reperfusion after successful CPR
Coronary heart disease is the most frequent cause of out-of-
hospital cardiac arrest. Many of these patients will have an acute
coronary occlusion with signs of STEMI on the ECG, but cardiac
arrest due to ischaemic heart disease can also occur in absence
of these ﬁndings. In patients with STEMI or new LBBB on ECG
following ROSC after out-of-hospital cardiac arrest, immediate
angiography andPCI or ﬁbrinolysis should be considered.316,321 It is
reasonable to perform immediate angiography and PCI in selected
patients despite the lack of ST elevation on the ECG or prior clinical
ﬁndings such as chest pain. It is reasonable to include reperfu-
sion treatment in a standardised post-cardiac arrest protocol as
part of a strategy to improve outcome.317 Reperfusion treatment
should not preclude other therapeutic strategies including thera-
peutic hypothermia.
Primary and secondary prevention
Preventive interventions in patients presenting with an ACS
should be initiated early after hospital admission and should be
continued if already in place. Preventive measures improve prog-
nosis by reducing the number of major adverse cardiac events.
Prevention with drugs encompasses beta-blockers, angiotensin
converting enzyme (ACE) inhibitors/angiotensin receptor block-
ers (ARB) and statins, as well as basic treatment with ASA and, if
indicated, thienopyridines.
Paediatric life support
Paediatric basic life support
Sequence of actions
Rescuers who have been taught adult BLS and have no speciﬁc
knowledge of paediatric resuscitation may use the adult sequence,
as outcome isworse if they donothing. Non-specialistswhowish to
learn paediatric resuscitation because they have responsibility for
children (e.g., teachers, school nurses, lifeguards), should be taught
that it is preferable to modify adult BLS and perform ﬁve initial
breaths followed by approximately one minute of CPR before they
go for help (see adult BLS guideline).
J.P. Nolan et al. / Resuscitation
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tig. 1.11. Paediatric basic life support algorithm for those with a duty to respond.
The following sequence is to be followed by those with a duty
o respond to paediatric emergencies (usually health professional
eams) (Fig. 1.11).
1. Ensure the safety of rescuer and child.
2. Check the child’s responsiveness.
• Gently stimulate the child and ask loudly: Are you all right?
3A. If the child responds by answering or moving:
• Leave the child in the position in which you ﬁnd him (provided
he is not in further danger).
• Check his condition and get help if needed.
• Reassess him regularly.
3B. If the child does not respond:
• Shout for help.
• Turn carefully the child on his back.
• Open the child’s airway by tilting the head and lifting the chin.
◦ Place your hand on his forehead and gently tilt his head back.81 (2010) 1219–1276 1245
◦ At the same time, with your ﬁngertip(s) under the point of the
child’s chin, lift the chin. Do not push on the soft tissues under
the chin as this may obstruct the airway.
◦ If you still have difﬁculty in opening the airway, try a jaw
thrust: place the ﬁrst two ﬁngers of each hand behind each
side of the child’s mandible and push the jaw forward.
4. Keeping the airway open, look, listen and feel for normal breath-
ing by putting your face close to the child’s face and looking along
the chest:
• Look for chest movements.
• Listen at the child’s nose and mouth for breath sounds.
• Feel for air movement on your cheek.
In the ﬁrst few minutes after a cardiac arrest a child may be
taking slow infrequent gasps. Look, listen and feel for nomore than
10 s before deciding—if you have any doubt whether breathing is
normal, act as if it is not normal:
5A. If the child is breathing normally:
• Turn the child on his side into the recovery position (see below)
• Send or go for help—call the local emergency number for an
ambulance.
• Check for continued breathing.
5B. If breathing is not normal or absent:
• Remove carefully any obvious airway obstruction.
• Give ﬁve initial rescue breaths.
• While performing the rescue breaths note any gag or cough
response to your action. These responses or their absence will
form part of your assessment of ‘signs of life’, which will be
described later.
Rescue breaths for a child over 1 year of age:
• Ensure head tilt and chin lift.
• Pinch the soft part of the nose closed with the index ﬁnger and
thumb of your hand on his forehead.
• Allow the mouth to open, but maintain chin lift.
• Take a breath and place your lips around the mouth, making sure
that you have a good seal.
• Blow steadily into the mouth over about 1–1.5 s watching for
chest rise.
• Maintain head tilt and chin lift, take your mouth away from the
victim and watch for his chest to fall as air comes out.
• Take another breath and repeat this sequence ﬁve times. Identify
effectivenessbyseeing that thechild’s chesthas risenand fallen in
a similar fashion to the movement produced by a normal breath.
Rescue breaths for an infant:
• Ensure a neutral position of the head and a chin lift.
• Take a breath and cover the mouth and nose of the infant with
your mouth, making sure you have a good seal. If the nose and
mouth cannot be covered in the older infant, the rescuer may
attempt to seal only the infant’s nose or mouth with his mouth
(if the nose is used, close the lips to prevent air escape).
• Blow steadily into the infant’s mouth and nose over 1–1.5 s, suf-
ﬁcient to make the chest visibly rise.
• Maintain head position and chin lift, take your mouth away from
the victim and watch for his chest to fall as air comes out.
• Take another breath and repeat this sequence ﬁve times.
For both infants and children, if you have difﬁculty achieving an
effective breath, the airway may be obstructed:
• Open the child’s mouth and remove any visible obstruction. Do
not perform a blind ﬁnger sweep.
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son, the guidelines for the treatment of FBAO are different between
infants and children. Signs for the recognition of FBAO in a child are
listed in Table 1.2.
Table 1.2
Signs of foreign body airway obstruction.
General signs of FBAO
Witnessed episode
Coughing/choking
Sudden onset
Recent history of playing with/eating small objects
Ineffective coughing Effective cough246 J.P. Nolan et al. / Resusc
Ensure that there is adequate head tilt and chin lift but also that
the neck is not over extended.
If head tilt and chin lift has not opened the airway, try the jaw
thrust method.
Make up to ﬁve attempts to achieve effective breaths, if still
unsuccessful, move on to chest compressions.
6. Assess the child’s circulation
Take no more than 10 s to:
• Look for signs of life—this includes any movement, coughing or
normal breathing (not abnormal gasps or infrequent, irregular
breaths).
If you check the pulse, ensure you take no more than 10 s.
In a child over 1 year—feel for the carotid pulse in the neck.
In an infant—feel for the brachial pulse on the inner aspect of the
upper arm.
The femoral pulse in the groin, which is half way between the
anterior superior iliac spine and the symphysis pubis, can also be
used in infant and children.
7A. If you are conﬁdent that you can detect signs of lifewithin 10 s:
• Continue rescue breathing, if necessary, until the child starts
breathing effectively on his own.
• Turn the child on to his side (into the recovery position) if he
remains unconscious.
• Re-assess the child frequently.
7B. If there are no signs of life, unless you are CERTAIN you can feel
a deﬁnite pulse of greater than 60beatsmin−1 within 10 s:
• Start chest compressions.
• Combine rescue breathing and chest compressions:
Chest compressions
For all children, compress the lower half of the sternum.
To avoid compressing the upper abdomen, locate the xiphister-
um by ﬁnding the angle where the lowest ribs join in the middle.
ompress the sternum one ﬁnger’s breadth above this; the com-
ression should be sufﬁcient to depress the sternum by at least
ne-third of the depth of the chest. Don’t be afraid to push too hard:
Push Hard and Fast”. Release the pressure completely and repeat
t a rate of at least 100min−1 (but not exceeding 120min−1). After
5 compressions, tilt the head, lift the chin, and give two effective
reaths. Continue compressions and breaths in a ratio of 15:2. The
est method for compression varies slightly between infants and
hildren.
Chest compression in infants
The lone rescuer compresses the sternum with the tips of two
ngers. If there are two or more rescuers, use the encircling tech-
ique. Place both thumbs ﬂat side by side on the lower half of the
ternum(as above)with the tips pointing towards the infant’s head.
pread the rest of both hands with the ﬁngers together to encircle
he lower part of the infant’s rib cage with the tips of the ﬁngers
upporting the infant’s back. For both methods, depress the lower
ternum by at least one-third of the depth of the infant’s chest
approximately 4 cm).
Chest compression in children over 1 year of age
Place the heel of one hand over the lower half of the sternum (as
bove). Lift the ﬁngers to ensure that pressure is not applied over
he child’s ribs. Position yourself vertically above the victim’s chest
nd, with your arm straight, compress the sternum to depress it by
t least one-third of the depth of the chest (approximately 5 cm).
n larger children or for small rescuers, this is achieved most easily
y using both hands with the ﬁngers interlocked.8. Do not interrupt resuscitation until:
• The child shows signs of life (starts to wake up, to move, opens
eyes and to breathe normally or a deﬁnite pulse of greater than
60min−1 is palpated).81 (2010) 1219–1276
• Further qualiﬁed help arrives and takes over.
• You become exhausted.
When to call for assistance
It is vital for rescuers to get help as quickly as possible when a
child collapses.
• Whenmore than one rescuer is available, one starts resuscitation
while another rescuer goes for assistance.
• If only one rescuer is present, undertake resuscitation for about
1min before going for assistance. To minimise interruption in
CPR, it may be possible to carry an infant or small child while
summoning help.
• The only exception to performing 1min of CPR before going for
help is in the case of a child with a witnessed, sudden collapse
when the rescuer is alone. In this case, cardiac arrest is likely to
be caused by an arrhythmia and the child will need deﬁbrillation.
Seek help immediately if there is no one to go for you.
Recovery position
An unconscious child whose airway is clear, and who is breath-
ing normally, should be turned on his side into the recovery
position. The adult recovery position is suitable for use in children.
Foreign body airway obstruction (FBAO)
Back blows, chest thrusts and abdominal thrusts all increase
intra-thoracic pressure and can expel foreign bodies from the air-
way. In half of the episodes more than one technique is needed to
relieve the obstruction.465 There are nodata to indicatewhichmea-
sure should be used ﬁrst or in which order they should be applied.
If one is unsuccessful, try the others in rotation until the object is
cleared.
The FBAO algorithm for children was simpliﬁed and aligned
with the adult version in 2005 guidelines; this continues to be the
recommended sequence for managing FBAO (Fig. 1.12).
The most signiﬁcant difference from the adult algorithm is that
abdominal thrusts should not be used for infants. Although abdom-
inal thrusts have caused injuries in all age groups, the risk is
particularly high in infants and very young children. This is because
of the horizontal position of the ribs, which leaves the upper
abdominal viscera much more exposed to trauma. For this rea-Unable to vocalise Crying or verbal response to questions
Quiet or silent cough Loud cough
Unable to breathe Able to take a breath before coughing
Cyanosis Fully responsive
Decreasing level of consciousness
J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1247
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Table 1.3
General recommendation for cuffed anduncuffed tracheal tube sizes (internal diam-
eter in mm).
Uncuffed Cuffed
Neonates
Premature Gestational age in weeks/10 Not usedFig. 1.12. Paediatric foreign body ai
aediatric advanced life support
revention of cardiopulmonary arrest
In children, secondary cardiopulmonary arrests, caused by
ither respiratory or circulatory failure, are more frequent than
rimary arrests caused by arrhythmias.466–471 So-called asphyx-
al arrests or respiratory arrests are also more common in young
dulthood (e.g., trauma, drowning, poisoning).472,473 The outcome
rom cardiopulmonary arrests in children is poor; identiﬁcation of
he antecedent stages of cardiac or respiratory failure is a prior-
ty, as effective early intervention may be life saving. The order of
ssessment and intervention for any seriously ill or injured child
ollows the ABCDE principles outlined previously for adults. Sum-
oning a paediatric RRT or MET may reduce the risk of respiratory
nd/or cardiac arrest in hospitalised children outside the intensive
are setting.202,474–478
anagement of respiratory and circulatory failure
In children, there are many causes of respiratory and circula-
ory failure and they may develop gradually or suddenly. Both may
e initially compensated but will normally decompensate without
dequate treatment. Untreated decompensated respiratory or cir-
ulatory failurewill lead to cardiopulmonary arrest. Hence, the aim
f paediatric life support is early and effective intervention in chil-
renwith respiratory and circulatory failure to prevent progression
o full arrest.
irway and breathing
Open the airway and ensure adequate ventilation and oxygena-
tion. Deliver high-ﬂow oxygen.
Establish respiratory monitoring (ﬁrst line—pulse oximetry/
SpO2).
Achieving adequate ventilation and oxygenationmay require use
of airway adjuncts, bag-mask ventilation (BMV), use of a laryn-
geal mask airway (LMA), securing a deﬁnitive airway by tracheal
intubation and positive pressure ventilation.
Very rarely, a surgical airway may be required.
Rapid-sequence induction and intubation. The child who is in
ardiopulmonary arrest and deep coma does not require seda-Full term 3.5 Not usually used
Infants 3.5–4.0 3.0–3.5
Child 1–2 years 4.0–4.5 3.5–4.0
Child >2 years Age/4 +4 Age/4 +3.5
tion or analgesia to be intubated; otherwise, intubation must be
preceded by oxygenation (gentle BMV is sometimes required to
avoid hypoxia), rapid sedation, analgesia and the use of neuro-
muscular blocking drugs tominimize intubation complications and
failure.479 The intubator must be experienced and familiar with
drugs used for rapid-sequence induction. The use of cricoid pres-
sure may prevent or limit regurgitation of gastric contents,480,481
but it may distort the airway and make laryngoscopy and intuba-
tion more difﬁcult.482 Cricoid pressure should not be used if either
intubation or oxygenation is compromised.
A general recommendation for tracheal tube internal diameters
(ID) for different ages is shown in Table 1.3.483–488 This is a guide
only and tubes one size larger and smaller should always be avail-
able. Tracheal tube size can also be estimated from the length of
the child’s body as measured by resuscitation tapes.489
Uncuffed tracheal tubes have been used traditionally in children
up to 8 years of age but cuffed tubesmay offer advantages in certain
circumstances e.g., when lung compliance is poor, airway resis-
tance is high or if there is a large air leak from the glottis.483,490,491
The use of cuffed tubes also makes it more likely that the correct
tube size will be chosen on the ﬁrst attempt.483,484,492 As excessive
cuff pressure may lead to ischaemic damage to the surrounding
laryngeal tissueand stenosis, cuff inﬂationpressure shouldbemon-
itored and maintained at less than 25 cm H2O.493
Displaced, misplaced or obstructed tubes occur frequently in
the intubated child and are associated with increased risk of
death.281,494 No single technique is 100% reliable for distinguish-
ing oesophageal from tracheal intubation.495–497 Assessment of the
correct tracheal tube position is made by:
• laryngoscopic observation of the tube passing beyond the vocal
cords;
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detection of end-tidal CO2 if the child has a perfusing rhythm
(this may also be seen with effective CPR, but it is not completely
reliable);
observation of symmetrical chestwallmovement during positive
pressure ventilation;
observation of mist in the tube during the expiratory phase of
ventilation;
absence of gastric distension;
equal air entry heard on bilateral auscultation in the axillae and
apices of the chest;
absence of air entry into the stomach on auscultation;
improvement or stabilisation of SpO2 in the expected range
(delayed sign!);
heart rate moving closer to the age-expected value (or remaining
within the normal range) (delayed sign!).
If the child is in cardiopulmonary arrest and exhaled CO2 is not
etected despite adequate chest compressions, or if there is any
oubt, conﬁrm tracheal tube position by direct laryngoscopy.
Breathing. Give oxygen at the highest concentration (i.e., 100%)
uring initial resuscitation. Once circulation is restored, give sufﬁ-
ient oxygen to maintain an arterial oxygen saturation (SaO2) in
he range of 94–98%.498,499
Healthcare providers commonly provide excessive ventila-
ion during CPR and this may be harmful. Hyperventilation
auses increased intra-thoracic pressure, decreased cerebral and
oronary perfusion, and poorer survival rates in animals and
dults.224,225,286,500–503 Although normoventilation is the objec-
ive during resuscitation, it is difﬁcult to know the precise minute
olume that is being delivered. A simple guide to deliver an accept-
ble tidal volume is to achieve modest chest wall rise. Once the
irway is protected by tracheal intubation, continue positive pres-
ure ventilation at 10–12breathsmin−1 without interrupting chest
ompressions. When circulation is restored, or if the child still has
perfusing rhythm, ventilate at 12–20breathsmin−1 to achieve a
ormal arterial carbon dioxide tension (PaCO2).
Monitoring end-tidal CO2 (ETCO2) with a colorimetric detec-
or or capnometer conﬁrms tracheal tube placement in the child
eighing more than 2kg, and may be used in pre- and in-hospital
ettings, as well as during any transportation of the child.504–507
colour change or the presence of a capnographic waveform for
ore than four ventilated breaths indicates that the tube is in the
racheobronchial tree both in the presence of a perfusing rhythm
nd during cardiopulmonary arrest. Capnography does not rule
ut intubation of a bronchus. The absence of exhaled CO2 dur-
ng cardiopulmonary arrest does not guarantee tubemisplacement
ince a low or absent end tidal CO2 may reﬂect low or absent
ulmonary blood ﬂow.235,508–510 Capnography may also provide
nformation on the efﬁciency of chest compressions and can give an
arly indication of ROSC.511,512 Efforts should be made to improve
hest compression quality if the ETCO2 remains below 15mmHg
2 kPa). Current evidence does not support the use of a threshold
TCO2 value as an indicator for the discontinuation of resuscitation
fforts.
The self-inﬂating bulb or aspirating syringe (oesophageal detec-
or device, ODD) may be used for the secondary conﬁrmation of
racheal tube placement in childrenwith a perfusing rhythm.513,514here are no studies on the use of the ODD in children who are in
ardiopulmonary arrest.
Clinical evaluation of the oxygen saturation of arterial blood
SaO2) is unreliable; therefore, monitor the child’s peripheral oxy-
en saturation continuously by pulse oximetry (SpO2).81 (2010) 1219–1276
Circulation
• Establish cardiac monitoring [ﬁrst line—pulse oximetry (SpO2),
ECG and non-invasive blood pressure (NIBP)].
• Secure vascular access. This may be by peripheral IV or IO cannu-
lation. If already in situ, a central intravenous catheter should be
used.
• Give a ﬂuid bolus (20mlkg−1) and/or drugs (e.g., inotropes, vaso-
pressors, anti-arrhythmics) as required.
• Isotonic crystalloids are recommended as initial resuscitation
ﬂuid in infants and children with any type of shock, including
septic shock.515–518
• Assess and re-assess the child continuously, commencing each
time with the airway before proceeding to breathing and then
the circulation.
• During treatment, capnography, invasive monitoring of arterial
blood pressure, blood gas analysis, cardiac output monitoring,
echocardiography and central venous oxygen saturation (ScvO2)
may be useful to guide the management of respiratory and/or
circulatory failure.
Vascular access. Venous access can be difﬁcult to establish dur-
ing resuscitation of an infant or child: if attempts at establishing
IV access are unsuccessful after one minute, insert an IO needle
instead.519,520 Intraosseous or IV access is much preferred to the
tracheal route for giving drugs.521
Adrenaline. The recommended IV/IO dose of adrenaline in chil-
dren for the ﬁrst and for subsequent doses is 10gkg−1. The
maximum single dose is 1mg. If needed, give further doses of
adrenaline every 3–5min. Intratracheal adrenaline is no longer
recommended,522–525 but if this route is ever used, the dose is ten
times this (100gkg−1).
Advanced management of cardiopulmonary arrest
1. When a child becomes unresponsive, without signs of life (no
breathing, cough or any detectable movement), start CPR imme-
diately.
2. Provide BMV with 100% oxygen.
3. Commencemonitoring. Send for amanual deﬁbrillator or anAED
to identify and treat shockable rhythms as quickly as possible
(Fig. 1.13).
ABC
Commence and continue with basic life support
Oxygenate and ventilate with BMV
Provide positive pressure ventilation with a high inspired oxy-
gen concentration
Give ﬁve rescue breaths followed by external chest compression
and positive pressure ventilation in the ratio of 15:2
Avoid rescuer fatigue by frequently changing the rescuer per-
forming chest compressions
Establish cardiac monitoring
Assess cardiac rhythm and signs of life
(±Check for a central pulse for no more than 10 s)
Non-shockable—asystole, PEA
• −1Give adrenaline IV or IO (10gkg ) and repeat every 3–5min.
• Identify and treat any reversible causes (4Hs & 4Ts).
Shockable—VF/pulseless VT
Attempt deﬁbrillation immediately (4 J kg−1):
J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1249
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Charge the deﬁbrillator while another rescuer continues chest
compressions.
Once the deﬁbrillator is charged, pause the chest compressions,
ensure that all rescuers are clear of the patient. Minimise the
delay between stopping chest compressions and delivery of the
shock—even 5–10 s delay will reduce the chances of the shock
being successful.71,110
Give one shock.
Resume CPR as soon as possible without reassessing the rhythm.
After 2min, check brieﬂy the cardiac rhythm on the monitor
Give second shock (4 J kg−1) if still in VF/pulseless VT
Give CPR for 2min as soon as possible without reassessing the
rhythm.
Pause brieﬂy to assess the rhythm; if still in VF/pulseless VT give
a third shock at 4 J kg−1.
Give adrenaline 10gkg−1 and amiodarone 5mgkg−1 after the
third shock once CPR has been resumed.pport algorithm. © 2010 ERC.
• Give adrenaline every alternate cycle (i.e., every 3–5min during
CPR)
• Give a seconddoseof amiodarone5mgkg−1 if still inVF/pulseless
VT after the ﬁfth shock.526
If the child remains in VF/pulseless VT, continue to alternate
shocks of 4 J kg−1 with 2min of CPR. If signs of life become evident,
check the monitor for an organised rhythm; if this is present, check
for signsof life anda central pulse andevaluate thehaemodynamics
of the child (blood pressure, peripheral pulse, capillary reﬁll time).
Identify and treat any reversible causes (4Hs & 4Ts) remember-
ing that the ﬁrst 2Hs (hypoxia and hypovolaemia) have the highest
prevalence in critically ill or injured children.
If deﬁbrillation was successful but VF/pulseless VT recurs,
resumeCPR, give amiodarone and deﬁbrillate again at the dose that
waseffectivepreviously. Start a continuous infusionof amiodarone.
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Echocardiography may be used to identify potentially treatable
auses of cardiac arrest in children. Cardiac activity can be rapidly
isualised527 and pericardial tamponade diagnosed.268 However,
ppropriately skilled operatorsmust be available and its use should
e balanced against the interruption to chest compressions during
xamination.
rrhythmias
Unstable arrhythmias. Check for signs of life and the central
ulse of any child with an arrhythmia; if signs of life are absent,
reat as for cardiopulmonary arrest. If the child has signs of life and
central pulse, evaluate the haemodynamic status. Whenever the
aemodynamic status is compromised, the ﬁrst steps are:
. Open the airway.
. Give oxygen and assist ventilation as necessary.
. Attach ECG monitor or deﬁbrillator and assess the cardiac
rhythm.
. Evaluate if the rhythm is slow or fast for the child’s age.
. Evaluate if the rhythm is regular or irregular.
. Measure QRS complex (narrow complexes: <0.08 s duration;
wide complexes: >0.08 s).
. The treatment options are dependent on the child’s haemody-
namic stability.
Bradycardia is caused commonly by hypoxia, acidosis and/or
evere hypotension; it may progress to cardiopulmonary arrest.
ive 100% oxygen, and positive pressure ventilation if required,
o any child presenting with bradyarrhythmia and circulatory fail-
re. If a poorly perfused child has a heart rate <60beatsmin−1,
nd they do not respond rapidly to ventilation with oxygen,
tart chest compressions and give adrenaline. If the brady-
ardia is caused by vagal stimulation (such as after passing
nasogastric tube), atropine may be effective. Cardiac pacing
either transvenous or external) is generally not useful dur-
ng resuscitation. It may be considered in cases of AV block
r sinus node dysfunction unresponsive to oxygenation, ven-
ilation, chest compressions and other medications; pacing is
ot effective in asystole or arrhythmias caused by hypoxia or
schaemia.528
If SVT is the likely rhythm, vagal manoeuvres (Valsalva or div-
ng reﬂex) may be used in haemodynamically stable children.
hey can also be used in haemodynamically unstable children, but
nly if they do not delay chemical (e.g., adenosine) or electrical
ardioversion.529 If the child is unstablewith a depressed conscious
evel, attempt synchronised electrical cardioversion immediately.
lectrical cardioversion (synchronised with R wave) is also indi-
ated when vascular access is not available, or when adenosine has
ailed to convert the rhythm. The ﬁrst energy dose for electrical
ardioversion of SVT is 0.5–1 J kg−1 and the second dose is 2 J kg−1.
In children, wide-QRS complex tachycardia is uncommon and
ore likely to be supraventricular than ventricular in origin.530
evertheless, in haemodynamically unstable children, it must be
onsidered to be VT until proven otherwise. Synchronised car-
ioversion is the treatment of choice for unstable VT with a
ulse. Consider anti-arrhythmic therapy if a second cardioversion
ttempt is unsuccessful or if VT recurs.
Stable arrhythmias. While maintaining the child’s airway,
reathing and circulation, contact an expert before initiating ther-
py. Depending on the child’s clinical history, presentation and ECG
iagnosis, a child with stable, wide-QRS complex tachycardia may
e treated for SVT and be given vagal manoeuvres or adenosine.
miodarone may be considered as a treatment option if this fails
r if the diagnosis of VT is conﬁrmed on an ECG.81 (2010) 1219–1276
Special circumstances
Channelopathy
When sudden unexplained cardiac arrest occurs in children and
young adults, obtain a complete past medical and family history
(including a history of syncopal episodes, seizures, unexplained
accidents/drownings, or sudden death) and review any available
previous ECGs. All infants, children, and young adults with sud-
den, unexpected death should, if possible, have an unrestricted,
completeautopsy,performedpreferablybypathologistswith train-
ing andexpertise in cardiovascular pathology.531–540 Consideration
should be given to preservation and genetic analysis of tissue
to determine the presence of a channelopathy. Refer families of
patients whose cause of death is not found on autopsy to a health
careprovider/centrewithexpertise incardiac rhythmdisturbances.
Single ventricle post-stage 1 repair
The incidence of cardiac arrest in infants following single ventri-
cle stage 1 repair is approximately 20%, with a survival to discharge
of 33%.541 There is no evidence that anything other than routine
resuscitative protocols should be followed. Diagnosis of the pre-
arrest state is difﬁcult but it may be assisted by monitoring the
oxygen extraction (superior vena caval ScvO2) or near infra-red
spectroscopy (cerebral and splanchnic circulations).542–544 Treat-
ment of high systemic vascular resistance with alpha-adrenergic
receptor blockade may improve systemic oxygen delivery,545
reduce the incidence of cardiovascular collapse,546 and improve
survival.547
Single ventricle post-Fontan
Children in thepre-arrest statewhohaveFontanorhemi-Fontan
anatomymaybeneﬁt from increased oxygenation and an improved
cardiac output by instituting negative pressure ventilation.548,549
Extracorporeal membrane oxygenation (ECMO) may be useful
rescue for children with failing Fontan circulations but no recom-
mendation can be made in favour or against ECMO in those with
hemi-Fontan physiology or for rescue during resuscitation.550
Pulmonary hypertension
There is an increased risk of cardiac arrest in children with pul-
monary hypertension.551,552 Follow routine resuscitation protocols
in these patients with emphasis on high FiO2 and alkalo-
sis/hyperventilation because this may be as effective as inhaled
nitric oxide in reducing pulmonary vascular resistance.553 Resus-
citation is most likely to be successful in patients with a reversible
cause who are treated with intravenous epoprostenol or inhaled
nitric oxide.554 If routinemedications that reducepulmonaryartery
pressure have been stopped, they should be restarted and the use
of aerosolised epoprostenol or inhaled nitric oxide considered.555
Right ventricular support devices may improve survival.556–559
Post-arrest management
The principles of post-cardiac arrest management and treat-
ment of the post-cardiac arrest syndrome in children are similar
to those of adults.
Temperature control and management
Hypothermia is common in the child following cardiopul-
monary resuscitation.350 Central hypothermia (32–34 ◦C) may be
beneﬁcial, whereas fever may be detrimental to the injured brain.
Mild hypothermia has an acceptable safety proﬁle in adults355,356
and neonates.560–565 While it may improve neurological outcome
in children, an observational study neither supports nor refutes the
use of therapeutic hypothermia in paediatric cardiac arrest.566
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A child who regains a spontaneous circulation, but remains
omatose after cardiopulmonary arrest, may beneﬁt from being
ooled to a core temperature of 32–34 ◦C for at least 24h. The suc-
essfully resuscitated childwith hypothermia and ROSC should not
e actively rewarmed unless the core temperature is below 32 ◦C.
ollowing a period of mild hypothermia, rewarm the child slowly
t 0.25–0.5 ◦Ch−1.
These guidelines are based on evidence from the use of thera-
eutic hypothermia in neonates and adults. At the time of writing,
here are ongoing, prospective, multicentre trials of therapeutic
ypothermia in children following in- and out-of-hospital cardiac
rrest. (www.clinicaltrials.gov; NCT00880087 and NCT00878644)
Fever is common following cardiopulmonary resuscitation and
s associated with a poor neurological outcome,346,348,349 the risk
ncreasing for each degree of body temperature greater than
7 ◦C.349 There are limited experimental data suggesting that
he treatment of fever with antipyretics and/or physical cooling
educes neuronal damage.567,568 Antipyretics and accepted drugs
o treat fever are safe; therefore, use them to treat fever aggres-
ively.
lucose control
Both hyper- and hypo-glycaemia may impair outcome of criti-
ally ill adults and children and should be avoided, but tight glucose
ontrol may also be harmful. Although there is insufﬁcient evi-
ence to support or refute a speciﬁc glucose management strategy
n children with ROSC after cardiac arrest,3,569,570 it is appropri-
te to monitor blood glucose and avoid hypoglycaemia as well as
ustained hyperglycaemia.
esuscitation of babies at birth
reparation
Relatively few babies need any resuscitation at birth. Of those
hat do need help, the overwhelming majority will require only
ssisted lung aeration. A small minority may need a brief period
f chest compressions in addition to lung aeration. Of 100,000
abies born in Sweden in one year, only 10 per 1000 (1%) babies
f 2.5 kg or more appeared to need resuscitation at delivery.571 Of
hose babies receiving resuscitation, 8 per 1000 responded to mask
nﬂation and only 2 per 1000 appeared to need intubation. The
ame study tried to assess the unexpected need for resuscitation
t birth and found that for low risk babies, i.e., those born after 32
eeks gestation and following an apparently normal labour, about
per 1000 (0.2%) appeared to need resuscitation at delivery. Of
hese, 90% responded to mask inﬂation alone while the remaining
0% appeared not to respond to mask inﬂation and therefore were
ntubated at birth (Fig. 1.14).
Resuscitation or specialist help at birth is more likely to be
eeded by babies with intrapartum evidence of signiﬁcant fetal
ompromise, babies delivering before 35 weeks gestation, babies
elivering vaginally by the breech, and multiple pregnancies.
lthough it is often possible to predict the need for resuscitation
r stabilisation before a baby is born, this is not always the case.
herefore, personnel trained innewborn life support should be eas-
ly available at every delivery and, should there be any need for
ntervention, the care of the baby should be their sole responsibil-
ty. One person experienced in tracheal intubation of the newborn
hould ideally be in attendance for deliveries associatedwith a high
isk of requiring neonatal resuscitation. Local guidelines indicat-
ng who should attend deliveries should be developed, based on
urrent practice and clinical audit.
An organised educational programme in the standards and skills
equired for resuscitation of the newborn is therefore essential for
ny institution in which deliveries occur.81 (2010) 1219–1276 1251
Planned home deliveries
Recommendations as to who should attend a planned home
delivery vary from country to country, but the decision to undergo
a planned home delivery, once agreed with medical and midwifery
staff, should not compromise the standard of initial resuscitation
at birth. There will inevitably be some limitations to resuscitation
of a newborn baby in the home, because of the distance from fur-
ther assistance, and this must be made clear to the mother at the
time plans for home delivery are made. Ideally, two trained profes-
sionals should be present at all home deliveries; one of these must
be fully trained and experienced in providing mask ventilation and
chest compressions in the newborn.
Equipment and environment
Unlike adult cardiopulmonary resuscitation (CPR), resuscitation
at birth is often a predictable event. It is therefore possible to pre-
pare the environment and the equipment before delivery of the
baby. Resuscitation should ideally take place in a warm, well-lit,
draught free area with a ﬂat resuscitation surface placed below a
radiant heater, with other resuscitation equipment immediately
available. All equipment must be checked frequently.
When a birth takes place in a non-designated delivery area, the
recommended minimum set of equipment includes a device for
safe assisted lung aeration of an appropriate size for the newborn,
warm dry towels and blankets, a sterile instrument for cutting the
umbilical cord and clean gloves for the attendant and assistants. It
may also be helpful to have a suction device with a suitably sized
suctioncatheter anda tonguedepressor (or laryngoscope) toenable
theoropharynx tobeexamined.Unexpecteddeliveriesoutsidehos-
pital aremost likely to involve emergency serviceswho should plan
for such events.
Temperature control
Naked, wet, newborn babies cannot maintain their body tem-
perature in a room that feels comfortably warm for adults.
Compromised babies are particularly vulnerable.572 Exposure of
the newborn to cold stress will lower arterial oxygen tension573
and increase metabolic acidosis.574 Prevent heat loss:
• Protect the baby from draughts.
• Keep the delivery room warm. For babies less than 28 weeks
gestation the delivery room temperature should be 26 ◦C.575,576
• Dry the term baby immediately after delivery. Cover the head
and body of the baby, apart from the face, with a warm towel
to prevent further heat loss. Alternatively, place the baby skin to
skin with mother and cover both with a towel.
• If the baby needs resuscitation then place the baby on a warm
surface under a preheated radiant warmer.
• In very preterm babies (especially below 28 weeks) drying and
wrappingmaynot be sufﬁcient. Amore effectivemethod of keep-
ing these babies warm is to cover the head and body of the baby
(apart from the face) with plastic wrapping, without drying the
baby beforehand, and then to place the baby so covered under
radiant heat.
Initial assessment
The Apgar score was proposed as a “simple, common, clear clas-
siﬁcation or grading of newborn infants” to be used “as a basis
for discussion and comparison of the results of obstetric practices,
types of maternal pain relief and the effects of resuscitation” (our
emphasis).577 It was not designed to be assembled and ascribed
in order to then identify babies in need of resuscitation.578 How-
ever, individual components of the score, namely respiratory rate,
1252 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
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eart rate and tone, if assessed rapidly, can identify babies needing
esuscitation.577 Furthermore, repeated assessment particularly of
eart rate and, to a lesser extent breathing, can indicate whether
he baby is responding or whether further efforts are needed.
reathing
Check whether the baby is breathing. If so, evaluate the rate,
epth and symmetry of breathing together with any evidence of an
bnormal breathing pattern such as gasping or grunting.eart rate
This is assessed best by listening to the apex beat with a stetho-
cope. Feeling the pulse in the base of the umbilical cord is oftent algorithm. © 2010 ERC.
effective but can be misleading, cord pulsation is only reliable if
found to be more than 100beatsmin−1.579 For babies requiring
resuscitation and/or continued respiratory support, amodernpulse
oximeter can give an accurate heart rate.580
Colour
Colour is a poor means of judging oxygenation,581 which is bet-
ter assessed using pulse oximetry if possible. A healthy baby is born
blue but starts to become pink within 30 s of the onset of effective
breathing. Peripheral cyanosis is common and does not, by itself,
indicate hypoxemia. Persistent pallor despite ventilation may indi-
cate signiﬁcant acidosis or rarely hypovolaemia. Although colour is
a poor method of judging oxygenation, it should not be ignored: if
a baby appears blue check oxygenation with a pulse oximeter.
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one
A very ﬂoppy baby is likely to be unconscious and will need
entilatory support.
actile stimulation
Drying the baby usually produces enough stimulation to induce
ffective breathing. Avoidmore vigorousmethods of stimulation. If
hebaby fails to establish spontaneousandeffectivebreaths follow-
ng a brief period of stimulation, further support will be required.
lassiﬁcation according to initial assessment
On the basis of the initial assessment, the baby can be placed
nto one of three groups:
. Vigorous breathing or crying
Good tone
Heart rate higher than 100min−1
This baby requires no intervention other than drying, wrapping
n a warm towel and, where appropriate, handing to the mother.
he baby will remain warm through skin-to-skin contact with
other under a cover, and may be put to the breast at this stage.
. Breathing inadequately or apnoeic
Normal or reduced tone
Heart rate less than 100min−1
Dry and wrap. This baby may improve with mask inﬂation but if
his does not increase the heart rate adequately, may also require
hest compressions.
. Breathing inadequately or apnoeic
Floppy
Low or undetectable heart rate
Often pale suggesting poor perfusion
Dry and wrap. This baby will then require immediate airway
ontrol, lung inﬂation and ventilation. Once this has been success-
ully accomplished thebabymayalsoneed chest compressions, and
erhaps drugs.
There remains a very rare group of babies who, though breath-
ng adequately andwith a goodheart rate, remainhypoxaemic. This
roup includes a range of possible diagnoses such as diaphragmatic
ernia, surfactant deﬁciency, congenital pneumonia, pneumotho-
ax, or cyanotic congenital heart disease.
ewborn life support
Commence newborn life support if assessment shows that the
aby has failed to establish adequate regular normal breathing, or
as a heart rate of less than 100min−1. Opening the airway and
erating the lungs isusually all that isnecessary. Furthermore,more
omplex interventions will be futile unless these two ﬁrst steps
ave been successfully completed.
irway
Place the baby on his back with the head in a neutral position.
2 cm thickness of the blanket or towel placed under the baby’s
houlders may be helpful in maintaining proper head position. In
oppy babies application of jaw thrust or the use of an appropri-
tely sized oropharyngeal airway may be helpful in opening the
irway.
Suction is needed only if the airway is obstructed and is best
one under direct vision. Aggressive pharyngeal suction can delay
he onset of spontaneous breathing and cause laryngeal spasm and
agal bradycardia.582 The presence of thick meconium in a non-
igorous baby is the only indication for considering immediate
uction of the oropharynx. Connect a 12–14FG suction catheter,
r a Yankauer sucker, to a suction source not exceeding minus
00mmHg.81 (2010) 1219–1276 1253
Breathing
After initial steps at birth, if breathing efforts are absent or
inadequate, lung aeration is the priority. In term babies, begin
resuscitationwith air. The primarymeasure of adequate initial lung
inﬂation is a prompt improvement in heart rate; assess chest wall
movement if heart rate does not improve.
For the ﬁrst few breaths maintain the initial inﬂation pres-
sure for 2–3 s. This will help lung expansion. Most babies needing
resuscitation at birth will respond with a rapid increase in heart
rate within 30 s of lung inﬂation. If the heart rate increases but
the baby is not breathing adequately, ventilate at a rate of about
30breathsmin−1 allowing approximately one second for each
inﬂation, until there is adequate spontaneous breathing.
Adequate passive ventilation is usually indicated by either a
rapidly increasingheart rate or a heart rate that ismaintained faster
than 100beatsmin−1. If the baby does not respond in this way the
most likely cause is inadequate airway control or inadequate venti-
lation. Without adequate lung aeration, chest compressions will be
ineffective; therefore, conﬁrm lung aeration before progressing to
circulatory support. Some practitioners will ensure airway control
by tracheal intubation, but this requires training and experience. If
this skill is not available and theheart rate is decreasing, re-evaluate
the airway position and deliver inﬂation breaths while summon-
ing a colleague with intubation skills. Continue ventilatory support
until the baby has established normal regular breathing.
Circulatory support
Circulatory support with chest compressions is effective only if
the lungs have ﬁrst been successfully inﬂated. Give chest compres-
sions if the heart rate is less than 60beatsmin−1 despite adequate
ventilation. The most effective technique for providing chest com-
pressions is to place the two thumbs side by side over the lower
third of the sternum just below an imaginary line joining the
nipples, with the ﬁngers encircling the torso and supporting the
back.583–586 An alternative way to ﬁnd the correct position of
the thumbs is to identify the xiphisternum and then to place the
thumbs on the sternum one ﬁnger’s breadth above this point. The
sternum is compressed to adepthof approximately one-thirdof the
anterior–posterior diameter of the chest allowing the chest wall to
return to its relaxed position between compressions.587
Use a CV ratio of 3:1, aiming to achieve approximately
120eventsmin−1, i.e., approximately 90 compressions and 30
breaths. Check theheart rate after about30 s andperiodically there-
after. Discontinue chest compressionswhen the spontaneous heart
rate is faster than 60beatsmin−1.
Drugs
Drugs are rarely indicated in resuscitation of the newly born
infant. Bradycardia in the newborn infant is usually caused by
inadequate lung inﬂation or profound hypoxia, and establishing
adequate ventilation is the most important step to correct it. How-
ever, if the heart rate remains less than 60beatsmin−1 despite
adequate ventilation and chest compressions, it is reasonable to
consider the use of drugs. These are best given via an umbilical
venous catheter.
Adrenaline
Despite the lack of human data it is reasonable to use adrenalinewhen adequate ventilation and chest compressions have failed to
increase the heart rate above 60beatsmin−1. If adrenaline is used,
give 10–30gkg−1 intravenously as soon as possible. The tracheal
route is not recommended but if it is used, it is highly likely that
doses of 50–100gkg−1 will be required. Neither the safety nor
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he efﬁcacy of these higher tracheal doses has been studied. Do not
ive these high doses intravenously.
icarbonate
There are insufﬁcient data to recommend routine use of bicar-
onate in resuscitation of the newly born. The hyperosmolarity and
arbon dioxide-generating properties of sodium bicarbonate may
mpair myocardial and cerebral function. Use of sodium bicarbon-
te is discouraged during brief CPR. If it is used during prolonged
rrests unresponsive to other therapy, it should be given only after
dequate ventilation and circulation is establishedwith CPR. A dose
f 1–2mmol kg−1 may be given by slow intravenous injection after
dequate ventilation and perfusion have been established.
luids
If there has been suspected blood loss or the infant appears to be
n shock (pale, poor perfusion, weak pulse) and has not responded
dequately to other resuscitative measures then consider giving
uid.588 This is a rare event. In the absence of suitable blood (i.e.,
rradiated and leucocyte-depleted group O Rh-negative blood),
sotonic crystalloid rather than albumin is the solution of choice
or restoring intravascular volume. Give a bolus of 10mlkg−1
nitially. If successful it may need to be repeated to maintain an
mprovement.
topping resuscitation
Local and national committees will determine the indications
or stopping resuscitation. If the heart rate of a newly born baby
s not detectable and remains undetectable for 10min, it is then
ppropriate to consider stopping resuscitation. In cases where the
eart rate is less than 60min−1 at birth and does not improve after
0 or 15min of continuous and apparently adequate resuscitative
fforts, the choice is much less clear. In this situation there is insuf-
cient evidence about outcome to enableﬁrmguidanceonwhether
o withhold or to continue resuscitation.
ommunication with the parents
It is important that the team caring for the newborn baby
nforms the parents of the baby’s progress. At delivery, adhere
o local plans for routine care and, if possible, hand the baby to
he mother at the earliest opportunity. If resuscitation is required
nform the parents of the procedures undertaken and why they
ere required. Record carefully all discussions and decisions in the
other’snotesprior todeliveryand in thebaby’s recordsafterbirth.
ardiac arrest in special circumstances
lectrolyte abnormalities
Life-threatening arrhythmias are associated most commonly
ith potassium disorders, particularly hyperkalaemia, and less
ommonly with disorders of serum calcium and magnesium.
n some cases therapy for life-threatening electrolyte disorders
hould start before laboratory results become available. There is
ittle or no evidence for the treatment of electrolyte abnormalities
uring cardiac arrest. Guidance during cardiac arrest is based on
he strategies used in the non-arrest patient. There are no major
hanges in the treatment of these disorders since the International
uidelines 2005.58981 (2010) 1219–1276
Poisoning
Poisoning rarely causes cardiac arrest, but is a leading cause of
death in victims younger than 40 years of age.590 Poisoning by
therapeutic or recreational drugs and by household products are
the main reasons for hospital admission and poison centre calls.
Inappropriate drug dosing, drug interactions and other medication
errors can also cause harm. Accidental poisoning is commonest in
children. Homicidal poisoning is uncommon. Industrial accidents,
warfareor terrorismcanalsocauseexposure toharmful substances.
Prevention of cardiac arrest
Assess and treat the victim using the ABCDE (Airway, Breath-
ing, Circulation, Disability, Exposure) approach. Airwayobstruction
and respiratory arrest secondary to a decreased conscious level is
a common cause of death after self-poisoning.591 Pulmonary aspi-
ration of gastric contents can occur after poisoning with central
nervous system depressants. Early tracheal intubation of uncon-
scious patients by a trained person decreases the risk of aspiration.
Drug-induced hypotension usually responds to ﬂuid infusion, but
occasionally vasopressor support (e.g., noradrenaline infusion) is
required. A long period of coma in a single position can cause pres-
sure sores and rhabdomyolysis. Measure electrolytes (particularly
potassium), blood glucose and arterial blood gases. Monitor tem-
perature because thermoregulation is impaired. Both hypothermia
and hyperthermia (hyperpyrexia) can occur after overdose of some
drugs. Retain samples of blood and urine for analysis. Patients
with severe poisoning should be cared for in a critical care
setting. Interventions such as decontamination, enhanced elim-
ination and antidotes may be indicated and are usually second
line interventions.592 Alcohol excess is often associated with self-
poisoning.
Modiﬁcations to basic and advanced life support
• Have a high index of personal safety where there is a suspicious
cause or unexpected cardiac arrest. This is especially so when
more than one casualty collapses simultaneously.
• Avoid mouth-to-mouth ventilation in the presence of chemicals
such as cyanide, hydrogen sulphide, corrosives and organophos-
phates.
• Treat life-threatening tachyarrhythmias with cardioversion
according to the peri-arrest arrhythmia guidelines (see Advanced
life support).6 This includes correctionof electrolyte andacid-base
abnormalities.
• Try to identify the poison(s). Relatives, friends and ambu-
lance crews can provide useful information. Examination of
the patient may reveal diagnostic clues such as odours, nee-
dle marks, pupil abnormalities, and signs of corrosion in the
mouth.
• Measure the patient’s temperature because hypo- or hyperther-
mia may occur after drug overdose (see Sections 8d and 8e).
• Beprepared to continue resuscitation for a prolongedperiod, par-
ticularly in young patients, as the poison may be metabolized or
excreted during extended life support measures.
• Alternative approaches thatmaybeeffective in severelypoisoned
patients include: higher doses of medication than in standard
protocols; non-standard drug therapies; prolonged CPR.
• Consult regional or national poisons centres for information on
treatment of the poisoned patient. The International Programme
on Chemical Safety (IPCS) lists poison centres on its website:
http://www.who.int/ipcs/poisons/centre/en/
• On-line databases for information on toxicology and hazardous
chemicals: (http://toxnet.nlm.nih.gov/)
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rowning
The World Health Organisation (WHO) estimates that, world-
ide, drowning accounts for approximately 450,000 deaths each
earanddrowning is a commoncauseof accidentaldeath inEurope.
fter drowning the duration of hypoxia is the most critical factor
n determining the victim’s outcome; therefore, oxygenation, ven-
ilation, and perfusion should be restored as rapidly as possible.
mmediate resuscitation at the scene is essential for survival and
eurological recovery after a drowning incident. This will require
rovision of CPR by a bystander and immediate activation of the
MSsystem.Victimswhohavespontaneouscirculationandbreath-
ng when they reach hospital usually recover with good outcomes.
esearch into drowning is limited in comparison with primary car-
iac arrest and there is a need for further research in this area.593
he guidelines described in detail in Section 8 of the ERCGuidelines
re intended for healthcare professionals and certain groups of lay
esponders that have a special interest in the care of the drowning
ictim e.g., lifeguards.10
ccidental hypothermia
Accidental hypothermia existswhen the body core temperature
nintentionally drops below 35 ◦C. Hypothermia can be classiﬁed
rbitrarily as mild (35–32 ◦C), moderate (32–28 ◦C) or severe (less
han 28 ◦C).594 In a hypothermic patient, no signs of life alone is
nreliable for declaringdeath. In thepre-hospital setting, resuscita-
ion should bewithheld only if the cause of a cardiac arrest is clearly
ttributable to a lethal injury, fatal illness, prolonged asphyxia, or if
he chest is incompressible. All the principles of prevention, basic
ndadvanced life support apply to thehypothermicpatient.Use the
ame ventilation and chest compression rates as for a normoth-
rmic patient. Hypothermia can cause stiffness of the chest wall,
aking ventilation and chest compressions more difﬁcult.
The hypothermic heart may be unresponsive to cardio-
ctive drugs, attempted electrical pacing and deﬁbrillation. Drug
etabolism is slowed, leading to potentially toxic plasma concen-
rations of any drugs given repeatedly.595 Withold adrenaline and
therCPRdrugsuntil thepatienthasbeenwarmed toa temperature
igher than approximately 30 ◦C. Once 30 ◦C has been reached, the
ntervals between drug doses should be doubled when compared
ith normothermia intervals. As normothermia is approached
over 35 ◦C), standard drug protocols should be used.
As the body core temperature decreases, sinus bradycardia
ends to give way to atrial ﬁbrillation followed by VF and ﬁnally
systole.596 Once in hospital, severely hypothermic victims in car-
iac arrest should be rewarmed with active internal methods.
rrhythmias other thanVF tend to revert spontaneously as the core
emperature increases, andusually donot require immediate treat-
ent. Bradycardiamaybephysiological in severehypothermia, and
ardiac pacing is not indicated unless bradycardia associated with
aemodynamic compromise persists after re-warming. The tem-
erature at which deﬁbrillation should ﬁrst be attempted and how
ften it should be tried in the severely hypothermic patient has
ot been established. AEDs may be used on these patients. If VF is
etected, give a shock at themaximumenergy setting; if VF/VTper-
ists after three shocks, delay further deﬁbrillation attempts until
he core temperature is above 30 ◦C.597 If an AED is used, follow the
ED prompts while rewarming the patient. CPR and rewarming
ay have to be continued for several hours to facilitate successful
eﬁbrillation.597Rewarming may be passive, active external, or active internal.
assive rewarming is appropriate in conscious victims with mild
ypothermiawho are still able to shiver. Hypothermic victimswith
n altered consciousness should be taken to a hospital capable of
ctive external and internal rewarming. In a hypothermic patient81 (2010) 1219–1276 1255
with apnoea and cardiac arrest, extracorporeal rewarming is the
preferred method of active internal rewarming because it provides
sufﬁcient circulation and oxygenationwhile the core body temper-
ature is increased by 8–12 ◦Ch−1.598
During rewarming, patients will require large volumes of ﬂuids
as vasodilation causes expansionof the intravascular space. Contin-
uous haemodynamic monitoring and warm IV ﬂuids are essential.
Avoid hyperthermia during and after re-warming. Although there
are no formal studies, once ROSC has been achieved use standard
strategies for post-resuscitation care, including mild hypothermia
if appropriate.
Hyperthermia
Hyperthermia occurs when the body’s ability to thermoregu-
late fails and core temperature exceeds that normally maintained
by homeostatic mechanisms. Hyperthermia may be exogenous,
caused by environmental conditions, or secondary to endogenous
heat production.
Environment-related hyperthermia occurs where heat, usually
in the formof radiant energy, is absorbedby the body at a rate faster
than can be lost by thermoregulatory mechanisms. Hyperther-
mia occurs along a continuum of heat-related conditions, starting
with heat stress, progressing to heat exhaustion, to heat stroke
(HS) and ﬁnally multiorgan dysfunction and cardiac arrest in some
instances.599
Heat stroke is a systemic inﬂammatory response with a core
temperature above 40.6 ◦C, accompanied by mental state change
and varying levels of organ dysfunction. There are two forms of
HS: classic non-exertional heat stroke (CHS) occurs during high
environmental temperatures and often effects the elderly during
heat waves600; Exertional heat stroke (EHS) occurs during strenu-
ous physical exercise in high environmental temperatures and/or
high humidity usually effects healthy young adults.601 Mortality
from heat stroke ranges between 10% and 50%.602
The mainstay of treatment is supportive therapy based on opti-
mizing the ABCDEs and rapidly cooling the patient.603–605 Start
cooling before the patient reaches hospital. Aim to reduce the core
temperature rapidly to approximately 39 ◦C. Patients with severe
heat stroke need to be managed in a critical-care setting.
There are no speciﬁc studies on cardiac arrest in hyperthermia.
If cardiac arrest occurs, follow standard procedures for basic and
advanced life support and cool the patient. Cooling techniques sim-
ilar to those used to induce therapeutic hypothermia should be
used. There are no data on the effects of hyperthermia on deﬁb-
rillation threshold; therefore, attempt deﬁbrillation according to
current guidelines, while continuing to cool the patient. Animal
studies suggest theprognosis is poor comparedwithnormothermic
cardiac arrest.606,607 The risk of unfavourable neurological outcome
increases for each degree of body temperature >37 ◦C.349
Asthma
Theworldwide prevalence of asthma symptoms ranges from 1%
to 18% of the population with a high prevalence in some European
countries (United Kingdom, Ireland and Scandinavia).608 Annual
worldwide deaths from asthma have been estimated at 250,000.
National and international guidance for themanagement of asthma
already exists.608,609 This guidance focuses on the treatment of
patients with near-fatal asthma and cardiac arrest.Causes of asthma-related cardiac arrest
Cardiac arrest in a person with asthma is often a terminal event
after a period of hypoxaemia; occasionally, it may be sudden. Car-
diac arrest in those with asthma has been linked to:
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severe bronchospasm and mucous plugging leading to asphyxia
(this condition causes the vast majority of asthma-related
deaths);
cardiac arrhythmias caused by hypoxia, which is the commonest
cause of asthma-related arrhythmia.610 Arrhythmias can also be
caused by stimulant drugs (e.g., beta-adrenergic agonists, amino-
phylline) or electrolyte abnormalities;
dynamic hyperinﬂation, i.e., auto-positive end-expiratory pres-
sure (auto-PEEP), can occur in mechanically ventilated asthmat-
ics. Auto-PEEP is caused by air trapping and ‘breath stacking’ (air
entering the lungs and being unable to escape). Gradual build-up
of pressure occurs and reduces venous return andbloodpressure;
tension pneumothorax (often bilateral).
ey interventions to prevent arrest
The patient with severe asthma requires aggressive medical
anagement to prevent deterioration. Base assessment and treat-
ent on an ABCDE approach. Patients with SaO2 <92% or with
eatures of life-threatening asthma are at risk of hypercapnic
espiratory failure and require arterial blood gas measurement.
xperienced clinicians should treat these high-risk patients in a
ritical-care area. The speciﬁc drugs and the treatment sequence
ill vary according to local practice but are described in detail in
ection 8f of the ERC Guidelines.10
reatment of cardiac arrest caused by asthma
Give basic life support according to standard guidelines. Venti-
ation will be difﬁcult because of increased airway resistance; try
o avoid gastric inﬂation. Modiﬁcations to standard ALS guidelines
nclude considering the need for early tracheal intubation. The very
igh airways resistancemeans that there is a signiﬁcant risk of gas-
ric inﬂation and hypoventilation of the lungs when attempting to
entilate a severe asthmatic without a tracheal tube. During car-
iac arrest this risk is even higher, because the lower oesophageal
phincter pressure is substantially less than normal.611
Respiratory rates of 8–10breathsmin−1 and tidal volume
equired for a normal chest rise during CPR should not cause
ynamic hyperinﬂation of the lungs (gas trapping). Tidal volume
epends on inspiratory time and inspiratory ﬂow. Lung emptying
epends on expiratory time and expiratory ﬂow. In mechani-
ally ventilated severe asthmatics, increasing the expiratory time
achieved by reducing the respiratory rate) provides onlymoderate
ains in terms of reduced gas trapping when a minute volume of
ess than 10 lmin−1 is used.612
There is limited evidence from case reports of unexpected ROSC
n patients with suspected gas trapping when the tracheal tube is
isconnected.613–617 If dynamic hyperinﬂation of the lungs is sus-
ected during CPR, compression of the chest wall and/or a period
f apnoea (disconnection from the tracheal tube) may relieve gas
rapping if dynamic hyperinﬂation occurs. Although this procedure
s supported by limited evidence, it is unlikely to be harmful in an
therwise desperate situation.15 Dynamic hyperinﬂation increases
ransthoracic impedance.618 Consider higher shock energies for
eﬁbrillation if initial deﬁbrillation attempts fail.14
There is no good evidence for the use of open-chest cardiac
ompressions in patients with asthma-associated cardiac arrest.
orking through the four Hs and four Ts will identify potentially
eversible causes of asthma-related cardiac arrest. Tension pneu-
othorax can be difﬁcult to diagnose in cardiac arrest; it may
e indicated by unilateral expansion of the chest wall, shifting
f the trachea and subcutaneous emphysema. Pleural ultrasound
n skilled hands is faster and more sensitive than chest X-ray for
he detection of pneumothorax.619 Always consider bilateral pneu-
othoraces in asthma-related cardiac arrest.81 (2010) 1219–1276
Extracorporeal life support (ECLS) can ensure both organ
perfusion and gas exchange in case of otherwise untreatable res-
piratory and circulatory failure. Cases of successful treatment of
asthma-related cardiac arrest in adults using ECLS have been
reported620,621; however, the role of ECLS in cardiac arrest caused
by asthma has never been investigated in controlled studies.
Anaphylaxis
Anaphylaxis is a severe, life-threatening, generalised or sys-
temic hypersensitivity reaction. This is characterised by rapidly
developing life-threatening airway and/or breathing and/or cir-
culation problems usually associated with skin and mucosal
changes.622,623 Anaphylaxis usually involves the release of inﬂam-
matory mediators from mast cells and, or basophils triggered by
an allergen interacting with cell-bound immunoglobulin E (IgE).
Non-IgE-mediated or non-immune release of mediators can also
occur. Histamine and other inﬂammatory mediator release are
responsible for the vasodilatation, oedema and increased capillary
permeability.
Anaphylaxis is the likely diagnosis if a patient who is exposed
to a trigger (allergen) develops a sudden illness (usually within
minutes) with rapidly developing life-threatening airway and/or
breathing and/or circulation problems usually associated with skin
and mucosal changes.
Use an ABCDE approach to recognise and treat anaphylaxis.
Adrenaline should be given to all patients with life-threatening
features. The intramuscular (IM) route is the best for most rescuers
who have to give adrenaline to treat anaphylaxis. Use the following
doses:
>12 years and adults 500g IM
>6–12 years 300g IM
>6 months–6 years 150g IM
<6 months 150g IM
Intravenous adrenaline should be used only by those experi-
enced in the use and titration of vasopressors in their normal clin-
ical practice (e.g., anaesthetists, emergency physicians, intensive
care doctors). In adults, titrate IV adrenaline using 50g boluses
according to response. Initially, give the highest concentration of
oxygen possible using a mask with an oxygen reservoir.427 Give a
rapid IV ﬂuid challenge (20mlkg−1) in a child or 500–1000ml in an
adult) and monitor the response; give further doses as necessary.
Other therapy (steroids, antihistamines, etc) for the treatment of
life-threatening asthma is detailed in Section 8g. If cardiac arrest
occurs, start CPR immediately and follow current guidelines. Pro-
longed CPR may be necessary. Rescuers should ensure that help is
on its way as early advanced life support (ALS) is essential.
Measurement of mast cell tryptase will to help conﬁrm a diag-
nosis of anaphylaxis. Ideally, take three samples: initial sample as
soon as feasible after resuscitation has started; second sample at
1–2h after the start of symptoms, third sample either at 24h or in
convalescence. All patients presenting with anaphylaxis should be
referred toanallergy clinic to identify the cause, and thereby reduce
the riskof future reactionsandprepare thepatient tomanage future
episodes themselves.
Cardiac arrest following cardiac surgery
Cardiac arrest following major cardiac surgery is relatively
common in the immediate post-operative phase, with a reported
incidence of 0.7–2.9%.624–632 It is usually preceded by physio-
logical deterioration,633 although it can occur suddenly in stable
patients.630 There are usually speciﬁc causes of cardiac arrest, such
as tamponade, hypovolaemia,myocardial ischaemia, tensionpneu-
mothorax, or pacing failure. These are all potentially reversible and
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f treated promptly cardiac arrest after cardiac surgery has a rel-
tively high survival rate. Key to the successful resuscitation of
ardiac arrest in these patients is recognition of the need the need
operformemergency resternotomyearly, especially in the context
f tamponade or haemorrhage, where external chest compressions
ay be ineffective.
tarting CPR
Start external chest compressions immediately in all patients
ho collapse without an output. Consider reversible causes:
ypoxia – check tube position, ventilate with 100% oxygen; ten-
ion pneumothorax – clinical examination, thoracic ultrasound;
ypovolaemia, pacing failure. In asystole, secondary to a loss of
ardiac pacing, chest compressions may be delayed momentarily
s long as the surgically inserted temporary pacing wires can be
onnected rapidly and pacing re-established (DDD at 100min−1 at
aximum amplitude). The effectiveness of compressions may be
eriﬁed by looking at the arterial trace, aiming to achieve a systolic
lood pressure of at least 80mmHg at a rate of 100min−1.
eﬁbrillation
There is concern that external chest compressions can cause
ternal disruption or cardiac damage.634–637 In the post-cardiac
urgery ICU, awitnessedandmonitoredVF/VTcardiac arrest should
e treated immediately with up to three quick successive (stacked)
eﬁbrillation attempts. Three failed shocks in the post-cardiac
urgery setting should trigger the need for emergency rester-
otomy. Further deﬁbrillation is attempted as indicated in the
niversal algorithmand should be performedwith internal paddles
t 20 J if resternotomy has been performed.
mergency drugs
Use adrenaline very cautiously and titrate to effect (intravenous
oses of up to 100g in adults). Give amiodarone 300mg after the
rd failed deﬁbrillation attempt but do not delay resternotomy.
mergency resternotomy
This is an integralpartof resuscitationafter cardiac surgery, once
ll other reversible causes have been excluded. Once adequate air-
ay and ventilation has been established, and if three attempts at
eﬁbrillation have failed in VF/VT, undertake resternotomy with-
ut delay. Emergency resternotomy is also indicated in asystole or
EA, when other treatments have failed.
nternal deﬁbrillation
Internal deﬁbrillation using paddles applied directly across
he ventricles requires considerably less energy than that used
or external deﬁbrillation. Use 20 J in cardiac arrest, but 5 J if the
atient has been placed on cardiopulmonary bypass. Continuing
ardiac compressions using the internal paddleswhile charging the
eﬁbrillator and delivering the shock during the decompression
hase of compressions may improve shock success.638,639
raumatic cardiorespiratory arrestCardiac arrest caused by trauma has a very high mortality, with
n overall survival of just 5.6% (range 0–17%).640–646 For reasons
hat are unclear, reported survival rates in the last 5 years are
etter than reported previously. In those who survive (and where81 (2010) 1219–1276 1257
data are available) neurological outcome is good in only 1.6% of
those sustaining traumatic cardiorespiratory arrest (TCRA).
Commotio cordis
Commotio cordis is actual or near cardiac arrest caused by a
blunt impact to the chest wall over the heart.647–651 A blow to the
chest during the vulnerable phase of the cardiac cycle may cause
malignant arrhythmias (usually ventricular ﬁbrillation). Commotio
cordis occurs mostly during sports (most commonly baseball) and
recreational activities and victims are usually young males (mean
age 14 years). The overall survival rate from commotio cordis is
15%, but 25% if resuscitation is started within 3min.651
Signs of life and initial ECG activity
There are no reliable predictors of survival for TCRA. One study
reported that the presence of reactive pupils and sinus rhythm
correlate signiﬁcantly with survival.652 In a study of penetrat-
ing trauma, pupil reactivity, respiratory activity and sinus rhythm
were correlated with survival but were unreliable.646 Three stud-
ies reported no survivors in patients presenting with asystole or
agonal rhythms.642,646,653 Another reported no survivors among
those with PEA after blunt trauma.654 Based on these studies,
the American College of Surgeons and the National Association of
EMS physicians produced pre-hospital guidelines on withholding
resuscitation.655
Treatment
Survival from TCRA is correlated with duration of CPR and
pre-hospital time.644,656–660 Undertake only essential lifesaving
interventions on scene and, if the patient has signs of life,
transfer rapidly to the nearest appropriate hospital. Consider on
scene thoracotomy for appropriate patients.661,662 Do not delay
for unproven interventions such as spinal immobilization.663
Treat reversible causes: hypoxaemia (oxygenation, ventilation);
compressible haemorrhage (pressure, pressure dressings, tourni-
quets, novel haemostatic agents); non-compressible haemorrhage
(splints, intravenous ﬂuid); tension pneumothorax (chest decom-
pression); cardiac tamponade (immediate thoracotomy). Chest
compressions may not be effective in hypovolaemic cardiac arrest,
but most survivors do not have hypovolaemia and in this subgroup
standard advanced life support may be lifesaving. Standard CPR
should not delay the treatment of reversible causes (e.g., thoraco-
tomy for cardiac tamponade).
Resuscitative thoracotomy
If physicians with appropriate skills are on scene, prehospital
resuscitative thoracotomy may be indicated for selected patients
with cardiac arrest associated with penetrating chest injury.
Emergency department thoracotomy (EDT) is best applied to
patients with penetrating cardiac injuries who arrive at a trauma
centre after a short on scene and transport time with witnessed
signs of life or ECG activity (estimated survival rate 31%).664 After
blunt trauma, EDT should be limited to those with vital signs on
arrival andawitnessed cardiac arrest (estimated survival rate1.6%).
UltrasoundUltrasound is a valuable tool for the evaluation of the
compromised traumapatient. Haemoperitoneum, haemo-or pneu-
mothorax and cardiac tamponade can be diagnosed reliably in
minutes even in the pre-hospital phase.665 Pre-hospital ultrasound
is now available, although its beneﬁts are yet to be proven.666
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ardiac arrest associated with pregnancy
Mortality related to pregnancy in developed countries is rare,
ccurring in an estimated 1:30,000 deliveries.667 The fetus must
lways be consideredwhen an adverse cardiovascular event occurs
n a pregnant woman. Resuscitation guidelines for pregnancy are
ased largely on case series, extrapolation from non-pregnant
rrests, manikin studies and expert opinion based on the phys-
ology of pregnancy and changes that occur in normal labour.
tudies tend to address causes in developed countries, whereas
he most pregnancy-related deaths occur in developing countries.
here were an estimated 342,900 maternal deaths (death during
regnancy, childbirth, or in the 42 days after delivery) worldwide
n 2008.668
Causes of cardiac arrest in pregnant women include: cardiac
isease; pulmonary embolism; psychiatric disorders; hyperten-
ive disorders of pregnancy; sepsis; haemorrhage; amniotic ﬂuid
mbolism; and ectopic pregancy.669 Pregnant women can also sus-
ain cardiac arrest from the same causes as women of the same age
roup.
odiﬁcations to BLS guidelines for cardiac arrest during
regnancy
After 20 weeks’ gestation, the pregnant woman’s uterus can
ress down against the inferior vena cava and the aorta, impeding
enous return and cardiac output. Uterine obstruction of venous
eturn can cause pre-arrest hypotension or shock and, in the crit-
cally ill patient, may precipitate arrest.670,671 After cardiac arrest,
he compromise in venous return and cardiac output by the gravid
terus limits the effectiveness of chest compressions.
The key steps for BLS in a pregnant patient are:
Call for expert help early (including an obstetrician and neona-
tologist).
Start basic life support according to standard guidelines. Ensure
good quality chest compressions with minimal interruptions.
Manually displace the uterus to the left to remove caval compres-
sion.
Add left lateral tilt if this is feasible—the optimal angle of tilt is
unknown. Aim for between 15 and 30◦. The angle of tilt needs
to allow good quality chest compressions and if needed allow
caesarean delivery of the fetus (see below).
odiﬁcations to advanced life support
There is a greater potential for gastro-oesophageal sphincter
nsufﬁciency and risk of pulmonary aspiration of gastric contents.
arly tracheal intubation with correctly applied cricoid pressure
ecreases this risk. Tracheal intubation will make ventilation of
he lungs easier in the presence of increased intra-abdominal
ressure. A tracheal tube 0.5–1mm internal diameter (ID) smaller
han that used for a non-pregnant woman of similar size may be
ecessary because of maternal airway narrowing from oedema
nd swelling.672 There is no change in transthoracic impedance
uring pregnancy, suggesting that standard shock energies for
eﬁbrillation attempts should be used in pregnant patients.673
Rescuers should attempt to identify common and reversible
auses of cardiac arrest in pregnancyduring resuscitation attempts.
he 4Hs and 4Ts approach helps identify all the common causes
f cardiac arrest in pregnancy. Pregnant patients are at risk of all
he other causes of cardiac arrest for their age group (e.g., ana-
hylaxis, drug overdose, trauma). Consider the use of abdominal
ltrasound by a skilled operator to detect pregnancy and possible
auses during cardiac arrest in pregnancy; however, do not delay
ther treatments.81 (2010) 1219–1276
If immediate resuscitation attempts fail
Consider the need for an emergency hysterotomy or caesarean
section as soon as a pregnant woman goes into cardiac arrest. In
some circumstances immediate resuscitation attempts will restore
a perfusing rhythm; in early pregnancy this may enable the preg-
nancy to proceed to term. When initial resuscitation attempts fail,
delivery of the fetus may improve the chances of successful resus-
citation of the mother and fetus.674–676
• At gestational age <20 weeks, urgent caesarean delivery need not
be considered, because a gravid uterus of this size is unlikely to
signiﬁcantly compromise maternal cardiac output.
• At gestational age approximately 20–23 weeks, initiate emer-
gency hysterotomy to enable successful resuscitation of the
mother, not survival of the delivered infant, which is unlikely at
this gestational age.
• At gestational age approximately ≥24–25 weeks, initiate emer-
gency hysterotomy to save the life of both the mother and the
infant.
The best survival rate for infants over 24–25 weeks’ gestation
occurs when delivery of the infant is achieved within 5min after
the mother’s cardiac arrest. This requires that rescuers commence
the hysterotomy at about 4min after cardiac arrest.
Electrocution
Electrical injury is a relatively infrequent but potentially dev-
astating multisystem injury with high morbidity and mortality,
causing 0.54 deaths per 100,000 people each year. Most electrical
injuries in adults occur in the workplace and are associated gen-
erally with high voltage, whereas children are at risk primarily at
home, where the voltage is lower (220V in Europe, Australia and
Asia; 110V in theUSA andCanada).677 Electrocution from lightning
strikes is rare, but worldwide it causes 1000 deaths each year.678
Electric shock injuries are caused by the direct effects of
current on cell membranes and vascular smooth muscle.
Respiratory arrest may be caused by paralysis of the cen-
tral respiratory control system or the respiratory muscles.
Current may precipitate VF if it traverses the myocardium
during the vulnerable period (analogous to an R-on-T
phenomenon).679 Electrical current may also cause myocar-
dial ischaemia because of coronary artery spasm. Asystole may
be primary, or secondary to asphyxia following respiratory
arrest.
Lightning strikes deliver as much as 300kV over a few mil-
liseconds. In those who survive the initial shock, extensive
catecholamine release or autonomic stimulation may occur, caus-
ing hypertension, tachycardia, non-speciﬁc ECG changes (including
prolongation of the QT interval and transient T-wave inversion),
and myocardial necrosis. Mortality from lightning injuries is as
high as 30%, with up to 70% of survivors sustaining signiﬁcant
morbidity.680–682
Resuscitation
Ensure that any power source is switched off and do not
approach the casualty until it is safe. Start standard basic and
advanced life support without delay.• Airway management may be difﬁcult if there are electrical burns
around the face and neck. Early tracheal intubation is needed in
these cases, as extensive soft-tissue oedema may develop caus-
ing airway obstruction. Head and spine trauma can occur after
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electrocution. Immobilize the spine until evaluation can be per-
formed.
Muscular paralysis, especially after high voltage, may persist
for several hours681; ventilatory support is required during this
period.
VF is the commonest initial arrhythmia after high-voltage AC
shock; treat with prompt attempted deﬁbrillation. Asystole is
more common after DC shock; use standard protocols for this
and other arrhythmias.
Remove smouldering clothing and shoes to prevent further ther-
mal injury.
Vigorous ﬂuid therapy is required if there is signiﬁcant tis-
sue destruction. Maintain a good urine output to enhance the
excretion of myoglobin, potassium and other products of tissue
damage.683
Consider early surgical intervention in patients with severe ther-
mal injuries.
Maintain spinal immobilization if there is a likelihood of head or
neck trauma.684,685
Conduct a thorough secondary survey to exclude traumatic
injuries caused by tetanic muscular contraction or by the person
being thrown.685,686
Electrocution can cause severe, deep soft-tissue injury with rel-
atively minor skin wounds, because current tends to follow
neurovascular bundles; look carefully for features of compart-
ment syndrome, which will necessitate fasciotomy.
rinciples of education in resuscitation
Survival from cardiac arrest is determined by the quality of the
cientiﬁc evidence behind the guidelines, the effectiveness of edu-
ation and the resources for implementation of the guidelines.687
n additional factor is how readily guidelines can be applied in
linical practice and the effect of human factors on putting the the-
ry into practice.688 Implementation of Guidelines 2010 is likely to
emore successfulwith a carefully planned, comprehensive imple-
entation strategy that includes education. Delays in providing
raining materials and freeing staff for training were cited as rea-
ons for delays in the implementation of the 2005 guidelines.689,690
ey educational recommendations
The key issues identiﬁed by the Education, Implementation and
eams (EIT) task forceof ILCORduring theGuidelines2010evidence
valuation process are19:
Educational interventions shouldbeevaluated toensure that they
reliably achieve the learning objectives. The aim is to ensure that
learners acquire and retain the skills and knowledge that will
enable them to act correctly in actual cardiac arrests and improve
patient outcomes.
Short video/computer self-instruction courses, with minimal or
no instructor coaching, combined with hands-on practice can be
considered as an effective alternative to instructor-led basic life
support (CPR and AED) courses.
Ideally all citizens should be trained in standard CPR that includes
compressions and ventilations. There are circumstances how-
ever where training in compression-only CPR is appropriate (e.g.,
opportunistic training with very limited time). Those trained in
compression-only CPR should be encouraged to learn standard
CPR.
Basic and advanced life support knowledge and skills deteriorate
in as little as three to 6 months. The use of frequent assessments
will identify those individuals who require refresher training to
help maintain their knowledge and skills.81 (2010) 1219–1276 1259
• CPR prompt or feedback devices improve CPR skill acquisition
and retention and should be considered during CPR training for
laypeople and healthcare professionals.
• An increased emphasis on non-technical skills (NTS) such as
leadership, teamwork, taskmanagement and structured commu-
nication will help improve the performance of CPR and patient
care.
• Teambrieﬁngs to plan for resuscitation attempts, and debrieﬁngs
based on performance during simulated or actual resuscitation
attempts should be used to help improve resuscitation team and
individual performance.
• Research about the impact of resuscitation training on actual
patient outcomes is limited. Althoughmanikin studies are useful,
researchers should be encouraged to study and report the impact
of educational interventions on actual patient outcomes.
Who and how to train
Ideally all citizens should have some knowledge of CPR. There is
insufﬁcient evidence for or against the use of training interventions
that focus on high-risk populations. However, training can reduce
family member and, or patient anxiety, improve emotional adjust-
ment and empowers individuals to feel that they would be able to
start CPR.19
Peoplewho require resuscitation training range from laypeople,
thosewithout formal healthcare training butwith a role that places
a duty of care upon them (e.g., lifeguards, ﬁrst aiders), and health-
care professionals working in a variety of settings including the
community, emergency medical systems (EMS), general hospital
wards and critical care areas.
Training should be tailored to the needs of different types of
learners and learning styles to ensure acquisition and retention of
resuscitation knowledge and skills. Those who are expected to per-
form CPR regularly need to have knowledge of current guidelines
and be able to use them effectively as part of a multi-professional
team. These individuals require more complex training including
both technical and non-technical skills (e.g., teamwork, leadership,
structured communication skills).691,692 They are divided arbi-
trarily into basic level and advanced level training interventions
whereas in truth this is a continuum.
Basic level and AED training
Bystander CPR and early deﬁbrillation saves lives. Many fac-
tors decrease the willingness of bystanders to start CPR, including
panic, fear of disease, harming the victim or performing CPR
incorrectly.693–708 Providing CPR training to laypeople increases
willingness to perform CPR.696,702–704,709–714
CPR training and performing CPR during an actual cardiac arrest
is safe inmost circumstances. Individuals undertaking CPR training
should be advised of the nature and extent of the physical activity
required during the training program. Learnerswhodevelop signif-
icant symptoms (e.g., chest pain, severe shortness of breath) during
CPR training should be advised to stop. Rescuers who develop sig-
niﬁcant symptoms during actual CPR should consider stopping CPR
(seeBasic life support guidelines for further information about risks
to the rescuer).4
Basic life support and AED curriculumThe curriculum for basic life support and AED training should
be tailored to the target audience and kept as simple as possible.
The following should be considered as core elements of the basic
life support and AED curriculum13,19:
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Personal and environmental risks before starting CPR.
Recognition of cardiac arrest by assessment of responsiveness,
opening of the airway and assessment of breathing.4,13
Recognition of gasping or abnormal breathing as a sign of cardiac
arrest in unconscious unresponsive individuals.69,715
Good quality chest compressions (including adherence to rate,
depth, full recoil and minimizing hands-off time) and rescue
breathing.
Feedback/prompts (including from devices) during CPR training
should be considered to improve skill acquisition and retention
during basic life support training.716
All basic life support and AED training should aim to
teach standard CPR including rescue breathing/ventilations.
Chest compression-only CPR training has potential advantages
over chest compression and ventilation in certain speciﬁc
situations.694,699,702,707,708,711,717,718 Anapproach to teachingCPR
is suggested below.
tandard CPR versus chest compression-only CPR teaching
There is controversy about which CPR skills different types of
escuers should be taught. Compression-only CPR is easier and
uicker to teach especially when trying to teach a large num-
er of individuals who would not otherwise access CPR training.
n many situations however, standard CPR (which includes ven-
ilation/rescuer breathing) is better, for example in children,84
sphyxial arrests, and when bystander CPR is required for more
han a few minutes.13 A simpliﬁed, education-based approach is
herefore suggested:
Ideally, full CPR skills (compressions and ventilation using a 30:2
ratio) should be taught to all citizens.
When training is time-limited or opportunistic (e.g., EMS
telephone instructions to a bystander, mass events, publicity
campaigns, YouTube ‘viral’ videos, or the individual doesnotwish
to train), training should focus on chest compression-only CPR.
For those trained in compression-only CPR, subsequent train-
ing should include training in ventilation as well as chest
compressions. Ideally these individuals should be trained in
compression-only CPR and then offered training in chest com-
pressions with ventilation at the same training session.
Those laypersons with a duty of care, such as ﬁrst aid workers,
lifeguards, and child minders, should be taught how to do chest
compressions and ventilations.
For children, rescuers should be encouraged to use whichever
adult sequence they have been taught, as outcome is worse if
they do nothing. Non-specialists who wish to learn paediatric
resuscitation because they have responsibility for children (e.g.,
parents, teachers, school nurses, lifeguards etc), should be taught
that it is preferable to modify adult basic life support and give
ﬁve initial breaths followed by approximately one minute of CPR
before they go for help, if there is no-one to go for them. Chest
compression depth for children is at least 1/3 of the A-P diameter
of the chest.8
Citizen-CPR training should be promoted for all. However being
ntrained shouldnot be a barrier to performing chest compression-
nly CPR, preferably with dispatcher telephone advice.
asic life support and AED training methodsThere are numerous methods to deliver basic life support and
ED training. Traditional, instructor-led training courses remain
he most frequently used method for basic life support and AED
raining.719 When compared with traditional instructor-led train-
ng, well designed self-instruction programmes (e.g., video, DVD,81 (2010) 1219–1276
computer driven) with minimal or no instructor coaching can
be effective alternatives to instructor-led courses for laypeople
and healthcare providers learning basic life support and AED
skills.720–734 It is essential that courses include hands-on practice
as part of the programme. The use of CPR prompt/feedback devices
maybeconsideredduringCPR training for laypeopleandhealthcare
professionals.716
Duration and frequency of instructor-led basic life support and
AED training courses
The optimal duration of instructor-led basic life support and
AED training courses has not been determined and is likely to
vary according to the characteristics of the participants (e.g., lay
or healthcare; previous training; age), the curriculum, the ratio of
instructors to participants, the amount of hands-on training and
the use of end of course assessments.
Most studies show that CPR skills such as calling for help, chest
compressions and ventilations decay within 3–6 months after ini-
tial training.722,725,735–740 AED skills are retained for longer than
basic life support skills alone.736,741,742
Advanced level training
Advanced level training curriculum
Advanced level training is usually for healthcare providers. Cur-
ricula shouldbe tailored tomatch individual learningneeds, patient
case mix and the individual’s role within the healthcare system’s
response to cardiac arrest. Team training and rhythm recognition
skills will be essential to minimize hands-off time when using the
2010 manual deﬁbrillation strategy that includes charging during
chest compressions.117,743
Core elements for advanced life support curricula should
include:
• Cardiac arrest prevention.192,744
• Good quality chest compressions including adherence to rate,
depth, full recoil and minimising hands-off time, and ventilation
using basic skills (e.g., pocket mask, bag mask).
• Deﬁbrillation includingchargingduringcompressions formanual
deﬁbrillation.
• Advanced life support algorithms.
• Non-technical skills (e.g., leadership and team training, commu-
nication).
Advanced level training methods
A variety of methods (such as reading manuals, pretests and e-
learning can be used to prepare candidates before attending a life
support course 745–753
Simulation and realistic training techniques
Simulation training is an essential part of resuscitation training.
There is large variation in how simulation can be and is used for
resuscitation training.754 The lack of consistent deﬁnitions (e.g.,
high vs. low ﬁdelity simulation) makes comparisons of studies of
different types of simulation training difﬁcult.
Advanced life support training intervalsKnowledge and skill retention declines rapidly after initial
resuscitation training. Refresher training is invariably required
to maintain knowledge and skills; however, the optimal fre-
quency for refresher training is unclear. Most studies show
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hat advanced life support skills and knowledge decayed when
ested at three to 6 months after training, 737,755–762 two stud-
es suggested seven to 12 months,763,764 and one study 18
onths.765
he ethics of resuscitation and end-of-life decisions
Several considerations are required to ensure that the decisions
o attempt or withhold resuscitation attempts are appropriate, and
hat patients are treated with dignity. These decisions are com-
lex and may be inﬂuenced by individual, international and local
ultural, legal, traditional, religious, social and economic factors.766
The 2010 ERC Guidelines include the following topics relating
o ethics and end-of-life decisions.
Key principles of ethics.
Sudden cardiac arrest in a global perspective.
Outcome and prognostication.
When to start and when to stop resuscitation attempts.
Advance directives and do-not-attempt-resuscitation orders.
Family presence during resuscitation.
Organ procurement
Research in resuscitation and informed content.
Research and training on the recently dead.
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Basic life support (BLS) refers to maintaining airway patency
nd supporting breathing and the circulation, without the use
f equipment other than a protective device.1 This section con-
ains the guidelines for adult BLS and for the use of an automated
xternal deﬁbrillator (AED). It also includes recognition of sudden
ardiac arrest, the recovery position and management of choking
foreign-body airway obstruction). Guidelines for the use of man-
al deﬁbrillators and starting in-hospital resuscitation are found in
ections 3 and 4.2,3
ummary of changes since 2005 Guidelines
Many of the recommendations made in the ERC Guide-
ines 2005 remain unchanged, either because no new studies
ave been published or because new evidence since 2005 has
erely strengthened the evidence that was already available.
xamples of this are the general design of the BLS and AED
lgorithms, the way the need for cardiopulmonary resuscitation
CPR) is recognised, the use of AEDs (including the shock pro-
ocols), the 30:2 ratio of compressions and ventilations, and the
ecognition and management of a choking victim. In contrast,
ew evidence has been published since 2005 that necessitates
hanges to some components of the 2010 Guidelines. The 2010
hanges in comparison with the 2005 Guidelines are summarised
ere:
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• Dispatchers should be trained to interrogate callers with strict
protocols to elicit information. This information should focus on
the recognition of unresponsiveness and the quality of breathing.
In combination with unresponsiveness, absence of breathing or
any abnormality of breathing should start a dispatch protocol of
suspected cardiac arrest. The importance of gasping as signof car-
diac arrest should result in increased emphasis on its recognition
during training and dispatch interrogation.
• All rescuers, trained or not, should provide chest compressions
to victims of cardiac arrest. A strong emphasis on delivering high
quality chest compressions remains essential. The aim should be
to push to a depth of at least 5 cm at a rate of at least 100 com-
pressions per minute, to allow full chest recoil, and to minimise
interruptions in chest compressions. Trained rescuers should
also provide ventilations with a compression–ventilation ratio of
30:2. Telephone-guidedCPR is encouraged for untrained rescuers
who should be told to deliver uninterrupted chest compressions
only.
• In order to maintain high-quality CPR, feedback to rescuers is
important. The use of prompt/feedback devices during CPR will
enable immediate feedback to rescuers, and the data stored in
rescue equipment can be used to monitor the quality of CPR per-
formance and provide feedback to professional rescuers during
debrieﬁng sessions.
• When rescuers apply an AED, the analysis of the heart rhythm
and delivery of a shock should not be delayed for a period of CPR;
however, CPR should be given with minimal interruptions before
application of the AED and during its use.
• Further development of AED programmes is encouraged—there
is a need for further deployment of AEDs in both public and resi-
dential areas.
evier Ireland Ltd. All rights reserved.
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Sudden cardiac arrest (SCA) is a leading cause of death in
urope. Depending on the way SCA is deﬁned, it affects about
50,000–700,000 individuals a year.4,5 On initial heart-rhythm
nalysis, about 25–30% of SCA victims have ventricular ﬁbrillation
VF), a percentage that has declined over the last 20 years.6–10
t is likely that many more victims have VF or rapid ventricu-
ar tachycardia (VT) at the time of collapse but, by the time the
rst electrocardiogram (ECG) is recorded by ambulance personnel,
heir rhythm has deteriorated to asystole.11,12 When the rhythm is
ecorded soon after collapse, in particular by an on-site AED, the
roportion of victims in VF can be as high as 59%13 to 65%.14 Many
ictims of SCA can survive if bystanders act immediately while VF
s still present, but successful resuscitation is much less likely once
he rhythm has deteriorated to asystole.
The recommended treatment for VF cardiac arrest is immediate
ystander CPR (combined chest compression and rescue breathing)
nd early electrical deﬁbrillation. Most cardiac arrests of non-
ardiacorigin are fromrespiratory causes suchasdrowning (among
hem many children) and asphyxia. In many areas in the world
rowning is a major cause of death (see http://www.who.int/
ater sanitation health/diseases/drowning/en/), and rescue
reaths are even more critical for successful resuscitation of these
ictims.
he chain of survival
The following concept of the Chain of Survival summarises the
ital steps needed for successful resuscitation (Fig. 2.1). Most of
hese links apply to victims of both primary cardiac and asphyxial
rrest.15
. Early recognition of cardiac arrest: This includes recognition of
the cardiac origin of chest pain; recognition that cardiac arrest
has occurred; and rapid activation of the ambulance service by
telephoning 112 or the local emergency number. Recognizing
cardiac chest pain is particularly important, since the probability
of cardiac arrest occurring as a consequence of acute myocar-
dial ischaemia is at least 21–33% in the ﬁrst hour after onset
of symptoms.16,17 When a call to the ambulance service is made
before a victimcollapses, arrival of the ambulance is signiﬁcantly
sooner after collapse and survival tends to be higher.18
. Early bystander CPR: Immediate CPR can double or triple sur-
vival fromVF SCA.18–21 Performing chest-compression-only CPR
is better than giving no CPR at all.22,23 When a caller has not
been trained in CPR, the ambulance dispatcher should strongly
Fig. 2.1. Chain on 81 (2010) 1277–1292
encourage him to give chest compression-only CPR while await-
ing the arrival of professional help.24–27
3. Early deﬁbrillation: CPR plus deﬁbrillation within 3–5min of col-
lapse can produce survival rates as high as 49–75%.28–35 Each
minute of delay before deﬁbrillation reduces the probability of
survival to discharge by 10–12%.19,36
4. Early advanced life support and standardised post-resuscitation
care: The quality of treatment during the post-resuscitation
phase affects outcome.37–39 Therapeutic hypothermia is now an
established therapy that greatly contributes to improved sur-
vival with good neurological outcome.40–42
In most communities, the median time from ambulance call to
ambulance arrival (response interval) is 5–8min,13,14 or 11min to
a ﬁrst shock.43 During this time the victim’s survival is dependent
on bystanders who initiate BLS and use an AED for deﬁbrillation.
Victims of cardiac arrest need immediate CPR. This provides a
small but critical blood ﬂow to the heart and brain. It also increases
the likelihood that a deﬁbrillatory shock will terminate VF and
enable the heart to resume an effective rhythm and cardiac out-
put. Chest compression is especially important if a shock cannot
be delivered sooner than the ﬁrst few minutes after collapse.44
After deﬁbrillation, if the heart is still viable, its pacemaker activity
resumes and produces an organised rhythm followed by mechani-
cal contraction. In theﬁrst fewminutes after successful termination
of VF, the heart rhythm may be slow, and the force of contrac-
tions weak; chest compressions must be continued until adequate
cardiac function returns.45
Lay rescuers can be trained to use automated external deﬁbril-
lators (AEDs), which are increasingly available in public places. An
AED uses voice prompts to guide the rescuer, analyses the cardiac
rhythm and instructs the rescuer to deliver a shock if VF or rapid
ventricular tachycardia (VT) is detected. AEDs are extremely accu-
rate andwill deliver a shockonlywhenVF (or rapidVT) is present.46
AED function and operation are discussed in Section 3.
Several studies have shown the beneﬁt on survival of immedi-
ate CPR, and the detrimental effect of delay before deﬁbrillation.
For every minute delay in deﬁbrillation, survival from witnessed
VF decreases by 10–12%.19,36 When bystander CPR is provided,
the decline in survival is more gradual and averages 3–4% per
minute.12,36,47 Overall, bystander CPR doubles or triples survival
from witnessed cardiac arrest.19,47,48Adult BLS sequence
Throughout this section, the male gender implies both males
and females.
f survival.
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5b. If the breathing is not normal or absent
• send someone for help and to ﬁnd and bring an AED if avail-
able; or if you are on your own, use your mobile telephone
to alert the ambulance service—leave the victim only when
there is no other option.Fig. 2.2. Adult basic life support algorithm.
BLS consists of the following sequence of actions (Fig. 2.2).
1. Make sure you, the victim and any bystanders are safe.
2. Check the victim for a response (Fig. 2.3).
• gently shake his shoulders and ask loudly: “Are you all right?”
a. If he responds
• leave him in the position in which you ﬁnd him, provided
there is no further danger;
• try to ﬁnd outwhat is wrongwith him and get help if needed;
• reassess him regularly.
b. If he does not respond
• shout for help (Fig. 2.4)
◦ turn the victim onto his back and then open the airway
using head tilt and chin lift (Fig. 2.5);
◦ place your hand on his forehead and gently tilt his head
back;
◦ with your ﬁngertips under the point of the victim’s chin, lift
the chin to open the airway.
4. Keeping the airway open, look, listen and feel for breathing
(Fig. 2.6).
• look for chest movement;
• listen at the victim’s mouth for breath sounds;
• feel for air on your cheek;
• decide if breathing is normal, not normal or absent
In the ﬁrst fewminutes after cardiac arrest, a victimmay be
barely breathing, or taking infrequent, slow and noisy gasps.
Do not confuse this with normal breathing. Look, listen and
feel for no more than 10 s to determine whether the victim is
breathing normally. If you have any doubt whether breathing
is normal, act as if it is not normal.Fig. 2.3. Check the victim for a response.
5a. If he is breathing normally
• turn him into the recovery position (see below);
• send or go for help—call 112 or local emergency number for
an ambulance;
• continue to assess that breathing remains normal.Fig. 2.4. Shout for help.
1280 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292Fig. 2.5. Head tilt and chin lift.
• start chest compression as follows:
◦ kneel by the side of the victim;
◦ place the heel of one hand in the centre of the victim’s
chest; (which is the lower half of the victim’s breastbone
(sternum)) (Fig. 2.7);
◦ place the heel of your other hand on top of the ﬁrst hand
(Fig. 2.8);
◦ interlock the ﬁngers of your hands and ensure that pres-
sure is not applied over the victim’s ribs. Keep your arms
straight (Fig. 2.9). Do not apply any pressure over the upper
abdomen or the bottom end of the bony sternum (breast-
bone);◦ position yourself vertically above the victim’s chest and
press down on the sternum at least 5 cm (but not exceeding
6 cm) (Fig. 2.10);
◦ after each compression, release all the pressure on the
chest without losing contact between your hands and the
Fig. 2.6. Look, listen and feel for normal breathing.Fig. 2.7. Place the heel of one hand in the centre of the victim’s chest.
sternum; repeat at a rate of at least 100min−1 (but not
exceeding 120min−1);
◦ compression and release should take equal amounts of
time.
6a. Combine chest compression with rescue breaths.
• After 30 compressions open the airway again using head tilt
and chin lift (Fig. 2.5).
• Pinch the soft part of the nose closed, using the index ﬁnger
and thumb of your hand on the forehead.
• Allow the mouth to open, but maintain chin lift.
• Take a normal breath and place your lips around his mouth,
making sure that you have a good seal.
• Blow steadily into the mouth while watching for the chest to
rise (Fig. 2.11), taking about 1 s as in normal breathing; this is
an effective rescue breath.
• Maintaininghead tilt andchin lift, takeyourmouthaway from
the victim and watch for the chest to fall as air comes out
(Fig. 2.12).
• Take another normal breath and blow into the victim’smouth
once more to achieve a total of two effective rescue breaths.
The two breaths should not take more than 5 s in all. Then
return your hands without delay to the correct position on
the sternum and give a further 30 chest compressions.
• Continue with chest compressions and rescue breaths in a
ratio of 30:2.
• Stop to recheck the victim only if he starts to wake up: to
move, open eyes and to breathe normally. Otherwise, do not
interrupt resuscitation.
Fig. 2.8. Place the heel of your other hand on top of the ﬁrst hand.
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Checking the carotid pulse (or any other pulse) is an inaccu-
rate method of conﬁrming the presence or absence of circulation,
both for lay rescuers and for professionals.50–52 There is, however,
no evidence that checking for movement, breathing or cough-
ing (“signs of a circulation”) is diagnostically superior. HealthcareFig. 2.9. Interlock the ﬁngers of your hands. Keep your arms straight.
If your initial rescue breath does not make the chest rise as
in normal breathing, then before your next attempt:
• look into the victim’s mouth and remove any obstruction;
• recheck that there is adequate head tilt and chin lift;
• do not attempt more than two breaths each time before
returning to chest compressions.
If there is more than one rescuer present, another res-
cuer should take over delivering CPR every 2min to prevent
fatigue. Ensure that interruption of chest compressions is
minimal during the changeover of rescuers. For this purpose,
and to count 30 compressions at the required rate, it may
be helpful for the rescuer performing chest compressions
to count out loud. Experienced rescuers could do combined
two-rescuer CPR and in that situation they should exchange
roles/places every 2min.
b. Chest-compression-only CPR may be used as follows:
• If you are not trained, or are unwilling to give rescue breaths,
give chest compressions only.
• If only chest compressions are given, these should be con-
tinuous, at a rate of at least 100min−1 (but not exceeding
120min−1).
7. Do not interrupt resuscitation until:
• professional help arrives and takes over; or
• the victim starts to wake up: to move, open eyes and to
breathe normally; or
• you become exhausted.pening the airway
The jaw thrust is not recommended for lay rescuers because
t is difﬁcult to learn and perform and may itself cause spinalFig. 2.10. Press down on the sternum at least 5 cm.
movement.49 Therefore, the lay rescuer should open the airway
using a head-tilt-chin-lift manoeuvre for both injured and non-
injured victims.
Recognition of cardiorespiratory arrestFig. 2.11. Blow steadily into his mouth whilst watching for his chest to rise.
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Chest compressionig. 2.12. Take your mouth away from the victim and watch for his chest to fall as
ir comes out.
rofessionals, as well as lay rescuers, have difﬁculty determin-
ng the presence or absence of adequate or normal breathing in
nresponsive victims.53,54 This may be because the airway is not
pen or because the victim is making occasional (agonal) gasps.
hen bystanders are asked by ambulance dispatchers over the
elephone if breathing is present, they often misinterpret agonal
asps as normal breathing. This incorrect information can result
n the bystander withholding CPR from a cardiac arrest victim.55
gonal gasps are present in up to 40% of cardiac arrest victims
n the ﬁrst minutes after onset, and are associated with higher
urvival if recognised as a sign of cardiac arrest.56 Bystanders
escribe agonal gasps as barely breathing, heavy or laboured
reathing, or noisy or gasping breathing.57 Laypeople should,
herefore, be taught to begin CPR if the victim is unconscious
unresponsive) and not breathing normally. It should be empha-
ised during training that agonal gasps occur commonly in the
rst few minutes after SCA, and that they are an indication to
tart CPR immediately; they should not be confused with normal
reathing.
Adequate description of the victim is also of critical importance
uring communication with the ambulance dispatch centre. It is
mportant for the dispatcher that the caller can see the victim,
ut in a small minority of cases the caller is not at the scene.58
nformation about a victim’s breathing is most important, but the
escription of breathing by callers varies considerably. If the nature
f the victim’s breathing is not described or actively asked for
y the dispatcher, recognition that the victim has had a cardiac
rrest is much less likely than if the breathing is described as
bnormal or absent.59 If, when a caller describes an unconscious
ictim with absent or abnormal breathing, the dispatcher always
esponded as for cardiac arrest, cases of cardiac arrest would not be
issed.60
Conﬁrming the absence of a past medical history of seizures
an increase the likelihood of recognizing cardiac arrest among vic-
ims presenting with seizure activity.59,61 Asking about regularity
f breathing can also help to recognise cardiac arrest among callers
eporting seizure activity.
An experienced dispatcher can improve the survival rate sig-
iﬁcantly: if the dispatcher takes very few cardiac arrest calls per
ear, the survival rate ismuch lower than if he takesmore thannine
alls a year (22%versus 39%).58 The accuracy of identiﬁcation of car-
iac arrest by dispatchers varies from approximately 50% to over
0%. If the dispatcher recognises cardiac arrest, survival is more
ikely because appropriate measures can be taken (e.g. telephone-
nstructed CPR or appropriate ambulance response).25,60n 81 (2010) 1277–1292
Initial rescue breaths
In primary (non-asphyxial) cardiac arrest the arterial blood
is not moving and remains saturated with oxygen for several
minutes.62 If CPR is initiated within a few minutes, the blood oxy-
gencontent remains adequate, andmyocardial andcerebral oxygen
delivery is limited more by the reduced cardiac output than by a
lack of oxygen in the lungs and arterial blood. Initially, therefore,
ventilation is less important than chest compressions.63,64
In adults needing CPR, there is a high a-priori probability of a
primary cardiac cause. To emphasise the priority of chest com-
pressions, it is recommended that CPR should start with chest
compression rather than initial ventilations. Time should not be
spent checking the mouth for foreign bodies unless attempted res-
cue breathing fails to make the chest rise.
Ventilation
During CPR, the purpose of ventilation is to maintain adequate
oxygenation and to remove CO2. The optimal tidal volume, res-
piratory rate and inspired oxygen concentration to achieve this,
however, are not fully known. The current recommendations are
based on the following evidence:
1. During CPR, blood ﬂow to the lungs is substantially reduced, so
an adequate ventilation–perfusion ratio can be maintained with
lower tidal volumes and respiratory rates than normal.65
2. Hyperventilation is harmful because it increases intrathoracic
pressure, which decreases venous return to the heart and
reduces cardiac output. Survival is consequently reduced.66
3. Interruptions in chest compression (for example, to check the
heart rhythm or for a pulse check) have a detrimental effect on
survival.67
4. When the airway is unprotected, a tidal volume of 1 l pro-
duces signiﬁcantly more gastric distension than a tidal volume
of 500ml.68
5. Low minute-ventilation (lower than normal tidal volume and
respiratory rate) can maintain effective oxygenation and ven-
tilation during CPR.69–72 During adult CPR, tidal volumes of
approximately 500–600ml (6–7mlkg−1) are recommended.
The current recommendations are, therefore, for rescuers togive
each rescue breath over about 1 s, with enough volume to make
the victim’s chest rise, but to avoid rapid or forceful breaths. The
time taken to give two breaths should not exceed 5 s. These recom-
mendations apply to all forms of ventilation during CPR, including
mouth-to-mouth and bag-mask ventilation with and without sup-
plementary oxygen.
Mouth-to-nose ventilation is an acceptable alternative to
mouth-to-mouth ventilation.73 It may be considered if the vic-
tim’s mouth is seriously injured or cannot be opened, the rescuer is
assisting a victim in thewater, or amouth-to-mouth seal is difﬁcult
to achieve.
There is no published evidence on the safety, effectiveness or
feasibility of mouth-to-tracheostomy ventilation, but it may be
used for a victim with a tracheostomy tube or tracheal stoma who
requires rescue breathing.
To use bag-mask ventilation requires considerable practice and
skill.74,75 It can be used by properly trained and experienced res-
cuers who perform two-rescuer CPR.Chest compressions produce blood ﬂow by increasing the
intrathoracic pressure and by directly compressing the heart.
Although chest compressions, performed properly, can produce
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ystolic arterial pressure peaks of 60–80mmHg, diastolic pressure
emains low and mean arterial pressure in the carotid artery sel-
omexceeds 40mmHg.76 Chest compressions generate a small but
ritical amount of blood ﬂow to the brain and myocardium and
ncrease the likelihood that deﬁbrillation will be successful.
Since the 2005 Guidelines were published, chest compression
rompt/feedback devices have generated new data from victims in
ardiac arrest that supplement animal and manikin studies.77–81
ecommendations based on this evidence are:
. Each time compressions are resumed, place your hands without
delay ‘in the centre of the chest’.
. Compress the chest at a rate of at least 100min−1.
. Ensure that the full compression depth of at least 5 cm (for an
adult) is achieved.
. Allow the chest to recoil completely after each compression, i.e.
do not lean on the chest during the relaxation phase of the chest
compression.
. Take approximately the same amount of time for compression
as relaxation.
. Minimise interruptions in chest compression in order to ensure
the victim receives at least 60 compressions in each minute.
. Do not rely on feeling the carotid or other pulse as a gauge of
effective arterial ﬂow during chest compressions.50,82
and position
For adults receiving chest compressions, rescuers should place
heir hands on the lower half of the sternum. It is recommended
hat this location be taught in a simpliﬁed way, such as, “place the
eel of your hand in the centre of the chest with the other hand
n top.” This instruction should be accompanied by demonstrating
lacing the hands on the lower half of the sternum on a manikin.
se of the internipple line as a landmark for hand placement is not
eliable.83,84
ompression rate
There is apositive relationshipbetween thenumberof compres-
ions actually delivered per minute and the chance of successful
esuscitation.81 While the compression rate (the speed at which
he 30 consecutive compressions are given) should be at least
00min−1, the actual number of compressions delivered during
ach minute of CPR will be lower due to interruptions to deliver
escue breaths and allow AED analysis, etc. In one out-of-hospital
tudy, rescuers recorded compression rates of 100–120min−1 but
hemean number of compressionswas reduced to 64min−1 by fre-
uent interruptions.79 At least60compressions shouldbedelivered
ach minute.
ompression depth
Fear of doing harm, fatigue and limited muscle strength fre-
uently result in rescuers compressing the chest less deeply than
ecommended. There is evidence that a compression depth of 5 cm
nd over results in a higher rate of return of spontaneous circula-
ion (ROSC), and a higher percentage of victims admitted alive to
ospital, than a compression depth of 4 cm or below.77,78 There is
o direct evidence that damage from chest compression is related
o compression depth, nor has an upper limit of compression depth
een established in studies. Nevertheless, it is recommended that,
ven in large adults, chest compression depth should not exceed
cm.
CPR should be performed on a ﬁrm surface when possible. Air-
lled mattresses should be routinely deﬂated during CPR.85 There
s no evidence for or against the use of backboards,86,87 but if onen 81 (2010) 1277–1292 1283
is used, care should be taken to avoid interruption in CPR and dis-
lodging intravenous lines or other tubes during board placement.
Chest decompression
Allowing complete recoil of the chest after each compression
results in better venous return to the chest and may improve
the effectiveness of CPR.88,89 The optimal method of achieving
this goal, without compromising other aspects of chest compres-
sion technique such as compression depth, has not, however, been
established.
Feedback on compression technique
Rescuers can be assisted to achieve the recommended compres-
sion rateanddepthbyprompt/feedbackdevices that areeitherbuilt
into theAEDormanual deﬁbrillator, or are stand-alonedevices. The
use of such prompt/feedback devices, as part of an overall strategy
to improve thequality of CPR,maybebeneﬁcial. Rescuers should be
aware that the accuracyof devices thatmeasure compressiondepth
varies according to the stiffness of the support surface upon which
CPR is being performed (e.g. ﬂoor/mattress), and may overestimate
compression depth.87 Further studies are needed to determine if
these devices improve victim outcomes.
Compression–ventilation ratio
Animal data supported an increase in the ratio of compression
to ventilation to >15:2.90–92 A mathematical model suggests that
a ratio of 30:2 provides the best compromise between blood ﬂow
and oxygen delivery.93,94 A ratio of 30 compressions to 2 venti-
lations was recommended in the Guidelines 2005 for the single
rescuer attempting resuscitation of an adult or child out of hospi-
tal, an exceptionbeing that a trainedhealthcareprofessional should
use a ratio of 15:2 for a child. This decreased the number of inter-
ruptions in compression and the no-ﬂow fraction,95,96 and reduced
the likelihood of hyperventilation.66,97 Direct evidence that sur-
vival rates have increased from this change, however, is lacking.
Likewise, there is no new evidence that would suggest a change in
the recommended compression to ventilation ratio of 30:2.
Compression-only CPR
Some healthcare professionals as well as lay rescuers indicate
that they would be reluctant to perform mouth-to-mouth ventila-
tion, especially in unknown victims of cardiac arrest.98,99 Animal
studies have shown that chest-compression-only CPR may be as
effective as combined ventilation and compression in the ﬁrst few
minutes after non-asphyxial arrest.63,100 If the airway is open,
occasional gasps and passive chest recoil may provide some air
exchange, but this may result in ventilation of the dead space
only.56,101–103 Animal and mathematical model studies of chest-
compression-only CPR have shown that arterial oxygen stores
deplete in 2–4min.92,104
In adults, the outcome of chest compression without venti-
lation is signiﬁcantly better than the outcome of giving no CPR
at all in non-asphyxial arrest.22,23 Several studies of human car-
diac arrest have suggested equivalence of chest-compression-only
CPR and chest compressions combined with rescue breaths, but
none excluded the possibility that chest-compression-only is infe-
rior to chest compressions combined with ventilations.23,105 One
study suggested superiority of chest-compression-only CPR.22 All
these studies have signiﬁcant limitations because they were based
on retrospective database analyses, where the type of BLS was
not controlled and did not include CPR according to Guidelines
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005 (30:2 compressions to ventilation ratio). Chest compres-
ion alone may be sufﬁcient only in the ﬁrst few minutes after
ollapse. Professional help can be expected on average 8min or
ater after a call for help, and chest compression only will result
n insufﬁcient CPR in many cases. Chest-compression-only CPR
s not as effective as conventional CPR for cardiac arrests of
on-cardiac origin (e.g., drowning or suffocation) in adults and
hildren.106,107
Chest compression combined with rescue breaths is, therefore,
he method of choice for CPR delivered by both trained lay rescuers
nd professionals. Laypeople should be encouraged to perform
ompression-only CPR if they are unable or unwilling to provide
escue breaths, or when instructed during an emergency call to an
mbulance dispatcher centre.26,27
PR in conﬁned spaces
Over-the-head CPR for single rescuers and straddle-CPR for
wo rescuers may be considered for resuscitation in conﬁned
paces.108,109
isks to the victim during CPR
Many rescuers, concerned that delivering chest compressions
o a victim who is not in cardiac arrest will cause serious com-
lications, do not initiate CPR. In a study of dispatch-assisted
ystander CPR, however, where non-arrest victims received chest
ompressions, 12% experienced discomfort but only 2% suffered a
racture: no victims suffered visceral organ injury.110 Bystander
PR extremely rarely leads to serious harm in victims who are
ventually found not to be in cardiac arrest. Rescuers should not,
herefore, be reluctant to initiate CPR because of concern of causing
arm.
isks to the rescuer during training and during real-life CPR
hysical effects
Observational studies of training or actual CPR performance
ave described rare occurrences of muscle strain, back symptoms,
hortness of breath, hyperventilation, and case reports of pneu-
othorax, chest pain,myocardial infarctionandnerve injury.111,112
he incidence of these events is very low, and CPR training and
ctual performance is safe in most circumstances.113 Individuals
ndertaking CPR training should be advised of the nature and
xtent of the physical activity required during the training pro-
ramme. Learners and rescuers who develop signiﬁcant symptoms
e.g. chest pain or severe shortness of breath) during CPR training
hould be advised to stop.
escuer fatigue
Several manikin studies have found that chest compression
epth can decrease as little as 2min after starting chest compres-
ions. An in-hospital patient study showed that, even while using
eal-time feedback, the mean depth of compression deteriorated
etween 1.5 and 3min after starting CPR.114 It is therefore rec-
mmended that rescuers change about every 2min to prevent a
ecrease in compression quality due to rescuer fatigue. Changing
escuers should not interrupt chest compressions.isks during deﬁbrillation
A large randomised trial of public access deﬁbrillation showed
hat AEDs can be used safely by laypeople and ﬁrst responders.115
systematic review identiﬁed eight papers that reported a totaln 81 (2010) 1277–1292
of 29 adverse events associated with deﬁbrillation.116 The causes
included accidental or intentional deﬁbrillator misuse, device mal-
function and accidental discharge during training or maintenance
procedures. Four single-case reports described shocks to rescuers
from discharging implantable cardioverter deﬁbrillators (ICDs), in
one case resulting in a peripheral nerve injury. There are no reports
of harm to rescuers from attempting deﬁbrillation in wet environ-
ments.
Injury to the rescuer fromdeﬁbrillation is extremely rare.Never-
theless, rescuers should not continue manual chest compressions
during shock delivery. Victims should not be touched during ICD
discharge.Direct contactbetween the rescuer and thevictimshould
be avoided when deﬁbrillation is carried out in wet environments.
Psychological effects
One large, prospective trial of public access deﬁbrillation
reported a few adverse psychological effects associated with CPR
or AED use that required intervention.113 Two large, retrospec-
tive, questionnaire-based reports relating to performance of CPR
by a bystander reported that nearly all respondents regarded their
intervention as a positive experience.117,118 The rare occurrences
of adverse psychological effects in rescuers after CPR should be
recognised and managed appropriately.
Disease transmission
There are only very few cases reported where performing CPR
has been linked to disease transmission, implicating Salmonella
infantis, Staphylococcus aureus, severe acute respiratory syn-
drome (SARS), meningococcal meningitis, Helicobacter pylori,
Herpes simplexvirus, cutaneous tuberculosis, stomatitis, tracheitis,
Shigella and Streptococcus pyogenes. One report described her-
pes simplex virus infection as a result of training in CPR. One
systematic review found that in the absence of high-risk activ-
ities, such as intravenous cannulation, there were no reports of
transmission of hepatitis B, hepatitis C, human immunodeﬁciency
virus (HIV) or cytomegalovirus during either training or actual
CPR.119
The risk of disease transmission during training and actual CPR
performance is extremely low. Wearing gloves during CPR is rea-
sonable, but CPR should not be delayed orwithheld if gloves are not
available. Rescuers should take appropriate safety precautions if a
victim is known to have a serious infection (e.g. HIV, tuberculosis,
hepatitis B virus or SARS).
Barrier devices
No human studies have addressed the safety, effectiveness or
feasibility of using barrier devices (such as a face shield or face
mask) to prevent victim contact during rescuer breathing. Two
studies showed that barrier devices decreased transmission of bac-
teria in controlled laboratory settings.120,121 Because the risk of
disease transmission is very low, initiating rescue breathing with-
out a barrier device is reasonable. If the victim is known to have a
serious infection (e.g. HIV, tuberculosis, hepatitis B virus, or SARS)
a barrier device is recommended.There are several variations of the recovery position, each
with its own advantages. No single position is perfect for all
victims.122,123 The position should be stable, near to a true lateral
position with the head dependent, and with no pressure on the
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Fig. 2.13. Place the arm nearest to you out at right angles to his body, elbow bent
with the hand palm uppermost.
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Fig. 2.15. With your other hand, grasp the far leg just above the knee and pull it up,
keeping the foot on the ground.
important to ask the conscious victim “Are you choking?”
Table 2.1
Differentiation between mild and severe foreign body airway obstruction (FBAO).a
Sign Mild obstruction Severe obstructionig. 2.14. Bring the far arm across the chest, and hold the back of the hand against
he victim’s cheek nearest to you.
hest to impair breathing.124The ERC recommends the following
equence of actions to place a victim in the recovery position:
Kneel beside the victim and make sure that both legs are straight.
Place the armnearest to you out at right angles to the body, elbow
bent with the hand palm uppermost (Fig. 2.13).
Bring the far arm across the chest, and hold the back of the hand
against the victim’s cheek nearest to you (Fig. 2.14).
With your other hand, grasp the far leg just above the knee and
pull it up, keeping the foot on the ground (Fig. 2.15).
Keeping the hand pressed against the cheek, pull on the far leg to
roll the victim towards you onto his side.
Adjust the upper leg so that both hip and knee are bent at right
angles.
Tilt the head back to make sure the airway remains open.
Adjust the hand under the cheek, if necessary, to keep the head
tilted and facing downwards to allow liquid material to drain
from the mouth (Fig. 2.16).
Check breathing regularly.If the victim has to be kept in the recovery position for more
han 30min, turn him to the opposite side to relieve the pressure
n the lower arm.Fig. 2.16. The recovery position completed. Keep the head tilted to keep the airway
open. Keep the face downward to allow ﬂuids to go out.
Foreign-body airway obstruction (choking)
Foreign-body airway obstruction (FBAO) is an uncommon but
potentially treatable cause of accidental death.125 As most choking
events are associated with eating, they are commonly witnessed.
Thus, there is often the opportunity for early interventionwhile the
victim is still responsive.
Recognition
Because recognition of airway obstruction is the key to success-
ful outcome, it is important not to confuse this emergency with
fainting,myocardial infarction, seizureorother conditions thatmay
cause sudden respiratorydistress, cyanosis or loss of consciousness.
Foreign bodies may cause either mild or severe airway obstruction.
The signs and symptoms enabling differentiation between mild
and severe airway obstruction are summarised in Table 2.1. It is“Are you choking?” “Yes” Unable to speak, may nod
Other signs Can speak, cough,
breathe
Cannot breathe/wheezy
breathing/silent attempts to
cough/unconsciousness
a General signs of FBAO: attack occurs while eating; victim may clutch his neck.
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oFig. 2.17. Adult foreign body air
dult foreign-body airway obstruction (choking) sequence (this
equence is also suitable for use in children over the age of 1 year)
Fig. 2.17)
. If the victim shows signs of mild airway obstruction:
• Encourage continued coughing but do nothing else.
. If the victim shows signs of severe airway obstruction and is
conscious:
• Apply ﬁve back blows as follows:
◦ stand to the side and slightly behind the victim;
◦ support the chest with one hand and lean the victim well
forwards so that when the obstructing object is dislodged it
comes out of the mouth rather than goes further down the
airway;
◦ give ﬁve sharp blows between the shoulder blades with the
heel of your other hand.
• If ﬁve back blows fail to relieve the airway obstruction, give
ﬁve abdominal thrusts as follows:
◦ stand behind the victim and put both arms round the upper
part of the abdomen;
◦ lean the victim forwards;
◦ clench your ﬁst and place it between the umbilicus (navel)
and the ribcage;
◦ grasp this hand with your other hand and pull sharply
inwards and upwards;
◦ repeat ﬁve times.
• If the obstruction is still not relieved, continue alternating ﬁve
back blows with ﬁve abdominal thrusts.
. If the victim at any time becomes unconscious:
• support the victim carefully to the ground;
• immediately activate the ambulance service;
• begin CPR with chest compressions.
oreign-body airway obstruction causing mild airway obstructionCoughing generates high and sustained airway pressures and
ay expel the foreignbody. Aggressive treatment,with backblows,
bdominal thrusts and chest compression, may cause potentially
erious complications and could worsen the airway obstruction. It
hould be reserved for victims who have signs of severe airway
bstruction. Victims with mild airway obstruction should remainbstruction treatment algorithm.
under continuous observation until they improve, as severe airway
obstruction may subsequently develop.
Foreign-body airway obstruction with severe airway obstruction
The clinical data on choking are largely retrospective and anec-
dotal. For conscious adults and childrenover 1 yearwith a complete
FBAO, case reports demonstrate the effectiveness of back blows
or “slaps”, abdominal thrusts and chest thrusts.126 Approximately
50% of episodes of airway obstruction are not relieved by a single
technique.127 The likelihood of success is increased when combi-
nations of back blows or slaps, and abdominal and chest thrusts are
used.126
A randomised trial in cadavers128 and two prospective studies
in anaesthetised volunteers129,130 showed that higher airway pres-
sures can be generated using chest thrusts compared with abdom-
inal thrusts. Since chest thrusts are virtually identical to chest
compressions, rescuers should be taught to start CPR if a victim
of known or suspected FBAO becomes unconscious. The purpose of
the chest compressions is primarily to attempt to remove the air-
wayobstruction in theunconsciousandsupinevictim, andonly sec-
ondarily to promote circulation. Therefore, chest compressions are
required even when a professional rescuer still feels a pulse. If the
obstruction is not relieved, progressive bradycardia and asystole
will occur. During CPR for choking, each time the airway is opened
the victim’s mouth should be quickly checked for any foreign body
that has been partly expelled. During CPR in other cases, therefore,
a routine check of the mouth for foreign bodies is not necessary.
The ﬁnger sweep
No studies have evaluated the routine use of a ﬁnger sweep to
clear the airway in the absence of visible airway obstruction,131–133
and four case reports have documented harm to the victim131,134
or rescuer126 during this manoeuvre. Blind ﬁnger sweeps should,
therefore, be avoided, and solid material in the airway removed
manually only if it can be seen.Aftercare and referral for medical review
Following successful treatment for FBAO, foreign material may
nevertheless remain in the upper or lower respiratory tract and
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ause complications later. Victims with a persistent cough, difﬁ-
ulty swallowing or the sensation of an object being still stuck
n the throat should, therefore, be referred for a medical opinion.
bdominal thrusts and chest compressions can potentially cause
erious internal injuries, and all victims successfully treated with
hese measures should be examined afterwards for injury.
esuscitation of children (see also Section 6)134a and
ictims of drowning (see also Section 8c)134b
For victims of primary cardiac arrest who receive chest-
ompression-only CPR, oxygen stores become depleted about
–4min after initiation of CPR.92,104 The combination of chest com-
ressions with ventilation then becomes critically important. After
ollapse from asphyxial arrest, a combination of chest compres-
ions with ventilations is important immediately after the start of
esuscitation. Previous guidelines have tried to address this differ-
nce in pathophysiology, and have recommended that victims of
dentiﬁable asphyxia (drowning, intoxication) and children should
eceive 1min of CPR before the lone rescuer leaves the victim to get
Fig. 2.18. Algorithm for use of an automaten 81 (2010) 1277–1292 1287
help. Themajority of cases of SCA out of hospital, however, occur in
adults, and although the rate of VF as the ﬁrst recorded rhythm has
declined over recent years, the cause of adult cardiac arrest remains
VF inmost cases (59%)whendocumented in theearliest phasebyan
AED.13 In children, VF is much less common as the primary cardiac
arrest rhythm (approximately 7%).135 These additional recommen-
dations, therefore, added to the complexity of the guidelines while
affecting only a minority of victims.
It is important to be aware that many children do not receive
resuscitation because potential rescuers fear causing harm if they
are not speciﬁcally trained in resuscitation for children. This fear
is unfounded; it is far better to use the adult BLS sequence for
resuscitation of a child than to do nothing. For ease of teaching and
retention laypeople should be taught that the adult sequence may
also be used for children who are not responsive and not breathing
or not breathing normally.The following minor modiﬁcations to the adult sequence will
make it even more suitable for use in children.
• Give 5 initial rescue breaths before starting chest compressions
(adult sequence of actions, 5b).
d external deﬁbrillator. © 2010 ERC.
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• the victim starts to wake up: moves, open eyes and breathes
normally;
• you become exhausted.288 R.W. Koster et al. / Resus
A lone rescuer should perform CPR for approximately 1min
before going for help.
Compress the chest by at least one third of its depth; use 2 ﬁngers
for an infant under 1 year; use 1 or 2 hands for a child over 1 year
as needed to achieve an adequate depth of compression.
The same modiﬁcations of 5 initial breaths and 1min of CPR
y the lone rescuer before getting help, may improve outcome for
ictims of drowning. This modiﬁcation should be taught only to
hosewhohavea speciﬁcdutyof care topotential drowningvictims
e.g. lifeguards). Drowning is easily identiﬁed. It can be difﬁcult, on
he other hand, for a layperson to determine whether cardiores-
iratory arrest is a direct result of trauma or intoxication. These
ictims should, therefore, be managed according to the standard
LS protocols.
se of an automated external deﬁbrillator
Section 3 discusses the guidelines for deﬁbrillation using both
utomated external deﬁbrillators (AEDs) andmanual deﬁbrillators.
EDs are safe and effective when used by laypeople, and make
t possible to deﬁbrillate many minutes before professional help
rrives. Rescuers should continue CPR with minimal interruption
f chest compressions while applying an AED and during its use.
escuers should concentrateon following thevoiceprompts imme-
iately they are received, in particular, resuming CPR as soon as
nstructed.
StandardAEDs are suitable for use in children older than 8 years.
or children between 1 and 8 years paediatric pads should be used,
ogether with an attenuator or a paediatric mode if available; if
hese are not available, the AED should be used as it is. Use of AEDs
s not recommended for children <1 year. There are, however, a
ew case reports describing the use of AEDs in children aged <1
ear.136,137 The incidence of shockable rhythms in infants is very
ow except when there is cardiac disease135,138,139; in these rare
ases, if an AED is the only deﬁbrillator available its use should be
onsidered (preferably with dose attenuator).
equence for use of an AED
See Fig. 2.18
. Make sure you, the victim, and any bystanders are safe.
. Follow the Adult BLS sequence (steps 1–5).
• if the victim is unresponsive and not breathing normally, send
someone for help and to ﬁnd and bring an AED if available;
• if you are on your own, use your mobile telephone to alert
the ambulance service—leave the victim only when there is no
other option.
. Start CPR according to the adult BLS sequence. If you are on your
own and the AED is in your immediate vicinity, start by applying
the AED.
. As soon as the AED arrives
• switchon theAEDandattach the electrodepadson thevictim’s
bare chest (Fig. 2.19);
• if more than one rescuer is present, CPR should be continued
while electrode pads are being attached to the chest;
• follow the spoken/visual directions immediately;
• ensure that nobody is touching the victim while the AED is
analysing the rhythm (Fig. 2.20).
a. If a shock is indicated• ensure that nobody is touching the victim (Fig. 2.21);
• push shock button as directed (fully automatic AEDs will
deliver the shock automatically);
• immediately restart CPR 30:2 (Fig. 2.22);
• continue as directed by the voice/visual prompts.Fig. 2.19. Attaching the electrode pads. Place the ﬁrst electrode pad in the mid-
axillary line just below the armpit. Place the second electrode just below the right
collarbone (clavicle). © 2010 ERC.
b. If no shock is indicated
• immediately resume CPR, using a ratio of 30 compressions to
2 rescue breaths;
• continue as directed by the voice/visual prompts.
6. Continue to follow the AED prompts until
• professional help arrives and takes over;Fig. 2.20. While theAEDanalyses theheart rhythm,nobody should touch thevictim.
© 2010 ERC.
R.W. Koster et al. / Resuscitatio
Fig. 2.21. When the shock button is pressed, make sure that nobody touches the
victim. © 2010 ERC.
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sig. 2.22. After the shock the AED will prompt you to start CPR. Do not wait—start
PR immediately and alternate 30 chest compressionswith 2 rescue breaths.©2010
RC.
PR before deﬁbrillation
The importance of immediate deﬁbrillation, as soon as an AED
ecomes available, has always been emphasised in guidelines and
uring teaching, and is considered to have a major impact on
urvival from ventricular ﬁbrillation. This concept has been chal-
enged, because evidence has suggested that a period of chest
ompression before deﬁbrillation may improve survival when the
ime between calling for the ambulance and its arrival exceeds
min.140,141 Two recent clinical studies142,143 and a recent animal
tudy144 did not conﬁrm this survival beneﬁt. For this reason, a pre-n 81 (2010) 1277–1292 1289
speciﬁed period of CPR, as a routine before rhythm analysis and
shock delivery, is not recommended. High-quality CPR, however,
must continue while the deﬁbrillation pads are being applied and
the deﬁbrillator is being prepared. The importance of early deliv-
ery of minimally interrupted chest compression is emphasised.
Given the lack of convincing data either supporting or refuting
this strategy, it is reasonable for emergency medical services that
have already implemented a speciﬁed period of chest compression
before deﬁbrillation to continue this practice.
Voice prompts
In several places, the sequence of actions states “follow the
voice/visual prompts”. Voice prompts are usually programmable,
and it is recommended that they be set in accordance with the
sequence of shocks and timings for CPR given in Section 2. These
should include at least:
1. a single shock only, when a shockable rhythm is detected;
2. no rhythm check, or check for breathing or a pulse, after the
shock;
3. a voice prompt for immediate resumption of CPR after the shock
(giving chest compressions in the presence of a spontaneous
circulation is not harmful);
4. a period of 2min of CPR before a next prompt to re-analyse the
rhythm.
The shock sequence and energy levels are discussed in
Section 3.2
Fully automatic AEDs
Having detected a shockable rhythm, a fully automatic AED will
deliver a shockwithout further input fromthe rescuer.Onemanikin
study has shown that untrained nursing students commit fewer
safety errors using a fully automatic AED rather than a (semi-)
automated AED.145 There are no human data to determinewhether
these ﬁndings can be applied to clinical use.
Public access deﬁbrillation programmes
AED programmes should be actively considered for implemen-
tation in non-hospital settings. This refers to public places like
airports,32 sport facilities, ofﬁces, in casinos35 and on aircraft,33
where cardiac arrests are usually witnessed and trained rescuers
are quickly on scene. Lay rescuer AED programmes with very
rapid response times, and uncontrolled studies using police ofﬁ-
cers asﬁrst responders,146,147 haveachieved reported survival rates
as high as 49–74%. These programmes will be successful only if
enough trained rescuers and AEDs are available.
The full potential of AEDs has not yet been achieved, because
theyaremostlyused inpublic settings, yet60–80%of cardiacarrests
occur at home. Public access deﬁbrillation (PAD) and ﬁrst respon-
der AED programmes may increase the number of victims who
receive bystander CPR and early deﬁbrillation, thus improving sur-
vival from out-of-hospital SCA.148 Recent data from nationwide
studies in Japan and the USA13,43 showed that when an AED was
available, victims were deﬁbrillated much sooner and with a bet-
ter chance of survival. However, an AED delivered a shock in only
3.7% and 5% of all VF cardiac arrests, respectively. There was a clear
inverse relationship in the Japanese study between the number of
AEDs available per square km and the interval between collapse
and the ﬁrst shock, and a positive relationship with survival. In
both studies, AED shocks still occurred predominantly in a public
rather than a residential setting. Dispatched ﬁrst responders like
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olice and ﬁre ﬁghters will, in general, have longer response times,
ut have the potential to reach the whole population.
When implementing an AED programme, community and pro-
ramme leaders should consider factors such as the strategic
ocation of AEDs, development of a team with responsibility for
onitoring and maintaining the devices, training and retraining
rogrammes for the individuals who are likely to use the AED, and
dentiﬁcation of a group of volunteer individuals who are commit-
ed to using the AED for victims of cardiac arrest.149
The logistic problem for ﬁrst responder programmes is that the
escuer needs to arrive, not just earlier than the traditional ambu-
ance, but within 5–6min of the initial call, to enable attempted
eﬁbrillation in the electrical or circulatory phase of cardiac
rrest.44 With longer delays, the survival beneﬁts decrease:36,47
few minutes’ gain in time will have little impact when a ﬁrst
esponder arrives more than 10min after the call,14,150 or when
ﬁrst responder does not improve on an already short ambu-
ance response time.151 However, small reductions in response
ntervals achieved by ﬁrst-responder programmes that impact on
any residential victimsmaybemore cost-effective than the larger
eductions in response interval achieved by PAD programmes that
ave an impact on fewer cardiac arrest victims.152,153
Programmes that make AEDs publicly available in residential
reas have not yet been evaluated. The acquisition of an AED for
ndividual use at home, even for those considered at high risk of
udden cardiac arrest, has proved not to be effective.154
niversal AED signage
When a collapse occurs, and an AEDmust be found rapidly, sim-
le and clear signage indicating the location of, and the fastest way
o anAED is important. ILCORhas designed anAED sign thatmay be
ecognisedworldwide and is recommended for indicating the loca-
ion of an AED (Fig. 2.23). More detailed information on design and
pplication of this AED sign can be found at: https://www.erc.edu/
ndex.php/newsItem/en/nid=204/
ig. 2.23. Universal ILCOR signage to indicate presence of an AED. This sign can be
ombined with arrows to indicate the direction of the nearest AED.
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ection 3. Electrical therapies: Automated external deﬁbrillators, deﬁbrillation,
ardioversion and pacingharles D. Deakina,∗, Jerry P. Nolanb, Kjetil Sundec, Rudolph W. Kosterd
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Royal United Hospital, Bath, UK
Oslo University Hospital Ulleval, Oslo, Norway
Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlandsummary of changes since 2005 Guidelines
Themost important changes in the2010EuropeanResuscitation
ouncil (ERC) guidelines for electrical therapies include:
The importance of early, uninterrupted chest compressions is
emphasised throughout these guidelines.
Much greater emphasis on minimising the duration of the pre-
shock and post-shock pauses. The continuation of compressions
during charging of the deﬁbrillator is recommended.
Immediate resumption of chest compressions following deﬁb-
rillation is also emphasised; in combination with continuation
of compressions during deﬁbrillator charging, the delivery of
deﬁbrillation should be achievable with an interruption in chest
compressions of no more than 5 s.
Safety of the rescuer remains paramount, but there is recogni-
tion in these guidelines that the risk of harm to a rescuer from
a deﬁbrillator is very small, particularly if the rescuer is wearing
gloves. The focus is now on a rapid safety check to minimise the
pre-shock pause.
When treating out-of-hospital cardiac arrest, emergency med-
ical services (EMS) personnel should provide good-quality CPR
while a deﬁbrillator is retrieved, applied and charged, but rou-
tine delivery of a pre-speciﬁed period of CPR (e.g., 2 or 3min)
before rhythm analysis and a shock is delivered is no longer
recommended. For some emergency medical services that have
already fully implemented a pre-speciﬁed period of chest com-
pressions before deﬁbrillation, given the lack of convincing data
either supporting or refuting this strategy, it is reasonable for
them to continue this practice.
The use of up to three-stacked shocks may be considered if
ventricular ﬁbrillation/pulseless ventricular tachycardia (VF/VT)
∗ Corresponding author.
E-mail address: charlesdeakin@doctors.org.uk (C.D. Deakin).
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.008occurs during cardiac catheterisation or in the early post-
operative period following cardiac surgery. This three-shock
strategy may also be considered for an initial, witnessed VF/VT
cardiac arrest when the patient is already connected to a manual
deﬁbrillator.
• Electrode pastes and gels can spread between the two paddles,
creating the potential for a spark and should not be used
Introduction
The chapter presents guidelines for deﬁbrillation using both
automated external deﬁbrillators (AEDs) andmanual deﬁbrillators.
There are only a few differences from the 2005 ERC Guidelines. All
healthcare providers and lay responders can use AEDs as an inte-
gral component of basic life support. Manual deﬁbrillation is used
as part of advanced life support (ALS) therapy. Synchronised car-
dioversion and pacing options are included on many deﬁbrillators
and are also discussed in this chapter.
Deﬁbrillation is the passage of an electrical current across the
myocardium of sufﬁcient magnitude to depolarise a critical mass
of myocardium and enable restoration of coordinated electrical
activity. Deﬁbrillation is deﬁned as the termination of ﬁbrillation
or, more precisely, the absence of VF/VT at 5 s after shock deliv-
ery; however, the goal of attempted deﬁbrillation is to restore an
organised rhythm and a spontaneous circulation.
Deﬁbrillator technology is advancing rapidly. AED interaction
with the rescuer through voice prompts is now established and
future technologymayenablemore speciﬁc instructions tobegiven
by voice prompt. The evolving ability of deﬁbrillators to assess
the rhythm whilst CPR is in progress is an important advance and
enables rescuers to assess the rhythm without interrupting exter-
nal chest compressions. In the future, waveform analysis may also
enable the deﬁbrillator to calculate the optimal time at which to
give a shock.
evier Ireland Ltd. All rights reserved.
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vital link in the Chain of Survival
Deﬁbrillation is a key link in the Chain of Survival and is one
f the few interventions that have been shown to improve out-
ome from VF/VT cardiac arrest. The previous guidelines published
n 2005 rightly emphasized the importance of early deﬁbrillation
ith minimum delay.1,2
The probability of successful deﬁbrillation and subsequent sur-
ival to hospital discharge declines rapidly with time3,4 and the
bility to deliver early deﬁbrillation is one of the most impor-
ant factors in determining survival from cardiac arrest. For every
inute delay in deﬁbrillation, in the absence of bystander CPR, sur-
ival from witnessed VF decreases by 10–12%.4,5 EMS systems do
ot generally have the capability to deliver deﬁbrillation through
raditional paramedic responders within the ﬁrst few minutes of
call and the alternative use of trained lay responders to deliver
rompt deﬁbrillation using AEDs is now widespread. EMS sys-
ems that have reduced time to deﬁbrillation following cardiac
rrest using trained lay responders have reported greatly improved
urvival to hospital discharge rates,6–9 some as high as 75% if deﬁb-
illation is performed within 3min of collapse.10 This concept has
lso been extended to in-hospital cardiac arrests where staff, other
han doctors, are also being trained to deﬁbrillate using an AED
efore arrival of the cardiac arrest team.11
When bystander CPR is provided, the fall in survival is
ore gradual and averages 3–4% per minute from collapse to
eﬁbrillation3,4,12; bystander CPR can double3,4,13 or triple14 sur-
ival from witnessed out-of-hospital cardiac arrest. Resuscitation
nstructions given by the ambulance service before the arrival of
rained help increase the quantity and quality of bystander CPR15,16
nd use of video instructions by phone may improve performance
urther.17,18
All healthcare providers with a duty to perform CPR should be
rained, equipped, and encouraged to perform deﬁbrillation and
PR. Early deﬁbrillation should be available throughout all hospi-
als, outpatientmedical facilities andpublic areas ofmass gathering
see Section 2).19 Those trained in the use of an AED should also be
rained to deliver high-quality CPR before arrival of ALS providers
o that the effectiveness of early deﬁbrillation can be optimised.
utomated external deﬁbrillators
Automated external deﬁbrillators are sophisticated, reliable
omputerised devices that use voice and visual prompts to guide
ay rescuers and healthcare professionals to safely attempt deﬁb-
illation in cardiac arrest victims. Some AEDs combine guidance for
eﬁbrillation with guidance for the delivery of optimal chest com-
ressions. Use of AEDs by lay or non-healthcare rescuers is covered
n Section 2.19
Inmanysituations, anAED isused toprovide initial deﬁbrillation
ut is subsequently swapped for a manual deﬁbrillator on arrival
f EMS personnel. If such a swap is done without considering the
hase the AED cycle is in, the next shock may be delayed, which
aycompromiseoutcome.20 For this reason, EMSpersonnel should
eave the AED connected while securing airway and IV access. The
ED should be left attached for the next rhythm analysis and, if
ndicated, a shockdeliveredbefore theAED is swapped for amanual
eﬁbrillator.
Currentlymanymanufacturersuseproduct-speciﬁcelectrode to
eﬁbrillator connectors, which necessitates the deﬁbrillation pads
lso being removed and replaced with a pair compatible with the
ewdeﬁbrillator.Manufacturers are encouraged to collaborate and
evelop a universal connector that enables all deﬁbrillation pads
o be compatible with all deﬁbrillators. This will have signiﬁcant
atient beneﬁt and minimise unnecessary waste.n 81 (2010) 1293–1304
In-hospital use of AEDs
At the time of the 2010 Consensus on CPR Science Conference
there were no published randomised trials comparing in-hospital
use of AEDs with manual deﬁbrillators. Two lower level studies
of adults with in-hospital cardiac arrest from shockable rhythms
showed higher survival to hospital discharge rates when deﬁb-
rillation was provided through an AED programme than with
manual deﬁbrillation alone.21,22 One retrospective study23 demon-
strated no improvements in survival to hospital discharge for
in-hospital adult cardiac arrest when using an AED compared with
manual deﬁbrillation. In this study, patients in the AED group
with initial asystole or pulseless electrical activity (PEA) had a
lower survival to hospital discharge rate compared with those
in the manual deﬁbrillator group (15% versus 23%; p=0.04). A
manikin study showed that use of an AED signiﬁcantly increased
the likelihood of delivering three shocks but increased the time to
deliver the shocks when compared with manual deﬁbrillators.24
In contrast, a study of mock arrests in simulated patients showed
that use of monitoring leads and fully automated deﬁbrilla-
tors reduced time to deﬁbrillation when compared with manual
deﬁbrillators.25
Delayed deﬁbrillation may occur when patients sustain car-
diac arrest in unmonitored hospital beds and in outpatient
departments.26 In these areas several minutes may elapse before
resuscitation teams arrive with a deﬁbrillator and deliver shocks.
Despite limited evidence, AEDs should be considered for the hospi-
tal setting as a way to facilitate early deﬁbrillation (a goal of <3min
from collapse), especially in areaswhere healthcare providers have
no rhythm recognition skills or where they use deﬁbrillators infre-
quently. An effective system for training and retraining should be
in place.11 Enoughhealthcare providers should be trained to enable
achievement of the goal of providing the ﬁrst shock within 3min
of collapse anywhere in the hospital. Hospitals should monitor
collapse-to-ﬁrst shock intervals and monitor resuscitation out-
comes.
Shock in manual versus semi-automatic mode
ManyAEDs can be operated in bothmanual and semi-automatic
mode but few studies have compared these two options. The semi-
automaticmode has been shown to reduce time to ﬁrst shockwhen
used both in-hospital27 and pre-hospital28 settings, and results
in higher VF conversion rates,28 and delivery of fewer inappro-
priate shocks.29 Conversely, semi-automatic modes result in less
time spent performing chest compressions29,30 mainly because of
a longer pre-shock pause associated with automated rhythm anal-
ysis. Despite these differences, no overall difference in return of
spontaneous circulation (ROSC), survival, or discharge rate from
hospital has been demonstrated in any study.23,27,28 The deﬁbrilla-
tionmode that affords the best outcomewill depend on the system,
skills, training and ECG recognition skills of rescuers. A shorter pre-
shock pause and lower total hands-off-ratio increases vital organ
perfusion and the probability of ROSC.31–33 With manual deﬁbril-
lators and some AEDs it is possible to perform chest compressions
during charging and thereby reduce the pre-shock pause to less
than 5 s. Trained individuals may deliver deﬁbrillation in manual
mode but frequent team training and ECG recognition skills are
essential.
Automated rhythm analysisAutomated external deﬁbrillators have microprocessors that
analyse several features of the ECG, including frequency and ampli-
tude. Developing technology should soon enable AEDs to provide
information about frequency and depth of chest compressions dur-
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ng CPR that may improve basic life support (BLS) performance by
ll rescuers.34,35
Automated external deﬁbrillators have been tested extensively
gainst libraries of recorded cardiac rhythms and in many trials
n adults36,37 and children.38,39 They are extremely accurate in
hythm analysis. Although most AEDs are not designed to deliver
ynchronised shocks, all AEDs will recommend shocks for VT if the
ate and R-wave morphology and duration exceeds preset values.
ost AEDs require a ‘hands-off’ period while the device analyses
he rhythm. This ‘hands-off’ period results in interruption to chest
ompressions for varying but signiﬁcant periods of time40; a factor
hown to have signiﬁcant adverse impact on outcome from car-
iac arrest.41 Manufacturers of these devices should make every
ffort to develop software that minimises this analysis period to
nsure that interruptions to external chest compressions are kept
o a minimum.
trategies before deﬁbrillation
inimising the pre-shock pause
The delay between stopping chest compressions and delivery of
he shock (the pre-shock pause) must be kept to an absolute mini-
um; even 5–10 s delay will reduce the chances of the shock being
uccessful.31,32,42 The pre-shock pause can easily be reduced to less
han 5 s by continuing compressions during charging of the deﬁb-
illator and by having an efﬁcient team coordinated by a leader
ho communicates effectively. The safety check to ensure that
obody is in contact with the patient at the moment of deﬁbril-
ation should be undertaken rapidly but efﬁciently. The negligible
isk of a rescuer receiving an accidental shock is minimised even
urther if all rescuers wear gloves.43 The post-shock pause is min-
mised by resuming chest compressions immediately after shock
elivery (see below). The entire process of deﬁbrillation should be
chievable with no more than a 5 s interruption to chest compres-
ion.
afe use of oxygen during deﬁbrillation
In an oxygen-enriched atmosphere, sparking from poorly
pplied deﬁbrillator paddles can cause a ﬁre.44–49 There are several
eports of ﬁres being caused in this way and most have resulted
n signiﬁcant burns to the patient. There are no case reports of
res caused by sparking where deﬁbrillation was delivered using
dhesive pads. In two manikin studies the oxygen concentration
n the zone of deﬁbrillation was not increased when ventilation
evices (bag-valve device, self-inﬂating bag,modern intensive care
nit ventilator) were left attached to a tracheal tube or the oxygen
ourcewas vented at least 1mbehind the patient’smouth.50,51 One
tudy described higher oxygen concentrations and longer washout
eriods when oxygen is administered in conﬁned spaces without
dequate ventilation.52
The risk of ﬁre during attempteddeﬁbrillation can beminimised
y taking the following precautions:
Take off any oxygen mask or nasal cannulae and place them at
least 1m away from the patient’s chest.
Leave the ventilation bag connected to the tracheal tube or supra-
glottic airway device. Alternatively, disconnect any bag-valve
device from the tracheal tube or supraglottic airway device and
remove it at least 1m from the patient’s chest during deﬁbrilla-
tion.
If the patient is connected to a ventilator, for example in the
operating room or critical care unit, leave the ventilator tubing
(breathing circuit) connected to the tracheal tube unless chestn 81 (2010) 1293–1304 1295
compressions prevent the ventilator from delivering adequate
tidal volumes. In this case, the ventilator is usually substituted by
a ventilation bag, which can itself be left connected or detached
and removed to a distance of at least 1m. If the ventilator tub-
ing is disconnected, ensure it is kept at least 1m from the patient
or, better still, switch the ventilator off; modern ventilators gen-
erate massive oxygen ﬂows when disconnected. During normal
use, when connected to a tracheal tube, oxygen from a ventilator
in the critical care unit will be vented from the main ventilator
housing well away from the deﬁbrillation zone. Patients in the
critical care unit may be dependent on positive end expiratory
pressure (PEEP) to maintain adequate oxygenation; during car-
dioversion,when the spontaneous circulationpotentially enables
blood to remain well oxygenated, it is particularly appropriate to
leave the critically ill patient connected to the ventilator during
shock delivery.
• Minimise the risk of sparks during deﬁbrillation. Self-adhesive
deﬁbrillation pads are less likely to cause sparks than manual
paddles.
Some early versions of the LUCAS external chest compression
device are driven by high ﬂow rates of oxygen which discharges
waste gas over the patient’s chest. High ambient levels of oxygen
over the chesthavebeendocumentedusing thisdevice, particularly
in relatively conﬁned spaces such as the back of the ambulance and
caution should be usedwhen deﬁbrillating patientswhile using the
oxygen-powered model.52
The technique for electrode contact with the chest
Optimal deﬁbrillation technique aims to deliver current across
the ﬁbrillating myocardium in the presence of minimal transtho-
racic impedance. Transthoracic impedance varies considerably
with body mass, but is approximately 70–80 in adults.53,54 The
techniques described below aim to place external electrodes (pad-
dles or self-adhesive pads) in an optimal position using techniques
that minimise transthoracic impedance.
Shaving the chest
Patients with a hairy chest have poor electrode-to-skin electri-
cal contact and air trapping beneath the electrode. This causes high
impedance, reduced deﬁbrillation efﬁcacy, risk of arcing (sparks)
from electrode-to-skin and electrode to electrode and is more
likely to cause burns to the patient’s chest. Rapid shaving of the
area of intended electrode placement may be necessary, but do
not delay deﬁbrillation if a shaver is not immediately available.
Shaving the chest per se may reduce transthoracic impedance
slightly and has been recommended for elective DC cardioversion
with monophasic deﬁbrillators,55 although the efﬁcacy of biphasic
impedance-compensated waveforms may not be so susceptible to
higher transthoracic impedance.56
Paddle force
If using paddles, apply them ﬁrmly to the chest wall. This
reduces transthoracic impedance by improving electrical contact
at the electrode–skin interface and reducing thoracic volume.57
The deﬁbrillator operator should always press ﬁrmly on handheld
electrode paddles, the optimal force being 8kg in adult and 5kg in
children 1–8 years using adult paddles.58 Eight kilogram forcemay
be attainable only by the strongest members of the cardiac arrest
team and therefore it is recommended that these individuals apply
thepaddlesduringdeﬁbrillation.Unlike self-adhesivepads,manual
paddles have a baremetal plate that requires a conductivematerial
placed between the metal and patient’s skin to improve electrical
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ontact. Use of bare-metal paddles alone creates high transthoracic
mpedance and is likely to increase the risk of arcing and worsen
utaneous burns from deﬁbrillation.
lectrode position
No human studies have evaluated the electrode position as a
eterminant of ROSC or survival from VF/VT cardiac arrest. Trans-
yocardial current during deﬁbrillation is likely to be maximal
hen the electrodes are placed so that the area of the heart that
s ﬁbrillating lies directly between them (i.e. ventricles in VF/VT,
tria in AF). Therefore, the optimal electrode position may not be
he same for ventricular and atrial arrhythmias.
More patients are presenting with implantable medical devices
e.g., permanent pacemaker, implantable cardioverter deﬁbrillator
ICD)). Medic Alert bracelets are recommended for these patients.
hese devices may be damaged during deﬁbrillation if current is
ischarged through electrodes placed directly over the device.59,60
lace the electrode away from the device (at least 8 cm)59 or use an
lternative electrode position (anterior-lateral, anterior-posterior)
s described below.
Transdermal drug patches may prevent good electrode contact,
ausing arcing and burns if the electrode is placed directly over the
atch during deﬁbrillation.61,62 Remove medication patches and
ipe the area before applying the electrode.
lacement for ventricular arrhythmias and cardiac arrest
Place electrodes (either pads or paddles) in the conventional
ternal-apical position. The right (sternal) electrode is placed to
he right of the sternum, below the clavicle. The apical pad-
le is placed in the left mid-axillary line, approximately level
ith the V6 ECG electrode or female breast. This position should
e clear of any breast tissue. It is important that this electrode
s placed sufﬁciently laterally. Other acceptable pad positions
nclude
Placement of each electrode on the lateral chest walls, one on the
right and the other on the left side (bi-axillary).
One electrode in the standard apical position and the other on the
right upper back.
One electrode anteriorly, over the left precordium, and the other
electrode posteriorly to the heart just inferior to the left scapula.
It does not matter which electrode (apex/sternum) is placed in
ither position.
Transthoracic impedance has been shown to be minimised
hen the apical electrode is not placed over the female breast.63
symmetrically shaped apical electrodes have a lower impedance
hen placed longitudinally rather than transversely.64
lacement for atrial arrhythmias
Atrial ﬁbrillation is maintained by functional re-entry circuits
nchored in the left atrium. As the left atrium is located pos-
eriorly in the thorax, electrode positions that result in a more
osterior current pathway may theoretically be more effective
or atrial arrhythmias. Although some studies have shown that
ntero-posterior electrode placement is more effective than the
raditional antero-apical position in elective cardioversion of atrial
brillation,65,66 the majority have failed to demonstrate any clear
dvantage of any speciﬁc electrode position.67,68 Efﬁcacy of car-
ioversionmaybe lessdependentonelectrodepositionwhenusing
iphasic impedance-compensated waveforms.56 The following
lectrode positions all appear safe and effective for cardioversion
f atrial arrhythmias:n 81 (2010) 1293–1304
• Traditional antero-apical position.
• Antero-posterior position (one electrode anteriorly, over the left
precordium, and the other electrode posteriorly to the heart just
inferior to the left scapula).
Respiratory phase
Transthoracic impedance varies during respiration, being min-
imal at end-expiration. If possible, deﬁbrillation should be
attemptedat thisphaseof the respiratory cycle. Positiveendexpira-
tory pressure (PEEP) increases transthoracic impedance and should
be minimised during deﬁbrillation. Auto-PEEP (gas trapping) may
be particularly high in asthmatics and may necessitate higher than
usual energy levels for deﬁbrillation.69
Electrode size
The Association for the Advancement of Medical Instrumen-
tation recommends a minimum electrode size of for individual
electrodes and the sumof the electrode areas should be aminimum
of 150 cm2.70 Larger electrodes have lower impedance, but exces-
sively large electrodes may result in less transmyocardial current
ﬂow.71
For adult deﬁbrillation, both handheld paddle electrodes and
self-adhesive pad electrodes 8–12 cm in diameter are used and
function well. Deﬁbrillation success may be higher with electrodes
of 12 cm diameter compared with those of 8 cm diameter.54,72
Standard AEDs are suitable for use in children over the age of 8
years. In children between 1 and 8 years use paediatric pads with
an attenuator to reduce delivered energy or a paediatric mode if
they are available; if not, use the unmodiﬁed machine, taking care
to ensure that the adult pads do not overlap. Use of AEDs is not
recommended in children less than 1 year.
Coupling agents
If using manual paddles, disposable gel pads should be used to
reduce impedance at the electrode–skin interface. Electrode pastes
andgels can spreadbetween the twopaddles, creating thepotential
for a spark and should not be used. Do not use bare electrodeswith-
out gel pads because the resultant high transthoracic impedance
may impair the effectiveness of deﬁbrillation, increase the sever-
ity of any cutaneous burns and risk arcing with subsequent ﬁre or
explosion.
Pads versus paddles
Self-adhesive deﬁbrillation pads have practical beneﬁts over
paddles for routine monitoring and deﬁbrillation.73–77 They are
safe and effective and are preferable to standard deﬁbrillation
paddles.72 Consideration should be given to use of self-adhesive
pads in peri-arrest situations and in clinical situations where
patient access is difﬁcult. They have a similar transthoracic
impedance71 (and therefore efﬁcacy)78,79 to manual paddles and
enable the operator to deﬁbrillate the patient from a safe distance
rather than leaning over the patient as occurs with paddles. When
used for initial monitoring of a rhythm, both pads and paddles
enable quicker delivery of the ﬁrst shock compared with standard
ECG electrodes, but pads are quicker than paddles.80
When gel pads are used with paddles, the electrolyte gel
becomes polarised and thus is a poor conductor after deﬁbrillation.
This can cause spurious asystole thatmay persist for 3–4minwhen
used to monitor the rhythm; a phenomenon not reported with
self-adhesive pads.74,81 When using a gel pad/paddle combination
conﬁrm a diagnosis of asystole with independent ECG electrodes
rather than the paddles.
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ibrillation waveform analysis
It is possible to predict, with varying reliability, the success of
eﬁbrillation from theﬁbrillationwaveform.82–101 If optimal deﬁb-
illation waveforms and the optimal timing of shock delivery can
e determined in prospective studies, it should be possible to pre-
ent the delivery of unsuccessful high energy shocks andminimise
yocardial injury. This technology is under active development
nd investigation but current sensitivity and speciﬁcity is insuf-
cient to enable introduction of VF waveform analysis into clinical
ractice.
PR versus deﬁbrillation as the initial treatment
A number of studies have examined whether a period of CPR
rior to deﬁbrillation is beneﬁcial, particularly in patients with
n unwitnessed arrest or prolonged collapse without resuscita-
ion. A review of evidence for the 2005 guidelines resulted in
he recommendation that it was reasonable for EMS personnel
o give a period of about 2min of CPR (i.e. about ﬁve cycles
t 30:2) before deﬁbrillation in patients with prolonged collapse
>5min).1 This recommendation was based on clinical studies
here response times exceeded 4–5min, a period of 1.5–3min
f CPR by paramedics or EMS physicians before shock delivery
mproved ROSC, survival to hospital discharge102,103 and one year
urvival103 for adults with out-of-hospital VF/VT compared with
mmediate deﬁbrillation. In some animal studies of VF lasting at
east 5min, CPR before deﬁbrillation improved haemodynamics
nd survival.103–106 A recent ischaemic swine model of cardiac
rrest showed a decreased survival after pre-shock CPR.107
In contrast, two randomized controlled trials, a period of
.5–3min of CPR by EMS personnel before deﬁbrillation did not
mproveROSCor survival tohospital discharge inpatientswithout-
f-hospital VF/VT, regardless of EMS response interval.108,109 Four
ther studies have also failed to demonstrate signiﬁcant improve-
ents in overall ROSC or survival to hospital discharge with an
nitial period of CPR,102,103,110,111 although one did show a higher
ate of favourable neurological outcome at 30 days and one year
fter cardiac arrest.110
The duration of collapse is frequently difﬁcult to estimate accu-
ately and there is evidence that performing chest compressions
hile retrieving and charging a deﬁbrillator improves the proba-
ility of survival.112 For these reasons, in any cardiac arrest they
ave not witnessed, EMS personnel should provide good-quality
PR while a deﬁbrillator is retrieved, applied and charged, but rou-
ine delivery of a pre-speciﬁed period of CPR (e.g., 2 or 3min) before
hythm analysis and a shock is delivered is not recommended.
ome EMS systems have already fully implemented a pre-speciﬁed
eriod of chest compressions before deﬁbrillation; given the lack
f convincing data either supporting or refuting this strategy, it is
easonable for them to continue this practice.
In hospital environments, settings with an AED on-site and
vailable (including lay responders), or EMS-witnessed events,
eﬁbrillation should be performed as soon as the deﬁbrillator
s available. Chest compressions should be performed until just
efore the deﬁbrillation attempt (see Section 4 advanced life
upport).113
The importance of early, uninterrupted chest compressions is
mphasised throughout these guidelines. In practice, it is often dif-
cult to ascertain the exact time of collapse and, in any case, CPR
hould be started as soon as possible. The rescuer providing chest
ompressions should interrupt chest compressions only for ven-
ilations, rhythm analysis and shock delivery, and should resume
hest compressions as soon as a shock is delivered. When two res-
uers are present, the rescuer operating the AED should apply the
lectrodes whilst CPR is in progress. Interrupt CPR only when it isn 81 (2010) 1293–1304 1297
necessary to assess the rhythm and deliver a shock. The AED oper-
ator should be prepared to deliver a shock as soon as analysis is
complete and the shock is advised, ensuring no rescuer is in contact
with the victim.
Delivery of deﬁbrillation
One-shock versus three-stacked shock sequence
Amajor change in the 2005 guidelineswas the recommendation
to give single rather than three-stacked shocks. This was because
animal studies had shown that relatively short interruptions in
external chest compression to deliver rescue breaths114,115 or per-
form rhythm analysis33 were associated with post-resuscitation
myocardial dysfunction and reduced survival. Interruptions in
external chest compression also reduced the chances of converting
VF to another rhythm.32 Analysis of CPR performance during out-
of-hospital34,116 and in-hospital35 cardiac arrest also showed that
signiﬁcant interruptions were common, with chest compressions
comprising no more than 51–76%34,35 of total CPR time.
With ﬁrst shock efﬁcacy of biphasic waveforms generally
exceeding 90%,117–120 failure to cardiovert VF successfully is more
likely to suggest the need for a period of CPR rather than a further
shock. Even if the deﬁbrillation attempt is successful in restoring a
perfusing rhythm, it is very rare for a pulse to be palpable immedi-
ately after deﬁbrillation and the delay in trying to palpate a pulse
will further compromise themyocardium if a perfusing rhythmhas
not been restored.40
Subsequent studies have shown a signiﬁcantly lower hands-
off-ratio with the one-shock protocol121 and some,41,122,123 but
not all,121,124 have suggested a signiﬁcant survival beneﬁt from
this single-shock strategy. However, all studies except one124 were
before-after studies and all introducedmultiple changes in the pro-
tocol, making it difﬁcult to attribute a possible survival beneﬁt to
one of the changes.
Whendeﬁbrillation iswarranted, give a single shockand resume
chest compressions immediately following the shock. Do not delay
CPR for rhythm reanalysis or a pulse check immediately after a
shock. Continue CPR (30 compressions:2 ventilations) for 2min
until rhythm reanalysis is undertaken and another shock given (if
indicated) (see Section 4 advanced life support).113 This single-
shock strategy is applicable to both monophasic and biphasic
deﬁbrillators.
If VF/VT occurs during cardiac catheterisation or in the early
post-operative period following cardiac surgery (when chest com-
pressions could disrupt vascular sutures), consider delivering up
to three-stacked shocks before starting chest compressions (see
Section 8 special circumstances).125 This three-shock strategymay
also be considered for an initial, witnessed VF/VT cardiac arrest if
the patient is already connected to amanual deﬁbrillator. Although
there are no data supporting a three-shock strategy in any of these
circumstances, it is unlikely that chest compressions will improve
the already very high chance of return of spontaneous circulation
when deﬁbrillation occurs early in the electrical phase, immedi-
ately after onset of VF.
Waveforms
Historically, deﬁbrillators delivering a monophasic pulse had
been the standardof careuntil the 1990s.Monophasic deﬁbrillators
deliver current that is unipolar (i.e. one direction of current ﬂow)
(Fig. 3.1). Monophasic deﬁbrillators were particularly susceptible
to waveform modiﬁcation depending on transthoracic impedance.
Small patients with minimal transthoracic impedance received
considerably greater transmyocardial current than larger patients,
1298 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304
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aFig. 3.1. Monophasic damped sinusoidal waveform (MDS).
here not only was the current less, but the waveform lengthened
o the extent that its efﬁcacy was reduced.
Monophasic deﬁbrillators are no longer manufactured, and
lthough many will remain in use for several years, biphasic deﬁb-
illators have now superseded them. Biphasic deﬁbrillators deliver
urrent that ﬂows in a positive direction for a speciﬁed duration
efore reversing and ﬂowing in a negative direction for the remain-
ng milliseconds of the electrical discharge. There are two main
ypes of biphasic waveform: the biphasic truncated exponential
BTE) (Fig. 3.2) and rectilinear biphasic (RLB) (Fig. 3.3). Biphasic
eﬁbrillators compensate for the wide variations in transthoracic
mpedance by electronically adjusting the waveform magnitude
ndduration toensureoptimal currentdelivery to themyocardium,
rrespective of the patient’s size.
A pulsed biphasic waveform has recently been described in
hich the current rapidly oscillates between baseline and a pos-
tive value before inverting in a negative pattern. This waveform is
lso in clinical use. It may have a similar efﬁcacy as other biphasic
aveforms, but the single clinical study of this waveform was not
erformed with an impedance compensating device.126,127 There
re several other different biphasic waveforms, all with no clini-
al evidence of superiority for any individual waveform compared
ith another.
All manual deﬁbrillators and AEDs that allow manual override
f energy levels should be labelled to indicate their waveform
monophasic or biphasic) and recommended energy levels for
ttempted deﬁbrillation of VF/VT.
Fig. 3.2. Biphasic truncated exponential waveform (BTE).Fig. 3.3. Rectilinear biphasic waveform (RLB).
Monophasic versus biphasic deﬁbrillation
Although biphasic waveforms are more effective at terminating
ventricular arrhythmias at lower energy levels, have demonstrated
greater ﬁrst shock efﬁcacy than monophasic waveforms, and have
greater ﬁrst shock efﬁcacy for long duration VF/VT,128–130 no
randomised studieshavedemonstrated superiority in termsofneu-
rologically intact survival to hospital discharge.
Some,119,128–133 but not all,134 studies suggest the biphasic
waveform improves short-term outcomes of VF termination com-
pared with monophasic deﬁbrillation.
Biphasic waveforms have been shown to be superior to
monophasic waveforms for elective cardioversion of atrial ﬁbril-
lation, with greater overall success rates, using less cumulative
energy and reducing the severity of cutaneous burns,135–138 and
are the waveform of choice for this procedure.
Multiphasic versus biphasic deﬁbrillation
A number of multiphasic waveforms (e.g. triphasic, quadripha-
sic, multiphasic) have also been trialled in animal studies. Animal
data suggest that multiphasic waveforms may deﬁbrillate at lower
energies and induce lesspost-shockmyocardial dysfunction.139–141
These results are limited by studies of short duration of VF (approx-
imately 30 s) and lack of human studies for validation. At present,
there are no human studies comparing a multiphasic waveform
with biphasic waveforms for deﬁbrillation and no deﬁbrillator cur-
rently available uses multiphasic waveforms.
Energy levels
Deﬁbrillation requires the delivery of sufﬁcient electrical energy
todeﬁbrillate a criticalmassofmyocardium,abolish thewavefronts
ofVF andenable restorationof spontaneous synchronizedelectrical
activity in the form of an organised rhythm. The optimal energy for
deﬁbrillation is that which achieves deﬁbrillation whilst causing
theminimumofmyocardial damage.142 Selection of an appropriate
energy level also reduces the number of repetitive shocks, which
in turn limits myocardial damage.143Optimal energy levels for both monophasic and biphasic wave-
forms are unknown. The recommendations for energy levels are
based on a consensus following careful review of the current
literature. Although energy levels are selected for deﬁbrillation,
it is the transmyocardial current ﬂow that achieves deﬁbrilla-
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ion. Current correlates well with successful deﬁbrillation and
ardioversion.144 The optimal current for deﬁbrillation using a
onophasicwaveform is in the range of 30–40A. Indirect evidence
rom measurements during cardioversion for atrial ﬁbrillation
uggests that the current during deﬁbrillation using biphasicwave-
orms is in the range of 15–20A.137 Future technology may enable
eﬁbrillators to discharge according to transthoracic current; a
trategy that may lead to greater consistency in shock success.
eak current amplitude, average current and phase duration all
eed to be studied to determine optimal values andmanufacturers
re encouraged to explore further this move from energy-based to
urrent-based deﬁbrillation.
irst shock
onophasic deﬁbrillators
There are no new published studies looking at the optimal
nergy levels for monophasic waveforms since publication of the
005 guidelines. First shock efﬁcacy for long duration cardiac arrest
sing monophasic deﬁbrillation has been reported as 54–63% for
200 J monophasic truncated exponential (MTE) waveform129,145
nd 77–91% using a 200 J monophasic damped sinusoidal (MDS)
aveform.128–130,145 Because of the lower efﬁcacy of this wave-
orm, the recommended initial energy level for the ﬁrst shock using
monophasic deﬁbrillator is 360 J. Although higher energy levels
isk a greater degree of myocardial injury, the beneﬁts of earlier
onversion to a perfusing rhythm are paramount. Atrioventricular
lock is more common with higher monophasic energy levels, but
s generally transient and has been shown not to affect survival
o hospital discharge.146 Only one of 27 animal studies demon-
trated harm caused by attempted deﬁbrillation using high energy
hocks.147
iphasic deﬁbrillators
Relatively few studies have been published in the past 5 years
n which to reﬁne the 2005 guidelines. There is no evidence that
ne biphasic waveform or device is more effective than another.
irst shock efﬁcacy of the BTE waveform using 150–200 J has been
eported as 86–98%.128,129,145,148,149 First shock efﬁcacy of the RLB
aveform using 120 J is up to 85% (data not published in the paper
ut supplied by personnel communication).130 First shock efﬁcacy
f a new pulsed biphasic waveform at 130 J showed a ﬁrst shock
uccess rate of 90%.126 Two studies have suggested equivalence
ith lower andhigher starting energy biphasic deﬁbrillation.150,151
lthough human studies have not shown harm (raised biomarkers,
CG changes, ejection fraction) from any biphasic waveform up to
60 J,150,152 several animal studies have suggested the potential for
arm with higher energy levels.153–156
The initial biphasic shock should be no lower than 120 J for RLB
aveforms and150 J for BTEwaveforms. Ideally, the initial biphasic
hock energy should be at least 150 J for all waveforms.
Manufacturers should display the effective waveform dose
ange on the face of the biphasic deﬁbrillator; older monophasic
eﬁbrillators should also be marked clearly with the appropriate
ose range. If the rescuer is unaware of the recommended energy
ettings of the deﬁbrillator, use the highest setting for all shocks.
econd and subsequent shocks
The 2005 guidelines recommended either a ﬁxed or escalating
nergy strategy for deﬁbrillation. Subsequent to these recommen-
ations, several studies have demonstrated that although an esca-
ating strategy reduces the number of shocks required to restore
n organised rhythm compared with ﬁxed-dose biphasic deﬁb-
illation, and may be needed for successful deﬁbrillation,157,158
ates of ROSC or survival to hospital discharge are not signiﬁ-n 81 (2010) 1293–1304 1299
cantly different between strategies.150,151 Conversely, a ﬁxed-dose
biphasic protocol demonstrated high cardioversion rates (>90%)
with a three-shock ﬁxed dose protocol but the small number of
cases did not exclude a signiﬁcant lower ROSC rate for recurrent
VF.159 Several in-hospital studies using an escalating shock energy
strategy have demonstrated improvement in cardioversion rates
(compared with ﬁxed dose protocols) in non-arrest rhythms with
the same level of energy selected for both biphasic andmonophasic
waveforms.135,137,160–163
Monophasic deﬁbrillators
Because the initial shock has been unsuccessful at 360 J, second
and subsequent shocks should all be delivered at 360 J.
Biphasic deﬁbrillators
There is no evidence to support either a ﬁxed or escalating
energy protocol. Both strategies are acceptable; however, if the ﬁrst
shock is not successful and the deﬁbrillator is capable of delivering
shocks of higher energy it is reasonable to increase the energy for
subsequent shocks.
Recurrent ventricular ﬁbrillation
If a shockable rhythm recurs after successful deﬁbrillation with
ROSC, give the next shockwith the energy level that had previously
been successful.
Other related deﬁbrillation topics
Deﬁbrillation of children
Cardiac arrest is less common in children. Common causes of VF
in children include trauma, congenital heart disease, long QT inter-
val, drug overdose and hypothermia.164–166 Ventricular ﬁbrillation
is relatively rare comparedwith adult cardiac arrest, occurring in 7-
15% of paediatric and adolescent arrests.166–171 Rapid deﬁbrillation
of these patients may improve outcome.171,172
The optimal energy level, waveform and shock sequence is
unknownbut aswith adults, biphasic shocks appear to be at least as
effective as, and less harmful than, monophasic shocks.173–175 The
upper limit for safe deﬁbrillation is unknown, but doses in excess
of the previously recommended maximum of 4 J kg−1 (as high as
9 J kg−1) have deﬁbrillated children effectively without signiﬁcant
adverse effects.38,176,177
The recommended energy levels for manual monophasic deﬁb-
rillation are 4 J kg−1 for the initial shock and subsequent shocks.
The same energy levels are recommended for manual biphasic
deﬁbrillation.178 As with adults, if a shockable rhythm recurs, use
the energy level for deﬁbrillation that had previously been success-
ful.
For deﬁbrillation of children above the age of 8 years, an
AED with standard electrodes is used and standard energy set-
tings accepted. For deﬁbrillation of children between 1 and 8
years, special paediatric electrodes and energy attenuators are
recommended; these reduce the delivered energy to a level that
approaches that of the energy recommended formanual deﬁbrilla-
tors.When these electrodes are not available, anAEDwith standard
electrodes should be used. For deﬁbrillation of children below 1
year of age, an AED, is not recommended; however, there are a few
case reports describing the use of AEDs in children aged less than
1 year.179,180 The incidence of shockable rhythms in infants is very
low except when there is cardiac disease167,181,182; in these rare
cases, if an AED is the only deﬁbrillator available, its use should be
considered (preferably with dose attenuator).
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ardioversion
If electrical cardioversion is used to convert atrial or ventric-
lar tachyarrhythmias, the shock must be synchronised to occur
ith the R wave of the electrocardiogram rather than with the T
ave: VF can be induced if a shock is delivered during the relative
efractory portion of the cardiac cycle.183 Synchronisation can be
ifﬁcult in VT because of the wide-complex and variable forms of
entricular arrhythmia. Inspect the synchronisation marker care-
ully for consistent recognition of the R wave. If needed, choose
nother lead and/or adjust the amplitude. If synchronisation fails,
ive unsynchronised shocks to the unstable patient in VT to avoid
rolonged delay in restoring sinus rhythm. Ventricular ﬁbrillation
r pulselessVT requires unsynchronised shocks. Consciouspatients
ust be anaesthetised or sedated before attempting synchronised
ardioversion.
trial ﬁbrillation
Optimal electrode position has been discussed previously, but
nterolateral and antero-posterior are both acceptable positions.
iphasic waveforms are more effective than monophasic wave-
orms for cardioversion of AF135–138; and cause less severe skin
urns.184 When available, a biphasic deﬁbrillator should be used
n preference to a monophasic deﬁbrillator. Differences in biphasic
aveforms themselves have not been established.
onophasic waveforms
A study of electrical cardioversion for atrial ﬁbrillation indicated
hat 360 Jmonophasic damped sinusoidal (MDS) shocksweremore
ffective than 100 or 200 J MDS shocks.185 Although a ﬁrst shock
f 360 J reduces overall energy requirements for cardioversion,185
60 J may cause greater myocardial damage and skin burns than
ccurswith lowermonophasic energy levels and thismust be taken
nto consideration. Commence synchronised cardioversion of atrial
brillation using an initial energy level of 200 J, increasing in a
tepwise manner as necessary.
iphasic waveforms
More data are needed before speciﬁc recommendations can
e made for optimal biphasic energy levels. Commencing at high
nergy levels has not shown to result inmore successful cardiover-
ion rates compared to lower energy levels.135,186–191 An initial
ynchronised shock of 120–150 J, escalating if necessary is a rea-
onable strategy based on current data.
trial ﬂutter and paroxysmal supraventricular tachycardia
Atrial ﬂutter and paroxysmal SVT generally require less energy
han atrial ﬁbrillation for cardioversion.190 Give an initial shock
f 100 J monophasic or 70–120 J biphasic. Give subsequent shocks
sing stepwise increases in energy.144
entricular tachycardia
The energy required for cardioversion of VT depends on the
orphological characteristics and rate of the arrhythmia.192 Ven-
ricular tachycardia with a pulse responds well to cardioversion
sing initial monophasic energies of 200 J. Use biphasic energy lev-
ls of 120–150 J for the initial shock. Consider stepwise increases if
he ﬁrst shock fails to achieve sinus rhythm.192n 81 (2010) 1293–1304
Pacing
Consider pacing in patients with symptomatic bradycardia
refractory to anti-cholinergic drugs or other second line ther-
apy (see Section 4).113 Immediate pacing is indicated especially
when the block is at or below the His-Purkinje level. If transtho-
racic pacing is ineffective, consider transvenous pacing. Whenever
a diagnosis of asystole is made, check the ECG carefully for the
presence of P waves because this will likely respond to cardiac
pacing. The use of epicardial wires to pace the myocardium fol-
lowing cardiac surgery is effective and discussed elsewhere. Do not
attempt pacing for asystole unless P waves are present; it does not
increase short or long-term survival in- or out-of-hospital.193–201
For haemodynamically unstable, conscious patients with brad-
yarrhythmias, percussion pacing as a bridge to electrical pacing
may be attempted, although its effectiveness has not been estab-
lished.
Implantable cardioverter deﬁbrillators
Implantable cardioverter deﬁbrillators (ICDs) are becoming
increasingly commonas the devices are implantedmore frequently
as the population ages. They are implanted because a patient is con-
sidered to be at risk from, or has had, a life-threatening shockable
arrhythmia and are usually embedded under the pectoral mus-
cle below the left clavicle (in a similar position to pacemakers,
from which they cannot be immediately distinguished). On sens-
ing a shockable rhythm, an ICD will discharge approximately 40 J
through an internal pacing wire embedded in the right ventricle.
On detecting VF/VT, ICD devices will discharge no more than eight
times, but may reset if they detect a new period of VF/VT. Patients
with fractured ICD leadsmay suffer repeated internal deﬁbrillation
as the electrical noise is mistaken for a shockable rhythm; in these
circumstances, the patient is likely to be conscious, with the ECG
showing a relatively normal rate. Amagnet placed over the ICDwill
disable the deﬁbrillation function in these circumstances.
Discharge of an ICD may cause pectoral muscle contraction in
the patient, and shocks to the rescuer have been documented.202 In
view of the low energy levels discharged by ICDs, it is unlikely that
any harm will come to the rescuer, but the wearing of gloves and
minimisingcontactwith thepatientwhilst thedevice isdischarging
is prudent. Cardioverter and pacing function should always be re-
evaluated followingexternal deﬁbrillation, both to check thedevice
itself and to check pacing/deﬁbrillation thresholds of the device
leads.
Pacemaker spikes generated by devices programmed to unipo-
lar pacing may confuse AED software and emergency personnel,
and may prevent the detection of VF.203 The diagnostic algorithms
of modern AEDs are insensitive to such spikes.
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Themost important changes in the2010EuropeanResuscitation
ouncil Advanced Life Support (ALS) Guidelines include:
Increased emphasis on the importance of minimally interrupted
high-quality chest compressions throughout any ALS interven-
tion: chest compressionsarepausedbrieﬂyonly toenable speciﬁc
interventions.
Increased emphasis on the use of ‘track and trigger systems’ to
detect the deteriorating patient and enable treatment to prevent
in-hospital cardiac arrest.
Increased awareness of the warning signs associated with the
potential risk of sudden cardiac death out of hospital.
Removal of the recommendation for a pre-speciﬁed period
of cardiopulmonary resuscitation (CPR) before out-of-hospital
deﬁbrillation following cardiac arrest unwitnessed by the emer-
gency medical services (EMS).
Continuation of chest compressions while a deﬁbrillator is
charged—this will minimise the preshock pause.
The role of the precordial thump is de-emphasised.
The use of up to three quick successive (stacked) shocks for
ventricular ﬁbrillation/pulseless ventricular tachycardia (VF/VT)
occurring in the cardiac catheterisation laboratory or in the
immediate post-operative period following cardiac surgery.
Delivery of drugs via a tracheal tube is no longer
recommended—if intravenous access cannot be achieved,
drugs should be given by the intraosseous route.
When treating VF/VT cardiac arrest, adrenaline 1mg is given
after the third shock once chest compressions have restarted and
∗ Corresponding author.
E-mail address: jerry.nolan@btinternet.com (J.P. Nolan).
1 These individuals contributed equally to this manuscript and are equal ﬁrst
o-authors.
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.017then every 3–5min (during alternate cycles of CPR). Amiodarone
300mg is also given after the third shock.
• Atropine is no longer recommended for routine use in asystole or
pulseless electrical activity.
• Reduced emphasis on early tracheal intubation unless achieved
by highly skilled individuals with minimal interruption to chest
compressions.
• Increased emphasis on the use of capnography to conﬁrm and
continually monitor tracheal tube placement, quality of CPR and
toprovide anearly indicationof returnof spontaneous circulation
(ROSC).
• Thepotential role of ultrasound imagingduringALS is recognised.
• Recognition of the potential harm caused by hyperoxaemia after
ROSC is achieved: once ROSC has been established and the oxy-
gen saturation of arterial blood (SaO2) can be monitored reliably
(by pulse oximetry and/or arterial blood gas analysis), inspired
oxygen is titrated to achieve a SaO2 of 94–98%.
• Much greater detail and emphasis on the treatment of the post-
cardiac arrest syndrome.
• Recognition that implementation of a comprehensive, structured
post-resuscitation treatment protocol may improve survival in
cardiac arrest victims after ROSC.
• Increased emphasis on the use of primary percutaneous coro-
nary intervention in appropriate, but comatose, patients with
sustained ROSC after cardiac arrest.
• Revision of the recommendation for glucose control: in adults
with sustained ROSC after cardiac arrest, blood glucose values
>10mmol l−1 (>180mgdl−1) should be treated but hypogly-
caemia must be avoided.
• Use of therapeutic hypothermia to include comatose sur-
vivors of cardiac arrest associated initially with non-shockable
rhythms as well shockable rhythms. The lower level of evi-
dence for use after cardiac arrest from non-shockable rhythms is
acknowledged.
• Recognition that many of the accepted predictors of poor out-
come in comatose survivors of cardiac arrest are unreliable,
evier Ireland Ltd. All rights reserved.
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especially if the patient has been treated with therapeutic
hypothermia.
a Prevention of in-hospital cardiac arrest
Early recognition of the deteriorating patient and prevention
f cardiac arrest is the ﬁrst link in the chain of survival.1 Once
ardiac arrest occurs, fewer than 20% of patients suffering an in-
ospital cardiac arrest will survive to go home.2–4 Prevention of
n-hospital cardiac arrest requires staff education, monitoring of
atients, recognition of patient deterioration, a system to call for
elp and an effective response.5
he problem
Cardiac arrest in patients in unmonitored ward areas is not
sually a sudden unpredictable event, nor is it usually caused
y primary cardiac disease.6 These patients often have slow and
rogressive physiological deterioration, involving hypoxaemia and
ypotension that is unnoticed by staff, or is recognised but treated
oorly.7–9 Many of these patients have unmonitored arrests, and
he underlying cardiac arrest rhythm is usually non-shockable.3,10
urvival to hospital discharge is poor.2,4,10
The records of patients who have a cardiac arrest or unan-
icipated intensive care unit (ICU) admission often contain
vidence of unrecognised, or untreated, respiratory and circula-
ion problems.6,8,11–16 The ACADEMIA study showed antecedents
n79%of cardiac arrests, 55%of deaths and54%of unanticipated ICU
dmissions.8 Early and effective treatment of seriously ill patients
ight prevent some cardiac arrests, deaths and unanticipated ICU
dmissions. Several studies show that up to a third of patients who
ave a false cardiac arrest call subsequently die.17–19
ature of the deﬁciencies in the recognition and response
o patient deterioration
These often include: infrequent, late or incomplete vital signs
ssessments; lack of knowledge of normal vital signs values; poor
esign of vital signs charts; poor sensitivity and speciﬁcity of ‘track
nd trigger’ systems; failure of staff to increase monitoring or esca-
ate care, and staff workload.20–28 There is also often a failure to
reat abnormalities of the patient’s airway, breathing and circula-
ion, incorrect use of oxygen therapy, poor communication, lack of
eamwork and insufﬁcient use of treatment limitation plans.7,14,29
ducation in acute care
Several studies show that medical and nursing staff lack knowl-
dge and skills in acute care,30 e.g., oxygen therapy,31 ﬂuid
nd electrolyte balance,32 analgesia,33 issues of consent,34 pulse
ximetry35,36 and drug doses.37 Medical school training provides
oor preparation for doctors’ early careers, and fails to teach them
he essential aspects of applied physiology and acute care.38 There
s a need for an increased emphasis on acute care training of under-
raduate and newly qualiﬁed doctors.39,40 There is also little to
uggest that the acute care training and knowledge of senior medi-
al staff is better.41,42 Staff often lack conﬁdencewhen dealingwith
cute care problems, and rarely use a systematic approach to the
ssessment of critically ill patients.43
Staff education is an essential part of implementing a system
o prevent cardiac arrest.44 However, there are no randomised
ontrolled studies addressing the impact of speciﬁc educational
nterventions on improvements in patient outcomes such as the
arlier recognition or rescue of the deteriorating patient at risk of
ardiac or respiratory arrest.n 81 (2010) 1305–1352
In an Australian study, virtually all the improvement in the hos-
pital cardiac arrest rate occurred during the educational phase of
implementation of a medical emergency team (MET) system.45,46
In studies from Australian and American hospitals with estab-
lished rapid response teams, education about the speciﬁc criteria
for activating their teams led to proactive ICU admission of patients
and a reduction in the number of ward cardiac arrests.47–49 A UK
study found that the number of cardiac arrest calls decreasedwhile
pre-arrest calls increased after implementing a standardised edu-
cational program in two hospitals; the intervention was associated
with a decrease in true arrests, and increase in initial survival after
cardiac arrest and survival to discharge.50,51
Monitoring and recognition of the critically ill patient
In general, the clinical signs of acute illness are similar what-
ever the underlying process, as they reﬂect failing respiratory,
cardiovascular and neurological systems. Abnormal physiology is
common on general wards,52 yet the measurement and recording
of important physiological observations of sick patients occurs less
frequently than is desirable.6,8,13,16,24,53,54
To assist in the early detection of critical illness, each patient
should have a documented plan for vital signs monitoring that
identiﬁes which variables need to be measured and the frequency
of measurement.26 Many hospitals now use early warning scores
(EWS) or calling criteria to identify the need to escalate monitor-
ing, treatment, or to call for expert help.13,24,55–57 The use of these
systems has been shown to increase the frequency of patient vital
signs measurements.54,58,59
These calling criteria or ‘track-and-trigger’ systems include
single-parameter systems, multiple-parameter systems, aggregate
weighted scoring systems or combination systems.60 The aggre-
gate weighted track-and-trigger systems offer a graded escalation
of care,whereas single parameter track and trigger systemsprovide
an all-or-nothing response.
Most of these systems lack robust data to suggest they have
acceptable accuracy for use in the roles for which they are pro-
posed. Low sensitivity of systems means that a signiﬁcant number
of patients at risk of deterioration leading to cardiac arrest are likely
to be missed.61,62 Hospitals should use a system validated for their
speciﬁc patient population to identify individuals at increased risk
of serious clinical deterioration, cardiac arrest, or death, both on
admission and during hospital stay.
Alterations in physiological variables, singly or in combination
are associated with, or can be used to predict the occurrence of car-
diac arrest,9,13,15,63,64 hospital death22,23,65–82 and unplanned ICU
admission,15,80,83 with varying sensitivity and speciﬁcity. Differ-
ing criteria for ICU admission between hospitals make the use of
unplanned ICU admission a less useful endpoint to study.
As one would expect, an increased number of derangements
increases the likelihood of death.11,15,20,63,77,84–91 The best combi-
nation and cut off values to allow early prediction is not known.
For aggregate-weighted scoring systems, inclusion of heart rate
(HR), respiratory rate (RR), systolic blood pressure (SBP), AVPU
(alert, vocalizing, pain, unresponsive), temperature, age, and oxy-
gen saturation achieve the best predictive value.22,61 For single
parameter track-and-trigger systems, cut-off points of HR <35 and
>140min−1; RR <6 and >32min−1; and SBP<80mmHg achieved
the best positive predictive value.23 Taking account of the patient’s
age improves the predictive value of both aggregate and single
parameter scoring systems.77 Aggregate-weighted scoring systems
appear to have a rank order of performance that is relatively
constant.92 A newly devised, aggregate-weighted scoring system
discriminates better than all others tested using mortality within
24h of an early warning score as the outcome.92
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Thedesignof vital signs charts or theuseof technologymayhave
n important role in the detection of deterioration and requires
urther study.21,93,94
alling for help
The traditional response to cardiac arrest is a reactive one in
hich hospital staff (‘the cardiac arrest team’) attend the patient
fter the cardiac arrest has occurred. Cardiac arrest teams appear
o improve survival after cardiac arrest in circumstances where no
eam has previously existed.95 However, the role of the cardiac
rrest team has been questioned. In one small study, only patients
ho had return of spontaneous circulation before the cardiac arrest
eam arrived were discharged from hospital alive.96 When com-
ined with the poor survival rate after in-hospital cardiac arrest,
his emphasises the importance of early recognition and treatment
f critically ill patients to prevent cardiac arrest.
Nursing staff and junior doctors often ﬁnd it difﬁcult to ask for
elp or escalate treatment as they feel their clinical judgement
ay be criticised. Hospitals should ensure all staff are empowered
o call for help and also trained to use structured communica-
ion tools such as RSVP (Reason-Story-Vital Signs-Plan)97 or SBAR
Situation-Background-Assessment-Recommendation)98 tools to
nsure effective inter-professional communication.
he response to critical illness
The response to patients who are critically ill or who are at risk
f becoming critically ill is usually provided by medical emergency
eams (MET), rapid response teams (RRT), or critical care outreach
eams (CCOT).99–101 These teams replace or coexistwith traditional
ardiac arrest teams, which typically respond to patients already in
ardiac arrest.MET/RRT usually comprisemedical and nursing staff
rom intensive care and general medicine and respond to speciﬁc
alling criteria. CCOT are common in the UK, based predominantly
n individual or teams of nurses.60 Outreach services exist in many
orms, ranging froma single nurse to a 24-h, 7 days perweekmulti-
rofessional team. Any member of the healthcare team can initiate
MET/RRT/CCOT call. In some hospitals, the patient’s family and
riendsarealsoencouraged toactivate the team, if necessary.102–104
eam interventions often involve simple tasks such as starting
xygen therapy and intravenous ﬂuids.105–109 However, post hoc
nalysis of the MERIT study data suggests that all nearly all MET
alls required ‘critical care-type’ interventions.110 A circadian pat-
ern of team activation has been reported, which may suggest that
ystems for identifying and responding to medical emergencies
ay not be uniform throughout the 24-h period.111,112
Studying the effect of the MET/RRT/CCOT systems on patient
utcomes is difﬁcult because of the complex nature of the inter-
ention. During the period ofmost studies of rapid response teams,
here has been a major international focus on improving other
spects of patient safety, e.g., hospital acquired infections, ear-
ier treatment of sepsis and better medication management, all of
hichhave thepotential to inﬂuencepatientdeteriorationandmay
ave a beneﬁcial impact on reducing cardiac arrests and hospital
eaths. Additionally, a greater focus on improving ‘end of life’ care
nd the making of ‘do not attempt resuscitation’ (DNAR) decisions
lso impact cardiac arrest call rates. The available studies do not
orrect for these confounding factors.
Nevertheless, numerous single centre studies have reported
educed numbers of cardiac arrests after the implementation
f RRT/MET systems.45,47,107,111,113–125 However, a well-designed,
luster-randomised controlled trial of the MET system (MERIT
tudy) involving 23 hospitals24 did not show a reduction in car-
iac arrest rate after introduction of a MET when analyzed on an
ntention-to-treat basis. This study was unable to demonstrate an 81 (2010) 1305–1352 1307
difference between control and intervention hospitals in reduction
in a composite outcomeof (a) cardiac arrestswithout a pre-existing
not-for-resuscitation (NFR) order, (b) unplanned ICU admissions,
and (c) unexpected deaths (deaths without a pre-existing NFR
order) taking place in generalwards during the 6-month studyMET
period. Both the control and MET groups demonstrated improved
outcome compared to baseline. Post hoc analysis of theMERIT study
showed there was a decrease in cardiac arrest and unexpected
mortality rate with increased activation of the MET system.126
Several other studies have also been unable to show a reduc-
tion in cardiac arrest rates associated with the introduction of
RRT/MET systems.105,106,108,109,127–130 A single-centre study of the
implementation of an early warning scoring system showed an
increase in cardiac arrests among patients who had higher early
warning scores, compared with similar scored patients before the
intervention.56
A recent meta-analysis showed RRT/MET systems were associ-
ated with a reduction in rates of cardiopulmonary arrest outside
the intensive care unit but are not associated with lower hospital
mortality rates.131
Appropriate placement of patients
Ideally, the sickest patients should be admitted to an area that
can provide the greatest supervision and the highest level of organ
support and nursing care. This often occurs, but some patients are
placed incorrectly.132 International organisations have offered def-
initions of levels of care and produced admission and discharge
criteria for high dependency units (HDUs) and ICUs.133,134
Stafﬁng levels
Hospital stafﬁng tends to be at its lowest during the night and
at weekends. This may inﬂuence patient monitoring, treatment
and outcomes. Data from the US National Registry of CPR Inves-
tigators shows that survival rates from in-hospital cardiac arrest
are lower during nights and weekends.135 Admission to a gen-
eral medical ward after 17.00h136 or to hospital at weekends137 is
associated with increased mortality. Patients who are discharged
from ICUs to general wards at night have an increased risk of in-
hospital death compared with those discharged during the day and
those discharged to HDUs.138,139 Several studies show that higher
nurse stafﬁng is associated with lower rates of failure-to-rescue,
and reductions in rates of cardiac arrest rates, pneumonia, shock
and death.25,140,141
Resuscitation decisions
The decision to start, continue and terminate resuscitation
efforts is based on the balance between the risks, beneﬁts and bur-
dens these interventions place on patients, family members and
healthcare providers. There are circumstances where resuscitation
is inappropriate and should not be provided. Consider a ‘do not
attempt resuscitation’ (DNAR) decision when the patient:
• does not wish to have CPR;
• will not survive cardiac arrest even if CPR is attempted.
Hospital staff often fail to consider whether resuscitation
attempts are appropriate and resuscitation attempts in futile cases
are common.142 Even when there is clear evidence that cardiac
arrest or death is likely, ward staff rarely make decisions about
the patient’s resuscitation status.8 Many European countries have
no formal policy for recording DNAR decisions and the practice of
consulting patients about the decision is variable.143,144 Improved
knowledge, training and DNAR decision-making should improve
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atient care and prevent futile CPR attempts (see Section 10).145
edical emergency teamsmayhavean important role in improving
nd-of-life and DNAR decision-making.142,146–148
uidelines for prevention of in-hospital cardiac arrest
Hospitals should provide a system of care that includes: (a) staff
ducation about the signs of patient deterioration, and the ratio-
ale for rapid response to illness, (b) appropriate and regular vital
igns monitoring of patients, (c) clear guidance (e.g., via calling cri-
eria or early warning scores) to assist staff in the early detection
f patient deterioration, (d) a clear, uniform system of calling for
ssistance, and (e) an appropriate and timely clinical response to
alls for assistance.5 The following strategies may prevent avoid-
ble in-hospital cardiac arrests.
1. Provide care for patients who are critically ill or at risk of clin-
ical deterioration in appropriate areas, with the level of care
provided matched to the level of patient sickness.
2. Critically ill patients need regular observations: each patient
should have a documented plan for vital signs monitoring that
identiﬁes which variables need to be measured and the fre-
quency of measurement according to the severity of illness or
the likelihood of clinical deterioration and cardiopulmonary
arrest. Recent guidance suggests monitoring of simple physi-
ological variables including pulse, blood pressure, respiratory
rate, conscious level, temperature and arterial blood oxygen
saturation by pulse oximetry (SpO2).26,149
3. Use a track-and-trigger system (either ‘calling criteria’ or early
warning system) to identify patients who are critically ill and,
or at risk of clinical deterioration and cardiopulmonary arrest.
4. Use a patient charting system that enables the regular mea-
surement and recording of vital signs and, where used, early
warning scores.
5. Have a clear and speciﬁc policy that requires a clinical response
to abnormal physiology, based on the track and trigger system
used. This should include advice on the further clinicalmanage-
ment of the patient and the speciﬁc responsibilities of medical
and nursing staff.
6. The hospital should have a clearly identiﬁed response to crit-
ical illness. This may include a designated outreach service or
resuscitation team (e.g., MET, RRT system) capable of respond-
ing in a timely fashion to acute clinical crises identiﬁed by the
track-and-trigger system or other indicators. This service must
be available 24h per day. The team must include staff with the
appropriate acute or critical care skills.
7. Train all clinical staff in the recognition, monitoring and man-
agement of the critically ill patient. Include advice on clinical
management while awaiting the arrival of more experienced
staff. Ensure that staff know their role(s) in the rapid response
system.
8. Hospitals must empower staff of all disciplines to call for help
when they identify a patient at risk of deterioration or cardiac
arrest. Staff should be trained in the use of structured com-
munication tools to ensure effective handover of information
between doctors, nurses and other healthcare professions.
9. Identify patients for whom cardiopulmonary arrest is an antic-
ipated terminal event and in whom CPR is inappropriate, and
patients who do not wish to be treated with CPR. Hospitals
should have a DNAR policy, based on national guidance, which
is understood by all clinical staff.
0. Ensure accurate audit of cardiac arrest, “false arrest”, unex-
pected deaths and unanticipated ICU admissions using
common datasets. Audit also the antecedents and clinical
response to these events.n 81 (2010) 1305–1352
Prevention of sudden cardiac death (SCD)
out-of-hospital
Coronary artery disease is the commonest cause of SCD. Non-
ischaemic cardiomyopathy and valvular disease account for most
other SCD events. A small percentage of SCDs are caused by
inherited abnormalities (e.g., Brugada syndrome, hypertrophic car-
diomyopathy) or congenital heart disease.
Most SCD victims have a history of cardiac disease and warn-
ing signs, most commonly chest pain, in the hour before cardiac
arrest.150 Inpatientswithaknowndiagnosisof cardiacdisease, syn-
cope (with or without prodrome—particularly recent or recurrent)
is as an independent risk factor for increased risk of death.151–161
Chest pain on exertion only, and palpitations associated with
syncope only, are associated with hypertrophic cardiomyopathy,
coronary abnormalities, Wolff–Parkinson–White, and arrhythmo-
genic right ventricular cardiomyopathy.
Apparently healthy children and young adults who suffer SCD
canalsohave signsandsymptoms (e.g., syncope/pre-syncope, chest
pain and palpitations) that should alert healthcare professionals to
seek expert help to prevent cardiac arrest.162–170
Children and young adults presentingwith characteristic symp-
toms of arrhythmic syncope should have a specialist cardiology
assessment, which should include an ECG and in most cases an
echocardiogram and exercise test. Characteristics of arrhythmic
syncope include: syncope in the supine position, occurring dur-
ing or after exercise, with no or only brief prodromal symptoms,
repetitive episodes, or in individuals with a family history of
sudden death. In addition, non-pleuritic chest pain, palpitations
associated with syncope, seizures (when resistant to treatment,
occurring at night or precipitated by exercise, syncope, or loud
noise), and drowning in a competent swimmer should raise suspi-
cion of increased risk. Systematic evaluation in a clinic specializing
in the care of those at risk for SCD is recommended in family mem-
bers of young victims of SCDor thosewith a knowncardiac disorder
resulting in an increased risk of SCD.151,171–175 A family history of
syncope or SCD, palpitations as a symptom, supine syncope and
syncope associated with exercise and emotional stress are more
common in patients with long QT syndrome (LQTS).176 In older
adults177,178 the absence of nausea and vomiting before syncope
and ECG abnormalities is an independent predictor of arrhythmic
syncope.
Inexplicable drowning and drowning in a strong swimmer
may be due to LQTS or catecholaminergic polymorphic ventricu-
lar tachycardia (CPVT).179 There is an association between LQTS
andpresentationwith seizure phenotype.180,181 Guidancehas been
published for the screeningof competitive athletes to identify those
at risk of sudden death.182
4b Prehospital resuscitation
EMS personnel
There is considerable variation across Europe in the structure
and process of EMS systems. Some countries have adopted almost
exclusivelyparamedic/emergencymedical technician (EMT)-based
systemswhile other incorporate prehospital physicians to a greater
or lesser extent. In adult cardiac arrest, physician presence during
resuscitation, compared with paramedics alone, has been reported
to increase compliance with guidelines183,184 and physicians in
some systems can perform advanced resuscitation procedures
more successfully.183,185–188 When compared within individual
systems, there are contradictory ﬁndings with some studies sug-
gesting improved survival to hospital discharge when physicians
are part of the resuscitation team189–192 and other studies suggest-
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ng no difference in short- or long-term survival.183,189,191,193–199
n one study, survival of the event was lower when physicians
ere part of the resuscitation team.199 Studies indirectly compar-
ng resuscitation outcomes between physician-staffed and other
ystems are difﬁcult to interpret because of the extremely high
ariability between systems, independent of physician-stafﬁng.200
lthough some studies have documented higher survival rates
fter cardiac arrest in EMS systems that include experienced
hysicians,186,188,201–203 compared with those that rely on non-
hysician providers,201,202,204,205 other comparisons have found no
ifference in survival between systems using paramedics or physi-
ians as part of the response.206,207 Well-organised non-physician
ystems with highly trained paramedics have also reported high
urvival rates.200 Given the inconsistent evidence, the inclusion or
xclusion of physicians among prehospital personnel responding
o cardiac arrests will depend largely on existing local policy.
ermination of resuscitation rules
One high-quality, prospective study has demonstrated that
pplication of a ‘basic life support termination of resuscitation rule’
s predictive of death when applied by deﬁbrillation-only emer-
ency medical technicians.208 The rule recommends termination
hen there is no return of spontaneous circulation, no shocks are
dministered, and the arrest is not witnessed by EMS personnel. Of
76 patients with cardiac arrest for whom the rule recommended
ermination, four survived [0.5% (95% CI 0.2–0.9)]. Implementation
f the rule would reduce the transportation rate by almost two
hirds. Four studies have shown external generalisability of this
ule.209–212
Additional studies have shown associations with futility of cer-
ain variables such as no ROSC at scene; non-shockable rhythm;
nwitnessed arrest; no bystander CPR, call response time and
atient demographics.213–218
Two in-hospital studies and one emergency department study
howed that the reliability of termination of resuscitation rules is
imited in these settings.219–221
Prospectively validated termination of resuscitation rules such
s the ‘basic life support termination of resuscitation rule’ can be
sed to guide termination of prehospital CPR in adults; however,
hese must be validated in an emergency medical services system
imilar to theone inwhich implementation is proposed.Other rules
or various provider levels, including in-hospital providers, may be
elpful to reduce variability in decision-making; however, rules
hould be prospectively validated prior to implementation.
PR versus deﬁbrillation ﬁrst
There is evidence that performing chest compressions while
etrieving and charging a deﬁbrillator improves the probability of
urvival.222 EMS personnel should provide good-quality CPR while
deﬁbrillator is retrieved, appliedandcharged, but routinedelivery
f apre-speciﬁedperiodofCPR (e.g., 2 or3min)before rhythmanal-
sis and a shock is delivered is not recommended. Some emergency
edical services have already fully implemented a pre-speciﬁed
eriod of chest compressions before deﬁbrillation; given the lack
f convincing data either supporting or refuting this strategy, it is
easonable for them to continue this practice (see Section 3).223
c In-hospital resuscitationAfter in-hospital cardiac arrest, the division between basic life
upport and advanced life support is arbitrary; in practice, the
esuscitationprocess is a continuumand isbasedoncommonsense.
he public expect that clinical staff canundertake cardiopulmonaryn 81 (2010) 1305–1352 1309
resuscitation (CPR). For all in-hospital cardiac arrests, ensure that:
• cardiorespiratory arrest is recognised immediately;
• help is summoned using a standard telephone number;
• CPR is started immediately using airway adjuncts, e.g., a pocket
mask and, if indicated, deﬁbrillation attempted as rapidly as pos-
sible and certainly within 3min.
The exact sequence of actions after in-hospital cardiac arrest
will depend on many factors, including:
• location (clinical/non-clinical area; monitored/unmonitored
area);
• training of the ﬁrst responders;
• number of responders;
• equipment available;
• hospital response system to cardiac arrest and medical emergen-
cies (e.g., MET, RRT).
Location
Patients who have monitored arrests are usually diagnosed
rapidly. Ward patients may have had a period of deterioration and
an unwitnessed arrest.6,8 Ideally, all patients who are at high risk
of cardiac arrest should be cared for in a monitored area where
facilities for immediate resuscitation are available.
Training of ﬁrst responders
All healthcare professionals should be able to recognise cardiac
arrest, call for help and start CPR. Staff should do what they have
been trained to do. For example, staff in critical care and emer-
gency medicine will have more advanced resuscitation skills than
staff who are not involved regularly in resuscitation in their nor-
mal clinical role. Hospital staff who attend a cardiac arrest may
have different levels of skill to manage the airway, breathing and
circulation. Rescuers must undertake only the skills in which they
are trained and competent.
Number of responders
The single responder must ensure that help is coming. If other
staff are nearby, several actions can be undertaken simultaneously.
Equipment available
All clinical areas should have immediate access to resuscitation
equipment and drugs to facilitate rapid resuscitation of the patient
in cardiopulmonary arrest. Ideally, the equipment used for CPR
(including deﬁbrillators) and the layout of equipment and drugs
should be standardised throughout the hospital.224,225
Resuscitation team
The resuscitation teammay take the formof a traditional cardiac
arrest team, which is called only when cardiac arrest is recognised.
Alternatively, hospitals may have strategies to recognise patients
at risk of cardiac arrest and summon a team (e.g., MET or RRT)
before cardiac arrest occurs. The term ‘resuscitation team’ reﬂects
the range of response teams. In hospital cardiac arrests are rarely
sudden or unexpected. A strategy of recognising patients at risk of
cardiac arrest may enable some of these arrests to be prevented, or
may prevent futile resuscitation attempts in thosewho are unlikely
to beneﬁt from CPR.
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mmediate actions for a collapsed patient in a hospital
An algorithm for the initial management of in-hospital cardiac
rrest is shown in Fig. 4.1.
Ensure personal safety.
Check the victim for a response.
When healthcare professionals see a patient collapse or ﬁnd a
patient apparently unconscious in a clinical area, they should ﬁrst
shout for help, then assess if the patient is responsive. Gently
shake the shoulders and ask loudly: ‘Are you all right?’
If other members of staff are nearby, it will be possible to under-
take actions simultaneously.
he responsive patient
Urgent medical assessment is required. Depending on the local
rotocols, this may take the form of a resuscitation team (e.g., MET,
RT). While awaiting this team, give the patient oxygen, attach
onitoring and insert an intravenous cannula.
he unresponsive patient
The exact sequence will depend on the training of staff and
xperience in assessment of breathing and circulation. Trained
ealthcare staff cannot assess the breathing and pulse sufﬁciently
eliably to conﬁrm cardiac arrest.226–235 Agonal breathing (occa-
ional gasps, slow, laboured or noisy breathing) is common in the
arly stages of cardiac arrest and is a sign of cardiac arrest and
hould not be confused as a sign of life/circulation.236–239 Agonal
reathing can also occur during chest compressions as cerebral per-
usion improves, but is not indicative of a return of spontaneous
irculation.
Fig. 4.1. Algorithm for the treatment of inn 81 (2010) 1305–1352
• Shout for help (if not already)
Turn the victim on to his back and then open the airway:
• Open Airway and check breathing:
◦ Open the airway using a head tilt chin lift.
◦ Look in the mouth. If a foreign body or debris is visible attempt
to remove with a ﬁnger sweep, forceps or suction as appropri-
ate.
◦ If you suspect that there may have been an injury to the neck,
try to open the airway using a jaw thrust. Remember thatmain-
taining an airway and adequate ventilation is the overriding
priority in managing a patient with a suspected spinal injury. If
this isunsuccessful, use just enoughhead tilt to clear theairway.
Use manual in-line stabilisation to minimise head movement if
sufﬁcient rescuers are available. Efforts to protect the cervical
spine must not jeopardise oxygenation and ventilation.
Keeping theairwayopen, look, listen, and feel fornormalbreath-
ing (an occasional gasp, slow, laboured or noisy breathing is not
normal):
• Look for chest movement;
• Listen at the victim’s mouth for breath sounds;
• Feel for air on your cheek.
Look, listen, and feel for no more than 10 s to determine if the
victim is breathing normally• Check for signs of a circulation:
◦ It may be difﬁcult to be certain that there is no pulse. If the
patient has no signs of life (consciousness, purposeful move-
ment, normal breathing, or coughing), start CPR until more
experience help arrives or the patient shows signs of life.
-hospital cardiac arrest. © 2010 ERC.
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◦ Those experienced in clinical assessment should assess the
carotid pulse whilst simultaneously looking for signs of life for
not more than 10 s.
◦ If the patient appears to have no signs of life, or if there is
doubt, start CPR immediately. Delivering chest compressions
to a patient with a beating heart is unlikely to cause harm.240
However, delays in diagnosis of cardiac arrest and starting CPR
will adversely effect survival and must be avoided.
If there is a pulse or signs of life, urgent medical assess-
ent is required. Depending on the local protocols, this may take
he form of a resuscitation team. While awaiting this team, give
he patient oxygen, attach monitoring, and insert an intravenous
annula. When a reliable measurement of oxygen saturation
f arterial blood (e.g., pulse oximetry (SpO2)) can be achieved,
itrate the inspired oxygen concentration to achieve a SpO2 of
4–98%.
If there is no breathing, but there is a pulse (respiratory arrest),
entilate the patient’s lungs and check for a circulation every 10
reaths.
tarting in-hospital CPR
One person starts CPR as others call the resuscitation team and
collect the resuscitation equipment and a deﬁbrillator. If only one
member of staff is present, this will mean leaving the patient.
Give 30 chest compressions followed by 2 ventilations.
Minimise interruptions and ensure high-quality compressions.
Undertaking good-quality chest compressions for a prolonged
time is tiring;withminimal interruption, try to change theperson
doing chest compressions every 2min.
Maintain the airway and ventilate the lungswith themost appro-
priate equipment immediately to hand. A pocket mask, which
maybesupplementedwithanoral airway, isusually readily avail-
able. Alternatively, use a supraglottic airway device (SAD) and
self-inﬂating bag, or bag-mask, according to local policy. Tracheal
intubation should be attempted only by those who are trained,
competent and experienced in this skill. Waveform capnogra-
phy should be routinely available for conﬁrming tracheal tube
placement (in the presence of a cardiac output) and subsequent
monitoring of an intubated patient.
Use an inspiratory time of 1 s and give enough volume to produce
anormal chest rise. Add supplemental oxygen as soon as possible.
Once the patient’s trachea has been intubated or a SAD has been
inserted, continue chest compressions uninterrupted (except
for deﬁbrillation or pulse checks when indicated), at a rate of
at least 100min−1, and ventilate the lungs at approximately
10breathsmin−1. Avoid hyperventilation (both excessive rate
and tidal volume), which may worsen outcome. Mechanical ven-
tilators may free up a rescuer and ensure appropriate ventilation
rates and volumes.
If there is no airway and ventilation equipment available, con-
sider giving mouth-to-mouth ventilation. If there are clinical
reasons to avoid mouth-to-mouth contact, or you are unwilling
or unable to do this, do chest compressions until help or airway
equipment arrives.
When the deﬁbrillator arrives, apply the paddles to the patient
and analyse the rhythm. If self-adhesive deﬁbrillation pads are
available, apply these without interrupting chest compressions.
The use of adhesive electrode pads or a ‘quick-look’ paddles tech-
nique will enable rapid assessment of heart rhythm compared
with attaching ECG electrodes.241 Pause brieﬂy to assess the
heart rhythm. With a manual deﬁbrillator, if the rhythm is VF/VT
charge the deﬁbrillator while another rescuer continues chest
compressions. Once the deﬁbrillator is charged, pause the chest
compressions, ensure that all rescuers are clear of the patient andn 81 (2010) 1305–1352 1311
then give one shock. If using an automated external deﬁbrillation
(AED) follow the AED’s audio-visual prompts.
• Restart chest compressions immediately after the deﬁbrillation
attempt. Minimise interruptions to chest compressions. Using a
manual deﬁbrillator it is possible to reduce the pause between
stopping and restarting of chest compressions to less than 5 s.
• Continue resuscitation until the resuscitation team arrives or the
patient shows signs of life. Follow the voice prompts if using an
AED. If using a manual deﬁbrillator, follow the universal algo-
rithm for advanced life support (Section 4d).
• Once resuscitation is underway, and if there are sufﬁcient staff
present, prepare intravenous cannulae anddrugs likely to beused
by the resuscitation team (e.g., adrenaline).
• Identify one person to be responsible for handover to the resus-
citation team leader. Use a structured communication tool for
handover (e.g., SBAR, RSVP).97,98 Locate the patient’s records.
• The quality of chest compressions during in-hospital CPR is
frequently sub-optimal.242,243 The importance of uninterrupted
chest compressions cannot be over emphasised. Even short inter-
ruptions to chest compressions are disastrous for outcome and
every effort must be made to ensure that continuous, effective
chest compression is maintained throughout the resuscitation
attempt. Chest compressions should commence at the beginning
of a resuscitation attempt and continue uninterrupted unless
they are brieﬂy paused for a speciﬁc intervention (e.g., pulse
check). The team leader should monitor the quality of CPR and
alternate CPR providers if the quality of CPR is poor. Continu-
ous ETCO2 monitoring can be used to indicate the quality of CPR:
although an optimal target for ETCO2 during CPR has not been
established, a value of less than 10mmHg (1.4 kPa) is associated
with failure to achieve ROSC and may indicate that the quality of
chest compressions should be improved. If possible, the person
providing chest compressions should be alternated every 2min,
but without causing long pauses in chest compressions.
4d ALS treatment algorithm
Introduction
Heart rhythms associated with cardiac arrest are divided into
two groups: shockable rhythms (ventricular ﬁbrillation/pulseless
ventricular tachycardia (VF/VT)) andnon-shockable rhythms (asys-
tole and pulseless electrical activity (PEA)). The principal difference
in the treatment of these two groups of arrhythmias is the need for
attempted deﬁbrillation in those patients with VF/VT. Subsequent
actions, including high-quality chest compressions with minimal
interruptions, airway management and ventilation, venous access,
administration of adrenaline and the identiﬁcation and correction
of reversible factors, are common to both groups.
Although the ALS cardiac arrest algorithm (Fig. 4.2) is applicable
to all cardiac arrests, additional interventions may be indicated for
cardiac arrest caused by special circumstances (see Section 8).
The interventions that unquestionably contribute to improved
survival after cardiac arrest are prompt and effective bystander
basic life support (BLS), uninterrupted, high-quality chest compres-
sions and early deﬁbrillation for VF/VT. The use of adrenaline has
been shown to increase return of spontaneous circulation (ROSC),
but no resuscitation drugs or advanced airway interventions have
been shown to increase survival to hospital discharge after cardiac
arrest.244–247 Thus, although drugs and advanced airways are still
included among ALS interventions, they are of secondary impor-
tance to early deﬁbrillation and high-quality, uninterrupted chest
compressions.
As with previous guidelines, the ALS algorithm distinguishes
between shockable and non-shockable rhythms. Each cycle is
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roadly similar, with a total of 2min of CPR being given before
ssessing the rhythm and where indicated, feeling for a pulse.
drenaline 1mg is given every 3–5min until ROSC is achieved—the
iming of the initial dose of adrenaline is described below. In VF/VT,
single dose of amiodarone is indicated after three unsuccessful
hocks.
Fig. 4.2. Advanced life support cardian 81 (2010) 1305–1352
Shockable rhythms (ventricular ﬁbrillation/pulseless
ventricular tachycardia)
The ﬁrst monitored rhythm is VF/VT in approximately 25% of
cardiac arrests, both in-4 or out-of-hospital.248–250 VF/VT will also
occur at some stage during resuscitation in about 25% of cardiac
c arrest algorithm. © 2010 ERC.
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rrestswith an initial documented rhythmof asystole or PEA.4 Hav-
ng conﬁrmed cardiac arrest, summon help (including the request
or a deﬁbrillator) and start CPR, beginning with chest compres-
ions, with a compression:ventilation (CV) ratio of 30:2. When the
eﬁbrillator arrives, continue chest compressions while applying
he paddles or self-adhesive pads. Identify the rhythm and treat
ccording to the ALS algorithm.
If VF/VT is conﬁrmed, charge the deﬁbrillator while another
rescuer continues chest compressions. Once the deﬁbrillator is
charged, pause the chest compressions, quickly ensure that all
rescuers are clear of the patient and then give one shock (360-J
monophasic or 150–200 J biphasic).
Minimise the delay between stopping chest compressions and
delivery of the shock (the preshock pause); even 5–10 s delay
will reduce the chances of the shock being successful.251,252
Without reassessing the rhythmor feeling for apulse, resumeCPR
(CV ratio 30:2) immediately after the shock, starting with chest
compressions. Even if the deﬁbrillation attempt is successful in
restoring a perfusing rhythm, it takes time until the post-shock
circulation is established253 and it is very rare for a pulse to
be palpable immediately after deﬁbrillation.254 Furthermore, the
delay in trying to palpate a pulse will further compromise the
myocardium if a perfusing rhythm has not been restored.255
Continue CPR for 2min, thenpause brieﬂy to assess the rhythm; if
still VF/VT, give a second shock (360-J monophasic or 150–360-J
biphasic). Without reassessing the rhythm or feeling for a pulse,
resume CPR (CV ratio 30:2) immediately after the shock, starting
with chest compressions.
Continue CPR for 2min, then pause brieﬂy to assess the rhythm;
if still VF/VT, give a third shock (360-J monophasic or 150–360-J
biphasic). Without reassessing the rhythm or feeling for a pulse,
resume CPR (CV ratio 30:2) immediately after the shock, starting
with chest compressions. If IV/IO access has been obtained, give
adrenaline1mgandamiodarone300mgoncecompressionshave
resumed. If ROSC has not been achieved with this 3rd shock the
adrenaline will improve myocardial blood ﬂow and may increase
the chance of successful deﬁbrillation with the next shock. In
animal studies, peak plasma concentrations of adrenaline occur
at about 90 s after a peripheral injection.256 If ROSC has been
achieved after the 3rd shock it is possible that the bolus dose of
adrenaline will cause tachycardia and hypertension and precip-
itate recurrence of VF. However, naturally occurring adrenaline
plasma concentrations are high immediately after ROSC,257 and
any additional harm caused by exogenous adrenaline has not
been studied. Interrupting chest compressions to check for a per-
fusing rhythm midway in the cycle of compressions is also likely
to be harmful. The use of waveform capnography may enable
ROSC to be detected without pausing chect compressions and
may be a way of avoiding a bolus injection of adenaline after
ROSC has been achieved. Two prospective human studies have
shown that a signiﬁcant increase in end-tidal CO2 occurs when
return of spontaneous circulation occurs.258,259
After each 2-min cycle of CPR, if the rhythm changes to asystole
or PEA, see ‘non-shockable rhythms’ below. If a non-shockable
rhythmispresent and the rhythmisorganised (complexes appear
regular or narrow), try to palpate a pulse. Rhythm checks should
be brief, and pulse checks should be undertaken only if an organ-
ised rhythm is observed. If there is any doubt about the presence
of a pulse in the presence of an organised rhythm, resume CPR. If
ROSC has been achieved, begin post-resuscitation careDuring treatment of VF/VT, healthcare providers must prac-
ice efﬁcient coordination between CPR and shock delivery. When
F is present for more than a few minutes, the myocardium isn 81 (2010) 1305–1352 1313
depleted of oxygen and metabolic substrates. A brief period of
chest compressions will deliver oxygen and energy substrates and
increase the probability of restoring a perfusing rhythm after shock
delivery.260 Analyses of VF waveform characteristics predictive of
shock success indicate that the shorter the time between chest
compression and shock delivery, the more likely the shock will
be successful.260,261 Reduction in the interval from compression to
shock delivery by even a few seconds can increase the probability
of shock success.251,252
Regardless of the arrest rhythm, give adrenaline 1mg every
3–5min until ROSC is achieved; in practice, this will be once every
two cycles of the algorithm. If signs of life return during CPR
(purposeful movement, normal breathing, or coughing), check the
monitor; if an organised rhythm is present, check for a pulse. If
a pulse is palpable, continue post-resuscitation care and/or treat-
ment of peri-arrest arrhythmia. If no pulse is present, continue CPR.
Providing CPR with a CV ratio of 30:2 is tiring; change the individ-
ual undertaking compressions every 2min, while minimising the
interruption in compressions.
Witnessed, monitored VF/VT in the cardiac catheter lab or after
cardiac surgery
If a patient has a monitored and witnessed cardiac arrest in the
catheter laboratory or early after cardiac surgery:
• Conﬁrm cardiac arrest and shout for help.
• If the initial rhythm is VF/VT, give up to three quick successive
(stacked) shocks. Start chest compressions immediately after the
third shock and continue CPR for 2min.
This three-shock strategy may also be considered for an initial,
witnessed VF/VT cardiac arrest if the patient is already connected
to a manual deﬁbrillator. Although there are no data supporting a
three-shock strategy in any of these circumstances, it is unlikely
that chest compressions will improve the already very high chance
of return of spontaneous circulation when deﬁbrillation occurs
early in the electrical phase, immediately after onset of VF (see
Section 3).223
Precordial thump
A single precordial thump has a very low success rate for
cardioversion of a shockable rhythm262–264 and is only likely to
succeed if given within the ﬁrst few seconds of the onset of a
shockable rhythm.265 There is more success with pulseless VT than
with VF. Delivery of a precordial thump must not delay calling for
help or accessing a deﬁbrillator. It is therefore appropriate therapy
only when several clinicians are present at a witnessed, monitored
arrest, andwhen adeﬁbrillator is not immediately to hand (see Sec-
tion 3).223,266 In practice, this is only likely to be in a critical care
environment such as the emergency department or ICU.264
A precordial thump should be undertaken immediately after
conﬁrmation of cardiac arrest and only by healthcare professionals
trained in the technique. Using the ulnar edge of a tightly clenched
ﬁst, deliver a sharp impact to the lower half of the sternum from a
height of about 20 cm, then retract the ﬁst immediately to create an
impulse-like stimulus. There are very rare reports of a precordial
thump converting a perfusing to a non-perfusing rhythm.267Airway and ventilation
During the treatmentofpersistentVF, ensuregood-quality chest
compressions between deﬁbrillation attempts. Consider reversible
causes (4 Hs and 4 Ts) and, if identiﬁed, correct them. Check the
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lectrode/deﬁbrillating paddle positions and contacts, and the ade-
uacy of the coupling medium, e.g., gel pads. Tracheal intubation
rovides the most reliable airway, but should be attempted only if
he healthcare provider is properly trained and has regular, ongo-
ng experience with the technique. Personnel skilled in advanced
irway management should attempt laryngoscopy and intubation
ithout stopping chest compressions; a brief pause in chest com-
ressions may be required as the tube is passed between the vocal
ords, but this pause should not exceed 10 s. Alternatively, to avoid
ny interruptions in chest compressions, the intubation attempt
ay be deferred until return of spontaneous circulation. No studies
ave shown that tracheal intubation increases survival after cardiac
rrest. After intubation, conﬁrm correct tube position and secure it
dequately. Ventilate the lungs at 10breathsmin−1; do not hyper-
entilate thepatient. Once thepatient’s tracheahas been intubated,
ontinue chest compressions, at a rate of 100min−1 without paus-
ng during ventilation. A pause in the chest compressions enables
he coronary perfusion pressure to fall substantially. On resuming
ompressions there is some delay before the original coronary per-
usion pressure is restored, thus chest compressions that are not
nterrupted for ventilation (or any reason) result in a substantially
igher mean coronary perfusion pressure.
In the absence of personnel skilled in tracheal intubation, a
upraglottic airway device (e.g., laryngeal mask airway) is an
cceptable alternative (Section 4e). Once a supraglottic airway
evice has been inserted, attempt to deliver continuous chest
ompressions, uninterrupted during ventilation. If excessive gas
eakage causes inadequate ventilation of the patient’s lungs, chest
ompressions will have to be interrupted to enable ventilation
using a CV ratio of 30:2).
ntravenous access and drugs
eripheral versus central venous drug delivery
Establish intravenous access if this has not already been
chieved. Although peak drug concentrations are higher and cir-
ulation times are shorter when drugs are injected into a central
enous catheter compared with a peripheral cannula,268 insertion
f a central venouscatheter requires interruptionofCPRand is asso-
iated with several complications. Peripheral venous cannulation
s quicker, easier to perform and safer. Drugs injected peripherally
ust be followed by a ﬂush of at least 20ml of ﬂuid and elevation
f the extremity for 10–20 s to facilitate drug delivery to the central
irculation.
ntraosseous route
If intravenous access is difﬁcult or impossible, consider the IO
oute.Althoughnormally consideredas analternative route for vas-
ular access in children, it is nowestablished as an effective route in
dults.269 Intraosseous injectionofdrugsachieves adequateplasma
oncentrations in a time comparable with injection through a cen-
ral venous catheter.270 The recent availability of mechanical IO
evices has increased the ease of performing this technique.271
racheal route
Unpredictable plasma concentrations are achieved when drugs
re given via a tracheal tube, and the optimal tracheal dose
f most drugs is unknown. During CPR, the equipotent dose of
drenaline given via the trachea is three to ten times higher than
he intravenous dose.272,273 Some animal studies suggest that the
ower adrenaline concentrations achieved when the drug is given
ia the trachea may produce transient beta-adrenergic effects,
hich will cause hypotension and lower coronary artery perfusion
ressure.274–277 Given the completely unreliable plasma concen-
rations achieved and increased availability of suitable IO devices,
he tracheal route for drug delivery is no longer recommended.n 81 (2010) 1305–1352
Drug delivery via a supraglottic airway device is even less reliable
and should not be attempted.278
Adrenaline
Despite the widespread use of adrenaline during resuscitation,
and several studies involving vasopressin, there is no placebo-
controlled study that shows that the routine use of any vasopressor
at any stage during human cardiac arrest increases neurologically
intact survival to hospital discharge. Current evidence is insufﬁ-
cient to support or refute the routine use of any particular drug
or sequence of drugs. Despite the lack of human data, the use
of adrenaline is still recommended, based largely on animal data
and increased short-term survival in humans.245,246 The alpha-
adrenergic actions of adrenaline cause vasoconstriction, which
increases myocardial and cerebral perfusion pressure. The higher
coronary blood ﬂow increases the frequency and amplitude of
the VF waveform and should improve the chance of restoring a
circulation when deﬁbrillation is attempted.260,279,280 Although
adrenaline improves short-term survival, animal data indicate
that it impairs the microcirculation281,282 and post-cardiac arrest
myocardial dysfunction,283,284 which both might impact on long-
term outcome. The optimal dose of adrenaline is not known, and
there are no data supporting the use of repeated doses. There are
few data on the pharmacokinetics of adrenaline during CPR. The
optimal duration of CPR and number of shocks that should be given
before giving drugs is unknown. On the basis of expert consensus,
for VF/VT give adrenaline after the third shock once chest compres-
sions have resumed, and then repeat every 3–5min during cardiac
arrest (alternate cycles). Do not interrupt CPR to give drugs.
Anti-arrhythmic drugs
There is no evidence that giving any anti-arrhythmic drug rou-
tinely during human cardiac arrest increases survival to hospital
discharge. In comparison with placebo285 and lidocaine,286 the
use of amiodarone in shock-refractory VF improves the short-term
outcome of survival to hospital admission. In these studies, the
anti-arrhythmic therapy was given if VF/VT persisted after at least
three shocks; however, these were delivered using the conven-
tional three-stacked shocks strategy. There are no data on the use
of amiodarone for shock-refractory VF/VT when single shocks are
used. On the basis of expert consensus, if VF/VT persists after three
shocks, give 300mg amiodarone by bolus injection. A further dose
of 150mg may be given for recurrent or refractory VF/VT, followed
by an infusion of 900mg over 24h. Lidocaine, 1mgkg−1, may be
used as an alternative if amiodarone is not available, but do not
give lidocaine if amiodarone has been given already.
Magnesium
The routineuseofmagnesium in cardiac arrest doesnot increase
survival.287–291 and is not recommended in cardiac arrest unless
torsades de pointes is suspected (see peri-arrest arrhythmias).
Bicarbonate
Routine administration of sodium bicarbonate during cardiac
arrest and CPR or after return of spontaneous circulation is not rec-
ommended. Give sodium bicarbonate (50mmol) if cardiac arrest
is associated with hyperkalaemia or tricyclic antidepressant over-
dose; repeat the dose according to the clinical condition and the
result of serial blood gas analysis. During cardiac arrest, arterial
blood gas values do not reﬂect the acid–base state of the tissues292;
the tissue pH will be lower than that in arterial blood. If a central
venous catheter is in situ, central venousbloodgas analysiswill pro-
vide a closer estimate of tissue acid/base state than that provided
by arterial blood.
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ersistent ventricular ﬁbrillation/pulseless ventricular tachycardia
In VF/VT persists, consider changing the position of the
ads/paddles (see Section 3).223 Review all potentially reversible
auses (see below) and treat any that are identiﬁed. Persistent
F/VT may be an indication for percutaneous coronary interven-
ion or thrombolysis—in these cases, a mechanical device CPR may
elp to maintain high-quality CPR for a prolonged period.293
The duration of any individual resuscitation attempt is a matter
f clinical judgement, taking into consideration the circumstances
nd the perceived prospect of a successful outcome. If it was con-
idered appropriate to start resuscitation, it is usually considered
orthwhile continuing, as long as the patient remains in VF/VT.
on-shockable rhythms (PEA and asystole)
Pulseless electrical activity (PEA) is deﬁned as cardiac arrest in
hepresenceof electrical activity thatwouldnormallybeassociated
ith a palpable pulse. These patients often have some mechani-
al myocardial contractions, but these are too weak to produce a
etectable pulse or blood pressure—this sometimes described as
pseudo-PEA’ (see below). PEA is often caused by reversible con-
itions, and can be treated if those conditions are identiﬁed and
orrected. Survival following cardiac arrest with asystole or PEA is
nlikely unless a reversible cause can be found and treated effec-
ively.
If the initial monitored rhythm is PEA or asystole, start CPR 30:2
nd give adrenaline 1mg as soon as venous access is achieved. If
systole is displayed, checkwithout stoppingCPR, that the leads are
ttached correctly. Once an advanced airway has been sited, con-
inue chest compressionswithout pausing during ventilation. After
min of CPR, recheck the rhythm. If asystole is present, resumeCPR
mmediately. If an organised rhythm is present, attempt to palpate
pulse. If no pulse is present (or if there is anydoubt about the pres-
nce of a pulse), continue CPR. Give adrenaline 1mg (IV/IO) every
lternate CPR cycle (i.e., about every 3–5min) once vascular access
s obtained. If a pulse is present, begin post-resuscitation care. If
igns of life return during CPR, check the rhythm and attempt to
alpate a pulse.
Whenever a diagnosis of asystole is made, check the ECG care-
ully for the presence of P waves, because this may respond to
ardiac pacing. There is no beneﬁt in attempting to pace true
systole. If there is doubt about whether the rhythm is asys-
ole or ﬁne VF, do not attempt deﬁbrillation; instead, continue
hest compressions and ventilation. Fine VF that is difﬁcult to
istinguish from asystole will not be shocked successfully into a
erfusing rhythm. Continuing good-quality CPR may improve the
mplitude and frequency of the VF and improve the chance of suc-
essful deﬁbrillation to a perfusing rhythm. Delivering repeated
hocks in an attempt to deﬁbrillate what is thought to be ﬁne
F will increase myocardial injury, both directly from the elec-
ricity and indirectly from the interruptions in coronary blood
ow.
During the treatment of asystole or PEA, following a 2-min cycle
f CPR, if the rhythm has changed to VF, follow the algorithm for
hockable rhythms. Otherwise, continue CPR and give adrenaline
very 3–5min following the failure to detect a palpable pulse with
he pulse check. If VF is identiﬁed on themonitormidway through a
-min cycle of CPR, complete the cycle of CPR before formal rhythm
ndshockdelivery if appropriate—this strategywillminimise inter-
uptions in chest compressions.otentially reversible causes
Potential causes or aggravating factors for which speciﬁc treat-
ent exists must be considered during any cardiac arrest. For easen 81 (2010) 1305–1352 1315
of memory, these are divided into two groups of four based upon
their initial letter: either H or T. More details on many of these
conditions are covered in Section 8.294
Use of ultrasound imaging during advanced life support
Several studies have examined the use of ultrasound during
cardiac arrest to detect potentially reversible causes. Although no
studieshave shown thatuseof this imagingmodality improvesout-
come, there is no doubt that echocardiography has the potential to
detect reversible causes of cardiac arrest (e.g., cardiac tamponade,
pulmonary embolism, ischaemia (regional wall motion abnor-
mality), aortic dissection, hypovolaemia, pneumothorax).295–302
When available for use by trained clinicians, ultrasound may be
of use in assisting with diagnosis and treatment of potentially
reversible causes of cardiac arrest. The integration of ultrasound
into advanced life support requires considerable training if inter-
ruptions to chest compressions are to be minimised. A sub-xiphoid
probe position has been recommended.295,301,303 Placement of the
probe just before chest compressions are paused for a planned
rhythmassessment enables awell-trained operator to obtain views
within 10 s.
Absence of cardiac motion on sonography during resuscitation
of patients in cardiac arrest is highly predictive of death304–306
although sensitivity and speciﬁcity has not been reported.
The four ‘Hs’
Minimise the risk of hypoxia by ensuring that the patient’s lungs
are ventilated adequatelywith 100% oxygen during CPR.Make sure
there is adequate chest rise and bilateral breath sounds. Using the
techniquesdescribed in Section4e, check carefully that the tracheal
tube is not misplaced in a bronchus or the oesophagus.
Pulseless electrical activity caused by hypovolaemia is due usu-
ally to severe haemorrhage. This may be precipitated by trauma
(Section 8h),294 gastrointestinal bleeding or rupture of an aortic
aneurysm. Intravascular volume should be restored rapidly with
warmed ﬂuid, coupled with urgent surgery to stop the haemor-
rhage. Hyperkalaemia, hypokalaemia, hypocalcaemia, acidaemia
and other metabolic disorders are detected by biochemical tests
or suggested by the patient’s medical history, e.g., renal failure
(Section 8a).294 A 12-lead ECG may be diagnostic. Intravenous
calcium chloride is indicated in the presence of hyperkalaemia,
hypocalcaemia and calcium channel-blocker overdose. Suspect
hypothermia in any drowning incident (Sections 8c and d)294; use
a low-reading thermometer.
The four ‘Ts’
A tension pneumothorax may be the primary cause of PEA
and may follow attempts at central venous catheter insertion. The
diagnosis is made clinically. Decompress rapidly by needle thora-
cocentesis, and then insert a chest drain. In the context of cardiac
arrest from major trauma, bilateral thoracostomies may provide
a more reliable way of decompressing a suspected tension pneu-
mothorax.
Cardiac tamponade is difﬁcult to diagnose because the typical
signs of distendedneck veins andhypotension are usually obscured
by the arrest itself. Cardiac arrest after penetrating chest trauma
is highly suggestive of tamponade and is an indication for nee-
dle pericardiocentesis or resuscitative thoracotomy (see Section
8h).294 The increasing use of ultrasound is making the diagnosis
of cardiac tamponade much more reliable.
In the absence of a speciﬁc history, the accidental or deliberate
ingestion of therapeutic or toxic substances may be revealed only
by laboratory investigations (Section 8b).294 Where available, the
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The rescuer’s hand is placed on the patient’s forehead and the
head gently tilted back; the ﬁngertips of the other hand are placed
under thepoint of thepatient’s chin,which is lifted gently to stretch
the anterior neck structures (Fig. 4.3).310–315316 C.D. Deakin et al. / Resus
ppropriate antidotes should be used, but most often treatment is
upportive and standard ALS protocols should be followed.
The commonest cause of thromboembolic or mechanical cir-
ulatory obstruction is massive pulmonary embolus. If pulmonary
mbolism is a possible cause of the cardiac arrest, consider giving
ﬁbrinolytic drug immediately (Section 4f).307
e Airway management and ventilation
ntroduction
Patients requiring resuscitation often have an obstructed air-
ay, usually secondary to loss of consciousness, but occasionally
t may be the primary cause of cardiorespiratory arrest. Prompt
ssessment, with control of the airway and ventilation of the lungs,
s essential. This will help to prevent secondary hypoxic damage to
he brain and other vital organs. Without adequate oxygenation it
ay be impossible to restore a spontaneous cardiac output. These
rinciples may not apply to the witnessed primary cardiac arrest in
he vicinity of a deﬁbrillator; in this case, the priority is immediate
eﬁbrillation.
irway obstruction
auses of airway obstruction
Obstruction of the airway may be partial or complete. It may
ccur at any level, from the nose and mouth down to the trachea.
n the unconscious patient, the commonest site of airway obstruc-
ion is at the soft palate and epiglottis.308,309 Obstruction may also
e caused by vomit or blood (regurgitation of gastric contents or
rauma), or by foreign bodies. Laryngeal obstructionmay be caused
y oedema fromburns, inﬂammation or anaphylaxis. Upper airway
timulation may cause laryngeal spasm. Obstruction of the airway
elow the larynx is less common, but may arise from excessive
ronchial secretions, mucosal oedema, bronchospasm, pulmonary
edema or aspiration of gastric contents.
ecognition of airway obstruction
Airway obstruction can be subtle and is often missed by health-
are professionals, let alone by laypeople. The ‘look, listen and
eel’ approach is a simple, systematic method of detecting airway
bstruction.
Look for chest and abdominal movements.
Listen and feel for airﬂow at the mouth and nose.
In partial airway obstruction, air entry is diminished and usually
oisy. Inspiratory stridor is caused by obstruction at the laryngeal
evel or above. Expiratory wheeze implies obstruction of the lower
irways, which tend to collapse and obstruct during expiration.
ther characteristic sounds include:
Gurgling is caused by liquid or semisolid foreign material in the
large airways.
Snoring arises when the pharynx is partially occluded by the soft
palate or epiglottis.
Crowing is the sound of laryngeal spasm.In a patient who is making respiratory efforts, complete airway
bstruction causes paradoxical chest and abdominal movement,
ften described as ‘see-saw’ breathing. As the patient attempts
o breathe in, the chest is drawn in and the abdomen expands;
he opposite occurs during expiration. This is in contrast to then 81 (2010) 1305–1352
normal breathing pattern of synchronous movement upwards and
outwards of the abdomen (pushed down by the diaphragm) with
the lifting of the chest wall. During airway obstruction, other
accessory muscles of respiration are used, with the neck and the
shoulder muscles contracting to assist movement of the thoracic
cage. Full examination of the neck, chest and abdomen is required
to differentiate the paradoxical movements that may mimic nor-
mal respiration. The examination must include listening for the
absence of breath sounds in order to diagnose complete airway
obstruction reliably; any noisy breathing indicates partial airway
obstruction. During apnoea, when spontaneous breathing move-
ments are absent, complete airway obstruction is recognised by
failure to inﬂate the lungs during attempted positive pressure ven-
tilation. Unless airway patency can be re-established to enable
adequate lung ventilation within a period of a very few minutes,
neurological and other vital organ injury may occur, leading to
cardiac arrest.
Basic airway management
Once any degree of obstruction is recognised, immediate mea-
sures must be taken to create and maintain a clear airway. There
are three manoeuvres that may improve the patency of an airway
obstructed by the tongue or other upper airway structures: head
tilt, chin lift, and jaw thrust.
Head tilt and chin liftFig. 4.3. Head tilt and chin lift.
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or suspected basal skull fracture an oral airway is preferred but, if
this is not possible and the airway is obstructed, gentle insertion of
a nasopharyngeal airway may be life saving (i.e., the beneﬁts may
far outweigh the risks).Fig. 4.4. Jaw thrust.
aw thrust
Jaw thrust is an alternative manoeuvre for bringing the
andible forward and relieving obstruction by the soft palate and
piglottis. The rescuer’s index and other ﬁngers are placed behind
he angle of the mandible, and pressure is applied upwards and
orwards. Using the thumbs, themouth is opened slightly by down-
ard displacement of the chin (Fig. 4.4).
These simple positional methods are successful in most cases
here airwayobstruction results fromrelaxationof the soft tissues.
f a clear airway cannot be achieved, look for other causes of airway
bstruction. Use a ﬁnger sweep, forceps or suction to remove any
olid foreign body seen in the mouth. Remove broken or displaced
entures, but leave well-ﬁtting dentures as they help to maintain
he contours of the mouth, facilitating a good seal for ventilation.
irway management in patients with suspected cervical spine
njury
If spinal injury is suspected (e.g., if the victim has fallen, been
truck on the head or neck, or has been rescued after diving into
hallowwater),maintain thehead, neck, chest and lumbar region in
he neutral position during resuscitation. Excessive head tilt could
ggravate the injury and damage the cervical spinal cord;316–320
owever, this complication has not been documented and the rel-
tive risk is unknown. When there is a risk of cervical spine injury,
stablish a clear upper airway by using jaw thrust or chin lift in
ombination with manual in-line stabilisation (MILS) of the head
nd neck by an assistant.321,322 If life-threatening airway obstruc-
ion persists despite effective application of jaw thrust or chin lift,
ddhead tilt in small incrementsuntil the airway is open; establish-
ng a patent airway takes priority over concerns about a potential
ervical spine injury.n 81 (2010) 1305–1352 1317
Adjuncts to basic airway techniques
Despite a total lack of published data on the use of nasopharyn-
geal and oropharyngeal airways during CPR, they are often helpful,
and sometimes essential, to maintain an open airway, particularly
when resuscitation is prolonged. The position of the head and neck
must bemaintained to keep the airway aligned. Oropharyngeal and
nasopharyngeal airways overcome backward displacement of the
soft palate and tongue in an unconscious patient, but head tilt and
jaw thrust may also be required.
Oropharyngeal airways
Oropharyngeal airways are available in sizes suitable for the
newborn to large adults. Anestimateof the size required is obtained
by selecting an airway with a length corresponding to the vertical
distance between the patient’s incisors and the angle of the jaw.
The most common sizes are 2, 3 and 4 for small, medium and large
adults, respectively.
If the glossopharyngeal and laryngeal reﬂexes are present,
insertion of an oropharyngeal may cause airway vomiting or
laryngospasm; thus, insertion should be attempted only in
comatose patients (Fig. 4.5). The oropharyngeal airway can become
obstructed at three possible sites:323 part of the tongue can occlude
the end of the airway; the airway can lodge in the vallecula; and
the airway can be obstructed by the epiglottis.
Nasopharyngeal airways
In patients who are not deeply unconscious, a nasopharyn-
geal airway is tolerated better than an oropharyngeal airway. The
nasopharyngeal airwaymaybe life saving inpatientswith clenched
jaws, trismus or maxillofacial injuries, when insertion of an oral
airway is impossible. Inadvertent insertion of a nasopharyngeal air-
way through a fracture of the skull base and into the cranial vault
is possible, but extremely rare.324,325 In the presence of a knownFig. 4.5. Insertion of oropharyngeal airway.
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The tubes are sized in millimetres according to their internal
iameter, and the length increases with diameter. The traditional
ethods of sizing a nasopharyngeal airway (measurement against
he patient’s little ﬁnger or anterior nares) do not correlatewith the
irway anatomy and are unreliable.326 Sizes of 6–7mmare suitable
or adults. Insertion can cause damage to the mucosal lining of the
asal airway, resulting in bleeding in up to 30% of cases.327 If the
ube is too long it may stimulate the laryngeal or glossopharyngeal
eﬂexes to produce laryngospasm or vomiting.
xygen
During CPR, give oxygen whenever it is available. There are no
ata to indicate the optimal arterial blood oxygen saturation (SaO2)
uring CPR. There are animal data328 and some observational clini-
al data indicatinganassociationbetweenhighSaO2 afterROSCand
orse outcome.329 A standard oxygen mask will deliver up to 50%
xygen concentration, providing the ﬂowof oxygen is high enough.
mask with a reservoir bag (non-rebreathing mask), can deliver
n inspired oxygen concentration of 85% at ﬂows of 10–15 lmin−1.
nitially, give the highest possible oxygen concentration. As soon
s the arterial blood oxygen saturation can be measured reliably,
y pulse oximeter (SpO2) or arterial blood gas analysis, titrate the
nspired oxygen concentration to achieve an arterial blood oxygen
aturation in the range of 94–98%.
uction
Useawide-bore rigid sucker (Yankauer) to remove liquid (blood,
aliva and gastric contents) from the upper airway. Use the sucker
autiously if the patient has an intact gag reﬂex; pharyngeal stim-
lation can provoke vomiting.
entilation
Provideartiﬁcial ventilationas soonaspossible for anypatient in
hom spontaneous ventilation is inadequate or absent. Expired air
entilation (rescue breathing) is effective, but the rescuer’s expired
xygen concentration is only 16–17%, so itmust be replaced as soon
s possible by ventilation with oxygen-enriched air. The pocket
esuscitation mask is used widely. It is similar to an anaesthetic
acemask, and enables mouth-to-mask ventilation. It has a unidi-
ectional valve, which directs the patient’s expired air away from
he rescuer. Themask is transparent so that vomit or blood from the
atient can be seen. Some masks have a connector for the addition
f oxygen. When using masks without a connector, supplemental
xygen can be given by placing the tubing underneath one side and
nsuring an adequate seal. Use a two-hand technique to maximise
he seal with the patient’s face (Fig. 4.6).
High airway pressures can be generated if the tidal volume or
nspiratory ﬂow is excessive, predisposing to gastric inﬂation and
ubsequent risk of regurgitation and pulmonary aspiration. The
ossibility of gastric inﬂation is increased by:
malalignment of the head and neck, and an obstructed airway;
an incompetent oesophageal sphincter (present in all patients
with cardiac arrest);
a high airway inﬂation pressure.
Conversely, if inspiratory ﬂow is too low, inspiratory time will
e prolonged and the time available to give chest compressions
s reduced. Deliver each breath over approximately 1 s and trans-
er a volume that corresponds to normal chest movement; this
epresents a compromise between giving an adequate volume,
inimising the risk of gastric inﬂation, and allowing adequate time
or chest compressions. During CPR with an unprotected airway,Fig. 4.6. Mouth-to-mask ventilation.
give two ventilations after each sequence of 30 chest compres-
sions.
Self-inﬂating bag
The self-inﬂating bag can be connected to a facemask, tracheal
tube or supraglottic airway device (SAD). Without supplemental
oxygen, the self-inﬂating bag ventilates the patient’s lungs with
ambient air (21% oxygen). The delivered oxygen concentration can
be increased to about 85%byusing a reservoir systemand attaching
oxygen at a ﬂow 10 lmin−1.
Although the bag-mask device enables ventilation with high
concentrations of oxygen, its use by a single person requires con-
siderable skill. When used with a face mask, it is often difﬁcult to
achieve a gas-tight seal between the mask and the patient’s face,
and to maintain a patent airway with one hand while squeezing
the bag with the other.330 Any signiﬁcant leak will cause hypoven-
tilation and, if the airway is not patent, gas may be forced into
the stomach.331,332 This will reduce ventilation further and greatly
increase the risk of regurgitation and aspiration.333 Cricoid pres-
sure can reduce this risk334,335 but requires thepresenceof a trained
assistant. Poorly applied cricoidpressuremaymake itmoredifﬁcult
to ventilate the patient’s lungs.334,336–339
The two-person technique for bag-mask ventilation is prefer-
able (Fig. 4.7). One person holds the facemask in place using a jaw
thrust with both hands, and an assistant squeezes the bag. In this
way, a better seal can be achieved and the patient’s lungs can be
ventilated more effectively and safely.
Once a tracheal tube or a supraglottic airway device has been
inserted, ventilate the lungs at a rate of 10breathsmin−1 and con-
tinue chest compressions without pausing during ventilations. The
laryngeal seal achievedwith a supraglottic airwaydevice is unlikely
to be good enough to prevent at least some gas leaking when inspi-
ration coincides with chest compressions. Moderate gas leakage is
acceptable, particularly as most of this gas will pass up through the
patient’s mouth. If excessive gas leakage results in inadequate ven-
tilation of the patient’s lungs, chest compressions will have to be
C.D. Deakin et al. / Resuscitatio
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performance in this setting.365 Reported rates of successful venti-Fig. 4.7. The two-person technique for bag-mask ventilation.
nterrupted to enable ventilation, using a compression-ventilation
atio of 30:2.
utomatic ventilators
Very few studies address speciﬁc aspects of ventilation dur-
ng advanced life support. There is some data indicating that the
entilation rates delivered by healthcare personnel during cardiac
rrest are excessive,242,340,341 although other studies have shown
ore normal ventilation rates.245,342,343 Automatic ventilators or
esuscitators provide a constant ﬂow of gas to the patient during
nspiration; the volume delivered is dependent on the inspiratory
ime (a longer time provides a greater tidal volume). Because pres-
ure in the airway rises during inspiration, these devices are often
ressure limited to protect the lungs against barotrauma. An auto-
atic ventilator can be usedwith either a facemask or other airway
evice (e.g., tracheal tube, supraglottic airway device).
An automatic resuscitator should be set initially to deliver a tidal
olume of 6–7mlkg−1 at 10breathsmin−1. Some ventilators have
oordinated markings on the controls to facilitate easy and rapid
djustment for patients of different sizes, and others are capable of
ophisticated variation in respiratory parameters. In the presence
f a spontaneous circulation, the correct settingwill be determined
y analysis of the patient’s arterial blood gases.
Automatic resuscitators provide many advantages over alterna-
ive methods of ventilation.
In unintubated patients, the rescuer has both hands free for mask
and airway alignment.
Cricoid pressure can be applied with one hand while the other
seals the mask on the face.
In intubated patients they free the rescuer for other tasks.344
Once set, they provide a constant tidal volume, respiratory rate
and minute ventilation; thus, they may help to avoid excessive
ventilation.
Are associated with lower peak airway pressures than manual
ventilation, which reduces intrathoracic pressure and facilitates
improved venous return and subsequent cardiac output.n 81 (2010) 1305–1352 1319
A manikin study of simulated cardiac arrest and a study involv-
ingﬁre-ﬁghters ventilating the lungs of anaesthetisedpatients both
showed a signiﬁcant decrease in gastric inﬂation with manually-
triggered ﬂow-limited oxygen-powered resuscitators and mask
comparedwith a bag-mask.345,346 However, the effect of automatic
resuscitators on gastric inﬂation in humans in cardiac arrest has not
been studied, and there are no data demonstrating clear beneﬁt
over bag-valve-mask devices.
Passive oxygen delivery
In the presence of a patent airway, chest compressions alone
may result in some ventilation of the lungs.347 Oxygen can be deliv-
ered passively, either via an adapted tracheal tube (Boussignac
tube),348,349 or with the combination of an oropharyngeal air-
way and standard oxygen mask with non-rebreather reservoir.350
Althoughone studyhas shownhigher neurologically intact survival
with passive oxygen delivery (oral airway and oxygen mask) com-
pared with bag-mask ventilation after out-of-hospital VF cardiac
arrest, this was a retrospective analysis and is subject to numer-
ous confounders.350 There is insufﬁcient evidence to support or
refute the use of passive oxygen delivery during CPR to improve
outcome when compared with oxygen delivery by positive pres-
sure ventilation. Until further data are available, passive oxygen
delivery without ventilation is not recommended for routine use
during CPR.
Alternative airway devices
The tracheal tube has generally been considered the opti-
mal method of managing the airway during cardiac arrest. There
is evidence that, without adequate training and experience, the
incidenceof complications, suchasunrecognisedoesophageal intu-
bation (6–17% in several studies involving paramedics)351–354 and
dislodgement, is unacceptably high.355 Prolonged attempts at tra-
cheal intubation are harmful; the cessation of chest compressions
during this time will compromise coronary and cerebral perfusion.
Several alternative airway devices have been considered for air-
way management during CPR. There are published studies on the
use during CPR of the Combitube, the classic laryngeal mask air-
way (cLMA), the laryngeal tube (LT) and the I-gel, but none of these
studies have been powered adequately to enable survival to be
studiedas aprimaryendpoint; instead,most researchershave stud-
ied insertion and ventilation success rates. The supraglottic airway
devices (SADs) are easier to insert than a tracheal tube and, unlike
tracheal intubation, can generally be inserted without interrupting
chest compressions.356
There are no data supporting the routine use of any speciﬁc
approach to airway management during cardiac arrest. The best
technique is dependent on the precise circumstances of the cardiac
arrest and the competence of the rescuer.
Laryngeal mask airway (LMA)
The laryngeal mask airway (Fig. 4.8) is quicker and easier to
insert than a tracheal tube.357–364 The original LMA (cLMA), which
is reusable, has been studied during CPR, but none of these stud-
ies has compared it directly with the tracheal tube. A wide variety
of single-use LMAs are used for CPR, but they have different char-
acteristics to the cLMA and there are no published data on theirlation during CPRwith the LMAare very high for in-hospital studies
(86–100%)366–369 but generally less impressive (71–90%)370–372 for
out-of-hospital cardiac arrest (OHCA). The reason for the relatively
disappointing results from the LMA in OHCA is not clear.
1320 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
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The ProSeal LMA (PLMA) has been studied extensively in anaes-
thetised patients, but there are no studies of its function and
performance during CPR. It has several attributes that, in the-
ory, make it more suitable than the cLMA for use during CPR:
improved sealwith the larynx enabling ventilation at higher airwayFig. 4.8. Insertion of a laryngeal mask airway.
When used by inexperienced personnel, ventilation of the lungs
f anaesthetised patients is more efﬁcient and easier with an LMA
han with a bag-mask.330 When an LMA can be inserted with-
ut delay it is preferable to avoid bag-mask ventilation altogether.
n comparison with bag-mask ventilation, use of a self-inﬂating
ag and LMA during cardiac arrest reduces the incidence of
egurgitation.333 One study showed similar arterial blood gas
alues in patients successfully resuscitated after out-of-hospital
ardiac arrest when either an LMA or bag mask was used.373
In comparisonwith tracheal intubation, theperceiveddisadvan-
ages of the LMA are the increased risk of aspiration and inability
o provide adequate ventilation in patients with low lung and/or
hest-wall compliance. There are no data demonstrating whether
rnot it is possible toprovideadequateventilationvia anLMAwith-
ut interruption of chest compressions. The ability to ventilate the
ungs adequately while continuing to compress the chest may be
ne of the main beneﬁts of a tracheal tube. There are remarkably
ew cases of pulmonary aspiration reported in the studies of the
MA during CPR.
ombitube
The Combitube is a double-lumen tube introduced blindly over
he tongue, and provides a route for ventilation whether the tube
aspassed into theoesophagus. There aremany studies of theCom-
itube in CPR and successful ventilation was achieved in 79–98%
f patients.371,374–381 Two RCTs of the Combitube versus tracheal
ntubation for out-of-hospital cardiac arrest showed no difference
n survival.380,381 Use of theCombitube iswaning and inmanyparts
f the world it is being replaced by other devices such as the LT.
aryngeal tube
The LT was introduced in 2001 (Fig. 4.9); it is known as the King
T airway in theUnited States. In anaesthetisedpatients, theperfor-
ance of the LT is favourable in comparison with the classic LMAnd ProSeal LMA.382,383 After just 2h of training, nurses success-
ully inserted a laryngeal tube and achieved ventilation in 24 of 30
80%) of OHCAs.384 A disposable version of the laryngeal tube (LT-
) is available and was inserted successfully by paramedics in 92
HCAs (85 on the ﬁrst attempt and 7 on the second attempt).385Fig. 4.9. Laryngeal tube. © 2010 ERC.
In a manikin CPR study, use of the LT-D reduced the no-ﬂow time
signiﬁcantly in comparison with use of a tracheal tube.386
I-gel
The cuff of the I-gel is made of thermoplastic elastomer gel
(styrene ethylene butadene styrene) and does not require inﬂa-
tion; the stem of the I-gel incorporates a bite block and a narrow
oesophageal drain tube (Fig. 4.10). It is very easy to insert,
requiring only minimal training and a laryngeal seal pressure
of 20–24 cmH2O can be achieved.387,388 In two manikin studies,
insertion of the I-gel was signiﬁcantly faster than several other
airway devices.356,389 The ease of insertion of the I-gel and its
favourable leak pressure make it theoretically very attractive as
a resuscitation airway device for those inexperienced in tracheal
intubation. Use of the I-gel during cardiac arrest has been reported
but more data on its use in this setting are awaited.390,391
Other airway devices
ProSeal LMAFig. 4.10. I-gel. © 2010 ERC.
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ressures,392 the inclusion of a gastric drain tube enabling venting
f liquid regurgitated gastric contents from the upper oesophagus
nd passage of a gastric tube to drain liquid gastric contents, and
he inclusion of a bite block. The PLMA is slightly more difﬁcult to
nsert than a cLMA and is relatively expensive. The Supreme LMA
SLMA) is adisposable versionof thePLMA. Studies in anaesthetised
atients indicate that it is relatively easy to insert and laryngeal seal
ressures of 24–28 cmH2O can be achieved.393–395 Data on the use
f the SLMA during cardiac arrest are awaited.
ntubating LMA
The intubating LMA (ILMA) is relatively easy to insert396,397 but
ubsequent blind insertion of a tracheal tube generally requires
ore training.398 One study has documented use of the ILMA after
ailed intubation by direct laryngoscopy in 24 cardiac arrests by
rehospital physicians in France.399
racheal intubation
There is insufﬁcient evidence to support or refute the use of
ny speciﬁc technique to maintain an airway and provide ventila-
ion in adults with cardiopulmonary arrest. Despite this, tracheal
ntubation is perceived as the optimal method of providing and
aintaining a clear and secure airway. It should be used only when
rained personnel are available to carry out the procedure with a
igh level of skill and conﬁdence. A recent systematic review of
andomised controlled trials (RCTs) of tracheal intubation versus
lternative airway management in acutely ill and injured patients
dentiﬁed just three trials400: two were RCTs of the Combitube
ersus tracheal intubation for out-of-hospital cardiac arrest,380,381
hich showed no difference in survival. The third study was a
CT of prehospital tracheal intubation versus management of the
irway with a bag-mask in children requiring airway manage-
ent for cardiac arrest, primary respiratory disorders and severe
njuries.401 There was no overall beneﬁt for tracheal intubation; on
he contrary, of the children requiring airway management for a
espiratory problem, those randomised to intubation had a lower
urvival rate that those in the bag-mask group. The Ontario Prehos-
ital Advanced Life Support (OPALS) studydocumentedno increase
n survival to hospital discharge when the skills of tracheal intuba-
ion and injectionof cardiacdrugswere added to anoptimisedbasic
ife support-automated external deﬁbrillator (BLS-AED) system.244
The perceived advantages of tracheal intubation over bag-mask
entilation include: enabling ventilation without interrupting
hest compressions402; enabling effective ventilation, particularly
hen lung and/or chest compliance is poor; minimising gastric
nﬂation and therefore the risk of regurgitation; protection against
ulmonary aspiration of gastric contents; and the potential to free
he rescuer’s hands for other tasks. Use of the bag-mask is more
ikely to cause gastric distension that, theoretically, is more likely
o cause regurgitation with risk of aspiration. However, there are
o reliable data to indicate that the incidence of aspiration is any
ore in cardiac arrest patients ventilated with bag-mask versus
hose that are ventilated via tracheal tube.
The perceived disadvantages of tracheal intubation over bag-
alve-mask ventilation include:
The risk of an unrecognised misplaced tracheal tube—in patients
with out-of-hospital cardiac arrest the reliably documented inci-
dence ranges from 0.5% to 17%: emergency physicians—0.5%403;
paramedics—2.4%,404 6%,351,352 9%,353 17%.354
A prolonged periodwithout chest compressionswhile intubation
is attempted—in a study of prehospital intubation by paramedics
during 100 cardiac arrests the total duration of the interruptions
in CPR associated with tracheal intubation attempts was 110 sn 81 (2010) 1305–1352 1321
(IQR 54–198 s; range 13–446 s) and in 25% the interruptionswere
more than 3min.405 Tracheal intubation attempts accounted for
almost 25% of all CPR interruptions.
• A comparatively high failure rate. Intubation success rates cor-
relate with the intubation experience attained by individual
paramedics.406 Rates for failure to intubate are as high as 50%
in prehospital systems with a low patient volume and providers
who do not perform intubation frequently.407,408
Healthcare personnel who undertake prehospital intubation
should do so only within a structured, monitored programme,
which should include comprehensive competency-based training
and regular opportunities to refresh skills. Rescuersmustweigh the
risks and beneﬁts of intubation against the need to provide effec-
tive chest compressions. The intubation attempt may require some
interruption of chest compressions but, once an advanced airway is
in place, ventilation will not require interruption of chest compres-
sions. Personnel skilled in advanced airwaymanagement should be
able to undertake laryngoscopy without stopping chest compres-
sions; a brief pause in chest compressions will be required only as
the tube is passed through the vocal cords. Alternatively, to avoid
any interruptions in chest compressions, the intubation attempt
may be deferred until return of spontaneous circulation.350,409
No intubation attempt should interrupt chest compressions for
more than 10 s; if intubation is achievablewithin these constraints,
recommence bag-mask ventilation. After intubation, tube place-
ment must be conﬁrmed and the tube secured adequately.
Conﬁrmation of correct placement of the tracheal tube
Unrecognised oesophageal intubation is the most serious com-
plication of attempted tracheal intubation. Routine use of primary
and secondary techniques to conﬁrm correct placement of the tra-
cheal tube should reduce this risk.
Clinical assessment
Primary assessment includes observation of chest expansion
bilaterally, auscultation over the lung ﬁelds bilaterally in the axil-
lae (breath sounds should be equal and adequate) and over the
epigastrium (breath sounds should not be heard). Clinical signs of
correct tube placement (condensation in the tube, chest rise, breath
sounds on auscultation of lungs, and inability to hear gas entering
the stomach) are not completely reliable. The reported sensitiv-
ity (proportion of tracheal intubations correctly identiﬁed) and
speciﬁcity (proportion of oesophageal intubations correctly identi-
ﬁed) of clinical assessment varies: sensitivity 74–100%; speciﬁcity
66–100%.403,410–413
Secondary conﬁrmation of tracheal tube placement by an
exhaled carbon dioxide or oesophageal detection device should
reduce the riskofunrecognisedoesophageal intubationbut theper-
formanceof the available devices varies considerably. Furthermore,
none of the secondary conﬁrmation techniques will differentiate
between a tube placed in a main bronchus and one placed correctly
in the trachea.
Thereare inadequatedata to identify theoptimalmethodof con-
ﬁrming tubeplacementduring cardiac arrest, andall devices should
be considered as adjuncts to other conﬁrmatory techniques.414
There are no data quantifying their ability to monitor tube position
after initial placement.
Oesophageal detector device
The oesophageal detector device creates a suction force at the
tracheal end of the tracheal tube, either by pulling back the plunger
on a large syringe or releasing a compressed ﬂexible bulb. Air is
aspirated easily from the lower airways through a tracheal tube
placed in the cartilage-supported rigid trachea. When the tube is in
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he oesophagus, air cannot be aspirated because the oesophagus
ollapses when aspiration is attempted. The oesophageal detec-
or device may be misleading in patients with morbid obesity, late
regnancy or severe asthma or when there are copious tracheal
ecretions; in these conditions the tracheamay collapsewhen aspi-
ation is attempted.352,410,415–417 The performance of the syringe
esophageal detector device for identifying tracheal tube posi-
ion has been reported in ﬁve cardiac arrest studies352,418–421:
he sensitivity was 73–100% and the speciﬁcity 50–100%. The
erformance of the bulb oesophageal detector device for identi-
ying tracheal tube position has been reported in three cardiac
rrest studies410,415,421: the sensitivity was 71–75% and speciﬁcity
9–100%.
arbon dioxide detectors
Carbon dioxide (CO2) detector devices measure the concentra-
ion of exhaled carbon dioxide from the lungs. The persistence of
xhaled CO2 after six ventilations indicates placement of the tra-
heal tube in the trachea or a main bronchus.403 Conﬁrmation of
orrect placement above the carina will require auscultation of the
hest bilaterally in themid-axillary lines. Broadly, there three types
f carbon dioxide detector device:
. Disposable colorimetric end-tidal carbon dioxide (ETCO2) detec-
tors use a litmus paper to detect CO2, and these devices generally
give readings of purple (ETCO2 <0.5%), tan (ETCO2 0.5–2%) and
yellow (ETCO2 >2%). In most studies, tracheal placement of the
tube is considered veriﬁed if the tan colour persists after a
few ventilations. In cardiac arrest patients, eight studies reveal
62–100% sensitivity in detecting tracheal placement of the tra-
cheal tubeandan86–100%speciﬁcity in identifyingnon-tracheal
position.258,414,420,422–426 Although colorimetric CO2 detectors
identify placement in patients with good perfusion quite well,
these devices are less accurate than clinical assessment in car-
diac arrest patients becausepulmonarybloodﬂowmaybe so low
that there is insufﬁcient exhaled carbon dioxide. Furthermore, if
the tracheal tube is in the oesophagus, six ventilations may lead
to gastric distension, vomiting and aspiration.
. Non-waveform electronic digital ETCO2 devices generally mea-
sure ETCO2 using an infrared spectrometer and display the
results with a number; they do not provide a waveform graph-
ical display of the respiratory cycle on a capnograph. Five
studies of these devices for identiﬁcation of tracheal tube posi-
tion in cardiac arrest document 70–100% sensitivity and 100%
speciﬁcity.403,412,414,418,422,427
. End-tidal CO2 detectors that include a waveform graphical dis-
play (capnographs) are the most reliable for veriﬁcation of
tracheal tube position during cardiac arrest. Two studies of
waveform capnography to verify tracheal tube position in vic-
tims of cardiac arrest demonstrate 100% sensitivity and 100%
speciﬁcity in identifying correct tracheal tube placement.403,428
Three studies with a cumulative total of 194 tracheal and 22
oesophageal tube placements documented an overall 64% sensi-
tivity and 100% speciﬁcity in identifying correct tracheal tube
placement when using a capnograph in prehospital cardiac
arrest victims.410,415,421 However, in these studies intubation
was undertaken only after arrival at hospital (time to intuba-
tion averaged more than 30min) and many of the cardiac arrest
victims studied had prolonged resuscitation times and very pro-
longed transport time.Based on the available data, the accuracy of colorimetric CO2
etectors, oesophageal detector devices and non-waveform cap-
ometers does not exceed the accuracy of auscultation and direct
isualization for conﬁrming the tracheal position of a tube in vic-
ims of cardiac arrest.Waveform capnography is themost sensitiven 81 (2010) 1305–1352
and speciﬁc way to conﬁrm and continuously monitor the position
of a tracheal tube invictimsof cardiac arrest andshould supplement
clinical assessment (auscultation and visualization of tube through
cords). Waveform capnography will not discriminate between tra-
cheal and bronchial placement of the tube—careful auscultation
is essential. Existing portable monitors make capnographic initial
conﬁrmation and continuous monitoring of tracheal tube position
feasible in almost all settings, including out-of-hospital, emer-
gency department, and in-hospital locations where intubation is
performed. In the absence of a waveform capnograph it may be
preferable to use a supraglottic airway device when advanced air-
way management is indicated.
Thoracic impedance
There are smaller changes in thoracic impedance with
oesophageal ventilations than with ventilation of the lungs.429–431
Changes in thoracic impedancemaybeused todetect ventilation432
andoesphageal intubation402,433 during cardiac arrest. It is possible
that this technology can be used to measure tidal volume during
CPR. The role of thoracic impedance as a tool to detect tracheal tube
position and adequate ventilation during CPR is undergoing further
research but is not yet ready for routine clinical use.
Cricoid pressure
In non-arrest patients cricoid pressure may offer some measure
of protection to the airway from aspiration but it may also impede
ventilation or interfere with intubation. The role of cricoid during
cardiac arrest has not been studied. Application of cricoid pressure
during bag-mask ventilation reduces gastric inﬂation.334,335,434,435
Studies in anaesthetised patients show that cricoid pressure
impairs ventilation in many patients, increases peak inspiratory
pressures and causes complete obstruction in up to 50% of patients
depending on the amount of cricoid pressure (in the range of rec-
ommended effective pressure) that is applied.334–339,436,437
The routine use of cricoid pressure in cardiac arrest is not rec-
ommended. If cricoid pressure is used during cardiac arrest, the
pressure should be adjusted, relaxed or released if it impedes ven-
tilation or intubation.
Securing the tracheal tube
Accidentaldislodgementof a tracheal tubecanoccurat any time,
but may be more likely during resuscitation and during transport.
The most effective method for securing the tracheal tube has yet to
be determined; use either conventional tapes or ties, or purpose-
made tracheal tube holders.
Cricothyroidotomy
Occasionally itwill be impossible to ventilate an apnoeic patient
with a bag-mask, or to pass a tracheal tube or alternative airway
device. This may occur in patients with extensive facial trauma
or laryngeal obstruction caused by oedema or foreign material.
In these circumstances, delivery of oxygen through a needle or
surgical cricothyroidotomy may be life-saving. A tracheostomy is
contraindicated in an emergency, as it is time consuming, haz-
ardous and requires considerable surgical skill and equipment.
Surgical cricothyroidotomyprovides adeﬁnitive airway that can
be used to ventilate the patient’s lungs until semi-elective intu-
bation or tracheostomy is performed. Needle cricothyroidotomy
is a much more temporary procedure providing only short-term
oxygenation. It requires a wide-bore, non-kinking cannula, a high-
pressure oxygen source, runs the risk of barotrauma and can be
particularly ineffective in patients with chest trauma. It is also
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rone to failure because of kinking of the cannula, and is unsuitable
or patient transfer.
f Assisting the circulation
rugs and ﬂuids for cardiac arrest
This topic is divided into: drugs used during the management
f a cardiac arrest; anti-arrhythmic drugs used in the peri-arrest
eriod; otherdrugsused in theperi-arrestperiod;ﬂuids; and routes
or drug delivery. Every effort has been made to provide accurate
nformation on the drugs in these guidelines, but literature from
he relevant pharmaceutical companies will provide the most up-
o-date data.
rugs used during the treatment of cardiac arrest
Only a few drugs are indicated during the immediate manage-
ent of a cardiac arrest, and there is limited scientiﬁc evidence
upporting their use. Drugs should be considered only after initial
hocks have been delivered (if indicated) and chest compressions
nd ventilation have been started. The evidence for the optimal
iming and order of drug delivery, and the optimal dose, is limited.
There are three groups of drugs relevant to the management of
ardiac arrest that were reviewed during the 2010 Consensus Con-
erence: vasopressors, anti-arrhythmics and other drugs. Routes of
rug delivery other than the optimal intravenous route were also
eviewed and are discussed.
asopressors
Despite the continued widespread use of adrenaline and
ncreased use of vasopressin during resuscitation in some coun-
ries, there is no placebo-controlled study that shows that the
outine use of any vasopressor during human cardiac arrest
ncreases survival to hospital discharge, although improved short-
erm survival has been documented.245,246 The primary goal of
ardiopulmonary resuscitation is to re-establish blood ﬂow to vital
rgans until the restoration of spontaneous circulation. Despite the
ack of data from cardiac arrest in humans, vasopressors continue
o be recommended as ameans of increasing cerebral and coronary
erfusion during CPR.
drenaline (epinephrine) versus vasopressin
Adrenaline has been the primary sympathomimetic agent
or the management of cardiac arrest for 40 years.438 Its
lpha-adrenergic, vasoconstrictive effects cause systemic vaso-
onstriction, which increases coronary and cerebral perfusion
ressures. The beta-adrenergic actions of adrenaline (inotropic,
hronotropic) may increase coronary and cerebral blood ﬂow, but
oncomitant increases in myocardial oxygen consumption, ectopic
entricular arrhythmias (particularly when the myocardium is
cidotic), transient hypoxaemia due to pulmonary arteriovenous
hunting, impaired microcirculation,281 and worse post-cardiac
rrest myocardial dysfunction283,284 may offset these beneﬁts.
The potentially deleterious beta-effects of adrenaline have led
o exploration of alternative vasopressors. Vasopressin is a nat-
rally occurring antidiuretic hormone. In very high doses it is a
owerful vasoconstrictor that acts by stimulation of smooth mus-
le V1 receptors. Three randomised controlled trials439–441 and a
eta-analysis442 demonstrated no difference in outcomes (ROSC,
urvival to discharge, or neurological outcome) with vasopressin
ersus adrenaline as a ﬁrst line vasopressor in cardiac arrest. Two
ore recent studies comparing adrenaline alone or in combination
ith vasopressin also demonstrated no difference in ROSC, survivaln 81 (2010) 1305–1352 1323
to discharge or neurological outcome.443,444 There are no alterna-
tive vasopressors that provide survival beneﬁt during cardiac arrest
resuscitation when compared with adrenaline.
Participants at the 2010Consensus Conference debated in depth
the treatment recommendations that should follow from this evi-
dence. Despite the absence of data demonstrating an increase in
long-term survival, adrenaline has been the standard vasopressor
in cardiac arrest. It was agreed that there is currently insufﬁcient
evidence to support or refute the use of any other vasopressor as
an alternative to, or in combination with, adrenaline in any cardiac
arrest rhythmto improve survival orneurological outcome.Current
practice still supports adrenaline as the primary vasopressor for the
treatment of cardiac arrest of all rhythms. Although the evidence
of beneﬁt from the use of adrenaline is limited, it was felt that the
improved short-term survival documented in some studies245,246
warranted its continued use, although in the absence of clinical
evidence, the dose and timing have not been changed in the 2010
guidelines.
Adrenaline
Indications.
• Adrenaline is the ﬁrst drug used in cardiac arrest of any cause:
it is included in the ALS algorithm for use every 3–5min of CPR
(alternate cycles).
• Adrenaline is preferred in the treatment of anaphylaxis (Section
8g).294
• Adrenaline is a second-line treatment for cardiogenic shock.
Dose. During cardiac arrest, the initial IV/IO dose of adrenaline
is 1mg. There are no studies showing survival beneﬁt for higher
doses of adrenaline for patients in refractory cardiac arrest. In some
cases, an adrenaline infusion is required in the post-resuscitation
period.
Following return of spontaneous circulation, even small doses
of adrenaline (50–100g) may induce tachycardia, myocardial
ischaemia, VT and VF. Once a perfusing rhythm is established, if
further adrenaline is deemednecessary, titrate the dose carefully to
achieve an appropriate blood pressure. Intravenous doses of 50g
are usually sufﬁcient formost hypotensive patients. Use adrenaline
cautiously in patients with cardiac arrest associated with cocaine
or other sympathomimetic drugs.
Use. Adrenaline is available most commonly in two dilutions:
• 1 in 10,000 (10ml of this solution contains 1mg of adrenaline).
• 1 in 1000 (1ml of this solution contains 1mg of adrenaline).
Both these dilutions are used routinely in Europe.
Anti-arrhythmics
As with vasopressors, the evidence that anti-arrhythmic drugs
are of beneﬁt in cardiac arrest is limited. No anti-arrhythmic drug
given during human cardiac arrest has been shown to increase sur-
vival to hospital discharge, although amiodarone has been shown
to increase survival to hospital admission.285,286 Despite the lack
of human long-term outcome data, the balance of evidence is in
favour of the use anti-arrhythmic drugs for the management of
arrhythmias in cardiac arrest.Amiodarone
Amiodarone is a membrane-stabilising anti-arrhythmic drug
that increases the duration of the action potential and refrac-
tory period in atrial and ventricular myocardium. Atrioventricular
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onduction is slowed, and a similar effect is seen with accessory
athways. Amiodarone has a mild negative inotropic action and
auses peripheral vasodilation through non-competitive alpha-
locking effects. The hypotension that occurs with intravenous
miodarone is related to the rate of delivery and is due more
o the solvent (Polysorbate 80 and benzyl alcohol), which causes
istamine release, rather than the drug itself.445 The use of an
queous amiodarone preparation that is relatively free from these
ide effects has recently been approved for use in the United
tates.446,447
Following three initial shocks, amiodarone in shock-refractory
F improves the short-term outcome of survival to hospital admis-
ion compared with placebo285 or lidocaine.286 Amiodarone also
ppears to improve the response to deﬁbrillation when given to
umans or animalswithVF or haemodynamically unstable ventric-
lar tachycardia.446–450 There is no evidence to indicate the optimal
ime at which amiodarone should be given when using a single-
hock strategy. In the clinical studies to date, the amiodarone was
iven if VF/VT persisted after at least three shocks. For this rea-
on, and in the absence of any other data, amiodarone 300mg is
ecommended if VF/VT persists after three shocks.
Indications. Amiodarone is indicated in
refractory VF/VT;
haemodynamically stable ventricular tachycardia (VT) and other
resistant tachyarrhythmias (Section 4g).
Dose. Consider an initial intravenous dose of 300mg amio-
arone, diluted in 5% dextrose (or other suitable solvent) to a
olume of 20ml (or from a pre-ﬁlled syringe), if VF/VT persists
fter the third shock. Give a further dose of 150mg if VF/VT per-
ists. Amiodarone can cause thrombophlebitis when injected into
peripheral vein; use a central vein if a central venous catheter is in
itu but, if not, use a large peripheral vein or the IO route followed
y a generous ﬂush. Details about the use of amiodarone for the
reatment of other arrhythmias are given in Section 4g.
Clinical aspects of use. Amiodarone may paradoxically be
rrhythmogenic, especially if given concurrently with drugs that
rolong the QT interval. However, it has a lower incidence of
ro-arrhythmic effects than other anti-arrhythmic drugs under
imilar circumstances. The major acute adverse effects from amio-
arone are hypotension and bradycardia, which can be prevented
y slowing the rate of drug infusion, or can be treated with ﬂuids
nd/or inotropic drugs. The side effects associated with prolonged
ral use (abnormalities of thyroid function, corneal microdeposits,
eripheral neuropathy, and pulmonary/hepatic inﬁltrates) are not
elevant in the acute setting.
idocaine
Until the publication of the 2000 ILCOR guidelines, lidocaine
as the anti-arrhythmic drug of choice. Comparative studies with
miodarone286 have displaced it from this position, and lido-
aine is now recommended only when amiodarone is unavailable.
miodarone should be available at all hospital arrests and at all
ut-of-hospital arrests attended by emergency medical services.
Lidocaine is a membrane-stabilising anti-arrhythmic drug that
cts by increasing the myocyte refractory period. It decreases ven-
ricular automaticity, and its local anaesthetic action suppresses
entricular ectopic activity. Lidocaine suppresses activity of depo-
arised, arrhythmogenic tissues while interfering minimally with
he electrical activity of normal tissues. Therefore, it is effective
n suppressing arrhythmias associated with depolarisation (e.g.,
schaemia, digitalis toxicity) but is relatively ineffective againstn 81 (2010) 1305–1352
arrhythmias occurring in normally polarised cells (e.g., atrial ﬁb-
rillation/ﬂutter). Lidocaine raises the threshold for VF.
Lidocaine toxicity causes paraesthesia, drowsiness, confusion
andmuscular twitching progressing to convulsions. It is considered
generally that a safe dose of lidocaine must not exceed 3mgkg−1
over the ﬁrst hour. If there are signs of toxicity, stop the infu-
sion immediately; treat seizures if they occur. Lidocaine depresses
myocardial function, but to a much lesser extent than amiodarone.
The myocardial depression is usually transient and can be treated
with intravenous ﬂuids or vasopressors.
Indications. Lidocaine is indicated in refractory VF/VT (when
amiodarone is unavailable).
Dose. Whenamiodarone is unavailable, consider an initial dose
of 100mg (1–1.5mgkg−1) of lidocaine for VF/pulseless VT refrac-
tory to three shocks. Give an additional bolus of 50mg if necessary.
The total dose should not exceed 3mgkg−1 during the ﬁrst hour.
Clinical aspects of use. Lidocaine ismetabolised by the liver, and
its half-life is prolonged if the hepatic blood ﬂow is reduced, e.g.,
in the presence of reduced cardiac output, liver disease or in the
elderly. During cardiac arrest normal clearance mechanisms do not
function, thus high plasma concentrations may be achieved after a
single dose. After 24h of continuous infusion, the plasma half-life
increases signiﬁcantly. Reduce thedose in these circumstances, and
regularly review the indication for continued therapy. Lidocaine is
less effective in the presence of hypokalaemia and hypomagne-
saemia, which should be corrected immediately.
Magnesium
Magnesium is an important constituent of many enzyme sys-
tems, especially those involved with ATP generation in muscle.
It plays a major role in neurochemical transmission, where it
decreases acetylcholine release and reduces the sensitivity of the
motor endplate.Magnesiumalso improves the contractile response
of the stunned myocardium, and limits infarct size by a mechanism
that has yet to be fully elucidated.451 The normal plasma range of
magnesium is 0.8–1.0mmol l−1.
Hypomagnesaemia is often associated with hypokalaemia, and
may contribute to arrhythmias and cardiac arrest. Hypomag-
nesaemia increases myocardial digoxin uptake and decreases
cellular Na+/K+-ATP-ase activity. Patients with hypomagnesaemia,
hypokalaemia, or both may become cardiotoxic even with ther-
apeutic digitalis levels. Magnesium deﬁciency is not uncommon
in hospitalised patients and frequently coexists with other
electrolyte disturbances, particularly hypokalaemia, hypophos-
phataemia, hyponatraemia and hypocalcaemia.
Although the beneﬁts of givingmagnesium in known hypomag-
nesaemic states are recognised, the beneﬁt of giving magnesium
routinely during cardiac arrest is unproven. Studies in adults in and
out of hospital287–291,452 have failed to demonstrate any increase
in the rate of ROSC when magnesium is given routinely during CPR.
Indications. Magnesium sulphate is indicated in
• ventricular or supraventricular tachycardia associated with
hypomagnesaemia;
• torsades de pointes;Dose. Give an initial intravenous dose of 2 g (4ml (8mmol))
of 50% magnesium sulphate) peripherally over 1–2min; it may
be repeated after 10–15min. Preparations of magnesium sulphate
solutions differ among European countries.
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Clinical aspects of use. Hypokalaemic patients are often hypo-
agnesaemic. If ventricular tachyarrhythmias arise, intravenous
agnesium is a safe, effective treatment. The role of magnesium in
cutemyocardial infarction is still in doubt. Magnesium is excreted
y the kidneys, but side effects associatedwith hypermagnesaemia
re rare, even in renal failure. Magnesium inhibits smooth muscle
ontraction, causing vasodilation and a dose-related hypotension,
hich is usually transient and responds to intravenous ﬂuids and
asopressors.
ther drugs
There is no evidence that routinely giving other drugs (e.g.,
tropine, procainamide, bretylium, calcium and hormones) dur-
ng human cardiac arrest increases survival to hospital discharge.
ecommendations for the use of these drugs are based on limited
linical studies, our understanding of the drug’s pharmacodynamic
roperties and the pathophysiology of cardiac arrest.
tropine
Atropine antagonises the action of the parasympathetic neu-
otransmitter acetylcholine at muscarinic receptors. Therefore, it
locks the effect of the vagus nerve on both the sinoatrial (SA) node
nd the atrioventricular (AV) node, increasing sinus automaticity
nd facilitating AV node conduction.
Side effects of atropine are dose-related (blurred vision, dry
outh and urinary retention); they are not relevant during a
ardiac arrest. Acute confusional states may occur after intra-
enous injection, particularly in elderly patients. After cardiac
rrest, dilated pupils should not be attributed solely to atropine.
Asystole during cardiac arrest is usually due to primarymyocar-
ial pathology rather than excessive vagal tone and there is no
vidence that routine use of atropine is beneﬁcial in the treatment
f asystole or PEA. Several recent studieshave failed todemonstrate
ny beneﬁt from atropine in out-of-hospital or in-hospital cardiac
rrests244,453–458; and its routineuse for asystole or PEA is no longer
ecommended.
Atropine is indicated in:
sinus, atrial, or nodal bradycardia when the haemodynamic con-
dition of the patient is unstable (see Section 4g).
alcium
Calcium plays a vital role in the cellular mechanisms underlying
yocardial contraction. There is no data supporting any beneﬁ-
ial action for calcium after most cases of cardiac arrest453,459–463;
onversely, other studies have suggested a possible adverse effect
hen given routinely during cardiac arrest (all rhythms).464,465
igh plasma concentrations achieved after injection may be harm-
ul to the ischaemicmyocardiumandmay impair cerebral recovery.
ive calcium during resuscitation only when indicated speciﬁcally,
.e., in pulseless electrical activity caused by
hyperkalaemia;
hypocalcaemia;
overdose of calcium channel-blocking drugs.
The initial dose of 10ml 10% calcium chloride (6.8mmol Ca2+)
ay be repeated if necessary. Calcium can slow the heart rate and
recipitate arrhythmias. In cardiac arrest, calcium may be given
y rapid intravenous injection. In the presence of a spontaneous
irculation give it slowly. Do not give calcium solutions and sodium
icarbonate simultaneously by the same route.n 81 (2010) 1305–1352 1325
Buffers
Cardiac arrest results in combined respiratory and metabolic
acidosis because pulmonary gas exchange ceases and cellular
metabolism becomes anaerobic. The best treatment of acidaemia
in cardiac arrest is chest compression; some additional beneﬁt is
gained by ventilation. During cardiac arrest, arterial gas valuesmay
be misleading and bear little relationship to the tissue acid–base
state292; analysis of central venous blood may provide a better
estimation of tissue pH (see Section 4d). Bicarbonate causes gener-
ation of carbon dioxide, which diffuses rapidly into cells. It has the
following effects.
• It exacerbates intracellular acidosis.
• It produces a negative inotropic effect on ischaemicmyocardium.
• It presents a large, osmotically active, sodium load to an already
compromised circulation and brain.
• It produces a shift to the left in the oxygen dissociation curve,
further inhibiting release of oxygen to the tissues.
Mild acidaemia causes vasodilation and can increase cerebral
blood ﬂow. Therefore, full correction of the arterial blood pH may
theoretically reduce cerebral blood ﬂow at a particularly critical
time. As the bicarbonate ion is excreted as carbon dioxide via the
lungs, ventilation needs to be increased.
Several animal and clinical studies have examined the use of
buffers during cardiac arrest. Clinical studies using Tribonate®466
or sodium bicarbonate as buffers have failed to demonstrate
any advantage.466–472 Only two studies have found clinical
beneﬁt, suggesting that EMS systems using sodium bicarbon-
ate earlier and more frequently had signiﬁcantly higher ROSC
and hospital discharge rates and better long-term neurological
outcome.473,474 Animal studies have generally been inconclusive,
but some have shown beneﬁt in giving sodium bicarbonate to
treat cardiovascular toxicity (hypotension, cardiac arrhythmias)
caused by tricyclic antidepressants and other fast sodium channel
blockers (Section 8b).294,475 Giving sodium bicarbonate routinely
during cardiac arrest and CPR or after return of spontaneous
circulation is not recommended. Consider sodium bicarbonate
for
• life-threatening hyperkalaemia;
• cardiac arrest associated with hyperkalaemia;
• tricyclic overdose.
Give 50mmol (50ml of an 8.4% solution) of sodium bicarbon-
ate intravenously. Repeat the dose as necessary, but use acid/base
analysis (either arterial, central venous or marrow aspirate from
IO needle) to guide therapy. Severe tissue damage may be caused
by subcutaneous extravasation of concentrated sodium bicarbon-
ate. The solution is incompatible with calcium salts as it causes the
precipitation of calcium carbonate.
Fibrinolysis during CPR
Thrombus formation is a common cause of cardiac arrest,
most commonly due to acute myocardial ischaemia following
coronary artery occlusion by thrombus, but occasionally due to
a dislodged venous thrombus causing a pulmonary embolism.
The use of ﬁbrinolytic drugs to break down coronary artery
and pulmonary artery thrombus has been the subject of sev-
eral studies. Fibrinolytics have also been demonstrated in animal
studies to have beneﬁcial effects on cerebral blood ﬂow dur-
ing cardiopulmonary resuscitation,476,477 and a clinical study has
reported less anoxic encephalopathy after ﬁbrinolytic therapy dur-
ing CPR.478
Several studies have examined the use of ﬁbrinolytic ther-
apy given during non-traumatic cardiac arrest unresponsive to
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tandard therapy.307,479–484 and some have shown non-signiﬁcant
mprovements in survival to hospital discharge,307,481 and greater
CU survival.478 A small series of case reports also reported sur-
ival to discharge in three cases refractory to standard therapy
ith VF or PEA treated with ﬁbrinolytics.485 Conversely, two large
linical trials486,487 failed to show any signiﬁcant beneﬁt for ﬁb-
inolytics in out-of-hospital cardiac arrest unresponsive to initial
nterventions.
Results from the use of ﬁbrinolytics in patients suffering car-
iac arrest from suspected pulmonary embolus have been variable.
meta-analysis, which included patients with pulmonary embo-
us as a cause of the arrest, concluded that ﬁbrinolytics increased
he rate of ROSC, survival to discharge and long-term neuro-
ogical function.488 Several other studies have demonstrated an
mprovement in ROSC and admission to hospital or the inten-
ive care unit, but not in survival to neurologically intact hospital
ischarge.307,479–481,483,484,489–492
Although several relatively small clinical studies307,479,481,490
nd case series478,485,493–495 have not demonstrated any increase
n bleeding complications with thrombolysis during CPR in
on-traumatic cardiac arrest, a recent large study487 and
eta-analysis488 have shown an increased risk of intracranial
leeding associated with the routine use of ﬁbrinolytics dur-
ng non-traumatic cardiac arrest. Successful ﬁbrinolysis during
ardiopulmonary resuscitation isusually associatedwithgoodneu-
ological outcome.488,490,491
Fibrinolytic therapy should not be used routinely in cardiac
rrest. Consider ﬁbrinolytic therapy when cardiac arrest is caused
y proven or suspected acute pulmonary embolus. Following ﬁb-
inolysis during CPR for acute pulmonary embolism, survival and
ood neurological outcome have been reported in cases requiring
n excess of 60min of CPR. If a ﬁbrinolytic drug is given in these
ircumstances, consider performing CPR for at least 60–90min
efore termination of resuscitation attempts.496,497 Mortality from
urgical embolectomy is high if it follows cardiac arrest and
hould be avoided in patients requiring CPR. In patients who are
ot candidates for ﬁbrinolytic therapy, percutaneous mechanical
hromboembolectomy should be considered. Ongoing CPR is not a
ontraindication to ﬁbrinolysis.
ntravenous ﬂuids
Hypovolaemia is a potentially reversible cause of cardiac arrest.
nfuse ﬂuids rapidly if hypovolaemia is suspected. In the initial
tages of resuscitation there are no clear advantages to using col-
oid, so use 0.9% sodium chloride or Hartmann’s solution. Avoid
extrose, which is redistributed away from the intravascular space
apidly and causes hyperglycaemia, which may worsen neurologi-
al outcome after cardiac arrest.498–505
Whether ﬂuids should be infused routinely during cardiac arrest
s controversial. There are no published human studies of rou-
ine ﬂuid use compared to no ﬂuids during normovolaemic cardiac
rrest. Two animal studies506,507 show that the increase in right
trial pressure produced by infusion of normothermic ﬂuid dur-
ng CPR decreases coronary perfusion pressure, and another animal
tudy508 shows that the coronary perfusion pressure rise with
drenaline during CPR is not improved with the addition of a ﬂuid
nfusion.
Small clinical studies have not shown any beneﬁt with hyper-
onic ﬂuid509 or chilled ﬂuid.510,511 One animal study shows that
ypertonic saline improves cerebral blood ﬂow during CPR.512
nsure normovolaemia, but in the absence of hypovolaemia, infu-
ion of an excessive volume of ﬂuid is likely to be harmful.513 Use
ntravenous ﬂuid to ﬂush peripherally injected drugs into the cen-
ral circulation.n 81 (2010) 1305–1352
Alternative routes for drug delivery
Intraosseous route
If intravenous access cannot be establishedwithin theﬁrst 2min
of resuscitation, consider gaining IO access. Intraosseous access has
traditionally been used for children because of the difﬁculties in
gaining intravenous access, but this route has now become estab-
lished as a safe and effective route for gaining vascular access in
adults too.271,514–517 Tibial and humeral sites are readily accessible
and provide equal ﬂow rates for ﬂuids.514 Intraosseous delivery of
resuscitation drugs will achieve adequate plasma concentrations.
Several studies indicate that IO access is safe and effective for ﬂuid
resuscitation and drug delivery.269,518–524
Drugs given via the tracheal tube
Resuscitation drugs can also be given via the tracheal tube, but
the plasma concentrations achieved using this route are very vari-
able although generally considerably lower than those achieved by
the IV or IO routes, particularly with adrenaline. Additionally, rel-
atively large volumes of intratracheal ﬂuid impair gas exchange.
With the ease of gaining IO access and the lack of efﬁcacy of tra-
cheal drug administration, tracheal administration of drugs is no
longer recommended
CPR techniques and devices
At best, standard manual CPR produces coronary and cerebral
perfusion that is just 30% of normal.525 Several CPR techniques
and devices may improve haemodynamics or short-term survival
when used by well-trained providers in selected cases. However,
the success of any technique or device depends on the education
and training of the rescuers and on resources (including personnel).
In the hands of some groups, novel techniques and adjuncts may
be better than standard CPR. However, a device or technique which
provides good quality CPR when used by a highly trained team or
in a test setting may show poor quality and frequent interruptions
when used in an uncontrolled clinical setting.526 While no circula-
tory adjunct is currently recommended for routine use instead of
manual CPR, some circulatory adjuncts are being routinely used in
bothout-of-hospital and in-hospital resuscitation. It is prudent that
rescuers are well-trained and that if a circulatory adjunct is used, a
program of continuous surveillance be in place to ensure that use
of the adjunct does not adversely affect survival. Although man-
ual chest compressions are often performed very poorly,527–529 no
adjunct has consistently been shown to be superior to conventional
manual CPR.
Open-chest CPR
Open-chest CPR produces better coronary perfusion coronary
pressure than standard CPR530 and may be indicated for patients
with cardiac arrest caused by trauma, in the early postopera-
tive phase after cardiothoracic surgery531,532 (see Section 8i)294 or
when the chest or abdomen is already open (transdiaphragmatic
approach), for example, in trauma surgery.
Interposed abdominal compression (IAC-CPR)The IAC-CPR technique involves compression of the abdomen
during the relaxation phase of chest compression.533,534 This
enhances venous return during CPR535,536 and improves ROSC and
short-term survival.537,538 Two studies showed improved survival
to hospital discharge with IAC-CPR compared with standard CPR
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or in-hospital cardiac arrest,537,538 but another showedno survival
dvantage.539
ctive compression-decompression CPR (ACD-CPR)
ACD-CPR is achieved with a hand-held device equipped with a
uction cup to lift the anterior chest actively during decompression.
ecreasing intrathoracic pressure during the decompression phase
ncreases venous return to the heart and increases cardiac output
nd subsequent coronary and cerebral perfusion pressures dur-
ng the compression phase.540–543 Results of ACD-CPR have been
ixed. In someclinical studiesACD-CPR improvedhaemodynamics
ompared with standard CPR,541,543–545 but in another study it did
ot.546 In three randomised studies,545,547,548 ACD-CPR improved
ong-term survival after out-of-hospital cardiac arrest; however,
n ﬁve other randomised studies, ACD-CPR made no difference to
utcome.549–553 The efﬁcacy of ACD-CPR may be highly dependent
n the quality and duration of training.554
A meta-analysis of 10 trials of out-of-hospital cardiac arrest and
wo of in-hospital cardiac arrest showed no early or late survival
eneﬁt to ACD-CPR over conventional CPR.205 Two post-mortem
tudies have shown more rib and sternal fractures after ACD-
PR compared with conventional CPR,555,556 but another found no
ifference.557
mpedance threshold device (ITD)
The impedance threshold device (ITD) is a valve that lim-
ts air entry into the lungs during chest recoil between chest
ompressions; this decreases intrathoracic pressure and increases
enous return to the heart. When used with a cuffed tracheal tube
nd active compression–decompression (ACD),558–560 the ITD is
hought to act synergistically to enhance venous return during
ctive decompression. The ITD has also been used during conven-
ional CPR with a tracheal tube or facemask.561 If rescuers can
aintain a tight face-mask seal, the ITD may create the same neg-
tive intrathoracic pressure as when used with a tracheal tube.561
Most,562–569 but not all,570–573 animal studies have shown
mproved haemodynamics or outcomes during CPRwhenusing the
evice. Several randomised trials have showndiffering results. Two
rials suggest that the use of an ITD in combination with ACD-CPR
mproves 24h survival and survival to ICU admission in adult OHCA
atients,560,574 but these contrast with others which failed to show
ny improvement in ROSC or 24h survival.558,561 A recent meta-
nalysis demonstrated improved ROSC and short-term survival but
o signiﬁcant improvement in either survival to discharge or neu-
ologically intact survival to discharge associatedwith the use of an
TD in themanagement of adult OHCApatients.575 In the absence of
ata showing that the ITD increases survival to hospital discharge,
ts routine use in cardiac arrest is not recommended.
echanical piston CPR
Mechanical piston devices depress the sternum by means of
compressed gas-powered plunger mounted on a backboard. In
everal studies in animals,576 mechanical piston CPR improved
nd-tidal carbon dioxide, cardiac output, cerebral blood ﬂow, MAP
nd short-term neurological outcome. Studies in humans also doc-
ment improvement in end-tidal carbon dioxide and mean arterial
ressure when using mechanical piston CPR compared with con-
entional CPR.577–579 One study has documented that the use of a
iston CPR device compared with manual CPR increases interrup-
ion inCPRdue to settingupandremovalof thedevice frompatients
uring transportation in out-of-hospital adult cardiac arrest.580n 81 (2010) 1305–1352 1327
Lund University cardiac arrest system (LUCAS) CPR
The Lund University cardiac arrest system (LUCAS) is a gas-
driven sternal compression device that incorporates a suction cup
for active decompression. Although animal studies showed that
LUCAS-CPR improveshaemodynamicandshort-termsurvival com-
paredwith standardCPR.581,582 There are nopublished randomised
human studies comparing LUCAS-CPR with standard CPR. A study
using LUCAS for witnessed OHCA was unable to show any ben-
eﬁt (ROSC, survival to hospital or survival to hospital discharge)
over standard CPR.583 Case series totalling 200 patients have
reported variable success in use of the LUCAS device, when imple-
mented after an unsuccessful period of manual CPR.347,581,584–586
One case series used LUCAS to perform CPR while PCI was being
performed.293 Eleven of 43 patients survived to hospital discharge
neurologically intact. There are several other reports documenting
use of LUCAS during PCI.585,587,588 One post-mortem study showed
similar injuries with LUCAS compared with standard CPR.589 The
early versions of the LUCAS device which were driven by high ﬂow
oxygen (LUCASTM1) should not be used in conﬁned spaces where
deﬁbrillation in high ambient oxygen concentrations may risk a
ﬁre.590
Load-distributing band CPR (AutoPulse)
The load-distributing band (LDB) is a circumferential chest com-
pression device comprising a pneumatically actuated constricting
band and backboard. Although the use of LDB CPR improves
haemodynamics,591–593 results of clinical trials have been con-
ﬂicting. Evidence from one multicenter randomised control trial
in over 1000 adults documented no improvement in 4-h sur-
vival and worse neurological outcome when LDB-CPR was used
by EMS providers for patients with primary out-of-hospital car-
diac arrest.594 However, a post hoc analysis of this study revealed
signiﬁcant heterogeneity between study sites.598 A further study
demonstrated lower odds of 30-day survival (OR 0.4) but subgroup
analysis showed an increased rate of ROSC in LDB-CPR treated
patients.595 Other non-randomised human studies have reported
increased rates of sustained ROSC,596,597 increased survival to dis-
charge following OHCA597 and improved hemodynamics following
failed resuscitation from in-hospital cardiac arrest.591 Evidence
frombothclinical594,598 andsimulation599 studies suggest that site-
speciﬁc factors may inﬂuence resuscitation quality and efﬁcacy of
this device.
The current status of LUCAS and AutoPulse
Two large prospective randomised multicentre studies are cur-
rentlyunderway toevaluate the load-distributingband (AutoPulse)
and the Lund University cardiac arrest system (LUCAS). The
results of these studies are awaited with interest. In hospi-
tal, mechanical devices have been used effectively to support
patients undergoing primary coronary intervention (PCI)293,585
and CT scans600 and also for prolonged resuscitation attempts
(e.g., hypothermia,601,602 poisoning, thrombolysis for pulmonary
embolism, prolonged transport, etc.) where rescuer fatigue may
impair the effectiveness of manual chest compression. In the pre-
hospital environment where extrication of patients, resuscitation
in conﬁned spaces and movement of patients on a trolley often
preclude effective manual chest compressions, mechanical devices
may also have an important role. During transport to hospital,man-
ual CPR is often performed poorly; mechanical CPR can maintain
good quality CPR during an ambulance transfer.343,603 Mechanical
devices also have the advantage of allowing deﬁbrillation without
interruption in external chest compression. The role of mechanical
devices in all situations requires further evaluation.
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g Peri-arrest arrhythmias
The correct identiﬁcation and treatment of arrhythmias in the
ritically ill patient may prevent cardiac arrest from occurring or
rom reoccurring after successful initial resuscitation. The treat-
ent algorithms described in this section have been designed to
nable the non-specialist ALS provider to treat the patient effec-
ively and safely in an emergency; for this reason, they have been
ept as simple as possible. If patients are not acutely ill there may
e several other treatment options, including the use of drugs (oral
r parenteral) thatwill be less familiar to the non-expert. In this sit-
ation there will be time to seek advice from cardiologists or other
enior doctors with the appropriate expertise.
More comprehensive information on the management of
rrhythmias can be found at www.escardio.org.
rinciples of treatment
The initial assessment and treatment of a patient with an
rrhythmia should follow the ABCDE approach. Key elements in
his process include assessing for adverse signs; administration of
igh ﬂow oxygen; obtaining intravenous access, and establishing
onitoring (ECG, bloodpressure, SpO2).Whenever possible, record
12-lead ECG; this will help determine the precise rhythm, either
efore treatment or retrospectively. Correct any electrolyte abnor-
alities (e.g., K+, Mg2+, Ca2+). Consider the cause and context of
rrhythmias when planning treatment.
The assessment and treatment of all arrhythmias addresses two
actors: the condition of the patient (stable versus unstable), and
he nature of the arrhythmia. Anti-arrhythmic drugs are slower in
nset and less reliable than electrical cardioversion in converting a
achycardia to sinus rhythm; thus, drugs tend tobe reserved for sta-
le patients without adverse signs, and electrical cardioversion is
sually the preferred treatment for the unstable patient displaying
dverse signs.
dverse signs
The presence or absence of adverse signs or symptoms will dic-
ate the appropriate treatment formost arrhythmias. The following
dverse factors indicate a patient who is unstable because of the
rrhythmia.
. Shock—this is seen as pallor, sweating, cold and clammy extrem-
ities (increased sympathetic activity), impaired consciousness
(reduced cerebral blood ﬂow), and hypotension (e.g., systolic
blood pressure <90mmHg).
. Syncope—loss of consciousness, which occurs as a consequence
of reduced cerebral blood ﬂow.
. Heart failure—arrhythmias compromise myocardial perfor-
mance by reducing coronary artery blood ﬂow. In acute
situations this ismanifestedbypulmonaryoedema (failureof the
left ventricle) and/or raised jugular venous pressure, and hepatic
engorgement (failure of the right ventricle).
. Myocardial ischaemia—this occurs when myocardial oxygen
consumption exceeds delivery. Myocardial ischaemia may
present with chest pain (angina) or may occur without pain as
an isolated ﬁnding on the 12 lead ECG (silent ischaemia). The
presence ofmyocardial ischaemia is especially important if there
is underlying coronary artery disease or structural heart dis-
ease because itmay cause further life-threatening complications
including cardiac arrest.n 81 (2010) 1305–1352
Treatment options
Having determined the rhythm and the presence or absence of
adverse signs, the options for immediate treatment are categorised
as:
1. Electrical (cardioversion, pacing).
2. Pharmacological (anti-arrhythmic (and other) drugs).
Tachycardias
If the patient is unstable
If the patient is unstable and deteriorating, with any of the
adverse signs and symptoms described above being caused by
the tachycardia, attempt synchronised cardioversion immediately
(Fig. 4.11). In patients with otherwise normal hearts, serious
signs and symptoms are uncommon if the ventricular rate is
<150beatsmin−1. Patients with impaired cardiac function or sig-
niﬁcant comorbidity may be symptomatic and unstable at lower
heart rates. If cardioversion fails to restore sinus rhythm and the
patient remains unstable, give amiodarone 300mg intravenously
over 10–20min and re-attempt electrical cardioversion. The load-
ing dose of amiodarone can be followed by an infusion of 900mg
over 24h.
Repeated attempts at electrical cardioversion are not appro-
priate for recurrent (within hours or days) paroxysms (self-
terminating episodes) of atrial ﬁbrillation. This is relatively
common in critically ill patients who may have ongoing precipi-
tating factors causing the arrhythmia (e.g., metabolic disturbance,
sepsis). Cardioversion does not prevent subsequent arrhythmias. If
there are recurrent episodes, treat them with drugs.
Synchronised electrical cardioversion
If electrical cardioversion is used to convert atrial or ventricu-
lar tachyarrhythmias, the shock must be synchronised with the R
waveof the ECG rather thanwith the Twave.604 By avoiding the rel-
ative refractory period in this way, the risk of inducing ventricular
ﬁbrillation is minimised. Conscious patients must be anaesthetised
or sedated before synchronised cardioversion is attempted. For a
broad-complex tachycardia and AF, start with 200-J monophasic
or 120–150 J biphasic and increase in increments if this fails (see
Section 3).223 Atrial ﬂutter and paroxysmal supraventricular tachy-
cardia (SVT)will often convertwith lower energies: startwith100-J
monophasic or 70–120-J biphasic.
If the patient is stable
If the patient with tachycardia is stable (no adverse signs or
symptoms) and is not deteriorating, pharmacological treatment
may be possible. Evaluate the rhythm using a 12-lead ECG and
assess the QRS duration. If the QRS duration is greater than 0.12 s
(3 small squares on standard ECG paper) it is classiﬁed as a broad
complex tachycardia. If the QRS duration is less than 0.12 s it is a
narrow complex tachycardia.
All anti-arrhythmic treatments –physicalmanoeuvres, drugs, or
electrical treatment – can also be pro-arrhythmic, so that clinical
deterioration may be caused by the treatment rather than lack of
effect. The use of multiple anti-arrhythmic drugs or high doses of
a single drug can cause myocardial depression and hypotension.
This may cause a deterioration of the cardiac rhythm. Expert help
should be sought before using repeated doses or combinations of
anti-arrhythmic drugs.
C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1329
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road-complex tachycardia
Broad-complex tachycardias are usually ventricular in origin.605
lthough broad-complex tachycardiasmay be caused by supraven-
ricular rhythms with aberrant conduction, in the unstable patient
n the peri-arrest context assume they are ventricular in origin. In
he stable patient with broad-complex tachycardia, the next step
s to determine if the rhythm is regular or irregular.
egular broad complex tachycardia
A regular broad-complex tachycardia is likely to be ventricular
achycardia or SVTwith bundle branch block. If there is uncertainty
bout the source of the arrhythmia, give intravenous adenosine
using the strategy described below) as it may convert the rhythm
o sinus and help diagnose the underlying rhythm.606
Stable ventricular tachycardia can be treated with amiodarone
00mg intravenously over 20–60min followed by an infusion of
00mg over 24h. Specialist advice should be sought before con-
idering alternatives treatments such as procainamide, nifekalant
r sotalol.
rregular broad complex tachycardia
Irregular broad complex tachycardia is most likely to be AF with
undle branch block. Another possible cause is AF with ventric-
lar pre-excitation (Wolff–Parkinson–White (WPW) syndrome).
here is more variation in the appearance and width of the QRS
omplexes than in AF with bundle branch block. A third possi-
le cause is polymorphic VT (e.g., torsades de pointes), although
his rhythm is relatively unlikely to be present without adverse
eatures.
Seek expert help with the assessment and treatment of irreg-
lar broad-complex tachyarrhythmia. If treating AF with bundle
ranch block, treat as for AF (see below). If pre-excited AF (or
trial ﬂutter) is suspected, avoid adenosine, digoxin, verapamil
nd diltiazem. These drugs block the AV node and cause a
elative increase in pre-excitation—this can provoke severe tachy-
ardias. Electrical cardioversion is usually the safest treatment
ption.
Treat torsades de pointes VT immediately by stopping all drugs
nown to prolong the QT interval. Correct electrolyte abnor-
alities, especially hypokalaemia. Give magnesium sulphate, 2 g,
ntravenously over 10min.607,608 Obtain expert help, as other treat-
ent (e.g., overdrive pacing) may be indicated to prevent relapse
nce the arrhythmiahas been corrected. If adverse features develop
which is usual), arrange immediate synchronised cardioversion. If
he patient becomes pulseless, attempt deﬁbrillation immediately
cardiac arrest algorithm).
arrow-complex tachycardia
Theﬁrst step in the assessment of a narrowcomplex tachycardia
s to determine if it is regular or irregular.
The commonest regular narrow-complex tachycardias include:
sinus tachycardia;
AV nodal re-entry tachycardia (AVNRT, the commonest type of
SVT);
AV re-entry tachycardia (AVRT), which is associated with
Wolff–Parkinson–White (WPW) syndrome;
atrial ﬂutter with regular AV conduction (usually 2:1).
Irregular narrow-complex tachycardia is most commonly AF
r sometimes atrial ﬂutter with variable AV conduction (‘variable
lock’).n 81 (2010) 1305–1352
Regular narrow-complex tachycardia
Sinus tachycardia. Sinus tachycardia is a commonphysiological
response to a stimulus such as exercise or anxiety. In a sick patient
it may be seen in response to many stimuli, such as pain, fever,
anaemia, blood loss and heart failure. Treatment is almost always
directed at the underlying cause; trying to slow sinus tachycardia
will make the situation worse.
AVNRT and AVRT (paroxysmal SVT). AVNRT is the common-
est type of paroxysmal SVT, often seen in people without any
other form of heart disease and is relatively uncommon in a peri-
arrest setting.609 It causes a regular narrow-complex tachycardia,
often with no clearly visible atrial activity on the ECG. Heart rates
are usually well above the typical range of sinus rates at rest
(60–120beatsmin−1). It is usually benign, unless there is additional
co-incidental structural heart disease or coronary disease.
AV re-entry tachycardia (AVRT) is seen in patients with the
WPW syndrome and is also usually benign unless there happens to
be additional structural heart disease. The common type of AVRT is
a regular narrow-complex tachycardia, also often having no visible
atrial activity on the ECG.
Atrial ﬂutter with regular AV conduction (often 2:1 block). Atrial
ﬂutter with regular AV conduction (often 2:1 block) produces a
regular narrow-complex tachycardia in which it may be difﬁcult
to see atrial activity and identify ﬂutter waves with conﬁdence, so
it may be indistinguishable initially from AVNRT and AVRT. When
atrial ﬂutter with 2:1 block or even 1:1 conduction is accompa-
nied by bundle branch block, it produces a regular broad-complex
tachycardia thatwill usually beverydifﬁcult todistinguish fromVT.
Treatment of this rhythm as if it were VT will usually be effective,
or will lead to slowing of the ventricular response and identiﬁca-
tion of the rhythm. Most typical atrial ﬂutter has an atrial rate of
about 300beatsmin−1, so atrial ﬂutter with 2:1 block tends to pro-
duce a tachycardia of about 150beatsmin−1. Much faster rates are
unlikely to be due to atrial ﬂutter with 2:1 block.
Treatment of regular narrow complex tachycardia. If the patient
is unstable with adverse features caused by the arrhythmia,
attempt synchronised electrical cardioversion. It is reasonable to
give adenosine to an unstable patient with a regular narrow-
complex tachycardiawhile preparations aremade for synchronised
cardioversion; however, do not delay electrical cardioversion if the
adenosine fails to restore sinus rhythm. In the absence of adverse
features, proceed as follows.
• Start with vagal manoeuvres609: carotid sinus massage or the
Valsalva manoeuvre will terminate up to a quarter of episodes
of paroxysmal SVT. Carotid sinus massage stimulates barorecep-
tors, which increase vagal tone and reduces sympathetic drive,
which slows conduction via the AV node. Carotid sinus mas-
sage is given by applying pressure over the carotid artery at the
level of the cricoid cartilage. Massage the area with ﬁrm cir-
cular movements for about 5 s. If this does not terminate the
arrhythmia, repeat on the opposite side. Avoid carotid massage
if a carotid bruit is present: rupture of an atheromatous plaque
could cause cerebral embolism and stroke. A Valsalvamanoeuvre
(forced expiration against a closed glottis) in the supine positionthis without protracted explanation is to ask the patient to blow
into a 20ml syringe with enough force to push back the plunger.
Record an ECG (preferably multi-lead) during each manoeuvre.
If the rhythm is atrial ﬂutter, slowing of the ventricular response
will often occur and demonstrate ﬂutter waves.
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If the arrhythmia persists and is not atrial ﬂutter, use adeno-
sine. Give 6mg as a rapid intravenous bolus. Record an ECG
(preferably multi-lead) during each injection. If the ventricular
rate slows transiently but the arrhythmia then persists, look for
atrial activity such as atrial ﬂutter or other atrial tachycardia and
treat accordingly. If there is no response to adenosine 6mg, give
a 12mg bolus; if there is no response, give one further 12mg-
bolus. This strategy will terminate 90–95% of supraventricular
arrhythmias.610
Successful termination of a tachyarrhythmia by vagal manoeu-
vres or adenosine indicates that it was almost certainly AVNRT
or AVRT. Monitor the patients for further rhythm abnormali-
ties. Treat recurrence either with further adenosine or with a
longer-acting drug with AV nodal-blocking action (e.g., diltiazem
or verapamil).
If adenosine is contraindicated or fails to terminate a
regular narrow-complex tachycardia without demon-
strating that it is atrial ﬂutter, give a calcium channel blocker
(e.g., verapamil or diltiazem).
rregular narrow-complex tachycardia
An irregular narrow-complex tachycardia ismost likely to be AF
ith an uncontrolled ventricular response or, less commonly, atrial
utter with variable AV block. Record a 12-lead ECG to identify
he rhythm. If the patient is unstable with adverse features caused
y the arrhythmia, attempt synchronised electrical cardioversion
s described above. The European Society of Cardiology provides
etailed guidelines on the management of AF.611
If there are no adverse features, treatment options include:
rate control by drug therapy;
rhythmcontrol usingdrugs to encourage chemical cardioversion;
rhythm control by electrical cardioversion;
treatment to prevent complications (e.g., anticoagulation).
Obtainexperthelp todetermine themost appropriate treatment
or the individual patient. The longer a patient remains in AF, the
reater is the likelihoodof atrial clotdeveloping. Ingeneral, patients
ho have been in AF for more than 48h should not be treated by
ardioversion (electrical or chemical) until they have received full
nticoagulationor absenceof atrial clot has been shownby transoe-
ophageal echocardiography. If the clinical scenario dictates that
ardioversion is required and the duration of AF is greater than
8h (or the duration is unknown) give an initial intravenous bolus
njection of heparin followed by a continuous infusion to maintain
he activated partial thromboplastin time at 1.5–2 times the refer-
nce control value. Anticoagulation should be continued for at least
weeks thereafter.611
If the aim is to control heart rate, the drugs of choice are beta-
lockers612,613 and diltiazem.614,615 Digoxin and amiodarone may
e used in patients with heart failure. Magnesium has also been
sed although the data supporting this is more limited.616,617
If the duration of AF is less than 48h and rhythm control is
onsidered appropriate, chemical cardioversionmay be attempted.
eek expert help and consider ibutilide, ﬂecainide or dofetilide.
miodarone (300mg intravenously over 20–60min followed by
00mg over 24h) may also be used but is less effective. Elec-
rical cardioversion remains an option in this setting and will
estore sinus rhythm in more patients than chemical cardiover-
ion.Seek expert help if anypatientwithAF is knownor found tohave
entricular pre-excitation (WPW syndrome). Avoid using adeno-
ine, diltiazem, verapamil or digoxin in patients with pre-excited
F or atrial ﬂutter, as these drugs block the AV node and cause a
elative increase in pre-excitation.n 81 (2010) 1305–1352 1331
Bradycardia
A bradycardia is deﬁned as a heart rate of <60beatsmin−1.
Bradycardia can have cardiac causes (e.g., myocardial infarction;
myocardial ischaemia; sick sinus syndrome), non-cardiac causes
(e.g., vasovagal response, hypothermia; hypoglycaemia; hypothy-
roidism, raised intracranial pressure) or be caused by drug toxicity
(e.g., digoxin; beta-blockers; calcium channel blockers).
Bradycardias are caused by reduced sinoatrial node ﬁring or
failure of the atrial-ventricular conduction system. Reduced sinoa-
trial node ﬁring is seen in sinus bradycardia (caused by excess
vagal tone), sinus arrest, and sick sinus syndrome. Atrioventricu-
lar (AV) blocks are divided into ﬁrst, second, and third degrees and
may be associated with multiple medications or electrolyte distur-
bances, as well as structural problems caused by acute myocardial
infarction and myocarditis. A ﬁrst-degree AV block is deﬁned by
a prolonged P–R interval (>0.20 s), and is usually benign. Second-
degree AV block is divided into Mobitz types I and II. In Mobitz
type I, the block is at the AV node, is often transient and may be
asymptomatic. In Mobitz type II, the block is most often below the
AV node at the bundle of His or at the bundle branches, and is often
symptomatic, with the potential to progress to complete AV block.
Third-degree heart block is deﬁned by AV dissociation, which may
be permanent or transient, depending on the underlying cause.
Initial assessment
Assess the patient with bradycardia using the ABCDE approach.
Consider the potential cause of the bradycardia and look for the
adverse signs. Treat any reversible causes of bradycardia identiﬁed
in the initial assessment. If adverse signs are present start to treat
the bradycardia. Initial treatments are pharmacological, with pac-
ing being reserved for patients unresponsive to pharmacological
treatments or with risks factors for asystole (Fig. 4.12).
Pharmacological treatment
If adverse signs are present, give atropine, 500g, intravenously
and, if necessary, repeat every 3–5min to a total of 3mg. Doses
of atropine of less than 500g, paradoxically, may cause fur-
ther slowing of the heart rate.618 In healthy volunteers a dose of
3mg produces the maximum achievable increase in resting heart
rate.619 Use atropine cautiously in the presence of acute coro-
nary ischaemia or myocardial infarction; increased heart rate may
worsen ischaemia or increase the zone of infarction
If treatment with atropine is ineffective, consider second
line drugs. These include isoprenaline (5gmin−1 starting dose),
adrenaline (2–10gmin−1) and dopamine (2–10gkg−1 min−1).
Theophylline (100–200mg slow intravenous injection) should be
considered if the bradycardia is caused by inferior myocardial
infarction, cardiac transplant or spinal cord injury. Consider giving
intravenous glucagon if beta-blockers or calcium channel blockers
are a potential cause of the bradycardia. Do not give atropine to
patients with cardiac transplants—it can cause a high-degree AV
block or even sinus arrest.620
Pacing
Initiate transcutaneous pacing immediately if there is no
response to atropine, or if atropine is unlikely to be effective.
Transcutaneous pacing can be painful and may fail to pro-
duce effective mechanical capture. Verify mechanical capture and
reassess the patient’s condition. Use analgesia and sedation to con-
trol pain, and attempt to identify the cause of the bradyarrhythmia.
If atropine is ineffective and transcutaneous pacing is not imme-
diately available, ﬁst pacing can be attempted while waiting for
1332 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
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acing equipment621–623: Give serial rhythmic blows with the
losed ﬁst over the left lower edge of the sternum to pace the heart
t a physiological rate of 50–70beatsmin−1.
Seek expert help to assess the need for temporary transve-
ous pacing. Temporary transvenous pacing should be considered
f there are is a history of recent asystole; Möbitz type II AV block;
omplete (third-degree) heart block (especially with broad QRS or
nitial heart rate <40beatsmin−1) or evidence of ventricular stand-
till of more than 3 s.
nti-arrhythmic drugsdenosine
Adenosine is a naturally occurring purine nucleotide. It slows
ransmission across the AV node but has little effect on other
yocardial cells or conduction pathways. It is highly effective forrithm. © 2010 ERC.
terminating paroxysmal SVT with re-entrant circuits that include
the AV node (AVNRT). In other narrow-complex tachycardias,
adenosine will reveal the underlying atrial rhythms by slowing the
ventricular response. It has an extremely short half-life of 10–15 s
and, therefore, is given as a rapid bolus into a fast running intra-
venous infusion or followed by a saline ﬂush. The smallest dose
likely to be effective is 6mg (which is outside some current licences
for an initial dose) and, if unsuccessful this can be followed with
up to two doses each of 12mg every 1–2min. Patients should be
warned of transient unpleasant side effects, in particular nausea,
ﬂushing, and chest discomfort.624 Adenosine is not available in
some European countries, but adenosine triphosphate (ATP) is an
alternative. In a few European countries neither preparation may
be available; verapamil is probably the next best choice. Theo-
phylline and related compounds block the effect of adenosine.
Patients receiving dipyridamole or carbamazepine, or with dener-
vated (transplanted) hearts, display a markedly exaggerated effect
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hatmay be hazardous. In these patients, or if injected into a central
ein, reduce the initial dose of adenosine to 3mg. In the presence
f WPW syndrome, blockage of conduction across the AV node by
denosine may promote conduction across an accessory pathway.
n the presence of supraventricular arrhythmias this may cause a
angerously rapid ventricular response. In the presence of WPW
yndrome, rarely, adenosinemayprecipitate atrial ﬁbrillation asso-
iated with a dangerously rapid ventricular response.
miodarone
Intravenous amiodarone has effects on sodium, potassium and
alcium channels as well as alpha- and beta-adrenergic blocking
roperties. Indications for intravenous amiodarone include:
control of haemodynamically stable monomorphic VT, polymor-
phic VT and wide-complex tachycardia of uncertain origin;
paroxysmal SVT uncontrolled by adenosine, vagalmanoeuvres or
AV nodal blockade;
to control rapid ventricular rate due to accessory pathway con-
duction in pre-excited atrial arrhythmias;
unsuccessful electrical cardioversion.
Give amiodarone, 300mg intravenously, over 10–60min
epending on the circumstances and haemodynamic stability of
he patient. This loading dose is followed by an infusion of 900mg
ver 24h. Additional infusions of 150mg can be repeated as
ecessary for recurrent or resistant arrhythmias to a maximum
anufacturer-recommended total daily dose of 2 g (this maxi-
um licensed dose varies between different countries). In patients
ith severely impaired heart function, intravenous amiodarone is
referable to other anti-arrhythmic drugs for atrial and ventricular
rrhythmias. Major adverse effects from amiodarone are hypoten-
ion and bradycardia, which can be prevented by slowing the rate
f drug infusion. The hypotension associated with amiodarone is
aused by vasoactive solvents (Polysorbate 80 and benzyl alcohol).
new aqueous formulation of amiodarone does not contain these
olvents and causes nomore hypotension than lidocaine.446 When-
ver possible, intravenous amiodarone should be given via a central
enous catheter; it causes thrombophlebitis when infused into a
eripheral vein. In an emergency it can be injected into a large
eripheral vein.
alcium channel blockers: verapamil and diltiazem
Verapamil and diltiazem are calcium channel blocking drugs
hat slow conduction and increase refractoriness in the AV node.
ntravenous diltiazem is not available in some countries. These
ctions may terminate re-entrant arrhythmias and control ventric-
lar response rate in patients with a variety of atrial tachycardias.
ndications include:
stable regular narrow-complex tachycardias uncontrolled or
unconverted by adenosine or vagal manoeuvres;
to control ventricular rate in patients with AF or atrial ﬂutter and
preserved ventricular function when the duration of the arrhyth-
mia is less than 48h.
The initial dose of verapamil is 2.5–5mg intravenously given
ver 2min. In the absence of a therapeutic response or drug-
nduced adverse event, give repeated doses of 5–10mg every
5–30min to amaximumof 20mg. Verapamil should be given only
o patients with narrow-complex paroxysmal SVT or arrhythmias
nown with certainty to be of supraventricular origin. The admin-
stration of calcium channel blockers to a patient with ventricular
achycardia may cause cardiovascular collapse.n 81 (2010) 1305–1352 1333
Diltiazem at a dose of 250gkg−1, followed by a second dose of
350gkg−1, is as effective as verapamil. Verapamil and, to a lesser
extent, diltiazem may decrease myocardial contractility and criti-
cally reduce cardiac output in patients with severe LV dysfunction.
For the reasons stated under adenosine (above), calcium channel
blockers are considered harmful when given to patients with AF or
atrial ﬂutter associated with pre-excitation (WPW) syndrome.
Beta-adrenergic blockers
Beta-blocking drugs (atenolol, metoprolol, labetalol (alpha- and
beta-blocking effects), propranolol, esmolol) reduce the effects of
circulating catecholamines and decrease heart rate and blood pres-
sure. They also have cardioprotective effects for patientswith acute
coronary syndromes. Beta-blockers are indicated for the following
tachycardias:
• narrow-complex regular tachycardias uncontrolled by vagal
manoeuvres and adenosine in the patient with preserved ven-
tricular function;
• to control rate in AF and atrial ﬂutter when ventricular function
is preserved.
The intravenous dose of atenolol (beta1) is 5mg given over
5min, repeated if necessary after 10min. Metoprolol (beta1) is
given in doses of 2–5mg at 5-min intervals to a total of 15mg.
Propranolol (beta1 and beta2 effects), 100gkg−1, is given slowly
in three equal doses at 2–3-min intervals.
Intravenous esmolol is a short-acting (half-life of 2–9min)
beta1-selective beta-blocker. It is given as an intravenous load-
ing dose of 500gkg−1 over 1min, followed by an infusion of
50–200gkg−1 min−1.
Side effects of beta-blockade include bradycardia, AV con-
duction delay and hypotension. Contraindications to the use of
beta-adrenergic blocking drugs include second- or third-degree
heart block, hypotension, severe congestive heart failure and lung
disease associated with bronchospasm.
Magnesium
Magnesium is the ﬁrst line treatment for polymorphic ven-
tricular tachycardia. It may also reduce ventricular rate in atrial
ﬁbrillation.617,625–627 Give magnesium sulphate 2g (8mmol) over
10min. This can be repeated once if necessary.
4h Post-resuscitation care
Introduction
Successful ROSC is the just the ﬁrst step toward the goal of
complete recovery from cardiac arrest. The complex pathophys-
iological processes that occur following whole body ischaemia
during cardiac arrest and the subsequent reperfusion response
following successful resuscitation have been termed the post-
cardiac arrest syndrome.628 Many of these patients will require
multiple organ support and the treatment they receive this
post-resuscitation period inﬂuences signiﬁcantly the ultimate neu-
rological outcome.184,629–633 The post-resuscitation phase starts
at the location where ROSC is achieved but, once stabilised, the
patient is transferred to the most appropriate high-care area (e.g.,
intensive care unit, coronary care unit) for continued monitor-
ing and treatment. Of those patients admitted to intensive care
units after cardiac arrest, approximately 25–56% will survive to
be discharged from hospital depending on the system and qual-
ity of care.498,629,632,634–638 Of the patients that survive to hospital
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ischarge, the vast majority have a good neurological outcome
lthough many with some cognitive impairment.639
ost-cardiac arrest syndrome
The post-cardiac arrest syndrome comprises post-cardiac arrest
rain injury, post-cardiac arrest myocardial dysfunction, the
ystemic ischaemia/reperfusion response, and the persistent pre-
ipitating pathology.628 The severity of this syndrome will vary
ith the duration and cause of cardiac arrest. It may not occur
t all if the cardiac arrest is brief. Post-cardiac arrest brain injury
anifests as coma, seizures, myoclonus, varying degrees of neu-
ocognitive dysfunction and brain death. Among patients surviving
o ICU admission but subsequently dying in-hospital, brain injury is
he cause of death in 68% after out-of hospital cardiac arrest and in
3% after in-hospital cardiac arrest.245,640 Post-cardiac arrest brain
njury may be exacerbated by microcirculatory failure, impaired
utoregulation, hypercarbia, hyperoxia, pyrexia, hyperglycaemia
nd seizures. Signiﬁcant myocardial dysfunction is common after
ardiac arrest but typically recovers by 2–3 days.641,642 The whole
ody ischaemia/reperfusion of cardiac arrest activates immuno-
ogical and coagulation pathways contributing to multiple organ
ailure and increasing the risk of infection.643,644 Thus, the post-
ardiac arrest syndrome hasmany features in commonwith sepsis,
ncluding intravascular volume depletion and vasodilation.645,646
irway and breathing
Patientswhohavehadabrief periodof cardiac arrest responding
mmediately to appropriate treatment may achieve an immediate
eturn of normal cerebral function. These patients do not require
racheal intubation and ventilation but should be given oxygen via
facemask. Hypoxaemia and hypercarbia both increase the likeli-
ood of a further cardiac arrest and may contribute to secondary
rain injury. Several animal studies indicate that hyperoxaemia
auses oxidative stress and harms post-ischaemic neurones.647–650
ne animal study has demonstrated that adjusting the frac-
ional inspired concentration (FiO2) to produce an arterial oxygen
aturation of 94–96% in the ﬁrst hour after ROSC (‘controlled reoxy-
enation’) achieved better neurological outcomes than achieved
ith the delivery of 100% oxygen.328 A recent clinical registry study
hat includedmore than6000patients supports theanimaldataand
hows post-resuscitation hyperoxaemia is associated with worse
utcome, compared with both normoxaemia and hypoxaemia.329
n clinical practice, as soon as arterial blood oxygen saturation can
e monitored reliably (by blood gas analysis and/or pulse oxime-
ry), it may be more practicable to titrate the inspired oxygen
oncentration to maintain the arterial blood oxygen saturation in
he range of 94–98%.
Consider tracheal intubation, sedation and controlled venti-
ation in any patient with obtunded cerebral function. Ensure
he tracheal tube is positioned correctly well above the carina.
ypocarbia causes cerebral vasoconstriction and a decreased cere-
ral blood ﬂow.651 After cardiac arrest, hypocapnoea induced by
yperventilation causes cerebral ischaemia.652–655 There are no
ata to support the targeting of a speciﬁc arterial PCO2 after resus-
itation fromcardiac arrest, but it is reasonable to adjust ventilation
o achieve normocarbia and to monitor this using the end-tidal
CO2 and arterial blood gas values.
Insert a gastric tube to decompress the stomach; gastric disten-
ion causedbymouth-to-mouthor bag-mask-valve ventilationwill
plint thediaphragmand impair ventilation.Give adequatedosesof
edative, which will reduce oxygen consumption. Bolus doses of a
euromuscular blocking drugmay be required, particularly if using
herapeutic hypothermia (see below), but try to avoid infusions of
euromuscular blocking drugs because these may mask seizures.n 81 (2010) 1305–1352
Obtain a chest radiograph to check the position of the tracheal tube
and central venous lines, assess for pulmonary oedema, and detect
complications from CPR such as a pneumothorax associated with
rib fractures.
Circulation
The majority of out-of-hospital cardiac arrest patients have
coronary artery disease.656,657 Acute changes in coronary plaque
morphology occur in 40–86% of cardiac arrest survivors and in
15–64% of autopsy studies.658 It is well recognised that post-
cardiac arrest patients with ST elevation myocardial infarction
(STEMI) should undergo early coronary angiography and per-
cutaneous coronary intervention (PCI) but, because chest pain
and/or ST elevation are poor predictors of acute coronary occlu-
sion in these patients,659 this intervention should be considered
in all post-cardiac arrest patients who are suspected of hav-
ing coronary artery disease.629,633,659–665 Several studies indicate
that the combination of therapeutic hypothermia and PCI is fea-
sible and safe after cardiac arrest caused by acute myocardial
infarction.629,633,638,665,666
Post-cardiac arrest myocardial dysfunction causes haemody-
namic instability, which manifests as hypotension, low cardiac
index and arrhythmias.641 Early echocardiography will enable the
degree of myocardial dysfunction to be quantiﬁed.642 In the ICU
an arterial line for continuous blood pressure monitoring is essen-
tial. Treatment with ﬂuid, inotropes and vasopressors may be
guided by blood pressure, heart rate, urine output, and rate of
plasma lactate clearance and central venous oxygen saturations.
Non-invasive cardiac output monitors may help to guide treat-
ment but there is no evidence that their use affects outcome. If
treatment with ﬂuid resuscitation and vasoactive drugs is insufﬁ-
cient to support the circulation, consider insertion of an intra-aortic
balloon pump.629,638 Infusion of relatively large volumes of ﬂu-
ids are tolerated remarkably well by patients with post-cardiac
arrest syndrome.513,629,630,641 Although early goal directed ther-
apy is well-established in the treatment of sepsis,667 and has
been proposed as a treatment strategy after cardiac arrest,630
there are no randomised, controlled data to support its routine
use.
There are very few randomised trials evaluating the role of
bloodpressureon theoutcomeafter cardiac arrest.One randomised
study demonstrated no difference in the neurological outcome
among patients randomised to a mean arterial blood pressure
(MAP) of >100mmHg versus ≤100mmHg 5min after ROSC; how-
ever, good functional recovery was associated with a higher blood
pressure during the ﬁrst 2h after ROSC.668 In a registry study of
more than 6000 post-cardiac arrest patients, hypotension (systolic
blood pressure <90mmHg) on admission to ICU was associated
with worse outcome.668a Good outcomes have been achieved in
studies of patients admitted after out-of-hospital cardiac arrest
where the MAP target was low as 65–75mmHg629 to as high
as 90–100mmHg.632,669 In the absence of deﬁnitive data, target
the mean arterial blood pressure to achieve an adequate urine
output (1ml kg−1 h−1) and normal or decreasing plasma lactate
values, taking into consideration the patient’s normal blood pres-
sure, the cause of the arrest and the severity of any myocardial
dysfunction.628 Importantly, hypothermia may increase urine out-
put and impair lactate clearance.
Immediately after a cardiac arrest there is typically a
period of hyperkalaemia. Subsequent endogenous catecholamine
release promotes intracellular transportation of potassium, caus-
ing hypokalaemia. Hypokalaemia may predispose to ventricular
arrhythmias.Givepotassiumtomaintain the serumpotassiumcon-
centration between 4.0 and 4.5mmol l−1.
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isability (optimising neurological recovery)
erebral perfusion
Immediately after ROSC there is a period of cerebral
yperaemia.670 After asphyxial cardiac arrest, brain oedema may
ccur transientlyafterROSCbut it is rarelyassociatedwithclinically
elevant increases in intracranial pressure.671,672 Autoregulation of
erebral blood ﬂow is impaired for some time after cardiac arrest,
hichmeans that cerebral perfusion varieswith cerebral perfusion
ressure instead of being linked to neuronal activity.673,674 As dis-
ussedpreviously, followingROSC,maintainmeanarterial pressure
ear the patient’s normal level.
edation
Although it has been common practice to sedate and ventilate
atients for at least 24h after ROSC, there are no high-level data to
upport a deﬁned period of ventilation, sedation and neuromuscu-
ar blockade after cardiac arrest. Patients need to be well-sedated
uring treatment with therapeutic hypothermia, and the duration
f sedation and ventilation is therefore inﬂuenced by this treat-
ent. There are no data to indicate whether or not the choice
f sedation inﬂuences outcome, but a combination of opioids
nd hypnotics is usually used. Short-acting drugs (e.g., propofol,
lfentanil, remifentanil) will enable earlier neurological assess-
ent. Adequate sedation will reduce oxygen consumption. During
ypothermia, optimal sedation can reduce or prevent shivering,
hich enable the target temperature to be achieved more rapidly.
se of published sedation scales formonitoring these patients (e.g.,
he Richmond or Ramsay Scales) may be helpful.675,676
ontrol of seizures
Seizures or myoclonus or both occur in 5–15% of adult
atients who achieve ROSC and 10–40% of those who remain
omatose.498,677–680 Seizures increase cerebral metabolism by up
o 3-fold681 and may cause cerebral injury: treat promptly and
ffectively with benzodiazepines, phenytoin, sodium valproate,
ropofol, or a barbiturate.Myoclonus can be particularly difﬁcult to
reat; phenytoin is often ineffective. Clonazepam is the most effec-
ive antimyoclonic drug, but sodium valproate, levetiracetam and
ropofol may also be effective.682 Maintenance therapy should be
tarted after the ﬁrst event once potential precipitating causes (e.g.,
ntracranial haemorrhage, electrolyte imbalance) are excluded. No
tudies directly address the use of prophylactic anticonvulsant
rugs after cardiac arrest in adults.
lucose control
There is a strong association between high blood glucose
fter resuscitation from cardiac arrest and poor neurological
utcome.498–501,504,634,683,684 Although one randomised controlled
rial in a cardiac surgical intensive care unit showed that tight con-
rol of blood glucose (4.4–6.1mmol l−1 or 80–110mgdl−1) using
nsulin reduced hospital mortality in critically ill adults,685 a sec-
nd study by the same group in medical ICU patients showed
o mortality beneﬁt from tight glucose control.686 In one ran-
omised trial of patients resuscitated from OHCA with ventricular
brillation, strict glucose control (72–108mgdl−1, 4–6mmol l−1])
ave no survival beneﬁt compared with moderate glucose control
108–144mgdl−1, 6–8mmol l−1) and there were more episodes of
ypoglycaemia in the strict glucose control group.687 A large ran-
omised trial of intensive glucose control (4.5–6.0mmol l−1) versus
onventional glucose control (10mmol l−1 or less) in general ICU
atients reported increased 90-day mortality in patients treatedn 81 (2010) 1305–1352 1335
with intensive glucose control.688 Another recent study and two
meta-analyses of studies of tight glucose control versus conven-
tional glucose control in critically ill patients showed no signiﬁcant
difference in mortality but found tight glucose control was associ-
ated with a signiﬁcantly increased risk of hypoglycaemia.689–691
Severe hypoglycaemia is associated with increased mortality in
critically ill patients,692 and comatose patients are at particular
risk from unrecognised hypoglycaemia. There is some evidence
that, irrespective of the target range, variability in glucose values is
associated with mortality.693
Based on the available data, following ROSC blood glucose
should be maintained at ≤10mmol l−1 (180mgdl−1).694 Hypo-
glycaemia should be avoided. Strict glucose control should not
be implemented in adult patients with ROSC after cardiac arrest
because of the increased risk of hypoglycaemia.
Temperature control
Treatment of hyperpyrexia
A period of hyperthermia (hyperpyrexia) is common in the
ﬁrst 48h after cardiac arrest.695–697 Several studies document
an association between post-cardiac arrest pyrexia and poor
outcomes.498,695,697–700 There are no randomised controlled trials
evaluating the effect of treatment of pyrexia (deﬁned as ≥37.6 ◦C)
compared tono temperature control in patients after cardiac arrest.
Although the effect of elevated temperature on outcome is not
proved, it seems prudent to treat any hyperthermia occurring after
cardiac arrest with antipyretics or active cooling.
Therapeutic hypothermia
Animal and human data indicate that mild hypothermia is
neuroprotective and improves outcome after a period of global
cerebral hypoxia-ischaemia.701,702 Cooling suppresses many of
the pathways leading to delayed cell death, including apopto-
sis (programmed cell death). Hypothermia decreases the cerebral
metabolic rate for oxygen (CMRO2) by about 6% for each 1 ◦C reduc-
tion in temperature703 and thismay reduce the releaseof excitatory
amino acids and free radicals.701 Hypothermia blocks the intra-
cellular consequences of excitotoxin exposure (high calcium and
glutamate concentrations) and reduces the inﬂammatory response
associated with the post-cardiac arrest syndrome.
Which post-cardiac arrest patients should be cooled?. All stud-
ies of post-cardiac arrest therapeutic hypothermia have included
only patients in coma. There is good evidence supporting the use
of induced hypothermia in comatose survivors of out-of-hospital
cardiac arrest caused by VF. One randomised trial704 and a pseudo-
randomised trial669 demonstrated improved neurological outcome
at hospital discharge or at 6 months in comatose patients after
out-of-hospital VF cardiac arrest. Coolingwas initiatedwithinmin-
utes to hours after ROSC and a temperature range of 32–34 ◦C was
maintained for 12–24h. Two studies with historical control groups
showed improvement in neurological outcome after therapeutic
hypothermia for comatose survivors of VF cardiac arrest.705–707
Extrapolationof thesedata toother cardiac arrests (e.g., other initial
rhythms, in-hospital arrests, paediatric patients) seems reasonable
but is supported by only lower level data.
One small, randomised trial showed reduced plasma lactate
values and oxygen extraction ratios in a group of comatose sur-
vivors after cardiac arrest with asystole or PEA who were cooled
with a cooling cap.708 Six studies with historical control groups
have shown beneﬁt using therapeutic hypothermia in comatose
survivors of OHCA after all rhythm arrests.629,632,709–712 Two non-
randomised studies with concurrent controls indicate possible
beneﬁt of hypothermia following cardiac arrest from other initial
rhythms in- and out-of-hospital.713,714
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How to cool?. The practical application of therapeutic
ypothermia is divided into three phases: induction, maintenance,
nd rewarming.715 External and/or internal cooling techniques can
e used to initiate cooling. An infusion of 30mlkg−1 of 4 ◦C saline
r Hartmann’s solution decreases core temperature by approxi-
ately 1.5 ◦C629,633,638,706,707,711,716–727 and this technique can be
sed initiate cooling prehospital.511,728–731
Other methods of inducing and/or maintaining hypothermia
nclude:
Simple ice packs and/or wet towels are inexpensive; however,
these methods may be more time consuming for nursing staff,
may result in greater temperature ﬂuctuations, and do not enable
controlled rewarming.633,638,669,705,709,710,725,726,732–734 Ice cold
ﬂuids alone cannot be used tomaintain hypothermia,719 but even
the addition of simple ice packs may control the temperature
adequately.725
Cooling blankets or pads.727,735–740
Transnasal evaporative cooling.740a
Waterorair circulatingblankets.629,630,632,706,707,712,713,727,741–744
Water circulating gel-coated pads.629,711,720,721,727,738,743,745
Intravascular heat exchanger, placed usually in the femoral or
subclavian veins.629,630,713,714,718,724,727,732,733,742,746–748
Cardiopulmonary bypass.749
In most cases, it is easy to cool patients initially after ROSC
ecause the temperature normally decreases within this ﬁrst
our.498,698 Initial cooling is facilitated by neuromuscular block-
de and sedation, which will prevent shivering.750 Magnesium
ulphate, a naturally occurring NMDA receptor antagonist, that
educes the shivering threshold slightly, can also be given to reduce
he shivering threshold.715,751
In the maintenance phase, a cooling method with effective
emperature monitoring that avoids temperature ﬂuctuations is
referred. This is best achieved with external or internal cooling
evices that include continuous temperature feedback to achieve
set target temperature. The temperature is typically monitored
rom a thermistor placed in the bladder and/or oesophagus.715 As
et, there are no data indicating that any speciﬁc cooling technique
ncreases survival when compared with any other cooling tech-
ique; however, internal devices enable more precise temperature
ontrol compared with external techniques.727
Plasma electrolyte concentrations, effective intravascular vol-
me and metabolic rate can change rapidly during rewarming, as
hey do during cooling. Thus, rewarming must be achieved slowly:
he optimal rate is not known, but the consensus is currently about
.25–0.5 ◦C of warming per hour.713
When to cool?. Animal data indicate that earlier cooling
fter ROSC produces better outcomes.752 Ultimately, starting
ooling during cardiac arrest may be most beneﬁcial—animal
ata indicate that this may facilitate ROSC.753,754 Several clin-
cal studies have shown that hypothermia can be initiated
rehospital,510,728,729,731,740,740a but, as yet, there are no human
ata proving that time target temperature produces better out-
omes. One registry-based case series of 986 comatose post-cardiac
rrest patients suggested that time to initiation of cooling was not
ssociatedwith improvedneurological outcomepost-discharge.665
case series of 49 consecutive comatose post-cardiac arrest
atients intravascularly cooled after out-of-hospital cardiac arrest
lso documented that time to target temperature was not an inde-
endent predictor of neurologic outcome.748
Physiological effects and complications of hypothermia. The
ell-recognised physiological effects of hypothermia need to be
anaged carefully715:n 81 (2010) 1305–1352
• Shivering will increase metabolic and heat production, thus
reducing cooling rates—strategies to reduce shivering are dis-
cussed above.
• Mild hypothermia increases systemic vascular resistance, causes
arrhythmias (usually bradycardia).714
• It causes a diuresis and electrolyte abnormalities such
as hypophosphatemia, hypokalemia, hypomagesemia and
hypocalcemia.715,755
• Hypothermia decreases insulin sensitivity and insulin secretion,
hyperglycemia,669 which will need treatment with insulin (see
glucose control).
• Mild hypothermia impairs coagulation and increases bleeding
although this has not be conﬁrmed inmany clinical studies.629,704
In one registry study an increased rate ofminor bleedingoccurred
with the combination of coronary angiography and therapeutic
hypothermia, but this combination of interventions was the also
the best predictor of good outcome.665
• Hypothermia can impair the immune system and increase infec-
tion rates.715,734,736
• The serum amylase concentration is commonly increased during
hypothermia but the signiﬁcance of this unclear.
• The clearance of sedative drugs and neuromuscular blockers is
reduced by up to 30% at a core temperature of 34 ◦C.756
Contraindications to hypothermia. Generally recognised con-
traindications to therapeutic hypothermia, but which are not
applied universally, include: severe systemic infection, established
multiple organ failure, and pre-existing medical coagulopathy
(ﬁbrinolytic therapy is not a contraindication to therapeutic
hypothermia).
Other therapies
Neuroprotective drugs (coenzyme Q10,737 thiopental,757
glucocorticoids,758,759 nimodipine,760,761 lidoﬂazine,762 or
diazepam452) used alone, or as an adjunct to therapeutic hypother-
mia, have not been demonstrated to increase neurologically intact
survival when included in the post-arrest treatment of cardiac
arrest. There is also insufﬁcient evidence to support the routine
use of high-volume haemoﬁltration763 to improve neurological
outcome in patients with ROSC after cardiac arrest.
Prognostication
Two thirds of those dying after admission to ICU following out-
of-hospital cardiacarrestdie fromneurological injury; thishasbeen
shown both with245 and without640 therapeutic hypothermia. A
quarter of those dying after admission to ICU following in-hospital
cardiac arrest die from neurological injury. A means of predicting
neurological outcome that can be applied to individual patients
immediately after ROSC is required. Many studies have focused on
prediction of poor long term outcome (vegetative state or death),
based on clinical or test ﬁndings that indicate irreversible brain
injury, to enable clinicians to limit care or withdraw organ sup-
port. The implications of these prognostic tests are such that they
should have 100% speciﬁcity or zero false positive rate (FPR), i.e.,
proportion of individuals who eventually have a ‘good’ long-term
outcome despite the prediction of a poor outcome. This topic of
prognostication after cardiac arrest is controversial because: (1)
many studies are confounded by self-fulﬁlling prophecy (treat-
ment is rarely continued for long enough in sufﬁcient patients
to enable a true estimate of the false positive rate for any given
prognosticator); (2) many studies include so few patients that
even if the FPR is 0%, the upper limit of the 95% conﬁdence inter-
val may be high; and (3) most prognostication studies have been
undertaken before implementation of therapeutic hypothermia
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nd there is evidence that this therapy makes these tests less reli-
ble.
linical examination
There are no clinical neurological signs that reliably predict poor
utcome (cerebral performance category [CPC] 3 or 4, or death) less
han 24h after cardiac arrest. In adult patients who are comatose
fter cardiac arrest, and who have not been treated with hypother-
ia andwhodonothave confounding factors (suchashypotension,
edatives or muscle relaxants), the absence of both pupillary light
nd corneal reﬂex at ≥72h reliably predicts poor outcome (FPR
%; 95% CI 0–9%).680 Absence of vestibulo-ocular reﬂexes at ≥24h
FPR 0%; 95% CI 0–14%)764,765 and a GCS motor score of 2 or less at
72h (FPR 5%; 95%CI 2–9%)680 are less reliable. Other clinical signs,
ncluding myoclonus, are not recommended for predicting poor
utcome. The presence of myoclonus status in adults is strongly
ssociated with poor outcome,679,680,766–768 but rare cases of good
eurological recovery have been described and accurate diagnosis
s problematic.769–773
iochemical markers
Serum neuronal speciﬁc enolase elevations are associ-
ted with poor outcome for comatose patients after cardiac
rrest.680,748,774–792 Although speciﬁc cut-off values with a false
ositive rate of 0% have been reported, clinical application is
imited due to variability in the 0% FPR cut-off values reported
mong various studies.
Serum S100 elevations are associated with
oor outcome for comatose patients after cardiac
rrest.680,774–776,782,784,785,787,788,791,793–798
Many other serum markers measured after sustained return
f spontaneous circulation have been associated with poor out-
ome after cardiac arrest, including BNP,799 vWF,800 ICAM-1,800
rocalcitonin,794 IL-1ra, RANTES, sTNFRII, IL-6, IL-8 and IL-10.645
owever, other studies found no relationship between outcome
nd serum IL-8,793 and procalcitonin and sTREM-1.801
Worse outcomes for comatose survivors of cardiac arrest
re also associated with increased levels of cerebrospinal ﬂuid
CSF)-CK802,803 and cerebrospinal ﬂuid-CKBB.774,775,777,789,803–807
owever, one study found no relationship between cerebrospinal
uid-CKBB and prognosis.808
Outcomes are also associatedwith increased cerebrospinal ﬂuid
evels of other markers including NSE,775,784,789), S100,784 LDH,
OT,777,803 neuroﬁlament,809 acid phosphatase and lactate.803
erebrospinal ﬂuid levels of beta-d-N-acetylglucosaminidase, and
yruvate were not associated with the prognosis of cardiac
rrest.803
In summary, evidence does not support the use of serum or
SF biomarkers alone as predictors of poor outcomes in comatose
atients after cardiac arrest with or without treatment with ther-
peutic hypothermia (TH). Limitations included small numbers of
atients and/or inconsistency in cut-off values for predicting poor
utcome.
lectrophysiological studies
No electrophysiological study reliably predicts outcome of a
omatose patient within the ﬁrst 24h after cardiac arrest. If
omatosensory evoked potentials (SSEP) are measured after 24h
n comatose cardiac arrest survivors not treated with therapeu-
ic hypothermia, bilateral absence of the N20 cortical response to
edian nerve stimulation predicts poor outcome (death or CPC 3 or
)withaFPRof0.7% (95%CI0.1–3.7).774 In theabsenceof confound-
ng circumstances such as sedatives, hypotension, hypothermia orn 81 (2010) 1305–1352 1337
hypoxemia, it is reasonable to use unprocessed EEG interpretation
(speciﬁcally identifying generalized suppression to less than 20V,
burst suppressionpatternwithgeneralizedepileptic activity, ordif-
fuse periodic complexes on a ﬂat background) observed between
24 and 72h after ROSC to assist the prediction of a poor outcome
(FPR 3%, 95% CI 0.9–11%) in comatose survivors of cardiac arrest
not treated with hypothermia.774 There is inadequate evidence to
support the routine use of other electrophysiological studies (e.g.,
abnormal brainstem auditory evoked potentials) for prognostica-
tion of poor outcome in comatose cardiac arrest survivors.606
Imaging studies
Many imaging modalities (magnetic resonance imaging [MRI],
computed tomography [CT], single photon emission computed
tomography [SPECT], cerebral angiography, transcranial Doppler,
nuclear medicine, near infra-red spectroscopy [NIRS]) have been
studied to determine their utility for prediction of outcome in adult
cardiac arrest survivors.606 There are no level one or level two stud-
ies that support theuse of any imagingmodality to predict outcome
of comatose cardiac arrest survivors. Overall, those imaging stud-
ies that have been undertaken were limited by small sample sizes,
variable timeof imaging (manyvery late in the course), lack of com-
parison with a standardised method of prognostication, and early
withdrawal of care. Despite tremendous potential, neuroimaging
has yet to be proven as an independently accurate modality for
prediction of outcome in individual comatose cardiac arrest sur-
vivors and, at this time, its routine use for this purpose is not
recommended.
Impact of therapeutic hypothermia on prognostication
There is inadequate evidence to recommend a speciﬁc approach
to prognosticating poor outcome in post-cardiac arrest patients
treated with therapeutic hypothermia. There are no clinical neuro-
logical signs, electrophysiological studies, biomarkers, or imaging
modalities that can reliably predict neurological outcome in the
ﬁrst 24h after cardiac arrest. Based on limited available evidence,
potentially reliable prognosticators of poor outcome in patients
treated with therapeutic hypothermia after cardiac arrest include
bilateral absence of N20 peak on SSEP≥24h after cardiac arrest
(FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil-
lary reﬂexes 3 or more days after cardiac arrest (FPR 0%, 95%
CI 0–48%).766,810 Limited available evidence also suggests that a
Glasgow Motor Score of 2 or less at 3 days post-ROSC (FPR 14%
[95% CI 3–44%])766 and the presence of status epilepticus (FPR of
7% [95% CI 1–25%] to 11.5% [95% CI 3–31%])811,812 are potentially
unreliable prognosticators of poor outcome in post-cardiac arrest
patients treated with therapeutic hypothermia. One study of 111
post-cardiac arrest patients treated with therapeutic hypothermia
attempted to validate prognostic criteria proposed by the Amer-
ican Academy of Neurology.774,813 This study demonstrated that
clinical exam ﬁndings at 36–72h were unreliable predictors of
poor neurological outcome while bilaterally absent N20 peak on
somatosensory evoked potentials (false positive rate 0%, 95% CI
0–13%) and unreactive electroencephalogram background (false
positive rate 0%, 95% CI 0–13%) were the most reliable. A decision
rule derived using this dataset demonstrated that the presence of
two independent predictors of poor neurological outcome (incom-
plete recovery brainstem reﬂexes, early myoclonus, unreactive
electroencephalogram and bilaterally absent cortical SSEPs) pre-
dicted poor neurological outcome with a false positive rate of 0%
(95%CI 0–14%). Serumbiomarkers such asNSE are potentially valu-
able as adjunctive studies in prognostication of poor outcome in
patients treated with hypothermia, but their reliability is limited
because few patients have been studied and the assay is not well
1 citatio
s
s
s
O
d
i
i
d
n
d
t
t
o
o
s
a
o
C
p
T
p
t
v
g
c
d
i
p
h
T
c
p
S
d
r
s
i
s
p
s
i
a
i
R338 C.D. Deakin et al. / Resus
tandardisation.814,815 Given the limited available evidence, deci-
ions to limit care should not be made based on the results of a
ingle prognostication tool.
rgan donation
Solid organs have been successfully transplanted after cardiac
eath.816 This group of patients offers an untapped opportunity to
ncrease theorgandonorpool. Organ retrieval fromnon-heart beat-
ng donors is classiﬁed as controlled or uncontrolled.817 Controlled
onation occurs after planned withdrawal of treatment following
on-survivable injuries/illnesses. Uncontrolled donation describes
onation after a patient is brought in dead or with on-going CPR
hat fails to restore a spontaneous circulation.
Graft function after transplantation is inﬂuenced by the dura-
ion of warm ischaemia time from cessation of cardiac output until
rgan preservation is undertaken. Where delays in the initiation
f organ preservation are anticipated mechanical chest compres-
ion devices may be useful for maintaining effective circulation
nd organ perfusion whilst the necessary regulatory steps to allow
rgan donation to occur are undertaken.818–820
ardiac arrest centres
There is wide variability in survival among hospitals caring for
atients after resuscitation from cardiac arrest.498,631,635,636,821–823
here is some low-level evidence that ICUs admittingmore than 50
ost-cardiac arrest patients per year produce better survival rates
han those admitting less than 20 cases per year.636 Another obser-
ational study showed that unadjusted survival to discharge was
reater in hospitals that received ≥40 cardiac arrest patients/year
omparedwith those that received <40 per year, but this difference
isappeared after adjustment for patient factors.824
Several studies with historic control groups have shown
mproved survival after implementation of a comprehensive
ackage of post-resuscitation care that includes therapeutic
ypothermia and percutaneous coronary intervention.629,632,633
here is also evidence of improved survival after out-of-hospital
ardiac arrest in large hospitalswith cardiac catheter facilities com-
ared with smaller hospitals with no cardiac catheter facilities.631
everal studies of out-of-hospital adult cardiac arrest failed to
emonstrate any effect of transport interval from the scene to the
eceiving hospital on survival to hospital discharge if return of
pontaneous circulation was achieved at the scene and transport
ntervals were short (3–11min).825–827 This implies that it may be
afe to bypass local hospitals and transport the post-cardiac arrest
atient to a regional cardiac arrest centre.
There is indirect evidence that regional cardiac resuscitation
ystems of care improve outcome after ST elevation myocardial
nfarction (STEMI).828–850
The implication from all these data is that specialist cardiac
rrest centres and systems of caremay be effective but, as yet, there
s no direct evidence to support this hypothesis.851–853
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ummary of main changes since 2005 Guidelines
Changes in the management of acute coronary syndrome since
he 2005 guidelines include:
eﬁnitions
The term non-ST-elevation myocardial infarction-acute coro-
ary syndrome (non-STEMI-ACS) has been introduced for both
STEMI and unstable angina pectoris because the differential diag-
osis is dependent on biomarkers thatmay be detectable only after
ours, whereas decisions on treatment are dependent on the clin-
cal signs at presentation.
hest pain units and decision rules for early discharge
History, clinical examinations, biomarkers, ECG criteria and risk
scores are unreliable for the identiﬁcation of patients who may
be safely discharged early.
The role of chest pain observation units (CPUs) is to identify, by
using repeated clinical examinations, ECG and biomarker testing,
those patients who require admission for invasive procedures.
This may include provocative testing and, in selected patients,
imaging procedures as cardiac computed tomography, magnetic
resonance imaging, etc.
ymptomatic treatment
Non-steroidal anti-inﬂammatory drugs (NSAIDs) should be
avoided.
Nitrates should not be used for diagnostic purposes.
Supplementary oxygen to be given only to those patients with
hypoxaemia, breathlessness or pulmonary congestion. Hyperox-
aemia may be harmful in uncomplicated infarction.
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• Guidelines for treatment with acetyl salicylic acid (ASA) have
been made more liberal and it may now be given by bystanders
with or without dispatchers assistance.
• Revised guidance for new antiplatelet and antithrombin treat-
ment forpatientswithSTelevationmyocardial infarction (STEMI)
and non-STEMI-ACS based on therapeutic strategy.
• Gp IIb/IIIa inhibitors before angiography/percutaneous coronary
intervention (PCI) are discouraged.
Reperfusion strategy in STEMI
• Primary PCI (PPCI) is the preferred reperfusion strategy provided
it is performed in a timely manner by an experienced team.
• A nearby hospital may be bypassed by emergency medical ser-
vices (EMS) provided PPCI can be achieved without too much
delay.
• The acceptable delay between start of ﬁbrinolysis and ﬁrst bal-
loon inﬂation varies widely between about 45 and 180min
depending on infarct localisation, age of the patient, and duration
of symptoms.
• ‘Rescue PCI’ should be undertaken if ﬁbrinolysis fails.
• The strategy of routine PCI immediately after ﬁbrinolysis (‘facili-
tated PCI’) is discouraged.
• Patients with successful ﬁbrinolysis but not in a PCI-capable hos-
pital should be transferred for angiography and eventual PCI,
performed optimally 6–24h after ﬁbrinolysis (the ‘pharmaco-
invasive’ approach).
• Angiography and, if necessary, PCI may be reasonable in patients
with return of spontaneous circulation (ROSC) after cardiac arrest
and may be part of a standardised post-cardiac arrest protocol.
• To achieve these goals, the creation of networks including EMS,
non-PCI capable hospitals and PCI hospitals is useful.Primary and secondary prevention
• Recommendations for the use of beta-blockers are more
restricted: there is no evidence for routine intravenous beta-
blockers except in speciﬁc circumstances such as for the
evier Ireland Ltd. All rights reserved.
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treatment of tachyarrhythmias. Otherwise, beta-blockers should
be started in low doses only after the patient is stabilised.
Guidelines on the use of prophylactic anti-arrhythmics
angiotensin converting enzyme (ACE) inhibitors/angiotensin
receptor blockers (ARBs) and statins are unchanged.
ntroduction
The incidence of acute ST-elevationmyocardial infarction (AMI)
s decreasing in many European countries [1]; however, the inci-
ence of non-STEMI acute coronary syndrome (non-STEMI ACS)
s increasing [2,3]. Although in-hospital mortality from STEMI has
een reduced signiﬁcantly by modern reperfusion therapy and
mproved secondary prophylaxis, the overall 28-day mortality is
irtually unchanged because about two thirds of those who die do
o before hospital arrival, mostly from lethal arrhythmias triggered
y ischaemia [4]. Thus, the best chance of improving survival from
n ischaemic attack is reducing the delay from symptom onset to
rst medical contact and targeted treatment started in the early
ut-of-hospital phase.
The term acute coronary syndrome (ACS) encompasses three
ifferent entities of the acute manifestation of coronary heart dis-
ase (Fig. 5.1): STEMI, NSTEMI and unstable angina pectoris (UAP).
on-ST-elevation myocardial infarction and UAP are usually com-
ined in the term non-STEMI-ACS. The common pathophysiology
f ACS is a ruptured or eroded atherosclerotic plaque [5]. Elec-
rocardiographic (ECG) characteristics (absence or presence of ST
levation) differentiate STEMI fromnon-STEMI-ACS. The lattermay
resentwithST-segmentdepression, nonspeciﬁcST-segmentwave
bnormalities, or even a normal ECG. In the absence of ST elevation,
n increase in the plasma concentration of cardiac biomarkers, par-
icularly troponin T or I as the most speciﬁc markers of myocardial
ell necrosis, indicates NSTEMI.
Acute coronary syndromes are the commonest cause of malig-
ant arrhythmias leading to sudden cardiac death. The therapeutic
oals are to treat acute life-threatening conditions, such as ven-
ricular ﬁbrillation (VF) or extreme bradycardia, and to preserve
eft ventricular function and prevent heart failure by minimising
he extent of myocardial damage. The current guidelines address
ig. 5.1. Deﬁnitions of acute coronary syndromes (ACS) (STEMI, ST-elevation myocardial
ectoris).n 81 (2010) 1353–1363
the ﬁrst hours after onset of symptoms. Out-of-hospital treatment
and initial therapy in the emergency department (ED) may vary
according to local capabilities, resources and regulations. The data
supporting out-of-hospital treatment are often extrapolated from
studies of initial treatment after hospital admission; there are few
high-quality out-of-hospital studies. Comprehensive guidelines for
the diagnosis and treatment of ACS with and without ST eleva-
tion have been published by the European Society of Cardiology
and the American College of Cardiology/American Heart Associa-
tion. Thecurrent recommendationsare in linewith theseguidelines
[6,7].
Diagnosis and risk stratiﬁcation in acute coronary
syndromes
Since early treatment offers the greatest beneﬁts, and myocar-
dial ischaemia is the leading precipitant of sudden cardiac death, it
is essential that the public is aware of the typical symptoms associ-
atedwith ACS. Several groups of patients however, are less likely to
seek prompt medical care when symptoms of an ACS appear. Thus
signiﬁcant delays in the initiation of treatment/reperfusion have
been reported in women, the elderly, people belonging to ethnic
and racialminorities or low socioeconomic classes, and those living
alone [8].
Patients at risk, and their families, should be able to recognize
characteristic symptoms such as chest pain, which may radiate
into other areas of the upper body, often accompanied by other
symptoms including dyspnoea, sweating, nausea or vomiting and
syncope. They should understand the importance of early activa-
tion of the emergency medical service (EMS) system and, ideally,
should be trained in basic life support (BLS). Optimal strategies for
increasing layperson awareness of the various ACS presentations
and improvement of ACS recognition in vulnerable populations
remain to be determined.
Moreover, EMS dispatchers must be trained to recognize ACS
symptomsand toask targetedquestions.WhenanACS is suspected,
an EMS crew trained in advanced life support (ALS) and capable of
making the diagnosis and starting treatment should be alerted.
infarction; NSTEMI, non-ST-elevation myocardial infarction; UAP, unstable angina
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Given the high urgency for emergency revascularisation in
TEMI and other high-risk patients, speciﬁc systems of care can
e implemented to improve STEMI recognition and shorten time
o treatment.
The sensitivity, speciﬁcity, and clinical impact of various diag-
ostic strategies have been evaluated for ACS. Information from
linical presentation, ECG, biomarker testing and imaging tech-
iques should all be taken into account in order to establish the
iagnosis and at the same time estimate the risk so that optimal
ecisions for patient admission and therapy/reperfusion are made.
igns and symptoms of ACS
Typically ACS appears with symptoms such as radiating chest
ain, shortness of breath and sweating; however, atypical symp-
oms or unusual presentationsmay occur in the elderly, in females,
nd in diabetics [9,10]. None of these signs and symptoms of ACS
an be used alone for the diagnosis of ACS. A reduction in chest
ain after nitroglycerin administration can be misleading and is
ot recommended as a diagnostic manoeuvre [11]. Symptomsmay
e more intense and last longer in patients with STEMI but are not
eliable for discriminating between STEMI and non-STEMI-ACS.
The patient’s history should be evaluated carefully during ﬁrst
ontact with healthcare providers. It may provide the ﬁrst clues for
he presence of an ACS, trigger subsequent investigations and, in
ombinationwith information fromother diagnostic tests, can help
n making triage and therapeutic decisions in the out-of-hospital
etting and the emergency department (ED).
2-lead ECG
A 12-lead ECG is the key investigation for assessment of an ACS.
n case of STEMI, it indicates the need for immediate reperfusion
herapy (i.e. primary percutaneous coronary intervention (PCI) or
rehospital ﬁbrinolysis). When an ACS is suspected, a 12-lead ECG
hould be acquired and interpreted as soon as possible after ﬁrst
atient contact, to facilitate earlier diagnosis and triage. Prehospital
r EDECGyields useful diagnostic informationwhen interpretedby
rained health care providers [12].
Recording of a 12-lead ECG out-of-hospital enables advanced
otiﬁcation to the receiving facility and expedites treatment
ecisions after hospital arrival: in many studies, the time from
ospital admission to initiating reperfusion therapy is reduced by
0–60min [13,14]. Trained EMS personnel (emergency physicians,
aramedics and nurses) can identify STEMI, deﬁned by ST elevation
f ≥0.1mV elevation in at least two adjacent limb leads or >0.2mV
n two adjacent precordial leads, with a high speciﬁcity and sensi-
ivity comparable to diagnostic accuracy in the hospital [15–17]. It
s thus reasonable that paramedics and nurses be trained to diag-
ose STEMI without direct medical consultation, as long as there is
trict concurrent provision ofmedically directed quality assurance.
If interpretation of the prehospital ECG is not available on-site,
omputer interpretation [18,19] or ﬁeld transmission of the ECG is
easonable. Recording and transmission of diagnostic quality ECGs
o thehospital usually takes less than5min.Whenused for theeval-
ation of patients with suspected ACS, computer interpretation of
he ECG may increase the speciﬁcity of diagnosis of STEMI, espe-
ially for clinicians inexperienced in reading ECGs. The beneﬁt of
omputer interpretation; however, is dependent on the accuracy
f the ECG report. Incorrect reports may mislead inexperienced
CG readers. Thus computer-assisted ECG interpretation should
ot replace, but may be used as an adjunct to, interpretation by
n experienced clinician.n 81 (2010) 1353–1363 1355
Biomarkers
In the absence of ST elevation on the ECG, the presence of
a suggestive history and elevated concentrations of biomarkers
(troponin T and troponin I, CK, CK-MB, myoglobin) characterise
non-STEMI and distinguish it from STEMI and unstable angina
respectively. Measurement of a cardiac-speciﬁc troponin is prefer-
able. Elevated concentrations of troponin are particularly helpful in
identifying patients at increased risk of adverse outcome [20].
Cardiac biomarker testing shouldbepart of the initial evaluation
of all patients presenting to the ED with symptoms suggestive of
cardiac ischaemia [21]. However, the delay in release of biomark-
ers from damaged myocardium prevents their use in diagnosing
myocardial infarction in the ﬁrst 4–6h after the onset of symptoms
[22]. For patients who present within 6h of symptom onset, and
have an initial negative cardiac troponin, biomarkers should be re-
measured between 6 and 12h after symptom onset. In order to use
the measured biomarker optimally, clinicians should be familiar
with the sensitivity, precision and institutional norms of the assay,
and also the release kinetics and clearance. Highly sensitive (ultra-
sensitive) cardiac troponin assays have been developed. They can
increase sensitivity for the diagnosis of MI in patients with symp-
toms suspicious of cardiac ischaemia [23]. If the highly sensitive
cardiac troponin assays are unavailable, multi-marker evaluation
with CK-MB or myoglobin in conjunction with troponin may be
considered to improve the sensitivity of diagnosing AMI.
There is no evidence to support the use of troponin point-of-
care testing (POCT) in isolation as a primary test in the prehospital
setting to evaluate patients with symptoms suspicious of cardiac
ischaemia [23]. In the ED, use of point-of-care troponin assays
may help to shorten time to treatment and length of ED stay [24].
Until further randomised control trials are performed, other serum
assays should not be considered ﬁrst-line steps in the diagnosis and
management of patients presenting with ACS symptoms [25].
Decision rules for early discharge
Attempts have been made to combine evidence from history,
physical examination serial ECGs and serial biomarker measure-
ment in order to form clinical decision rules that would help triage
of ED patients with suspected ACS.
None of these rules is adequate and appropriate to identify ED
chest pain patients with suspected ACS who can be safely dis-
charged from the ED [26].
Likewise, the scoring systems for risk stratiﬁcation of patients
with ACS that have been validated in the inpatient environment
(e.g. Thrombolysis in Myocardial Infarction (TIMI) score, Global
Registry of Acute Coronary Events (GRACE) score, Fast Revascular-
isation in Instability in Coronary Disease (FRISC) score or Goldman
Criteria) should not be used to identify low-risk patients suitable
for discharge from the ED.
A subgroup of patients younger than 40 yearswith non-classical
presentations and lacking signiﬁcant past medical history, who
have normal serial biomarkers and 12-lead ECGs, have a very low
short-term event rate.
Chest pain observation protocols
Inpatients suspectedof anACS the combinationof anunremark-
able past history and physical examination with negative initial
ECG and biomarkers cannot be used to exclude ACS reliably. There-
fore a follow up period is mandatory in order to reach a diagnosis
and make therapeutic decisions.
Chest pain observation protocols are rapid systems for assess-
ment of patientswith suspectedACS. They should generally include
a history and physical examination, followed by a period of obser-
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ation, duringwhich serial electrocardiography and cardiacmarker
easurements are performed. Patient evaluation should be com-
lemented by either a non-invasive evaluation for anatomical
oronary disease or provocative testing for inducible myocardial
schaemia at some point after AMI is excluded. These protocols
ay be used to improve accuracy in identifying patients requiring
npatient admissionor further diagnostic testingwhilemaintaining
atient safety, reducing length of stay and reducing costs [27].
In patients presenting to the EDwith a history suggestive of ACS,
ut normal initial workup, chest pain (observation) units may rep-
esent a safe and effective strategy for evaluating patients. They
ay be recommended as ameans to reduce length of stay, hospital
dmissions and healthcare costs, improve diagnostic accuracy and
mprove quality of life [28]. There is nodirect evidence demonstrat-
ng that chest pain units or observation protocols reduce adverse
ardiovascular outcomes, particularly mortality, for patients pre-
enting with possible ACS.
maging techniques
Effective screening of patients with suspected ACS, but with
egative ECG and negative cardiac biomarkers, remains chal-
enging. Non-invasive imaging techniques (CT angiography [29],
ardiac magnetic resonance, myocardial perfusion imaging [30],
nd echocardiography [31]) have been evaluated as means of
creening these low-risk patients and identifying subgroups that
an be discharged home safely.
Although there are no largemulticentre trials, existing evidence
ndicates that these diagnostic modalities enable early and accu-
ig. 5.2. Treatment algorithm for acute coronary syndromes (BP, blood pressure; PCI, per
oading dose, may be chosen as an alternative to clopidogrel in patients with STEMI and p
he time of writing, ticagrelor has not yet been approved as an alternative to clopidogrel.n 81 (2010) 1353–1363
rate diagnosis with a reduction in length of stay and costs without
increasing cardiac events. Both the exposure to radiation and iod-
inated contrast should be considered when using multi-detector
computer tomography (MDCT) and myocardial perfusion imaging.
Treatment of acute coronary syndromes—symptoms
Nitrates
Glyceryl trinitrate is an effective treatment for ischaemic chest
pain and has beneﬁcial haemodynamic effects, such as dilation of
the venous capacitance vessels, dilation of the coronary arteries
and, to a minor extent, the peripheral arteries. Glyceryl trinitrate
may be considered if the systolic blood pressure is above 90mmHg
and the patient has ongoing ischaemic chest pain (Fig. 5.2). Glyceryl
trinitrate can also be useful in the treatment of acute pulmonary
congestion. Nitrates should not be used in patients with hypoten-
sion (systolic blood pressure ≤90mmHg), particularly if combined
with bradycardia, and in patients with inferior infarction and sus-
pected right ventricular involvement. Use of nitrates under these
circumstances can decrease the blood pressure and cardiac output.
AnalgesiaMorphine is the analgesic of choice for nitrate-refractory pain
and also has calming effects on the patient making sedatives
unnecessary in most cases. Since morphine is a dilator of venous
capacitance vessels, it may have additional beneﬁt in patients with
pulmonary congestion. Give morphine in initial doses of 3–5mg
cutaneous coronary intervention; UFH, unfractionated heparin). *Prasugrel, 60mg
lanned PPCI provided there is no history of stroke or transient ischaemic attack. At
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ntravenously and repeat every few minutes until the patient is
ain-free. Non-steroidal anti-inﬂammatory drugs (NSAIDs) should
e avoided for analgesia because of their pro-thrombotic effects
32].
xygen
Monitoring of the arterial oxygen saturation with pulse oxime-
ry (SpO2)will help todetermine theneed for supplemental oxygen.
hese patients do not need supplemental oxygen unless they are
ypoxaemic. Limited data suggest that high-ﬂow oxygen may
e harmful in patients with uncomplicated myocardial infarction
33–35]. Aim to achieve an oxygen saturation of 94–98%, or 88–92%
f the patient is at risk of hypercapnic respiratory failure [36].
reatment of acute coronary syndromes—cause
nhibitors of platelet aggregation
Inhibition of platelet aggregation is of primary importance for
nitial treatment of coronary syndromes as well as for secondary
revention, since platelet activation and aggregation is the key
rocess initiating an ACS.
cetylsalicylic acid (ASA)
Large randomised controlled trials indicate decreasedmortality
henASA (75–325mg) is given to hospitalised patientswithACS. A
ew studies have suggested reducedmortality if ASA is given earlier
37,38]. Therefore, give ASA as soon as possible to all patients with
uspected ACS unless the patient has a known true allergy to ASA.
SA may be given by the ﬁrst healthcare provider, bystander or by
ispatcher assistance according to local protocols. The initial dose
f chewable ASA is 160–325mg. Other forms of ASA (soluble, IV)
ay be as effective as chewed tablets.
denosine diphosphate (ADP)-receptor inhibitors
Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl-
riazolo-pyrimidine, ticagrelor, inhibit the ADP-receptor irre-
ersibly, which further reduces platelet aggregation in addition to
hatproducedbyASA. In contrast to clopidogrel,metabolismofpra-
ugrel and of ticagrelor is independent of a genetically determined
ariability of drug metabolism and activation. Therefore prasug-
el and ticagrelor lead to a more reliable and stronger inhibition of
latelet aggregation.
A large randomised study comparing a loading dose of 300mg
lopidogrel followed by 75mg daily with prasugrel (loading dose
0mg, followed by 10mg daily) in patients with ACS resulted in
ewer major adverse cardiac events (MACE) with prasugrel; how-
ver, the bleeding rate was higher. Bleeding risk was increased
arkedly in patients weighing less than 60kg and those older than
5 years [39]. A signiﬁcantly increased intracranial bleeding rate
as observed in patients with a history of transient ischaemic
ttack (TIA) and/or stroke. In another study, ticagrelor proved to
e superior to clopidogrel with respect to MACE [40]. At the time
f writing, ticagrelor has not yet been approved as an alternative
o clopidogrel.
DP-receptor inhibitors in NON-STEMI ACSClopidogrel. If given in addition to heparin andASA in high-risk
on-STEMI-ACS patients, clopidogrel improves outcome [41,42].
ven if there is no large scale study investigating pre-treatment
ith clopidogrel, compared with peri-interventional applicationn 81 (2010) 1353–1363 1357
– either with a 300 or 600mg loading dose – do not postpone
treatment until angiography/PCI is undertaken because the high-
est event rates are observed in the early phase of the syndrome. In
unselected patients undergoing PCI, pre-treatment with a higher
loading dose of clopidogrel resulted in better outcome [43].
Therefore, clopidogrel should be given as early as possible in
addition to ASA and an antithrombin to all patients presentingwith
non-STEMI ACS. If a conservative approach is selected, give a load-
ing dose of 300mg; with a planned PCI strategy, an initial dose of
600mg may be preferred.
Prasugrel. Prasugrel (60mg loading dose)may be given instead
of clopidogrel to patients with high-risk non-STEMI ACS and
planned PCI at angiography, provided coronary stenoses are suit-
able for PCI. Contraindications (history of TIA/stroke) and the
beneﬁt – risk relation in patients with high bleeding risk (weight
<60kg, age >75 years) should be considered.
ADP-receptor inhibitors in STEMI
Clopidogrel. Although there isno large studyon theuseof clopi-
dogrel for pre-treatment of patients presenting with STEMI and
planned PCI, it is likely that this strategy is beneﬁcial. Since platelet
inhibition is more profound with a higher dose, a 600mg load-
ing dose given as soon as possible is recommended for patients
presenting with STEMI and planned PCI.
Two large randomised trials studied clopidogrel comparedwith
placebo in patients with STEMI treated conservatively or with ﬁb-
rinolysis [44,45]. One study included patients up to 75 years of age,
treated with ﬁbrinolysis, ASA, an antithrombin and a loading dose
of 300mg clopidogrel [45]. Treatment with clopidogrel resulted in
fewer occluded culprit coronary arteries at angiography and fewer
re-infarctions, without an increased bleeding risk. The other study
investigated STEMI patients without age limits to be treated con-
servatively orwith ﬁbrinolysis. In this trial, clopidogrel (no loading,
75mg daily) comparedwith placebo resulted in fewer deaths and a
reductionof thecombinedendpointofdeathandstroke [44]. There-
fore patientswith STEMI treatedwith ﬁbrinolysis should be treated
with clopidogrel (300mg loading dose up to an age of 75 years and
75mg without loading dose if >75 years of age) in addition to ASA
and an antithrombin.
Prasugrel. Prasugrel with a loading dose of 60mgmay be given
in addition to ASA and an antithrombin to patients presentingwith
STEMI with planned PCI. Contraindications (history of TIA/stroke),
and relation of bleeding risk vs beneﬁt in patients with a body
weight <60kgor aged>75years shouldbe taken into account. There
is no data on prehospital treatment with prasugrel and no data on
prasugrel if used in the context of ﬁbrinolysis.
Glycoprotein (Gp) IIB/IIIA inhibitors
Gp IIB/IIIA receptor inhibition is thecommonﬁnal linkofplatelet
aggregation. Eptiﬁbatide and tiroﬁban lead to reversible inhibition,
while abciximab leads to irreversible inhibition of the Gp IIB/IIIA
receptor. Older studies from the pre-stent era mostly support the
use of this class of drugs [46,47]. Newer studies mostly document
neutral or worsened outcomes [48–51]. Finally in most support-
ing, as well as neutral or opposing studies, bleeding occurred in
more patients treated with Gp IIB/IIIA receptor blockers. There are
insufﬁcient data to support routine pre-treatment with Gp IIB/IIIA
inhibitors in patients with STEMI or non-STEMI-ACS. For high-
risk patients with non-STEMI-ACS, in-hospital upstream treatment
with eptiﬁbatide or tiroﬁbanmaybe acceptablewhereas abciximab
may be given only in the context of PCI [47,52]. Newer alterna-
tives for antiplatelet treatment should be considered because of
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he increased bleeding risk with Gp IIB/IIIA inhibitors when used
ith heparins.
ntithrombins
Unfractionated heparin (UFH) is an indirect inhibitor of throm-
in, which in combination with ASA is used as an adjunct with
brinolytic therapy or primary PCI (PPCI) and is an important part
f treatment of unstable angina and STEMI. Limitations of unfrac-
ionated heparin include its unpredictable anticoagulant effect in
ndividual patients, the need to give it intravenously and the need
o monitor aPTT. Moreover, heparin can induce thrombocytope-
ia. Since publication of the 2005 ERC guidelines on ACS, large
andomised trials have been performed testing several alternative
ntithrombins for the treatment of patients with ACS. In compar-
son with UFH, these alternatives have a more speciﬁc factor Xa
ctivity (low molecular weight heparins [LMWH], fondaparinux)
r are direct thrombin inhibitors (bivalirudin). With these newer
ntithrombins, in general, there is no need to monitor the coagula-
ion system and there is a reduced risk of thrombocytopenia.
ntithrombins in non-STEMI-ACS
In comparisonwithUFH, enoxaparin reduces the combinedend-
oint of mortality, myocardial infarction and the need for urgent
evascularisation, if givenwithin the ﬁrst 24–36h of onset of symp-
oms of non-STEMI-ACS [53,54]. Although enoxaparin causesmore
inor bleeding than UFH, the incidence of serious bleeding is not
ncreased.
Bleeding worsens the prognosis of patients with ACS [55]. Fon-
aparinux and bivalirudin cause less bleeding than UFH [56–59]. In
ost of the trials on patients presenting with non-STEMI-ACS, the
FH alternatives were given only after hospital admission; it may
e invalid to extrapolate the results of these studies to the prehos-
ital or ED setting. For patients with a planned initial conservative
pproach, fondaparinux and enoxaparin are reasonable alterna-
ives to UFH. There are insufﬁcient data to recommend any LMWH
ther than enoxaparin. For patients with an increased bleeding
isk consider giving fondaparinux or bivalirudin. For patients with
planned invasive approach, enoxaparin or bivalirudin are rea-
onable alternatives to UFH. In one study, catheter thrombi were
bserved in patients undergoing PCI who had received fonda-
arinux – additional UFH was required [56]. Since enoxaparin and
ondaparinux may accumulate in patients with renal impairment,
ose adjustment is necessary; bivalirudin orUFHare alternatives in
his situation. Bleeding riskmay be increased by switching the anti-
oagulant; therefore, the initial agent should be maintained with
he exception of fondaparinux where additional UFH is necessary
or patients undergoing PCI [60].
ntithrombins in STEMI
ntithrombins for patients to be treated with ﬁbrinolysis
Enoxaparin. Several randomised studiesofpatientswithSTEMI
ndergoing ﬁbrinolysis have shown that additional treatmentwith
noxaparin instead of UFH produced better clinical outcomes (irre-
pective of the ﬁbrinolytic used) but a slightly increased bleeding
ate in elderly (≥75 years) and low weight patients (BW<60kg)
61–63]. Reduced doses of enoxaparin in elderly and low weight
atients maintained the improved outcome while reducing the
leeding rate [64]. It is also reasonable to give enoxaparin instead
f UFH for prehospital treatment.
Dosing of enoxaparin: In patients <75 years, give an initial
olus of 30mg IV followed by 1mgkg−1 SC every 12h (ﬁrst
C dose shortly after the IV bolus). Treat patients ≥75 yearsn 81 (2010) 1353–1363
with 0.75mgkg−1 SC every 12h without an initial IV dose.
Patients with known impaired renal function (creatinine clearance
<30ml−1 min−1) may be given 1mgkg−1 enoxaparin SC once daily
or may be treated with UFH. There are insufﬁcient data to recom-
mend other LMWH.
Fondaparinux. Several studies show superiority or neutral out-
comewhen fondaparinuxwas comparedwithUFHas anadjunct for
ﬁbrinolysis in STEMI patients [56]. Fondaparinux (initially 2.5mg
SC followedby2.5mgSC. daily)maybe considered speciﬁcallywith
non-ﬁbrin-speciﬁc ﬁbrinolytics (i.e. streptokinase) in patients with
a plasma creatinine concentration <3mgdl−1 (250ml−1).
Bivalirudin. There are insufﬁcient data to recommend
bivalirudin instead of UFH in STEMI patients to be treated
with ﬁbrinolysis. Since bleeding risk may be increased by switch-
ing the anticoagulants, the initial agent should bemaintained, with
the exception of fondaparinux, where additional UFH is necessary
if an invasive procedure is planned [60].
Antithrombins for STEMI patients to be treated with primary PCI
(PPCI)
There is a paucity of studies on prehospital or ED initiation of
antithrombin treatment for patients with STEMI and planned PPCI.
Therefore treatment recommendations for these settings have to
be extrapolated from in-hospital investigations, until themore spe-
ciﬁc results of ongoing studies are available.
Enoxaparin. Several registries and smaller studies documented
favourable or neutral outcome when enoxaparin was compared
with UFH for contemporary PPCI (i.e. broad use of thienopyridines
and/or Gp IIB/IIIA receptor blockers) [65,66]. Therefore, enoxaparin
is a safe and effective alternative to UFH. There are insufﬁcient
data to recommend any LMWH other than enoxaparin for PPCI in
STEMI. Switching from UFH to enoxaparin or vice versa may lead
to an increased bleeding risk and therefore should be avoided [60].
Dose adjustment of enoxaparin is necessary for patients with renal
impairment.
Fondaparinux. When compared with UFH, fondaparinux
resulted in similar clinical outcomes but less bleedingwhenused in
the context of PPCI [56]; however, thrombus formationoncatheters
required treatment with additional UFH. Even if fondaparinux
reduces the bleeding risk compared with UFH in STEMI patients
undergoing PPCI, the use of the two agents is not recommended
over UFH alone. The dose of fondaparinux requires adjustment in
patients with renal impairment.
Bivalirudin. Two large randomised studies documented less
bleeding and a reduction in short and long term mortality when
bivalirudinwas comparedwithUFHplusGp IIB/IIIA receptor block-
ers in patients with STEMI and planned PCI [67–69]. Several other
studies and case series showed also better or neutral results and
less bleeding when bivalirudin was compared with UFH; there-
fore, bivalirudin is a safe alternative to UFH. However, a slightly
increased rate of stent thrombosis was observed within the ﬁrst
24h after PCI [67].
Strategies and systems of careSeveral systematic strategies to improve quality of out-of-
hospital care for patients with ACS have been investigated. These
strategies are principally intended to promptly identify patients
with STEMI in order to shorten the delay to reperfusion treatment.
Also triage criteria have been developed to select high-risk patients
citation 81 (2010) 1353–1363 1359
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Table 5.1
Contraindications for ﬁbrinolysis.a
Absolute contraindications
Haemorrhagic stroke or stroke of unknown origin at any time
Ischaemic stroke in the preceding 6 months
Central nervous system damage or neoplasms
Recent major trauma/surgery/head injury (within the preceding 3 weeks)
Gastro-intestinal bleeding within the last month
Known bleeding disorder
Aortic dissection
Relative contraindications
Transient ischaemic attack in preceding 6 months
Oral anticoagulant therapy
Pregnancy within 1-week post-partum
Non-compressible punctures
Traumatic resuscitation
Refractory hypertension (systole. blood pressure >180mmHg
Advanced liver diseaseH.-R. Arntz et al. / Resus
ith non-STEMI-ACS for transport to tertiary care centres offering
4/7 PCI services. In this context, several speciﬁc decisions have to
e made during initial care beyond the basic diagnostic steps nec-
ssary for clinical evaluation of the patient and interpretation of a
2-lead ECG. These decisions relate to:
1) Reperfusion strategy in patients with STEMI i.e. PPCI vs (pre-)
hospital ﬁbrinolysis.
2) Bypassingacloserbutnon-PCI capablehospital and takingmea-
sures to shorten the delay to intervention if PPCI is the chosen
strategy.
3) Procedures in special situations e.g. for patients successfully
resuscitated from non-traumatic cardiac arrest, patients with
shockor patientswithnon-STEMIACSwhoareunstable or have
signs of very high risk.
eperfusion strategy in patients presenting with STEMI
Reperfusion therapy in patients with STEMI is the most impor-
ant advance in the treatment ofmyocardial infarction in the last 25
ears. For patients presenting with STEMI within 12h of symptom
nset, reperfusion should be initiated as soon as possible indepen-
ent of themethod chosen [7,70–72]. Reperfusionmay be achieved
ith ﬁbrinolysis, with PPCI, or a combination of both. Efﬁcacy of
eperfusion therapy is profoundly dependent on the duration of
ymptoms. Fibrinolysis is effective speciﬁcally in the ﬁrst 2–3h
fter symptom onset; PPCI is less time sensitive [73].
ibrinolysis
A meta-analysis of six trials involving 6434 patients docu-
ented a 17% decrease in mortality among patients treated with
ut-of-hospital ﬁbrinolysis compared with in-hospital ﬁbrinolysis
74]. An effective and safe system for out-of-hospital ﬁbrinolytic
herapy requires adequate facilities for the diagnosis and treatment
f STEMI and its complications. Ideally, there should be a capability
f communicating with experienced hospital doctors (e.g. emer-
ency physicians or cardiologists). The average time gained with
ut-of-hospital ﬁbrinolysis was 60min, and the results were inde-
endent of the experience of the provider. Thus, giving ﬁbrinolytics
ut-of-hospital to patientswith STEMI or signs and symptoms of an
CSwith presumednewLBBB is beneﬁcial. Fibrinolytic therapy can
e given safely by trained paramedics, nurses or physicians using
n established protocol [75–80]. The efﬁcacy is greatest within the
rst 3h of the onset of symptoms [74]. Patients with symptoms of
CS and ECG evidence of STEMI (or presumably new LBBB or true
osterior infarction) presenting directly to the ED should be given
brinolytic therapy as soon as possible unless there is timely access
o PPCI.
isks of ﬁbrinolytic therapy
Healthcare professionals who give ﬁbrinolytic therapy must be
ware of its contraindications (Table 5.1) and risks. Patients with
arge AMIs (e.g. indicated by extensive ECG changes) are likely to
ain most from ﬁbrinolytic therapy. Beneﬁts of ﬁbrinolytic ther-
py are less impressive in inferior wall infarctions than in anterior
nfarctions. Older patients have an absolute higher risk of death,
ut the absolute beneﬁt of ﬁbrinolytic therapy is similar to that
f younger patients. Patients over 75 years have an increased
isk of intracranial bleeding from ﬁbrinolysis; thus, the absolute
eneﬁt of ﬁbrinolysis is reduced by this complication. The risk
f intracranial bleeding is increased in patients with a systolic
lood pressure of over 180mmHg; this degree of hypertension
s a relative contraindication to ﬁbrinolytic therapy. The risk of
ntracranial bleeding is also depending on the use of antithrombin
nd antiplatelet therapy.Infective endocarditis
Active peptic ulcer
a According to the guidelines of the European Society of Cardiology.
Primary percutaneous intervention
Coronary angioplasty with or without stent placement has
become the ﬁrst-line treatment for patients with STEMI, because
it has been shown to be superior to ﬁbrinolysis in the combined
endpoints of death, stroke and reinfarction in several studies and
meta-analyses [81,82]. This improvement was found when PPCI
was undertaken by a skilled person in a high-volume centre with a
limited delay to ﬁrst balloon inﬂation after ﬁrst medical contact
[83]. Therefore PPCI performed at a high-volume centre shortly
after ﬁrst medical contact (FMC), by an experienced operator who
maintains an appropriate expert status, is the preferred treatment
as it improves morbidity and mortality as compared with immedi-
ate ﬁbrinolysis.
Fibrinolysis vs primary PCI
Primary PCI has been limited by access to catheter laboratory
facilities, appropriately skilled clinicians and delay to ﬁrst bal-
loon inﬂation. Fibrinolysis therapy is awidely available reperfusion
strategy. Both treatment strategies are well established and have
been the subject of large randomisedmulticentre trials over the last
decades. Over this time both therapies have evolved signiﬁcantly
and the bodyof evidence is heterogeneous. In the randomised stud-
ies comparing PPCIwith ﬁbrinolytic therapy, the typical delay from
decision to the beginning of treatment with either PPCI or ﬁbri-
nolytic therapywas less than 60min. Several reports and registries
comparingﬁbrinolytic (includingprehospital administration) ther-
apy with PPCI showed a trend of improved survival if ﬁbrinolytic
therapywas initiatedwithin2hofonsetof symptomsandwascom-
bined with rescue or delayed PCI [84–86]. In registries that reﬂect
standard practice more realistically the acceptable PPCI related
delay (i.e. the diagnosis to balloon interval minus the diagnosis
to needle interval) to maintain the superiority of PPCI over ﬁbri-
nolysis varied considerably between 45 and >180min depending
on the patients’ conditions (i.e. age, localisation of infarction, and
duration of symptoms) [87]. Moreover there are few data for ben-
eﬁt of PPCI over ﬁbrinolysis in speciﬁc subgroups such as patients
post-CABG, with renal failure or with diabetes [88,89]. Time delay
to PCI may be signiﬁcantly shortened by improving the systems of
care [13,90–93], e.g.• Prehospital ECG registration
• ECG transmission to the receiving hospital
• Arranging single call activation of the catheterization laboratory
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Requiring the catheterization laboratory to be ready within
20min
Having an attending cardiologists always at the hospital
Providing real-time data feedback
Fostering senior management commitment
Encouraging a team-based approach
If PPCI cannot be accomplished within an adequate timeframe,
ndependent of the need for emergent transfer, then immediate
brinolysis should be considered unless there is a contraindication.
or thosepatientswith a contraindication toﬁbrinolysis, PCI should
till be pursued despite the delay, rather than not providing reper-
usion therapy at all. For those STEMI patients presenting in shock,
rimary PCI (or coronary artery bypass surgery) is the preferred
eperfusion treatment. Fibrinolysis should only be considered if
here is a substantial delay to PCI.
riage and inter-facility transfer for primary PCI
The risk of death, reinfarction or stroke is reduced if patients
ith STEMI are transferred promptly from community hospitals to
ertiary care facilities for PPCI [82,94,95]. It is less clear whether
mmediate ﬁbrinolytic therapy (in- or out-of-hospital) or transfer
or PPCI is superior for younger patients presenting with anterior
nfarction and within a short duration of <2–3h [87]. Transfer of
TEMI patients for PPCI is reasonable for those presenting more
han 3h but less than 12h after the onset of symptoms, provided
hat the transfer can be achieved rapidly.
ombination of ﬁbrinolysis and percutaneous coronary
ntervention
Fibrinolysis and PCI may be used in a variety of combinations
o restore coronary blood ﬂow andmyocardial perfusion. There are
everal ways in which the two therapies can be combined. There is
ome lack of uniformity in the nomenclature used to describe PCI
n these regimens. Facilitated PCI is used to describe PCI performed
mmediately after ﬁbrinolysis, a pharmaco-invasive strategy refers
o PCI performed routinely 3–24h after ﬁbrinolysis, and rescue PCI
s deﬁned as PCI performed for a failed reperfusion (as evidenced by
50% resolution of ST-segment elevation at 60–90min after com-
letion of ﬁbrinolytic treatment). These strategies are distinct from
routine PCI approach where the angiography and intervention is
erformed several days after successful ﬁbrinolysis.
Several studies andmeta-analyses demonstrateworse outcome
ith routine PCI performed immediately or as early as possible
fter ﬁbrinolysis [48,95]. Therefore routine facilitated PCI is not
ecommended even if there may be some speciﬁc subgroups of
atients which may beneﬁt from this procedure [96]. It is reason-
ble to perform angiography and PCI when necessary in patients
ith failedﬁbrinolysis according to clinical signs and/or insufﬁcient
T-segment resolution [97].
In case of clinically successful ﬁbrinolysis (evidenced by clinical
igns and ST-segment resolution >50%), angiography delayed by
everal hours after ﬁbrinolysis (the ‘pharmaco-invasive’ approach)
as been shown to improve outcome. This strategy includes early
ransfer for angiography andPCI if necessary after ﬁbrinolytic treat-
ent [98,99].
pecial situations
ardiogenic shockCardiogenic shock (and to some extent severe left ventricular
ailure) is one of the complications of ACS and has a mortality of
ore than 50%. Cardiogenic shock in STEMI is not a contraindica-
ion to ﬁbrinolytic therapy, but PCI is the treatment of choice. Earlyn 81 (2010) 1353–1363
revascularisation (i.e. PPCI, PCI early after ﬁbrinolysis) is indicated
for those patients who develop shock within 36h after symptom
onset of AMI and are suitable for revascularisation [100].
Suspect right ventricular infarction in patients with inferior
infarction, clinical shock andclear lungﬁelds. ST-segment elevation
≥1mm in lead V4R is a useful indicator of right ventricular infarc-
tion. These patients have an in-hospital mortality of up to 30% and
many beneﬁt greatly from reperfusion therapy. Avoid nitrates and
other vasodilators, and treat hypotension with intravenous ﬂuid.
Reperfusion after successful CPR
Coronary heart disease is the most frequent cause of out-of-
hospital cardiac arrest. Many of these patients will have an acute
coronary occlusion with signs of STEMI on the ECG, but cardiac
arrest due to ischaemic heart disease can also occur in the absence
of these ﬁndings. Several case series have shown that angiography
and, if necessary, PCI is feasible in patients with return of spon-
taneous circulation (ROSC) after cardiac arrest. In many patients
coronary artery occlusion or high degree stenoses can be identiﬁed
and treated. Fibrinolysismay be an alternative in patientswith ECG
signs of STEMI [101]. Therefore in patientswith STEMI or new LBBB
on ECG following ROSC after out-of-hospital cardiac arrest, imme-
diate angiography and percutaneous intervention or ﬁbrinolysis
should be considered [102,103]. It is reasonable to perform imme-
diate angiography and PCI in selected patients despite the lack of
ST elevation on the ECG or prior clinical ﬁndings such as chest pain.
It is reasonable to include reperfusion treatment in a standard-
ized post-cardiac arrest protocol as part of a strategy to improve
outcome [104]. Reperfusion treatment should not preclude other
therapeutic strategies including therapeutic hypothermia.
Primary and secondary prevention
Preventive interventions in patients presenting with an ACS
should be initiated early after hospital admission and should be
continued if already in place. Preventive measures improve prog-
nosis by reducing the number of major adverse cardiac events.
Prevention with drugs encompasses beta-blockers, angiotensin
converting enzyme (ACE) inhibitors/angiotensin receptor block-
ers (ARB) and statins, as well as basic treatment with ASA and, if
indicated, thienopyridines.
Beta-blockers
Several studies, undertaken mainly in the pre-reperfusion era,
indicate a decreased mortality, incidence of reinfarction and car-
diac rupture as well as a lower incidence of ventricular ﬁbrillation
and supraventricular arrhythmia in patients treated early with a
beta-blocker [105]. Intravenous beta-blockade may also reduce
mortality in patients undergoing PPCI who are not on oral beta-
blockers.
Beta-blocker studies are very heterogeneous with respect to
timeof start of treatment. There is paucity of data onadministration
in the prehospital or ED settings. Moreover, recent studies indicate
an increased risk of cardiogenic shock in patients with STEMI, even
if the rate of severe tachyarrhythmia is reduced by beta-blockade
[106].There is no evidence to support routine intravenous beta-
blockers in the prehospital or initial ED settings. Itmay be indicated
in special situations such as severe hypertension or tachyarrhyth-
mias in the absence of contraindications. It is reasonable to start
oral beta-blockers at low doses only after the patient is stabilized.
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nti-arrhythmics
There is no evidence to support the use of anti-arrhythmic pro-
hylaxis after ACS. Ventricular ﬁbrillation (VF) accounts for most
f the early deaths from ACS; the incidence of VF is highest in the
rst hours after onset of symptoms. This explains why numerous
tudies have been performed with the aim of demonstrating the
rophylactic effect of antiarrhythmic therapy [107]. The effects of
ntiarrhythmic drugs (lidocaine, magnesium, disopyramide, mex-
letine, verapamil, sotalol, and tocainamide) given prophylactically
o patients with ACS have been studied. Prophylaxis with lidocaine
educes the incidence of VF but may increase mortality [108]. Rou-
ine treatment with magnesium in patients with AMI does not
mprove mortality. Arrhythmia prophylaxis using disopyramide,
exiletine, verapamil, or other anti-arrhythmics given within the
rst hours of an ACS does not improve mortality. Therefore pro-
hylactic anti-arrhythmics are not recommended.
ngiotensin-converting enzyme inhibitors and angiotensin
eceptor blockers
Oral ACE inhibitors reduce mortality when given to patients
ith AMI with or without early reperfusion therapy. The beneﬁcial
ffects are most pronounced in patients presenting with ante-
ior infarction, pulmonary congestion or left ventricular ejection
raction <40%. Do not give ACE inhibitors if the systolic blood pres-
ure is less than 100mmHg on admission or if there is a known
ontraindication to these drugs. A trend towards higher mortal-
ty has been documented if an intravenous ACE inhibitor is started
ithin the ﬁrst 24h after onset of symptoms. Therefore, give an
ral ACE inhibitorwithin 24h after symptomonset in patientswith
MI regardless of whether early reperfusion therapy is planned,
articularly in those patients with anterior infarction, pulmonary
ongestion or a left ventricular ejection fraction below 40%. Do not
ive intravenous ACE inhibitors within 24h of onset of symptoms.
ive an angiotensin receptor blocker (ARB) to patients intolerant
f ACE inhibitors [109,110].
tatins
Statins reduce the incidence of major adverse cardiovascular
vents when given early within the ﬁrst days after onset an ACS
111,112]. Initiation of statin therapy should be considered within
4h of onset of symptoms of ACS unless contraindicated (target
DL cholesterol values <80mgdl−1 [2.1mmol l−1]). If patients are
lready receiving statin therapy, it should be not interrupted [113].
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These guidelines on paediatric life support are based on two
ain principles: (1) the incidence of critical illness, particularly
ardiopulmonary arrest, and injury in children is much lower than
n adults; (2) most paediatric emergencies are served primarily by
roviders who are not paediatric specialists and who have limited
aediatric emergencymedical experience. Therefore, guidelines on
aediatric life supportmust incorporate thebest available scientiﬁc
vidence but must also be simple and feasible. Finally, interna-
ional guidelines need to acknowledge the variation in national and
ocal emergency medical infrastructures and allow ﬂexibility when
ecessary.
he process
The European Resuscitation Council (ERC) published guide-
ines for paediatric life support (PLS) in 1994, 1998, 2000
nd 2005.1–5 The latter two were based on the International
onsensus on Science published by the International Liaison Com-
ittee on Resuscitation (ILCOR).6–8 This process was repeated in
009/2010, and the resulting Consensus on Science with Treat-
ent Recommendations (CoSTR) was published simultaneously in
esuscitation, Circulation andPediatrics.9,10 The PLSWorking Party
f the ERC has developed the ERC PLS Guidelines based on the
010 CoSTR and supporting scientiﬁc literature. The guidelines for
esuscitation of babies at birth are now covered in Section 7.11
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Guideline changes have been made in response to convincing
new scientiﬁc evidence and to simplify teaching and retention.
As before, there remains a paucity of good-quality evidence on
paediatric resuscitation. Therefore to facilitate and support dissem-
ination and implementation of the PLS Guidelines, changes have
been made only if there is new, high-level scientiﬁc evidence or
to ensure consistency with the adult guidelines. The feasibility of
applying the same guidance for all adults and children remains
a major topic of study. Major changes in these new guidelines
include:
Recognition of cardiac arrest
Healthcare providers cannot reliably determine the presence
or absence of a pulse in less than 10 s in infants or children.12,13
Therefore pulse palpation cannot be the sole determinant of car-
diac arrest and the need for chest compressions. If the victim is
unresponsive, not breathing normally, and there are no signs of life,
lay rescuers should begin CPR. Healthcare providers should look for
signs of life and if they are conﬁdent in the technique, theymay add
pulse palpation for diagnosing cardiac arrest and decide whether
they should begin chest compressions or not. The decision to begin
CPR must be taken in less than 10 s. According to the child’s age,
carotid (children), brachial (infants) or femoral pulse (children and
infants) checks may be used.14,15Compression ventilation ratios
The compression ventilation (CV) ratio used for children should
bebasedonwhether one, ormore thanone rescuer is present.16 Lay
rescuers, who usually learn only single-rescuer techniques, should
evier Ireland Ltd. All rights reserved.
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e taught touse a ratio of 30 compressions to2ventilationswhich is
he sameas theadult guidelines andenables anyone trained inbasic
ife support (BLS) to resuscitate children with minimal additional
nformation. Rescuers with a duty to respond should learn and use
15:2 CV ratio as this has been validated in animal and manikin
tudies.17–21 This latter group, who would normally be healthcare
rofessionals, should receive enhanced training targeted speciﬁ-
ally at the resuscitation of children. For them, simplicity would
e lost if a different ratio was taught for the scenario when one or
wo or more rescuers were present. However, those with a duty to
espond can use the 30:2 ratio if they are alone, particularly if they
re not achieving an adequate number of compressions because
f difﬁculty in the transition between ventilation and compres-
ion. Ventilation remains a very important component of CPR in
sphyxial arrests.22 Rescuers who are unable or unwilling to pro-
idemouth-to-mouth ventilation should be encouraged toperform
t least compression-only CPR.
PR quality
The compression technique for infants includes two-ﬁnger
ompression for single rescuers and the two-thumb encircling
echnique for two or more rescuers.23–27 For older children, a
ne- or two-hand technique can be used, according to rescuer
reference.28 The emphasis is on achieving an adequate depth of
ompression: at least 1/3 of the anterior-posterior chest diameter
n all children (i.e., approximately 4 cm in infants and approxi-
ately 5 cm in children). Subsequent complete release should also
e emphasised. Chest compressions must be performed with min-
mal interruptions to minimise no-ﬂow time. For both infants and
hildren, the compression rate shouldbeat least 100butnot greater
han 120min−1.
eﬁbrillation
utomated external deﬁbrillators
Case reports indicate that automated external deﬁbrillators
AEDs) are safe and successful when used in children older than
year of age.29,30 Automated external deﬁbrillators are capable of
dentifying arrhythmias in children accurately; in particular, they
re extremely unlikely to advise a shock inappropriately.31–33 Con-
equently, the use of AEDs is indicated in all children aged greater
han 1 year.34 Nevertheless, if there is any possibility that an AED
ay need to be used in children, the purchaser should check that
he performance of the particular model has been tested against
aediatric arrhythmias. Many manufacturers now supply purpose-
ade paediatric pads or software, which typically attenuate the
utput of the machine to 50–75 J35 and these are recommended
or children aged 1–8 years.36,37 If an attenuated shock or a manu-
lly adjustable machine is not available, an unmodiﬁed adult AED
ay be used in children older than 1 year.38 The evidence to sup-
ort a recommendation for the use of AEDs in children aged less
han 1 year is limited to case reports.39,40 The incidence of shock-
ble rhythms in infants is very low except when they suffer from
ardiac disease.41–43 In these rare cases, the risk/beneﬁt ratio may
e favourable and use of an AED (preferably with dose attenuator)
hould be considered.
anual deﬁbrillatorsThe treatment recommendation for paediatric ventricular ﬁb-
illation (VF) or paediatric pulseless ventricular tachycardia (VT)
emains immediate deﬁbrillation. In adult advanced life support
ALS), the recommendation is to give a single shock and then
esume CPR immediately without checking for a pulse or re-81 (2010) 1364–1388 1365
assessing the rhythm (see Section 4).44–47 To reduce the no-ﬂow
time, chest compressions should be continued while applying and
charging the paddles or self-adhesive pads (if the size of the child’s
chest allows this). Chest compressions should be brieﬂy paused
once the deﬁbrillator is charged to deliver the shock. The ideal
energy dose for safe and effective deﬁbrillation in children is
unknown, but animalmodels and small paediatric case series show
thatdoses larger than4 J kg−1 deﬁbrillate effectivelywithnegligible
side effects.29,37,48,49 Clinical studies in children indicate that doses
of 2 J kg−1 are insufﬁcient in most cases.13,42,50 Biphasic shocks are
at least as effective and produce less post-shock myocardial dys-
function than monophasic shocks.36,37,49,51–53
Therefore, for simplicity and consistency with adult BLS and
ALS guidance, a single-shock strategy using a non-escalating dose
of 4 J kg−1 (preferably biphasic but monophasic is acceptable) is
recommended for deﬁbrillation in children. Use the largest size
paddles or pads that ﬁt on the infant or child’s chest in the antero-
lateral or antero-posterior position without the pads/paddles
touching each other.13
Airway
Cuffed tracheal tubes
Cuffed tracheal tubes can be used safely in infants and young
children. The size should be selected by applying a validated for-
mula.
Cricoid pressure
The safety and value of using cricoid pressure during tracheal
intubation is not clear. Therefore, the applicationof cricoidpressure
should be modiﬁed or discontinued if it impedes ventilation or the
speed or ease of intubation.
Capnometry
Monitoring exhaled carbon dioxide (CO2), ideally by capnog-
raphy, is helpful to conﬁrm correct tracheal tube position and
recommended during CPR to help assess and optimize its quality.
Titration of oxygen
Based on increasing evidence of potential harm from hyperox-
aemia after cardiac arrest, once spontaneous circulation is restored,
inspiredoxygenshouldbe titrated to limit the riskofhyperoxaemia.
Rapid response systems
Implementation of a rapid response system in a paediatric in-
patient setting may reduce rates of cardiac and respiratory arrest
and in-hospital mortality.
New topics
New topics in the 2010 guidelines include channelopathies (i.e.,
the importance of autopsy and subsequent family testing) and
several new special circumstances: trauma, single ventricle pre-
and post-1st stage repair, post-Fontan circulation, and pulmonary
hypertension.Terminology
In the following text the masculine includes the feminine and
child refers to both infants and children unless noted otherwise.
1 itation 81 (2010) 1364–1388
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he term newly born refers to a neonate immediately after deliv-
ry. A neonate is a child within 4 weeks of age. An infant is a child
nder 1 year of age, and the term child refers to children between
year and onset of puberty. From puberty children are referred to
s adolescents for whom the adult guidelines apply. Furthermore,
t is necessary to differentiate between infants and older children,
s there are some important differences with respect to diagnos-
ic and interventional techniques between these two groups. The
nset of puberty, which is the physiological end of childhood, is the
ost logical landmark for the upper age limit for use of paediatric
uidance. If rescuers believe the victim to be a child they should use
he paediatric guidelines. If a misjudgement is made and the victim
urns out to be a young adult, little harm will accrue, as studies of
etiology have shown that the paediatric pattern of cardiac arrest
ontinues into early adulthood.54
. Paediatric basic life support
equence of actions
Rescuers who have been taught adult BLS and have no speciﬁc
nowledge of paediatric resuscitation may use the adult sequence,
s outcome isworse if they donothing. Non-specialistswhowish to
earn paediatric resuscitation because they have responsibility for
hildren (e.g., teachers, school nurses, lifeguards), should be taught
hat it is preferable to modify adult BLS and perform ﬁve initial
reaths followed by approximately 1min of CPR before they go for
elp (see adult BLS guideline).
The following sequence is to be followed by those with a duty
o respond to paediatric emergencies (usually health professional
eams) (Fig. 6.1).
. Ensure the safety of rescuer and child.
. Check the child’s responsiveness:
• Gently stimulate the child and ask loudly: are you all right?
A. If the child responds by answering or moving:
• Leave the child in the position in which you ﬁnd him (pro-
vided he is not in further danger).
• Check his condition and get help if needed.
• Re-assess him regularly.
B. If the child does not respond:
• Shout for help.
• Turn carefully the child on his back.
• Open the child’s airwayby tilting theheadand lifting the chin.
◦ Place your hand on his forehead and gently tilt his head
back.
◦ At the same time, with your ﬁngertip(s) under the point of
the child’s chin, lift the chin. Do not push on the soft tissues
under the chin as this may obstruct the airway.
◦ If you still have difﬁculty in opening the airway, try a jaw
thrust: place the ﬁrst two ﬁngers of each hand behind each
side of the child’s mandible and push the jaw forward.
Have a low threshold for suspecting an injury to the neck; if so,
ry to open the airway by jaw thrust alone. If jaw thrust alone does
ot enable adequate airway patency, add head tilt a small amount
t a time until the airway is open.
. Keeping the airway open, look, listen and feel for normal breath-
ingbyputting your face close to the child’s face and looking along
the chest:
• Look for chest movements.
• Listen at the child’s nose and mouth for breath sounds.
• Feel for air movement on your cheek.Fig. 6.1. Paediatric basic life support algorithm for those with a duty to respond to
paediatric emergencies.
In the ﬁrst few minutes after a cardiac arrest a child may be
taking slow infrequent gasps. Look, listen and feel for no more than
10 s before deciding – if you have any doubt whether breathing is
normal, act as if it is not normal:
A. If the child is breathing normally:
• Turn the child on his side into the recovery position (see
below).
• Send or go for help – call the local emergency number for an
ambulance.
• Check for continued breathing.
5B. If breathing is not normal or absent:
• Carefully remove any obvious airway obstruction.
• Give ﬁve initial rescue breaths.
• While performing the rescue breaths note any gag or cough
response to your action. These responses or their absencewill
form part of your assessment of ‘signs of life’, which will be
described later.
Rescue breaths for a child over 1 year of age (Fig. 6.2):
• Ensure head tilt and chin lift.
• Pinch the soft part of the nose closed with the index ﬁnger andthumb of your hand on his forehead.
• Allow the month to open, but maintain chin lift.
• Take a breath and place your lips around the mouth, making sure
that you have a good seal.
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7Fig. 6.2. Mouth-to-mouth ventilation – child.
Blow steadily into the mouth over about 1–1.5 s watching for
chest rise.
Maintain head tilt and chin lift, take your mouth away from the
victim and watch for his chest to fall as air comes out.
Take another breath and repeat this sequence ﬁve times. Identify
effectivenessbyseeing that thechild’s chesthas risenand fallen in
a similar fashion to the movement produced by a normal breath.
Rescue breaths for an infant (Fig. 6.3):
Ensure aneutral positionof thehead (as an infant’s head is usually
ﬂexed when supine, this may require some extension) and a chin
lift.
Take a breath and cover the mouth and nose of the infant with
your mouth, making sure you have a good seal. If the nose and
mouth cannot be covered in the older infant, the rescuer may
attempt to seal only the infant’s nose or mouth with his mouth
(if the nose is used, close the lips to prevent air escape).
Blow steadily into the infant’s mouth and nose over 1–1.5 s, suf-
ﬁcient to make the chest visibly rise.
Maintain head position and chin lift, take your mouth away from
the victim and watch for his chest to fall as air comes out.
Take another breath and repeat this sequence ﬁve times.
Fig. 6.3. Mouth-to-mouth and nose ventilation – infant.81 (2010) 1364–1388 1367
For both infants and children, if you have difﬁculty achieving an
effective breath, the airway may be obstructed:
• Open the child’s mouth and remove any visible obstruction. Do
not perform a blind ﬁnger sweep.
• Ensure that there is adequate head tilt and chin lift but also that
the neck is not over extended.
• If head tilt and chin lift has not opened the airway, try the jaw
thrust method.
• Make up to ﬁve attempts to achieve effective breaths, if still
unsuccessful, move on to chest compressions.
6. Assess the child’s circulation.
Take no more than 10 s to:
• Look for signs of life – this includes anymovement, coughingor
normal breathing (not abnormal gasps or infrequent, irregular
breaths).
If you check the pulse, ensure you take no more than 10 s.
In a child over 1 year – feel for the carotid pulse in the neck.
In an infant – feel for the brachial pulse on the inner aspect of
the upper arm.
The femoral pulse in the groin, which is half way between the
anterior superior iliac spine and the symphysis pubis, can also
be used in infant and children.
A. If you are conﬁdent that you can detect signs of life within 10 s:
• Continue rescue breathing, if necessary, until the child starts
breathing effectively on his own.
• Turn the child on to his side (into the recovery position) if he
remains unconscious.
• Re-assess the child frequently.
7B. If there are no signs of life, unless you are CERTAIN you can feel
a deﬁnite pulse of greater than 60 beats min−1 within 10 s:
• Start chest compressions.
• Combine rescue breathing and chest compressions:
Chest compressions:
For all children, compress the lower half of the sternum: To avoid
compressing the upper abdomen, locate the xiphisternum by ﬁnd-
ing the anglewhere the lowest ribs join in themiddle. Compress the
sternumoneﬁnger’s breadthabove this; the compression shouldbe
sufﬁcient to depress the sternum by at least one third of the depth
of the chest. Don’t be afraid to push too hard: “Push Hard and Fast”.
Release the pressure completely and repeat at a rate of at least
100min−1 (but not exceeding 120min−1). After 15 compressions,
tilt the head, lift the chin, and give two effective breaths. Continue
compressions and breaths in a ratio of 15:2. The best method for
compression varies slightly between infants and children.
Chest compression in infants (Fig. 6.4): The lone rescuer com-
presses the sternum with the tips of two ﬁngers. If there are two
or more rescuers, use the encircling technique. Place both thumbs
ﬂat side by side on the lower half of the sternum (as above) with
the tips pointing towards the infant’s head. Spread the rest of both
hands with the ﬁngers together to encircle the lower part of the
infant’s rib cage with the tips of the ﬁngers supporting the infant’s
back. For both methods, depress the lower sternum by at least one
third of the depth of the infant’s chest.
Chest compression in children over 1 year of age (Figs. 6.5 and 6.6):
Place the heel of one hand over the lower half of the sternum (as
above). Lift the ﬁngers to ensure that pressure is not applied over
the child’s ribs. Position yourself vertically above the victim’s chest
and, with your arm straight, compress the sternum to depress it
by at least one third of the depth of the chest. In larger children or
for small rescuers, this is achieved most easily by using both hands
with the ﬁngers interlocked.
1368 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388
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. Do not interrupt resuscitation until:
• The child shows signs of life (starts to wake up, to move, opens
eyes and to breathe normally or a deﬁnite pulse of greater than
60min−1 is palpated).
• Further qualiﬁed help arrives and takes over.
• You become exhausted.
hen to call for assistance
It is vital for rescuers to get help as quickly as possible when a
hild collapses.
When more than one rescuer is available, one starts resuscitation
while another rescuer goes for assistance.
If only one rescuer is present, undertake resuscitation for about
1min before going for assistance. To minimise interruption in
CPR, it may be possible to carry an infant or small child whilst
summoning help.
Fig. 6.5. Chest compression with one hand – child.Fig. 6.6. Chest compression with two hands – child.
• The only exception to performing 1min of CPR before going for
help is in the case of a child with a witnessed, sudden collapse
when the rescuer is alone. In this case, cardiac arrest is likely to
be caused by an arrhythmia and the child will need deﬁbrillation.
Seek help immediately if there is no one to go for you.
Recovery position
An unconscious child whose airway is clear, and who is breath-
ing normally, should be turned on his side into the recovery
position.
There are several recovery positions; they all aim to prevent
airwayobstructionand reduce the likelihoodofﬂuids suchas saliva,
secretions or vomit from entering into the upper airway.
There are important principles to be followed.
• Place the child in as near true lateral position as possible, with
his mouth dependent, which should enable the free drainage of
ﬂuid.
• The position should be stable. In an infant, this may require a
small pillow or a rolled-up blanket to be placed along his back to
maintain the position, so preventing the infant from rolling into
either the supine or prone position.
• Avoidanypressureon thechild’s chest thatmay impairbreathing.
• It should be possible to turn the child onto his side and back again
to the recovery position easily and safely, taking into consider-
ation the possibility of cervical spine injury by in-line cervical
stabilisation techniques.
D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1369
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If back blows do not relieve the FBAO, give chest thrusts to
infants or abdominal thrusts to children. These manoeuvres create
an artiﬁcial cough, increasing intrathoracic pressure anddislodging
the foreign body.
Table 6.1
Sign of foreign body airway obstruction.
General signs of FBAO
Witnessed episode
Coughing/choking
Sudden onset
Recent history of playing with/eating small objects
Ineffective coughing Effective coughFig. 6.7. Paediatric foreign b
Regularly change side to avoidpressurepoints (i.e., every30min).
The adult recovery position is suitable for use in children.
oreign body airway obstruction
No new evidence on this subject was presented during the 2010
onsensus Conference. Back blows, chest thrusts and abdominal
hrusts all increase intrathoracic pressure and can expel foreign
odies from the airway. In half of the episodes more than one tech-
ique is needed to relieve the obstruction.55 There are no data to
ndicate which measure should be used ﬁrst or in which order they
hould be applied. If one is unsuccessful, try the others in rotation
ntil the object is cleared.
The foreign body airway obstruction (FBAO) algorithm for chil-
ren was simpliﬁed and aligned with the adult version in 2005
uidelines; this continues to be the recommended sequence for
anaging FBAO (Fig. 6.7).
The most signiﬁcant difference from the adult algorithm is that
bdominal thrusts should not be used for infants. Although abdom-
nal thrusts have caused injuries in all age groups, the risk is
articularly high in infants and very young children. This is because
f the horizontal position of the ribs, which leaves the upper
bdominal viscera much more exposed to trauma. For this rea-
on, the guidelines for the treatment of FBAO are different between
nfants and children.
ecognition of foreign body airway obstruction
When a foreign body enters the airway the child reacts imme-
iately by coughing in an attempt to expel it. A spontaneous cough
s likely to be more effective and safer than any manoeuvre a
escuer might perform. However, if coughing is absent or ineffec-
ive and the object completely obstructs the airway, the child will
apidly become asphyxiated. Active interventions to relieve FBAO
re therefore required only when coughing becomes ineffective,
ut they then need to be commenced rapidly and conﬁdently. The
ajority of choking events in infants and childrenoccur duringplay
r eating episodes, when a carer is usually present; thus, the events
re frequently witnessed and interventions are usually initiated
hen the child is conscious.
Foreign body airway obstruction is characterised by the sud-
en onset of respiratory distress associated with coughing, gaggingrway obstruction algorithm.
or stridor (Table 6.1). Similar signs and symptoms may be asso-
ciated with other causes of airway obstruction such as laryngitis
or epiglottitis; these conditions are managed differently to that of
FBAO. Suspect FBAO if the onset was very sudden and there are no
other signs of illness; there may be clues to alert the rescuer, e.g.,
a history of eating or playing with small items immediately before
the onset of symptoms.
Relief of FBAO (Fig. 6.7)
1. Safety and summoning assistance
Safety is paramount: rescuersmust not place themselves indan-
ger and should consider the safest treatment of the choking child.
If the child is coughing effectively, no external manoeuvre is
necessary. Encourage the child to cough, and monitor continually.
If the child’s coughing is (or is becoming) ineffective, shout for
help immediately and determine the child’s conscious level.
2. Conscious child with FBAO
If the child is still conscious but has absent or ineffective cough-
ing, give back blows.Unable to vocalise Crying or verbal response to questions
Quiet or silent cough Loud cough
Unable to breathe Able to take a breath before coughing
Cyanosis Fully responsive
Decreasing level of consciousness
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Back blows in infants.
Support the infant in a head downward, prone position, to enable
gravity to assist removal of the foreign body.
A seated or kneeling rescuer should be able to support the infant
safely across their lap.
Support the infant’s head by placing the thumb of one hand, at
the angle of the lower jaw, and one or two ﬁngers from the same
hand, at the same point on the other side of the jaw.
Do not compress the soft tissues under the infant’s jaw, as this
will exacerbate the airway obstruction.
Deliver up to ﬁve sharp back blows with the heel of one hand in
the middle of the back between the shoulder blades.
The aim is too relieve the obstruction with each blow rather than
to give all ﬁve.
Back blows in children over 1 year.
Backblowsaremoreeffective if thechild ispositionedheaddown.
A small child may be placed across the rescuer’s lap as with the
infant.
If this is not possible, support the child in a forward leaning posi-
tion and deliver the back blows from behind.
If back blows fail to dislodge the object, and the child is still
onscious, use chest thrusts for infants or abdominal thrusts for
hildren. Do not use abdominal thrusts (Heimlich manoeuvre) in
nfants.
Chest thrusts for infants.
Turn the infant into a head downward supine position. This is
achieved safely by placing the free arm along the infant’s back
and encircling the occiput with the hand.
Support the infant down your arm, which is placed down (or
across) your thigh.
Identify the landmark for chest compressions (on the lowerhalf of
the sternum, approximately a ﬁnger’s breadth above the xiphis-
ternum).
Give ﬁve chest thrusts; these are similar to chest compressions
but sharper and delivered at a slower rate.
Abdominal thrusts for children over 1 year.
Stand or kneel behind the child; place your arms under the child’s
arms and encircle his torso.
Clench your ﬁst and place it between the umbilicus and xiphis-
ternum.
Grasp this handwith the other hand andpull sharply inwards and
upwards.
Repeat up to ﬁve times.
Ensure that pressure is not applied to the xiphoid process or the
lower rib cage – this may cause abdominal trauma.
Following the chest or abdominal thrusts, re-assess the child.
f the object has not been expelled and the victim is still con-
cious, continue the sequence of back blows and chest (for infant)
r abdominal (for children) thrusts. Call out, or send, for help if it is
till not available. Do not leave the child at this stage.
If the object is expelled successfully, assess the child’s clinical
ondition. It is possible that part of the object may remain in the
espiratory tract and cause complications. If there is anydoubt, seek
edical assistance. Abdominal thrusts may cause internal injuries
nd all victims treated with abdominal thrusts should be examined
y a doctor.581 (2010) 1364–1388
3. Unconscious child with FBAO
If the child with FBAO is, or becomes, unconscious, place him on
a ﬁrm, ﬂat surface. Call out, or send, for help if it is still not available.
Do not leave the child at this stage; proceed as follows:
Airway opening. Open the mouth and look for any obvious
object. If one is seen, make an attempt to remove it with a sin-
gle ﬁnger sweep. Do not attempt blind or repeated ﬁnger sweeps
– these can impact the object more deeply into the pharynx and
cause injury.
Rescue breaths. Open the airway using a head tilt/chin lift and
attemptﬁve rescuebreaths. Assess the effectiveness of eachbreath:
if a breath does not make the chest rise, reposition the head before
making the next attempt.
Chest compressions and CPR.
• Attempt ﬁve rescue breaths and if there is no response (moving,
coughing, spontaneous breaths) proceed to chest compressions
without further assessment of the circulation.
• Follow the sequence for single rescuer CPR (step 7B above) for
approximately a minute before summoning the EMS (if this has
not already been done by someone else).
• When the airway is opened for attempted delivery of rescue
breaths, look to see if the foreign body can be seen in the mouth.
• If an object is seen, attempt to remove it with a single ﬁnger
sweep.
• If it appears the obstruction has been relieved, open and check
the airway as above; deliver rescue breaths if the child is not
breathing.
• If the child regains consciousness and exhibits spontaneous
effective breathing, place him in a safe position onhis side (recov-
ery position) and monitor breathing and conscious level whilst
awaiting the arrival of the EMS.
B. Paediatric advanced life support
Prevention of cardiopulmonary arrest
In children, secondary cardiopulmonary arrests, caused by
either respiratory or circulatory failure, are more frequent than
primary arrests caused by arrhythmias.56–61 So-called asphyxial
arrests or respiratory arrests are alsomore common in young adult-
hood (e.g., trauma, drowning, poisoning).62,63 The outcome from
cardiopulmonary arrests in children is poor; identiﬁcation of the
antecedent stages of cardiac or respiratory failure is a priority, as
effective early intervention may be life saving.
The order of assessment and intervention for any seriously ill or
injured child follows the ABC principles.
• A indicates airway (Ac for airway and cervical spine stabilisation
for the injured child).
• B indicates breathing.
• C indicates circulation (with haemorrhage control in injured
child).
Interventions are made at each step of the assessment as abnor-
malities are identiﬁed. Thenext stepof theassessment isnot started
until the preceding abnormality has been managed and corrected
if possible. Summoning a paediatric rapid response team or med-
ical emergency team may reduce the risk of respiratory and/or
cardiac arrest in hospitalised children outside the intensive care
setting.64–69 This team should include at least one paediatrician
with speciﬁc knowledge in the ﬁeld and one specialised nurse, and
should be called to evaluate a potentially critically ill child who is
itation
n
e
D
m
p
•
•
•
•
e
c
C
•
•
•
•
D
b
g
m
v
r
f
•
•
•
•
•
•
•
•
DD. Biarent et al. / Resusc
ot already in a paediatric intensive care unit (PICU) or paediatric
mergency department (ED).
iagnosing respiratory failure: assessment of A and B
Assessment of a potentially critically ill child starts with assess-
ent of airway (A) and breathing (B). Abnormalities in airway
atency or gas exchange in the lungs can lead to respiratory failure.
Signs of respiratory failure include:
Respiratory rate outside the normal range for the child’s age –
either too fast or too slow.
Initially increasing work of breathing, which may progress to
inadequate/decreased work of breathing as the patient tires or
compensatory mechanisms fail, additional noises such as stridor,
wheeze, grunting, or the loss of breath sounds.
Decreased tidal volume marked by shallow breathing, decreased
chest expansion or decreased air entry at auscultation.
Hypoxaemia (without/with supplemental oxygen) generally
identiﬁed by cyanosis but best evaluated by pulse oximetry.
There may be associated signs in other organ systems that are
ither affected by inadequate ventilation and oxygenation or act to
ompensate the respiratory problem. These are detectable in step
of the assessment and include:
Increasing tachycardia (compensatory mechanism in an attempt
to increase oxygen delivery).
Pallor.
Bradycardia (ominous indicator of the loss of compensatory
mechanisms).
Alteration in the level of consciousness (a sign that compensatory
mechanisms are overwhelmed).
iagnosing circulatory failure: assessment of C
Circulatory failure (or shock) is characterised by a mismatch
etween metabolic demand by the tissues and delivery of oxy-
en and nutrients by the circulation.70 Physiological compensatory
echanisms lead to changes in the heart rate, in the systemic
ascular resistance (which commonly increases as an adaptive
esponse) and in tissue and organ perfusion. Signs of circulatory
ailure include:
Increased heart rate (bradycardia is an ominous sign of physio-
logical decompensation).
Decreased systemic blood pressure.
Decreased peripheral perfusion (prolonged capillary reﬁll time,
decreased skin temperature, pale or mottled skin).
Weak or absent peripheral pulses.
Decreased or increased intravascular volume.
Decreased urine output and metabolic acidosis.
Other systems may be affected, for example:
Respiratory frequencymay be increased initially, in an attempt to
improve oxygen delivery, later becoming slow and accompanied
by decompensated circulatory failure.
Level of consciousness may decrease because of poor cerebral
perfusion.
iagnosing cardiopulmonary arrest
Signs of cardiopulmonary arrest include:81 (2010) 1364–1388 1371
• Unresponsiveness to pain (coma).
• Apnoea or gasping respiratory pattern.
• Absent circulation.
• Pallor or deep cyanosis.
Palpation of a pulse is not reliable as the sole determinant of the
need for chest compressions.71,72 If cardiac arrest is suspected, and
in the absence of signs of life, rescuers (lay and professional) should
begin CPR unless they are certain they can feel a central pulse
within 10 s (infants – brachial or femoral artery; children – carotid
or femoral artery). If there is any doubt, start CPR.72–75 If personnel
skilled in echocardiography are available, this investigation may
help to detect cardiac activity and potentially treatable causes for
the arrest.76 However, echocardiography must not interfere with
the performance of chest compressions.
Management of respiratory and circulatory failure
In children, there are many causes of respiratory and circula-
tory failure and they may develop gradually or suddenly. Both may
be initially compensated but will normally decompensate without
adequate treatment. Untreated decompensated respiratory or cir-
culatory failurewill lead to cardiopulmonary arrest. Hence, the aim
of paediatric life support is early and effective intervention in chil-
drenwith respiratory and circulatory failure to prevent progression
to full arrest.
Airway and breathing
• Open the airway and ensure adequate ventilation and oxygena-
tion. Deliver high-ﬂow oxygen.
• Establish respiratory monitoring (ﬁrst line – pulse oximetry/
SpO2).
• Achieving adequate ventilation and oxygenationmay require use
of airway adjuncts, bag-mask ventilation (BMV), use of a laryn-
geal mask airway (LMA), securing a deﬁnitive airway by tracheal
intubation and positive pressure ventilation.
• Very rarely, a surgical airway may be required.
Circulation
• Establish cardiac monitoring (ﬁrst line – pulse oximetry/SpO2,
electrocardiography/ECG and non-invasive blood pres-
sure/NIBP).
• Secure intravascular access. This may be by peripheral intra-
venous (IV) or by intraosseous (IO) cannulation. If already in situ,
a central intravenous catheter should be used.
• Give a ﬂuid bolus (20mlkg−1) and/or drugs (e.g., inotropes, vaso-
pressors, anti-arrhythmics) as required.
• Isotonic crystalloids are recommended as initial resuscitation
ﬂuid in infants and children with any type of shock, including
septic shock.77–80
• Assess and re-assess the child continuously, commencing each
time with the airway before proceeding to breathing and then
the circulation.• During treatment, capnography, invasive monitoring of arterial
blood pressure, blood gas analysis, cardiac output monitoring,
echocardiography and central venous oxygen saturation (ScvO2)
may be useful to guide the treatment of respiratory and/or circu-
latory failure.
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Table 6.2
General recommendation for cuffed anduncuffed tracheal tube sizes (internal diam-
eter in mm).
Uncuffed Cuffed
Neonatespremature Gestational age in weeks/10 Not used
Neonates Full term 3.5 Not usually used372 D. Biarent et al. / Resusc
irway
Open the airway using basic life support techniques. Oropha-
yngeal and nasopharyngeal airways adjuncts can help maintain
he airway. Use the oropharyngeal airway only in the unconscious
hild, inwhom there is no gag reﬂex. Use the appropriate size (from
he incisors to the angle of the mandible), to avoid pushing the
ongue backward and obstructing the epiglottis, or directly com-
ressing the glottis. The soft palate in the child can be damaged
y insertion of the oropharyngeal airway – avoid this by insert-
ng the oropharyngeal airway with care; do not use any force. The
asopharyngeal airway is usually tolerated better in the conscious
r semi-consciouschild (whohasaneffectivegag reﬂex), but should
ot be used if there is a basal skull fracture or a coagulopathy. The
orrect insertion depth should be sized from the nostrils to the
ngle of themandible butmust be re-assessed after insertion. These
imple airway adjuncts do not protect the airway from aspiration
f secretions, blood or stomach contents.
aryngeal mask airway (LMA)
Although bag-mask ventilation remains the recommended ﬁrst
ine method for achieving airway control and ventilation in chil-
ren, the LMA is an acceptable airway device for providers trained
n its use.81,82 It is particularly helpful in airway obstruction caused
y supraglottic airway abnormalities or if bag-mask ventilation is
ot possible. The LMA does not totally protect the airway from
spiration of secretions, blood or stomach contents, and therefore
lose observation is required. Use of the LMA is associated with a
igher incidence of complications in small children compared with
dults.83,84 Other supraglottic airway devices (e.g., laryngeal tube),
hich have been used successfully in children’s anaesthesia, may
lso be useful in an emergency but there are few data on the use of
hese devices in paediatric emergencies.85
racheal intubation
Tracheal intubation is the most secure and effective way to
stablish and maintain the airway, prevent gastric distension, pro-
ect the lungs against pulmonary aspiration, enable optimal control
f the airway pressure and provide positive end expiratory pres-
ure (PEEP). The oral route is preferable during resuscitation. Oral
ntubation is quicker and simpler, and is associated with fewer
omplications than nasal placement. In the conscious child, the
udicious use of anaesthetics, sedatives and neuromuscular block-
ng drugs is essential in order to avoidmultiple intubation attempts
r intubation failure.86–95 The anatomy of a child’s airway dif-
ers signiﬁcantly from that of an adult; hence, intubation of a
hild requires special training and experience. Clinical examina-
ion and capnography must be used to conﬁrm correct tracheal
ube placement. The tracheal tube must be secured and vital signs
onitored.96 It is also essential to plan an alternative airway man-
gement technique in case the trachea cannot be intubated.
There is currently no evidence-based recommendation deﬁning
he setting-, patient- and operator-related criteria for prehospital
racheal intubation of children. Prehospital tracheal intubation of
hildren may be considered if:
1) the airway and/or breathing is seriously compromised or
threatened;2) the mode and duration of transport require the airway to be
secured early (e.g., air transport); and
3) if the operator is adequately skilled in advanced paediatric
airway management including the use of drugs to facilitate
tracheal intubation.97Infants 3.5–4.0 3.0–3.5
Child 1–2 years 4.0–4.5 3.5–4.0
Child >2 years Age/4 +4 Age/4 +3.5
Rapid-sequence induction and intubation
The child who is in cardiopulmonary arrest and/or deep coma
does not require sedation or analgesia to be intubated; otherwise,
intubation must be preceded by oxygenation (gentle BMV is some-
times required to avoid hypoxia), rapid sedation, analgesia and the
use of neuromuscular blocking drugs to minimise intubation com-
plications and failure.98 The intubator must be experienced and
familiar with drugs used for rapid-sequence induction. The use
of cricoid pressure may prevent or limit regurgitation of gastric
contents99,100 but itmay distort the airway andmake laryngoscopy
and intubation more difﬁcult.101 Cricoid pressure should not be
used if either intubation or oxygenation is compromised.
Tracheal tube sizes
A general recommendation for tracheal tube internal diameters
(ID) for different ages is shown in Table 6.2.102–107 This is a guide
only and tubes one size larger and smaller should always be avail-
able. Tracheal tube size can also be estimated from the length of
the child’s body as measured by resuscitation tapes.108
Cuffed versus uncuffed tracheal tubes
Uncuffed tracheal tubes have been used traditionally in children
up to 8 years of age but cuffed tubesmay offer advantages in certain
circumstances e.g., when lung compliance is poor, airway resis-
tance is high or if there is a large air leak from the glottis.102,109,110
The use of cuffed tubes also makes it more likely that the correct
tube sizewill be chosen on the ﬁrst attempt.102,103,111 The correctly
sized cuffed tracheal tube is as safe as an uncuffed tube for infants
and children (not for neonates) provided attention is paid to its
placement, size and cuff inﬂation pressure.109,110,112 As excessive
cuff pressure may lead to ischaemic damage to the surrounding
laryngeal tissueand stenosis, cuff inﬂationpressure shouldbemon-
itored and maintained at less than 25 cm H2O.112
Conﬁrmation of correct tracheal tube placement
Displaced, misplaced or obstructed tubes occur frequently in
the intubated child and are associated with increased risk of
death.113,114 No single technique is 100% reliable for distinguishing
oesophageal from tracheal intubation.115–117
Assessment of the correct tracheal tube position is made by:
• laryngoscopic observation of the tube passing beyond the vocal
cords;
• detection of end-tidal CO2 (by colorimetry or capnometry/-
graphy) if the child has a perfusing rhythm (this may also be seen
with effective CPR, but it is not completely reliable);
• observation of symmetrical chestwallmovement during positive
pressure ventilation;
• observation of mist in the tube during the expiratory phase of
ventilation;• absence of gastric distension;
• equal air entry heard on bilateral auscultation in the axillae and
apices of the chest;
• absence of air entry into the stomach on auscultation;
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improvement or stabilisation of SpO2 in the expected range
(delayed sign!);
improvement of heart rate towards the age-expected value (or
remaining within the normal range) (delayed sign!).
If the child is in cardiopulmonary arrest and exhaled CO2 is not
etected despite adequate chest compressions, or if there is any
oubt, conﬁrm tracheal tube position by direct laryngoscopy. After
orrect placement and conﬁrmation, secure the tracheal tube and
e-assess its position. Maintain the child’s head in the neutral posi-
ion. Flexion of the head drives the tube further into the trachea
hereas extension may pull it out of the airway.118 Conﬁrm the
osition of the tracheal tube at the mid-trachea by chest X-ray; the
racheal tube tip should be at the level of the 2nd or 3rd thoracic
ertebra.
DOPES is auseful acronymfor the causesof suddendeterioration
n an intubated child:
Displacement of the tracheal tube.
Obstruction of the tracheal tube or of the heat and moisture
exchanger (HME).
Pneumothorax.
Equipment failure (source of gas, bag-mask, ventilator, etc.).
Stomach (gastric distension may alter diaphragm mechanics).
reathing
xygenation
Give oxygen at the highest concentration (i.e., 100%) during
nitial resuscitation. Once circulation is restored, give sufﬁcient
xygen to maintain an arterial oxygen saturation (SaO2) in the
ange of 94–98%.119,120
Studies in neonates suggest some advantages of using room air
uring resuscitation (see Section 7).11,121–124 In the older child,
here is no evidence of beneﬁt for air instead of oxygen, so use
00% oxygen for initial resuscitation and after return of a sponta-
eous circulation (ROSC) titrate the fraction inspired oxygen (FiO2)
o achieve a SaO2 in the range of 94–98%. In smoke inhalation (car-
on monoxide poisoning) and severe anaemia however a high FiO2
hould be maintained until the problem has been solved because
n these circumstances dissolved oxygen plays an important role in
xygen transport.
entilation
Healthcare providers commonly provide excessive ventilation
uring CPR and this may be harmful. Hyperventilation causes
ncreased intrathoracic pressure, decreased cerebral and coronary
erfusion, and poorer survival rates in animals and adults.125–131
lthough normoventilation is the objective during resuscitation, it
s difﬁcult to know the precise minute volume that is being deliv-
red. A simple guide to deliver an acceptable tidal volume is to
chievemodest chestwall rise. Use a ratio of 15 chest compressions
o 2 ventilations and a compression rate of 100–120min−1.125 Once
OSC has been achieved, provide normal ventilation (rate/volume)
ased on the victim’s age and, as soon as possible, by monitoring
nd-tidal CO2 and blood gas values.
Once the airway is protected by tracheal intubation, continue
ositive pressure ventilation at 10–12 breaths min−1 without
nterrupting chest compressions. Take care to ensure that lung
nﬂation is adequate during chest compressions. When circulation
s restored, or if the child still has a perfusing rhythm, ventilate at
2–20 breaths min−1 to achieve a normal arterial carbon dioxide
ension (PaCO2). Hyperventilation and hypoventilation are harm-
ul.81 (2010) 1364–1388 1373
Bag-mask ventilation (BMV)
Bag-mask ventilation (BMV) is effective and safe for a child
requiring assisted ventilation for a short period, i.e., in the prehos-
pital setting or in an emergency department.114,132–135 Assess the
effectiveness of BMV by observing adequate chest rise, monitor-
ing heart rate and auscultating for breath sounds, and measuring
peripheral oxygen saturation (SpO2). Any healthcare provider with
a responsibility for treating children must be able to deliver BMV
effectively.
Prolonged ventilation
If prolonged ventilation is required, the beneﬁts of a secured air-
way probably outweigh the potential risks associatedwith tracheal
intubation. For emergency intubation, both cuffed and uncuffed
tracheal tubes are acceptable.
Monitoring of breathing and ventilation
End-tidal CO2
Monitoring end-tidal CO2 (ETCO2) with a colorimetric detec-
tor or capnometer conﬁrms tracheal tube placement in the child
weighing more than 2kg, and may be used in pre- and in-hospital
settings, as well as during any transportation of the child.136–139
A colour change or the presence of a capnographic waveform for
more than four ventilated breaths indicates that the tube is in the
tracheobronchial tree both in the presence of a perfusing rhythm
and during cardiopulmonary arrest. Capnography does not rule out
intubation of a bronchus. The absence of exhaled CO2 during car-
diopulmonary arrest does not guarantee tube misplacement since
a low or absent ETCO2 may reﬂect low or absent pulmonary blood
ﬂow.140–143
Capnography may also provide information on the efﬁciency of
chest compressions and can give an early indication of ROSC.144,145
Efforts should be made to improve chest compression quality if
the ETCO2 remains below 15mmHg (2kPa). Care must be taken
when interpreting ETCO2 values especially after the administration
of adrenaline or other vasoconstrictor drugs when there may be
a transient decrease in values,146–150 or after the use of sodium
bicarbonate when there may be a transient increase.151 Current
evidence does not support the use of a threshold ETCO2 value as an
indicator for the discontinuation of resuscitation efforts.
Oesophageal detector devices
The self-inﬂating bulb or aspirating syringe (oesophageal detec-
tor device, ODD) may be used for the secondary conﬁrmation of
tracheal tube placement in childrenwith a perfusing rhythm.152,153
There are no studies on the use of the ODD in children who are in
cardiopulmonary arrest.
Pulse oximetry
Clinical evaluation of the oxygen saturation of arterial blood
(SaO2) is unreliable; therefore, monitor the child’s peripheral
oxygen saturation continuously by pulse oximetry (SpO2). Pulse
oximetry can be unreliable under certain conditions, for example,
if the child is in circulatory failure, in cardiopulmonary arrest or has
poor peripheral perfusion. Although pulse oximetry is relatively
simple, it is a poor guide to tracheal tube displacement. Capnog-
raphy detects tracheal tube dislodgement more rapidly than pulse
oximetry.154
CirculationVascular access
Vascular access is essential to enable drugs and ﬂuids to be
given, and blood samples obtained. Venous access can be dif-
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cult to establish during resuscitation of an infant or child. In
ritically ill children, whenever venous access is not readily attain-
ble intraosseous access should be considered early, especially
f the child is in cardiac arrest or decompensated circulatory
ailure.155–157 In any case, in critically ill children, if attempts at
stablishing intravenous (IV) access are unsuccessful after 1min,
nsert an intraosseous (IO) needle instead.155,158
ntraosseous access
Intraosseous access is a rapid, safe, and effective route to give
rugs, ﬂuids and blood products.159–168 The onset of action and
ime to achieve adequate plasma drug concentrations are sim-
lar to that achieved via the central venous route.169,170 Bone
arrow samples can be used to cross match for blood type or
roup171 for chemical analysis172,173 and for blood gas measure-
ent (the values are comparable to central venous blood gases if
o drug has been injected in the cavity).172,174–176 However sam-
les can damage autoanalysers and should be used preferably in
artridge analyser. Flush each drug with a bolus of normal saline
o ensure dispersal beyond the marrow cavity, and to achieve
aster distribution to the central circulation. Inject large boluses
f ﬂuid using manual pressure. Intraosseous access can be main-
ained until deﬁnitive IV access has been established. The beneﬁts
f semi-automated IO devices remain to be seen but preliminary
xperiences show them to be rapid and effective for obtaining cir-
ulatory access.167,168,177,178
ntravenous access
Peripheral IV access provides plasma concentrations of
rugs and clinical responses equivalent to central or IO
ccess.156,157,179–181 Central venous lines provide more secure
ong-term access but, compared with IO or peripheral IV access,
ffer no advantages during resuscitation.156,179–181
racheal tube access
Intraosseous or IV access should be deﬁnitely preferred to the
racheal route for giving drugs.182 Drugs given via the trachea have
ighly variable absorption but, for guidance, the following dosages
ave been recommended:
drenaline 100gkg−1
idocaine 2–3mgkg−1
tropine 30gkg−1
The optimal dose of naloxone is not known.
Dilute the drug in 5ml of normal saline and follow adminis-
ration with ﬁve ventilations.183–185 Do not give non-lipid soluble
edications (e.g., glucose, bicarbonate, calcium) via the tracheal
ube because they will damage the airway mucosa.
luids and drugs
Volume expansion is indicated when a child shows signs of
irculatory failure in the absence of volume overload.186 Isotonic
rystalloids are recommended as the initial resuscitation ﬂuid for
nfants and children with any type of circulatory failure.
If systemic perfusion is inadequate, give a bolus of 20mlkg−1 of
n isotonic crystalloideven if the systemicbloodpressure isnormal.
ollowing every bolus, re-assess the child’s clinical state, usingABC,
o decide whether a further bolus or other treatment is required.
There are insufﬁcient data to make recommendations about the
se of hypertonic saline for circulatory failure associated with head
njuries or hypovolaemia.187,188
There are also insufﬁcient data to recommend delayed
uid resuscitation in the hypotensive child with blunt
rauma.189 Avoid dextrose containing solutions unless there81 (2010) 1364–1388
is hypoglycaemia.190–193 Monitor glucose levels and avoid hypo-
glycaemia; infants and small children are particularly prone to
hypoglycaemia.
Adenosine
Adenosine is an endogenous nucleotide that causes a brief atri-
oventricular (AV) block and impairs accessory bundle re-entry at
the level of the AV node. Adenosine is recommended for the treat-
ment of supraventricular tachycardia (SVT).194 It is safe because
it has a short half-life (10 s); give it intravenously via upper limb
or central veins to minimise the time taken to reach the heart.
Give adenosine rapidly, followed by a ﬂush of 3–5ml of normal
saline.195 Adenosine must be used with caution in asthmatics, sec-
ond or third degree AV block, long QT syndromes and in cardiac
transplant recipients.
Adrenaline (epinephrine)
Adrenaline is an endogenous catecholamine with potent , 1
and 2 adrenergic actions. It is placed prominently in the car-
diac arrest treatment algorithms for non-shockable and shockable
rhythms. Adrenaline induces vasoconstriction, increases diastolic
pressure and thereby improves coronary artery perfusion pres-
sure, enhances myocardial contractility, stimulates spontaneous
contractions, and increases the amplitude and frequency of VF, so
increasing the likelihood of successful deﬁbrillation.
The recommended IV/IO dose of adrenaline in children for
the ﬁrst and for subsequent doses is 10gkg−1. The max-
imum single dose is 1mg. If needed, give further doses of
adrenaline every 3–5min. Intratracheal adrenaline is no longer
recommended,196–199 but if this route is ever used, the dose is ten
times this (100gkg−1).
The use of higher doses of adrenaline via the IV or IO route
is not recommended routinely as it does not improve survival or
neurological outcome after cardiopulmonary arrest.200–203
Once spontaneous circulation is restored, a continuous infu-
sion of adrenaline may be required. Its haemodynamic effects are
dose related; there is also considerable variability in response
between children; therefore, titrate the infusion dose to the
desired effect. High infusion rates may cause excessive vasocon-
striction, compromising extremity, mesenteric, and renal blood
ﬂow. High-dose adrenaline can cause severe hypertension and
tachyarrhythmias.204
To avoid tissue damage it is essential to give adrenaline through
a secure intravascular line (IV or IO). Adrenaline (and other cate-
cholamines) is inactivated by alkaline solutions and should never
be mixed with sodium bicarbonate.205
Amiodarone
Amiodarone is a non-competitive inhibitor of adrenergic recep-
tors: it depresses conduction in myocardial tissue and therefore
slows AV conduction, and prolongs the QT interval and the
refractory period. Except when given for the treatment of refrac-
tory VF/pulseless VT, amiodarone must be injected slowly (over
10–20min) with systemic blood pressure and ECG monitoring to
avoid causing hypotension. This side effect is less commonwith the
aqueous solution.206 Other rare but signiﬁcant adverse effects are
bradycardia and polymorphic VT.207Atropine
Atropine accelerates sinus and atrial pacemakers by blocking
the parasympathetic response. It may also increase AV conduction.
Small doses (< 100g) may cause paradoxical bradycardia.208 In
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radycardiawith poor perfusion that is unresponsive to ventilation
nd oxygenation, the ﬁrst line drug is adrenaline, not atropine.
Atropine is recommended for bradycardia caused by increased
agal tone or cholinergic drug toxicity.209–212
alcium
Calcium is essential for myocardial function213,214 but routine
se of calcium does not improve the outcome from cardiopul-
onary arrest.215–217
Calcium is indicated in the presence of hypocalcaemia,
alcium channel blocker overdose, hypermagnesaemia and
yperkalaemia.218–220
lucose
Data from neonates, children and adults indicate that both
yper- and hypo-glycaemia are associatedwith poor outcome after
ardiopulmonary arrest,221–223 but it is uncertain if this is causative
rmerely an association.224 Checkbloodor plasmaglucose concen-
ration andmonitor closely in any ill or injured child, including after
ardiac arrest. Do not give glucose-containing ﬂuids during CPR
nlesshypoglycaemia is present. Avoidhyper- andhypo-glycaemia
ollowingROSC. Strict glucose control has not shown survival bene-
ts in adults when compared with moderate glucose control225,226
nd it increases the risk of hypoglycaemia in neonates, children and
dults.227–231
agnesium
There is no evidence for giving magnesium routinely during
ardiopulmonary arrest.232 Magnesium treatment is indicated in
he child with documented hypomagnesaemia or with torsades de
ointes VT regardless of the cause.233
odium bicarbonate
Do not give sodium bicarbonate routinely during cardiopul-
onary arrest or after ROSC.220,234,235 After effective ventilation
nd chest compressions have been achieved and adrenaline given,
odiumbicarbonatemaybeconsidered for the childwithprolonged
ardiopulmonary arrest and/or severe metabolic acidosis. Sodium
icarbonate may also be considered in case of haemodynamic
nstability and co-existing hyperkalaemia, or in the management
f tricyclic antidepressant drug overdose. Excessive quantities of
odium bicarbonate may impair tissue oxygen delivery, produce
ypokalaemia, hypernatraemia, hyperosmolality, and inactivate
atecholamines.
idocaine
Lidocaine is less effective than amiodarone for deﬁbrillation-
esistant VF/pulseless VT in adults236 and therefore is not the ﬁrst
ine treatment in deﬁbrillation-resistant VF/pulseless VT in chil-
ren.
rocainamide
Procainamide slows intra-atrial conduction and prolongs the
RS and QT intervals. It can be used in SVT237–239 or VT240 resis-
ant to other medications in the haemodynamically stable child.
owever, paediatric data are sparse and procainamide should be
sed cautiously.241,242 Procainamide is a potent vasodilator and can
ause hypotension: infuse it slowly with careful monitoring.243–24581 (2010) 1364–1388 1375
Vasopressin – terlipressin
Vasopressin is an endogenous hormone that acts at speciﬁc
receptors, mediating systemic vasoconstriction (via V1 receptor)
and the reabsorption of water in the renal tubule (by the V2
receptor).246 There is currently insufﬁcient evidence to support or
refute the use of vasopressin or terlipressin as an alternative to,
or in combination with, adrenaline in any cardiac arrest rhythm in
adults or children.247–258
Some studies have reported that terlipressin (a long-acting
analogueof vasopressinwith comparable effects) improveshaemo-
dynamics in children with refractory, vasodilatory septic shock,
but its impact on survival is less clear.255–257,259,260 Two paediatric
series suggested that terlipressin could be effective in refractory
cardiac arrest.258,261
These drugs could be used in cardiac arrest refractory to several
adrenaline doses.
Deﬁbrillators
Deﬁbrillators are either automatically or manually operated,
and may be capable of delivering either monophasic or biphasic
shocks. Manual deﬁbrillators capable of delivering the full energy
requirements from neonates upwards must be available within
hospitals and in other healthcare facilities caring for children at
risk of cardiopulmonary arrest. Automated external deﬁbrillators
(AEDs) are preset for all variables including the energy dose.
Pad/paddle size for deﬁbrillation
Select the largestpossibleavailablepaddles toprovidegoodcon-
tact with the chest wall. The ideal size is unknown but there should
be good separation between the pads.13,262,263
Recommended sizes are:
• 4.5 cm diameter for infants and children weighing <10kg.
• 8–12 cm diameter for children >10kg (older than 1 year).
To decrease skin and thoracic impedance, an electrically con-
ducting interface is required between the skin and the paddles.
Preformed gel pads or self-adhesive deﬁbrillation electrodes are
effective. Do not use ultrasound gel, saline-soaked gauze, alcohol-
soaked gauze/pads or ultrasound gel.
Position of the paddles
Apply the paddles ﬁrmly to the bare chest in the antero-lateral
position, one paddle placed below the right clavicle and the other
in the left axilla (Fig. 6.8). If the paddles are too large and there is a
danger of charge arcing across the paddles, one should be placed on
the upper back, below the left scapula and the other on the front,
to the left of the sternum. This is known as the antero-posterior
position and is also acceptable.
Optimal paddle force
To decrease transthoracic impedance during deﬁbrillation,
apply a force of 3 kg for childrenweighing<10kg and 5kg for larger
children.264,265 In practice, this means that the paddles should be
applied ﬁrmly.Energy dose in children
The ideal energy dose for safe and effective deﬁbrillation
is unknown. Biphasic shocks are at least as effective and pro-
duce less post-shock myocardial dysfunction than monophasic
1376 D. Biarent et al. / Resuscitation
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to identify and treat shockable rhythms as quickly as possible.Fig. 6.8. Paddle positions for deﬁbrillation – child.
hocks.36,49,51–53,266 Animal models show better results with pae-
iatric doses of 3–4 J kg−1 thanwith lowerdoses,49 or adult doses.38
linical studies in children indicate that doses of 2 J kg−1 are insuf-
cient in most cases.12,38,42 Doses larger than 4 J kg−1 (as much as
J kg−1) have deﬁbrillated children effectively with negligible side
ffects.29,48 When using a manual deﬁbrillator, use 4 J kg−1 (prefer-
bly biphasic but monophasic waveform is also acceptable) for the
rst and subsequent shocks.
If no manual deﬁbrillator is available, use an AED that can
ecognise paediatric shockable rhythms.31,32,267 The AED should
e equipped with a dose attenuator which decreases the deliv-
red energy to a lower dose more suitable for children aged 1–8
ears (50–75 J).34,37 If such an AED in not available, use a stan-
ard AED and the preset adult energy levels. For children above
years, use a standard AED with standard paddles. Although the
vidence to support a recommendation for the use of AEDs (prefer-
bly with dose attenuator) in children less than 1 year is limited to
ase reports,39,40 it is acceptable if no other option is available.
dvanced management of cardiopulmonary arrest
Fig. 6.9)
BC
Commence and continue with basic life support
Oxygenate and ventilate with BMV
Provide positive pressure ventilationwith a high inspired oxygen
concentration
Give ﬁve rescue breaths followed by external chest compression
and positive pressure ventilation in the ratio of 15:2
Avoid rescuer fatigue by frequently changing the rescuer per-
forming chest compressions
Establish cardiac monitoring
Assess cardiac rhythm and signs of life
(±check for a central pulse for no more than 10 s)on-shockable – asystole, pulseless electrical activity (PEA)
Give adrenaline IV or IO (10gkg−1) and repeat every 3–5min.
Identify and treat any reversible causes (4 Hs and 4 Ts) (Fig. 6.10).81 (2010) 1364–1388
Shockable – VF/pulseless VT
Attempt deﬁbrillation immediately (4 J kg−1):
• Charge the deﬁbrillator while another rescuer continues chest
compressions.
• Once the deﬁbrillator is charged, pause the chest compressions,
ensure that all rescuers are clear of the patient. Minimise the
delay between stopping chest compressions and delivery of the
shock – even 5–10 s delay will reduce the chances of the shock
being successful.268,269
• Give one shock.
• ResumeCPR as soon as possiblewithout re-assessing the rhythm.
• After 2min, check brieﬂy the cardiac rhythm on the monitor.
• Give second shock (4 J kg−1) if still in VF/pulseless VT.
• Give CPR for 2min as soon as possible without re-assessing the
rhythm.
• Pause brieﬂy to assess the rhythm; if still in VF/pulseless VT give
a third shock at 4 J kg−1.
• Give adrenaline 10gkg−1 and amiodarone 5mgkg−1 after the
third shock once CPR has been resumed.
• Give adrenaline every alternate cycle (i.e., every 3–5min during
CPR).
• Give a second dose of amiodarone 5mg/kg270 if still in
VF/pulseless VT after the ﬁfth shock.
If the child remains in VF/pulseless VT, continue to alternate
shocks of 4 J kg−1 with 2min of CPR. If signs of life become evident,
check the monitor for an organised rhythm; if this is present, check
for signsof life anda central pulse andevaluate thehaemodynamics
of the child (blood pressure, peripheral pulse, capillary reﬁll time).
Identify and treat any reversible causes (4 Hs and 4 Ts) remem-
bering that the ﬁrst 2 Hs (hypoxia and hypovolaemia) have the
highest prevalence in critically ill or injured children (Fig. 6.11).
If deﬁbrillation was successful but VF/pulseless VT recurs,
resumeCPR, give amiodaroneanddeﬁbrillate again at 4 J Kg−1. Start
a continuous infusion of amiodarone.
Reversible causes of cardiac arrest
The reversible causes of cardiac arrest can be considered quickly
by recalling the 4 Hs and 4 Ts:
• Hypoxia.
• Hypovolaemia.
• Hyper/hypokalaemia.
• Hypothermia.
• Tension pneumothorax.
• Toxic/therapeutic disturbances.
• Tamponade (coronary or pulmonary).
• Thrombosis (coronary or pulmonary).
Sequence of events in cardiopulmonary arrest
1. When a child becomes unresponsive, without signs of life (no
breathing, cough or any detectable movement), start CPR imme-
diately.
2. Provide BMV with 100% oxygen.
3. Commencemonitoring. Send for amanual deﬁbrillator or anAEDIn the less common circumstance of a witnessed sudden col-
lapse, early activation of the emergency services and getting an
AED may be more appropriate; start CPR as soon as possible.
D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1377
anced
C
a
a
o
c
a
m
a
a
t
cFig. 6.9. Paediatric adv
ardiac monitoring
Position the cardiac monitor leads or deﬁbrillation paddles
s soon as possible to enable differentiation between a shock-
ble and a non-shockable cardiac rhythm. Invasive monitoring
f systemic blood pressure may help to improve effectiveness of
hest compression271 but must not delay the provision of basic or
dvanced resuscitation.
Shockable rhythms are pulseless VT and VF. These rhythms are
ore likely after sudden collapse in children with heart disease or
dolescents.41–43 Non-shockable rhythms are pulseless electrical
ctivity (PEA), bradycardia (<60min−1 with no signs of circula-
ion), and asystole. PEA and bradycardia often have wide-QRS
omplexes.life support algorithm.
Echocardiography may be used to identify potentially treatable
causes of cardiac arrest in children. Cardiac activity can be rapidly
visualised76 and pericardial tamponade diagnosed.272 However,
appropriately skilled operatorsmust be available and its use should
be balanced against the interruption to chest compressions during
examination.
Non-shockable rhythmsMost cardiopulmonary arrests in children and adolescents
are of respiratory origin.54,58,273–275 A period of immediate CPR
is therefore mandatory in this age group before searching for
an AED or manual deﬁbrillator, as its immediate availabil-
ity will not improve the outcome of a respiratory arrest.17,276
1378 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388
Fig. 6.10. Paediatric algorithm for non-shockable rhythm.
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ystander CPR is associated with a better neurological out-
ome in adults and children.277–279 The most common ECG
atterns in infants, children and adolescents with cardiopul-
onary arrest are asystole and PEA. PEA is characterised by
rganised, wide or narrow complex electrical activity, usually
but not always) at a slow rate, and absent pulses. It com-
only follows a period of hypoxia or myocardial ischaemia,
ut occasionally can have a reversible cause (i.e., one of the 4
s and 4 Ts) that led to a sudden impairment of cardiac out-
ut.
hockable rhythms
Primary VF occurs in 3.8–19% of cardiopulmonary arrests
n children.13,41–43,60,274,275,277 The incidence of VF/pulseless VT
ncreaseswith age.267,280 Theprimarydeterminant of survival from
T/pulselessVTcardiopulmonaryarrest is the time todeﬁbrillation.
rehospital deﬁbrillation within the ﬁrst 3min of witnessed adult
F arrest results in>50%survival.However, the successofdeﬁbrilla-
ion decreases dramatically the longer the time until deﬁbrillation:for shockable rhythm.
for every minute delay in deﬁbrillation (without any CPR), survival
decreases by 7–10%. Survival after more than 12min of VF in adult
victims is <5%.281 Cardiopulmonary resuscitation provided before
deﬁbrillation for response intervals longer than 5min improved
outcome in some studies,282,283 but not in others.284
Secondary VF is present at somepoint in up to 27% of in-hospital
resuscitation events. It has a much poorer prognosis than primary
VF.43
Drugs in shockable rhythms
Adrenaline (epinephrine)
Adrenaline is given every 3–5min by the IV or IO route in pref-
erence to the tracheal tube route.Amiodarone in VF/pulseless VT
Amiodarone is indicated in deﬁbrillation-resistant VF/pulseless
VT. Experimental and clinical experience with amiodarone in chil-
dren is scarce; evidence from adult studies236,285,286 demonstrates
increased survival to hospital admission, but not to hospital dis-
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harge.Onepaediatric case series demonstrates the effectiveness of
miodarone for life-threatening ventricular arrhythmias.287 There-
ore, IV amiodarone has a role in the treatment of deﬁbrillation
efractory or recurrent VF/pulseless VT in children.
xtracorporeal life support
Extracorporeal life support should be considered for children
ith cardiac arrest refractory to conventional CPR, if the arrest
ccurs in a highly supervised environment and available exper-
ise and equipment to rapidly initiate extracorporeal life support
ECLS).
rrhythmias
nstable arrhythmias
Check for signs of life and the central pulse of any child with an
rrhythmia; if signs of life are absent, treat as for cardiopulmonary
rrest. If the child has signs of life and a central pulse, evaluate
he haemodynamic status. Whenever the haemodynamic status is
ompromised, the ﬁrst steps are:
. Open the airway.
. Give oxygen and assist ventilation as necessary.
. Attach ECG monitor or deﬁbrillator and assess the cardiac
rhythm.
. Evaluate if the rhythm is slow or fast for the child’s age.
. Evaluate if the rhythm is regular or irregular.
. Measure QRS complex (narrow complexes: <0.08 s duration;
wide complexes: >0.08 s).
. The treatment options are dependent on the child’s haemody-
namic stability.
radycardia
Bradycardia is caused commonly by hypoxia, acidosis and/or
evere hypotension; it may progress to cardiopulmonary arrest.
ive 100% oxygen, and positive pressure ventilation if required, to
ny child presenting with bradyarrhythmia and circulatory failure.
If a poorly perfused child has a heart rate <60 beats min−1,
nd they do not respond rapidly to ventilation with oxygen, start
hest compressionsandgiveadrenaline. If thebradycardia is caused
y vagal stimulation (such as after passing a nasogastric tube),
tropine may be effective.
Cardiac pacing (either transvenous or external) is generally
ot useful during resuscitation. It may be considered in cases of
V block or sinus node dysfunction unresponsive to oxygena-
ion, ventilation, chest compressionsandothermedications;pacing
s not effective in asystole or arrhythmias caused by hypoxia or
schaemia.288
achycardia
arrow complex tachycardia
If SVT is the likely rhythm, vagalmanoeuvres (Valsalva or diving
eﬂex) may be used in haemodynamically stable children. They can
lso be used in haemodynamically unstable children, but only if
heydonotdelay chemical or electrical cardioversion.289 If the child
s unstable with a depressed conscious level, attempt synchronised
lectrical cardioversion immediately.
Adenosine is usually effective in converting SVT into sinus
hythm. It is given by rapid, intravenous injection as close as prac-
icable to the heart (see above), and followed immediately by a
olus of normal saline. If the child is too haemodynamically unsta-81 (2010) 1364–1388 1379
ble, omit vagal manoeuvres and adenosine and attempt electrical
cardioversion immediately.
Electrical cardioversion (synchronisedwith Rwave) is also indi-
cated when vascular access is not available, or when adenosine
has failed to convert the rhythm. The ﬁrst energy dose for elec-
trical cardioversion of SVT is 0.5–1 J kg−1 and the second dose is
2 J kg−1. If unsuccessful, give amiodarone or procainamide under
guidance from a paediatric cardiologist or intensivist before the
third attempt. Verapamil may be considered as an alternative
therapy in older children but should not be routinely used in
infants.
Amiodarone has been shown to be effective in the treatment of
SVT in several paediatric studies.270,287,290–297 However, sincemost
studies of amiodarone use in narrow complex tachycardias have
been for junctional ectopic tachycardia in postoperative children,
the applicability of its use in all cases of SVT may be limited. If the
child is haemodynamically stable, early consultationwith anexpert
is recommended before giving amiodarone. An expert should also
be consulted about alternative treatment strategies because the
evidence to support other drugs in the treatment of SVT is limited
and inconclusive.298,299 If amiodarone is used in this circumstance,
avoid rapid administration because hypotension is common.
Wide complex tachycardia
In children, wide-QRS complex tachycardia is uncommon and
more likely to be supraventricular than ventricular in origin.300
Nevertheless, in haemodynamically unstable children, it must be
considered tobeVTuntil provenotherwise.Ventricular tachycardia
occurs most often in the child with underlying heart disease (e.g.,
after cardiac surgery, cardiomyopathy, myocarditis, electrolyte
disorders, prolonged QT interval, central intracardiac catheter).
Synchronised cardioversion is the treatment of choice for unsta-
ble VT with a pulse. Consider anti-arrhythmic therapy if a second
cardioversion attempt is unsuccessful or if VT recurs.
Amiodarone has been shown to be effective in treating pae-
diatric arrhythmias,291 although cardiovascular side effects are
common.270,287,292,297,301
Stable arrhythmias
Whilst maintaining the child’s airway, breathing and circula-
tion, contact an expert before initiating therapy. Depending on the
child’s clinical history, presentation and ECG diagnosis, a childwith
stable, wide-QRS complex tachycardia may be treated for SVT and
be given vagal manoeuvres or adenosine. Amiodarone may be con-
sidered as a treatment option if this fails or if the diagnosis of VT is
conﬁrmed on an ECG. Procainamide may also be considered in sta-
ble SVT refractory to vagal manoeuvres and adenosine,239,302–304
and in stable VT.239,240,305,306 Do not give procainamide with amio-
darone.
Special circumstances
Channelopathy
When sudden unexplained cardiac arrest occurs in children and
young adults, obtain a complete past medical and family history
(including a history of syncopal episodes, seizures, unexplained
accidents/drownings, or sudden death) and review any available
previous ECGs. All infants, children, and young adults with sud-
den, unexpected death should, if possible, have an unrestricted,
completeautopsy,performedpreferablybypathologistswith train-
ing andexpertise in cardiovascular pathology.307–316 Consideration
should be given to preservation and genetic analysis of tissue
to determine the presence of a channelopathy. Refer families of
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atients whose cause of death is not found on autopsy to a health
areprovider/centrewithexpertise incardiac rhythmdisturbances.
ife support for blunt or penetrating trauma
There is averyhighmortality associatedwithcardiac arrest from
ajor (blunt or penetrating) trauma.317–320 There is little evidence
o support any additional speciﬁc interventions that are different
rom the routine management of cardiac arrest; however, the use
f resuscitative thoracotomy may be considered in children with
enetrating injuries.321–325
ingle ventricle post-stage 1 repair
The incidence of cardiac arrest in infants following single ventri-
le stage 1 repair is approximately 20%, with a survival to discharge
f 33%.326 There is no evidence that anything other than routine
esuscitative protocols should be followed. Diagnosis of the pre-
rrest state is difﬁcult but it may be assisted by monitoring the
xygen extraction (superior vena caval ScvO2) or near infrared
pectroscopy (cerebral and splanchnic circulations).327–329 Treat-
ent of high systemic vascular resistance with alpha-adrenergic
eceptor blockade may improve systemic oxygen delivery,330
educe the incidence of cardiovascular collapse,331 and improve
urvival.332
ingle ventricle post-Fontan
Children in thepre-arrest statewhohaveFontanorhemi-Fontan
natomymaybeneﬁt from increased oxygenation and an improved
ardiac output by instituting negative pressure ventilation.333,334
xtracorporeal membrane oxygenation (ECMO) may be useful
escue for children with failing Fontan circulations but no recom-
endation can be made in favour or against ECMO in those with
emi-Fontan physiology or for rescue during resuscitation.335
ulmonary hypertension
There is an increased risk of cardiac arrest in children with pul-
onary hypertension.336,337 Follow routine resuscitation protocols
n these patients with emphasis on high FiO2 and alkalo-
is/hyperventilation because this may be as effective as inhaled
itric oxide in reducing pulmonary vascular resistance.338 Resus-
itation is most likely to be successful in patients with a reversible
ause who are treated with intravenous epoprostenol or inhaled
itric oxide.339 If routinemedications that reducepulmonaryartery
ressure have been stopped, they should be restarted and the use
f aerosolised epoprostenol or inhaled nitric oxide considered.340
ight ventricular support devices may improve survival.341–344
ost-arrest management
After prolonged, complete, whole-body hypoxia-ischaemia
OSC has been described as an unnatural pathophysiological state,
reated by successful CPR.345 Post-arrest management must be a
ultidisciplinary activity and include all the treatments needed
or complete neurological recovery. The main goals are to reverse
rain injury and myocardial dysfunction, and to treat the systemic
schaemia/reperfusion response and any persistent precipitating
athology.yocardial dysfunction
Myocardial dysfunction is common after cardiopulmonary
esuscitation.345–348 Vasoactive drugs (adrenaline, dobutamine,81 (2010) 1364–1388
dopamine and noradrenaline) may improve the child’s post-arrest
haemodynamic values but the drugs must be titrated according to
the clinical condition.349–359
Temperature control and management
Hypothermia is common in the child following cardiopul-
monary resuscitation.360 Central hypothermia (32–34 ◦C) may be
beneﬁcial, whereas fever may be detrimental to the injured brain.
Mild hypothermia has an acceptable safety proﬁle in adults361,362
and neonates.363–368 Whilst it may improve neurological outcome
in children, an observational study neither supports nor refutes the
use of therapeutic hypothermia in paediatric cardiac arrest.369
A child who regains a spontaneous circulation, but remains
comatose after cardiopulmonary arrest, may beneﬁt from being
cooled to a core temperature of 32–34 ◦C for at least 24h. The suc-
cessfully resuscitated child with hypothermia and ROSC should not
be actively rewarmed unless the core temperature is below 32 ◦C.
Following a period of mild hypothermia, rewarm the child slowly
at 0.25–0.5 ◦Ch−1.
There are several methods to induce, monitor and maintain
body temperature in children. External and/or internal cooling
techniques can be used to initiate cooling.370–372 Shivering can be
prevented by deep sedation and neuromuscular blockade. Com-
plications can occur and include an increased risk of infection,
cardiovascular instability, coagulopathy, hyperglycaemia and elec-
trolyte abnormalities.373–375
These guidelines are based on evidence from the use of thera-
peutic hypothermia in neonates and adults. At the time of writing,
there are ongoing, prospective, multicentre trials of therapeutic
hypothermia in children following in- and out-of-hospital cardiac
arrest (www.clinicaltrials.gov; NCT00880087 and NCT00878644).
Fever is common following cardiopulmonary resuscitation and
is associated with a poor neurological outcome,376–378 the risk
increasing for each degree of body temperature greater than
37 ◦C.376 There are limited experimental data suggesting that
the treatment of fever with antipyretics and/or physical cooling
reduces neuronal damage.379,380 Antipyretics and accepted drugs
to treat fever are safe; therefore, use them to treat fever aggres-
sively.
Glucose control
Both hyper- and hypo-glycaemia may impair outcome of criti-
cally ill adults and children and should be avoided,228–230,381–383
but tight glucose control may also be harmful.231,384 Although
there is insufﬁcient evidence to support or refute a speciﬁc glu-
cose management strategy in children with ROSC after cardiac
arrest,225,226,345 it is appropriate to monitor blood glucose and
avoid hypoglycaemia as well as sustained hyperglycaemia.
Prognosis of cardiopulmonary arrest
Although several factors are associated with outcome after
cardiopulmonary arrest and resuscitation41,60,385–389 there are no
simple guidelines to determine when resuscitative efforts become
futile.
After 20min of resuscitation, the resuscitation team leader
should consider whether or not to stop.273,390–394 The rele-
vant considerations in the decision to continue the resuscitation
include the cause of arrest,60,395 pre-existing medical conditions,
age,41,389 site of arrest, whether the arrest was witnessed,60,394
the duration of untreated cardiopulmonary arrest (‘no ﬂow’), num-
ber of doses of adrenaline, the ETCO2 value, the presence of a
shockable rhythm as the ﬁrst or subsequent rhythm,386,387 the
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romptness of extracorporeal life support for a reversible disease
rocess,396–398 and associated special circumstances (e.g., icywater
rowning,277,399,400 exposure to toxic drugs).
arental presence
In some Western societies, the majority of parents prefer to
e present during the resuscitation of their child.401–410 Parental
resence has neither been perceived as disruptive403,411–415 nor
tressful for the staff.401,403,412 Parents witnessing their child’s
esuscitation believe their presence to be beneﬁcial to the
hild.401–403,410,414–417 Allowing parents to be at the side of their
hild helps them to gain a realistic view of the attempted resus-
itation and the child’s death. Furthermore, they may have the
pportunity to say goodbye to their child. Families who are present
t their child’s death show better adjustment and undergo a better
rieving process.402–404,414,415,417,418
Parental presence in the resuscitation roommayhelphealthcare
roviders maintain their professional behaviour, whilst helping
hem to see the child as a human being and a family member.411
owever in out-of-hospital resuscitation, someEMSprovidersmay
eel threatened by the presence of relatives or are concerned that
elatives may interfere with their resuscitation efforts.419 Evidence
bout parental presence during resuscitation comes from selected
ountries and can probably not be generalised to all of Europe,
here there could be different socio-cultural and ethical consid-
rations.
amily presence guidelines
When relatives are allowed in the resuscitation room, a dedi-
ated member of the resuscitation team should be present with the
arents to explain the process in an empathetic manner, ensuring
hat the parents do not interfere with or distract the resuscitation
rocess. If the presence of the parents is impeding the progress of
he resuscitation, they should be sensitively asked to leave. When
ppropriate, physical contact with the child should be allowed and,
herever possible, the parents should be allowed to be with their
ying child at the ﬁnal moment.411,420–423
The leader of the resuscitation team, not the parents, will decide
hen to stop the resuscitation; this should be expressed with sen-
itivity and understanding. After the event, the team should be
ebriefed, to enable any concerns to be expressed and for the team
o reﬂect on their clinical practice in a supportive environment.
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ection 7. Resuscitation of babies at birth
am Richmonda,1, Jonathan Wyllieb,∗,1
Neonatology, Sunderland Royal Hospital, Sunderland, UK
Neonatology and Paediatrics, The James Cook University Hospital, Middlesbrough, UK
ntroduction
The following guidelines for resuscitation at birth have been
eveloped during the process that culminated in the 2010 Inter-
ational Consensus Conference on Emergency Cardiovascular Care
ECC) and Cardiopulmonary Resuscitation (CPR) Science with
reatment Recommendations.1,2 They are an extension of the
uidelines already published by the ERC3 and take into account
ecommendationsmade by other national and international organ-
sations.
ummary of changes since 2005 Guidelines
The following are the main changes that have been made to the
uidelines for resuscitation at birth in 2010:
For uncompromised babies, a delay in cord clamping of at least
1min from the complete delivery of the infant, is now recom-
mended. As yet there is insufﬁcient evidence to recommend an
appropriate time for clamping the cord inbabieswhoare severely
compromised at birth.
For term infants, air should be used for resuscitation at birth.
If, despite effective ventilation, oxygenation (ideally guided by
oximetry) remains unacceptable, use of a higher concentration
of oxygen should be considered.
Preterm babies less than 32 weeks gestation may not reach
the same arterial blood oxygen saturations in air as those
achieved by term babies. Therefore blended oxygen and air
should be given judiciously and its use guided by pulse oxime-
try. If a blend of oxygen and air is not available use what is
available.
Preterm babies of less than 28 weeks gestation should be com-
pletely covered in a food-grade plastic wrap or bag up to their
necks, without drying, immediately after birth. They should then
be nursed under a radiant heater and stabilised. They should
∗ Corresponding author.
E-mail address: jonathan.wyllie@stees.nhs.uk (J. Wyllie).
1 Both authors contributed equally to this manuscript and share ﬁrst authorship.
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.018remain wrapped until their temperature has been checked after
admission. For these infants delivery room temperatures should
be at least 26 ◦C.
• The recommendedcompression:ventilation ratio forCPRremains
at 3:1 for newborn resuscitation.
• Attempts to aspirate meconium from the nose and mouth of
the unborn baby, while the head is still on the perineum, are
not recommended. If presented with a ﬂoppy, apnoeic baby
born through meconium it is reasonable to rapidly inspect the
oropharynx to remove potential obstructions. If appropriate
expertise is available, tracheal intubation and suction may be
useful. However, if attempted intubation is prolonged or unsuc-
cessful, start mask ventilation, particularly if there is persistent
bradycardia.
• If adrenaline (epinephrine) is given then the intravenous route is
recommendedusing adose of 10–30gkg−1. If the tracheal route
is used, it is likely that a dose of at least 50–100gkg−1 will be
needed to achieve a similar effect to 10gkg−1 intravenously.
• Detection of exhaled carbon dioxide in addition to clinical assess-
ment is recommended as the most reliable method to conﬁrm
placement of a tracheal tube in neonates with spontaneous cir-
culation.
• Newlyborn infants born at termornear-termwith evolvingmod-
erate to severe hypoxic–ischemic encephalopathy should, where
possible, be offered therapeutic hypothermia. This does not affect
immediate resuscitation but is important for post-resuscitation
care.
The guidelines that follow do not deﬁne the only way that resusci-
tation at birth should be achieved; they merely represent a widely
accepted view of how resuscitation at birth can be carried out both
safely and effectively (Fig. 7.1).
Preparation
Relatively few babies need any resuscitation at birth. Of those
that do need help, the overwhelming majority will require only
assisted lung aeration. A small minority may need a brief period of
chest compressions in addition to lung aeration. Of 100,000 babies
born in Sweden in 1 year, only 10 per 1000 (1%) babies of 2.5 kg or
more appeared to need resuscitation at delivery.4 Of those babies
evier Ireland Ltd. All rights reserved.
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eceiving resuscitation, 8 per 1000 responded tomask inﬂation and
nly 2 per 1000 appeared to need intubation. The same study tried
o assess the unexpected need for resuscitation at birth and found
hat for low risk babies, i.e. those born after 32 weeks gestation
nd following an apparently normal labour, about 2 per 1000 (0.2%)
ppeared to need resuscitation at delivery. Of these, 90% responded
o mask inﬂation alone while the remaining 10% appeared not to
espond to mask inﬂation and therefore were intubated at birth.
Resuscitation or specialist help at birth is more likely to be
eeded by babies with intrapartum evidence of signiﬁcant fetal
ompromise, babies delivering before 35 weeks gestation, babiesupport algorithm.
delivering vaginally by the breech, and multiple pregnancies.
Although it is often possible to predict the need for resuscitation
or stabilisation before a baby is born, this is not always the case.
Therefore, personnel trained innewborn life support should be eas-
ily available at every delivery and, should there be any need for
intervention, the care of the baby should be their sole responsibil-
ity. One person experienced in tracheal intubation of the newborn
should ideally be in attendance for deliveries associatedwith a high
risk of requiring neonatal resuscitation. Local guidelines indicat-
ing who should attend deliveries should be developed, based on
current practice and clinical audit.
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Anorganised educational programme in the standards and skills
equired for resuscitation of the newborn is therefore essential for
ny institution in which deliveries occur.
lanned home deliveries
Recommendations as to who should attend a planned home
elivery vary from country to country, but the decision to undergo
planned home delivery, once agreedwithmedical andmidwifery
taff, should not compromise the standard of initial resuscitation
t birth. There will inevitably be some limitations to resuscitation
f a newborn baby in the home, because of the distance from fur-
her assistance, and this must be made clear to the mother at the
ime plans for home delivery aremade. Ideally, two trained profes-
ionals should be present at all home deliveries; one of these must
e fully trained and experienced in providingmask ventilation and
hest compressions in the newborn.
quipment and environment
Unlike adult CPR, resuscitation at birth is often a predictable
vent. It is therefore possible to prepare the environment and the
quipment before delivery of the baby. Resuscitation should ideally
akeplace in awarm,well-lit, draught free areawith aﬂat resuscita-
ion surface placed below a radiant heater, with other resuscitation
quipment immediately available. All equipment must be checked
requently.
When a birth takes place in a non-designated delivery area, the
ecommended minimum set of equipment includes a device for
afe assisted lung aeration of an appropriate size for the newborn,
arm dry towels and blankets, a sterile instrument for cutting the
mbilical cord and clean gloves for the attendant and assistants. It
ay also be helpful to have a suction device with a suitably sized
uctioncatheter anda tonguedepressor (or laryngoscope) toenable
heoropharynx tobeexamined.Unexpecteddeliveriesoutsidehos-
ital aremost likely to involve emergency serviceswho should plan
or such events.
emperature control
Naked, wet, newborn babies cannot maintain their body tem-
erature in a room that feels comfortably warm for adults.
ompromised babies are particularly vulnerable.5 Exposure of the
ewborn to cold stress will lower arterial oxygen tension6 and
ncrease metabolic acidosis.7 Prevent heat loss:
Protect the baby from draughts.
Keep the delivery room warm. For babies less than 28 weeks
gestation the delivery room temperature should be 26 ◦C.8,9
Dry the term baby immediately after delivery. Cover the head
and body of the baby, apart from the face, with a warm towel
to prevent further heat loss. Alternatively, place the baby skin to
skin with mother and cover both with a towel.
If the baby needs resuscitation then place the baby on a warm
surface under a preheated radiant warmer.
In very preterm babies (especially below 28 weeks) drying and
wrappingmaynot be sufﬁcient. Amore effectivemethod of keep-
ing these babies warm is to cover the head and body of the baby
(apart from the face) with plastic wrapping, without drying the
baby beforehand, and then to place the baby so covered under
radiant heat.tion 81 (2010) 1389–1399 1391
Initial assessment
The Apgar scorewas proposed as a “simple, common, clear clas-
siﬁcation or grading of newborn infants” to be used “as a basis
for discussion and comparison of the results of obstetric practices,
types of maternal pain relief and the effects of resuscitation” (our
emphasis).10 It was not designed to be assembled and ascribed in
order to then identify babies in need of resuscitation.11 However,
individual components of the score, namely respiratory rate, heart
rate and tone, if assessed rapidly, can identify babies needing resus-
citation (and Virginia Apgar herself found that heart rate was the
most important predictor of immediate outcome).10 Furthermore,
repeatedassessmentparticularlyofheart rateand, toa lesser extent
breathing, can indicate whether the baby is responding or whether
further efforts are needed.
Breathing
Check whether the baby is breathing. If so, evaluate the rate,
depth and symmetry of breathing together with any evidence of an
abnormal breathing pattern such as gasping or grunting.
Heart rate
This is best assessed by listening to the apex beat with a stetho-
scope. Feeling the pulse in the base of the umbilical cord is often
effective but can be misleading, cord pulsation is only reliable if
found to be more than 100 beats per minute (bpm).12 For babies
requiring resuscitation and/or continued respiratory support, a
modern pulse oximeter can give an accurate heart rate.13
Colour
Colour is a poor means of judging oxygenation,14 which is bet-
ter assessed using pulse oximetry if possible. A healthy baby is born
blue but starts to become pink within 30 s of the onset of effective
breathing. Peripheral cyanosis is common and does not, by itself,
indicate hypoxemia. Persistent pallor despite ventilationmay indi-
cate signiﬁcant acidosis or rarely hypovolaemia. Although colour is
a poor method of judging oxygenation, it should not be ignored: if
a baby appears blue check oxygenation with a pulse oximeter.
Tone
A very ﬂoppy baby is likely to be unconscious and will need
ventilatory support.
Tactile stimulation
Drying the baby usually produces enough stimulation to induce
effective breathing. Avoidmore vigorousmethods of stimulation. If
thebaby fails to establish spontaneousandeffectivebreaths follow-
ing a brief period of stimulation, further support will be required.
Classiﬁcation according to initial assessment
On the basis of the initial assessment, the baby can be placed
into one of three groups:1. Vigorous breathing or crying
Good tone
Heart rate higher than 100min−1
This baby requires no intervention other than drying, wrap-
ping in a warm towel and, where appropriate, handing to the
1 uscitation 81 (2010) 1389–1399
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mother. The baby will remain warm through skin-to-skin con-
tact with mother under a cover, and may be put to the breast at
this stage.
. Breathing inadequately or apnoeic
Normal or reduced tone
Heart rate less than 100min−1
Dry and wrap. This baby may improve with mask inﬂation
but if this does not increase the heart rate adequately, may also
require chest compressions.
. Breathing inadequately or apnoeic
Floppy
Low or undetectable heart rate
Often pale suggesting poor perfusion
Dry and wrap. This baby will then require immediate air-
way control, lung inﬂation and ventilation. Once this has been
successfully accomplished the baby may also need chest com-
pressions, and perhaps drugs.
There remains a very rare group of babies who, though breath-
ng adequately andwith a goodheart rate, remainhypoxaemic. This
roup includes a range of possible diagnoses such as diaphragmatic
ernia, surfactant deﬁciency, congenital pneumonia, pneumotho-
ax, or cyanotic congenital heart disease.
ewborn life support
Commence newborn life support if assessment shows that the
aby has failed to establish adequate regular normal breathing, or
as a heart rate of less than 100min−1. Opening the airway and
erating the lungs isusually all that isnecessary. Furthermore,more
omplex interventions will be futile unless these two ﬁrst steps
ave been successfully completed.
irway
Place the baby on his or her back with the head in a neutral
osition (Fig. 7.2). A 2 cm thickness of the blanket or towel placed
nder the baby’s shoulder may be helpful in maintaining proper
ead position. In ﬂoppy babies application of jaw thrust or the use
f an appropriately sized oropharyngeal airway may be helpful in
pening the airway.
Suction is needed only if the airway is obstructed. Obstruction
ay be caused by particulate meconium but can also be caused
y blood clots, thick tenacious mucus or vernix even in deliver-
es where meconium staining is not present. However, aggressive
haryngeal suction can delay the onset of spontaneous breathing
nd cause laryngeal spasm and vagal bradycardia.15 The presence
f thick meconium in a non-vigorous baby is the only indication
or considering immediate suction of the oropharynx. If suction is
Fig. 7.2. Newborn with head in neutral position.Fig. 7.3. Mask ventilation of newborn.
attempted this is best done under direct vision. Connect a 12–14
FG suction catheter, or a Yankauer sucker, to a suction source not
exceeding minus 100mmHg.
Breathing
After initial steps at birth, if breathing efforts are absent or inad-
equate, lung aeration is the priority (Fig. 7.3). In term babies, begin
resuscitationwith air. The primarymeasure of adequate initial lung
inﬂation is a prompt improvement in heart rate; assess chest wall
movement if heart rate does not improve.
For the ﬁrst ﬁve inﬂation breaths maintain the initial inﬂation
pressure for 2–3 s. Thiswill help lung expansion.Most babies need-
ing resuscitation at birth will respond with a rapid increase in
heart rate within 30 s of lung inﬂation. If the heart rate increases
but the baby is not breathing adequately, ventilate at a rate of
about 30breathsmin−1 allowing approximately 1 s for each inﬂa-
tion, until there is adequate spontaneous breathing.
Adequate passive ventilation is usually indicated by either a
rapidly increasingheart rate or a heart rate that ismaintained faster
than 100min−1. If the baby does not respond in this way the most
likely cause is inadequate airway control or inadequate ventilation.
Look for passive chest movement in time with inﬂation efforts; if
these are present then lung aeration has been achieved. If these
are absent then airway control and lung aeration has not been con-
ﬁrmed. Without adequate lung aeration, chest compressions will
be ineffective; therefore, conﬁrm lung aeration before progressing
to circulatory support.
Some practitioners will ensure airway control by tracheal intu-
bation, but this requires training and experience. If this skill is not
available and the heart rate is decreasing, re-evaluate the airway
position anddeliver inﬂationbreathswhile summoning a colleague
with intubation skills.
Continue ventilatory support until the babyhas establishednor-
mal regular breathing.
Circulatory supportCirculatory support with chest compressions is effective only
if the lungs have ﬁrst been successfully inﬂated. Give chest com-
pressions if the heart rate is less than 60min−1 despite adequate
ventilation.
S. Richmond, J. Wyllie / Resuscita
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Communication with the parents
It is important that the team caring for the newborn baby
informs the parents of the baby’s progress. At delivery, adhere toFig. 7.4. Ventilation and chest compression of newborn.
The most effective technique for providing chest compressions
s to place the two thumbs side by side over the lower third of the
ternum just below an imaginary line joining the nipples, with the
ngers encircling the torso and supporting the back (Fig. 7.4).16–19
n alternative way to ﬁnd the correct position of the thumbs
s to identify the xiphisternum and then to place the thumbs
n the sternum one ﬁnger’s breadth above this point. The ster-
um is compressed to a depth of approximately one-third of the
nterior–posterior diameter of the chest allowing the chest wall to
eturn to its relaxed position between compressions.20
Use a ratio of three compressions to one ventilation, aiming to
chieve approximately 120 events per minute, i.e. approximately
0 compressions and 30 ventilations. There are theoretical advan-
ages to allowing a relaxation phase that is very slightly longer than
he compressionphase.21 However, thequality of the compressions
nd breaths are probably more important than the rate.
Check the heart rate after about 30 s and every 30 s thereafter.
iscontinue chest compressions when the spontaneous heart rate
s faster than 60min−1.
rugs
Drugs are rarely indicated in resuscitation of the newly born
nfant. Bradycardia in the newborn infant is usually caused by
nadequate lung inﬂation or profound hypoxia, and establishing
dequate ventilation is the most important step to correct it. How-
ver, if the heart rate remains less than 60min−1 despite adequate
entilation and chest compressions, it is reasonable to consider the
se of drugs. These are best given via an umbilical venous catheter
Fig. 7.5).
drenaline
Despite the lack of human data it is reasonable to use adrenaline
hen adequate ventilation and chest compressions have failed to
ncrease the heart rate above 60min−1. If adrenaline is used, a dose
f 10–30gkg−1 should be administered intravenously as soon as
ossible.
The tracheal route is not recommended (see below) but if it
s used, it is highly likely that doses of 50–100gkg−1 will be
equired. Neither the safety nor the efﬁcacy of these higher tracheal
oses has been studied. Do not give these high doses intravenously.tion 81 (2010) 1389–1399 1393
Bicarbonate
If effective spontaneous cardiac output is not restored despite
adequate ventilation and adequate chest compressions, reversing
intracardiac acidosismay improvemyocardial functionandachieve
a spontaneous circulation. There are insufﬁcient data to recom-
mend routine use of bicarbonate in resuscitation of the newly born.
The hyperosmolarity and carbon dioxide-generating properties of
sodium bicarbonate may impair myocardial and cerebral function.
Use of sodium bicarbonate is discouraged during brief CPR. If it
is used during prolonged arrests unresponsive to other therapy,
it should be given only after adequate ventilation and circulation
is established with CPR. A dose of 1–2mmol kg−1 may be given by
slow intravenous injectionafter adequate ventilationandperfusion
have been established.
Fluids
If there has been suspected blood loss or the infant appears to be
in shock (pale, poor perfusion, weak pulse) and has not responded
adequately to other resuscitative measures then consider giving
ﬂuid.22 This is a rare event. In the absence of suitable blood (i.e.
irradiated and leucocyte-depleted groupORh-negative blood), iso-
tonic crystalloid rather than albumin is the solution of choice for
restoring intravascular volume. Give a bolus of 10mlkg−1 initially.
If successful it may need to be repeated to maintain an improve-
ment.
Stopping resuscitation
Local and national committees will determine the indications
for stopping resuscitation. If the heart rate of a newly born baby
is not detectable and remains undetectable for 10min, it is then
appropriate to consider stopping resuscitation. The decision to
continue resuscitation efforts when the heart rate has been unde-
tectable for longer than 10min is often complex and may be
inﬂuenced by issues such as the presumed aetiology, the gesta-
tion of the baby, the potential reversibility of the situation, and
the parents’ previous expressed feelings about acceptable risk of
morbidity.
In cases where the heart rate is less than 60min−1 at birth and
does not improve after 10 or 15min of continuous and apparently
adequate resuscitative efforts, the choice is much less clear. In this
situation there is insufﬁcient evidence about outcome to enable
ﬁrm guidance onwhether to withhold or to continue resuscitation.Fig. 7.5. Newborn umbilical cord showing the arteries and veins.
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he routine local plan and, if possible, hand the baby to the mother
t the earliest opportunity. If resuscitation is required inform the
arents of the procedures undertaken andwhy theywere required.
Decisions to discontinue resuscitation should ideally involve
enior paediatric staff. Whenever possible, the decision to attempt
esuscitation of an extremely pretermbaby should be taken in close
onsultation with the parents and senior paediatric and obstetric
taff. Where a difﬁculty has been foreseen, for example in the case
f severe congenitalmalformation, discuss the options andprogno-
is with the parents, midwives, obstetricians and birth attendants
efore delivery.23 Record carefully all discussions and decisions in
he mother’s notes prior to delivery and in the baby’s records after
irth.
peciﬁc questions addressed at the 2010 Consensus
onference on CPR Science
aintaining normal temperature in preterm infants
Signiﬁcantly preterm babies are likely to become hypothermic
espite careful application of the traditional techniques for keeping
hem warm (drying, wrapping and placing under radiant heat).24
everal randomised controlled trials and observational studies
ave shown that placing the preterm baby under radiant heat and
hen covering the baby with food-grade plastic wrapping with-
ut drying them, signiﬁcantly improves temperature on admission
o intensive care compared with traditional techniques.25–27 The
aby’s temperaturemust bemonitored closely because of the small
ut described risk of inducing hyperthermia with this technique.28
ll resuscitation procedures including intubation, chest compres-
ion and insertion of lines, can be achieved with the plastic cover
n place. Signiﬁcantly preterm babies maintain their temperature
etter when the ambient temperature of the delivery room is 26 ◦C
r higher.8,9
Infants born to febrile mothers have a higher incidence of peri-
atal respiratory depression, neonatal seizures, early mortality,
nd cerebral palsy.28–30 Animal studies indicate that hyperthermia
uring or following ischaemia is associated with a progression of
erebral injury.31,32 Hyperthermia should be avoided.
econium
In the past it was hoped that clearing meconium from the air-
ay of babies at birth would reduce the incidence and severity
f meconium aspiration syndrome (MAS). However, studies sup-
orting this view were based on a comparison of suctioning on
he outcome of a group of babies with the outcome of historical
ontrols.33,34 Furthermore other studies failed to ﬁnd any evidence
f beneﬁt from this practice.35,36 More recently, amulti-centre ran-
omised controlled trial reported in 200037 showed that routine
lective intubation and suctioning of these infants, if vigorous at
irth, didnot reduceMASanda further randomisedstudypublished
n 2004 showed that suctioning the nose andmouth of such babies
n the perineum and before delivery of the shoulders (intrapartum
uctioning)was also ineffective.38 Intrapartum suctioning and rou-
ine intubation and suctioning of vigorous infants born through
econium-stained liquor are not recommended. There remains
he question of what to do with non-vigorous infants in this sit-
ation. Observational studies have conﬁrmed that these babies are
t increased risk of meconium aspiration syndrome but there have
een no randomised studies of the effect of intubation followed by
uctioning versus no intubation in this group.
Recommendation: In the absence of randomised, controlled tri-
ls, there is insufﬁcient evidence to recommend a change in the
urrent practice of performing direct oropharyngeal and trachealtion 81 (2010) 1389–1399
suctioning of non-vigorous babies with meconium-stained amni-
otic ﬂuid, if feasible. However, if attempted intubation is prolonged
or unsuccessful, mask ventilation should be implemented, partic-
ularly if there is persistent bradycardia.
Air or 100% oxygen
For the newly born infant in need of resuscitation at birth, the
rapid establishment of pulmonary gas exchange to replace the fail-
ure of placental respiration is the key to success. In the past it has
seemed reasonable that delivery of a high concentration of oxygen
to the tissues at risk of hypoxiamight help to reduce the number of
cells which were damaged by the anaerobic process. However, in
the last 30 years the ‘oxygen paradox’ – the fact that cell and tissue
injury is increased if hypoxic tissue is then exposed to high concen-
trations of oxygen – has been recognized, the role of free radicals,
antioxidants and their link with apoptosis and reperfusion injury
has been explored, and the idea of oxidative stress established. In
the light of this knowledge it has become increasingly difﬁcult to
sustain the idea that exposure to high concentrations of oxygen,
however brief, is without risk. Furthermore, randomised studies in
asphyxiated newborn babies strongly suggest that air is certainly
as effective as 100% oxygen, if not more effective, at least in the
short term.39
There is also abundant evidence from animal and human stud-
ies that hyperoxaemia alone is damaging to the brain and other
organs at the cellular level, particularly after asphyxia. Animal
studies suggest that the risk is greatest to the immature brain
during the brain growth spurt (mid-pregnancy to 3 years).40
These risks include deleterious effects on glial progenitor cells and
myelination.41
Other issues include concerns that pulmonary vascular resis-
tance may take longer to resolve if air is used rather than oxygen
for lung inﬂation at birth.However, though two studies have shown
that it may be reduced a little further and a little faster by use of
oxygen rather than air, there is a price to pay. Exposure to high con-
centrations of oxygen at birth results in the creation of increased
reactive oxygen species which, in turn, reduces the potential for
pulmonary artery vaso-relaxation later in the neonatal course.
There are now numerous reports of oximetry data following
delivery. When using technology available from the early 2000 s, a
reliable reading can be obtained from >90% of normal term births,
approximately 80% of those born preterm, and 80–90% of those
apparently requiring resuscitation,within 2min of birth.42 Uncom-
promised babies born at term at sea level have SaO2 ∼60% during
labour,43 which increases to >90% by 10min.44 The 25th percentile
is approximately 40% at birth and increases to ∼80% at 10min.45
Values are lower in those born by Caesarean section46 and those
born at altitude.47 Those born preterm may take longer to reach
>90%.45 Those given supplemental oxygen had a higher incidence
of SaO2 >95%, evenwhen aprotocol to decrease the FiO2 was imple-
mented, although the extent of this was restricted by insufﬁcient
power and the particular protocols used in the studies.48,49
Recommendation: In term infants receiving resuscitation at birth
with positive-pressure ventilation, it is best to begin with air as
opposed to 100% oxygen. If, despite effective ventilation, there is
no increase in heart rate or oxygenation (guided by oximetrywher-
ever possible) remains unacceptable, use a higher concentration of
oxygen.
As many preterm babies less than 32 weeks gestation will not
achieve target values for transcutaneous oxygen saturation in air,
blended oxygen and airmaybe given judiciously and ideally guided
by pulse oximetry. Both hyperoxaemia and hypoxemia should be
avoided. If a blend of oxygen and air is not available, resuscitation
should be initiated with air.
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iming of cord clamping
Cine-radiographic studies of babies taking their ﬁrst breath at
elivery showed that those whose cords were clamped prior to
his had an immediate decrease in the size of the heart during the
ubsequent three or four cardiac cycles. The heart then increased in
ize to almost the same size as the fetal heart. The initial decrease
n size could be interpreted as being due to ﬁlling of the of the
ewly-openedpulmonaryvascular systemduringaerationwith the
ubsequent increase in size occurring as a consequence of blood
eturning to the heart from the lung.50 Brady and James drew
ttention to the occurrence of a bradycardia apparently induced
y clamping the cord before the ﬁrst breath and noted that this
id not occur in babies where clamping occurred after breath-
ng was established.51 Might such early clamping of the cord in
signiﬁcantly preterm infant, whose ability to inﬂate his lungs
y generating negative intrathoracic pressures is already compro-
ised, either induce or prolong a bradycardia leading to a ‘need’
or resuscitation?
Studies in term infants clamped late have shown an improve-
ent in iron status and a number of other haematological indices
ver the next 3–6 months. They have also shown greater use of
hototherapy for jaundice in the delayed group but the use of
hototherapy was neither controlled nor deﬁned and many would
egard this of little consequence.
Studies in preterm infants have consistently shown improved
tability in the immediate postnatal period and reduced exposure
o blood transfusion in the ensuing weeks. Some studies have sug-
ested a reduced incidence of intraventricular haemorrhage and of
ate-onset sepsis.52 Again some studies report increased jaundice
nduseofphototherapybut therehavebeenno reportsof increased
se of exchange transfusion.
Studies have not addressed any effect of delaying cord clamping
n babies apparently needing resuscitation at birth because such
abies have been excluded.
Recommendation: Delay in umbilical cord clamping for at least
min is recommended for newborn infants not requiring resus-
itation. A similar delay should be applied to premature babies
eing stabilised. For babies requiring resuscitation, resuscitative
ntervention remains the priority.
nitial breaths and assisted ventilation
In term infants, spontaneous or assisted initial inﬂations
reate a functional residual capacity (FRC).53–59 The optimum
ressure, inﬂation time and ﬂow required to establish an
ffective FRC has not been determined. Average initial peak
nﬂating pressures of 30–40 cmH2O (inﬂation time undeﬁned)
sually ventilate unresponsive term infants successfully.54,56,57,59
ssisted ventilation rates of 30–60breathsmin−1 are used com-
only, but the relative efﬁcacy of various rates has not been
nvestigated.
Where pressure is being monitored, an initial inﬂation pressure
f 20 cmH2O may be effective, but 30–40 cmH2O or higher may
e required in some term babies. If pressure is not being moni-
ored but merely limited by a non-adjustable ‘blow-off’ valve, use
he minimum inﬂation required to achieve an increase in heart
ate. There is insufﬁcient evidence to recommend an optimum
nﬂation time. In summary, try to provide artiﬁcial ventilation at
0–60breathsmin−1 to achieveormaintainaheart ratehigher than
00min−1 promptly.ssisted ventilation of preterm infants
Animal studies show that preterm lungs are easily damaged
y large-volume inﬂations immediately after birth60 and thattion 81 (2010) 1389–1399 1395
maintaining a positive end expiratory pressure (PEEP) imme-
diately after birth protects against lung damage. Positive end
expiratory pressure also improves lung compliance and gas
exchange.61,62
Both over-inﬂation and repeated collapse of the alveoli have
been shown to cause damage in animal studies. Inﬂation pressure
is measured in an imperfect attempt to limit tidal volume. Ideally
tidal volume would be measured, and after lung aeration, limited
to between 4 and 8mlkg−1 to avoid over-distension.63
When ventilating preterm infants, very obvious passive chest
wall movement may indicate excessive tidal volumes and should
be avoided. Monitoring of pressure may help to provide consistent
inﬂations and avoid high pressures. If positive-pressure ventilation
is required, an initial inﬂation pressure of 20–25 cmH2O is ade-
quate for most preterm infants.64,65 If a prompt increase in heart
rate or chest movement is not obtained, higher pressures may be
needed. If continuedpositive-pressure ventilation is required, PEEP
may be beneﬁcial. Continuous positive airway pressure (CPAP) in
spontaneously breathing preterm infants following resuscitation
may also be beneﬁcial.65
Devices
Effective ventilation can be achieved with a ﬂow-inﬂating, a
self-inﬂating bag or with a T-piece mechanical device designed to
regulate pressure.66–68 The blow-off valves of self-inﬂating bags
are ﬂow-dependent and pressures generatedmay exceed the value
speciﬁed by the manufacturer if compressed vigoruously.69 Target
inﬂation pressures and long inspiratory times are achieved more
consistently in mechanical models when using T-piece devices
than when using bags,70 although the clinical implications are not
clear. More training is required to provide an appropriate pres-
sure using ﬂow-inﬂating bags compared with self-inﬂating bags.71
A self-inﬂating bag, a ﬂow-inﬂating bag, or a T-piece mechanical
device, all designed to regulate pressure or limit pressure applied
to the airway, can be used to ventilate a newborn.
Laryngeal mask airways
A number of studies have shown that laryngeal mask airways
(LMAs) can be effectively used at birth to ventilate babies weighing
over 2000g, greater than 33 weeks gestation and apparently need-
ing resuscitation. Case reports suggest that laryngeal masks have
been successfully used when intubation has been tried and failed –
and occasionally vice-versa. There are few data on smaller or less
mature babies.
Recommendation: The laryngeal mask airway can be used in
resuscitation of the newborn, particularly if facemask ventilation
is unsuccessful or tracheal intubation is unsuccessful or not feasi-
ble. The laryngealmask airwaymay be considered as an alternative
to a facemask for positive-pressure ventilation among newborns
weighing more than 2000g or delivered ≥34 weeks gestation.
There is limited evidence, however, to evaluate its use for new-
borns weighing <2000g or delivered <34 weeks gestation. The
laryngeal mask airway may be considered as an alternative to tra-
cheal intubation as a secondary airway for resuscitation among
newborns weighing more than 2000g or delivered ≥34 weeks
gestation.72–74 The laryngealmaskairwayhasnotbeenevaluated in
the setting of meconium-stained ﬂuid, during chest compressions,
or for the administration of emergency intra-tracheal medica-
tions.Carbon dioxide detection with face mask or LMA ventilation
Colorimetric exhaledCO2 detectors havebeenusedduringmask
ventilation of a few preterm infants in the intensive care unit75 and
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Table 7.1
Oral tracheal tube lengths by gestation.
Gestation (weeks) Tracheal tube at lips (cm)
23–24 5.5
25–26 6.0
27–29 6.5
30–32 7.0
33–34 7.5
35–37 8.0
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Newborn animals thatwere hypoglycaemic at the time of an anoxic38–40 8.5
41–43 9.0
n thedelivery room,76 andmayhelp to identify airwayobstruction.
either additional beneﬁt aboveclinical assessmentalone, nor risks
ttributed to their use have been identiﬁed. The use of exhaled CO2
etectorswithother interfaces (e.g. nasal airways, laryngealmasks)
uring PPV in the delivery room has not been reported.
onﬁrming tracheal tube placement
Tracheal intubation may be considered at several points during
eonatal resuscitation:
Whensuctioning to removemeconiumorother tracheal blockage
is required.
If bag-mask ventilation is ineffective or prolonged.
When chest compressions are performed.
Special circumstances (e.g. congenital diaphragmatic hernia or
birth weight below 1000g).
he use and timing of tracheal intubation will depend on the skill
nd experience of the available resuscitators. Appropriate tube
engths based on gestation are shown in Table 7.1.77
Tracheal tube placement must be assessed visually during intu-
ation, and positioning conﬁrmed. Following tracheal intubation
nd intermittent positive-pressure, a prompt increase in heart rate
s a good indication that the tube is in the tracheobronchial tree.78
xhaled CO2 detection is effective for conﬁrmation of tracheal tube
lacement in infants, including VLBW infants79–82 and neonatal
tudies suggest that it conﬁrms tracheal intubation in neonates
ith a cardiac output more rapidly and more accurately than clin-
cal assessment alone.81–83 Failure to detect exhaled CO2 strongly
uggests oesophageal intubation79,81 but false negative readings
ave been reported during cardiac arrest79 and in VLBW infants
espite models suggesting efﬁcacy.84 However, neonatal studies
ave excluded infants in need of extensive resuscitation. There is
o comparative information to recommend any one method for
etection of exhaled carbon dioxide in the neonatal population.
alse positives may occur with colorimetric devices contaminated
ith adrenaline (epinephrine), surfactant and atropine.75
Poor or absent pulmonary blood ﬂow or tracheal obstruction
ay prevent detection of exhaled CO2 despite correct tracheal tube
lacement. Tracheal tubeplacement is identiﬁed correctly in nearly
ll patients who are not in cardiac arrest;80 however, in critically
ll infants with poor cardiac output, inability to detect exhaled
O2 despite correct placement may lead to unnecessary extuba-
ion. Other clinical indicators of correct tracheal tube placement
nclude evaluation of condensed humidiﬁed gas during exhalation
nd presence or absence of chest movement, but these have not
een evaluated systematically in newborn babies.Recommendation: Detection of exhaled carbon dioxide in addi-
ion to clinical assessment is recommended as the most reliable
ethod to conﬁrm tracheal placement in neonates with sponta-
eous circulation.tion 81 (2010) 1389–1399
Route and dose of adrenaline (epinephrine)
Despite the widespread use of adrenaline during resuscitation,
noplacebo controlled clinical trials haveevaluated its effectiveness,
nor has the ideal dose or route of administration been deﬁned.
Neonatal case series or case reports85,86 indicate that adrenaline
administered by the tracheal route using a wide range of doses
(3–250gkg−1) may be associatedwith return of spontaneous cir-
culation (ROSC) or an increase in heart rate. These case series are
limited by inconsistent standards for adrenaline administration
and are subject to both selection and reporting bias.
One good quality case series indicates that tracheal adrenaline
(10gkg−1) is likely to be less effective than the same dose
administered intravenously.87 This is consistent with evidence
extrapolated from neonatal animal models indicating that higher
doses (50–100gkg−1) of adrenaline may be required when given
via the tracheal route to achieve the sameblood adrenaline concen-
trations andhaemodynamic responseas achievedafter intravenous
administration.88,89 Adult animal models demonstrate that blood
concentrations of adrenaline are signiﬁcantly lower following tra-
cheal compared with intravenous administration90,91 and that
tracheal doses ranging from 50 to 100gkg−1 may be required to
achieve ROSC.92
Although it has been widely assumed that adrenaline can be
given faster by the tracheal route than by the intravenous route,
no clinical trials have evaluated this hypothesis. Two studies have
reported cases of inappropriately early use of tracheal adrenaline
before airway and breathing are established.85,86 One case series
describing in-hospital paediatric cardiac arrests suggested that sur-
vival was higher among infants who received their ﬁrst dose of
adrenaline by the tracheal route; however, the time required for
ﬁrst dose administration using the tracheal and intravenous routes
were not provided.93
Paediatric94,95 and newborn animal studies96 showed no ben-
eﬁt and a trend toward reduced survival and worse neurological
status after high-dose intravenous adrenaline (100mcgkg−1) dur-
ing resuscitation. This is in contrast to a single paediatric case
series using historic controls that indicated amarked improvement
in ROSC using high-dose intravenous adrenaline (100mcgkg−1).
However, a meta-analysis of ﬁve adult clinical trials indicates that
whilst high-dose intravenous adrenaline may increase ROSC, it
offers no beneﬁt in survival to hospital discharge.97
Recommendation: If adrenaline is administered, give an intra-
venous dose 10–30gkg−1 as soon as possible. Higher intravenous
doses shouldnotbegivenandmaybeharmful. If intravenous access
isnot available, then itmaybe reasonable to try tracheal adrenaline.
If adrenaline is administered by the tracheal route, it is likely that a
larger dose (50–100gkg−1) will be required to achieve a similar
effect to the 10gkg−1 intravenous dose.
Post-resuscitation care
Babies who have required resuscitation may later deteriorate.
Once adequate ventilation and circulation are established, the
infant should be maintained in or transferred to an environment
in which close monitoring and anticipatory care can be provided.
Glucose
Hypoglycaemia was associated with adverse neurological out-
come in a neonatal animal model of asphyxia and resuscitation.98or hypoxic–ischemic insult had larger areas of cerebral infarction
and/or decreased survival compared to controls.99,100 One clinical
study demonstrated an association between hypoglycaemia and
poor neurological outcome following perinatal asphyxia.101 In
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dults, children and extremely low-birth-weight infants receiving
ntensive care, hyperglycaemia has been associated with a worse
utcome.102–104 However, in paediatric patients, hyperglycaemia
fter hypoxia–ischaemia does not appear to be harmful,105 which
onﬁrms data from animal studies106 some of which suggest it
ay be protective.107 However, the range of blood glucose con-
entration that is associated with the least brain injury following
sphyxia and resuscitation cannot be deﬁned based on available
vidence. Infants who require signiﬁcant resuscitation should be
onitored and treated to maintain glucose in the normal range.
nduced hypothermia
Several randomised, controlled, multi-centre trials of
nduced hypothermia (33.5–34.5 ◦C) of babies born at more
han 36 weeks gestational age, with moderate to severe
ypoxic–ischemic encephalopathy have shown that cooling
igniﬁcantly reduced death and neuro-developmental disability at
8 months.108–111 Systemic and selective head cooling produced
imilar results.109–113 Modest hypothermia may be associated
ith bradycardia and elevated blood pressure that do not usually
equire treatment, but a rapid increase in body temperature may
ause hypotension.114 Profound hypothermia (core temperature
elow 33 ◦C) may cause arrhythmia, bleeding, thrombosis, and
epsis, but studies so far have not reported these complications in
nfants treated with modest hypothermia.109,115
Newly born infants born at term or near-term with evolv-
ng moderate to severe hypoxic–ischemic encephalopathy should,
here possible, be offered therapeutic hypothermia. Whole body
ooling and selective head cooling are both appropriate strategies.
ooling should be initiated and conducted under clearly deﬁned
rotocols with treatment in neonatal intensive care facilities and
ith the capabilities for multidisciplinary care. Treatment should
e consistent with the protocols used in the randomised clini-
al trials (i.e. commence within 6h of birth, continue for 72h of
irth and re-warm over at least 4h). Animal data would strongly
uggest that the effectiveness of cooling is related to early inter-
ention. There is no evidence in human newborns that cooling
s effective if started more than 6h after birth. Carefully mon-
tor for known adverse effects of cooling – thrombocytopenia
nd hypotension. All treated infants should be followed longitu-
inally.
ithholding or discontinuing resuscitation
Mortality andmorbidity fornewbornsvaries according to region
nd to availability of resources.116 Social science studies indicate
hat parents desire a larger role in decisions to resuscitate and to
ontinue life support in severely compromised babies.117 Opinions
ary amongst providers, parents and societies about the balance of
eneﬁts and disadvantages of using aggressive therapies in such
abies.118,119
ithholding resuscitation
It is possible to identify conditions associated with high mor-
ality and poor outcome, where withholding resuscitation may be
onsidered reasonable, particularlywhen therehasbeen theoppor-
unity for discussion with parents.24,120,121
A consistent and coordinated approach to individual cases by
he obstetric and neonatal teams and the parents is an impor-
ant goal.23 Withholding resuscitation and discontinuation of
ife-sustaining treatment during or following resuscitation are
onsidered by many to be ethically equivalent and clinicians
hould not be hesitant to withdraw support when the pos-
ibility of functional survival is highly unlikely. The followingtion 81 (2010) 1389–1399 1397
guidelines must be interpreted according to current regional out-
comes.
• Where gestation, birth weight, and/or congenital anomalies are
associated with almost certain early death, and unacceptably
highmorbidity is likely among the rare survivors, resuscitation is
not indicated.122 Examples from the published literature include:
extreme prematurity (gestational age less than 23 weeks and/or
birthweight less than 400g), and anomalies such as anencephaly
and conﬁrmed Trisomy 13 or 18.
• Resuscitation is nearly always indicated in conditions associated
with a high survival rate and acceptablemorbidity. This will gen-
erally include babies with gestational age of 25 weeks or above
(unless there is evidence of fetal compromise such as intrauterine
infection or hypoxia–ischaemia) and those with most congenital
malformations.
• In conditions associated with uncertain prognosis, where there
is borderline survival and a relatively high rate of morbidity, and
where the anticipated burden to the child is high, parental desires
regarding resuscitation should be supported.
Withdrawing resuscitation efforts
Data from infants without signs of life from birth, lasting at
least 10min or longer, show either high mortality or severe neuro-
developmental disability.123,124 If faced with a newly born baby
with no detectable heart rate which remains undetectable for
10min, it is appropriate to then consider stopping resuscitation.
The decision to continue resuscitation efforts when the infant has
no detectable heart rate for longer than 10min is often complex
and may be inﬂuenced by issues such as the presumed aetiology
of the arrest, the gestation of the baby, the potential reversibility
of the situation, and the parents’ previous expressed feelings about
acceptable risk of morbidity.
If the heart rate is less than 60min−1 at birth and persisting after
10 or 15min the situation is even less clear and a ﬁrm recommen-
dation cannot be made.
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a. Life-threatening electrolyte disorders
verview
Electrolyte abnormalities can cause cardiac arrhythmias or car-
iopulmonary arrest. Life-threatening arrhythmias are associated
ost commonly with potassium disorders, particularly hyper-
alaemia, and less commonly with disorders of serum calcium and
agnesium. In some cases therapy for life-threatening electrolyte
isorders should start before laboratory results become available.
The electrolyte values for deﬁnitions have been chosen as a
uide to clinical decision-making. The precise values that trigger
reatment decisions will depend on the patient’s clinical condition
nd rate of change of electrolyte values.
There is little or no evidence for the treatment of electrolyte
bnormalities during cardiac arrest. Guidance during cardiac arrest
s based on the strategies used in the non-arrest patient. There are
∗ Corresponding author.
E-mail address: jas.soar@btinternet.com (J. Soar).
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.015no major changes in the treatment of these disorders since Guide-
lines 2005.1
Prevention of electrolyte disorders
Identify and treat life-threatening electrolyte abnormalities
before cardiac arrest occurs. Remove any precipitating factors (e.g.,
drugs) and monitor electrolyte values to prevent recurrence of the
abnormality. Monitor renal function in patients at risk of elec-
trolyte disorders (e.g., chronic kidney disease, cardiac failure). In
haemodialysis patients, review the dialysis prescription regularly
to avoid inappropriate electrolyte shifts during treatment.
Potassium disorders
Potassium homeostasisExtracellular potassium concentration is regulated tightly
between 3.5 and 5.0mmol l−1. A large concentration gradient
normally exists between intracellular and extracellular ﬂuid
compartments. This potassium gradient across cell membranes
contributes to the excitability of nerve and muscle cells, including
evier Ireland Ltd. All rights reserved.
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he myocardium. Evaluation of serum potassium must take into
onsideration the effects of changes in serum pH. When serum
H decreases (acidaemia), serum potassium increases because
otassium shifts from the cellular to the vascular space. When
erum pH increases (alkalaemia), serum potassium decreases
ecause potassium shifts intracellularly. Anticipate the effects of
H changes on serum potassium during therapy for hyperkalaemia
r hypokalaemia.
yperkalaemia
This is the most common electrolyte disorder associated with
ardiopulmonary arrest. It is usually causedby increasedpotassium
elease from cells, impaired excretion by the kidneys or accidental
otassium chloride administration.
eﬁnition
There is nouniversal deﬁnition.Wehavedeﬁnedhyperkalaemia
s a serum potassium concentration higher than 5.5mmol l−1; in
ractice, hyperkalaemia is a continuum. As the potassium con-
entration increases above this value the risk of adverse events
ncreases and the need for urgent treatment increases. Severe
yperkalaemia has been deﬁned as a serum potassium concentra-
ion higher than 6.5mmol l−1.
auses
There are several potential causes of hyperkalaemia, includ-
ng renal failure, drugs (angiotensin converting enzyme inhibitors
ACE-I), angiotensin II receptor antagonists, potassium spar-
ng diuretics, non-steroidal anti-inﬂammatory drugs (NSAIDs),
eta-blockers, trimethoprim), tissue breakdown (rhabdomyolysis,
umour lysis, haemolysis), metabolic acidosis, endocrine disorders
Addison’s disease), hyperkalaemic periodic paralysis, or diet (may
e sole cause in patients with advanced chronic kidney disease).
bnormal erythrocytes or thrombocytosis may cause a spuriously
igh potassium concentration.2 The risk of hyperkalaemia is even
reaterwhen there is a combination of factors such as the concomi-
ant use of ACE-I and NSAIDs or potassium sparing diuretics.
ecognition of hyperkalaemia
Exclude hyperkalaemia in patients with an arrhythmia or
ardiac arrest.3 Patients may present with weakness progress-
ng to ﬂaccid paralysis, paraesthesia, or depressed deep tendon
eﬂexes. Alternatively, the clinical picture can be overshadowed
y the primary illness causing hyperkalaemia. The ﬁrst indicator
f hyperkalaemia may also be the presence of ECG abnormali-
ies, arrhythmias, cardiopulmonary arrest or sudden death. The
ffect of hyperkalaemia on the ECG depends on the absolute serum
otassium as well as the rate of increase. Most patients will have
CG abnormalities at a serumpotassium concentration higher than
.7mmol l−1.4 The use of a blood gas analyser that measures potas-
ium can reduce delay in recognition.
The ECG changes associated with hyperkalaemia are usually
rogressive and include:
ﬁrst degree heart block (prolonged PR interval) [>0.2 s];
ﬂattened or absent P waves;
tall, peaked (tented) T waves [T wave larger than R wave in more
than 1 lead];
ST-segment depression;
S and T wave merging (sine wave pattern);
widened QRS [>0.12 s];
ventricular tachycardia;
bradycardia;1 (2010) 1400–1433 1401
• cardiac arrest (pulseless electrical activity [PEA], ventricular ﬁb-
rillation/pulseless ventricular tachycardia [VF/VT], asystole).
Treatment of hyperkalaemia
There are three key treatments for hyperkalaemia5:
1. cardiac protection;
2. shifting potassium into cells;
3. removing potassium from the body.
Intravenous calcium salts are not generally indicated in the
absence of ECG changes. Monitor effectiveness of treatment,
be alert to rebound hyperkalaemia and take steps to prevent
recurrence of hyperkalaemia. When hyperkalaemia is strongly
suspected, e.g., in the presence of ECG changes, start life-saving
treatment even before laboratory results are available. The treat-
ment of hyperkalaemia has been the subject of a Cochrane review.6
Patient not in cardiac arrest. Assess ABCDE (Airway, Breathing,
Circulation, Disability, Exposure) and correct any abnormalities.
Obtain intravenous access, check serum potassium and record
an ECG. Treatment is determined according to severity of hyper-
kalaemia.
Approximate values are provided to guide treatment.
Mild elevation (5.5–5.9mmol l−1):
• Remove potassium from body: potassium exchange resins –
calcium resonium 15–30g OR sodium polystyrene sulfonate
(Kayexalate) 15–30g in 50–100ml of 20% sorbitol, given either
orally or by retention enema (onset in 1–3h; maximal effect at
6h).
• Address cause of hyperkalaemia to correct and avoid further rise
in serum potassium (e.g., drugs, diet).
Moderate elevation (6–6.4mmol l−1) without ECG changes:
• Shift potassium intracellularly with glucose/insulin: 10 units
short-acting insulin and 25g glucose IV over 15–30min (onset in
15–30min;maximal effect at 30–60min;monitorbloodglucose).
• Remove potassium from the body as described above.
• Haemodialysis: consider if oliguric; haemodialysis is more efﬁ-
cient than peritoneal dialysis at removing potassium.
Severe elevation (≥6.5mmol l−1) without ECG changes. Seek expert
help and:
• Use multiple shifting agents.
• Glucose/insulin (see above).
• Salbutamol 5mg nebulised. Several doses (10–20mg) may be
required (onset in 15–30min).
• Sodium bicarbonate: 50mmol IV over 5min if metabolic acidosis
present (onset in 15–30min). Bicarbonate alone is less effective
than glucose plus insulin or nebulised salbutamol; it is best used
in conjunction with these medications.7,8
• Use removal strategies above.
Severe elevation (≥6.5mmol l−1) WITH toxic ECG changes. Seek• Protect the heart ﬁrst with calcium chloride: 10ml 10% calcium
chloride IV over 2–5min to antagonise the toxic effects of hyper-
kalaemia at the myocardial cell membrane. This protects the
heart by reducing the risk of pulseless VT/VF but does not lower
serum potassium (onset in 1–3min).
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Use multiple shifting agents (see above).
Use removal strategies.
Prompt specialist referral is essential.
Patient in cardiac arrest. Modiﬁcations to BLS There are no
odiﬁcations to basic life support in the presence of electrolyte
bnormalities.
Modiﬁcations to ALS
Follow the universal algorithm. Hyperkalaemia can be conﬁrmed
rapidly using a blood gas analyser if available. Protect the heart
ﬁrst: give 10ml 10% calcium chloride IV by rapid bolus injection.
Shift potassium into cells:
◦ Glucose/insulin: 10 units short-acting insulin and 25g glucose
IV by rapid injection.
◦ Sodium bicarbonate: 50mmol IV by rapid injection (if severe
acidosis or renal failure).
Remove potassium from body: dialysis: consider this for car-
diac arrest induced by hyperkalaemia that is resistant to medical
treatment. Several dialysis modes have been used safely and
effectively in cardiac arrest, but this may only be available in
specialist centres.
ndications for dialysis
Haemodialysis (HD) is the most effective method for removal
f potassium from the body. The principle mechanism of action
s the diffusion of potassium ions across the membrane down the
otassium ion gradient. The typical decline in serum potassium is
mmol l−1 in the ﬁrst 60min, followed by 1mmol l−1 over the next
h. The efﬁcacy of HD in decreasing serum potassium concentra-
ion can be improved by performing dialysis with a low potassium
oncentration in the dialysate,9 a high blood ﬂow rate10 or a high
ialysate bicarbonate concentration.11
Consider haemodialysis early for hyperkalaemia associated
ith established renal failure, oliguric acute kidney injury
<400mlday−1 urine output) orwhen there ismarked tissue break-
own. Dialysis is also indicated when hyperkalaemia is resistant
o medical treatment. Serum potassium frequently rebounds after
nitial treatment. In unstable patients continuous renal replace-
ent therapy (CRRT) (e.g., continuous veno-veno haemoﬁltration)
s less likely to compromise cardiac output than intermittent
aemodialysis. CRRT is nowwidely available inmany intensive care
nits.
ardiac arrest in haemodialysis patients
Cardiac arrest is themost common cause of death in haemodial-
sis patients.12 Events occurring particularly during haemodialysis
reatment, pose several novel considerations.
Initial steps. Call the resuscitation team and seek expert help
mmediately. Whilst BLS is underway, a trained dialysis nurse
hould be assigned to the dialysis machine. The conventional
ractice is to return the patient’s blood volume and take off
aemodialysis, although this approach is not the most time-
fﬁcient.13
Deﬁbrillation. A shockable cardiac rhythm (VF/VT) is more
ommon inpatientsundergoinghaemodialysis14,15 than in thegen-
ral population.16,17
The safest method to deliver a shock during dialysis requires
urther study. Most haemodialysis machine manufacturers rec-
mmend disconnection from the dialysis equipment prior to
eﬁbrillation.18 An alternative and rapid disconnect technique for
aemodialysis has been described. Disconnection during contin-
ous venovenous haemoﬁltration is not required.13 The use of1 (2010) 1400–1433
automated external deﬁbrillators in dialysis centres can facilitate
early deﬁbrillation.19
Vascular access. In life-threatening circumstances and cardiac
arrest, vascular access used for haemodialysis can be used to give
drugs.13
Potentially reversible causes. All of the standard reversible
causes (4 Hs and 4 Ts) apply to dialysis patients. Electrolyte
disorders, particularly hyperkalaemia, and ﬂuid overload (e.g., pul-
monary oedema) are most common causes.
Hypokalaemia
Hypokalaemia is common in hospital patients.20 Hypokalaemia
increases the incidenceof arrhythmias, particularly inpatientswith
pre-existing heart disease and in those treated with digoxin.
Deﬁnition
Hypokalaemia is deﬁned as a serum potassium<3.5mmol l−1.
Severe hypokalaemia is deﬁned as a K+ <2.5mmol l−1 and may be
associated with symptoms.
Causes
Causes of hypokalaemia include gastrointestinal loss (diar-
rhoea), drugs (diuretics, laxatives, steroids), renal losses (renal
tubular disorders, diabetes insipidus, dialysis), endocrine disorders
(Cushing’s Syndrome, hyperaldosteronism), metabolic alkalosis,
magnesium depletion, and poor dietary intake. Treatment strate-
gies used for hyperkalaemia may also induce hypokalaemia.
Recognition of hypokalaemia
Exclude hypokalaemia in every patient with an arrhythmia or
cardiac arrest. In dialysis patients, hypokalaemia occurs commonly
at the end of a haemodialysis session or during treatment with
peritoneal dialysis.
As serum potassium concentration decreases, the nerves and
muscles are predominantly affected causing fatigue, weakness,
leg cramps, constipation. In severe cases (K+ <2.5mmol l−1), rhab-
domyolysis, ascending paralysis and respiratory difﬁculties may
occur.
ECG features of hypokalaemia are:
• U waves;
• T wave ﬂattening;
• ST-segment changes;
• arrhythmias, especially if patient is taking digoxin;
• cardiopulmonary arrest (PEA, pulseless VT/VF, asystole).
Treatment
This depends on the severity of hypokalaemia and the presence
of symptomsandECGabnormalities.Gradual replacementofpotas-
sium is preferable, but in an emergency, intravenous potassium
is required. The maximum recommended IV dose of potassium
is 20mmolh−1, but more rapid infusion (e.g., 2mmolmin−1 for
10min, followed by 10mmol over 5–10min) is indicated for unsta-
ble arrhythmias when cardiac arrest is imminent. Continuous ECG
monitoring is essential during IV infusion and the dose should be
titrated after repeated sampling of serum potassium levels.
Many patients who are potassium deﬁcient are also deﬁcient
in magnesium. Magnesium is important for potassium uptake and
for the maintenance of intracellular potassium levels, particularly
in the myocardium. Repletion of magnesium stores will facilitate
more rapid correction of hypokalaemia and is recommended in
severe cases of hypokalaemia.21
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Table 8.1
Calcium and magnesium disorders with associated clinical presentation, ECG manifestations and recommended treatment.
Disorder Causes Presentation ECG Treatment
Hypercalcaemia
[Calcium]>2.6mmol l−1
Primary or tertiary
hyperparathyroidism
Confusion Short QT interval Fluid replacement IV
Malignancy Weakness Prolonged QRS Interval Furosemide 1mgkg−1 IV
Sarcoidosis Abdominal pain Flat T waves Hydrocortisone 200–300mg IV
Drugs Hypotension AV-block Pamidronate 30–90mg IV
Arrhythmias Cardiac arrest Treat underlying cause
Cardiac arrest
Hypocalcaemia
[Calcium]<2.1mmol l−1
Chronic renal failure Paraesthesia Prolonged QT interval Calcium chloride 10% 10–40ml
Acute pancreatitis Tetany T wave inversion Magnesium sulphate 50%
4–8mmol (if necessary)
Calcium channel blocker
overdose
Seizures Heart block
Toxic shock syndrome AV-block Cardiac arrest
Rhabdomyolysis Cardiac arrest
Tumour lysis syndrome
Hypermagnesaemia
[Magnesium]>1.1mmol l−1
Renal failure Confusion Prolonged PR and QT
intervals
Consider treatment when
[Magnesium]>1.75mmol l−1
Iatrogenic Weakness T wave peaking
Respiratory depression AV-block Calcium chloride 10% 5–10ml
repeated if necessary
AV-block Cardiac arrest Ventilatory support if
necessary
Cardiac arrest Saline diuresis – 0.9% saline
with furosemide 1mgkg−1 IV
Haemodialysis
Hypomagnesaemia
[Magnesium]<0.6mmol l−1
GI loss Tremor Prolonged PR and QT
Intervals
Severe or symptomatic:
Polyuria Ataxia ST-segment depression 2g 50% magnesium sulphate
(4ml; 8mmol) IV over 15min.
Starvation Nystagmus T-wave inversion Torsade de pointes:
Alcoholism Seizures Flattened P waves 2g 50% magnesium sulphate
(4ml; 8mmol) IV over 1–2min.
Malabsorption Arrhythmias – torsade de pointes Increased QRS duration Seizure:
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alcium and magnesium disorders
The recognition and management of calcium and magnesium
isorders is summarised in Table 8.1.
ummary
Electrolyte abnormalities are among the most common causes
f cardiac arrhythmias. Of all the electrolyte abnormalities, hyper-
alaemia is most rapidly fatal. A high degree of clinical suspicion
nd aggressive treatment of underlying electrolyte abnormalities
an prevent many patients from progressing to cardiac arrest.
b. Poisoning
eneral considerations
Poisoning rarely causes cardiac arrest, but is a leading cause
f death in victims younger than 40 years of age.22 Evidence for
reatment consists primarily of small case-series, animal studies
nd case reports. Poisoning by therapeutic or recreational drugs
nd by household products are the main reasons for hospital
dmission and poison centre calls. Inappropriate drug dosing, drug
nteractions and othermedication errors can also cause harm. Acci-
ental poisoning is commonest in children. Homicidal poisoning
s uncommon. Industrial accidents, warfare or terrorism can also
ause exposure to harmful substances.Torsade de pointes 2 g 50% magnesium sulphate
(4ml; 8mmol) IV over 10min.
Prevention of cardiac arrest
Assess using the ABCDE (Airway, Breathing, Circulation, Dis-
ability, Exposure) approach. Airway obstruction and respiratory
arrest secondary to a decreased conscious level is a common cause
of death after self-poisoning.23 Pulmonary aspiration of gastric
contents can occur after poisoning with central nervous system
depressants. Early tracheal intubation of unconscious patients by
a trained person decreases the risk of aspiration. Drug-induced
hypotension usually responds to ﬂuid infusion, but occasionally
vasopressor support (e.g., noradrenaline infusion) is required. A
long period of coma in a single position can cause pressure sores
and rhabdomyolysis. Measure electrolytes (particularly potas-
sium), blood glucose and arterial blood gases.Monitor temperature
because thermoregulation is impaired. Both hypothermia and
hyperthermia (hyperpyrexia) can occur after overdose of some
drugs. Retain samples of blood and urine for analysis. Patients with
severe poisoning should be cared for in a critical-care setting.
Interventions such as decontamination, enhanced elimina-
tion and antidotes may be indicated and are usually second
line interventions.24 Alcohol excess is often associated with self-
poisoning.Modiﬁcations to BLS/ALS
• Have a high index of personal safety where there is a suspicious
cause or unexpected cardiac arrest. This is especially so when
more than one casualty collapses simultaneously.
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Avoid mouth-to-mouth ventilation in the presence of chemicals
such as cyanide, hydrogen sulphide, corrosives and organophos-
phates.
Treat life-threatening tachyarrhythmias with cardioversion
according to the peri-arrest arrhythmia guidelines (see Section 4,
Advanced Life Support).24a This includes correction of electrolyte
and acid-base abnormalities.
Try to identify the poison(s). Relatives, friends and ambulance
crews can provide useful information. Examination of the patient
may reveal diagnostic clues such as odours, needle marks, pupil
abnormalities, and signs of corrosion in the mouth.
Measure the patient’s temperature because hypo- or hyperther-
mia may occur after drug overdose (see Sections 8d and 8e).
Be prepared to continue resuscitation for a prolongedperiod, par-
ticularly in young patients, as the poison may be metabolized or
excreted during extended life support measures.
Alternative approaches which may be effective in severely poi-
soned patients include: higher doses of medication than in
standardprotocols; non-standarddrug therapies; prolongedCPR.
Consult regional or national poisons centres for information on
treatment of the poisoned patient. The International Programme
on Chemical Safety (IPCS) lists poison centres on its website:
http://www.who.int/ipcs/poisons/centre/en/.
Online databases for information on toxicology and hazardous
chemicals: (http://toxnet.nlm.nih.gov/).
peciﬁc therapeutic measures
There are few speciﬁc therapeutic measures for poisoning that
re useful immediately and improve outcomes.25–29
Therapeutic measures include decontamination, multiple-dose
ctivated charcoal, enhancing elimination and the use of speciﬁc
ntidotes. Many of these interventions should be used only based
n expert advice. For up-to-date guidance in severe or uncommon
oisonings, seek advice from a poisons centre.
astrointestinal decontamination
Activated charcoal adsorbs most drugs. Its beneﬁt decreases
ver time after ingestion. There is no evidence that treatment with
ctivated charcoal improves clinical outcome. Consider giving a
ingle dose of activated charcoal to patients who have ingested a
otentially toxic amount of poison (known to be adsorbed by acti-
ated charcoal) up to 1h previously.30 Give it only to patients with
n intact or protected airway.
Multiple-dose activated charcoal signiﬁcantly increases drug
limination, but no controlled study in poisoned patients has
hown a reduction in morbidity and mortality and should only be
sed following expert advice. There is little evidence to support
he use of gastric lavage. It should only be considered within 1h of
ngestion of a potentially life-threatening amount of a poison. Even
hen, clinical beneﬁt has not been conﬁrmed in controlled stud-
es. Gastric lavage is contraindicated if the airway is not protected
nd if a hydrocarbon with high aspiration potential or a corrosive
ubstance has been ingested.27,28
Volunteer studies show substantial decreases in the bioavail-
bility of ingested drugs but no controlled clinical trials show that
hole-bowel irrigation improves the outcome of the poisoned
atient. Based on volunteer studies, whole-bowel irrigation may
e considered for potentially toxic ingestions of sustained-release
r enteric-coated drugs. Its use for the removal of iron, lead, zinc,
r packets of illicit drugs is a theoretical option. Whole-bowel
rrigation is contraindicated in patients with bowel obstruction,
erforation, ileus, and haemodynamic instability.311 (2010) 1400–1433
Laxatives (cathartics) or emetics (e.g., ipecacuanha) have no role
in the management of the acutely poisoned patient and are not
recommended.26,32,33
Enhancing elimination
Urine alkalinisation (urine pH of 7.5 or higher) by intra-
venous sodium bicarbonate infusion is a ﬁrst line treatment
for moderate-to-severe salicylate poisoning in patients who
do not need haemodialysis.25 Urine alkalinisation with high
urine ﬂow (approximately 600mlh−1) should also be con-
sidered in patients with severe poisoning by the herbicides
2,4-dichlorophenoxyacetic acid and methylchlorophenoxypro-
pionic acid (mecoprop). Hypokalaemia is the most common
complication of alkalaemia.
Haemodialysis or haemoperfusion should be considered in
speciﬁc life-threatening poisonings only. Haemodialysis removes
drugs or metabolites that are water soluble, have a low volume
of distribution and low plasma protein binding. Haemoperfusion
can remove substances that have a high degree of plasma protein
binding
Speciﬁc poisonings
These guidelines address only some causes of cardiorespiratory
arrest due to acute poisoning.
Benzodiazepines
Patients at risk of cardiac arrest
Overdose of benzodiazepines can cause loss of consciousness,
respiratory depression and hypotension. Flumazenil, a competi-
tive antagonist of benzodiazepines, should only be used only for
reversal of sedation caused by a single ingestion of any of the
benzodiazepines and when there is no history or risk of seizures.
Reversal of benzodiazepine intoxication with ﬂumazenil can be
associated with signiﬁcant toxicity (seizure, arrhythmia, hypoten-
sion, and withdrawal syndrome) in patients with benzodiazepine
dependence or co-ingestion of proconvulsant medications such as
tricyclic antidepressants.34–36 The routine use of ﬂumazenil in the
comatose overdose patient is not recommended.
Modiﬁcations to BLS/ALS
There are no speciﬁc modiﬁcations required for cardiac arrest
caused by benzodiazepines.36–40
Opioids
Opioid poisoning causes respiratory depression followedby res-
piratory insufﬁciency or respiratory arrest. The respiratory effects
of opioids are reversed rapidly by the opiate antagonist naloxone.
Patients at risk of cardiac arrest
In severe respiratory depression caused by opioids, there are
fewer adverse events when airway opening, oxygen administra-
tion and ventilation are carried out before giving naloxone.41–47
The use of naloxone can prevent the need for intubation. The pre-
ferred route forgivingnaloxonedependson theskills of the rescuer:
IV, intramuscular (IM), subcutaneous (SC) and intranasal (IN) routes
can be used. The non-IV routes can be quicker because time is saved
in not having to establish IV access, which can be extremely difﬁ-
cult in an IV drug abuser. The initial doses of naloxone are 400g
IV,43 800g IM, 800g SC,43 or 2mg IN.48,49 Large opioid over-
doses may require titration of naloxone to a total dose of 6–10mg.
The duration of action of naloxone is approximately 45–70min, but
respiratory depression can persist for 4–5h after opioid overdose.
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hus, the clinical effects of naloxone may not last as long as those
f a signiﬁcant opioid overdose. Titrate the dose until the victim is
reathing adequately and has protective airway reﬂexes.
Acute withdrawal from opioids produces a state of sympathetic
xcess and may cause complications such as pulmonary oedema,
entricular arrhythmia and severe agitation. Use naloxone reversal
f opioid intoxication with caution in patients suspected of opioid
ependence.
odiﬁcations for ALS
There are no studies supporting the use of naloxone once car-
iac arrest associated with opioid toxicity has occurred. Cardiac
rrest is usually secondary to a respiratory arrest and associated
ith severe brain hypoxia. Prognosis is poor.42 Giving naloxone is
nlikely to be harmful. Once cardiac arrest has occurred, follow
tandard resuscitation protocols.
ricyclic antidepressants
This section addresses both tricyclic and related cyclic
rugs (e.g., amitriptyline, desipramine, imipramine, nortriptyline,
oxepin, and clomipramine). Self-poisoning with tricyclic antide-
ressants is common and can cause hypotension, seizures, coma
nd life-threatening arrhythmias. Cardiac toxicity mediated by
nticholinergic and Na+ channel-blocking effects can produce a
ide complex tachycardia (VT). Hypotension is exacerbated by
lpha-1 receptor blockade. Anticholinergic effects include mydri-
sis, fever, dry skin, delirium, tachycardia, ileus, and urinary
etention. Most life-threatening problems occur within the ﬁrst 6h
fter ingestion.50–52
atient at risk of cardiac arrest
A widening QRS complex (>100ms) and right axis deviation
ndicates a greater risk of arrhythmias.53–55 Sodium bicarbon-
te should be considered for the treatment of tricyclic-induced
entricular conduction abnormalities.56–63 While no study has
nvestigated the optimal target arterial pH with bicarbonate ther-
py, a pH of 7.45–7.55 has been commonly accepted and seems
easonable.
Intravenous lipid infusions in experimental models of tricyclic
oxicity have suggested beneﬁt but there are few human data.64,65
nti-tricyclic antibodies have also been beneﬁcial in experimental
odels of tricyclic cardiotoxicity.66–71 One small human study72
rovided evidence of safety but clinical beneﬁt has not been shown.
odiﬁcations to BLS/ALS
There are no randomised controlled trials evaluating conven-
ional versus alternative treatments for cardiac arrest caused by
ricyclic toxicity. One small case-series of cardiac arrest patients,
howed improvement with the use of sodium bicarbonate.73
ocaine
Sympathetic overstimulation associated with cocaine toxicity
an cause agitation, tachycardia, hypertensive crisis, hyperthermia
nd coronary vasoconstriction causing myocardial ischaemia with
ngina.
atients at risk of cardiac arrest
In patients with severe cardiovascular toxicity, alpha blockers
phentolamine),74 benzodiazepines (lorazepam, diazepam),75,76alcium channel blockers (verapamil),77 morphine,78 and sub-
ingual nitroglycerine79,80 may be used as needed to control
ypertension, tachycardia,myocardial ischaemiaandagitation. The
vidence for or against the use of beta-blocker drugs,81–84 includ-
ng those beta-blockers with alpha blocking properties (carvedilol1 (2010) 1400–1433 1405
and labetolol).85–87 is limited. The best choice of anti-arrhythmic
drug for the treatment of cocaine-induced tachyarrhythmias is not
known.
Modiﬁcations to BLS/ALS
If cardiac arrest occurs, follow standard resuscitation
guidelines.88
Local anaesthetics
Systemic toxicity of local anaesthetics involves the central
nervous system, the cardiovascular system. Severe agitation,
loss of consciousness, with or without tonic–clonic convulsions,
sinus bradycardia, conduction blocks, asystole and ventricular
tachyarrhythmias can all occur. Toxicity can bepotentiated in preg-
nancy, extremes of age, or hypoxaemia. Toxicity typically occurs in
thesettingof regional anaesthesia,whenabolusof local anaesthetic
inadvertently enters an artery or vein.
Patients at risk of cardiac arrest
Evidence for speciﬁc treatment is limited to case reports involv-
ing cardiac arrest and severe cardiovascular toxicity and animal
studies. Patients with both cardiovascular collapse and cardiac
arrest attributable to local anaesthetic toxicity may beneﬁt from
treatment with intravenous 20% lipid emulsion in addition to stan-
dard advanced life support.89–103 Give an initial intravenous bolus
of 20% lipid emulsion followed by an infusion at 15mlkg−1 h−1.
Give up to three bolus doses of lipid at 5-min intervals and con-
tinue the infusion until the patient is stable or has received up to a
maximum of 12mlkg−1 of lipid emulsion.104
Modiﬁcations to BLS/ALS
Standard cardiac arrests drugs (e.g., adrenaline) should be
given according to standard guidelines, although animal studies
provide inconsistent evidence for their role in local anaesthetic
toxicity.100,103,105–107
Beta-blockers
Beta-blocker toxicity causes bradyarrhythmias and negative
inotropic effects that are difﬁcult to treat, and can lead to cardiac
arrest.
Patients at risk of cardiac arrest
Evidence for treatment is based on case reports and ani-
mal studies. Improvement has been reported with glucagon
(50–150gkg−1),108–121 high-dose insulin and glucose,122–124
phosphodiesterase inhibitors,125,126 calcium salts,127 extracorpo-
real and intra-aortic balloon pump support,128–130 and calcium
salts.131
Calcium channel blockers
Calcium channel blocker overdose is emerging as a common
cause of prescription drug poisoning deaths.22,132 Overdose of
short-acting drugs can rapidly progress to cardiac arrest. Overdose
by sustained-release formulations can result in delayed onset of
arrhythmias, shock, and sudden cardiac collapse. Asymptomatic
patients are unlikely to develop symptoms if the interval between
the ingestion and the call is greater than 6h for immediate-release
products, 18h for modiﬁed-release products other than verapamil,
and 24h for modiﬁed-release verapamil.
Patients at risk of cardiac arrest
Intensive cardiovascular support is needed for managing a
massive calcium channel blocker overdose. While calcium chlo-
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ide in high doses can overcome some of the adverse effects, it
arely restores normal cardiovascular status. Haemodynamic insta-
ility may respond to high doses of insulin given with glucose
upplementation and electrolyte monitoring in addition to stan-
ard treatments including ﬂuids and inotropic drugs.133–148 Other
otentially useful treatments include glucagon, vasopressin and
hosphodiesterse inhibitors.139,149
igoxin
Althoughcasesofdigoxinpoisoningare fewer than those involv-
ng calcium channel and beta-blockers, the mortality rate from
igoxin is far greater. Other drugs including calcium channel
lockers and amiodarone can also cause plasma concentrations of
igoxin to rise. Atrioventricular conduction abnormalities and ven-
ricular hyperexcitability due to digoxin toxicity can lead to severe
rrhythmias and cardiac arrest.
atients at risk of cardiac arrest
Standard resuscitation measures and speciﬁc antidote therapy
ith digoxin-speciﬁc antibody fragments should be used if there
re arrhythmias associated with haemodynamic instability.150–163
ntibody-speciﬁc therapy may also be effective in poisoning from
lants as well as Chinese herbal medications containing digitalis
lycosides.150,164,165 Digoxin-speciﬁc antibody fragments interfere
ith digoxin immunoassay measurements and can lead to overes-
imation of plasma digoxin concentrations.
yanide
Cyanide is generally considered to be a rare cause of acute poi-
oning; however, cyanide exposure occurs relatively frequently in
atients with smoke inhalation from residential or industrial ﬁres.
ts main toxicity results from inactivation of cytochrome oxidase
at cytochrome a3), thus uncouplingmitochondrial oxidative phos-
horylation and inhibiting cellular respiration, even in thepresence
f adequate oxygen supply. Tissues with the highest oxygen needs
brain and heart) are the most severely affected by acute cyanide
oisoning.
atients at risk of cardiac arrest
Patients with severe cardiovascular toxicity (cardiac arrest, car-
iovascular instability,metabolic acidosis, or alteredmental status)
aused by known or suspected cyanide poisoning should receive
yanide antidote therapy in addition to standard resuscitation,
ncluding oxygen. Initial therapy should include a cyanide scav-
nger (either intravenous hydroxocobalamin or a nitrite – i.e.,
ntravenous sodium nitrite and/or inhaled amyl nitrite), followed
s soon as possible by intravenous sodium thiosulphate.166–175
ydroxocobalamin and nitrites are equally effective but hydroxo-
obalamin may be safer because it does not cause methaemoglobin
ormation or hypotension.
odiﬁcations to BLS/ALS
In case of cardiac arrest caused by cyanide, standard ALS treat-
ent will fail to restore spontaneous circulation as long as cellular
espiration is blocked. Antidote treatment is needed for reactiva-
ion of cytochrome oxidase.
arbon monoxideCarbon monoxide poisoning is common. There were about
5,000 carbon monoxide related hospital admissions reported in
he US in 2005.176 Patients who develop cardiac arrest caused
y carbon monoxide rarely survive to hospital discharge, even if1 (2010) 1400–1433
return of spontaneous circulation is achieved; however, hyper-
baric oxygen therapy may be considered in these patients as it
may reduce the risk of developing persistent or delayed neuro-
logical injury.177–185 The risks inherent in transporting critically
ill post-arrest patients to a hyperbaric facility may be signiﬁcant,
and must be weighed against the possibility of beneﬁt on a case-
by-case basis. Patients who develop myocardial injury caused by
carbon monoxide have an increased risk of cardiac and all-cause
mortality lasting at least 7 years after the event; it is reasonable to
recommend cardiology follow-up for these patients.186,187
8c. Drowning
Overview
Drowning is a common cause of accidental death in Europe.
After drowning the duration of hypoxia is the most critical factor
in determining the victim’s outcome; therefore, oxygenation, ven-
tilation, and perfusion should be restored as rapidly as possible.
Immediate resuscitation at the scene is essential for survival and
neurological recovery after a drowning incident. This will require
provision of CPR by a bystander and immediate activation of the
EMSsystem.Victimswhohavespontaneouscirculationandbreath-
ing when they reach hospital usually recover with good outcomes.
Research into drowning is limited in comparison with primary car-
diac arrest and there is a need for further research in this area.188
These guidelines are intended for healthcare professionals and cer-
tain groups of lay responders that have a special interest in the care
of the drowning victim, e.g., lifeguards.
Epidemiology
The World Health Organization (WHO) estimates that, world-
wide, drowning accounts for approximately 450,000 deaths each
year. A further 1.3 million disability-adjusted life-years are lost
each year as a result of premature death or disability from
drowning189; 97% of deaths from drowning occur in low- and
middle-income countries.189 In 2006 there were 312 accidental
deaths from drowning in the United Kingdom190 and 3582 in
the United States,191 yielding an annual incidence of drowning of
0.56 and 1.2 per 100,000 population, respectively.192 Death from
drowning is more common in young males, and is the leading
cause of accidental death in Europe in this group.189 Factors associ-
atedwith drowning (e.g., suicide, trafﬁc accidents, alcohol and drug
abuse) varies between countries.193
Deﬁnitions, classiﬁcations and reporting
Over 30 different terms have been used to describe the
process and outcome from submersion- and immersion-related
incidents.194 The International Liaison Committee on Resuscita-
tion (ILCOR) deﬁnes drowning as “a process resulting in primary
respiratory impairment from submersion/immersion in a liquid
medium. Implicit in this deﬁnition is that a liquid/air interface
is present at the entrance of the victim’s airway, preventing the
victim from breathing air. The victim may live or die after this pro-
cess, but whatever the outcome, he or she has been involved in a
drowning incident”.195 Immersion means to be covered in water or
other ﬂuid. For drowning to occur, usually at least the face and air-
way must be immersed. Submersion implies that the entire body,
including the airway, is under the water or other ﬂuid.
ILCOR recommends that the following terms, previously used,
should no longer be used: dry andwet drowning, active andpassive
drowning, silent drowning, secondary drowning and drowned ver-
sus near-drowned.195 The Utstein drowning style should be used
ation 8
w
c
P
d
h
f
i
E
i
a
b
p
s
o
T
r
s
R
i
f
w
a
b
f
n
D
i
v
b
v
t
s
t
a
B
p
t
v
i
o
l
t
i
d
N
m
i
s
i
(
p
a
c
v
i
oJ. Soar et al. / Resuscit
hen reporting outcomes from drowning incidents to improve
onsistency in information between studies.195
athophysiology
The pathophysiology of drowning has been described in
etail.195,196 In brief, after submersion, the victim initially breath
olds before developing laryngospasm. During this time the victim
requently swallows large quantities of water. As breath hold-
ng/laryngospasm continues, hypoxia and hypercapnia develops.
ventually these reﬂexes abate and the victim aspirates water
nto their lungs leading to worsening hypoxaemia. Without rescue
nd restoration of ventilation the victim will become bradycardic
efore sustaining a cardiac arrest. The key feature to note in the
athophysiology of drowning is that cardiac arrest occurs as a con-
equence of hypoxia and correction of hypoxaemia is critical to
btaining a return of spontaneous circulation.
reatment
Treatment of a drowning victim involves four distinct but inter-
elated phases. These comprise (i) aquatic rescue, (ii) basic life
upport, (iii) advanced life support, and (iv) post-resuscitation care.
escue and resuscitation of the drowning victim almost always
nvolves a multi-professional team approach. The initial rescue
rom the water is usually undertaken either by bystanders or those
ith a duty to respond such as trained lifeguards or lifeboat oper-
tors. Basic life support is often provided by the initial responders
efore arrival of the emergency medical services. Resuscitation
requently continues into hospital where, if return of sponta-
eous circulation is achieved, transfer to critical care often follows.
rowning incidents vary in their complexity from an incident
nvolving a single victim to one that involves several or multiple
ictims. The emergency response will vary according to the num-
er of victims involved and available resources. If the number of
ictims outweighs the available resources then a system of triage
o determine who to prioritise for treatment is likely to be neces-
ary. The remainder of this sectionwill focus on themanagement of
he individual drowningvictimwhere there are sufﬁcient resources
vailable.
asic life support
Aquatic rescue and recovery from the water. Always be aware of
ersonal safety and minimize the danger to yourself and the vic-
im at all times. Whenever possible, attempt to save the drowning
ictim without entry into the water. Talking to the victim, reach-
ng with a rescue aid (e.g., stick or clothing), or throwing a rope
r buoyant rescue aid may be effective if the victim is close to dry
and. Alternatively, use a boat or other water vehicle to assist with
he rescue. Avoid entry into the water whenever possible. If entry
nto the water is essential, take a buoyant rescue aid or ﬂotation
evice.197 It is safer to enter thewaterwith two rescuers thanalone.
ever dive head ﬁrst in the water when attempting a rescue. You
ay lose visual contact with the victim and run the risk of a spinal
njury.
Remove all drowning victims from the water by the fastest and
afest means available and resuscitate as quickly as possible. The
ncidence of cervical spine injury in drowning victims is very low
approximately 0.5%).198 Spinal immobilisation can be difﬁcult to
erform in the water and can delay removal from the water and
dequate resuscitation of the victim. Poorly applied cervical collars
an also cause airway obstruction in unconscious patients.199 Cer-
ical spine immobilisation is not indicated unless signs of severe
njury are apparent or the history is consistent with the possibility
f severe injury.200 These circumstances include a history of diving,1 (2010) 1400–1433 1407
water-slide use, signs of trauma or signs of alcohol intoxication. If
the victim is pulseless and apnoeic remove them from the water as
quickly as possible (even if a back support device is not available),
while attempting to limit neck ﬂexion and extension.
Rescue breathing. The ﬁrst and most important treatment for
the drowning victim is alleviation of hypoxaemia. Prompt initia-
tion of rescue breathing or positive pressure ventilation increases
survival.201–204 If possible supplement rescue breaths/ventilations
with oxygen.205 Give ﬁve initial ventilations/rescue breaths as soon
as possible.
Rescuebreathing canbe initiatedwhilst thevictim is still in shal-
low water provided the safety of the rescuer is not compromised.
It is likely to be difﬁcult to pinch the victim’s nose, so mouth-to-
nose ventilation may be used as an alternative to mouth-to-mouth
ventilation.
If the victim is in deep water, open their airway and if there is
no spontaneous breathing start in-water rescuebreathing if trained
to do so. In-water resuscitation is possible,206 but should ideally be
performed with the support of a buoyant rescue aid.207 Give 10–15
rescue breaths over approximately 1min.207 If normal breathing
does not start spontaneously, and the victim is <5min of from land,
continue rescue breaths while towing. If more than an estimated
5min from land, give further rescue breaths over 1min, then bring
the victim to land as quickly as possible without further attempts
at ventilation.207
Chest compression. The victim should be placed on a ﬁrm
surface before starting chest compressions as compressions are
ineffective in the water.208,209 Conﬁrm the victim is unresponsive
and not breathing normally and then give 30 chest compressions.
Continue CPR in a ratio of 30 compressions to 2 ventilations. Most
drowning victims will have sustained cardiac arrest secondary to
hypoxia. In these patients, compression-only CPR is likely to be less
effective and should be avoided.
Automated external deﬁbrillation. Once CPR is in progress, if an
AED is available, dry the victim’s chest, attach the AED pads and
turn the AED on. Deliver shocks according to the AED prompts.
Regurgitation during resuscitation. Although rescue breathing
is difﬁcult to perform perfectly on a drowning victim because of
the need for very high inﬂation pressures or the presence of ﬂuid
in the airway, every attempt should be made to continue ventila-
tion until advanced life support providers arrive. Regurgitation of
stomach contents and swallowed/inhaled water is common during
resuscitation from drowning.210 If this prevents ventilation com-
pletely, turn the victim on their side and remove the regurgitated
material using directed suction if possible. Care should be taken
if spinal injury is suspected but this should not prevent or delay
life-saving interventions such as airway opening, ventilations and
chest compressions. Abdominal thrusts can cause regurgitation of
gastric contents and other life-threatening injuries and should not
be used.211
Advanced life support
Airway and breathing. Give high-ﬂow oxygen, ideally through
an oxygen mask with reservoir bag, during the initial assessment
of the spontaneously breathing drowning victim.205 Consider non-
invasive ventilation or continuous positive airway pressure if the
victim fails to respond to treatment with high-ﬂow oxygen.212 Use
pulse oximetry and arterial blood gas analysis to titrate the con-
centration of inspired oxygen. Consider early tracheal intubation
and controlled ventilation for victims who fail to respond to these
initialmeasures orwhohave a reduced level of consciousness. Take
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are to ensure optimal preoxygenation before intubation. Use a
apid-sequence inductionwith cricoidpressure to reduce the riskof
spiration.213 Pulmonary oedema ﬂuid may pour from the airway
nd may need suctioning to enable a view of the larynx.
After the tracheal tube is conﬁrmed in position, titrate the
nspired oxygen concentration to achieve an SaO2 of 94–98%.205 Set
ositive end-expiratory pressure (PEEP) to at least 5–10 cm H2O,
owever higher PEEP levels (15–20 cm H2O) may be required if the
atients is severely hypoxaemic.214
In the event of cardiopulmonary arrest protect the airway of
he victim early in the resuscitation attempt, ideally with a cuffed
racheal tube – reduced pulmonary compliance requiring high
nﬂationpressuresmay limit theuseof a supraglottic airwaydevice.
Circulation and deﬁbrillation. Differentiating respiratory from
ardiac arrest is particularly important in the drowning victim.
elaying the initiation of chest compressions if the victim is in
ardiac arrest will reduce survival.
The typical post-arrest gasping is very difﬁcult to distinguish
rom the initial respiratory efforts of a spontaneous recovering
rowning victim. Palpation of the pulse as the sole indicator of the
resence or absence of cardiac arrest is unreliable.215 When avail-
ble additional diagnostic information should be obtained from
ther monitoring modalities such as ECG trace, end-tidal CO2, and
chocardiography to conﬁrm the diagnosis of cardiac arrest.
If the victim is in cardiac arrest, follow standard advanced life
upport protocols. If the victims core body temperature is less than
0 ◦C, limit deﬁbrillation attempts to three, and withhold IV drugs
ntil the core body temperature increases above 30 ◦C (see Section
d).
During prolonged immersion, victims may become hypo-
olaemic from the hydrostatic pressure of the water on the body.
ive IV ﬂuid to correct hypovolaemia. After return of spontaneous
irculation, use haemodynamic monitoring to guide ﬂuid resusci-
ation.
iscontinuing resuscitation efforts
Making a decision to discontinue resuscitation efforts on a
ictim of drowning is notoriously difﬁcult. No single factor can
ccurately predict good or poor survival with 100% certainty.
ecisions made in the ﬁeld frequently prove later to have been
ncorrect.216 Continue resuscitation unless there is clear evidence
hat such attempts are futile (e.g., massive traumatic injuries, rigor
ortis, putrefaction etc), or timely evacuation to a medical facility
s not possible. Neurologically intact survival has been reported in
everal victims submerged for greater than 60min however these
are case reports almost invariably occur in children submerged in
ce-cold water.217,218
ost-resuscitation care
Salt versus fresh water. Much attention has focused in the
ast on differences between salt-water and fresh-water drowning.
xtensive data from animal studies and human case-series have
hown that, irrespective of the tonicity of the inhaled ﬂuid, the
redominant pathophysiological process is hypoxaemia, driven by
urfactant wash-out and dysfunction, alveolar collapse, atelecta-
is, and intrapulmonary shunting. Small differences in electrolyte
isturbance are rarely of any clinical relevance and do not usually
equire treatment.Lung injury. Victims of drowning are at risk of developing
cute respiratory distress syndrome (ARDS) after submersion.219
lthough there are no randomised controlled trials undertaken
peciﬁcally in this population of patients it seems reasonable to
nclude strategies such as protective ventilation that have been1 (2010) 1400–1433
shown to improve survival in patients with ARDS.220 The severity
of lung injury varies from a mild self-limiting illness to refractory
hypoxaemia. In severe cases extracorporeal membrane oxygena-
tion has been used with some success.221,222 The clinical and cost
effectiveness of these interventions has not been formally tested in
randomised controlled trials.
Pneumonia is common after drowning. Prophylactic antibiotics
have not been shown to be of beneﬁt,223 although they may be
considered after submersion in grossly contaminated water such
as sewage. Give broad-spectrum antibiotics if signs of infection
develop subsequently.200,224
Hypothermia after drowning. Victims of submersion may
develop primary or secondary hypothermia. If the submersion
occurs in icy water (<5 ◦C or 41◦F), hypothermia may develop
rapidly and provide some protection against hypoxia. Such effects,
however, have typically been reported after submersion of children
in ice-coldwater.189 Hypothermiamay also develop as a secondary
complication of the submersion and subsequent heat loss through
evaporation during attempted resuscitation (see Section 8d).
Case reports describing patients with severe accidental
hypothermia have shown that survival is possible after either pas-
sive or active warming.200 In contrast, there is evidence of beneﬁt
from induced hypothermia for comatose victims resuscitated from
pre-hospital cardiac arrests.225,226 To date, there is no convinc-
ing evidence to guide therapy in this patient group. A pragmatic
approach might be to consider rewarming until a core temperature
of 32–34 ◦C is achieved, taking care to avoid hyperthermia (>37 ◦C)
during the subsequent period of intensive care (International Life
Saving Federation, 2003).
Other supportive care. Attempts have been made to improve
neurological outcome following drowning with the use of barbitu-
rates, intracranial pressure (ICP) monitoring, and steroids. None of
these interventions has been shown to alter outcome. In fact, signs
of intracranial hypertension serve as a symptom of signiﬁcant neu-
rological hypoxic injury, and there is no evidence that attempts to
alter the ICP will affect outcome.200
Follow-up. Cardiac arrhythmias may cause rapid loss of con-
sciousness leading to drowning if the victim is in water at the time.
Take a careful history in survivors of a drowning incident to identify
features suggestive of arrhythmic syncope. Symptoms may include
syncope (whilst supine position, during exercise,with brief prodro-
mal symptoms, repetitive episodesor associatedwithpalpitations),
seizures or a family history of sudden death. The absence of struc-
tural heart disease at post-mortem examination does not rule the
possibility of sudden cardiac death. Post-mortem genetic analysis
has proved helpful in these situations and should be considered if
there is uncertainty over the cause of a drowning death.227–229
8d. Accidental hypothermia
Deﬁnition
Accidental hypothermia existswhen the body core temperature
unintentionally drops below 35 ◦C. Hypothermia can be classiﬁed
arbitrarily as mild (35–32 ◦C), moderate (32–28 ◦C) or severe (less
than 28 ◦C).230 The Swiss staging system231 based on clinical signs
can be used by rescuers at the scene to describe victims: stage I –
clearly conscious and shivering; stage II – impaired consciousness
without shivering; stage III – unconscious; stage IV – no breathing;
and stage V – death due to irreversible hypothermia.
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iagnosis
Accidental hypothermia may be under-diagnosed in countries
ith a temperate climate. In persons with normal thermoreg-
lation, hypothermia may develop during exposure to cold
nvironments, particularly wet or windy conditions, and in people
ho have been immobilised, or following immersion in cold water.
hen thermoregulation is impaired, for example, in the elderly
nd very young, hypothermia may follow a mild insult. The risk of
ypothermia is also increased by drug or alcohol ingestion, exhaus-
ion, illness, injury or neglect especially when there is a decrease
n the level of consciousness. Hypothermia may be suspected from
he clinical history or a brief external examination of a collapsed
atient. A low-reading thermometer is needed to measure the core
emperature and conﬁrm thediagnosis. The core temperaturemea-
ured in the lower third of the oesophagus correlates well with the
emperature of the heart. Epitympanic (‘tympanic’) measurement
using a thermistor technique – is a reliable alternative but may
e lower than the oesophageal temperature if the environmental
emperature is very cold, the probe is not well insulated, the exter-
al auditory canal is blocked or during cardiac arrest when there is
o ﬂow in the carotid artery.232 Widely available ‘tympanic’ ther-
ometers based on infrared technique donot seal the ear canal and
renotdesigned for lowcore temperature readings.233 In thehospi-
al setting, the method of temperature measurement should be the
ame throughout resuscitation and rewarming. Use oesophageal,
ladder, rectal or tympanic temperature measurements.234,235
ecision to resuscitate
Cooling of the human body decreases cellular oxygen consump-
ion by ∼6% per 1 ◦C decrease in core temperature.236 At 28 ◦C
xygen consumption is reduced by ∼50% and at 22 ◦C by ∼75%.
n some cases, hypothermia can exert a protective effect on the
rain and vital organs237 and intact neurological recovery may
e possible even after prolonged cardiac arrest if deep hypother-
ia develops before asphyxia. Beware of diagnosing death in a
ypothermic patient because cold alone may produce a very slow,
mall-volume, irregular pulse and unrecordable blood pressure. In
hypothermic patient, no signs of life (Swiss hypothermia stage
V) alone is unreliable for declaring death. At 18 ◦C the brain can
olerate periods of circulatory arrest for ten times longer than at
7 ◦C. Dilated pupils can be caused by a variety of insults and must
ot be regarded as a sign of death. Good quality survival has been
eported after cardiac arrest and a core temperature of 13.7 ◦C after
mmersion in cold water with prolonged CPR.238 In another case,
severely hypothermic patient was resuscitated successfully after
ix and a half hours of CPR.239
In the pre-hospital setting, resuscitation should be withheld
nly if the cause of a cardiac arrest is clearly attributable to a lethal
njury, fatal illness, prolonged asphyxia, or if the chest is incom-
ressible. In all other patients the traditional guiding principle that
no one is dead until warm and dead” should be considered. In
emotewilderness areas, the impracticalities of achieving rewarm-
ng have to be considered. In the hospital setting involve senior
octors and use clinical judgment to determinewhen to stop resus-
itating a hypothermic arrest victim.
esuscitation
All the principles of prevention, basic and advanced life support
pply to the hypothermic patient. Use the same ventilation and
hest compression rates as for a normothermic patient. Hypother-
ia can cause stiffness of the chest wall, making ventilation and
hest compressions more difﬁcult. Do not delay urgent procedures,
uch as inserting vascular catheters and tracheal intubation. The1 (2010) 1400–1433 1409
advantages of adequate oxygenation and protection from aspira-
tion outweigh the minimal risk of triggering VF by performing
tracheal intubation.240
Clear the airway and, if there is no spontaneous respiratory
effort, ventilate the patient’s lungswithhigh concentrations of oxy-
gen. Consider careful tracheal intubationwhen indicated according
to advanced life support guidelines. Palpate a central artery, look
at the ECG (if available), and look for signs of life for up to 1min
before concluding that there is no cardiac output. Echocardiogra-
phy or ultrasound with Doppler may be used to establish whether
there is a cardiac output or peripheral blood ﬂow. If there is any
doubt about whether a pulse is present, start CPR immediately.
Once CPR is under way, conﬁrm hypothermia with a low-reading
thermometer.
The hypothermic heart may be unresponsive to cardio-
active drugs, attempted electrical pacing and deﬁbrillation. Drug
metabolism is slowed, leading to potentially toxic plasma concen-
trations of any drugs given repeatedly.241 The evidence for the
efﬁcacy of drugs in severe hypothermia is limited and basedmainly
on animal studies. For instance, in severe hypothermic cardiac
arrest, adrenalinemaybe effective in increasing coronary perfusion
pressure, but not survival.242,243 The efﬁcacy of amiodarone is also
reduced.244 For these reasons, withhold adrenaline and other CPR
drugs until the patient has been warmed to a temperature higher
than approximately 30 ◦C. Once 30 ◦C has been reached, the inter-
vals between drug doses should be doubled when compared with
normothermia intervals. As normothermia is approached (over
35 ◦C), standard drug protocols should be used. Remember to rule
out other primary causes of cardiorespiratory arrest using the 4 Hs
and 4 Ts approach (e.g., drug overdose, hypothyroidism, trauma).
Arrhythmias
As the body core temperature decreases, sinus bradycardia
tends to give way to atrial ﬁbrillation followed by VF and ﬁnally
asystole.245 Once in hospital, severely hypothermic victims in car-
diac arrest should be rewarmed with active internal methods.
Arrhythmias other thanVF tend to revert spontaneously as the core
temperature increases, andusually donot require immediate treat-
ment. Bradycardiamaybephysiological in severehypothermia, and
cardiac pacing is not indicated unless bradycardia associated with
haemodynamic compromise persists after rewarming.
The temperature at which deﬁbrillation should ﬁrst be
attempted and how often it should be tried in the severely
hypothermic patient has not been established. AEDs may be used
on these patients. If VF is detected, give a shock at the maximum
energy setting; if VF/VT persists after three shocks, delay further
deﬁbrillation attempts until the core temperature is above 30 ◦C.246
If an AED is used, follow the AED prompts while rewarming the
patient. CPR and rewarming may have to be continued for several
hours to facilitate successful deﬁbrillation.246
Rewarming
General measures for all victims include removal from the
cold environment, prevention of further heat loss and rapid trans-
fer to hospital. In the ﬁeld, a patient with moderate or severe
hypothermia (Swiss stages≥ II) should be immobilised and han-
dled carefully, oxygenated adequately, monitored (including ECG
and core temperature), and the whole body dried and insulated.241
Wet clothes shouldbecutoff rather than strippedoff; thiswill avoid
excessive movement of the victim. Conscious victims can mobilise
as exercise rewarms a person more rapidly than shivering. Exer-
cise can increase any after-drop, i.e., further cooling after removal
from a cold environment. Somnolent or comatose victims have a
low threshold for developing VF or pulseless VT and should be
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mmobilised and kept horizontal to avoid an after-drop or cardio-
ascular collapse. Adequate oxygenation is essential to stabilise the
yocardiumandall victims should receive supplemental oxygen. If
he patient is unconscious, the airway should be protected. Pre hos-
ital, prolonged investigation and treatments should be avoided, as
urther heat loss is difﬁcult to prevent.
Rewarming may be passive, active external, or active internal.
assive rewarming is appropriate in conscious victims with mild
ypothermia who are still able to shiver. This is best achieved by
ull body insulation with wool blankets, aluminium foil, cap and
arm environment. The application of chemical heat packs to the
runk is particularly helpful in moderate and severe hypothermia
o prevent further heat loss in the pre hospital setting. If the patient
s unconscious and the airway is not secured, insulation should
e arranged around the patient in the recovery (lateral decubitus)
osition. Rewarming in theﬁeldwith heated intravenous ﬂuids and
armhumidiﬁedgases isnot efﬁcient. Infusinga litreof 40 ◦Cwarm
uid to a 70kg patient at 28 ◦C elevates the core temperature by
nly about 0.3 ◦C.241 Intensive active rewarming must not delay
ransport to a hospital where advanced rewarming techniques,
ontinuous monitoring and observation are available. In general,
lert hypothermic and shivering victims without an arrhythmia
ay be transported to the nearest hospital for passive rewarming
nd observation. Hypothermic victims with an altered conscious-
ess should be taken to a hospital capable of active external and
nternal rewarming.
Several active in-hospital rewarming techniques have been
escribed, although in a patient with stable circulation no tech-
ique has shown better survival over others. Active external
ewarming techniques include forced air rewarming and warmed
up to 42 ◦C) intravenous ﬂuids. These techniques are effective
rewarming rate 1–1.5 ◦Ch−1) in patients with severe hypothermia
nd a perfusing rhythm.247,248 Even in severe hypothermia no sig-
iﬁcant after-drop or malignant arrhythmias have been reported.
ewarming with forced air and warm ﬂuid has been widely imple-
ented by clinicians because it is easy and effective. Active internal
ewarming techniques include warm humidiﬁed gases; gastric,
eritoneal, pleural or bladder lavage with warmed ﬂuids (at 40 ◦C),
nd extracorporeal rewarming.237,249–253
In a hypothermic patient with apnoea and cardiac arrest,
xtracorporeal rewarming is the preferred method of active inter-
al rewarming because it provides sufﬁcient circulation and
xygenation while the core body temperature is increased by
–12 ◦Ch−1.253 Survivors in one case-series had an average of
5min of conventional CPR before cardiopulmonary bypass,254
hich underlines that continuous CPR is essential. Unfortunately,
acilities for extracorporeal rewarming arenot always available and
combination of rewarming techniques may have to be used. It
s advisable to contact the destination hospital well in advance
f arrival to make sure that the unit can accept the patient for
xtracorporeal rewarming. Extracorporealmembrane oxygenation
ECMO) reduces the risk of intractable cardiorespiratory failure
ommonly observed after rewarming and may be a preferable
xtracorporeal rewarming procedure.255
During rewarming, patients will require large volumes of ﬂuids
s vasodilation causes expansionof the intravascular space. Contin-
ous haemodynamic monitoring and warm IV ﬂuids are essential.
void hyperthermia during and after rewarming. Although there
re no formal studies, once ROSC has been achieved use standard
trategies for post-resuscitation care, including mild hypothermia
f appropriate (Section 4g).24avalanche burial
In Europe and North America, there are about 150 snow
valanche deaths each year. Most are sports-related and involve1 (2010) 1400–1433
skiers, snowboarders and snowmobilers. Death from avalanches
is due to asphyxia, trauma and hypothermia. Avalanches occur in
areas that are difﬁcult to access by rescuers in a timelymanner, and
burials frequently involve multiple victims. The decision to initiate
full resuscitative measures should be determined by the number of
victims and the resources available, and should be informed by the
likelihood of survival.256 Avalanche victims are not likely to survive
when they are:
• buried >35min and in cardiac arrest with an obstructed airway
on extrication;
• buried initially and in cardiac arrest with an obstructed airway
on extrication, and an initial core temperature of <32◦;
• buried initially and in cardiac arrest on extrication with an initial
serum potassium of >12mmol.
Full resuscitative measures, including extracorporeal rewarm-
ing, when available, are indicated for all other avalanche victims
without evidence of an unsurvivable injury.
8e. Hyperthermia
Deﬁnition
Hyperthermia occurs when the body’s ability to thermoregu-
late fails and core temperature exceeds that normally maintained
by homeostatic mechanisms. Hyperthermia may be exogenous,
caused by environmental conditions, or secondary to endogenous
heat production.
Environment-related hyperthermia occurs where heat, usually
in the formof radiant energy, is absorbedby the body at a rate faster
than can be lost by thermoregulatory mechanisms. Hyperther-
mia occurs along a continuum of heat-related conditions, starting
with heat stress, progressing to heat exhaustion, to heat stroke
(HS) and ﬁnally multiorgan dysfunction and cardiac arrest in some
instances.257
Malignant hyperthermia (MH) is a rare disorder of skeletal
muscle calcium homeostasis characterised by muscle contracture
and life-threatening hypermetabolic crisis following exposure of
genetically predisposed individuals to halogenated anaesthetics
and depolarizing muscle relaxants.258,259
The key features and treatment of heat stress and heat exhaus-
tion are included in Table 8.2.
Heat stroke
Heat stroke is a systemic inﬂammatory response with a core
temperature above 40.6 ◦C, accompanied by mental state change
and varying levels of organ dysfunction. There are two forms of HS:
classic non-exertional heat stroke (CHS) occurs during high envi-
ronmental temperatures and often effects the elderly during heat
waves260; The 2003 heatwave in France was associated with an
increased incidence of cardiac arrests in those over 60-years old.261
Exertional heat stroke (EHS) occurs during strenuousphysical exer-
cise in high environmental temperatures and/or high humidity
usually effects healthy young adults.262 Mortality from heat stroke
ranges between 10 and 50%.263
Predisposing factorsThe elderly are at increased risk for heat-related illness because
of underlying illness, medication use, declining thermoregula-
tory mechanisms and limited social support. There are several
risk factors: lack of acclimatization, dehydration, obesity, alco-
hol, cardiovascular disease, skin conditions (psoriasis, eczema,
J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1411
Table 8.2
Heat stress and heat exhaustion.
Condition Features Treatment
Heat stress Normal or mild temperature elevation Rest
Heat oedema: swelling of feet and ankles Elevation of oedematous limbs
Heat syncope: vasodilation causing hypotension
Heat cramps: sodium depletion causing cramps
Cooling
Oral rehydration
Salt replacement
Heat exhaustion Systemic reaction to prolonged heat exposure
(hours to days)
As above
Consider IV ﬂuids and ice packs for severe cases
Temperature >37 ◦C and<40 ◦C
Headache, dizziness, nausea, vomiting, tachycardia,
hypotension, sweating muscle pain, weakness and
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Haemoconcentration
Hyponatraemia or hypernatraemia
May progress rapidly to heat stroke
cleroderma, burn, cystic ﬁbrosis), hyperthyroidism, phaeochro-
ocytoma and drugs (anticholinergics, diamorphine, cocaine,
mphetamine, phenothiazines, sympathomimetics, calcium chan-
el blockers, beta-blockers).
linical presentation
Heat stroke can resemble septic shock and may be caused by
imilar mechanisms.264 A single centre case-series reported 14 ICU
eaths in 22 heat stroke patients admitted to ICU with multiple
rgan failure.265 Features include:
core temperature 40.6 ◦C or more;
hot, dry skin (sweating is present in about 50% of cases of exer-
tional heat stroke);
early signs and symptoms, e.g., extreme fatigue, headache, faint-
ing, facial ﬂushing, vomiting and diarrhoea;
cardiovascular dysfunction including arrhythmias266 and
hypotension;
respiratory dysfunction including ARDS267;
central nervous system dysfunction including seizures and
coma268;
liver and renal failure269;
coagulopathy267;
rhabdomyolysis.270
Other clinical conditions need to be considered, including:
drug toxicity271,272;
drug withdrawal syndrome;
serotonin syndrome273;
neuroleptic malignant syndrome274;
sepsis275;
central nervous system infection;
endocrinedisorders, e.g., thyroid storm, phaeochromocytoma.276
anagement
The mainstay of treatment is supportive therapy based on opti-
izing the ABCDEs and rapidly cooling the patient.277–279 Start
ooling before the patient reaches hospital. Aim to rapidly reduce
he core temperature to approximately 39 ◦C. Patients with severe
eat stroke need to be managed in a critical-care setting. Use
aemodynamic monitoring to guide ﬂuid therapy. Large volumes
f ﬂuid may be required. Correct electrolyte abnormalities as
escribed in Section 8a.Cooling techniques
Several cooling methods have been described, but there are few
formal trials to determine which method is best. Simple cooling
techniques include drinking cool ﬂuids, fanning the completely
undressed patient and spraying tepid water on the patient. Ice
packs over areas where there are large superﬁcial blood vessels
(axillae, groins, neck) may also be useful. Surface cooling methods
may cause shivering. In cooperative stable patients, immersion in
cold water can be effective280; however, this may cause periph-
eral vasoconstriction, shunt blood away from the periphery and
reduce heat dissipation. Immersion is also not practical in the sick-
est patients.
Further techniques to cool patients with hyperthermia are sim-
ilar to those used for therapeutic hypothermia after cardiac arrest
(see Section 4g).24a Cold intravenous ﬂuids will decrease body
temperature. Gastric, peritoneal,281 pleural or bladder lavage with
cold water will lower the core temperature. Intravascular cooling
techniques include the use of cold IV ﬂuids,282 intravascular cool-
ing catheters283,284 and extracorporeal circuits,285 e.g., continuous
veno-veno haemoﬁltration or cardiopulmonary bypass.
Drug therapy in heat stroke
There are no speciﬁc drug therapies in heat stroke to lower core
temperature. There is no good evidence that antipyretics (e.g., non-
steroidal anti-inﬂammatory drugs or paracetamol) are effective in
heat stroke. Diazepam may be useful to treat seizures and facili-
tate cooling.286 Dantrolene (see below) has not been shown to be
beneﬁcial.287–289
Malignant hyperthermia
Malignant hyperthermia is a life-threatening genetic sensitivity
of skeletalmuscles to volatile anaesthetics and depolarizing neuro-
muscular blocking drugs, occurring during or after anaesthesia.290
Stop triggering agents immediately; give oxygen, correct acido-
sis and electrolyte abnormalities. Start active cooling and give
dantrolene.291
Other drugs such as 3,4-methylenedioxymethamphetamine
(MDMA, ‘ecstasy’) and amphetamines also cause a condition sim-
ilar to malignant hyperthermia and the use of dantrolene may be
beneﬁcial.292Modiﬁcations to cardiopulmonary resuscitation and
post-resuscitation care
There are no speciﬁc studies on cardiac arrest in hyperther-
mia. If cardiac arrest occurs, follow standard procedures for basic
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Oxygen
Use a concentration of inspired oxygen thatwill achieve an SaO2
94–98%.205 High-ﬂow oxygen by mask is sometimes necessary.
Table 8.3
The severity of asthma.
Asthma Features
Near-fatal Raised PaCO2 and/or requiring
mechanical ventilation with raised
inﬂation pressures
Life-threatening Any one of:
PEF <33% best or predicted
bradycardia
SpO2 <92%, dysrhythmia
PaO2 <8kPa, hypotension
Normal PaCO2 (4.6–6.0 kPa
(35–45mmHg)), exhaustion
Silent chest, confusion
Cyanosis, coma
Feeble respiratory effort
Acute severe Any one of:
PEF 33–50% best or predicted
Respiratory rate >25min−1
Heart rate >110min−1
Inability to complete sentences in
one breath
Moderate
exacerbation
Increasing symptoms
PEF>50–75% best or predicted
No features of acute severe asthma
Brittle Type 1: wide PEF variability (>40%
diurnal variation for >50% of the
time over a period >150 days)412 J. Soar et al. / Resuscit
nd advanced life support and cool the patient. Cooling techniques
imilar to those used to induce therapeutic hypothermia should
e used (see Section 4g).24a There are no data on the effects of
yperthermia on deﬁbrillation threshold; therefore, attempt deﬁb-
illation according to current guidelines, while continuing to cool
he patient. Animal studies suggest the prognosis is poor compared
ith normothermic cardiac arrest.293,294 The risk of unfavourable
eurological outcome increases for each degree of body tempera-
ure >37 ◦C.295 Provide post-resuscitation care according to normal
uidelines.
f. Asthma
ntroduction
Worldwide, approximately 300 million people of all ages and
thnic backgrounds have asthma.296 The worldwide prevalence of
sthma symptoms ranges from 1 to 18% of the population with
high prevalence in some European countries (United Kingdom,
reland and Scandinavia).296 International differences in asthma
ymptom prevalence appears to be decreasing in recent years,
specially in adolescents.297 The World Health Organisation has
stimated that 15 million disability-adjusted life-years (DALYs) are
ost annually from asthma, representing 1% of the global disease
urden. Annual worldwide deaths from asthma have been esti-
ated at 250,000. The death rate does not appear to be correlated
ith asthma prevalence.296 National and international guidance
or the management of asthma already exists.296,298 This guidance
ocuses on the treatment of patients with near-fatal asthma and
ardiac arrest.
atients at risk of asthma-related cardiac arrest
The risk of near-fatal asthma attacks is not necessarily related
o asthma severity.299 Patients most at risk include those with:
a history of near-fatal asthma requiring intubation and mechan-
ical ventilation;
a hospitalisation or emergency care for asthma in the past
year300;
low or no use of inhaled corticosteroids301;
an increasing use and dependence of beta-2 agonists302;
anxiety, depressive disorders and/or poor compliance with
therapy.303
auses of cardiac arrest
Cardiac arrest in a person with asthma is often a terminal event
fter a period of hypoxaemia; occasionally, it may be sudden. Car-
iac arrest in those with asthma has been linked to:
severe bronchospasm and mucous plugging leading to asphyxia
(this condition causes the vast majority of asthma-related
deaths);
cardiac arrhythmias caused by hypoxia, which is the commonest
cause of asthma-related arrhythmia.304 Arrhythmias can also be
caused by stimulant drugs (e.g., beta-adrenergic agonists, amino-
phylline) or electrolyte abnormalities;
dynamic hyperinﬂation, i.e., auto-positive end-expiratory pres-
sure (auto-PEEP), can occur in mechanically ventilated asthmat-
ics. Auto-PEEP is caused by air trapping and ‘breath stacking’ (air
entering the lungs and being unable to escape). Gradual build-up
of pressure occurs and reduces venous return andbloodpressure;
tension pneumothorax (often bilateral).1 (2010) 1400–1433
Diagnosis
Wheezing is a common physical ﬁnding, but severity does
not correlate with the degree of airway obstruction. The absence
of wheezing may indicate critical airway obstruction, whereas
increased wheezing may indicate a positive response to bron-
chodilator therapy. SaO2 may not reﬂect progressive alveolar
hypoventilation, particularly if oxygen is being given. The SaO2
may initially decrease during therapy because beta-agonists cause
both bronchodilation and vasodilation and may initially increase
intrapulmonary shunting.
Other causes of wheezing include: pulmonary oedema,
chronic obstructive pulmonary disease (COPD), pneumonia,
anaphylaxis,305 pneumonia, foreign bodies, pulmonary embolism,
bronchiectasis and subglottic mass.306
The severity of an asthma attack is deﬁned in Table 8.3.
Key interventions to prevent arrest
The patient with severe asthma requires aggressive medical
management to prevent deterioration. Base assessment and treat-
ment on an ABCDE approach. Patients with SaO2 <92% or with
features of life-threatening asthma are at risk of hypercapnia and
require arterial blood gas measurement. Experienced clinicians
should treat these high-risk patients in a critical-care area. The spe-
ciﬁc drugs and the treatment sequence will vary according to local
practice.despite intense therapy
Type 2: sudden severe attacks on a
background of apparently well
controlled asthma
PEF, peak expiratory ﬂow.
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ebulised beta-2 agonists
Salbutamol, 5mg nebulised, is the cornerstone of therapy
or acute asthma in most of the world. Repeated doses every
5–20min are often needed. Severe asthma may necessitate con-
inuous nebulised salbutamol. Nebuliser units that can be driven
y high-ﬂow oxygen should be available. The hypoventilation
ssociated with severe or near-fatal asthma may prevent effec-
ive delivery of nebulised drugs. If a nebuliser is not immediately
vailable beta-2 agonists can be temporarily administered by
epeating activations of a metered dose inhaler via a large volume
pacer device.298,307 Nebulised adrenaline does not provide addi-
ional beneﬁt over and above nebulised beta-2 agonists in acute
sthma.308
ntravenous corticosteroids
Early use of systemic corticosteroids for acute asthma in the
mergency department signiﬁcantly reduces hospital admission
ates, especially for those patients not receiving concomitant cor-
icosteroid therapy.309 Although there is no difference in clinical
ffects between oral and IV formulations of corticosteroids,310 the
V route is preferable because patients with near-fatal asthma may
omit or be unable to swallow.
ebulised anticholinergics
Nebulised anticholinergics (ipratropium, 0.5mg 4–6 hourly)
ay produce additional bronchodilation in severe asthma or in
hose who do not respond to beta-agonists.311,312
ebulised magnesium sulphate
Results of small randomised controlled trials showed that a neb-
lised isotonic solution of magnesium sulphate (250mmol l−1) in a
olume of 2.5–5ml in combination with beta-2 agonists is safe and
t is associated with both an improvement of pulmonary function
ests and a non-signiﬁcant trend towards lower rates of hospital
dmission in patients with acute severe asthma.313 Further studies
re needed to conﬁrm those ﬁndings.
ntravenous bronchodilators
Nebulised bronchodilators are the ﬁrst line treatment for acute
evere and life-threatening exacerbations of asthma. There is a
ack of deﬁnitive evidence for or against the use of intravenous
ronchodilators in this setting. Trials haveprimarily included spon-
aneously breathing patients with moderate to life-threatening
xacerbations of asthma, evidence in ventilated patients with
ife-threatening asthma or cardiac arrest is sparse. The use of intra-
enous bronchodilators should generally be restricted to patients
nresponsive to nebulised therapy or where nebulised/inhaled
herapy is not possible (e.g., a patient receiving bag-mask venti-
ation).
ntravenous magnesium sulphate
Studies of intravenous magnesium sulphate in acute severe and
ife-threatening asthma have produced conﬂicting results.314,315
agnesium sulphate causes bronchial smooth muscle relaxation
ndependent of the serummagnesium level andhas onlyminor side
ffects (ﬂushing, light-headedness). Given the low risk of serious
ide effects from magnesium sulphate it would seem reasonable to
se intravenous magnesium sulphate (1.2–2g IV slowly) in adults
ith life-threatening unresponsive to nebulised therapy. The mul-
icentre randomised controlled trial 3Mg (ISRCTN04417063) is due1 (2010) 1400–1433 1413
to report in 2012 and should provide deﬁnitive evidence on the role
of magnesium in acute severe asthma.
Aminophylline
A Cochrane review of intravenous aminophylline found no
evidence of beneﬁt and a higher incidence of adverse effects
(tachycardia, vomiting) compared with standard care alone.316,317
Whether aminophylline has a place as an additional therapy after
treatment with established medications such as inhaled beta-
agonists and systemic corticosteroids remains uncertain. If after
obtaining senior advice the decision is taken to administer IV
aminophylline a loading dose of 5mgkg−1 is given over 20–30min
(unless on maintenance therapy), followed by an infusion of
500–700gkg−1 h−1. Serum theophylline concentrations should
be maintained below 20gml−1 to avoid toxicity.
Beta-2 agonists
A Cochrane review on intravenous beta-2 agonists compared
with nebulised beta-2 agonists found no evidence of beneﬁt and
some evidence of increased side effects compared with inhaled
treatment.318 Salbutamolmay be given as either a slow IV injection
(250g IV slowly) or continuous infusion of 3–20gmin−1.
Leukotriene receptor antagonists
There are few data on the use of intravenous leukotriene recep-
tor antagonists.319 Further studies are required to conﬁrm the
ﬁndings of a recent randomised controlled trial which demon-
strated evidence of additional bronchodilation when intravenous
LRTA montelukast was used as a rescue therapy.320
Subcutaneous or intramuscular adrenaline and terbutaline
Adrenaline and terbutaline are adrenergic agents that may be
given subcutaneously to patients with acute severe asthma. The
dose of subcutaneous adrenaline is 300g up to a total of 3 doses
at 20-min intervals. Adrenalinemay cause an increase in heart rate,
myocardial irritability and increased oxygen demand; however,
its use (even in patients over 35-years old) is well tolerated.321
Terbutaline is given in a dose of 250g subcutaneously, which can
be repeated in 30–60min. These drugs are more commonly given
to children with acute asthma and, although most studies have
shown them to be equally effective,322 one study concluded that
terbutaline was superior.323 These alternative routes may need to
be considered when IV access is impossible. Patients with asthma
are at increased risk of anaphylaxis. Sometimes it may be difﬁcult
to distinguish severe life-threatening asthma from anaphylaxis. In
these circumstances intramuscular adrenaline given according to
the anaphylaxis guidelines may be appropriate (Section 8g).
Intravenous ﬂuids and electrolytes
Severe or near-fatal asthma is associated with dehydration and
hypovolaemia, and this will further compromise the circulation
in patients with dynamic hyperinﬂation of the lungs. If there is
evidence of hypovolaemia or dehydration, give IV ﬂuids. Beta-2
agonists and steroids may induce hypokalaemia, which should be
corrected with electrolyte supplements.Heliox
Heliox is a mixture of helium and oxygen (usually 80:20 or
70:30). Ameta-analysis of four clinical trials did not support theuse
of heliox in the initial treatment of patients with acute asthma.324
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eferral to intensive care
Patients that fail to respond to initial treatment, or develop signs
f life-threatening asthma, should be assessed by an intensive care
pecialist. Admission to intensive care after asthma-related car-
iac arrest is associated with signiﬁcantly poorer outcomes than
f cardiac arrest does not occur.325
Rapid sequence induction and tracheal intubation should be
onsidered if, despite efforts to optimize drug therapy, the patient
as:
a decreasing conscious level, coma;
persisting or worsening hypoxaemia;
deteriorating respiratory acidosis despite intensive therapy;
ﬁndings of severe agitation, confusion and ﬁghting against the
oxygen mask (clinical signs of hypoxaemia);
progressive exhaustion;
respiratory or cardiac arrest.
Elevation of the PaCO2 alone does not indicate the need for tra-
heal intubation.326 Treat the patient, not the numbers.
on-invasive ventilation
Non-invasive ventilationdecreases the intubation rate andmor-
ality in COPD327; however, its role in patients with severe acute
sthma is uncertain. There is insufﬁcient evidence to recommend
ts routine use in asthma.328
reatment of cardiac arrest
asic life support
Give basic life support according to standard guidelines. Venti-
ation will be difﬁcult because of increased airway resistance; try
o avoid gastric inﬂation.
dvanced life support
Modiﬁcations to standard ALS guidelines include considering
he need for early tracheal intubation. The peak airway pressures
ecorded during ventilation of patients with severe asthma (mean
7.8±11.1 cm H2O in 12 patients) are signiﬁcantly higher than
he normal lower oesophageal sphincter pressure (approximately
0 cm H2O).329 There is a signiﬁcant risk of gastric inﬂation and
ypoventilation of the lungs when attempting to ventilate a severe
sthmatic without a tracheal tube. During cardiac arrest this risk is
ven higher, because the lower oesophageal sphincter pressure is
ubstantially less than normal.330
Respiratory rates of 8–10 breathsmin−1 and tidal volume
equired for a normal chest rise during CPR should not cause
ynamic hyperinﬂation of the lungs (gas trapping). Tidal volume
epends on inspiratory time and inspiratory ﬂow. Lung emptying
epends on expiratory time and expiratory ﬂow. In mechani-
ally ventilated severe asthmatics, increasing the expiratory time
achieved by reducing the respiratory rate) provides onlymoderate
ains in terms of reduced gas trapping when a minute volume of
ess than 10 lmin−1 is used.329
There is limited evidence from case reports of unexpected ROSC
n patients with suspected gas trapping when the tracheal tube is
isconnected.331–335 If dynamic hyperinﬂation of the lungs is sus-
ected during CPR, compression of the chest wall and/or a period
f apnoea (disconnection of tracheal tube) may relieve gas trap-
ing if dynamic hyperinﬂation occurs. Although this procedure is
upported by limited evidence, it is unlikely to be harmful in an
therwise desperate situation.3361 (2010) 1400–1433
Dynamic hyperinﬂation increases transthoracic impedance.337
Consider higher shock energies for deﬁbrillation if initial deﬁbril-
lation attempts fail.338
There is no good evidence for the use of open-chest cardiac
compressions in patients with asthma-associated cardiac arrest.
Working through the 4 Hs and 4 Ts will identify potentially
reversible causes of asthma-related cardiac arrest. Tension pneu-
mothorax can be difﬁcult to diagnose in cardiac arrest; it may
be indicated by unilateral expansion of the chest wall, shifting
of the trachea and subcutaneous emphysema. Pleural ultrasound
in skilled hands is faster and more sensitive than chest X-ray for
the detection of pneumothorax.339 If pneumothorax is suspected,
release air from the pleural space with needle decompression.
Insert a large-gauge cannula in the second intercostal space, above
the rib, in themid-clavicular line, being careful to avoiddirect punc-
ture of the lung. If air is emitted, insert a chest tube. Always consider
bilateral pneumothoraces in asthma-related cardiac arrest.
Extracorporeal life support (ECLS) can ensure both organ
perfusion and gas exchange in case of otherwise untreatable res-
piratory and circulatory failure. Cases of successful treatment of
asthma-related cardiac arrest in adults using ECLS have been
reported340,341; however, the role of ECLS in cardiac arrest caused
by asthma has never been investigated in controlled studies. The
use of ECLS requires appropriate skills and equipment which may
not be available everywhere.
8g. Anaphylaxis
Deﬁnition of anaphylaxis
A precise deﬁnition of anaphylaxis is not important for its
emergency treatment. There is no universally agreed deﬁnition.
The European Academy of Allergology and Clinical Immunol-
ogy Nomenclature Committee proposed the following broad
deﬁnition342: Anaphylaxis is a severe, life-threatening, generalised
or systemic hypersensitivity reaction. This is characterised by
rapidly developing life-threatening airway and/or breathing and/or
circulation problems usually associated with skin and mucosal
changes.305,343
Anaphylaxis usually involves the release of inﬂammatory medi-
ators from mast cells and, or basophils triggered by an allergen
interacting with cell-bound immunoglobulin E (IgE). Non-IgE-
mediated or non-immune release of mediators can also occur.
Histamine and other inﬂammatory mediator release are respon-
sible for the vasodilatation, oedema and increased capillary
permeability.
Epidemiology
The overall frequency of episodes of anaphylaxis using current
data lies between 30 and 950 cases per 100,000 persons per year
and a lifetime prevalence of between 50 and 2000 episodes per
100,000 persons or 0.05–2.0%.344 Anaphylaxis can be triggered by
any of a very broad range of triggers including foods, drugs, stinging
insects, and latex. Food is the commonest trigger in children and
drugs the commonest in adults.345 Virtually any food or drug can
be implicated, but certain foods (nuts) and drugs (muscle relax-
ants, antibiotics, NSAIDs and aspirin) cause most reactions.346 A
signiﬁcant number of cases of anaphylaxis are idiopathic.
The overall prognosis of anaphylaxis is good, with a case fatality
ratio of less than 1% reported in most population-based studies.
Anaphylaxis and risk of death is increased in those with pre-
existing asthma, particularly if the asthma is poorly controlled,
severeor in asthmaticswhodelay treatmentwithadrenaline.347,348
When anaphylaxis is fatal, death usually occurs very soon after
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ontact with the trigger. From a case-series, fatal food reactions
ause respiratory arrest typically after 30–35min; insect stings
ause collapse from shock after 10–15min; and deaths caused
y intravenous medication occur most commonly within 5min.
eath never occurred more than 6h after contact with the trig-
er.
ecognition of an anaphylaxis
Anaphylaxis is the likely diagnosis if a patient who is exposed
o a trigger (allergen) develops a sudden illness (usually within
inutes) with rapidly developing life-threatening airway and/or
reathing and/or circulation problems usually associated with skin
nd mucosal changes. The reaction is usually unexpected.
Many patients with anaphylaxis are not given the cor-
ect treatment.349 Confusion arises because some patients have
ystemic allergic reactions that are less severe. For example, gener-
lised urticaria, angioedema, and rhinitiswould not be described as
naphylaxis, because the life-threatening features are not present.
naphylaxis guidelines must therefore take into account some
nevitable diagnostic errors, with an emphasis on the need for
afety. Patients can have either an airway and/or breathing and/or
irculation problem:
irway problems
Airway swelling, e.g., throat and tongue swelling (pharyn-
geal/laryngeal oedema).
Hoarse voice.
Stridor.
reathing problems
Shortness of breath.
Wheeze.
Confusion caused by hypoxia.
Respiratory arrest.
Life-threatening asthma with no features of anaphylaxis can be
triggered by food allergy.350
irculation problems
Pale, clammy.
Tachycardia.
Hypotension.
Decreased conscious level.
Myocardial ischaemia and electrocardiograph (ECG) changes
even in individuals with normal coronary arteries.351
Cardiac arrest.
Circulation problems (often referred to as anaphylactic shock)
an be caused by direct myocardial depression, vasodilation and
apillary leak, and loss of ﬂuid from the circulation. Bradycardia is
sually a late feature, often preceding cardiac arrest.352
kin and, or mucosal changes
These should be assessed as part of the exposure when using
he ABCDE approach.They are often the ﬁrst feature and present in over 80% of ana-
phylaxis cases.353
They can be subtle or dramatic.
There may be just skin, just mucosal, or both skin and mucosal
changes any where on the body.1 (2010) 1400–1433 1415
• There may be erythema, urticaria (also called hives, nettle rash,
weals or welts), or angioedema (eyelids, lips, and sometimes in
the mouth and throat).
Most patients who have skin changes caused by allergy do not
go on to develop anaphylaxis.
Treatment of an anaphylaxis
Use an ABCDE approach to recognise and treat anaphylaxis.
Treat life-threatening problems as you ﬁnd them. The basic princi-
ples of treatment are the same for all age groups. All patients who
have suspected anaphylaxis should be monitored (e.g., by ambu-
lance crew, in the emergency department etc,) as soon as possible.
Minimal monitoring includes pulse oximetry, non-invasive blood
pressure and 3-lead ECG.
Patient positioning
Patients with anaphylaxis can deteriorate and are at risk of car-
diac arrest if made to sit up or stand up.354 All patients should be
placed in a comfortable position. Patients with airway and breath-
ing problemsmayprefer to sit up as thiswillmake breathing easier.
Lying ﬂat with or without leg elevation is helpful for patients with
a low blood pressure (circulation problem).
Remove the trigger if possible
Stop any drug suspected of causing anaphylaxis. Remove the
stinger after a bee sting. Early removal is more important than the
method of removal.355 Do not delay deﬁnitive treatment if remov-
ing the trigger is not feasible.
Cardiorespiratory arrest following an anaphylaxis
Start cardiopulmonary resuscitation (CPR) immediately and fol-
low current guidelines. Prolonged CPR may be necessary. Rescuers
should ensure that help is on its way as early advanced life support
(ALS) is essential.
Airway obstruction
Anaphylaxis can cause airway swelling and obstruction. This
willmake airwayandventilation interventions (e.g., bag-maskven-
tilation, tracheal intubation, cricothyroidotomy) difﬁcult. Call for
expert help early.
Drugs and their delivery
Adrenaline (epinephrine)
Adrenaline is the most important drug for the treatment of
anaphylaxis.356,357 Although there are no randomised controlled
trials,358 adrenaline is a logical treatment and there is consistent
anecdotal evidence supporting its use to ease breathing and circu-
lation problems associated with anaphylaxis. As an alpha-receptor
agonist, it reverses peripheral vasodilation and reduces oedema.
Its beta-receptor activity dilates the bronchial airways, increases
the force of myocardial contraction, and suppresses histamine and
leukotriene release. There are beta-2 adrenergic receptors on mast
cells that inhibit activation, and so early adrenaline attenuates
the severity of IgE-mediated allergic reactions. Adrenaline seems
to work best when given early after the onset of the reaction359but it is not without risk, particularly when given intravenously.
Adverse effects are extremely rare with correct doses injected
intramuscularly (IM).
Adrenaline should be given to all patients with life-threatening
features. If these features are absent but there are other features of
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systemic allergic reaction, the patient needs careful observation
nd symptomatic treatment using the ABCDE approach.
Intramuscular (IM) adrenaline. The intramuscular (IM) route
s the best for most individuals who have to give adrenaline to
reat anaphylaxis. Monitor the patient as soon as possible (pulse,
lood pressure, ECG, and pulse oximetry). This will help monitor
he response to adrenaline. The IM route has several beneﬁts:
There is a greater margin of safety.
It does not require intravenous access.
The IM route is easier to learn.
The best site for IM injection is the anterolateral aspect of the
iddle third of the thigh. The needle for injection needs to be long
nough to ensure that the adrenaline is injected into muscle.360
he subcutaneous or inhaled routes for adrenaline are not recom-
ended for the treatment of anaphylaxis because they are less
ffective than the IM route.361–363
Adrenaline IMdose. Theevidence for the recommendeddoses is
eak.Doses are basedonwhat is considered tobe safe andpractical
o draw up and inject in an emergency.
(The equivalent volume of 1:1000 adrenaline is shown in
rackets)
>12 years and adults: 500g IM (0.5ml)
>6–12 years: 300g IM (0.3ml)
>6 months–6 years: 150g IM (0.15ml)
<6 months: 150g IM (0.15ml)
Repeat the IM adrenaline dose if there is no improvement in
he patient’s condition. Further doses can be given at about 5-min
ntervals according to the patient’s response.
Intravenous (IV) adrenaline (for specialist use only). There is a
uch greater risk of causing harmful side effects by inappropriate
osageormisdiagnosis of anaphylaxiswhenusing IVadrenaline.364
ntravenous adrenaline should be used only by those experienced
n the use and titration of vasopressors in their normal clinical
ractice (e.g., anaesthetists, emergency physicians, intensive care
octors). In patients with a spontaneous circulation, intravenous
drenaline can cause life-threatening hypertension, tachycardia,
rrhythmias, and myocardial ischaemia. If IV access is not available
r not achieved rapidly, use the IM route for adrenaline. Patients
ho are given IV adrenaline must be monitored – continuous ECG
ndpulse oximetry and frequent non-invasive bloodpressuremea-
urements as a minimum. Patients who require repeated IM doses
f adrenaline may beneﬁt from IV adrenaline. It is essential that
hese patients receive expert help early.
Adrenaline IV bolus dose – adult. Titrate IV adrenaline using
0g boluses according to response. If repeated adrenaline doses
re needed, start an IV adrenaline infusion.352,365
Adrenaline IV bolus dose – children. IM adrenaline is the pre-
erred route for children having anaphylaxis. The IV route is
ecommended only in specialist paediatric settings by those famil-
arwith its use (e.g., paediatric anaesthetists, paediatric emergency
hysicians, paediatric intensivists) and if the patient is monitored
nd IV access is already available. There is no evidence on which
o base a dose recommendation – the dose is titrated according to
esponse. A child may respond to a dose as small as 1gkg−1. This
equires very careful dilution and checking to prevent dose errors.1 (2010) 1400–1433
Oxygen (give as soon as available)
Initially, give the highest concentration of oxygenpossible using
amaskwith an oxygen reservoir.205 Ensure high-ﬂowoxygen (usu-
ally greater than10 litresmin−1) toprevent collapseof the reservoir
during inspiration. If thepatient’s trachea is intubated, ventilate the
lungs with high concentration oxygen using a self-inﬂating bag.
Fluids (give as soon as available)
Large volumes of ﬂuid may leak from the patient’s circulation
during anaphylaxis. Therewill also be vasodilation. If there is intra-
venous access, infuse intravenous ﬂuids immediately. Give a rapid
IVﬂuid challenge (20mlkg−1) in a child or 500–1000ml in an adult)
and monitor the response; give further doses as necessary. There is
no evidence to support the use of colloids over crystalloids in this
setting. Consider colloid infusion as a cause in a patient receiving a
colloid at the time of onset of an anaphylaxis and stop the infusion.
A large volume of ﬂuid may be needed.
If intravenous access is delayed or impossible, the intra-osseous
route can be used for ﬂuids or drugs. Do not delay the administra-
tion of IM adrenaline attempting intra-osseous access.
Antihistamines (after initial resuscitation)
Antihistamines are a second line treatment for anaphylaxis. The
evidence to support their use is weak, but there are logical rea-
sons for them.366 Antihistamines (H1-antihistamine) help counter
histamine-mediated vasodilation and bronchoconstriction. There
is little evidence to support the routine use of an H2-antihistamine
(e.g., ranitidine, cimetidine) for the initial treatment of an anaphy-
laxis.
Steroids (give after initial resuscitation)
Corticosteroids may help prevent or shorten protracted reac-
tions although the evidence is very limited.367 In asthma, early
corticosteroid treatment is beneﬁcial in adults and children. There
is little evidence on which to base the optimum dose of hydrocor-
tisone in anaphylaxis.
Other drugs
Bronchodilators. The presenting symptoms and signs of a
severe anaphylaxis and life-threatening asthma can be the same.
Consider further bronchodilator therapy with salbutamol (inhaled
or IV), ipratropium (inhaled), aminophyline (IV) or magnesium (IV)
(see Section 8f above). Intravenous magnesium is a vasodilator and
can make hypotension worse.
Cardiac drugs. Adrenaline remains the ﬁrst line vasopressor
for the treatment of anaphylaxis. There are animal studies and
case reports describing the use of other vasopressors and inotropes
(noradrenaline, vasopressin, terlipressinmetaraminol, methoxam-
ine, and glucagon) when initial resuscitation with adrenaline and
ﬂuids has not been successful.368–380 Use these drugs only in spe-
cialist settings (e.g., intensive care units) where there is experience
in their use. Glucagon can be useful to treat anaphylaxis in a
patient taking a beta-blocker.381 Some case reports of cardiac arrest
suggest cardiopulmonary bypass 382,383 or mechanical support of
circulation384 may also be helpful.Investigations
Undertake the usual investigations appropriate for a medical
emergency, e.g., 12-lead ECG, chest X-ray, urea and electrolytes,
arterial blood gases etc.
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ast cell tryptase
The speciﬁc test to help conﬁrm a diagnosis of anaphylaxis is
easurement of mast cell tryptase. Tryptase is the major protein
omponent of mast cell secretory granules. In anaphylaxis, mast
ell degranulation leads to markedly increased blood tryptase con-
entrations. Tryptase concentrations in the blood may not increase
igniﬁcantly until 30min or more after the onset of symptoms, and
eak 1–2h after onset.385 The half-life of tryptase is short (approx-
mately 2h), and concentrations may be back to normal within
–8h, so timing of any blood samples is very important. The time
f onset of the anaphylaxis is the time when symptoms were ﬁrst
oticed.
(a) Minimum: one sample at 1–2h after the start of symptoms.
b) Ideally: three timed samples:
Initial sample as soon as feasible after resuscitation has started –
do not delay resuscitation to take sample.
Second sample at 1–2h after the start of symptoms
Third sample either at 24h or in convalescence (for example in a
follow-up allergy clinic). This provides baseline tryptase levels –
some individuals have an elevated baseline level.
Serial samples have better speciﬁcity and sensitivity than a sin-
le measurement in the conﬁrmation of anaphylaxis.386
ischarge and follow-up
Patients who have had suspected anaphylaxis (i.e., an airway,
reathing or circulation (ABC) problem) should be treated and
hen observed in a clinical area with facilities for treating life-
hreatening ABC problems. Patients with a good response to initial
reatment should be warned of the possibility of an early recur-
ence of symptoms and in some circumstances should be kept
nder observation. The exact incidence of biphasic reactions is
nknown. Although studies quote an incidence of 1–20%, it is not
lear whether all the patients in these studies actually had an ana-
hylaxis and whether the initial treatment was appropriate.387
here is no reliable way of predicting who will have a biphasic
eaction. It is therefore important that decisions about discharge
re made for each patient by an experienced clinician.
Before discharge from hospital all patients must be:
Reviewed by a senior clinician.
Given clear instructions to return to hospital if symptoms return.
Considered for antihistamines and oral steroids therapy for up to
3 days. This is helpful for treatment of urticaria and may decrease
the chance of further reaction.
Considered for an adrenaline auto-injector, or given a
replacement.388–390
Have a plan for follow-up, including contact with the patient’s
general practitioner.
An adrenaline auto-injector is an appropriate treatment for
atients at increased risk of idiopathic anaphylaxis, or for anyone
t continued high risk of reaction, e.g., to triggers such as venom
tings and food-induced reactions (unless easy to avoid). An auto-
njector is not usually necessary for patients who have suffered
rug-induced anaphylaxis, unless it is difﬁcult to avoid the drug.
deally, all patients should be assessed by an allergy specialist and
ave a treatment plan based on their individual risk.
Individuals provided with an auto-injector on discharge from
ospital must be given instructions and training on when and how
o use it. Ensure appropriate follow-up including contact with the1 (2010) 1400–1433 1417
patient’s general practitioner. All patients presenting with anaphy-
laxis should be referred to an allergy clinic to identify the cause,
and thereby reduce the risk of future reactions and prepare the
patient to manage future episodes themselves. Patients need to
know the allergen responsible and how to avoid it. Patients need
to be able to recognise the early symptoms of anaphylaxis, so that
they can summon help quickly and prepare to use their emergency
medication. Although there are no randomised clinical trials, there
is evidence that individualised action plans for self-management
should decrease the risk of recurrence.391
8h. Cardiac arrest following cardiac surgery
Cardiac arrest following major cardiac surgery is relatively
common in the immediate post-operative phase, with a reported
incidence of 0.7–2.9%.392–400 It is usually preceded by physio-
logical deterioration,401 although it can occur suddenly in stable
patients.398 There are usually speciﬁc causes of cardiac arrest, such
as tamponade, hypovolaemia,myocardial ischaemia, tensionpneu-
mothorax, or pacing failure. These are all potentially reversible and
if treated promptly cardiac arrest after cardiac surgery has a rel-
atively high survival rate. If cardiac arrest occurs during the ﬁrst
24h after cardiac surgery, the rate of survival to hospital discharge
is 54%399 to 79%398,402 in adults and 41% in children.401
Key to the successful resuscitation of cardiac arrest in these
patients is the need to perform emergency resternotomy early,
especially in the context of tamponade or haemorrhage, where
external chest compressions may be ineffective.
Identiﬁcation of cardiac arrest
Patients in the ICU are highly monitored and an arrest is most
likely to be signalled bymonitoring alarmswhere absence of pulsa-
tionorperfusingpressureon thearterial line, lossofpulseoximeter,
pulmonary artery (PA) trace, or end-tidal CO2 trace can be sufﬁ-
cient to indicate cardiac arrestwithout the need to palpate a central
pulse.
Starting CPR
Start external chest compressions immediately in all patients
who collapse without an output. Consider reversible causes:
hypoxia – check tube position, ventilate with 100% oxygen; ten-
sion pneumothorax – clinical examination, thoracic ultrasound;
hypovolaemia, pacing failure. In asystole, secondary to a loss of
cardiac pacing, external massage may be delayed momentarily as
long as the surgically inserted temporary pacing wires can be con-
nected rapidly and pacing re-established (DDD at 100min−1 at
maximum amplitude). The effectiveness of compressions may be
veriﬁed by looking at the arterial trace, aiming to achieve a sys-
tolic blood pressure of at least 80mmHg at a rate of 100min−1.
Inability to attain this pressure may indicate tamponade, tension
pneumothorax, or exanguinating haemorrhage and should precip-
itate emergency resternotomy. Intra-aortic balloon pumps should
be changed to pressure triggering during CPR. In PEA, switch off the
pacemaker – a temporary pacemaker may potentially hide under-
lying VF.
DeﬁbrillationThere is concern that external chest compressions can cause
sternal disruption or cardiac damage.403–406 In the post-cardiac
surgery ICU, awitnessedandmonitoredVF/VTcardiac arrest should
be treated immediately with up to three quick successive (stacked)
deﬁbrillation attempts. Three failed shocks in the post-cardiac
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urgery setting should trigger the need for emergency rester-
otomy. Further deﬁbrillation is attempted as indicated in the
niversal algorithmand should be performedwith internal paddles
t 20 J if resternotomy has been performed.
mergency drugs
Use adrenaline very cautiously and titrate to effect (intravenous
oses of 100 or less micrograms in adults). In order to exclude
medication error as the cause of the arrest, stop all drug infu-
ions and check if they are correct. If there is concern about patient
wareness, restart the anaesthetic drugs. Atropine is no longer rec-
mmended for the treatment of cardiac arrest as there is little
vidence to show it is effective in patients who have been given
drenaline. Individual clinicians may use atropine at their discre-
ion in post-cardiac surgery cardiac arrest if they feel it is indicated.
reat bradycardiawith atropine, according to the bradycardia algo-
ithm (see Section 4 Advanced Life Support).24a
Give amiodarone 300mg after the 3rd failed deﬁbrillation
ttempt but do not delay resternotomy. An irritable myocardium
ollowing cardiac surgery is caused most commonly by myocardial
schaemia and correction of this, rather than giving amiodarone, is
ore likely to achieve myocardial stability.
mergency resternotomy
This is an integral part of resuscitation after cardiac surgery,
nce all other reversible causes have been excluded. Once ade-
uate an airway and ventilation has been established, and if three
ttempts at deﬁbrillation have failed in VF/VT, undertake rester-
otomy without delay. Emergency resternotomy is also indicated
n asystole or PEA, when other treatments have failed. Resusci-
ation teams should be well rehearsed in this technique so that
t can be performed safely within 5min of the onset of cardiac
rrest. Resternotomy equipment should be prepared as soon as
n arrest is identiﬁed. Simpliﬁcation of the resternotomy tray and
egular manikin rehearsals are key measures to ensure a prompt
esternotomy.407,408 All medical members of the patient care team
hould be trained to perform resternotomy if a surgeon is not avail-
ble within 5min. Improved survival and better quality of life is
ell documented with rapid resternotomy.394,395,409
Resternotomy should be a standard part of resuscitation within
0 days after cardiac surgery. The overall survival to discharge
ollowing internal cardiac massage is 17%394 to 25%395 although
urvival rates are much lower when chest opening is performed
utside the specialised environment of the post-cardiac surgery
CU.395
einstitution of emergency cardiopulmonary bypass
The need for emergency cardiopulmonary bypass (CPB) occurs
n approximately 0.8% patients at a mean of 7h post-operatively396
nd is usually indicated to correct surgical bleeding or graft occlu-
ion and rest themyocardium. Emergency institution of CPB should
e available on all units undertaking cardiac surgery. Survival to
ischarge rates of 32%,395 42%396 and 56.3%410 have been reported
hen CPB is reinstituted on the ICU.
Survival ratesdecline rapidlywhen thisprocedure isundertaken
ore than 24h after surgery and when performed on the ward
ather than the ICU. Emergency CPB should probably be restricted
o patients who arrest within 72h of surgery, as surgically reme-
iable problems are unlikely after this time.395 Ensuring adequate
nticoagulation before starting CPB, or the use of a heparin-bonded
ircuit, is important. Theneed for a furtherperiodof cross-clamping
oes not preclude a favourable outcome.3961 (2010) 1400–1433
Patients with non-sternotomy cardiac surgery
These guidelines are appropriate for patients following non-
sternotomy cardiac surgery, but surgeons performing these
operations should have already given clear instructions for chest
reopening. Patients undergoing port-access mitral procedures or
minimally invasive coronary bypass graft surgery are likely to
require an emergency sternotomy, as very poor access is obtained
by opening or extending a mini-thoracotomy incision. Equipment
and guidelines should be kept close to the patient.
Children
The incidence of cardiac arrest after cardiac surgery in chil-
dren is 4%411 and survival rates are similar to those of adults. The
causes are also similar, although one case-series documented pri-
mary respiratory arrest in 11%. The guidance given in this section
is equally applicable to children, with appropriate modiﬁcation of
deﬁbrillation energy and drug doses (see Section 6 Paediatric Life
Support).411a Use extreme caution and check doses carefully when
giving intravenous adrenaline doses to children in cardiac arrest
after cardiac surgery. Use smaller doses of adrenaline in this setting
(e.g., 1gkg−1) under the guidance of experienced clinicians.
Internal deﬁbrillation
Internal deﬁbrillation using paddles applied directly across the
ventricles requires considerably less energy than that used for
external deﬁbrillation. Biphasic shocks are more effective than
monophasic shocks for direct deﬁbrillation.412 For biphasic shocks,
starting at 5 J creates the optimum conditions for lowest threshold
andcumulative energy,whereas10–20 J offers optimumconditions
for more rapid deﬁbrillation and fewer shocks,412 thus 20 J is the
most applicable energy in an arrest situation, whereas 5 J would be
adequate if thepatienthasbeenplacedoncardiopulmonarybypass.
Continuing cardiac compressions using the internal paddles
whilst charging the deﬁbrillator and delivering the shock during
the decompression phase of compressions may improve shock
success.413,414
It is acceptable to perform external deﬁbrillation after emer-
gency resternotomy. Apply external pads preoperatively to all
patients undergoing resternotomy surgery.415 Use the deﬁbril-
lation energy level indicated in the universal algorithm. If the
sternum is widely open the impedence may be signiﬁcantly
increased – if external deﬁbrillation is chosen over internal deﬁb-
rillation close the sternal retractor before shock delivery.
8i. Traumatic cardiorespiratory arrest
Introduction
Cardiac arrest caused by trauma has a very high mortality, with
an overall survival of just 5.6% (range 0–17%) (Table 8.4).416–422 For
reasons that are unclear, reported survival rates in the last 5 years
are better than reported previously (Table 8.4) In thosewho survive
(andwhere data are available) neurological outcome is good in only
1.6% of those sustaining traumatic cardiorespiratory arrest (TCRA).Diagnosis of traumatic cardiorespiratory arrest
The diagnosis of TCRA is made clinically: the trauma patient is
unresponsive, apnoeic and pulseless. Both asystole and organised
cardiac activity without cardiac output are regarded as TCRA.
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Table 8.4
Survival after out of hospital traumatic cardiac arrest.
Source Entry criteria:
children or adults
requiring CPR
before or on
hospital admission
Number of
patients/survivors/
good neurological
outcome
Penetrating/
survivors/good
neurological
outcome
Blunt/survivors/
good neurological
outcome
Shimazu and Shatney417 TCRA on admission 267
7
4
Rosemurgy et al.416 CPR before admission 138 42 96
0 0 0
0 0 0
Bouillon et al.429 CPR on scene 224
4
3
Battistella et al.418 CPR at scene, en route or in the ED 604 300 304
16 12 4
9 9 0
Fisher and Worthen430 Children requiring CPR before or on
admission after blunt trauma
65 65
1 1
0 0
Hazinski et al.431 Children requiring CPR or being
severely hypotensive on admission
after blunt trauma
38 38
1 1
0 0
Stratton et al.422 Unconscious, pulseless at scene 879 497 382
9 4 5
3 3 0
Calkins et al.432 Children requiring CPR after blunt
trauma
25 25
2 2
2 2
Yanagawa et al.433 OHCA in blunt trauma 332 332
6 6
0 0
Pickens et al.434 CPR on scene 184 94 90
14 9 5
9 5 4
Di Bartolomeo et al.435 CPR on scene 129
2
0
Willis et al.436 CPR on scene 89 18 71
4 2 2
4 2 2
David et al.437 CPR on scene 268
5
1
Crewdson et al.438 80 children who required CPR on
scene after trauma
80 7 73
7 0 7
3 0 3
Huber-Wagner et al.439 CPR on scene or after arrival 757 43 714
130 ? ?
28 ? ?
Pasquale et al.421 CPR before or on hospital admission 106 21 85
3 1 2
Lockey et al.440 CPR on scene 871 114 757
68 9 59
Cera et al.441 CPR on 161
T
C
b
cadmission
otals
ommotio cordisCommotio cordis is actual or near cardiac arrest caused by a
lunt impact to the chest wall over the heart.423–427 A blow to the
hest during the vulnerable phase of the cardiac cycle may cause15
5217 1136 3032
293 (5.6%) 37 (3.3%) 94 (3.1%)
malignant arrhythmias (usually ventricular ﬁbrillation). Syncope
after chestwall impactmaybe causedbynon-sustainedarrhythmic
events. Commotio cordis occurs mostly during sports (most com-
monly baseball) and recreational activities and victims are usually
youngmales (mean age 14 years). In a series of 1866 cardiac arrests
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n athletes inMinneapolis, 65 (3%)were due to commotio cordis.428
he registry is accruing 5–15 cases of commotio cordis each year.
he overall survival rate from commotio cordis is 15%, but 25% if
esuscitation is started within 3min.427
rauma secondary to medical events
A cardiorespiratory arrest due to a medical condition (e.g., car-
iac arrhythmia, hypoglycaemia, seizure) can cause a secondary
raumatic event (e.g., fall, road trafﬁc accident etc). Despite the
nitial reported mechanism, traumatic injuries may not be the pri-
ary cause of a cardiorespiratory arrest and standard advanced life
upport, including chest compressions, may be appropriate.
echanism of injury
lunt trauma
Of3032patientswith cardiac arrest after blunt trauma, 94 (3.1%)
urvived. Only 15 out of 1476 patients (1%) were reported to have
good neurological outcome (Table 8.4).
enetrating trauma
Of 1136 patients with cardiac arrest after penetrating injury,
here were 37 (3.3%) survivors 19 of which (1.9%) had a good neu-
ological outcome (Table 8.4).
A confounding factor in both blunt and penetrating trauma sur-
ival rates is that some studies report survival including those
ronounced dead on scene and others do not.
igns of life and initial ECG activity
There are no reliable predictors of survival for TCRA. One study
eported that the presence of reactive pupils and sinus rhythm
orrelate signiﬁcantly with survival.441 In a study of penetrat-
ng trauma, pupil reactivity, respiratory activity and sinus rhythm
ere correlated with survival but were unreliable.422 Three stud-
es reported no survivors in patients presenting with asystole or
gonal rhythms.418,422,442 Another reported no survivors in PEA
fter blunt trauma.443 Based on these studies, the American Col-
ege of Surgeons and the National Association of EMS physicians
roduced pre-hospital guidelines on withholding resuscitation.444
hey recommend withholding resuscitation in:
(i) blunt trauma patients presenting with apnoea, pulselessness
and without organised ECG activity;
ii) penetrating trauma patients found apnoeic and pulseless after
rapid assessment for signs of life such as pupillary reﬂexes,
spontaneous movement, or organised ECG activity.
Three retrospective studies question these recommendations
nd report survivors who would have had resuscitation withheld if
he guidelines had been followed.434,436,440
reatment
Survival from TCRA is correlated with duration of CPR and pre-
ospital time.420,445–449 Prolonged CPR is associated with a poor
utcome; the maximum CPR time associated with favourable out-
ome is 16min.420,445–447 The level of pre-hospital intervention
ill depend on the skills of local EMS providers, but treatment on
cene should focus on good quality BLS and ALS and exclusion of
eversible causes. Look for and treat any medical condition that
ay have precipitated the trauma event. Undertake only essential
ife-saving interventions on scene and, if the patient has signs of1 (2010) 1400–1433
life, transfer rapidly to the nearest appropriate hospital. Consider
on scene thoracostomy for appropriate patients.450,451 Donot delay
for unproven interventions such as spinal immobilisation.452
1. Treatment of reversible causes:
• Hypoxaemia (oxygenation, ventilation).
• Compressiblehaemorrhage (pressure, pressuredressings, tourni-
quets, novel haemostatic agents).
• Non-compressible haemorrhage (splints, intravenous ﬂuid).
• Tension pneumothorax (chest decompression).
• Cardiac tamponade (immediate thoracotomy)
2. Chest compressions: although they may not be effective in
hypovolaemic cardiac arrest most survivors do not have hypo-
volaemia and in this subgroup standard advanced life support may
be life-saving.
3. Standard CPR should not delay the treatment of reversible
causes (e.g., thoracotomy for cardiac tamponade).
Resuscitative thoracotomy
Pre-hospital
Resuscitative thoracotomy has been reported as futile if out of
hospital time has exceeded 30min448; others consider thoraco-
tomy to be futile in patients with blunt trauma requiring more
than 5min of pre-hospital CPR and in patients with penetrating
trauma requiring more than 15min of CPR.449 With these time
limits in mind, one UK service recommends that if surgical inter-
vention cannot be accomplished within 10min after loss of pulse
in patients with penetrating chest injury, on scene thoracotomy
should be considered.450 Based on this approach, of 71 patients
who underwent thoracotomy at scene, thirteen patients survived
and eleven of these made a good neurological recovery.453 In con-
trast, pre-hospital thoracotomy for 34 patients with blunt trauma
in Japan has not produced any survivors.454
Hospital
A relatively simple technique for resuscitative thoracotomy has
been described recently.451,455
The American College of Surgeons has published practice guide-
lines for emergency department thoracotomy (EDT) based on a
meta-analysis of 42 outcome studies including 7035 EDT’s.456 The
overall survival rate was 7.8% and, of 226 survivors (5%), only 34
(15%) had a neurological deﬁcit. The investigators concluded that
EDT:
1. After blunt trauma, should be limited to those with vital signs
on arrival and awitnessed cardiac arrest (estimated survival rate
1.6%).
2. Is best applied to patients with penetrating cardiac injuries who
arrive at the trauma centre after a short on scene and trans-
port time with witnessed signs of life or ECG activity (estimated
survival rate 31%).
3. Should be undertaken in penetrating non-cardiac thoracic
injuries even though survival rates are low.
4. Should be undertaken in patients with exsanguinating abdom-
inal vascular injury even though survival rates are low. This
procedure should be used as an adjunct to deﬁnitive repair of
abdominal vascular injury.
One European study reports a survival rate of 10% in blunt
trauma patients undergoing EDT within twenty min after wit-
nessed cardiac arrest. Three of the four survivors had intrabdominal
haemorrhage. They conclude that in moribund patients with blunt
chest or abdominal trauma EDT should be performed as early as
possible.457
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irway management
Effective airway management is essential to maintain oxygena-
ion of the severely compromised trauma patient. In one study,
racheal intubation on scene of patientswith TCRA doubled the tol-
rated period of CPR before emergency department thoracotomy –
he mean duration of CPR for survivors who were intubated in the
eld was 9.1 versus 4.2min for those were not intubated.447
Tracheal intubation in trauma patients is a difﬁcult procedure
ith a high failure rate if carried out by less experienced care
roviders.458–462 Use basic airway management manoeuvres and
lternative airways to maintain oxygenation if tracheal intubation
annot be accomplished immediately. If these measures fail a sur-
ical airway is indicated.
entilation
In low cardiac output conditions, positive pressure ventilation
auses further circulatory depression, or even cardiac arrest, by
mpeding venous return to the heart.463 Monitor ventilation with
ontinuous waveform capnography and adjust to achieve nor-
ocapnia. This may enable slow respiratory rates and low tidal
olumes and the corresponding decrease in transpulmonary pres-
ure may increase venous return and cardiac output.
hest decompression
Effective decompression of a tension pneumothorax can be
chieved quickly by lateral or anterior thoracostomy, which, in the
resence of positive pressure ventilation, is likely to be more effec-
ive than needle thoracostomy and quicker than inserting a chest
ube.464
ffectiveness of chest compressions in TCRA
In hypovolaemic cardiac arrest, chest compressions are unlikely
o be as effective as in cardiac arrest fromother causes.465 However
ost survivors of TCRAhave reasons other thanpurehypovolaemia
or their arrest and these patients may beneﬁt from standard
dvanced life support interventions.436,438,440 Patientswith cardiac
amponade are also less likely to beneﬁt from chest compressions
nd should, where possible, have immediate surgical release of
amponade. Return of spontaneous circulation with advanced life
upport in patients with TCRA has been described and chest com-
ressionsare still the standardof care inpatientswith cardiac arrest
rrespective of aetiology.
aemorrhage control
Early haemorrhage control is vital. Handle the patient gently
t all times to prevent clot disruption. Apply external compres-
ion, and pelvic and limb splints when appropriate. Delays in
urgical haemostasis are disastrous for patients with exsanguinat-
ng trauma. Recent conﬂicts have seen a resurgence in the use
f tourniquets to stop life-threatening limb haemorrhage.466 It is
nlikely that the same beneﬁts will be seen in civilian trauma prac-
ice.
ericardiocentesisIn patients with suspected trauma-related cardiac tamponade,
eedle pericardiocentesis is probably not a useful procedure.467
here is no evidence of beneﬁt in the literature. It may increase
cene time, can cause myocardial injury and delays effective ther-
peutic measures such as emergency thoracotomy.1 (2010) 1400–1433 1421
Fluids and blood transfusion on scene
Fluid resuscitation of trauma patients before haemorrhage is
controlled is controversial and there is no clear consensus on
when it should be started and what ﬂuids should be given.468,469
Limited evidence and general consensus support a more conser-
vative approach to intravenous ﬂuid infusion, with permissive
hypotensionuntil surgical haemostasis is achieved.470,471 In theUK,
the National Institute for Clinical Excellence (NICE) has published
guidelines on pre-hospital ﬂuid replacement in trauma.472 The rec-
ommendations includegiving250mlbolusesof crystalloid solution
until a radial pulse is achieved and not delaying rapid transport
of trauma victims for ﬂuid infusion in the ﬁeld. Pre-hospital ﬂuid
therapy may have a role in prolonged entrapments but there is no
reliable evidence for this.473,474
Ultrasound
Ultrasound is a valuable tool in the evaluation of the
compromised traumapatient. Haemoperitoneum, haemo-or pneu-
mothorax and cardiac tamponade can be diagnosed reliably in
minutes even in the pre-hospital phase.475 Diagnostic peritoneal
lavage and needle pericardiocentesis have virtually disappeared
from clinical practice since the introduction of sonography in
trauma care. Pre-hospital ultrasound is now available, although its
beneﬁts are yet to be proven.476
Vasopressors
The possible role of vasopressors (e.g., vasopressin) in trauma
resuscitation is unclear and is based mainly on case reports.477
8j. Cardiac arrest associated with pregnancy
Overview
Mortality related to pregnancy in developed countries is rare,
occurring in an estimated 1:30,000 deliveries.478 The fetus must
always be consideredwhen an adverse cardiovascular event occurs
in a pregnant woman. Fetal survival usually depends on mater-
nal survival. Resuscitation guidelines for pregnancy are based
largely on case series, extrapolation from non-pregnant arrests,
manikin studies and expert opinion based on the physiology
of pregnancy and changes that occur in normal labour. Studies
tend to address causes in developed countries, whereas the most
pregnancy-related deaths occur in developing countries. There
were an estimated 342,900 maternal deaths (death during preg-
nancy, childbirth, or in the 42 days after delivery) worldwide in
2008.479
Signiﬁcant physiological changes occur during pregnancy, e.g.,
cardiac output, blood volume, minute ventilation and oxygen con-
sumption all increase. Furthermore, the gravid uterus can cause
signiﬁcant compression of iliac and abdominal vessels when the
mother is in the supineposition, resulting in reduced cardiac output
and hypotension.
Causes
There are many causes of cardiac arrest in pregnant women. A
review of nearly 2 million pregnancies in the UK480 showed that
maternal deaths (death during pregnancy, childbirth, or in the 42
days after delivery) between 2003 and 2005 were associated with:
• cardiac disease;
• pulmonary embolism;
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psychiatric disorders;
hypertensive disorders of pregnancy;
sepsis;
haemorrhage;
amniotic-ﬂuid embolism;
ectopic pregnancy.
Pregnant women can also sustain cardiac arrest from the same
auses as women of the same age group.
ey interventions to prevent cardiac arrest
In an emergency, use an ABCDE approach. Many cardiovascu-
ar problems associated with pregnancy are caused by aortocaval
ompression. Treat a distressed or compromised pregnant patient
s follows:
Place thepatient in the left lateral positionormanually andgently
displace the uterus to the left.
Give high-ﬂow oxygen guided by pulse oximetry.
Give a ﬂuid bolus if there is hypotension or evidence of hyo-
volaemia.
Immediately re-evaluate the need for any drugs being given.
Seek expert help early. Obstetric and neonatal specialists should
be involved early in the resuscitation.
Identify and treat the underlying cause.
odiﬁcations to BLS guidelines for cardiac arrest
After 20 weeks gestation, the pregnant woman’s uterus can
ress down against the inferior vena cava and the aorta, impeding
enous return and cardiac output. Uterine obstruction of venous
eturn can cause pre-arrest hypotension or shock and, in the crit-
cally ill patient, may precipitate arrest.481,482 After cardiac arrest,
he compromise in venous return and cardiac output by the gravid
terus limits the effectiveness of chest compressions.
Non-arrest studies show that left lateral tilt improves mater-
al blood pressure, cardiac output and stroke volume 483–485 and
mproves fetal oxygenation and heart rate.486–488 Two studies
ound no improvement in maternal or fetal variables with 10–20◦
eft lateral tilt.489,490 One study found more aortic compression at
5◦ left lateral tilt when compared with a full left lateral tilt.484
ortic compression has been found to persist at over 30◦ of tilt.491
wonon-arrest studies show thatmanual left uterinedisplacement
ith the patient supine is as good as or better than left lateral tilt
n relieving aortocaval compression, as assessed by the incidence
f hypotension and ephedrine use.492,493 Non-cardiac arrest data
how that the gravid uterus can be shifted away from the cava
n most cases by placing the patient in 15◦ of left lateral decubi-
us position.494 The value of relieving aortic or caval compression
uring CPR is, however, unknown.
Unless the pregnant victim is on a tilting operating table, left
ateral tilt is not easy to perform whilst maintaining good quality
hest compressions. A variety ofmethods to achieve a left lateral tilt
ave been described including placing the victim on the rescuers
nees495, pillows or blankets, and the Cardiff wedge496 although
heir efﬁcacy in actual cardiac arrests is unknown. Even when a
ilting table is used, the angle of tilt is often overestimated.497 In a
anikin study, the ability to provide effective chest compressions
ecreased as the angle of left lateral tilt increased and that at an
◦ 496ngle of greater than 30 the manikin tended to roll.
The key steps for BLS in a pregnant patient are:
Call for expert help early (including an obstetrician and neona-
tologist).1 (2010) 1400–1433
• Start basic life support according to standard guidelines. Ensure
good quality chest compressions with minimal interruptions.
• Manually displace the uterus to the left to remove caval compres-
sion.
• Add left lateral tilt if this is feasible – the optimal angle of tilt is
unknown. Aim for between 15◦ and 30◦. Even a small amount of
tiltmay be better than no tilt. The angle of tilt used needs to allow
good quality chest compressions and if needed allow Caesarean
delivery of the fetus.
• Start preparing for emergency Caesarean section (see below) –
the fetus will need to be delivered if initial resuscitation efforts
fail.
Modiﬁcations to advanced life support
There is a greater potential for gastro-oesophageal sphincter
insufﬁciency and risk of pulmonary aspiration of gastric contents.
Early tracheal intubation with correctly applied cricoid pressure
decreases this risk. Tracheal intubation will make ventilation of the
lungs easier in the presence of increased intra-abdominal pressure.
A tracheal tube 0.5–1mm internal diameter (ID) smaller than
that used for a non-pregnant woman of similar size may be nec-
essary because of maternal airway narrowing from oedema and
swelling.498 One study documented that the upper airways in the
third trimester of pregnancy are narrower compared with their
postpartumstateand tonon-pregnant controls.499 Tracheal intuba-
tion may be more difﬁcult in the pregnant patient.500 Expert help,
a failed intubation drill and the use of alternative airway devices
may be needed (see Section 4).24a,501
There is no change in transthoracic impedance during preg-
nancy, suggesting that standard shock energies for deﬁbrillation
attempts should be used in pregnant patients.502 There is no evi-
dence that shocks from a direct current deﬁbrillator have adverse
effects on the fetal heart. Left lateral tilt and large breasts will
make it difﬁcult to place an apical deﬁbrillator paddle. Adhesive
deﬁbrillator pads are preferable to paddles in pregnancy.
Reversible causes
Rescuers should attempt to identify common and reversible
causes of cardiac arrest in pregnancyduring resuscitation attempts.
The 4 Hs and 4 Ts approach helps identify all the common causes of
cardiac arrest in pregnancy. Pregnant patients are at risk of all the
other causes of cardiac arrest for their age group (e.g., anaphylaxis,
drug overdose, trauma). Consider the use of abdominal ultrasound
bya skilledoperator todetectpregnancyandpossible causesduring
cardiac arrest in pregnancy; however, do not delay other treat-
ments. Speciﬁc causes of cardiac arrest in pregnancy include the
following.
Haemorrhage
Life-threatening haemorrhage can occur both antenatally and
postnatally. Postpartum haemorrhage is the commonest single
cause of maternal death worldwide and is estimated to cause one
maternal death every 7min.503 Associations include ectopic preg-
nancy, placental abruption, placenta praevia, placenta accreta, and
uterine rupture.480 Amassive haemorrhage protocolmust be avail-
able in all units and should be updated and rehearsed regularly in
conjunction with the blood bank. Women at high risk of bleeding
should be delivered in centres with facilities for blood transfu-
sion, intensive care and other interventions, and plans should be
made in advance for their management. Treatment is based on an
ABCDE approach. The key step is to stop the bleeding. Consider the
following:
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ﬂuid resuscitation including use of rapid transfusion system and
cell salvage504;
oxytocin and prostaglandin analogues to correct uterine
atony505;
massaging the uterus506;
correction of coagulopathy including use of tranexamic acid or
recombinant activated factor VII507–509;
uterine balloon tamponade510,511;
uterine compression sutures512;
angiography and endovascular embolization513;
hysterectomy514,515;
aortic cross-clamping in catastrophic haemorrhage.516
ardiovascular disease
Myocardial infarction and aneurysm or dissection of the aorta
r its branches, andperipartumcardiomyopathy causemost deaths
rom acquired cardiac disease.517,518 Patients with known cardiac
isease need to be managed in a specialist unit. Pregnant women
ay develop an acute coronary syndrome, typically in association
ith risk factors such as obesity, older age, higher parity, smok-
ng, diabetes, pre-existing hypertension and a family history of
schaemic heart disease.480,519 Pregnant patients can have atyp-
cal features such as epigastric pain and vomiting. Percutaneous
oronary intervention (PCI) is the reperfusion strategy of choice
or ST-elevation myocardial infarction in pregnancy. Thrombolysis
hould be considered if urgent PCI is unavailable. A review of 200
ases of thrombolysis for massive pulmonary embolism in preg-
ancy reported a maternal death rate of 1% and concluded that
hrombolytic therapy is reasonably safe in pregnancy.520
Increasing numbers ofwomenwith congenital heart disease are
ecoming pregnant.521 Heart failure and arrhythmias are the com-
onest problems, especially in those with cyanotic heart disease.
regnant women with known congenital heart disease should be
anaged in specialist centres.
re-eclampsia and eclampsia
Eclampsia is deﬁned as the development of convulsions and/or
nexplained coma during pregnancy or postpartum in patients
ith signs and symptoms of pre-eclampsia.522,523 Magnesium sul-
hate is effective in preventing approximately half of the cases
f eclampsia developing in labour or immediately postpartum in
omen with pre-eclampsia.524–526
ulmonary embolism
The estimated incidence of pulmonary embolism is 1–1.5 per
0,000pregnancies,with a case fatality of 3.5% (95%CI 1.1–8.0%).527
isk factors include obesity, increased age, and immobility. Suc-
essful use of ﬁbrinolytics for massive, life-threatening pulmonary
mbolism in pregnant women has been reported.520,528–531
mniotic-ﬂuid embolism
Amniotic-ﬂuid embolism usually presents around the time
f delivery with sudden cardiovascular collapse, breathlessness,
yanosis, arrhythmias, hypotension and haemorrhage associated
ith disseminated intravascular coagulopathy.532 Patients may
ave warning signs preceding collapse including breathlessness,
hest pain, feeling cold, light-headedness, distress, panic, a feeling
f pins and needles in the ﬁngers, nausea, and vomiting.
The UK Obstetric Surveillance System identiﬁed 60 cases of
mniotic-ﬂuid embolism between 2005 and 2009. The reported
ncidence was 2.0 per 100,000 deliveries (95% CI 1.5–2.5%)533
he case fatality is 13–30% and perinatal mortality is 9–44%.5321 (2010) 1400–1433 1423
Amniotic-ﬂuid embolism was associated with induction of labour,
multiple pregnancy, older, and ethnic-minority women. Caesarean
delivery was associated with postnatal amniotic-ﬂuid embolism.
Treatment is supportive, as there is no speciﬁc therapy based on
an ABCDE approach and correction of coagulopathy. Successful use
of extracorporeal life support techniques for women suffering life-
threatening amniotic-ﬂuid embolism during labour and delivery is
reported.534
If immediate resuscitation attempts fail
Consider the need for an emergency hysterotomy or Caesarean
section as soon as a pregnant woman goes into cardiac arrest. In
some circumstances immediate resuscitation attempts will restore
a perfusing rhythm; in early pregnancy this may enable the preg-
nancy to proceed to term. When initial resuscitation attempts fail,
delivery of the fetus may improve the chances of successful resus-
citation of the mother and fetus.535–537 One systematic review
documented 38 cases of Caesarean section during CPR,with 34 sur-
viving infants and 13 maternal survivors at discharge, suggesting
that Caesarean section may have improved maternal and neonatal
outcomes.538 The best survival rate for infants over 24–25 weeks
gestation occurs when delivery of the infant is achieved within
5min after the mother’s cardiac arrest.535,539–541 This requires that
the provider commence the hysterotomy at about 4min after car-
diac arrest. At older gestational ages (30–38 weeks), infant survival
is possible even when delivery was after 5min from the onset of
maternal cardiac arrest.538 A case-series suggests increased use of
Caesarean section during CPR with team training542; in this series
no deliveries were achieved within 5min after starting resuscita-
tion. Eight of the twelve women had ROSC after delivery, with two
maternal and ﬁve newborn survivors. Maternal case fatality rate
was 83%. Neonatal case fatality rate was 58%.542
Delivery will relieve caval compression and may improve
chances of maternal resuscitation. The Caesarean delivery also
enables access to the infant so that newborn resuscitation can
begin.
Decision-making for emergency hysterotomy (Caesarean section)
The gravid uterus reaches a size that will begin to compro-
mise aortocaval blood ﬂow at approximately 20 weeks gestation;
however, fetal viability begins at approximately 24–25 weeks.543
Portable ultrasound is available in some emergency departments
and may aid in determination of gestational age (in experienced
hands) and positioning, provided its use does not delay the deci-
sion toperformemergencyhysterotomy.544 Aimfordeliverywithin
5min of onset of cardiac arrest. This will mean that Caesarean
section needs to ideally take place where the cardiac arrest has
occurred to avoid delays.
• At gestational age less than 20 weeks, urgent Caesarean delivery
need not be considered, because a gravid uterus of this size is
unlikely to signiﬁcantly compromise maternal cardiac output.
• At gestational age approximately 20–23 weeks, initiate emer-
gency hysterotomy to enable successful resuscitation of the
mother, not survival of the delivered infant, which is unlikely at
this gestational age.
• At gestational age approximately ≥24–25 weeks, initiate emer-
gency hysterotomy to save the life of both the mother and the
infant.Post-resuscitation care
Post-resuscitation care should follow standard guidelines. Ther-
apeutic hypothermia has been used safely and effectively in early
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regnancy with fetal heart monitoring and resulted in favourable
aternal and fetal outcome after a term delivery.544a Implantable
ardioverter deﬁbrillators (ICDs) have been used in patients during
regnancy.545
reparation for cardiac arrest in pregnancy
Advanced life support in pregnancy requires coordination of
aternal resuscitation, Caesarean delivery of the fetus and new-
orn resuscitation ideally within 5min. To achieve this, units likely
o deal with cardiac arrest in pregnancy should:
have plans and equipment in place for resuscitation of both the
pregnant woman and newborn;
ensure early involvement of obstetric, anaesthetic and neonatal
teams;
ensure regular training in obstetric emergencies.546
k. Electrocution
ntroduction
Electrical injury is a relatively infrequent but potentially dev-
stating multisystem injury with high morbidity and mortality,
ausing 0.54 deaths per 100,000 people each year. Most electrical
njuries in adults occur in the workplace and are associated gen-
rally with high voltage, whereas children are at risk primarily at
ome, where the voltage is lower (220V in Europe, Australia and
sia; 110V in theUSA andCanada).547 Electrocution from lightning
trikes is rare, but worldwide it causes 1000 deaths each year.548
Electric shock injuries are caused by the direct effects of cur-
ent on cell membranes and vascular smooth muscle. The thermal
nergy associated with high-voltage electrocution will also cause
urns. Factors inﬂuencing the severity of electrical injury include
hether the current is alternating (AC) or direct (DC), voltage,mag-
itude of energy delivered, resistance to current ﬂow, pathway of
urrent through the patient, and the area and duration of contact.
kin resistance is decreased bymoisture,which increases the likeli-
ood of injury. Electric current follows the path of least resistance;
onductive neurovascular bundles within limbs are particularly
rone to damage.
Contact with AC may cause tetanic contraction of skeletal mus-
le, which may prevent release from the source of electricity.
yocardial or respiratory failure may cause immediate death.
Respiratory arrest may be caused by paralysis of the central res-
piratory control system or the respiratory muscles.
Current may precipitate VF if it traverses the myocardium during
the vulnerable period (analogous to an R-on-T phenomenon).549
Electrical current may also cause myocardial ischaemia because
of coronary artery spasm. Asystole may be primary, or secondary
to asphyxia following respiratory arrest.
urrent that traverses the myocardium is more likely to be fatal.
transthoracic (hand-to-hand) pathway is more likely to be fatal
han a vertical (hand-to-foot) or straddle (foot-to-foot) pathway.
here may be extensive tissue destruction along the current path-
ay.
ightning strikeLightning strikes deliver as much as 300kV over a few millisec-
nds. Most of the current from a lightning strike passes over the
urface of the body in a process called ‘external ﬂashover’. Both
ndustrial shocks and lightning strikes causedeepburns at thepoint
f contact. For industrial shocks the points of contact are usually on1 (2010) 1400–1433
the upper limbs, hands and wrists, whereas for lightning they are
mostly on the head, neck and shoulders. Injurymay also occur indi-
rectly through ground current or current “splashing” from a tree or
other object that is hit by lightning.550 Explosive force may cause
blunt trauma.551 The pattern and severity of injury from a light-
ning strike varies considerably, even among affected individuals
from a single group.552–554 As with industrial and domestic electric
shock, death is caused by cardiac553–557 or respiratory arrest.550,558
In those who survive the initial shock, extensive catecholamine
release or autonomic stimulationmay occur, causing hypertension,
tachycardia, non-speciﬁc ECG changes (including prolongation of
the QT interval and transient T-wave inversion), and myocardial
necrosis. Creatine kinase may be released from myocardial and
skeletal muscle. Lightning can also cause central and peripheral
nerve damage; brain haemorrhage and oedema, and peripheral
nerve injury are common. Mortality from lightning injuries is as
high as 30%, with up to 70% of survivors sustaining signiﬁcant
morbidity.559–561
Diagnosis
The circumstances surrounding the incident are not always
known. Unconscious patients with linear or punctuate burns or
feathering should be treated as a victims of lightning strike.550
Rescue
Ensure that any power source is switched off and do not
approach the casualty until it is safe. High-voltage (above domes-
tic mains) electricity can arc and conduct through the ground for
up to a few metres around the casualty. It is safe to approach and
handle casualties after lightning strike, although it would be wise
to move to a safer environment, particularly if lightning has been
seen within 30min.550
Resuscitation
Start standard basic and advanced life support without delay.
• Airway management may be difﬁcult if there are electrical burns
around the face and neck. Early tracheal intubation is needed in
these cases, as extensive soft-tissue oedema may develop caus-
ing airway obstruction. Head and spine trauma can occur after
electrocution. Immobilise the spine until evaluation can be per-
formed.
• Muscular paralysis, especially after high voltage, may persist
for several hours560; ventilatory support is required during this
period.
• VF is the commonest initial arrhythmia after high-voltage AC
shock; treat with prompt attempted deﬁbrillation. Asystole is
more common after DC shock; use standard protocols for this
and other arrhythmias.
• Remove smouldering clothing and shoes to prevent further ther-
mal injury.
• Vigorous ﬂuid therapy is required if there is signiﬁcant tis-
sue destruction. Maintain a good urine output to enhance the
excretion of myoglobin, potassium and other products of tissue
damage.557
• Consider early surgical intervention in patients with severe ther-
mal injuries.• Maintain spinal immobilisation if there is a likelihood of head or
neck trauma.562,563
• Conduct a thorough secondary survey to exclude traumatic
injuries caused by tetanic muscular contraction or by the person
being thrown.563,564
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Electrocution can cause severe, deep soft-tissue injury with rel-
atively minor skin wounds, because current tends to follow
neurovascular bundles; look carefully for features of compart-
ment syndrome, which will necessitate fasciotomy.
Patients struck by lightning are most likely to die if they sus-
ain immediate cardiac or respiratory arrest and are not treated
apidly. When multiple victims are struck simultaneously by light-
ing, rescuers should give highest priority to patients in respiratory
r cardiac arrest. Victims with respiratory arrest may require only
entilation to avoid secondary hypoxic cardiac arrest. Resuscitative
ttemptsmay have higher success rates in lightning victims than in
atients with cardiac arrest from other causes, and efforts may be
ffective even when the interval before the resuscitative attempt is
rolonged.558 Dilated or non-reactive pupils should never be used
s a prognostic sign, particularly in patients suffering a lightning
trike.550
There are conﬂicting reports on the vulnerability of the fetus to
lectric shock. The clinical spectrumof electrical injury ranges from
transient unpleasant sensation for the mother with no effect on
er fetus, to fetal death either immediately or a few days later. Sev-
ral factors, such as the magnitude of the current and the duration
f contact, are thought to affect outcome.565
urther treatment and prognosis
Immediate resuscitation of young victims in cardiac arrest from
lectrocution can result in long-term survival. Successful resuscita-
ion has been reported after prolonged life support. All those who
urvive electrical injury should be monitored in hospital if they
ave a history of cardiorespiratory problems or have had:
loss of consciousness;
cardiac arrest;
electrocardiographic abnormalities;
soft-tissue damage and burns.
Severe burns (thermal or electrical), myocardial necrosis, the
xtent of central nervous system injury, and secondary mul-
isystem organ failure determine the morbidity and long-term
rognosis. There is no speciﬁc therapy for electrical injury, and the
anagement is symptomatic. Prevention remains the best way to
inimize the prevalence and severity of electrical injury.
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Survival from cardiac arrest is determined by the quality of the
cientiﬁc evidence behind the guidelines, the effectiveness of edu-
ation and the resources for implementation of the guidelines.1 An
dditional factor is how readily guidelines can be applied in clinical
ractice and the effect of human factors on putting the theory into
ractice.2 Implementation of Guidelines 2010 is likely to be more
uccessful with a carefully planned, comprehensive implementa-
ion strategy that includes education. Delays in providing training
aterials and freeing staff for training were cited as reasons for
elays in the implementation of the 2005 guidelines.3,4
This chapter includes the key educational issues identiﬁed
y the International Liaison Committee on Resuscitation (ILCOR)
vidence evaluation,5 discusses the scientiﬁc basis of basic and
dvanced level resuscitation training and provides an update on
he European Resuscitation Council (ERC) life support courses.6
ey educational recommendationsThe key issues identiﬁed by the Education, Implementation and
eams (EIT) task forceof ILCORduring theGuidelines2010evidence
valuation process5 that are relevant to this chapter are:
∗ Corresponding author.
E-mail address: jas.soar@btinternet.com (J. Soar).
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.014• Educational interventions shouldbeevaluated toensure that they
reliably achieve the learning objectives. The aim is to ensure that
learners acquire and retain the skills and knowledge that will
enable them to act correctly in actual cardiac arrests and improve
patient outcomes.
• Short video/computer self-instruction courses, with minimal or
no instructor coaching, combined with hands-on practice can
be considered as an effective alternative to instructor-led basic
life support (cardiopulmonary resuscitation [CPR] andautomated
external deﬁbrillator [AED]) courses.
• Ideally all citizens should be trained in standard CPR that includes
compressions and ventilations. There are circumstances how-
everwhere training in compression-only CPR is appropriate (e.g.,
opportunistic training with very limited time). Those trained in
compression-only CPR should be encouraged to learn standard
CPR.
• Basic and advanced life support knowledge and skills deteriorate
in as little as three to sixmonths. The use of frequent assessments
will identify those individuals who require refresher training to
help maintain their knowledge and skills.
• CPR prompt or feedback devices improve CPR skill acquisition
and retention and should be considered during CPR training for
laypeople and healthcare professionals.
• An increased emphasis on non-technical skills (NTS) such as
leadership, teamwork, taskmanagement and structured commu-
nication will help improve the performance of CPR and patient
care.
• Teambrieﬁngs to plan for resuscitation attempts, and debrieﬁngs
based on performance during simulated or actual resuscitation
evier Ireland Ltd. All rights reserved.
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attempts should be used to help improve resuscitation team and
individual performance.
Research about the impact of resuscitation training on actual
patient outcomes is limited. Althoughmanikin studies are useful,
researchers should be encouraged to study and report the impact
of educational interventions on actual patient outcomes.
ho and how to train
Ideally all citizens should have some knowledge of CPR. There is
nsufﬁcient evidence for or against the use of training interventions
hat focus on high risk populations. However, training can reduce
amily member and, or patient anxiety, improve emotional adjust-
ent and empowers individuals to feel that they would be able to
tart CPR.5
People that require resuscitation training range from laypeople,
hosewithout formal healthcare training butwith a role that places
duty of care upon them (e.g., lifeguards, ﬁrst aiders), and health-
are professionals working in a variety of settings including the
ommunity, emergency medical systems (EMS), general hospital
ards and critical care areas.
Training should be tailored to the needs of different types of
earners and learning styles to ensure acquisition and retention of
esuscitation knowledge and skills. Thosewho are expected to per-
orm CPR regularly need to have knowledge of current guidelines
nd be able to use them effectively as part of a multi-professional
eam. These individuals require more complex training including
oth technical and non-technical skills (e.g., teamwork, leadership,
tructured communication skills).7,8 In the next section we have
rbitrarily divided these intobasic level andadvanced level training
nterventionswhereas in truth this is a continuum.Most research in
his area is based on training rescuers in adult resuscitation skills.
uch of this research also applies to training in resuscitation of
hildren and of the newborn.
asic level and AED training
Bystander CPR and early deﬁbrillation saves lives. Many fac-
ors decrease the willingness of bystanders to start CPR, including
anic, fear of disease, harming the victim or performing CPR
ncorrectly.9–24 Providing CPR training to laypeople increases will-
ngness to perform CPR.12,18–20,25–30
CPR training and doing CPR during an actual cardiac arrest is
afe in most circumstances. Individuals undertaking CPR training
hould be advised of the nature and extent of the physical activity
equired during the training program. Learnerswhodevelop signif-
cant symptoms (e.g., chest pain, severe shortness of breath) during
PR training should be advised to stop. Rescuers who develop sig-
iﬁcant symptoms during actual CPR should consider stopping CPR
see basic life support guidelines for further information about risks
o the rescuer).31
asic life support and AED curriculum
The curriculum for basic life support and AED training should
e tailored to the target audience and kept as simple as possible.
he following should be considered as core elements of the basic
ife support and AED curriculum5,32:Personal and environmental risks before starting CPR.
Recognition of cardiac arrest by assessment of responsiveness,
opening of the airway and assessment of breathing.31,32
Recognition of gasping or abnormal breathing as a sign of cardiac
arrest in unconscious unresponsive individuals.33,341 (2010) 1434–1444 1435
• Good quality chest compressions (including adherence to rate,
depth, full recoil and minimizing hands-off time) and rescue
breathing.
• Feedback/prompts (including from devices) during CPR training
should be considered to improve skill acquisition and retention
during basic life support training.35
• All basic life support and AED training should aim to
teach standard CPR including rescue breathing/ventilations.
Chest compression-only CPR training has potential advantages
over chest compression and ventilation in certain speciﬁc
situations.10,15,18,23,24,27,36,37 An approach to teaching CPR is sug-
gested below.
Standard CPR versus chest compression-only CPR teaching
There is controversy about which CPR skills different types of
rescuers should be taught. Compression-only CPR is easier and
quicker to teach especially when trying to teach a large num-
ber of individuals who would not otherwise access CPR training.
In many situations however, standard CPR (which includes ven-
tilation/rescuer breathing) is better, for example in children,38
asphyxial arrests, and when bystander CPR is required for more
than a few minutes.32 A simpliﬁed, education-based approach is
therefore suggested:
• Ideally, full CPR skills (compressions and ventilation using a 30:2
ratio) should be taught to all citizens.
• When training is time-limited or opportunistic (e.g., EMS
telephone instructions to a bystander, mass events, publicity
campaigns, YouTube ‘viral’ videos, or the individual doesnotwish
to train), training should focus on chest compression-only CPR.
• For those trained in compression-only CPR, subsequent train-
ing should include training in ventilation as well as chest
compressions. Ideally these individuals should be trained in
compression-only CPR and then offered training in chest com-
pressions with ventilation at the same training session.
• Those laypersons with a duty of care, such as ﬁrst aid workers,
lifeguards, and child minders, should be taught how to do chest
compressions and ventilations.
• For children, rescuers should be encouraged to use whichever
adult sequence theyhavebeen taught, as outcome isworse if they
do nothing. Non-specialists whowish to learn paediatric resusci-
tation because they have responsibility for children (e.g., parents,
teachers, school nurses, lifeguards etc), should be taught that it
is preferable to modify adult basic life support and give ﬁve ini-
tial breaths followed by approximately 1min of CPR before they
go for help, if there is no-one to go for them. Chest compression
depth for children is at least one-third of the A-P diameter of the
chest.39
• Citizen-CPR training should be promoted for all. However
being untrained should not be a barrier to performing chest
compression-only CPR, preferably with dispatcher telephone
advice.
Basic life support and AED training methods
There are numerous methods to deliver basic life support and
AED training. Traditional, instructor-led training courses remain
the most frequently used method for basic life support and AED
training.40 When compared with traditional instructor-led train-
ing, well designed self-instruction programmes (e.g., video, DVD,
computer driven) with minimal or no instructor coaching can be
effective alternatives to instructor-led courses for laypeople and
healthcare providers learning basic life support andAED skills.41–55
It is essential that courses include hands-on practice as part of the
programme.
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The use of AEDs by individuals without prior formal training
an be beneﬁcial andmay be life saving.45,56–60 Performance in the
se of an AED (e.g., speed of use, correct pad placement) can be
urther improved with brief training of laypeople and healthcare
rofessionals.45,50,61,62
uration and frequency of instructor-led basic life support
nd AED training courses
The optimal duration of instructor-led basic life support and
ED training courses has not been determined and is likely to
ary according to the characteristics of the participants (e.g., lay
r healthcare; previous training; age), the curriculum, the ratio of
nstructors to participants, the amount of hands-on training and
he use of end of course assessments.
Most studies show that CPR skills such as calling for help, chest
ompressions and ventilations decay within three to six months
fter initial training.43,46,63–68 AEDskills are retained for longer than
asic life support skills alone.59,64,69
CPR performance can be retained or improved with re-
valuation and, if required, a brief refresher, or retraining after as
ittle as three to six months.64,70–73
se of CPR prompt/feedback devices
The use of CPR prompt/feedback devices may be considered
uring CPR training for laypeople and healthcare professionals.35
evices can be prompting (i.e., signal to perform an action e.g.,
etronome for compression rate or voice feedback), give feed-
ack (i.e., after event information based on effect of an action
uch as visual display of compression depth), or a combination of
rompts and feedback. Training using a prompt/feedback device
an improve CPR skill performance, acquisition and retention. In
hese studies acquisition and retention was measured by testing
n a manikin without using the device.63,74–78 Instructors and res-
uers should be made aware that a compressible support surface
e.g.,mattress) can cause aprompt/feedbackdevice tooverestimate
epth of compression.79,80
dvanced level training
dvanced level training curriculum
Advanced level training is usually for healthcare providers. Cur-
icula shouldbe tailored tomatch individual learningneeds, patient
ase mix and the individual’s role within the healthcare systems
esponse to cardiac arrest. There is limited evidence about speciﬁc
nterventions that enhance learning and retention from advanced
evel life support courses. The ERC Advanced Life Support (ALS)
ourse following Guidelines 2005 has been shown to reduce “no-
ow” fraction but not other elements of quality of CPR performance
n cardiac arrest simulations.81 Increased clinical experience of
earners seems to improve long-term retention of knowledge and
kills.82,83
Studies of advanced life support in actual or simulated
n-hospital arrests,84–94 show improved resuscitation team per-
ormance when speciﬁc team and, or leadership training is added
o advanced level courses. Team training and rhythm recognition
kills will be essential to minimize hands-off time when using the
010 manual deﬁbrillation strategy that includes charging during
95,96hest compressions.
Core elements for advanced life support curricula should
nclude:
Cardiac arrest prevention.97,981 (2010) 1434–1444
• Good quality chest compressions including adherence to rate,
depth, full recoil and minimizing hands-off time, and ventilation
using basic skills (e.g., pocket mask, bag mask).
• Deﬁbrillation includingchargingduringcompressions formanual
deﬁbrillation.
• Advanced life support algorithms.
• Non-technical skills (e.g., leadership and team training, commu-
nication).
Extended training may cover advanced airway manage-
ment, management of peri-arrest arrhythmias; resuscitation in
special circumstances, vascular access, cardiac arrest drugs, post-
resuscitation care and ethics.
Advanced level training methods
Pre-course training
A variety of methods (such as reading manuals, pretests and
e-learning can be used to prepare candidates before attending a
life support course.99–107 A recent large randomized controlled
study of use of a commercially available e-learning simulation
programme before attending an advanced life support course com-
pared with standard preparation with a course manual showed
no improvement in cognitive or psychomotor skills during cardiac
arrest simulation testing.107,108
There are numerous studies of alternative teaching methods
that claim equivalence or beneﬁt for computer or video-
based training and decrease the time instructors spend with
learners.100,101,106,109–123 Any method of pre-course prepara-
tion that is aimed at improving knowledge and skills or
reducing instructor to learner face-to-face time should be for-
mally assessed to ensure equivalent or improved learning
outcomes compared with standard instructor-led courses. A
large multicentre randomised controlled trial to test if a 1-day
face-to-face ALS course supplemented by e-learning material
is equivalent to the 2-day face-to-face standard ALS course
with respect to the course learning outcomes is ongoing
[ISRCTN86380392].
Simulation and realistic training techniques
Simulation training is an essential part of resuscitation train-
ing. There is large variation in how simulation can be and is used
for resuscitation training.124 The lack of consistent deﬁnitions (e.g.,
high vs. low ﬁdelity simulation) makes comparisons of studies of
different types of simulation training difﬁcult.
Simulation training has fairly consistently,33,125–136 although
not universally137–143 been shown to improve knowledge and skill
performance on manikins. Evidence of change in real life perfor-
mance is more limited. A small number of before and after studies
examining the effects of resuscitation training (including simula-
tion) on real life performance have documented improvement in
actual patient outcomes.144–148 These studies are limited by their
inability to separate the effect of simulation training from other
educational and temporal factors. One randomised controlled trial
and a prospective case control study which allocated participants
to simulator or standard resuscitation training showed improved
real life performance of those skills.127,149
There are conﬂicting data on the effect of increas-
ing realism (e.g., use of actual resuscitation settings, high
ﬁdelity manikins) on learning, and few data on patient
outcomes.125,128,133,135,137,138,140,141,150–154 One study reported a
signiﬁcant increase in knowledge when using manikins or live
patient models for trauma teaching compared with no manikins
or live models.153 In this study there was no difference in knowl-
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dge acquisition between using manikins or live patient models,
lthough learners preferred using the manikins.
There is insufﬁcient evidence for or against the use of more
ealistic techniques (e.g., high-ﬁdelity manikins, in situ training)
o improve outcomes (e.g., skills performance on manikins, skills
erformance in real arrests, willingness to perform) when com-
aredwith standard training (e.g., low ﬁdelitymanikins, education
entre) in basic and advanced life support. The incremental cost
ffectiveness of higherﬁdelity simulators shouldbedetermined.141
Future studies should focus on measuring the effect of training
nterventions (including simulation) on patient and real life pro-
ess focused outcomes. Chart note review,155 quality assurance
tudies149 and quality of CPR monitoring technology89,156 have
onﬁrmed the feasibility of this approach.
dvanced life support training intervals
Knowledge and skill retention declines rapidly after initial
esuscitation training. Refresher training is invariably required to
aintain knowledge and skills; however, the optimal frequency
or refresher training is unclear. Most studies show that ALS
kills and knowledge decayed when tested at three to six months
fter training,65,157–164 two studies suggested seven to twelve
onths,165,166 and one study eighteen months.167
ssessment on advanced level courses
The best method of assessment during courses is unknown.
ritten tests in ALS courses do not reliably predictor practical skill
erformance and should not be used as a substitute for demonstra-
ion of clinical skill performance.168–171 Assessment at the end of
raining does seem to have a beneﬁcial effect on performance and
etention and should be considered.172,173
lternative strategies that may improve advanced life support
erformance
se of checklists and cognitive aids
Cognitive aids such as checklistsmay be used to improve adher-
nce to guidelines as long as they do not cause delays in starting
PR and the correct checklist is used.174–186 Checklists should be
ested in simulated resuscitations before implementation.84–94
ock codes
Mock cardiac arrest codes and drills provide the opportu-
ity to test the individual and system responses to cardiac
rrest. Mock codes can improve advanced life support provider
nowledge,187 skill performance,188 conﬁdence,189 familiarity
ith the environment190 and identify common system and user
rrors.191,192
eam brieﬁngs and debrieﬁngs
Brieﬁngs and debrieﬁngs should be used during both learning
nd actual clinical activities.
Successful teams such as sports teams meet before and after
vents. Surveys in the UK193,194 and Canada90 show that resuscita-
ion teams rarely have formal brieﬁngs anddebrieﬁngs. Debrieﬁngs
nd feedback are two separate but related entities in that various
orms of feedback are components of debrieﬁng. Debrieﬁng tends
o be face-to-face and involves both parties engaging in discussion.
eedback tends to provide information about prior events and can
se several methods (video recordings, deﬁbrillator downloads or
rained observer feedback). Debrieﬁng appears to be an effective
ethod for improving resuscitation performance and, potentially,
atient outcomes as long as objective data forms the basis for the1 (2010) 1434–1444 1437
discussion.87,89,127,129,149,187,195–205 The ideal format for debrieﬁng
remains to be determined.
European Resuscitation Council resuscitation courses
The ERC has a portfolio of training courses that aim to equip
learners with the ability to undertake resuscitation in a real clinical
situation at the level that they would be expected to perform – be
they laypeople, ﬁrst responders in the community or the hospital,
or a healthcare professional working for an EMS, on a general ward,
in an acute area, or as a member of a resuscitation team.
ERC courses focus on teaching in small groups using interactive
discussion and hands-on practice for skills and clinical simula-
tions using resuscitation manikins.6,206 Courses have a high ratio
of instructors to candidates (e.g. 1:3–1:6 depending on the type of
course). Full up to date information about ERC courses and termi-
nology is available on the ERC website www.erc.edu.
Ethos
ERC courses are taught by instructors who have been trained
in teaching and assessment. The ethos of ERC courses is to cre-
ate a positive environment that promotes learning. First names are
encouraged among both faculty and candidates to reduce appre-
hension. Interactions between faculty and candidates are designed
to be positive and teaching is conducted by encouragement with
constructive feedback and debrieﬁng on performance. A men-
tor/mentee system is used to enhance feedback and support for the
candidate. Some stress is inevitable,207 particularly during assess-
ment, but the aim of the instructors is to enable the candidates to
do their best.
Course management
Courses are overseen by specialist committees within each
National Resuscitation Council and by the ERC international course
committee. The ERC has developed a web-based course manage-
ment system (http://courses.erc.edu). The system can be used to
register all ERC courses and enables course organizers to register a
course fromanycountry, assign instructors, recordcandidateatten-
dance and outcomes, and ﬁle the course director’s report directly
with the ERC. Candidates may sign up online to a course, or may
contact the organizer to register their interest in the course. At
the end of the course the system will generate course certiﬁcates
for the candidates and faculty. These certiﬁcates are assigned a
unique number and can be accessed at any time by course organiz-
ers and directors. Participants that successfully complete courses
are referred to as providers. For example someone that successfully
completes an ALS course is known as an ALS provider. National
Resuscitation Councils have access to information about courses
organised in their country.
Language
Initially, the ERC courses were taught in English by an inter-
national faculty.206 As local instructors have been trained, and
manuals and course materials have been translated into different
languages, courses are now mainly taught in the native language.
Early translation of guidelines and course materials is essential as
delays in translation into the local language can cause signiﬁcant
delays to implementation of guidelines.3
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nstructors
A tried and testedmethod has evolved for identifying and train-
ng instructors.
dentiﬁcation of instructor potentials (IP)
These will be individuals who, in the opinion of the faculty,
ave passed and demonstrated a high level of performance dur-
ng a provider course and, importantly, have shown qualities of
eadership, team working and clinical credibility, with skills that
nclude being articulate, supportive, and motivated. These individ-
als will be invited to take part in an instructor course and are
alled instructor potentials. Instructor potentials wishing to teach
n Advanced Life Support (ALS), European Paediatric Life Support
EPLS), Newborn Life Support (NLS), Immediate Life Support (ILS),
nd European Paediatric Immediate Life Support (EPILS) courses
hould attend the Generic Instructor Course (GIC); for those wish-
ng to teach only on the ERC Basic Life Support (BLS)/Automated
xternal Deﬁbrillation (AED) Course there is a speciﬁc BLS/AED
nstructor Course.
nstructor courses
These are conducted by experienced instructors and, in the case
f the Generic Instructor Course (see below), include an educator
ho has undertaken speciﬁc training in medical educational prac-
ice and the principles of adult learning. Assessment is formative
y the faculty and feedback is given as appropriate.
nstructor candidate (IC) stage
Following successful completion of an instructor course (see
elow) the individual is designated instructor candidate (IC) status
nd normally will teach on two separate courses, under supervi-
ion, receiving constructive feedback on his or her performance.
ollowing successful completion of these two courses the IC nor-
ally progresses to full instructor status. Occasionally the faculty
ill decide that a further course is required or, rarely, that the can-
idate is not suitable to progress to be an instructor. An appeal can
e lodged with the relevant ERC International Course Committee
ho will make the ﬁnal decision.
ourse Director (CD) status
Each ERC course is led by an approved Course Director. Indi-
iduals are selected for approval as Course Directors through
omination by their peers and approved by their National Resus-
itation Council (NRC) or the ERC International Course Committee.
ourse Directors are relatively senior individuals who are clinically
redible, have demonstrated their qualities as a teacher and asses-
or and posses the leadership skills to lead a faculty of instructors.
heywill have embraced the educational principles inherent in the
nstructor course. A key component of ERC courses are the faculty
eetings. These usually take place at the start and end of each day
f the course. They are led by the course director. The aim of these
eetings is to brief the teaching faculty and to facilitate evaluation
f each candidate’s performance. At the end of each course a ﬁnal
aculty meeting is held. During this meeting the faculty will review
he performance of each candidate and decide whether they have
uccessfully completed the course. As described above, candidates
hat have shown exceptional ability are selected for invitation to
rain as instructors. Where there are instructor candidates on the
ourses, their performance is also evaluated and feedback provided
y their mentor or the course director. This faculty meeting also1 (2010) 1434–1444
gives the instructors an opportunity to debrief at the end of the
course.
The Basic Life Support (BLS) and Automated External
Deﬁbrillator (AED) Courses
BLS/AED courses are appropriate for a wide range of providers.
These may include clinical and non-clinical healthcare profession-
als (particularly those who are less likely to be faced with having
tomanage a cardiac arrest), general practitioners, dentists, medical
students, ﬁrst-aid workers, lifeguards, those with a duty of care for
others (such as school teachers and care workers), andmembers of
ﬁrst responder schemes, as well as members of the general public.
Separate BLS and AED provider courses are available, but the ERC
encourages candidates to combineBLS skillswith theuse of anAED.
Provider course format
The aim of this provider course is to enable each candidate
to gain competency in BLS and the use of an AED. Each BLS/AED
provider course lasts approximately half a day and consists of skill
demonstrations and hands-on practice, with a minimum number
of lectures. The recommended ratio of instructor to candidates is
1:6, with at least one manikin and one AED for each group of 6
candidates. Formal assessment is not usually undertaken, but each
candidate receives individual feedbackon their performance. Those
who need a certiﬁcate of competency for professional or personal
use may be assessed continuously during the course or deﬁnitively
at the end.
BLS/AED Instructor Course
Many of the candidates attending a BLS/AED provider course
are laypeople, and some want subsequently to become instruc-
tors themselves. For this reason, the ERC has developed a one-day
BLS/AED instructor course. Candidates for this course must be
healthcare professionals, or laypeople who hold the ERC BLS/AED
provider certiﬁcate and are designated as instructor potentials. The
aim is be as inclusive as possible regarding course attendance,
the overriding criterion being that all candidates should have the
potential and knowledge to teach the subject. The BLS/AED instruc-
tor course follows the principles of the Generic Instructor Course
(GIC), with an emphasis on teaching people. Following successful
completion of the course, each candidate becomes an instructor
candidate (IC) and teaches on two BLS/AED courses before becom-
ing a full instructor.
The Immediate Life Support (ILS) Course
The Immediate Life Support (ILS) course is for the majority
of healthcare professionals who attend cardiac arrests rarely but
have the potential to be ﬁrst responders or resuscitation team
members.208 The course teaches healthcare professionals the skills
that are most likely to result in successful resuscitation whilst
awaiting the arrival of the resuscitation team.209 Importantly, ILS
also includes a section on the initial care of the sick adult and pre-
venting cardiac arrest and complements other short courses that
focus on the initial treatment of sick patients.210 A recent cohort
study found that the number of cardiac arrest calls decreasedwhile
pre-arrest calls increased after implementing a programme that
included ILS teaching in two hospitals; the intervention was asso-
ciatedwith a decrease in true arrests, and increase in initial survival
after cardiac arrest and survival to discharge.211
Potential ILS candidates include nurses, nursing students, doc-
tors, medical students, dentists, physiotherapists, radiographers,
and cardiac technicians.
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ourse format
The ILS course is delivered over one day and comprises lectures,
ands-on skills teaching and cardiac arrest simulation teach-
ng (CASTeach) using manikins. The programme includes several
ptions that enable instructors to tailor the course to their candi-
ate group. The ILS course is designed to be straightforward to run.
ost courses are conducted in hospitals with small groups of can-
idates (average 12 candidates). Course centres should try as far as
ossible to train candidates to use the equipment (e.g., deﬁbrillator
ype) that is available locally.
ourse content
The course covers those skills that are most likely to result in
uccessful resuscitation: causes and prevention of cardiac arrest
ncluding use of the ABCDE approach, starting CPR, basic airway
kills and deﬁbrillation (AED or manual). The course includes an
ptional session on issues relevant to the candidate group (e.g.,
naphylaxis, equipment checks). Once all the skills have been cov-
red there is a cardiac arrest demonstration by the instructors
hat outlines the ﬁrst responder role to the candidates. This is
ollowed by the CASTeach station where candidates practice. ILS
andidates are not usually expected to undertake the role of team
eader. Candidates should be able to start a resuscitation attempt
nd continue until more experienced help arrives. When appro-
riate, the instructor takes over as resuscitation team leader. This
s not always necessary because in some simulations resuscitation
ay be successful beforemore experienced help arrives. Standard-
sed simulations are used that can be adapted to theworkplace and
linical role of the candidate.
ssessment
Candidates are assessed continuously andmust showtheir com-
etence throughout the ILS course. There are no formal testing
tations at the end of the course. Candidates are sent assessment
ormswith thepre-coursematerials. The forms indicate clearlyhow
heir performance will be measured against pre-determined cri-
eria. Assessment on the ILS course enables the candidate to see
hat is expected, and frame their learning around achievement
f these outcomes. The following practical skills are assessed on
he ILS course: airway management, CPR and deﬁbrillation. With a
upportive approach, most candidates achieve the course learning
utcomes.
he Advanced Life Support (ALS) Course
The target candidates for this course are doctors and senior
ursesworking in acute areas of the hospital and thosewhomay be
esuscitation team leaders and members.212,213 The course is also
uitable for senior paramedics and some hospital technicians. The
LS course is more suitable for ﬁrst responder nurses, doctors who
arely encounter cardiac arrest in their practice, and emergency
edical technicians.
Each instructor acts as a mentor for a small group of candidates.
he course normally lasts for 2 or 2.5 days.
ourse formatThe course format has very few formal lectures and teaching
oncentrates on hands-on skills, clinically-based simulations in
mall groups with emphasis on the team leader approach, and
nteractive group discussions. A formal mentor/mentee session is
ncluded to enable candidates to give and receive feedback.1 (2010) 1434–1444 1439
Course content
The course content is based on the current ERC Guidelines for
Resuscitation. Candidates are expected to have studied the ALS
course materials carefully before the course.
The course aims to train candidates to highlight the causes of
cardiac arrest and identify sick patients in danger of deterioration
and to manage cardiac arrest and the immediate peri-arrest prob-
lems encountered in and around the ﬁrst hour or so of the event.
It is not a course in advanced intensive care or cardiology. Compe-
tence in basic life support is expected before the candidate enrols
for the course.
Emphasis is placed on the techniques of safe deﬁbrillation and
ECG interpretation, the management of the airway and ventila-
tion, the management of peri-arrest rhythms, simple acid-base
balance, and of special circumstances relating to cardiac arrest.
Post-resuscitation care, ethical aspects related to resuscitation and
care of the bereaved are included in the course.
Assessment and testing
Each candidate is assessed continuously during the course and
reviewed at the end of each day at a faculty meeting. Feedback
is given as required. Candidates are expected to be able to use
the ABCDE approach to assess and treat the sick patient, recog-
nise cardiac arrest, provide good quality CPR and safe deﬁbrillation
throughout the course. There is a cardiac arrest simulation testing
(CASTest) towards the end of the course. This tests the participant’s
applied knowledge and skills during a simulated cardiac arrest.
The reliability and measurement properties of the CASTest have
been reported.169,214,215 A multiple choice question (MCQ) paper
taken at the end of the course tests core knowledge. Candidates are
required to achieve 75% to pass this test. The measurement prop-
erties of the multiple choice papers have been assessed from over
8000 candidates and found to have high internal consistency and
discrimination properties (Data from Resuscitation Council (UK)
and Dr Carl Gwinnutt).
The European Paediatric Life Support (EPLS) Course
The EPLS course is designed for healthcare workers who are
involved in the resuscitation of a newborn, an infant or a child
whether in or out-of-hospital. The course aims at providing care-
givers with knowledge and skills for the management of the
critically ill child during the ﬁrst hour of illness and to prevent
progression of diseases to cardiac arrest.
EPLS is not a course in neonatal or paediatric intensive care
aimed for advanced providers.
Competence in paediatric basic life support is a prerequisite
although refresher teaching inbasic life support and relief of foreign
body airway obstruction is included. The EPLS course is suitable
for doctors, nurses, emergencymedical technicians, paramedics etc
who have a duty to respond to sick newborns, infants and children
in their practice.216,217
Experience in paediatrics is necessary to keep simulations real-
istic and answer to candidates’ questions so a minimum of 50% of
the faculty must have regular experience in neonatal or paediatric
practice. The course lasts for 2–2.5 days.
Course formatThe course format has few formal lectures. Teaching of knowl-
edge and skills is delivered in small groups using clinically
based simulations (e.g., cardiac arrest, cardiac and respiratory fail-
ure, delivery room simulations). The emphasis is on assessment
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nd treatment of the sick child, team working and leader-
hip.
ourse content
Thecoursecontent follows thecurrentERCguidelines forneona-
al andpaediatric resuscitation. The course candidates are expected
o have studied the manual before attending the course. A pre-
ourse MCQ is sent with the manual to candidates 4–6 weeks
efore the course to encourage candidates to read the coursemate-
ials.
The EPLS course is aimed at training candidates to under-
tand the causes and mechanisms of cardiorespiratory arrest in
eonates and children, to recognise and treat the critically ill
eonate, infant or child and to manage cardiac arrest. Skills taught
nclude airway management, bag-mask ventilation, log roll and
ervical collar placement, oxygen delivery, an introduction to intu-
ation and vascular access, safe deﬁbrillation, cardioversion and
ED use.
Each candidate is assessed individually and reviewed by the fac-
lty. Feedback is given as required. A BLS assessment follows the
LS refresher course and a simulation-based test at the end of the
ourse emphasises the assessment of the sick child and other core
kills. An end of course MCQ with a pass mark of 74% tests core
nowledge.
he European Paediatric Immediate Life Support (EPILS)
ourse
ourse format
EPILS is a one-day course comprising one lecture, hands-on
kills and simulation teaching. The programme includes options
o enable teaching to be tailored for candidate groups.
ourse content
The course is aimed at training nurses, EMS personnel, and doc-
ors to recognize and treat critically ill infants and children, prevent
ardiorespiratory arrest and to treat children in cardiorespiratory
rrest during the ﬁrst few minutes whilst awaiting the arrival of a
esuscitation team. This interactive course is based on short practi-
al simulations adapted to the workplace and to the actual clinical
ole of candidates.
Basic life support, bag-mask ventilation, chest compressions,
hoking, and intraosseous access are included; drugs during car-
iac arrest and laryngeal mask insertion are optional. The EPILS
ourse is designed to be simple to run. Most courses are conducted
n hospitals with small groups of candidates (average 5–6 candi-
ates with one instructor). There needs to be at least one baby and
ne child manikin for every 6 candidates. Course centres should
ry as far as possible to train candidates to use the equipment (e.g.,
eﬁbrillator type) that is available in their clinical setting.
ssessment
Candidates are sent a pre-course MCQ paper with pre-course
aterials to help themprepare for the course. TheMCQpaper helps
o ensure that candidates read the course materials before attend-
ng the course and does not count towards the ﬁnal assessment.
here are no formal testing stations during the course. Candi-
ate’s performances are assessed continuously. Assessment forms
re given to the candidates at the beginning of the course and
nstructors provide feedback throughout the course. The following
ractical skills are assessed on the EPILS course: basic life support,1 (2010) 1434–1444
bag-mask ventilation and AED use. With a supportive approach,
most candidates achieve the course learning outcomes.
The Newborn Life Support (NLS) Course
This one-day course is designed for healthcare workers likely to
be present at the birth of a baby in the course of their job. It aims to
give thosewhomaybe called upon to start resuscitation at birth the
background knowledge and skills to approach the management of
the newborn infant during the ﬁrst 10–20min. The course is suit-
able for midwives, nurses, EMS personnel, and doctors and, like
most such courses, works best with candidates from a mixture of
specialties.
Course format
The NLS manual is sent to each of the candidates four weeks
before the course. Each candidate receives a MCQ together with
the manual and is asked to complete this and bring it with them to
the course. There is an introduction followed by two short lectures.
The candidates are then divided into four groups and undertake
three workstations before lunch. The afternoon is then taken up by
a demonstration simulation followed by two hours of simulation
teaching in small groups and, ﬁnally, a theoretical and practical
assessment by an MCQ and an individual practical airway test. The
course places appropriate emphasis on airway management but
also covers chest compression, umbilical venous access and drugs.
Both basic infant and four infant advanced manikins should be
available as well as other airway adjuncts. Resuscitaires, ideally
complete with sufﬁcient gas cylinders for the whole day, should
also be available.
The Generic Instructor Course (GIC)
This course is for candidates who have been recommended as
instructor potential (IP) emanating fromERCprovider courses (ALS,
EPLS, NLS, ILS, EPILS). Candidates with IP status from certain other
provider courses can also attend (e.g., European TraumaCourse, Pre
Hospital TraumaCare, Italy). There should be amaximumof 24 can-
didates with a ratio of at least one instructor to three candidates.
Instructors must be full and experienced ERC instructors who have
been through a formal process of training to become a GIC instruc-
tor. Groups should not exceed six candidates. The emphasis of the
course is on developing teaching and assessment skills, as well as
promoting team leadership and providing constructive feedback.
Core knowledge of the original provider course is assumed. The
course lasts for 2 days or 2.5 days.
Course format
The course format is largely interactive. An ERC medical educa-
tor plays a key role leading the educational process, the discussions
and feedback. This lecture is interspersedwith group activities. The
remainderof thecourse is conducted in small groupdiscussionsand
skill and simulation based hands on sessions. Mentor/mentee ses-
sions are included and there is a faculty meeting at the beginning
of the course and at the end of each day.
Course contentCandidates are given precourse reading material and are
expected to have read this before attending. The theoretical back-
ground of adult learning and effective teaching and assessment
is covered by the educator at the beginning of the course. Each
teaching and assessment skill is demonstrated by the faculty. The
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andidates then get the opportunity to practice: equipment famil-
arisation, lecturing, teaching skills by means of the four stage
pproach, intermediate ﬁdelity simulation sessions using simula-
ions, small group teaching sessions (open and closed discussions),
nd assessment.
For each teaching tool, a “mini-topic” is extracted from the orig-
nal provider course material. Throughout the course, emphasis is
laced on the role of the instructor and each candidate has the
pportunity to adopt the instructor role. The concept of construc-
ive feedback is a key element and is also emphasised. Finally, the
oles and qualities of an ERC Instructor are discussed.
ssessment
Eachcandidate is assessed formativelyby the faculty throughout
he course. Candidates’ performances and attitudes are discussed at
he daily facultymeetings and feedback given as required. Success-
ul candidates may proceed to the status of instructor candidate
IC). Candidates who successfully complete the course but who are
onsidered by the faculty to need speciﬁc support in their devel-
pment may be recommended to undertake their IC placements at
ominated centres.
he Educator Master Class
Medical Educators are an essential component of the GIC Fac-
lty. This two-day course is designed for those aspiring to become
edical educators for the ERC and is run when there is a need for
xpansion of Educator numbers. Suitable candidates are selected
y the ERC Educational Advisory Group (EAG) following a written
pplicationandgenerallymusthaveabackgroundandqualiﬁcation
n medical education or have demonstrated a special commitment
o educational practice over a number of years. They should have
xperience of a provider course and a GIC and should have studied
he background reading for the course.
The instructors for the course are experienced educators.
ourse format
The course consists mainly of closed discussion groups for the
hole course, led by one or two of the instructors, together with
reakout small group discussions and problem solving.
ourse content
The course covers the theoretical framework for medical edu-
ators, assessment and quality control, teaching methodologies,
ritical appraisal, the role of the mentor, multi-professional educa-
ion strategies andcontinueddevelopmentof themedical educator.
ssessment
Each candidate is assessed formatively by the faculty through-
ut the course. Successful candidates may proceed to the status
f educator candidate where they will be supervised and assessed
y an experienced educator and course director until it is decided
hether or not they will be suitable educators to work on their
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ntroduction
Sudden unexpected cardiac arrest is an event with often dev-
stating consequences to the individual victim, family and friends.
hile some resuscitation attempts are successful with good long-
erm outcome, the majority are not, despite signiﬁcant efforts and
ome improvements during the last decade.
Healthcare professionals are obliged to do what is necessary to
rotect and save lives. Society as awhole and especially emergency
edical services (EMS), hospitals and other healthcare institutions
eed to plan for, organise and provide an appropriate response
n case of sudden cardiac arrest. This often implies the use of
any resources and high costs, especially in the more afﬂuent
ountries. New technology and medical evidence and increasing
xpectations of the public have rendered ethical considerations
n important part of any end-of-life intervention or decision. This
ncludes achieving the best results for the individual patient, rela-
ives and for society as whole by appropriate allocation of available
esources.
Several considerations are required to ensure that decisions to
ttempt or withhold resuscitation attempts are appropriate, and
hat patients are treated with dignity. These decisions are complex
nd may be inﬂuenced by individual, international and local cul-
ural, legal, traditional, religious, social and economic factors.1–11
Sometimes the decisions can be made in advance, but often
hese difﬁcult decisions have to be made in a matter of seconds
r minutes at the time of the emergency and especially in the out-
f-hospital setting, based upon limited information. Therefore it
s important that healthcare providers understand the principles
nvolved before they are faced with a situation where a decision
o resuscitate or not must be made. For healthcare professionals
nd-of-life decisions and ethical considerations should be made in
dvance and in the context of the society. Although there is little
cience to guide end-of-life decision-making, the subject is impor-
∗ Corresponding author.
E-mail address: lippert@regionh.dk (F.K. Lippert).
300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Els
oi:10.1016/j.resuscitation.2010.08.013tant, which is why information for healthcare providers is included
in these resuscitation guidelines.
This section of the guidelines deals with some recurring ethical
aspects and end-of-life decisions.
• Key principles of ethics
• Sudden death in a global perspective
• Outcome and prognostication
• When to start and when to stop resuscitation attempts
• Advance directives and do-not-attempt resuscitation orders
• Organ procurement
• Family presence during resuscitation
• Research in resuscitation and informed consent
• Research and training on the recently dead
Principles of ethics
The key principles of ethics are referred to as autonomy, benef-
icence, non-maleﬁcence, justice and further more dignity and
honesty.12
Autonomy is the right of the patient to accept or refuse any treat-
ment. Autonomy relates to patients being able to make informed
decisions on their own behalf, rather than being subjected to
paternalistic decisions being made for them by healthcare pro-
fessionals. This principle has been introduced during the past
40 years, arising from legislature, primarily the Helsinki Decla-
ration of Human Rights and its subsequent modiﬁcations and
amendments.13 Autonomy requires that the patient is adequately
informed, competent, free from undue pressure and that there is
consistency in the patient’s preferences. The principle is considered
universal in medical practice; however, it may often be difﬁcult to
apply in an emergency, such as sudden cardiac arrest.
Non-maleﬁcence means doing no harm or, even more appro-
priate, no further harm. Resuscitation should not be attempted in
obviously futile cases.
Beneﬁcence implies that healthcare providersmust provide ben-
eﬁts in the best interest of the individual patient while balancing
beneﬁt and risks. Commonly, this will involve attempting resusci-
evier Ireland Ltd. All rights reserved.
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ation, but on occasion it will mean withholding cardiopulmonary
esuscitation (CPR).
Justice implies the concern and duty to distribute limited health
esources equally within a society, and the decision of who gets
hat treatment (fairness and equality). If resuscitation is provided,
t should be made available to all who will beneﬁt from it within
he frame of available resources.
Dignity and honesty are frequently added as essential elements
f ethics. Patients always have the right to be treated with dignity
nd information should be honest without suppressing important
acts. Transparency and disclosure of conﬂict of interests (COI) is
nother important part of the ethics of medical professionalism.
he importance of this is emphasized by the COI policy operated by
he International Liaison Committee on Resuscitation (ILCOR).14
udden death in a global perspective
In Europe, with 46 countries and with a population on the
uropean continent of 730 million, the incidence of sudden car-
iac arrest is estimated at between 0.4 and 1 per 1000 inhabitants
er year, thus involving between 350,000 and 700,000 people.15
pproximately, 275,000 persons have a cardiac arrest treated by
heEMS inEurope.16 Out-of-hospital cardiac arrest is the third lead-
ng cause of death in the USA.17 In Europe and USA ischaemic heart
isease is considered the main cause of sudden cardiac arrest.
Health challenges look different in a worldwide perspective.
n the World Health Organization (WHO) 2002 Annual Report,
wo extreme ﬁndings are found almost side by side: 170 million
hildren in poor countries were underweight, causing over three
illion deaths yearly, and on the other extreme at least 300 mil-
ion adults worldwide were overweight or clinically obese with
igh risk of sudden cardiac arrest.18 In parallel, the cause of sudden
eath differs widely across the world. Outside Europe and North
merica, cardiac arrest of non-cardiac aetiology, such as trauma,
rowning or newborn asphyxia, is more important than cardiac
etiology. More than 1.3 million people die yearly in road trafﬁc
ccidents.19 In 2008, there were 8.8 million deaths among children
ess than 5 years old, with considerable inequities between coun-
ries. Diarrhoea and pneumonia still kill almost 3 million children
ess than 5 years old annually, especially in low-income countries.
nd about one third of deaths among children less thanﬁve years of
ge occur in the ﬁrstmonth of life.More than 500,000womendie of
omplicationsduringpregnancyor childbirth, 99%of themindevel-
ping countries.20,21 Worldwide, it is estimated that approximately
50,000 people die from drowning each year, and the majority are
hildren.22
In summary, sudden death is a worldwide challenge. Aetiology
iffers and treatment and prevention have to be tailored to the
ocal problems and resources. The obligation and challenges to pro-
ect and save lives are evident both from the local and the global
erspective.
utcome from sudden cardiac arrest
Resuscitation efforts often focus on sudden and unexpected
ardiac arrest that should have been prevented. Included in the
ecision on whether to commence resuscitation is the likelihood
f success and, if initially successful, the quality of life that can
e expected following hospital discharge. Reliable and valid data
re therefore essential to guide healthcare providers. Resuscitation
ttempts are unsuccessful in 70–98% of cases and death ultimately
s inevitable.
Several studies have demonstrated that successful resuscitation
fter cardiac arrest produces a goodquality of life inmost survivors.
here is little evidence to suggest that resuscitation leads to a largen 81 (2010) 1445–1451
pool of survivorswith an unacceptable quality of life. Cardiac arrest
survivors may experience post-arrest problems including anxiety,
depression, post-traumatic stress, and difﬁculties with cognitive
function. Clinicians should be aware of these potential problems,
screen for them and, if found, treat them.23–38 Future interven-
tional resuscitation studies should include long-term follow up
evaluation.
Prognostication in cardiac arrest
In well-developed pre-hospital systems, about one third to one
half of patients may achieve Return of Spontaneous Circulation
(ROSC) with CPR, with a smaller proportion surviving to the hos-
pital critical care unit, and an even smaller proportion surviving to
hospital discharge with good neurological outcome. Prognostica-
tion is of the essence to guide clinicians, and it would be important
to be able to predict poor outcome with high speciﬁcity to reduce
unnecessary burden on the patient, family members and health
care providers, and reduce inappropriate use of resources. Unfor-
tunately, there are currently no valid tools for prognostication of
poor outcome in the emergency setting, including the ﬁrst few
hours after ROSC. In fact, prediction of ﬁnal neurological outcome
in patients remaining comatose after ROSC is difﬁcult during the
ﬁrst 3 days.39 The inclusion of therapeutic hypothermia has further
challenged the previously established prognostic criteria.40
Certain circumstances, for example hypothermia at the time of
cardiac arrest, will enhance the chances of recoverywithout neuro-
logical damage, and the normal prognostic criteria (such as asystole
persisting for more than 20min) are not applicable.41
When to start and when to stop resuscitation
attempts?
In all cases of sudden cardiac arrest the healthcare provider is
being challengedwith twomain questions:when to start andwhen
to stop resuscitation attempts? In the individual case, the decision
to start, continue or to terminate resuscitation attempts, is based
on the difﬁcult balance between the beneﬁts, risks and cost these
interventionswill place on patient, familymembers and healthcare
providers. In a broader perspective, cost to the society and health
care system is part of this. The standard of care remains the prompt
initiation of CPR. However, ethical principles such as beneﬁcence,
non-maleﬁcence, autonomy, and justice have to be applied in the
unique setting of emergency medicine. Physicians have to consider
the therapeutic efﬁcacy of CPR, the potential risks, and the patient’s
preferences.42,43
Resuscitation is inappropriate and should not be providedwhen
there is clear evidence that it will be futile or is against the
expressed wishes of the patient. Systems should be established to
communicate these prospective decisions and simple algorithms
should be developed to assist rescuers in limiting the burden of
futile and unnecessary costly treatments. One prospective study
demonstrated that a basic life support termination of resuscitation
rule (no shockable rhythm, unwitnessed by EMS and no return of
spontaneous circulation) was predictive of death when applied by
deﬁbrillation-only emergency medical technicians.44 Subsequent
studies showed external generalisability of this rule, but it has
also been challenged.45–47 Prospectively validated termination of
resuscitation rules are recommended to guide termination of pre-
hospital CPR in adults. Other rules for various provider levels,
including in-hospital providers,maybehelpful to reducevariability
in decision-making; but all rules should be validated prospectively
before implementation. The implementation of a termination rule
will carry a self-fulﬁlling prophecy, and should be challenged peri-
odically as new treatments evolve.
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ho should decide not to attempt resuscitation?
Resuscitation protocols or standard operating procedures
houlddeﬁnewhohas theobligation and responsibility tomake the
ifﬁcult decision not to attempt resuscitation or to abandon further
ttempts. This goes for the pre-hospital and in-hospital setting and
ight vary according to legislation, culture or local tradition.
In hospital, the decision is usually made, after appropriate con-
ultations, by the senior physician in charge of the patient or the
eader of the resuscitation team when called. Medical emergency
eams (METs), acting in response to concern about a patient’s con-
ition from ward staff, can initiate DNAR decisions.48–50 In the
re-hospital setting, in the absence of doctors, the decision can be
ade according to standard protocols or after consultation with a
hysician.
Legislation on who can make decisions about death varies
ithin countries. Many out-of-hospital cardiac arrest cases are
ttended by emergency medical technicians (EMTs) or paramedics,
ho face similar dilemmas about when to determine if resus-
itation is futile and when it should be abandoned. In general,
esuscitation is started inout-of-hospital cardiac arrestunless there
s a valid advanced directive to the contrary or it is clear that
esuscitation would be futile in cases of a mortal injury, such as
ecapitation, rigor mortis, dependent lividity and fetal maceration.
n such cases, the non-physician is making a diagnosis of death but
s not certifying death, which, in most countries, can be done only
y a physician.
hat constitutes futility?
Futility exists if resuscitation will be of no beneﬁt in terms
f prolonging life of acceptable quality. It is problematic that,
lthough predictors for non-survival after attempted resuscitation
ave been published, none have been tested on an indepen-
ent patient sample with sufﬁcient predictive value, apart from
nd-stage multi-organ failure with no reversible cause.51–56 Fur-
hermore, studies on resuscitation are particularly dependent on
ystem factors such as time to start of CPR, time to deﬁbrillation,
tc. These intervals may be prolonged in any study cohort but are
ften not applicable to an individual case. Inevitably, judgements
ill have to be made, and there will be grey areas where subjec-
ive opinions are required in patients with heart failure and severe
espiratory compromise, asphyxia, major trauma, head injury and
eurological disease. The age of the patient may inﬂuence the deci-
ion but age itself is only a relativelyweak independent predictor of
utcome.56–58 However, high age is frequently associated with co-
orbidity, which does have an inﬂuence on prognosis. At the other
nd of the scale,most physicianswill err on the side of intervention
n children for emotional reasons, even though the overall progno-
is in children is oftenworse than in adults. It is therefore important
hat clinicians understand the factors that inﬂuence resuscitation
uccess.
hen to abandon further resuscitation attempts
The vast majority of resuscitation attempts do not succeed and
herefore have to be abandoned. Several factors will inﬂuence the
ecision to stop the resuscitative effort. These will include the
edical history and anticipated prognosis from factors such as the
eriod between cardiac arrest and start of CPR by bystanders and
y healthcare professionals, the initial ECG rhythm, the interval to
eﬁbrillation and the period of advanced life support (ALS) with
ontinuing asystole, no reversible causes and no ROSC.59
In many cases, particularly in out-of-hospital cardiac arrest, the
nderlying cause of arrest may be unknown or merely surmised,
nd the decision is made to start resuscitation while further infor-n 81 (2010) 1445–1451 1447
mation is gathered. If it becomes clear that the underlying cause
renders the situation tobe futile, then resuscitation shouldbe aban-
doned if the patient remains in asystole with all ALS measures in
place. Additional information such as an advance directive may
become available and may render discontinuation of the resuscita-
tion attempt ethically correct.
In general, resuscitation should be continued as long as VF
persists. It is generally accepted that ongoing asystole for more
than 20min in the absence of a reversible cause, and with ongo-
ing ALS, constitutes grounds for abandoning further resuscitation
attempts.60 There are, of course, reports of exceptional cases
that do not support the general rule, and each case must be
assessed individually. Ultimately, the decision is based on the clin-
ical judgement that the patient’s arrest is unresponsive to ALS. In
out-of-hospital cardiac arrest of cardiac origin, if recovery is going
to occur, ROSC usually takes place on site. Patients with primary
cardiac arrest, who require ongoing CPR without any return of a
pulse during transport to hospital, rarely survive neurologically
intact.61,62
Many will persist with the resuscitation attempt for longer if
the patient is a child. This decision is not generally justiﬁed on sci-
entiﬁc grounds, though new data are encouraging.63 Nevertheless,
the decision to persist in the distressing circumstances of the death
of a child is understandable, and the potential enhanced recruit-
ment of cerebral cells in children after an ischaemic insult is an
as yet unknown factor. If faced with a newly born baby with no
detectable heart rate, which remains undetectable for 10min, it is
appropriate to then consider stopping resuscitation.64
Advance directives
Advance directives have been introduced in many coun-
tries, emphasizing the importance of patient autonomy. Advance
directives are a method of communicating the patient’s wishes
concerning future care, particularly towards the end-of-life, and
must be expressed while the patient is mentally competent and
not under duress. Advance directives are likely to specify limita-
tions concerning terminal care, including the withholding of CPR.
This may help healthcare attendants in assessing the patient’s
wishes should the patient later become mentally incompetent.
However, challenges can arise. The relative may misinterpret
the wishes of the patient, or may have a vested interest in the
death (or continued existence) of the patient. On the other hand,
healthcare providers tend to underestimate sick patients’ desire to
live.
Written directions by the patient, legally administered living
wills or powers of attorney may eliminate some of these prob-
lems but are not without limitations. The patient should describe
as precisely as possible the situation envisaged when life support
should be withheld or discontinued. This may be aided by a medi-
cal adviser. For instance, most people would prefer not to undergo
CPR in the presence of end-stage multi-organ failure with no obvi-
ous reversible cause, but the same persons would welcome the
attempt at resuscitation should ventricular ﬁbrillation (VF) occur in
associationwith a remediable primary cardiac cause. Patients often
change their minds with changes in circumstances, and therefore
the advanced directive should be as recent as possible and take into
account any change of circumstances.
In sudden out-of-hospital cardiac arrest, the attendants usually
do not know the patient’s situation and wishes, and an advance
directive is often not readily available. In these circumstances,
resuscitation should begin immediately and questions addressed
later. There is no ethical difference in stopping the resuscita-
tion attempt that has started if the healthcare providers are later
presented with an advance directive limiting care. There is con-
siderable international variation in the medical attitude towards
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rittenadvancedirectives.1 In somecountries, thewrittenadvance
irective is considered to be legally binding; in others not.
NAR orders
A do-not-attempt resuscitation (DNAR) order (also described
ore recently as a DNACPR decision) is a binding legal docu-
ent that states that resuscitation should not be attempted in the
vent of cardiac or respiratory arrest; meaning that CPR should
ot be performed. Other treatment should be continued, partic-
larly pain relief and sedation, as required and indicated, if they
re considered to be contributing to the quality of life. If not,
rders not to continue or initiate any such treatments should be
peciﬁed independently of DNAR orders. For many years, DNAR
rders in many countries were written by single doctors, often
ithout consulting the patient, relatives or other health person-
el, but there are now clear procedural requirements in many
ountries.65
Although the ultimate responsibility and decision for DNAR
estswith the seniordoctor in chargeof thepatient, it iswise for this
ndividual to consult others before making the decision. Following
he principle of patient autonomy it is wise, if possible, to ascer-
ain the patient’s wishes about a resuscitation attempt. This must
e done in advance, when the patient is able to make an informed
hoice. Opinions vary as to whether such discussions should occur
outinely for every hospital admission or only if the diagnosis of
potentially life-threatening condition is made. In presenting the
acts to the patient, the doctor must be as certain as possible of the
iagnosis and prognosis and may seek a second medical opinion
n this matter. It is vital that the doctor should not allow personal
ife values to distort the discussion—in matters of acceptability of
certain quality of life, the patient’s opinion should prevail. It is
onsidered essential for the doctor to have discussions with close
elatives if at all possible. Whereas they may inﬂuence the doctor’s
ecision, it should be made clear to them that the ultimate respon-
ibility and decision will be that of the doctor. It is neither fair nor
easonable to place the burden of decision on the relative.
According to the principle of autonomy, patients have the right
o refuse treatment; however, they do not have an automatic right
o demand a speciﬁc treatment—they cannot insist that resuscita-
ion must be attempted in any circumstance. A doctor is required
nly to provide treatment that is likely to beneﬁt the patient, and
s not required to provide treatment that would be futile. However,
t would be wise to seek a second opinion in making this decision,
or fear that the doctor’s own personal values, or the question of
vailable resources, might inﬂuence his or her opinion.66
In adult cardiac arrest various studieshaveaddressed the impact
f advance directives and DNAR orders in directing appropri-
te resuscitation efforts. Most of these studies are old and often
ontradictory.67–76 Standardised orders for limiting life-sustaining
reatments decrease the incidence of futile resuscitation attempts
nd should ensure that adult patient wishes are honoured. Instruc-
ions should be speciﬁc, detailed, and transferable across health
are settings, and easily understood. Processes, protocols, and sys-
ems should be developed that ﬁt within local cultural norms
nd legal limitations to allow providers to honour patient wishes
egarding resuscitation efforts.
rgan procurementThe issue of initiating life-prolonging treatment or continu-
ng otherwise futile resuscitation attempts with the sole purpose
f harvesting organs is debatable.77,78 There is variation between
ountries andcultures about theethics of this process; at presentno
onsensus exists. If considering prolonging CPR and other resusci-n 81 (2010) 1445–1451
tative measures to enable organ donation to take place mechanical
chest compressions may be valuable in these circumstances.79,80
Family presence during resuscitation
The concept of a familymember being present during the resus-
citation process was introduced in the 1980s and has become
accepted practice in many countries.81–86 Many relatives would
like to be present during resuscitation attempts and, of those who
have had this experience, over 90% would wish to do so again. Most
parents would wish to be with their child at this time.82
Relatives have considered several beneﬁts from being permit-
ted to be present during a resuscitation attempt, including coming
to terms with the reality of death. However, this is a choice entirely
to be made by the relatives. Several measures are required to
ensure that the experience of the relative is the best under the cir-
cumstances. This includes allocating personnel to take care of the
relatives.87,88
In the event of an out-of-hospital arrest, the relatives may
alreadybepresent, andpossiblyperformingbasic life support (BLS).
They should be offered the same choices and appreciation of their
effort as bystander offering BLS.With increasing experience of fam-
ily presence during resuscitation attempts, it is clear that problems
rarely arise. Fifteen years ago, most staff would not have counte-
nanced the presence of relatives during resuscitation, but there is
an increasingly open attitude and appreciation of the autonomy of
both patient and relatives.1 Cultural and social variations still exist,
and must be understood and appreciated with sensitivity.
Research in resuscitation and informed consent
There is an essential need to improve the quality of resuscita-
tion and thereby the long-term outcome. To achieve this, research
and randomised clinical trials are crucial, not only to introduce
new and better interventions, but also to abandon the use of inef-
ﬁcient and costly procedures and medications, whether old or
new. As the ILCOR 2010 consensus on CPR and ECC Science clearly
reveals many current practises are based upon tradition and not on
science.89,90
There are important ethical issues relating to undertaking ran-
domised clinical trials for patients in cardiac arrest who cannot
give informed consent to participate in research studies. Progress
in improving the dismal rates of successful resuscitation will only
come through the advancement of science through clinical stud-
ies. The utilitarian concept in ethics looks to the greatest good
for the greatest number of people. This must be balanced with
respect for patient autonomy, according to which patients should
not be enrolled in research studies without their informed con-
sent. Over the past decade, legal directives have been introduced
into the USA and the European Union91,92 that place signiﬁ-
cant barriers to research on patients during resuscitation without
informed consent from the patient or immediate relative.93 There
are data showing that such regulations deter research progress in
resuscitation.94 It can be argued that these directives may in them-
selves conﬂict with the fundamental human right to good medical
treatment as set down in theHelsinki Declaration.13 TheUS author-
ities have, to a very limited extent, sought to introduce methods
of exemption,95 but these are still associated with problems and
almost insurmountable difﬁculties.94,96,97Research and training on the recently dead
Research on the recently dead encounters similar restrictions
unless previous permission is granted as part of an advance direc-
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ive by the patient, or permission can be given immediately by the
elative. The management of resuscitation can be taught using sce-
arioswithmanikins and simulators or animalmodels, but training
n certain skills required during resuscitation is difﬁcult. Therefore
he question arises as to whether it is ethically and morally appro-
riate to undertake training and practice on the living or the dead.
here is a wide diversity of opinion on this matter.98,99 Many, par-
icularly those in the Islamic nations, ﬁnd the concept of any skills
raining and practice on the recently dead completely unaccept-
ble because of an innate respect for the deceased. Others will
ccept the practice of non-invasive procedures that do not leave
mark; and some accept that any procedure may be learned on
he dead body with the justiﬁcation that the learning of skills is
aramount for the well being of future patients. One option is to
equest informed consent for the procedure from the relative of
he deceased. It is advised that healthcare professionals learn local
ndhospital policies regarding this issue and follow the established
olicy.
ummary
Sudden unexpected cardiac arrest is a global challenge. Some
eaths are preventable and some arrests can be treated success-
ully and result in a very good long-term outcome. However, most
esuscitation attempts are futile and death is inevitable. End-of-life
ecision is an important part of resuscitation.
Scientiﬁc evidence does not provide much guidance for end-
f-life-decisions. Nevertheless, because of the importance of the
ubject, the ERC has produced this guidance on this important
nd difﬁcult topic for healthcare providers. End-of-life decisions
re complex and may be inﬂuenced by individual, international
nd local cultural, legal, traditional, religious, social and economic
actors. Solutions should be tailored accordingly. Sometimes the
ecisions canbemade in advance, but often thesedifﬁcult decisions
ave to be made in an emergency and based upon limited informa-
ion. Therefore it is important that healthcare providers understand
he principles involved, the challenges and the need for research
n resuscitation. End-of-life decisions and ethical considerations
hould be reﬂected in advance through education, discussions and
ebrieﬁngs for health care professionals to further strengthen indi-
idual ethical competence.
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